Clustering O 0 2.533422730266466e-06
of O 0 2.2345862760175805e-07
missense O 0 5.5177524700411595e-06
mutations O 0 3.269728043875375e-09
in O 0 1.1750865835935542e-09
the O 0 1.4481945243005612e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 4.9488489821669646e-06
in O 0 5.341639131017928e-09
a O 0 5.009663794908192e-10
sporadic B-Disease 0 1.9843055270030163e-06
T I-Disease 0 8.383395652344916e-06
- I-Disease 0 5.888859504921129e-06
cell I-Disease 0 2.05389460461447e-05
leukaemia I-Disease 1 0.9353772401809692
. O 0 8.828167210594984e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.5731423497200012
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.4214520185906743e-11
is O 0 5.11419520014128e-13
a O 0 1.038691268412384e-12
recessive B-Disease 0 5.017677384699937e-10
multi I-Disease 0 0.0003494207630865276
- I-Disease 0 0.006804227828979492
system I-Disease 0 4.608900781022385e-05
disorder I-Disease 0 2.8452714104787447e-05
caused O 0 6.612996261701198e-10
by O 0 1.1154764611998047e-11
mutations O 0 1.5928437388512684e-11
in O 0 4.104970703633359e-12
the O 0 4.216433799331121e-11
ATM O 0 4.774527724293876e-07
gene O 0 3.450780217129079e-10
at O 0 9.475646933765347e-09
11q22 O 0 2.156257687602192e-05
- O 0 7.297826869034907e-06
q23 O 0 8.423587132710963e-05
( O 0 5.196863384071548e-09
ref O 0 3.566005659649818e-07
. O 0 6.22154883167525e-10
3 O 0 1.0401559613626432e-09
) O 0 3.4403441206976026e-10
. O 0 1.3297158041325474e-08

The O 0 3.6210704479344713e-07
risk O 0 1.2271990499357344e-06
of O 0 4.935746460432711e-07
cancer B-Disease 0 0.02291681617498398
, O 0 6.240793215539497e-09
especially O 0 1.8988104955042218e-07
lymphoid B-Disease 1 0.9999936819076538
neoplasias I-Disease 1 0.9999997615814209
, O 0 2.648694596985024e-09
is O 0 1.2739828636476602e-10
substantially O 0 8.184050770410067e-09
elevated O 0 5.784927648022631e-09
in O 0 3.8887737474624373e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.695676569914212e-07
and O 0 3.471449794290038e-10
has O 0 7.770307834664703e-12
long O 0 1.3165528563174878e-11
been O 0 1.3330200658578928e-11
associated O 0 2.8195528134489223e-09
with O 0 3.5287091026958706e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 3.313624256406911e-05

By O 0 1.0860693677727795e-08
analysing O 0 1.6218497194131487e-06
tumour B-Disease 1 0.9999997615814209
DNA O 0 1.5463673435078817e-06
from O 0 5.354458543216367e-10
patients O 0 1.357752382746824e-10
with O 0 2.7211752816336254e-12
sporadic B-Disease 0 2.313426819000597e-07
T I-Disease 0 3.127153718196496e-07
- I-Disease 0 5.295242999636685e-07
cell I-Disease 0 2.676667645573616e-05
prolymphocytic I-Disease 1 0.9871183633804321
leukaemia I-Disease 1 0.9999949932098389
( O 0 1.8390028388992619e-09
T B-Disease 0 5.354377208277583e-07
- I-Disease 0 1.507996557847946e-06
PLL I-Disease 0 6.48842251393944e-05
) O 0 6.678755465339137e-11
, O 0 1.3252878829084214e-11
a O 0 3.1686788609652794e-11
rare O 0 9.347312923679851e-10
clonal B-Disease 0 2.717654581374518e-07
malignancy I-Disease 0 1.6996287968140678e-06
with O 0 5.5391111836167184e-11
similarities O 0 8.893922820440991e-10
to O 0 2.25259505493014e-10
a O 0 2.2002510924323815e-09
mature B-Disease 0 6.558556378877256e-06
T I-Disease 0 1.480981723034347e-06
- I-Disease 0 5.62788784463919e-07
cell I-Disease 0 2.3067213987815194e-06
leukaemia I-Disease 0 0.4044570028781891
seen O 0 8.591122480083868e-09
in O 0 3.8679057179358267e-10
A B-Disease 1 0.9999998807907104
- I-Disease 0 0.098249651491642
T I-Disease 1 0.9986132383346558
, O 0 7.96558652371715e-11
we O 0 1.2112632945260327e-11
demonstrate O 0 7.234442211956349e-11
a O 0 2.3065219439261098e-12
high O 0 2.6934577831982942e-11
frequency O 0 3.0548377716321795e-10
of O 0 6.72404409929328e-10
ATM O 0 3.4651800433493918e-06
mutations O 0 1.8959221748104937e-08
in O 0 3.650041335845344e-08
T B-Disease 0 5.4804277169751e-05
- I-Disease 0 0.0003717615909408778
PLL I-Disease 0 0.005971130449324846
. O 0 1.27126270399458e-06

In O 0 2.7600556506968132e-08
marked O 0 1.2578143859798274e-08
contrast O 0 1.4554204508243629e-09
to O 0 1.8117655986582548e-10
the O 0 4.732743086321989e-10
ATM O 0 3.528029083099682e-06
mutation O 0 3.115096625094793e-09
pattern O 0 2.204831339724933e-08
in O 0 7.679353153378088e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 8.501658821380431e-10
the O 0 6.471345681546836e-11
most O 0 2.5552448611881884e-12
frequent O 0 5.7384114821035226e-12
nucleotide O 0 4.3420983475428443e-10
changes O 0 1.1894502049969446e-10
in O 0 4.400919906277778e-11
this O 0 4.274282872085422e-10
leukaemia B-Disease 0 1.0687178473745007e-05
were O 0 1.3312896385286876e-07
missense O 0 1.973617690964602e-05
mutations O 0 2.915234347256046e-07
. O 0 2.8563303544615337e-07

These O 0 1.0924516402610607e-08
clustered O 0 3.8080308684129704e-08
in O 0 8.863385025925652e-11
the O 0 6.809208752400764e-11
region O 0 1.9819161867218327e-09
corresponding O 0 3.9367549220514775e-09
to O 0 4.020666577453369e-10
the O 0 2.536132637231958e-09
kinase O 0 1.590393239325749e-08
domain O 0 1.084841549925386e-08
, O 0 3.9779100152737e-11
which O 0 1.895741159538278e-12
is O 0 1.5732781397104212e-11
highly O 0 2.6393547347680624e-09
conserved O 0 6.3061014188292575e-09
in O 0 1.8602299700631875e-09
ATM O 0 0.004922347143292427
- O 0 4.734680203455355e-07
related O 0 2.023533909323305e-07
proteins O 0 3.9792187322973405e-09
in O 0 2.111948838035005e-09
mouse O 0 1.563414819827358e-08
, O 0 2.814017907581956e-10
yeast O 0 4.00751716256309e-08
and O 0 2.5470789921655523e-09
Drosophila O 0 4.83896030800679e-07
. O 0 5.902067101715147e-08

The O 0 3.143856730503103e-08
resulting O 0 1.3433316325972555e-07
amino O 0 5.714122153221979e-08
- O 0 1.1326143578571646e-08
acid O 0 1.11318210205269e-09
substitutions O 0 1.4125454139701787e-09
are O 0 4.155365981861614e-11
predicted O 0 1.6606657160522786e-09
to O 0 1.5431371458429766e-10
interfere O 0 5.454075946431658e-08
with O 0 9.85527104369055e-10
ATP O 0 4.5576329284813255e-05
binding O 0 2.644722840727809e-08
or O 0 4.253521979080688e-09
substrate O 0 9.972724512863351e-08
recognition O 0 2.934259555331664e-07
. O 0 6.932798441994237e-07

Two O 0 2.4034360279756584e-08
of O 0 2.0034786274436556e-08
seventeen O 0 6.006158059790323e-08
mutated O 0 1.7871785162881793e-09
T B-Disease 0 2.603357884822799e-08
- I-Disease 0 2.2615344263954285e-08
PLL I-Disease 0 1.8736930087470682e-06
samples O 0 2.1133068628387264e-09
had O 0 4.128166558592383e-11
a O 0 7.481730512903795e-12
previously O 0 2.377599783720541e-10
reported O 0 8.304718579488224e-10
A B-Disease 1 0.9999984502792358
- I-Disease 1 0.6386119723320007
T I-Disease 1 0.999990701675415
allele O 0 4.749133495351998e-06
. O 0 8.586258104514854e-07

In O 0 4.3621742662480756e-08
contrast O 0 7.857161143931535e-09
, O 0 1.0350573870221424e-10
no O 0 7.360011211599016e-11
mutations O 0 1.227212081955642e-10
were O 0 3.5190153568898097e-10
detected O 0 2.7772431021588773e-09
in O 0 2.0115778834317588e-11
the O 0 1.4548284799076328e-10
p53 O 0 1.0174746600810636e-09
gene O 0 2.267834392499779e-10
, O 0 1.8350241465237005e-11
suggesting O 0 2.7045321537855216e-10
that O 0 3.509239340088177e-12
this O 0 2.118863556832551e-10
tumour B-Disease 1 1.0
suppressor O 0 1.0635676517267711e-06
is O 0 5.484696030677583e-11
not O 0 1.8836507353903187e-10
frequently O 0 1.2684771011350904e-09
altered O 0 5.251246992798997e-09
in O 0 5.923341817037908e-10
this O 0 1.8718397942762977e-09
leukaemia B-Disease 0 0.0005030317115597427
. O 0 7.218862947411253e-07

Occasional O 0 1.209205947816372e-06
missense O 0 4.351489678811049e-06
mutations O 0 5.244020329087107e-09
in O 0 2.155543077364541e-09
ATM O 0 7.969139551278204e-05
were O 0 4.508162376737346e-08
also O 0 1.0249458226585517e-10
found O 0 1.0449119347555325e-10
in O 0 1.604284483036622e-10
tumour B-Disease 1 0.9999997615814209
DNA O 0 1.5673582538511255e-06
from O 0 2.708322677236197e-09
patients O 0 8.557167197054127e-10
with O 0 2.0784905047088742e-11
B B-Disease 0 9.084271113124487e-08
- I-Disease 0 5.1398977518601896e-08
cell I-Disease 0 3.9849214772402775e-06
non I-Disease 1 0.9978532195091248
- I-Disease 1 0.9999402761459351
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 0.0001529861183371395
( O 0 2.070179028201835e-10
B B-Disease 0 2.2677335209664307e-07
- I-Disease 0 1.6380010237071474e-08
NHL I-Disease 0 6.503229599275073e-08
) O 0 2.9075808601064512e-12
and O 0 6.552846806839874e-12
a O 0 5.59249833942399e-11
B B-Disease 0 4.9261814183410024e-08
- I-Disease 0 4.547100829199735e-08
NHL I-Disease 0 3.791835752053885e-07
cell O 0 1.309188746745349e-06
line O 0 2.6635555627763097e-07
. O 0 1.307261925376224e-07

The O 0 2.3200099619202774e-08
evidence O 0 2.454572900489893e-08
of O 0 3.3469291782495247e-09
a O 0 2.166861412522536e-10
significant O 0 1.2997747322884834e-09
proportion O 0 2.3071500265814393e-09
of O 0 7.949304547949509e-10
loss O 0 5.957687676527712e-09
- O 0 1.1105021791024683e-08
of O 0 1.2029839524529962e-07
- O 0 4.2366345098798774e-08
function O 0 3.1008633438744937e-09
mutations O 0 1.0909305403483671e-10
and O 0 9.711517614391374e-13
a O 0 1.6201437977661493e-12
complete O 0 2.417737399174058e-10
absence O 0 9.462313155239599e-10
of O 0 1.0277177719952846e-10
the O 0 1.1751548519012278e-11
normal O 0 2.527506814953284e-10
copy O 0 3.424814598584902e-10
of O 0 1.131842841672892e-09
ATM O 0 4.481516668874974e-07
in O 0 2.615998251354057e-10
the O 0 2.926690279014821e-10
majority O 0 3.578088103584065e-10
of O 0 6.896698767633325e-09
mutated O 0 4.6105571982479887e-07
tumours B-Disease 1 0.9999998807907104
establishes O 0 2.093860729246444e-08
somatic O 0 7.676720059635045e-08
inactivation O 0 1.421167468151907e-07
of O 0 6.70058053486855e-09
this O 0 1.2835413287781705e-10
gene O 0 1.1806484956355945e-10
in O 0 4.857169527694438e-11
the O 0 3.3723479564429226e-10
pathogenesis O 0 8.552326562494272e-07
of O 0 1.0940535588588318e-07
sporadic B-Disease 0 0.00012381604756228626
T I-Disease 0 6.182934157550335e-05
- I-Disease 0 0.00012700390652753413
PLL I-Disease 0 0.0006402534781955183
and O 0 3.96353727616372e-10
suggests O 0 1.6819363957143452e-10
that O 0 1.6058563983775698e-12
ATM O 0 1.774540976384742e-07
acts O 0 4.499629557841445e-09
as O 0 6.189251777755089e-09
a O 0 1.616329683429285e-07
tumour B-Disease 1 1.0
suppressor O 0 0.00029116871883161366
. O 0 7.498609306821891e-07

As O 0 8.976702936536185e-09
constitutional O 0 1.3603173698584214e-08
DNA O 0 2.543347648042982e-07
was O 0 5.494585675336339e-09
not O 0 1.9063771394822737e-11
available O 0 4.94653262794742e-10
, O 0 1.5416301915593955e-11
a O 0 3.0308394682876383e-10
putative O 0 3.358115350238222e-07
hereditary O 1 0.999874472618103
predisposition O 0 0.00017264907364733517
to O 0 4.941321458318271e-05
T B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999983310699463
PLL I-Disease 1 0.9999881982803345
will O 0 1.1860751270020842e-09
require O 0 1.274982563970184e-09
further O 0 5.050418971919157e-10
investigation O 0 5.84481840704143e-09
. O 0 1.512108105394816e-09
. O 0 1.902754576121879e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.56724127009511e-05
kinase O 0 2.8366322624151508e-08
is O 0 1.516259687250887e-11
involved O 0 2.331746185024741e-10
in O 0 1.8043708888138e-11
the O 0 3.207375684488589e-11
modulation O 0 2.977043500607124e-08
of O 0 5.922949242176401e-09
the O 0 5.037770200999603e-09
Ca2 O 0 1.5565363753466954e-07
+ O 0 1.865199976691656e-07
homeostasis O 0 1.8520810272093513e-06
in O 0 8.220111702428312e-09
skeletal O 0 0.0007969413418322802
muscle O 0 1.6361670986952959e-06
cells O 0 2.7974849217571318e-05
. O 0 3.672538923638058e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.95121830701828
DM B-Disease 1 1.0
) O 0 7.937702939386782e-09
, O 0 6.840424754406271e-11
the O 0 8.301752341122182e-11
most O 0 8.421331687546996e-11
prevalent O 0 0.029546217992901802
muscular B-Disease 1 0.9999954700469971
disorder I-Disease 1 0.9996988773345947
in O 0 3.161982320420975e-08
adults O 0 4.730572982225567e-07
, O 0 2.7906480945527612e-11
is O 0 1.2202232280156267e-11
caused O 0 1.2841272489794164e-09
by O 0 2.1892865298411834e-10
( O 0 2.0000937017705667e-10
CTG O 0 2.2850684899822227e-07
) O 0 4.227488151209435e-12
n O 0 1.1046241005230328e-10
- O 0 1.7958157183528556e-10
repeat O 0 3.2797622256941494e-11
expansion O 0 2.4395168177204773e-11
in O 0 9.810937869406122e-13
a O 0 8.828501081234452e-13
gene O 0 2.618077196009372e-12
encoding O 0 1.1087957219046984e-09
a O 0 2.5293260819125862e-09
protein O 0 5.2014179630077706e-08
kinase O 0 3.630627887218907e-08
( O 0 2.5723997154614153e-08
DM B-Disease 1 1.0
protein O 0 4.985248551747645e-07
kinase O 0 1.495553014763118e-08
; O 0 2.999714365792272e-10
DMPK O 0 0.008667212910950184
) O 0 3.3090311740702205e-11
and O 0 1.1480506649508282e-11
involves O 0 5.005776348987467e-10
changes O 0 2.6827998156342403e-10
in O 0 7.470473128989852e-10
cytoarchitecture O 0 2.3206512196338736e-06
and O 0 2.232681239888734e-08
ion O 0 4.871137207373977e-05
homeostasis O 0 0.0017665884224697948
. O 0 5.9030289776274e-06

To O 0 4.51289423608614e-08
obtain O 0 3.388994400665979e-07
clues O 0 3.167152158312092e-07
to O 0 2.643283092407245e-10
the O 0 4.291993982441511e-10
normal O 0 2.6485647453000638e-08
biological O 0 3.6596876640260234e-09
role O 0 3.1539815203984745e-09
of O 0 1.204283250899607e-07
DMPK O 1 0.9999992847442627
in O 0 4.990842583652011e-08
cellular O 0 8.897848147171317e-07
ion O 0 5.3913657893645e-07
homeostasis O 0 1.930510052261525e-06
, O 0 2.2296833823709505e-10
we O 0 6.830919857536699e-11
have O 0 2.517564065204758e-12
compared O 0 1.4416882965218036e-10
the O 0 5.323985696747968e-11
resting O 0 4.203416281711725e-08
[ O 0 2.6282978016212155e-09
Ca2 O 0 2.6407143138840183e-09
+ O 0 1.4907960421695066e-09
] O 0 2.1548278716920777e-09
i O 0 7.800221579756794e-10
, O 0 4.3484174594432545e-12
the O 0 1.0240991214771622e-11
amplitude O 0 9.503734466065339e-10
and O 0 6.42319045174311e-11
shape O 0 3.7495787807984016e-08
of O 0 1.3208867244429712e-07
depolarization O 0 2.388949496889836e-06
- O 0 1.0270132406731136e-06
induced O 0 1.5260140173722903e-07
Ca2 O 0 2.3990896380610138e-08
+ O 0 9.666316636014471e-09
transients O 0 2.33210410982565e-08
, O 0 3.5239350500149147e-12
and O 0 1.9680693706669583e-12
the O 0 1.1713438378968544e-11
content O 0 2.903410567522968e-10
of O 0 4.286055121927035e-10
ATP O 0 1.1061921867394631e-07
- O 0 2.3173519991814828e-08
driven O 0 2.7575721261996478e-08
ion O 0 2.4766617201521512e-08
pumps O 0 8.910601145828423e-09
in O 0 1.7833511334330865e-09
cultured O 0 6.706159638270037e-06
skeletal O 0 0.00019722130673471838
muscle O 0 3.718058394497348e-08
cells O 0 1.3309239932368655e-07
of O 0 1.351364886659212e-07
wild O 0 5.744377418182012e-09
- O 0 2.1853199250188027e-09
type O 0 1.6766075194851737e-09
and O 0 2.854263936313828e-09
DMPK O 0 0.2147831916809082
[ O 0 1.9243324800299888e-07
- O 0 1.2663049631100876e-07
/ O 0 9.713226489793669e-08
- O 0 8.778551574550875e-08
] O 0 4.7138563274984335e-08
knockout O 0 5.076396973890951e-06
mice O 0 3.510773751713714e-07
. O 0 3.969093853584127e-08

In O 0 8.110968110486283e-07
vitro O 0 2.991678002217668e-06
- O 0 1.2753719147440279e-06
differentiated O 0 1.6196919432331924e-06
DMPK O 0 0.006181086879223585
[ O 0 1.4719769581006403e-07
- O 0 1.356757621806537e-07
/ O 0 6.872487290365825e-08
- O 0 1.1137650801629206e-07
] O 0 2.3047761033012648e-08
myotubes O 0 1.1431038160480966e-07
exhibit O 0 6.876607616668196e-11
a O 0 6.950080788659108e-11
higher O 0 1.0266705707806523e-08
resting O 0 1.0560594887465413e-07
[ O 0 1.1317527359722135e-08
Ca2 O 0 9.756393914983619e-09
+ O 0 3.9641667726186824e-09
] O 0 4.206878845280926e-09
i O 0 9.310356929859154e-10
than O 0 1.384045048707927e-11
do O 0 2.8415068908937968e-11
wild O 0 2.325860615215447e-10
- O 0 3.3155841960841315e-10
type O 0 1.8632340115232182e-09
myotubes O 0 1.7652721453487175e-06
because O 0 2.2377952269003742e-10
of O 0 1.5320552604336513e-09
an O 0 5.971877072713516e-12
altered O 0 2.372245178072774e-10
open O 0 1.6684720272053255e-10
probability O 0 8.382218252833695e-10
of O 0 1.177963393494963e-09
voltage O 0 7.406970592427342e-09
- O 0 6.690338505421778e-09
dependent O 0 1.0831586294557383e-08
l O 0 7.22559345689433e-10
- O 0 4.560787747465156e-09
type O 0 2.589282566134443e-09
Ca2 O 0 3.813692828202875e-08
+ O 0 1.012096184638267e-08
and O 0 4.366725647741987e-09
Na O 0 1.2449493169697234e-06
+ O 0 5.336590902516036e-08
channels O 0 1.7937590257588454e-07
. O 0 3.6583074347618094e-08

The O 0 3.0002269113538205e-07
mutant O 0 5.443578174890717e-07
myotubes O 0 4.089906724402681e-06
exhibit O 0 1.8465844409121246e-09
smaller O 0 1.8578071026009724e-10
and O 0 7.618247005458656e-11
slower O 0 3.972289874809576e-08
Ca2 O 0 2.473626281584984e-08
+ O 0 1.813792671612191e-09
responses O 0 3.849386781551445e-11
upon O 0 2.0498612529618043e-10
triggering O 0 5.360579757862638e-10
by O 0 2.9493168324234986e-11
acetylcholine O 0 1.478738376192723e-08
or O 0 1.5969430222639858e-09
high O 0 3.3694067980150066e-08
external O 0 2.9120878934918437e-06
K O 0 3.515890739436145e-06
+ O 0 1.1280974376859376e-06
. O 0 1.5176775036707113e-07

In O 0 3.282564975393143e-08
addition O 0 5.2219020219013146e-09
, O 0 9.606993672806041e-11
we O 0 3.2355295526143024e-11
observed O 0 7.339669844119712e-11
that O 0 1.032967765143833e-12
these O 0 1.8521630409940038e-11
Ca2 O 0 5.203240505124995e-09
+ O 0 5.491473942242919e-09
transients O 0 7.852472450053938e-09
partially O 0 6.994101409141251e-10
result O 0 1.1341762251593224e-10
from O 0 5.679906545097424e-11
an O 0 7.464796142331309e-12
influx O 0 7.585728156733751e-10
of O 0 3.727528952168768e-09
extracellular O 0 1.8114217681386435e-08
Ca2 O 0 5.494313004561491e-09
+ O 0 1.5030904298996006e-09
through O 0 4.889491034276716e-10
the O 0 3.0573152343116305e-10
l O 0 7.818661829084306e-10
- O 0 6.591214241069565e-09
type O 0 3.105290691252094e-09
Ca2 O 0 5.0688470309978584e-08
+ O 0 7.103800925278847e-08
channel O 0 1.0390961335815518e-07
. O 0 3.8535212354418036e-08

Neither O 0 1.56964983943908e-06
the O 0 6.640414440539644e-09
content O 0 1.2149858008569936e-08
nor O 0 4.281204279976691e-09
the O 0 9.180670806907543e-11
activity O 0 4.9400012969158524e-09
of O 0 9.271445833292091e-09
Na O 0 7.902476681920234e-07
+ O 0 1.848742137156023e-08
/ O 0 1.5719635371169716e-08
K O 0 2.039925384167418e-08
+ O 0 5.991886986578265e-09
ATPase O 0 2.3519199032762117e-08
and O 0 1.3359867656603797e-09
sarcoplasmic O 0 1.6572149661442381e-06
reticulum O 0 4.329617240728112e-06
Ca2 O 0 7.847240226510621e-07
+ O 0 3.3176311831084604e-07
- O 0 1.1860649351547181e-07
ATPase O 0 1.1196053151252272e-07
are O 0 2.593664519268124e-11
affected O 0 3.926554081878919e-10
by O 0 1.2392415982276361e-09
DMPK O 0 0.052262499928474426
absence O 0 6.723551905452041e-06
. O 0 8.200021852644568e-07

In O 0 2.2359756712830858e-08
conclusion O 0 2.6037502820486225e-08
, O 0 1.524254750195908e-10
our O 0 5.487010845683926e-10
data O 0 7.541871571703496e-10
suggest O 0 9.86858372797883e-11
that O 0 1.4592681446892741e-12
DMPK O 0 6.519649559777463e-06
is O 0 4.960179402629938e-12
involved O 0 3.2392480364684673e-10
in O 0 4.4038668545187676e-11
modulating O 0 3.765142864153859e-09
the O 0 6.980344080531609e-11
initial O 0 1.1782078090938342e-10
events O 0 4.210647802649348e-11
of O 0 2.5519744650814857e-10
excitation O 0 2.2114021192010114e-07
- O 0 3.3155120604533295e-07
contraction O 0 1.2844953545254612e-08
coupling O 0 1.9162329500943542e-09
in O 0 1.3020425848608852e-09
skeletal O 0 1.912403058668133e-05
muscle O 0 7.864436213367298e-08
. O 0 2.798263665226841e-08
. O 0 1.2327267029377253e-07

Constitutional O 0 4.953777533955872e-05
RB1 O 1 0.9882251024246216
- O 0 4.749305389850633e-06
gene O 0 9.242172360757195e-09
mutations O 0 1.6700838489924763e-09
in O 0 6.176968658788695e-11
patients O 0 1.8731471929100962e-09
with O 0 2.0847011616975664e-10
isolated O 0 3.0267239026215975e-07
unilateral B-Disease 0 9.429134024685482e-07
retinoblastoma I-Disease 1 0.9999959468841553
. O 0 0.0001647340104682371

In O 0 1.499557633621862e-08
most O 0 3.7048591972066447e-10
patients O 0 8.145022434291604e-10
with O 0 2.391556744307799e-11
isolated O 0 1.0168193398385483e-08
unilateral B-Disease 0 1.987341491371808e-08
retinoblastoma I-Disease 1 0.9994291663169861
, O 0 1.3715140134706871e-09
tumor B-Disease 0 1.8394673872990097e-07
development O 0 3.8468311203132544e-08
is O 0 9.810905560181382e-12
initiated O 0 1.3810633192612443e-10
by O 0 8.519928686168132e-12
somatic O 0 2.946716426421858e-09
inactivation O 0 1.054796872068664e-08
of O 0 4.487277216469465e-10
both O 0 8.203907692072576e-11
alleles O 0 1.2236453517111556e-10
of O 0 2.6634214833620717e-09
the O 0 2.9997117678703944e-08
RB1 O 0 0.00017365570238325745
gene O 0 7.270556778848913e-08
. O 0 1.8648209731964016e-07

However O 0 1.2980591179712064e-07
, O 0 2.932115661380408e-10
some O 0 8.014043421933348e-12
of O 0 1.2960459094824017e-10
these O 0 1.2808243354811566e-10
patients O 0 2.030204893088694e-09
can O 0 9.122896882374221e-10
transmit O 0 1.4109029962128261e-06
retinoblastoma B-Disease 0 0.0019784350879490376
predisposition O 0 3.9045642097335076e-07
to O 0 7.889433106811339e-09
their O 0 5.0820030850218245e-08
offspring O 0 6.070809831726365e-06
. O 0 5.056472787146049e-07

To O 0 7.040978022843092e-09
determine O 0 1.2627348944249661e-08
the O 0 6.459214274556757e-10
frequency O 0 1.7440054733697252e-08
and O 0 8.363720827020416e-11
nature O 0 4.369339889898072e-10
of O 0 8.591052313988712e-10
constitutional O 0 7.733402895837571e-08
RB1 O 0 0.00375272985547781
- O 0 3.6333918984610136e-08
gene O 0 5.959355231510699e-10
mutations O 0 1.6732906726879548e-10
in O 0 1.93971765732881e-11
patients O 0 5.292571381154687e-10
with O 0 9.671194400873162e-11
isolated O 0 5.6603184361847525e-08
unilateral B-Disease 0 1.98289260566753e-08
retinoblastoma I-Disease 0 0.00045787316048517823
, O 0 2.834817658392552e-10
we O 0 5.7387539165176804e-11
analyzed O 0 9.328701144895035e-10
DNA O 0 1.9667186990091068e-08
from O 0 2.527747733349628e-10
peripheral O 0 3.307850136025081e-07
blood O 0 9.257839828080705e-09
and O 0 4.653802676557461e-09
from O 0 9.999276073813235e-08
tumor B-Disease 0 0.009776091203093529
tissue O 0 0.37279048562049866
. O 0 4.3258942241664045e-06

The O 0 2.1426650675948622e-08
analysis O 0 4.09250944244377e-08
of O 0 1.582233721819648e-07
tumors B-Disease 1 1.0
from O 0 5.778931466693393e-08
54 O 0 1.0985135645569244e-07
( O 0 8.903032477913797e-11
71 O 0 7.799038570510675e-08
% O 0 1.4800525249825114e-09
) O 0 2.3623906650338533e-12
of O 0 8.828577452435482e-11
76 O 0 5.898687760463872e-09
informative O 0 1.6488080900600721e-09
patients O 0 5.72606295712319e-10
showed O 0 2.4339421589303356e-09
loss O 0 1.2335676924379868e-09
of O 0 1.2053192222083453e-08
constitutional O 0 9.407531820215809e-07
heterozygosity O 1 0.9999568462371826
( O 0 0.00011438046931289136
LOH O 1 0.9999955892562866
) O 0 1.1954581324857827e-08
at O 0 1.7148732922578347e-07
intragenic O 0 1.7024520275299437e-05
loci O 0 1.456970494473353e-06
. O 0 5.364532285057066e-07

Three O 0 2.735757576033393e-08
of O 0 2.438455304343279e-08
13 O 0 1.0382402138020552e-07
uninformative O 0 8.041116961976513e-05
patients O 0 6.913494132732012e-08
had O 0 1.0420052376503008e-08
constitutional O 0 1.9194534672806185e-07
deletions O 0 5.823578135277785e-07
. O 0 5.210911240283167e-07

For O 0 6.306681399337322e-08
39 O 0 1.9418607166699076e-07
randomly O 0 6.932785368007899e-08
selected O 0 3.257001708334428e-07
tumors B-Disease 1 1.0
, O 0 1.37214533069141e-08
SSCP O 1 0.9989669322967529
, O 0 1.2657249470748866e-08
hetero O 0 2.1341911633498967e-06
- O 0 6.542605746062691e-08
duplex O 0 6.732354052019218e-08
analysis O 0 2.02808392302245e-09
, O 0 1.5159762334349125e-11
sequencing O 0 5.5672697563124984e-09
, O 0 8.037786582149042e-12
and O 0 1.8572639953751136e-11
Southern O 0 2.000544840896623e-09
blot O 0 2.4372232232394708e-08
analysis O 0 1.7924050021989046e-09
were O 0 2.989513081530504e-10
used O 0 6.439643263078665e-10
to O 0 2.1780255377024105e-09
identify O 0 1.0780798902487732e-06
mutations O 0 1.3827234397467691e-06
. O 0 9.728056511448813e-07

Mutations O 0 2.765637248103303e-07
were O 0 1.4233669354268841e-08
detected O 0 1.8767956078136194e-08
in O 0 1.1855091908152815e-10
21 O 0 9.370590969837167e-10
( O 0 2.2583501041451015e-11
91 O 0 1.901912938251371e-08
% O 0 2.8587643363664483e-09
) O 0 3.75083228365547e-11
of O 0 3.17077364364593e-09
23 O 0 5.910487288929289e-06
tumors B-Disease 1 1.0
with O 0 0.15827645361423492
LOH O 1 1.0
. O 0 2.9407432521111332e-05

In O 0 8.090605518873417e-08
6 O 0 2.159251799582762e-08
( O 0 1.3775433571616702e-10
38 O 0 7.430446036238436e-09
% O 0 1.1233990404591054e-09
) O 0 7.754110721569507e-12
of O 0 9.663878586252395e-10
16 O 0 4.834126912101055e-07
tumors B-Disease 1 1.0
without O 1 0.9969642758369446
LOH O 1 1.0
, O 0 3.052804953274091e-10
one O 0 4.4241652008558674e-11
mutation O 0 3.57276874751733e-10
was O 0 4.540364528793361e-09
detected O 0 2.3846189023402076e-08
, O 0 2.6569496602846243e-11
and O 0 3.486012173370412e-11
in O 0 2.562119127968998e-10
9 O 0 2.5929003388824867e-09
( O 0 3.0153043256708756e-11
56 O 0 1.1193272086984507e-08
% O 0 7.069556606786875e-10
) O 0 1.2998676787723262e-11
of O 0 1.1719708536972462e-09
the O 0 4.73196273276244e-08
tumors B-Disease 1 1.0
without O 1 0.9610437750816345
LOH O 1 1.0
, O 0 1.1007904587856387e-09
both O 0 8.172286181107324e-10
mutations O 0 2.189208148095645e-09
were O 0 5.497636568208009e-09
found O 0 3.923150249107721e-09
. O 0 5.925099344494811e-08

Thus O 0 1.5754702076264948e-07
, O 0 1.8813527125072227e-10
a O 0 5.7580398782342e-11
total O 0 2.2347754202733938e-10
of O 0 2.155681882998195e-10
45 O 0 1.9028771891527185e-09
mutations O 0 4.42409137102473e-10
were O 0 1.0187815036033498e-09
identified O 0 1.5583150769771237e-08
in O 0 3.01763192211979e-09
tumors B-Disease 1 1.0
of O 0 1.3657810995937325e-05
36 O 0 0.00041123529081232846
patients O 0 2.856068022083491e-06
. O 0 1.041709083438036e-06

Thirty O 0 1.1584242201934103e-05
- O 0 1.1553569123634588e-07
nine O 0 3.760994182755439e-09
of O 0 8.499129733330335e-10
the O 0 3.4028968531885084e-10
mutations O 0 7.321902528723001e-10
- O 0 5.185968321441692e-10
including O 0 5.7891382659880364e-11
34 O 0 1.2070702837263525e-07
small O 0 1.6267169833383832e-09
mutations O 0 2.0620040785956917e-08
, O 0 4.137573061946398e-10
2 O 0 2.9750681918017108e-08
large O 0 4.389422603168214e-09
structural O 0 1.5629515473847277e-05
alterations O 0 2.0838412240209436e-07
, O 0 7.892785314211892e-10
and O 0 1.3435302870234977e-09
hypermethylation O 0 0.0004106758569832891
in O 0 2.223141493118419e-08
3 O 0 3.103125720826938e-07
tumors O 1 1.0
- O 0 1.816390060582762e-08
were O 0 1.2868954790690168e-09
not O 0 2.4713776164420054e-11
detected O 0 7.743712893137911e-10
in O 0 1.2041730459988464e-11
the O 0 1.0823252016844975e-10
corresponding O 0 4.123459262928009e-08
peripheral O 0 1.7197618262798642e-06
blood O 0 1.0563918806383299e-07
DNA O 0 1.937116394401528e-05
. O 0 7.391166718662134e-07

In O 0 2.493079875875992e-07
6 O 0 5.9608268543343e-08
( O 0 2.2739286842377027e-10
17 O 0 1.5907959394212412e-09
% O 0 3.8859340745212023e-10
) O 0 1.6763619572340849e-12
of O 0 2.486488966113587e-11
the O 0 7.675245161653521e-11
36 O 0 9.328439354305829e-09
patients O 0 1.3289493949741882e-09
, O 0 1.5516130047465992e-11
a O 0 1.050098619170825e-10
mutation O 0 1.0666276750725956e-09
was O 0 3.5266367603981053e-09
detected O 0 4.854331159265257e-09
in O 0 7.178034555632706e-11
constitutional O 0 3.6941358860786977e-09
DNA O 0 4.173100194293511e-07
, O 0 6.88473167365089e-11
and O 0 3.08380924962659e-11
1 O 0 2.7138541414117867e-10
of O 0 1.275062139205474e-10
these O 0 1.4459256708621027e-11
mutations O 0 4.049803548067388e-11
is O 0 1.0290269070872826e-12
known O 0 8.229134387804926e-12
to O 0 3.123196493093339e-11
be O 0 2.766958051569901e-10
associated O 0 3.390681513337768e-08
with O 0 9.808707179814746e-10
reduced O 0 8.558544095649268e-07
expressivity O 0 6.613420555368066e-05
. O 0 4.99473742365808e-07

The O 0 2.892966044498735e-08
presence O 0 2.4089239492042225e-09
of O 0 4.799488362294824e-09
a O 0 3.6410538473141685e-10
constitutional O 0 4.0664414058255716e-09
mutation O 0 7.360716480775409e-10
was O 0 2.0443442771966858e-10
not O 0 1.0839190872982685e-12
associated O 0 5.904309680060393e-11
with O 0 6.690988366662987e-13
an O 0 5.402687303611431e-13
early O 0 7.884404240598997e-10
age O 0 7.622586117861374e-09
at O 0 1.6392127655251443e-09
treatment O 0 1.5571035305583791e-07
. O 0 6.713747069397868e-08

In O 0 6.5815306982131e-08
1 O 0 8.146568575284618e-08
patient O 0 2.566715124885377e-07
, O 0 4.891188565281368e-10
somatic O 0 2.841333355263487e-07
mosaicism O 0 7.597393050673418e-06
was O 0 2.273196963997748e-09
demonstrated O 0 2.71562522469182e-10
by O 0 1.2013347131314966e-12
molecular O 0 2.534930772235544e-11
analysis O 0 1.2018233630506359e-11
of O 0 1.0278014550557657e-11
DNA O 0 3.5197353920324304e-09
and O 0 9.46866474116348e-11
RNA O 0 1.2598941623309656e-07
from O 0 5.8888208087637395e-08
peripheral O 0 0.0006702811806462705
blood O 0 8.253401574620511e-06
. O 0 7.556963282695506e-06

In O 0 3.358166011935282e-08
2 O 0 1.3699695600166706e-08
patients O 0 1.4535700421092201e-09
without O 0 2.9524815925441317e-10
a O 0 3.3566899260151217e-10
detectable O 0 2.769569960037188e-07
mutation O 0 1.925145820536045e-09
in O 0 7.340779650810703e-10
peripheral O 0 2.6146396976400865e-06
blood O 0 3.781735244956508e-07
, O 0 7.771653542931745e-09
mosaicism O 0 0.2835523784160614
was O 0 7.240664956498222e-08
suggested O 0 2.5741848652671706e-09
because O 0 3.519832689202751e-11
1 O 0 1.565944041104217e-10
of O 0 1.9654530780677248e-10
the O 0 1.483927147827302e-10
patients O 0 6.909957939171818e-09
showed O 0 7.408231113004149e-07
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 6.242078853802013e-09
the O 0 2.6752282611397504e-09
other O 0 2.369929807954918e-10
later O 0 1.019779372057883e-08
developed O 0 4.074362536243825e-08
bilateral B-Disease 0 0.0015309732407331467
retinoblastoma I-Disease 0 0.3554791808128357
. O 0 2.0639852209569653e-06

In O 0 1.3167482215692417e-08
conclusion O 0 1.7082880887642204e-08
, O 0 1.5180776080647718e-10
our O 0 1.02136532564856e-09
results O 0 5.074093922807776e-10
emphasize O 0 1.3196893577926971e-09
that O 0 1.3041882027456375e-12
the O 0 2.2971801544313664e-11
manifestation O 0 1.5010284570848853e-08
and O 0 2.4791027564141643e-10
transmissibility O 0 9.338443760498194e-07
of O 0 6.758172244047955e-09
retinoblastoma B-Disease 0 5.718798661291657e-07
depend O 0 4.046605539542725e-08
on O 0 6.99139357518419e-10
the O 0 1.1279115141871188e-10
nature O 0 5.072855469023807e-10
of O 0 5.170708861079731e-10
the O 0 1.1109650699392404e-10
first O 0 7.115877886931798e-10
mutation O 0 5.896232391222611e-10
, O 0 1.0892417176555647e-11
its O 0 1.5614209144393376e-12
time O 0 1.4772175149779798e-10
in O 0 5.2318465532108505e-11
development O 0 8.415767638325633e-09
, O 0 1.5476493350763398e-11
and O 0 2.668731338348329e-12
the O 0 1.1893814058638874e-11
number O 0 2.8483928757316868e-11
and O 0 4.922367635024072e-12
types O 0 5.287567050871189e-10
of O 0 6.730576096458663e-10
cells O 0 1.948864625234137e-09
that O 0 1.3833772669058497e-11
are O 0 2.136002312524976e-11
affected O 0 9.417947532952553e-10
. O 0 1.2793697212742927e-09
. O 0 4.957966837082495e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999916553497314
the I-Disease 0 1.4390365322469734e-05
fifth I-Disease 0 8.433264156337827e-06
component I-Disease 0 3.6578336448656046e-07
of I-Disease 0 3.148261029650712e-08
complement I-Disease 0 9.874472084447916e-08
in O 0 1.564622920113834e-08
man O 0 2.047735506494064e-06
. O 0 1.9013162955161533e-06

I O 0 0.358129620552063
. O 0 8.957754289440345e-06

Clinical O 0 7.07745275576599e-05
, O 0 2.614025795821817e-08
immunochemical O 0 0.00037027394864708185
, O 0 1.5038503775599565e-09
and O 0 4.2233097574673195e-10
family O 0 2.1676480610466342e-09
studies O 0 3.256448266597545e-08
. O 0 3.9457326295178063e-08

The O 0 3.260973002738865e-08
first O 0 3.920748614660852e-09
recognized O 0 9.24760445997208e-09
human O 0 5.825663951242177e-09
kindred O 0 1.2587963283294812e-05
with O 0 1.8725334172131625e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 0 0.0011498399544507265
fifth I-Disease 0 3.647171979537234e-05
component I-Disease 0 1.268941900889331e-06
of I-Disease 0 2.7837309062306304e-06
complement I-Disease 0 8.742050340515561e-06
( O 0 2.322919812058899e-07
C5 O 1 0.999995231628418
) O 0 2.125665199415039e-09
is O 0 5.676400460785658e-10
described O 0 6.353393899871662e-08
. O 0 2.5645962864473404e-07

The O 0 4.4810039412368496e-07
proband O 0 2.595173464214895e-05
, O 0 3.154870253929687e-10
a O 0 7.919185446292332e-11
20 O 0 6.29223340098406e-10
- O 0 1.7426105003437442e-10
year O 0 8.893086961281327e-11
- O 0 9.084908825229832e-09
old O 0 1.8491799380626617e-07
black O 0 1.703855900814233e-08
female O 0 5.914455869060475e-06
with O 0 3.9169928641058505e-05
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999990463256836
age O 1 0.9676468372344971
11 O 0 1.98820586660986e-08
, O 0 1.5680901022108173e-10
lacked O 0 5.47293730335241e-08
serum O 0 6.280200892661014e-08
hemolytic O 0 4.5788326019646775e-07
complement O 0 6.876761915464158e-08
activity O 0 1.3497574968823756e-07
, O 0 2.42824677032516e-10
even O 0 1.67295885478147e-10
during O 0 1.0265809180509677e-07
remission O 0 9.57739757723175e-06
. O 0 1.2220189660183678e-07

C5 O 0 0.06557954847812653
was O 0 1.5879099919402506e-06
undetectable O 0 9.193087180392467e-07
in O 0 2.1895578405928262e-10
her O 0 2.3470778098833023e-10
serum O 0 1.3992478287150334e-09
by O 0 3.4816264454784474e-11
both O 0 1.0824559026900715e-09
immunodiffusion O 0 2.1077382825751556e-06
and O 0 4.5036907536655235e-09
hemolytic O 0 1.0487771760381293e-05
assays O 0 6.889114956720732e-06
. O 0 2.9321467991394456e-06

Other O 0 3.860051389636965e-09
complement O 0 5.799543956186426e-09
components O 0 2.4460481640176113e-08
were O 0 4.943844778004802e-10
normal O 0 4.629350236484697e-09
during O 0 6.029053700729037e-09
remission O 0 6.198096684784105e-07
of O 0 1.4317915741912657e-08
lupus O 0 1.5996576507859572e-07
, O 0 1.5216208293367117e-09
but O 0 8.353971736596577e-09
C1 O 0 0.006547453813254833
, O 0 2.3782126845617313e-07
C4 O 1 0.9995682835578918
, O 0 4.6162853095665923e-08
C2 O 0 7.11666580173187e-05
, O 0 2.8556975451010658e-08
and O 0 1.1879168937412032e-07
C3 O 1 0.8418741822242737
levels O 0 6.183123332448304e-05
fell O 0 5.1025290304096416e-06
during O 0 1.7648716266194242e-06
exacerbations O 0 0.0012659317580983043
. O 0 7.759220466141414e-07

A O 0 2.802216386044165e-06
younger O 0 1.6858297158250934e-06
half O 0 3.5764333716770125e-08
- O 0 1.685068795609368e-08
sister O 0 6.408245667444135e-08
, O 0 1.6508715228180648e-10
who O 0 2.4908808349266565e-10
had O 0 4.8889154946607505e-09
no O 0 6.073512359705546e-09
underlying O 1 0.9998488426208496
disease O 0 0.18760408461093903
, O 0 1.7234191851400738e-10
was O 0 1.969594265460728e-08
also O 0 5.4161564122523487e-11
found O 0 4.3653330950021996e-10
to O 0 4.271106579523121e-09
lack O 1 0.6007970571517944
immunochemically O 1 0.9999954700469971
detectable O 1 0.9975414276123047
C5 O 1 0.9845840930938721
. O 0 4.0558193177275825e-06

By O 0 1.4692533056859247e-07
hemolytic O 0 5.2139970648568124e-05
assay O 0 4.886070428256062e-07
, O 0 7.080328767727906e-09
she O 0 9.999343575373132e-10
exhibited O 0 1.4368738421310923e-09
1 O 0 7.656285605506241e-10
- O 0 4.93039720161903e-10
2 O 0 5.13486302089472e-11
% O 0 9.403942902164175e-11
of O 0 3.237665344157925e-11
the O 0 3.665439826661121e-11
normal O 0 3.2060412991086196e-08
serum O 0 5.471935438094988e-08
C5 O 0 1.6653171996949823e-06
level O 0 4.058454905475628e-08
and O 0 4.071404324790251e-11
normal O 0 6.27378105022558e-09
concentrations O 0 3.0745326284886687e-09
of O 0 5.824583038105402e-10
other O 0 1.6886352038891772e-10
complement O 0 3.6468890129981446e-08
components O 0 1.4446206932916539e-06
. O 0 7.92050855125126e-07

C5 O 0 0.00153700215741992
levels O 0 4.825715791412222e-07
of O 0 1.7639408156355785e-08
other O 0 1.8588740269276371e-10
family O 0 6.296600046917789e-11
members O 0 2.0055018409848024e-11
were O 0 2.6671362340913163e-10
either O 0 1.3349527039352438e-09
normal O 0 7.398445944772902e-08
or O 0 7.099010268518668e-11
approximately O 0 1.0913093345665814e-10
half O 0 1.6365878097168718e-10
- O 0 1.6081937170842053e-10
normal O 0 1.066127297555397e-09
, O 0 7.907801150008886e-12
consistent O 0 2.5544202308935837e-09
with O 0 3.086645522509812e-11
autosomal O 0 4.378504456781229e-07
codominant O 0 2.876174676202936e-06
inheritance O 0 4.1523374960661386e-08
of O 0 6.496085447338373e-09
the O 0 6.534235374999753e-09
gene O 0 3.5615059346127964e-07
determining O 1 0.9794151782989502
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.1535655832849443e-05

Normal O 0 0.00010641881090123206
hemolytic O 0 9.34696217882447e-05
titers O 0 6.4414271037094295e-06
were O 0 2.767087359245579e-08
restored O 0 8.187630129441459e-08
to O 0 3.6467528996553256e-10
both O 0 3.1175455550425113e-09
homozygous O 0 1.7827350120569463e-06
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 4.551542588160373e-05
C5D B-Disease 1 1.0
) O 0 7.191467421563402e-10
sera O 0 1.7230388227318372e-09
by O 0 1.1320656868527013e-12
addition O 0 5.301803787660653e-11
of O 0 7.247871192106459e-10
highly O 0 1.5488541293962044e-07
purified O 0 7.307314717763802e-07
human O 0 7.024628985163872e-07
C5 O 1 0.9716725945472717
. O 0 2.1053035652585095e-06

In O 0 1.0086509405482502e-07
specific O 0 1.937849987143636e-07
C5 O 0 0.0007143192924559116
titrations O 0 3.7471986615855712e-06
, O 0 1.3355860861707924e-10
however O 0 3.3961147782868295e-10
, O 0 1.6072667502475824e-11
it O 0 1.6736079752957544e-12
was O 0 4.500940731233527e-10
noted O 0 5.1295967473663495e-11
that O 0 8.641722320373857e-13
when O 0 8.388783591384286e-12
limited O 0 3.453425739818883e-11
amounts O 0 2.452525404983419e-10
of O 0 2.4742146109701935e-09
C5 O 0 3.6185269891575444e-06
were O 0 3.207843990438164e-09
assayed O 0 1.4883995902437164e-07
in O 0 1.0469228262088848e-10
the O 0 3.5442062479296155e-11
presence O 0 9.135812245597563e-11
of O 0 1.5040082512740582e-09
low O 0 3.1574078462881516e-08
dilutions O 0 6.090144211157167e-07
of O 0 3.712007057288247e-08
either O 0 3.803178515227046e-06
C5D B-Disease 1 1.0
serum O 0 1.145718101724924e-06
, O 0 3.330504205756313e-10
curving O 0 9.852357818473934e-10
rather O 0 9.536286343925227e-11
than O 0 4.613899106525876e-12
linear O 0 9.362551844915856e-10
dose O 0 6.345349579106596e-09
- O 0 7.139668856126491e-10
response O 0 2.803040265175749e-11
plots O 0 1.987844777673331e-09
were O 0 3.732279485468837e-10
consistently O 0 1.572303814922904e-10
obtained O 0 2.1597644506154978e-10
, O 0 1.1295342265682518e-11
suggesting O 0 7.152891057238264e-10
some O 0 5.087115798052544e-11
inhibitory O 0 4.7267672442785624e-08
effect O 0 1.9298527220712458e-08
. O 0 2.347694021409552e-07

Further O 0 4.242124873599096e-08
studies O 0 4.112508111830948e-09
suggested O 0 6.159864840427076e-10
that O 0 7.952481555217883e-12
low O 0 2.2184809544967266e-09
dilutions O 0 2.887173309318314e-07
of O 0 2.938070622349187e-07
C5D B-Disease 1 1.0
serum O 0 7.399270316454931e-07
contain O 0 8.479892898982655e-10
a O 0 8.359191810969335e-11
factor O 0 1.8847325089499378e-10
( O 0 1.0396828363512522e-11
or O 0 6.01828170632146e-11
factors O 0 8.87860063247814e-10
) O 0 2.23931845289016e-11
interfering O 0 1.175598374203446e-08
at O 0 6.198040303218022e-09
some O 0 4.176669426980695e-11
step O 0 1.5386589780064241e-09
in O 0 1.5991824531269572e-10
the O 0 1.3870009585303933e-09
hemolytic O 0 7.53156996324833e-07
assay O 0 2.0128999267399195e-07
of O 0 4.89658850710839e-06
C5 O 1 0.8456262946128845
, O 0 2.7844182515224247e-10
rather O 0 2.71175332189344e-10
than O 0 4.027173039489185e-11
a O 0 9.910445797345346e-10
true O 0 3.8612174080299155e-07
C5 O 0 0.00047739356523379683
inhibitor O 0 7.798265500014168e-08
or O 0 2.3906345347768365e-08
inactivator O 0 2.2498405087389983e-05
. O 0 9.096301027966547e-07

Of O 0 7.729229309916263e-07
clinical O 0 4.217110472382046e-06
interest O 0 1.2217179268247946e-08
are O 0 1.3360796843886469e-11
( O 0 8.782201528501066e-12
a O 0 2.4801417863873354e-11
) O 0 1.935082953249956e-12
the O 0 4.5605304255236234e-11
documentation O 0 5.92011758726585e-07
of O 0 1.1368135943712332e-07
membranous O 1 0.999976396560669
glomerulonephritis B-Disease 1 1.0
, O 0 9.167854386760155e-07
vasculitis B-Disease 1 1.0
, O 0 4.080093773950466e-08
and O 0 1.6368180411063804e-07
arthritis B-Disease 1 1.0
in O 0 9.69986672316736e-07
an O 0 4.368256589781794e-10
individual O 0 3.8606717822631254e-08
lacking O 1 0.9999997615814209
C5 O 1 0.9999991655349731
( O 0 1.0986860726758252e-10
and O 0 1.973758136097903e-11
its O 0 4.189073133514798e-12
biologic O 0 2.1187274157341562e-09
functions O 0 5.768705513276018e-10
) O 0 5.2953232076990986e-12
, O 0 4.8918087462712645e-12
and O 0 9.372350985581424e-12
( O 0 1.3900610697226146e-11
b O 0 1.48360740359621e-10
) O 0 2.9473977512101124e-12
a O 0 3.522976008141221e-11
remarkable O 0 3.788815039484916e-09
propensity O 0 4.30809059537296e-08
to O 0 7.246437228047853e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.3520211616935285e-09
the O 0 7.370086763103245e-10
proband O 0 6.762609814359166e-07
, O 0 2.485967161292013e-11
even O 0 4.266402335584285e-12
during O 0 3.244572110983057e-10
periods O 0 2.1253500293028083e-08
of O 0 2.270471366472293e-09
low O 0 1.3821293443072591e-08
- O 0 1.2608522004242673e-09
dose O 0 3.249043256658979e-10
or O 0 8.750366750631677e-12
alternate O 0 3.493443978541677e-09
- O 0 1.9149222652004028e-08
day O 0 3.15316484034156e-08
corticosteroid O 0 9.291509195463732e-05
therapy O 0 3.295909482403658e-05
. O 0 1.3050572533757077e-07

Other O 0 7.972890792018461e-09
observations O 0 9.489609986701453e-09
indicate O 0 1.7554516729134662e-09
that O 0 4.983850138140511e-12
the O 0 2.5709992468314624e-10
C5D B-Disease 1 1.0
state O 0 1.7585975731204684e-10
is O 0 3.582687098380166e-12
compatible O 0 8.213325131123383e-09
with O 0 3.185603864030995e-11
normal O 0 1.8546472801972413e-08
coagulation O 0 2.56594105962904e-08
function O 0 1.2748584410360309e-09
and O 0 4.3936229654484293e-11
the O 0 8.778555660171605e-11
capacity O 0 3.1317060056323953e-09
to O 0 1.6687201620513292e-10
mount O 0 2.3378454727662756e-07
a O 0 2.8493211345903546e-08
neutrophilic O 1 0.9865871071815491
leukocytosis O 0 0.00036421246477402747
during O 0 0.0001116921630455181
pyogenic B-Disease 0 0.3023519217967987
infection I-Disease 0 5.658900045091286e-05
. O 0 3.384736757539031e-08
. O 0 1.2484990463690337e-07

Susceptibility O 0 0.0011098133400082588
to O 0 5.4909949540160596e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 2.7305522962706164e-05
twins O 0 4.544235423509235e-07
: O 0 6.363763249001009e-12
the O 0 1.3158023282056064e-11
role O 0 1.0487694740435316e-10
of O 0 9.396667888239563e-10
genes O 0 2.1849533293760715e-09
, O 0 3.874004450565849e-10
HLA O 0 3.0403992923311307e-07
, O 0 1.5581112788876084e-10
and O 0 3.0063126987833755e-10
the O 0 2.181539748846717e-08
environment O 0 5.174027592147468e-06
. O 0 4.1700215547280095e-07

OBJECTIVE O 0 2.9816528694937006e-05
To O 0 1.3029319845259124e-09
determine O 0 2.8432283194490537e-09
the O 0 1.9204433876485183e-10
relative O 0 4.757710314606811e-08
effects O 0 1.1397941257484945e-08
of O 0 1.0717055021203237e-09
genetic O 0 6.225753690358715e-09
and O 0 4.0017364422162416e-11
environmental O 0 2.6445740042291277e-10
factors O 0 1.2209246114114336e-10
in O 0 2.1691719601091286e-11
susceptibility O 0 1.4023184391476207e-08
to O 0 3.3764519002943416e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.5607659816741943
AS B-Disease 1 1.0
) O 0 1.2000684002089201e-08
. O 0 3.66836907517154e-08

METHODS O 0 5.030714419262949e-06
Twins O 0 4.018739332423138e-07
with O 0 1.5311051038136014e-10
AS B-Disease 1 0.9326930642127991
were O 0 2.3545565497329335e-10
identified O 0 9.508987347528475e-11
from O 0 1.0055027123423432e-11
the O 0 4.7455310514532556e-11
Royal O 0 8.767006676180245e-08
National O 0 2.310507625225e-07
Hospital O 0 0.014242340810596943
for O 0 2.627898822993302e-07
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.0001453038421459496
. O 0 1.8452776657795766e-06

Clinical O 0 2.6860054731514538e-06
and O 0 1.3582969193848271e-09
radiographic O 0 2.2493007634238893e-07
examinations O 0 5.320664513419615e-07
were O 0 2.0011099444161573e-09
performed O 0 3.3050415737534422e-09
to O 0 1.0417994938949349e-10
establish O 0 4.149231624950289e-09
diagnoses O 0 2.3511849178703415e-07
, O 0 8.001385665146188e-11
and O 0 6.032651045373427e-10
disease O 0 0.0001687769399723038
severity O 1 0.9446611404418945
was O 0 1.6879317499274293e-08
assessed O 0 8.10547240437387e-10
using O 0 4.042919124480626e-11
a O 0 1.982345017303988e-11
combination O 0 1.9547791163532224e-10
of O 0 1.0634423341926436e-09
validated O 0 2.1199047850473107e-08
scoring O 0 1.0869168676208574e-08
systems O 0 6.193316721692099e-07
. O 0 1.9892230795903743e-07

HLA O 0 2.1601559637929313e-05
typing O 0 2.754736442511785e-06
for O 0 4.202437864364583e-08
HLA O 0 3.653263320302358e-06
- O 0 1.2859289881816949e-06
B27 O 0 2.2218796402739827e-06
, O 0 1.1218851403427266e-09
HLA O 0 8.224913727872263e-08
- O 0 1.592020026919272e-08
B60 O 0 1.835398535376953e-07
, O 0 1.384684034100303e-11
and O 0 2.3183123823433682e-11
HLA O 0 4.841767164975863e-08
- O 0 8.067753043405901e-08
DR1 O 1 0.7645071148872375
was O 0 8.75919281551063e-10
performed O 0 2.1188312215869587e-10
by O 0 3.7448256301475524e-12
polymerase O 0 8.529948969382417e-11
chain O 0 1.5070446626741507e-11
reaction O 0 2.356756066343446e-12
with O 0 1.1347138506589971e-12
sequence O 0 1.8463967854653873e-10
- O 0 2.2721163839278802e-10
specific O 0 5.7479885434696953e-11
primers O 0 1.1849287107068562e-09
, O 0 1.6496620042216747e-11
and O 0 4.327057462338857e-11
zygosity O 0 2.0443702908323758e-07
was O 0 4.006063036854357e-09
assessed O 0 1.6354473331148256e-08
using O 0 9.031952963312051e-09
microsatellite O 0 1.008124627333018e-06
markers O 0 3.4833593076655234e-07
. O 0 2.2106767971763475e-07

Genetic O 0 7.24883136626886e-07
and O 0 6.211434144809402e-10
environmental O 0 9.795148026014999e-11
variance O 0 1.3020488333348457e-11
components O 0 1.0500585817529995e-10
were O 0 1.4314754243072159e-11
assessed O 0 2.1873831912433417e-10
with O 0 1.1751655421346485e-12
the O 0 1.1922888024096245e-11
program O 0 9.91775758740765e-11
Mx O 0 7.380749900143257e-10
, O 0 3.923837979796091e-13
using O 0 4.416886995040059e-12
data O 0 1.2136434912601857e-10
from O 0 4.795043268696064e-12
this O 0 1.2810673745769496e-12
and O 0 3.509299838569402e-12
previous O 0 3.4087827005535587e-10
studies O 0 1.268205401805389e-10
of O 0 7.465825874186649e-11
twins O 0 3.6914733492210416e-09
with O 0 5.248981249650342e-10
AS B-Disease 1 0.9999998807907104
. O 0 1.0024527909990866e-06

RESULTS O 0 1.974090082512703e-06
Six O 0 1.075166551345319e-07
of O 0 1.6252787560233628e-08
8 O 0 4.4727041625947095e-08
monozygotic O 0 1.3190757499614847e-06
( O 0 1.9757375735451888e-09
MZ O 0 1.0396335710538551e-05
) O 0 9.52739623305554e-11
twin O 0 8.265863549183905e-09
pairs O 0 3.183912467008554e-09
were O 0 1.4996977881764906e-08
disease O 0 2.347687342307836e-07
concordant O 0 1.3318780247573159e-06
, O 0 7.125788847872627e-11
compared O 0 7.362176979164303e-10
with O 0 6.007933733842563e-12
4 O 0 4.038351320012623e-10
of O 0 7.103076460346358e-10
15 O 0 1.3600338633068532e-09
B27 O 0 1.0185763699155359e-07
- O 0 2.766996187730797e-09
positive O 0 2.060059761666011e-10
dizygotic O 0 1.4326334962788678e-07
( O 0 3.309834351039598e-10
DZ O 0 2.008178398682503e-06
) O 0 1.1522302556521424e-10
twin O 0 8.712276233779903e-09
pairs O 0 1.9878256818373075e-09
( O 0 1.6670533009577326e-10
27 O 0 1.2909008084704965e-08
% O 0 1.9717283361586624e-09
) O 0 7.146977887978467e-12
and O 0 2.842981405848377e-11
4 O 0 6.384522355240563e-10
of O 0 1.5980246015345756e-09
32 O 0 3.786952973428015e-08
DZ O 0 5.174086709303083e-06
twin O 0 2.4772948137297135e-08
pairs O 0 5.007565029302441e-09
overall O 0 4.207852271065349e-07
( O 0 1.741972399660341e-10
12 O 0 1.8310613025818157e-09
. O 0 5.4474865590625754e-11
5 O 0 3.8927661094589894e-10
% O 0 6.567680843616586e-10
) O 0 9.392182864775833e-11
. O 0 9.853527771497284e-09

Nonsignificant O 0 0.00033350728335790336
increases O 0 1.1232453189791158e-08
in O 0 1.4508381995792519e-10
similarity O 0 5.971655392400521e-10
with O 0 7.235404549804647e-12
regard O 0 1.907306534931763e-09
to O 0 1.60693042206006e-10
age O 0 1.811978762589206e-07
at O 0 1.8570046833588094e-08
disease O 0 1.1423021533119027e-06
onset O 0 0.012258642353117466
and O 0 1.223194878718914e-10
all O 0 2.829279345528679e-11
of O 0 4.549655374663786e-10
the O 0 9.28916055187301e-10
disease O 0 2.9899609899075585e-08
severity O 0 8.260740536059075e-09
scores O 0 3.4603372944808086e-10
assessed O 0 9.95033389017408e-10
were O 0 1.7413080699579808e-10
noted O 0 1.7350157421880397e-10
in O 0 1.6777934597200783e-10
disease O 0 3.4744338961445465e-08
- O 0 6.874939373346933e-08
concordant O 0 3.4449490158294793e-06
MZ O 0 5.442782276077196e-05
twins O 0 5.061774999148838e-08
compared O 0 2.747454042051345e-09
with O 0 2.6544283437957006e-10
concordant O 0 8.313421858474612e-06
DZ O 0 0.0013038681354373693
twins O 0 4.877405899605947e-06
. O 0 9.962798230844783e-07

HLA O 0 0.0011759704211726785
- O 0 3.438798012211919e-05
B27 O 0 9.91231354419142e-06
and O 0 1.1610973293940674e-09
B60 O 0 8.295130555779906e-07
were O 0 2.712560454032342e-10
associated O 0 3.7829067656147686e-10
with O 0 1.1498806247456361e-11
the O 0 1.0359427760064932e-09
disease O 0 1.2010770660708658e-05
in O 0 1.8344871177689015e-09
probands O 0 0.0017422552919015288
, O 0 3.480597060567803e-11
and O 0 1.7493298476445318e-11
the O 0 3.33725103107696e-10
rate O 0 2.364716955582935e-08
of O 0 7.228198040110101e-10
disease O 0 7.553982328545317e-09
concordance O 0 2.160573053799908e-09
was O 0 1.2405636518053598e-09
significantly O 0 1.240712754757567e-09
increased O 0 1.419416140180374e-09
among O 0 3.281728777615456e-10
DZ O 0 8.991098070509906e-07
twin O 0 8.121617156575667e-09
pairs O 0 8.858724864779788e-10
in O 0 1.686475403772647e-10
which O 0 8.475001950225547e-12
the O 0 1.885789580047259e-10
co O 0 4.847299450716491e-09
- O 0 8.172601262401713e-09
twin O 0 1.4029230221979105e-08
was O 0 1.7628096760091694e-09
positive O 0 3.875110995976705e-11
for O 0 1.8866628745395353e-11
both O 0 1.1838104940764538e-09
B27 O 0 4.514272859523771e-06
and O 0 3.3863962300983985e-08
DR1 O 1 0.5813348889350891
. O 0 1.1899288665517815e-06

Additive O 0 8.813263008278227e-08
genetic O 0 4.158239974572098e-09
effects O 0 1.6209591446880722e-09
were O 0 2.083810624053939e-10
estimated O 0 1.673382439559834e-11
to O 0 3.190485202420046e-12
contribute O 0 1.5256187979595381e-10
97 O 0 2.7371303445988815e-08
% O 0 3.493717093405735e-09
of O 0 8.824688202402342e-11
the O 0 1.1876864769444495e-10
population O 0 1.89915132231544e-11
variance O 0 1.1948145806073285e-09
. O 0 1.1612951489325951e-08

CONCLUSION O 0 8.050910764723085e-06
Susceptibility O 0 1.8548190610090387e-06
to O 0 3.8971609939153495e-08
AS B-Disease 1 1.0
is O 0 1.1191282345279774e-09
largely O 0 2.0283199564374854e-09
genetically O 0 1.2037418284371881e-10
determined O 0 2.930076847817986e-09
, O 0 4.4166444806981175e-11
and O 0 4.2287565810150696e-11
the O 0 3.5695876809960225e-10
environmental O 0 2.2554336176483503e-09
trigger O 0 9.31753341149033e-10
for O 0 5.869994768037401e-11
the O 0 1.4027671246807927e-09
disease O 0 2.760446307092934e-07
is O 0 3.258358582947096e-10
probably O 0 7.456571893271757e-08
ubiquitous O 0 6.325136041596124e-07
. O 0 1.9773320047988818e-07

HLA O 0 0.0001426332601113245
- O 0 6.930803010618547e-06
B27 O 0 5.0591675062605646e-06
accounts O 0 6.213234926555344e-10
for O 0 9.321452464072788e-12
a O 0 3.156150688021775e-11
minority O 0 7.627901088547162e-11
of O 0 2.3205963539663088e-10
the O 0 5.73655734026346e-10
overall O 0 1.095621797730928e-07
genetic O 0 2.2777420838338003e-08
susceptibility O 0 2.5702517447712125e-08
to O 0 2.8793689210715456e-08
AS B-Disease 1 1.0
. O 0 1.5732835890958086e-05

Cell O 0 4.424241069500567e-06
cycle O 0 2.0898801267321687e-06
- O 0 2.459484846895066e-07
dependent O 0 2.398367655587208e-07
colocalization O 0 2.3633340333617525e-06
of O 0 1.4792891533943475e-07
BARD1 O 1 0.9999738931655884
and O 0 1.028226570554125e-08
BRCA1 O 0 2.3504579615973853e-08
proteins O 0 1.119817294448211e-10
in O 0 6.228396270957504e-11
discrete O 0 6.215042702706342e-08
nuclear O 0 5.389083526097238e-07
domains O 0 4.7364054012177803e-07
. O 0 2.5642026457717293e-07

Germ O 1 0.7444448471069336
- O 0 1.85392073035473e-05
line O 0 1.149010273593376e-07
mutations O 0 2.301137946858489e-09
of O 0 5.940214098387742e-09
the O 0 1.217967326994085e-08
BRCA1 O 0 3.1508599818153016e-07
gene O 0 1.1497018892470123e-09
predispose O 0 1.2251574865729253e-08
women O 0 2.17906612892671e-11
to O 0 2.6302961544932835e-11
early O 0 6.883204264340748e-07
- O 0 0.006788777187466621
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.5550757126447934e-08
compromising O 0 2.6086871685038204e-07
the O 0 4.158436373025154e-10
genes O 0 7.390850709221297e-10
presumptive O 0 1.1411007960759889e-07
function O 0 4.518507346062961e-09
as O 0 4.432191280656639e-10
a O 0 3.342023768837521e-09
tumor B-Disease 0 3.7812119444424752e-06
suppressor O 0 5.967384822724853e-06
. O 0 5.473124815580377e-07

Although O 0 1.0582795795244238e-07
the O 0 1.1872505645271758e-08
biochemical O 0 1.4629280542521883e-07
properties O 0 1.6616739983987827e-08
of O 0 2.3951256977738922e-08
BRCA1 O 0 2.9851744187681106e-08
polypeptides O 0 2.122270137405735e-09
are O 0 2.6895907376256467e-12
not O 0 2.685223571274875e-12
understood O 0 5.866035435175831e-10
, O 0 4.044328674041031e-12
their O 0 7.673821647569135e-12
expression O 0 4.084855509400853e-10
pattern O 0 2.5201429831867017e-09
and O 0 1.0465035088502717e-10
subcellular O 0 6.418692350962374e-07
localization O 0 3.359631818966591e-06
suggest O 0 9.190280536586215e-09
a O 0 3.8487718567736806e-10
role O 0 3.7081839820984897e-09
in O 0 2.5811712767165318e-09
cell O 0 1.8401568695480819e-06
- O 0 6.477498004642257e-07
cycle O 0 9.533169418318721e-07
regulation O 0 2.729342440943583e-07
. O 0 6.722729750663348e-08

When O 0 9.159310820905375e-08
resting O 0 5.993037575535709e-06
cells O 0 5.800475832984375e-08
are O 0 1.6030823890567092e-10
induced O 0 5.85109827255792e-09
to O 0 1.1474711458792086e-10
proliferate O 0 4.120508823035607e-09
, O 0 6.885542049722693e-12
the O 0 1.3778796159602535e-10
steady O 0 1.0083488888312786e-07
- O 0 6.445996514337082e-10
state O 0 6.698044202613218e-11
levels O 0 4.118316798695787e-09
of O 0 1.1405351107995898e-09
BRCA1 O 0 8.4564732993897e-10
increase O 0 3.5881870391607507e-11
in O 0 2.36569236422568e-11
late O 0 5.704329453237733e-09
G1 O 0 6.626714110780085e-08
and O 0 1.2661945103520367e-10
reach O 0 2.9934974499212785e-09
a O 0 1.0138224287858932e-10
maximum O 0 3.45164452575375e-09
during O 0 2.0007215439932224e-08
S O 0 6.556659286616195e-07
phase O 0 5.636633886751952e-06
. O 0 9.784440635485225e-07

Moreover O 0 4.445625563676003e-06
, O 0 1.402914340253858e-09
in O 0 4.915167717278734e-10
S O 0 3.382594115919346e-08
phase O 0 1.4386222346729483e-06
cells O 0 1.4385642543857102e-07
, O 0 1.2186313069761923e-09
BRCA1 O 0 8.733839429453383e-09
polypeptides O 0 2.7226174648120605e-09
are O 0 3.5618126503766945e-11
hyperphosphorylated O 0 6.531708152124338e-08
and O 0 2.360829864933578e-10
accumulate O 0 9.314068405430476e-10
into O 0 8.649502225566152e-10
discrete O 0 2.525679008158477e-07
subnuclear O 0 7.820793143764604e-06
foci O 0 1.776950398379995e-06
termed O 0 8.266858344541106e-07
" O 0 4.997500582248904e-07
BRCA1 O 0 1.3723908978136024e-06
nuclear O 0 2.944144853245234e-06
dots O 0 4.371605427877512e-06
. O 0 8.741056376493361e-07

" O 0 2.273563495691633e-06
BRCA1 O 0 4.986312433175044e-06
associates O 0 2.084636179233712e-07
in O 0 1.6994734508557485e-09
vivo O 0 7.162071113953061e-08
with O 0 1.3926305941769357e-10
a O 0 2.9876507934289975e-09
structurally O 0 1.4861061572446488e-06
related O 0 2.0207003217365127e-06
protein O 0 1.4950559261706076e-06
termed O 0 2.8434631076379446e-06
BARD1 O 1 0.9707754850387573
. O 0 1.3165746395316091e-06

Here O 0 5.733203920499363e-07
we O 0 3.824274674713024e-09
show O 0 5.113012790936011e-10
that O 0 2.69055524387829e-12
the O 0 2.986371566704449e-11
steady O 0 1.0583340781522566e-07
- O 0 9.567190373260814e-10
state O 0 8.052276206926834e-11
levels O 0 4.923389251842991e-09
of O 0 1.942481731020962e-09
BARD1 O 0 0.00011828791321022436
, O 0 4.156570573843332e-11
unlike O 0 3.192564268506004e-10
those O 0 7.25229251652415e-11
of O 0 2.727997605589394e-09
BRCA1 O 0 2.380319941153175e-08
, O 0 6.929193330229566e-11
remain O 0 4.639498119018981e-09
relatively O 0 6.463108936927142e-10
constant O 0 1.4733856357196373e-09
during O 0 1.542409044930082e-08
cell O 0 1.9886275026692601e-07
cycle O 0 6.006857233842311e-07
progression O 0 1.7567541590324254e-06
. O 0 1.7111814543113724e-07

However O 0 3.252054341373878e-07
, O 0 5.595982344175354e-09
immunostaining O 0 5.385731583373854e-06
revealed O 0 2.581621458830341e-07
that O 0 1.0050434928743357e-09
BARD1 O 0 0.24564141035079956
resides O 0 8.925267991344299e-08
within O 0 1.7251082340408175e-08
BRCA1 O 0 1.0436023600846056e-08
nuclear O 0 2.9645660148958086e-08
dots O 0 1.0347050327652596e-08
during O 0 4.349322324515015e-08
S O 0 1.84865047714311e-08
phase O 0 2.819695055222837e-07
of O 0 3.5517144780783383e-09
the O 0 1.3060788561780612e-10
cell O 0 1.2428326146007862e-09
cycle O 0 1.7101909888239675e-09
, O 0 1.544820261295543e-12
but O 0 7.471729940485006e-13
not O 0 2.332001562341257e-12
during O 0 2.9449465088760007e-09
the O 0 2.303386148483355e-09
G1 O 0 1.0641347216733266e-06
phase O 0 1.8735037201622617e-06
. O 0 4.803612227988197e-07

Nevertheless O 0 2.5475779693806544e-05
, O 0 2.9671795687136182e-08
BARD1 O 0 0.0005867863656021655
polypeptides O 0 2.326621739712209e-08
are O 0 3.940709911165463e-11
found O 0 3.244836691007613e-11
exclusively O 0 2.6070820502432923e-10
in O 0 1.1368134732181456e-11
the O 0 2.2697069917976265e-11
nuclear O 0 3.73723896274214e-09
fractions O 0 2.3023858375381678e-08
of O 0 4.2168402103470726e-09
both O 0 3.034230422471751e-09
G1 O 0 7.538864110756549e-07
- O 0 6.294675358731183e-08
and O 0 9.239153886397844e-10
S O 0 7.766068392811576e-07
- O 0 7.790341527424971e-08
phase O 0 3.3975804853980662e-06
cells O 0 7.179783096944448e-07
. O 0 1.4737355513716466e-07

Therefore O 0 3.9090278391995525e-07
, O 0 8.994557321173602e-10
progression O 0 7.510727328963185e-08
to O 0 5.549307680041693e-10
S O 0 1.1183071357834251e-08
phase O 0 5.061272645434656e-08
is O 0 2.698265569311964e-11
accompanied O 0 1.997052745394967e-09
by O 0 1.2484930624057089e-11
the O 0 9.920500532167864e-11
aggregation O 0 5.888118326247138e-10
of O 0 1.1425491663885623e-09
nuclear O 0 6.529964480250783e-07
BARD1 O 0 0.001717046950943768
polypeptides O 0 1.1373084589649807e-06
into O 0 1.9458964573004778e-07
BRCA1 O 0 1.9249398519605165e-06
nuclear O 0 3.1072647743712878e-06
dots O 0 1.0404211025161203e-05
. O 0 1.600873929419322e-06

This O 0 8.291205944033209e-09
cell O 0 5.883162401687514e-08
cycle O 0 9.66184146022897e-08
- O 0 2.5411699411392874e-08
dependent O 0 2.7019879667022906e-08
colocalization O 0 3.1400759326061234e-07
of O 0 2.5559911520645073e-08
BARD1 O 1 0.9988975524902344
and O 0 1.3636053397547698e-09
BRCA1 O 0 9.046314808358602e-09
indicates O 0 5.332739250185625e-10
a O 0 3.0091738129067735e-11
role O 0 6.199882274238178e-10
for O 0 1.1725096449310968e-09
BARD1 O 1 0.9996360540390015
in O 0 1.508321645360411e-07
BRCA1 O 0 2.6550987968221307e-05
- O 0 1.0349880540161394e-05
mediated O 0 0.00033423746936023235
tumor B-Disease 0 0.0005937398527748883
suppression O 0 0.0006699966615997255
. O 0 2.4200805910368217e-06

Ethnic O 0 4.69727041263468e-07
differences O 0 2.218250045871173e-07
in O 0 7.832662851647854e-10
the O 0 3.0489659685883908e-09
HFE O 0 2.83430636045523e-05
codon O 0 4.894459948445729e-07
282 O 0 4.187427862234472e-07
( O 0 4.74168437847311e-08
Cys O 1 0.704586923122406
/ O 0 1.0655194273567759e-05
Tyr O 0 5.992637397866929e-06
) O 0 5.26809040835019e-09
polymorphism O 0 6.718512395309517e-07
. O 0 3.412429805393913e-07

Recent O 0 8.24748447314505e-09
studies O 0 1.0020784202424693e-09
have O 0 3.412682463010963e-12
shown O 0 8.038331666959664e-10
that O 0 2.0551709223326498e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.0009506525238975883
HH B-Disease 1 1.0
) O 0 2.3323332154490117e-10
is O 0 1.3778237231698576e-11
likely O 0 5.711606881897424e-11
to O 0 1.4622667660058042e-11
be O 0 1.48824980117368e-10
caused O 0 1.4400400871750207e-09
by O 0 1.1683769229886565e-10
homozygosity O 0 2.6000785169344454e-07
for O 0 9.822144486637541e-11
a O 0 1.4709624629460905e-09
Cys282Tyr O 0 3.1780705285200384e-06
mutation O 0 1.6819822201696866e-09
in O 0 2.2561941204202185e-10
the O 0 5.563480343084848e-09
HFE O 0 0.0001246975880349055
gene O 0 5.617062370788517e-08
located O 0 1.6818001213891876e-08
4 O 0 5.607931186091264e-08
. O 0 1.994039848796092e-07

5 O 0 8.723168889446242e-07
Mb O 0 6.573294376721606e-05
telomeric O 0 1.2082493412890472e-05
to O 0 1.1674205779854674e-07
HLA O 0 2.4184599169529974e-05
- O 0 5.472193151945248e-06
A O 0 2.2039375835447572e-06
. O 0 7.022043746474083e-07

Population O 0 1.6867981456059056e-09
studies O 0 3.720523333861081e-10
of O 0 1.0733618160951863e-10
this O 0 5.418923122724184e-12
polymorphism O 0 3.757130162540534e-09
are O 0 1.041195081541435e-11
facilitated O 0 1.655299231018148e-09
by O 0 2.1109924572271233e-11
the O 0 9.115030258355361e-11
fact O 0 7.930597845096088e-11
that O 0 3.4304202273932605e-12
the O 0 3.4746494570470077e-10
Cys282Tyr O 0 7.620802534802351e-06
mutation O 0 2.2133299637516757e-08
creates O 0 2.7082760478691625e-09
a O 0 6.332848023760107e-09
Rsal O 0 1.93420364666963e-05
restriction O 0 2.4074276794294747e-08
site O 0 2.6864276136961962e-08
. O 0 8.375545945682461e-08

We O 0 4.1850483967209584e-08
have O 0 2.6415492015985365e-10
studied O 0 2.7838673588576057e-09
the O 0 2.5696803018782077e-10
codon O 0 3.915407020826933e-08
282 O 0 1.6218049836425052e-07
( O 0 5.589574314512902e-08
Cys O 1 0.9936406016349792
/ O 0 5.531535407499177e-06
Tyr O 0 2.3398893063131254e-06
) O 0 2.959523737189329e-10
polymorphism O 0 1.7855949607792354e-08
in O 0 5.18256444703713e-11
different O 0 1.687485845502934e-10
ethnic O 0 3.11515013784458e-09
groups O 0 5.671260128181643e-10
. O 0 3.6507305622990316e-08

In O 0 3.2203681943343554e-09
agreement O 0 4.223730698527106e-09
with O 0 9.728324396052201e-11
previous O 0 6.359101689668023e-09
observations O 0 5.432653882309069e-09
the O 0 3.664169800909889e-10
Tyr O 0 4.1445513687676794e-08
allele O 0 2.844915414357274e-09
appeared O 0 7.850371464002137e-10
to O 0 7.839683763277705e-11
be O 0 5.405508818334681e-10
rare O 0 9.566738512489792e-09
or O 0 1.885237743692869e-08
absent O 0 0.006249699275940657
in O 0 1.7361230675305706e-08
Asiatic O 0 2.68209714704426e-06
( O 0 2.766725737401998e-10
Indian O 0 1.0475750045202403e-08
, O 0 1.6022112803160127e-10
Chinese O 0 4.661886876533572e-09
) O 0 2.461621739779929e-10
populations O 0 1.842946240060428e-09
. O 0 1.3186684633126333e-08

The O 0 1.817672412585125e-08
highest O 0 2.6922650775418333e-08
allele O 0 1.6958305870673485e-09
frequency O 0 4.162548528086063e-09
( O 0 1.4542729867561555e-11
7 O 0 9.757840091495495e-10
. O 0 4.815952497905229e-11
5 O 0 1.774521501962667e-10
% O 0 1.519520204107394e-10
) O 0 2.852066456268676e-12
was O 0 6.062988444632822e-10
found O 0 2.1634545543935957e-10
in O 0 1.0880217837794248e-09
Swedes O 0 1.0614351594995242e-05
. O 0 2.5017450298037147e-06

Saamis O 1 0.8377394080162048
( O 0 4.5882453392209754e-09
2 O 0 1.1484313056087103e-08
% O 0 5.143975023713665e-09
) O 0 7.664035205079411e-12
and O 0 1.98971755738242e-10
Mordvinians O 0 0.02481560967862606
( O 0 1.0037249503769274e-10
1 O 0 4.3212530775882385e-10
. O 0 3.1351393703360486e-11
8 O 0 4.58305671191539e-10
% O 0 1.8250631561578246e-10
) O 0 2.8351444456009567e-12
had O 0 1.4589404337406187e-11
significantly O 0 1.346205091845576e-10
lower O 0 5.242457579157644e-10
frequencies O 0 5.123558910469228e-09
of O 0 6.870989999185895e-09
the O 0 3.533991588255958e-08
Tyr O 0 1.8142149201594293e-05
allele O 0 8.196276439775829e-07
. O 0 7.117159270819684e-07

Comparisons O 0 6.018290577003427e-08
with O 0 3.081200017351904e-10
allele O 0 2.9975997239972685e-09
frequencies O 0 4.3145513828335424e-09
based O 0 5.5584047781165324e-11
on O 0 7.751013164636333e-10
prevalence O 0 8.682349950106527e-09
estimates O 0 1.5706942690929537e-10
of O 0 8.555225416984058e-10
HH B-Disease 0 0.010432938113808632
showed O 0 2.6676985953599797e-08
some O 0 1.1311430264671074e-10
disagreements O 0 4.70396770424486e-08
with O 0 1.6140130898456562e-11
the O 0 1.1372701669287721e-09
RFLP O 0 1.382753680445603e-06
data O 0 8.656492411773797e-08
, O 0 5.12985376399655e-10
particularly O 0 2.5881716769760033e-09
in O 0 3.865385345136474e-09
Finns O 0 1.0095108336827252e-05
. O 0 6.113940003160678e-07

The O 0 1.096859563176622e-07
newly O 0 3.7570964650512906e-07
described O 0 5.0480164048849474e-08
HFE O 0 0.0003235070616938174
marker O 0 3.283654237407063e-08
provides O 0 1.5076118131673866e-10
a O 0 1.2739578489351366e-11
new O 0 4.457365466309371e-12
approach O 0 1.5619081028539483e-10
to O 0 2.1944860859046678e-11
the O 0 7.068339663574008e-11
screening O 0 1.8777186472362928e-09
of O 0 7.062902707133389e-09
HH B-Disease 1 0.9998736381530762
as O 0 5.541354597404791e-10
well O 0 1.6719954587518515e-10
as O 0 1.3717717066430435e-11
studies O 0 1.5862292035428993e-10
of O 0 7.154360437411356e-11
the O 0 1.3769785311978922e-10
relationship O 0 5.279688686243844e-09
between O 0 1.2094782952942751e-08
the O 0 2.0861708804886803e-08
HFE O 0 0.00010060073691420257
Tyr O 0 7.759376217109093e-07
allele O 0 1.4611593712743343e-08
and O 0 3.865545938896986e-10
different O 0 2.1107862124836174e-08
disorders O 1 0.9952443242073059
including O 0 1.395428625983186e-06
cancer B-Disease 1 0.9999995231628418

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9960328936576843
associated O 0 3.436452189475858e-08
with O 0 6.53826853769246e-11
a O 0 1.9111474902633319e-10
missense O 0 1.4927488578564407e-08
mutation O 0 5.36130528860923e-10
encoding O 0 2.9941705292912957e-07
Gly23 O 0 0.014589609578251839
- O 0 0.00012555523426271975
- O 0 9.736329047882464e-06
> O 0 4.0626482586958446e-06
Val O 0 3.8653143974443083e-07
in O 0 9.083626295591785e-09
neurophysin O 0 1.9604885892476887e-05
II O 1 0.9814355969429016
. O 0 3.689973027576343e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 5.450103301996023e-08
ADNDI B-Disease 1 0.9999998807907104
) O 0 1.1731914051349435e-10
is O 0 4.5998864439678044e-11
an O 0 6.654979900488911e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.014331066980957985
by O 0 8.969275988590653e-09
progressive O 1 0.9995356798171997
degeneration O 1 0.9999996423721313
of O 0 1.0427893357700668e-05
the O 0 2.3202137100497566e-08
magnocellular O 0 1.0005712283600587e-05
neurons O 0 7.447077621236531e-08
of O 0 9.580177540158274e-09
the O 0 1.2749807432044236e-08
hypothalamus O 0 3.169916951151208e-08
leading O 0 8.615605118222902e-09
to O 0 1.3767349482662894e-09
decreased O 0 7.999948081760522e-08
ability O 0 2.812495347725985e-09
to O 0 1.7690164610950632e-10
produce O 0 1.5933375729915156e-09
the O 0 3.953753768826118e-09
hormone O 0 2.6845068390457527e-08
arginine O 0 2.847398548055935e-07
vasopressin O 0 1.3461981325235683e-06
( O 0 8.088242076098595e-09
AVP O 0 1.0495415153854992e-05
) O 0 6.18276230213155e-09
. O 0 2.2010922862136795e-07

Affected O 0 6.101393523749721e-07
individuals O 0 1.9018466801412615e-09
are O 0 2.7317696715822848e-11
not O 0 8.84690029567814e-11
symptomatic O 0 9.93731248399854e-08
at O 0 9.528128286362403e-10
birth O 0 5.986860784901182e-09
, O 0 1.8563999296117295e-11
but O 0 1.1371995359277243e-11
usually O 0 1.904525648299682e-09
develop O 0 5.183362191019114e-06
diabetes B-Disease 1 0.9999983310699463
insipidus I-Disease 1 0.9990671277046204
at O 0 4.07590988515949e-07
1 O 0 1.6406688985171058e-07
- O 0 1.3283474231684522e-07
6 O 0 2.4514942964515285e-08
yr O 0 2.3055492874846095e-06
of O 0 7.830307069411901e-09
age O 0 9.455466454255657e-08
. O 0 1.3577465551861678e-07

The O 0 5.6621757948960294e-08
genetic O 0 5.931499202915802e-08
locus O 0 4.740424497384765e-09
of O 0 3.431793293984242e-09
the O 0 7.484425523784921e-09
disease O 0 1.1830382391053718e-05
is O 0 4.547850984693014e-10
the O 0 3.941181958566631e-08
AVP O 1 0.9944601058959961
- O 0 0.2140059769153595
neurophysin O 1 0.8614456057548523
II O 1 1.0
( O 0 2.5621295662858756e-07
NPII O 1 0.9999960660934448
) O 0 3.1932401167722446e-10
gene O 0 3.058878428330303e-10
, O 0 1.070825806498421e-11
and O 0 3.5392071218165455e-11
mutations O 0 1.751939593397367e-09
that O 0 2.5964759856056396e-11
cause O 0 2.1258202309581975e-08
ADNDI B-Disease 1 0.997526228427887
have O 0 6.300877181120157e-11
been O 0 6.10393333100312e-11
found O 0 2.674174597039336e-11
in O 0 3.870817295165141e-12
both O 0 5.951704407092251e-12
the O 0 2.8630504217419528e-11
signal O 0 4.953833343535052e-09
peptide O 0 9.342733253703273e-10
of O 0 2.840848667418072e-09
the O 0 7.0386954043044625e-09
prepro O 0 5.637704816763289e-05
- O 0 0.00012009683268843219
AVP O 0 0.024711156263947487
- O 0 0.004678867757320404
NPII O 1 0.9998446702957153
precursor O 0 1.771325202071239e-07
and O 0 1.0617136059209997e-09
within O 0 1.3031966261678463e-07
NPII O 1 0.9991253018379211
itself O 0 5.8396956603701256e-08
. O 0 9.645601295460438e-08

An O 0 1.1004571476291858e-08
affected O 0 7.389336076357722e-08
girl O 0 3.311094758373656e-07
who O 0 7.612295793713031e-10
presented O 0 9.749287599447598e-09
at O 0 2.4535371512257598e-09
9 O 0 8.899709302845338e-10
months O 0 3.140790960642903e-10
of O 0 1.5807262443434666e-10
age O 0 3.0149853724736886e-09
and O 0 5.164575711535946e-11
her O 0 1.4900619627056244e-10
similarly O 0 5.64759849996932e-10
affected O 0 1.4153799243743492e-09
younger O 0 5.11771824918128e-09
brother O 0 3.4664162651409924e-09
and O 0 3.7486864307156864e-11
father O 0 1.2320023223821863e-08
were O 0 3.0578823917437603e-09
all O 0 2.5068894876634218e-11
found O 0 1.9694034597561583e-11
to O 0 1.0866353823690833e-11
have O 0 7.078535674276409e-12
a O 0 1.6226681456843473e-11
novel O 0 3.7682787445980637e-11
missense O 0 1.4216277932632693e-08
mutation O 0 4.145171983438445e-10
( O 0 7.796082529543114e-11
G1758 O 0 1.8521993752074195e-06
- O 0 4.785167107002053e-07
- O 0 1.1038358849191354e-07
> O 0 1.4420335148201957e-08
T O 0 1.1936188704098072e-09
) O 0 1.2163328070441404e-12
encoding O 0 3.437681250773039e-10
the O 0 7.498020260232607e-11
amino O 0 1.8358584097377673e-10
acid O 0 5.5088409528503135e-11
substitution O 0 2.4710218315959764e-09
Gly23 O 0 1.0830957762664184e-05
- O 0 8.945631634560414e-06
- O 0 4.871423243457684e-06
> O 0 2.4278247110487428e-06
Val O 0 1.0224250672763446e-06
within O 0 8.229525292335893e-07
NPII O 1 0.9987039566040039
. O 0 1.891394845188188e-06

The O 0 6.222016679657827e-08
mutation O 0 7.293722070755848e-09
was O 0 2.9363371734092425e-09
confirmed O 0 1.0425752483556039e-09
by O 0 4.494992919545915e-11
restriction O 0 4.6091017114058275e-10
endonuclease O 0 8.790041583495167e-09
analysis O 0 2.622435246735222e-08
. O 0 4.644538265097253e-08

A O 0 5.190048796066549e-06
T1 O 0 5.879763557459228e-05
- O 0 6.707897881597091e-08
weighted O 0 2.436723323118173e-10
magnetic O 0 1.5547813037031233e-09
resonance O 0 6.010521858001994e-09
imaging O 0 2.0242636367129307e-07
of O 0 1.2104544921953675e-08
the O 0 2.0438433168123993e-08
fathers O 0 5.34481341674109e-06
pituitary O 0 9.662582306191325e-05
gland O 0 2.961960490210913e-06
demonstrates O 0 2.9409347845898992e-08
an O 0 6.084350800961147e-10
attenuated O 0 2.3646371118957177e-06
posterior O 0 2.5322118744952604e-05
pituitary O 1 0.8071444034576416
bright O 0 4.853133941651322e-05
spot O 0 0.00020578633120749146
. O 0 3.1623824270354817e-06

This O 0 2.1565229602060754e-08
mutation O 0 2.735319348801113e-08
may O 0 2.022612910490551e-10
be O 0 9.725727168063969e-11
valuable O 0 1.6113386180904854e-09
for O 0 1.9371518278354927e-11
developing O 0 4.407367359959835e-09
models O 0 5.8719265005890975e-09
of O 0 1.300077911992048e-08
dominantly B-Disease 1 0.9957777261734009
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 5.001569824969465e-09
as O 0 5.448712661615396e-11
the O 0 3.030098047474006e-11
early O 0 9.962184410738928e-10
age O 0 1.2595205989285319e-09
of O 0 6.103366145815414e-10
onset O 0 0.0003603099612519145
of O 0 9.787728316723587e-08
symptoms O 0 0.00010177151852985844
suggests O 0 2.8787525696571947e-09
that O 0 4.834107506651586e-12
this O 0 1.762081973388785e-11
mutation O 0 9.170069703579031e-10
may O 0 1.413579669984344e-10
be O 0 1.1594043503038165e-09
particularly O 0 1.2258330350789493e-08
deleterious O 0 1.926667714258201e-08
to O 0 1.885157585590491e-09
the O 0 9.819834900781643e-08
magnocellular O 0 0.00013415941793937236
neuron O 0 7.888471600381308e-07
. O 0 2.3442526142503084e-08
. O 0 1.8334777962536464e-07

Frequent O 0 1.056481096384232e-06
inactivation O 0 3.276770075899549e-05
of O 0 0.00011951284250244498
PTEN O 1 0.9999903440475464
/ O 1 0.9575517177581787
MMAC1 O 1 0.9999991655349731
in O 0 7.955591740937962e-08
primary O 1 0.9994038343429565
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00016062513168435544

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 6.800237315474078e-06
the O 0 1.2868892440565105e-07
most O 0 6.5000360649492e-10
common O 0 3.45124462342028e-08
male B-Disease 0 8.87856640474638e-06
cancer I-Disease 0 4.366820007817296e-07
in O 0 5.063153007967003e-09
the O 0 2.9065830631225253e-08
Western O 0 4.6365013872673444e-07
world O 0 3.323498698470928e-10
, O 0 1.1270722202749717e-11
yet O 0 3.65646055100477e-11
many O 0 1.827987847896617e-12
of O 0 1.3785492712636849e-11
the O 0 9.411527980562884e-12
major O 0 6.735966645576852e-11
genetic O 0 5.464138586042111e-10
events O 0 6.409654057515368e-11
involved O 0 8.801361306431943e-10
in O 0 4.7756590348946304e-11
the O 0 1.9882076540689297e-10
progression O 0 3.714486638273229e-07
of O 0 1.876465427486096e-09
this O 0 3.2413741135606244e-10
often O 0 1.3171552737389902e-08
fatal O 0 9.136870357906446e-05
cancer B-Disease 0 4.8982619773596525e-05
remain O 0 5.049883839092217e-06
to O 0 6.176350542119735e-09
be O 0 5.7639056194602745e-08
elucidated O 0 0.00017665786435827613
. O 0 1.1128938695037505e-06

Numerous O 0 1.9295184472412075e-07
cytogenetic O 0 4.132916728849523e-05
and O 0 9.103990450398669e-09
allelotype O 0 3.0341739147843327e-06
studies O 0 1.9447987664733546e-09
have O 0 4.118412642167835e-12
reported O 0 1.4196827741175255e-11
frequent O 0 3.016247668297112e-11
loss O 0 6.074308833703412e-10
of O 0 2.246534513972165e-08
heterozygosity O 1 0.7119173407554626
on O 0 2.696968408599787e-07
chromosomal O 0 0.00022771063959226012
arm O 0 0.005368301644921303
10q O 1 0.9993672966957092
in O 0 8.844464787216566e-07
sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0003729074087459594

Deletion O 0 4.625690507964464e-06
mapping O 0 5.823033575325098e-07
studies O 0 1.8346490548992733e-08
have O 0 5.7416116999720046e-11
unambiguously O 0 1.4355288069367589e-09
identified O 0 7.839358606709368e-10
a O 0 7.517639288856515e-11
region O 0 1.0216502310811393e-08
of O 0 6.994117729419713e-09
chromosome O 0 2.6760622517940647e-07
10q23 O 0 2.60855995293241e-05
to O 0 2.380013408576076e-10
be O 0 1.140904384855368e-10
the O 0 3.055449782074504e-10
minimal O 0 2.1735120014909626e-07
area O 0 4.940924558383131e-09
of O 0 7.86446285871989e-09
loss O 0 2.412940318663459e-07
. O 0 5.244008320914872e-07

A O 0 1.1586643040573108e-06
new O 0 1.6719587492275423e-08
tumor B-Disease 0 1.181311858999834e-06
suppressor O 0 1.2228040304762544e-06
gene O 0 1.9005854667852873e-08
, O 0 4.6190837821313835e-09
PTEN O 0 0.0009615595336072147
/ O 0 3.967019802075811e-05
MMAC1 O 1 0.9999940395355225
, O 0 8.210188640056515e-10
was O 0 1.6996072105257554e-08
isolated O 0 6.522941298214846e-09
recently O 0 1.6264274649291366e-10
at O 0 3.263606399017682e-11
this O 0 2.8304329366402037e-12
region O 0 8.07499678234791e-10
of O 0 8.017735919629843e-10
chromosome O 0 4.264702369027873e-08
10q23 O 0 5.40305836693733e-06
and O 0 3.3624630857431725e-10
found O 0 2.5793195357337595e-10
to O 0 2.1626159196763695e-11
be O 0 2.152664851928776e-11
inactivated O 0 3.8877279173732404e-10
by O 0 9.67360566650477e-12
mutation O 0 2.2362292573241405e-10
in O 0 2.0861092020485472e-10
three O 0 4.637465522705497e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.48363086581230164
lines O 0 3.332665414745861e-07
. O 0 8.964045861148406e-08

We O 0 1.13290873571259e-07
screened O 0 5.877026865164225e-07
80 O 0 8.056602496253618e-07
prostate B-Disease 1 0.9830713868141174
tumors I-Disease 1 1.0
by O 0 3.988647190311667e-10
microsatellite O 0 2.9354424668781576e-08
analysis O 0 6.29084118131118e-10
and O 0 6.251673224239029e-12
found O 0 3.434861076123674e-11
chromosome O 0 3.065620202136188e-09
10q23 O 0 1.521668764326023e-06
to O 0 9.020362234934964e-10
be O 0 3.808333648436246e-09
deleted O 0 2.3295477546980692e-08
in O 0 7.366840470979241e-10
23 O 0 2.27504148853086e-08
cases O 0 3.1923284016244224e-09
. O 0 5.668767144584308e-08

We O 0 1.0774981795691474e-08
then O 0 1.422578443932565e-10
proceeded O 0 1.2752573441687787e-09
with O 0 8.544302418367344e-13
sequence O 0 3.821645777613014e-11
analysis O 0 7.814498353964083e-11
of O 0 5.807319555795054e-11
the O 0 2.3725982289946046e-10
entire O 0 1.4330449857880012e-06
PTEN O 0 0.01668163575232029
/ O 0 1.4158123121887911e-05
MMAC1 O 1 0.9724407196044922
coding O 0 3.666337579488754e-05
region O 0 1.757251411049765e-08
and O 0 3.470474949085478e-11
tested O 0 3.7302438915531866e-10
for O 0 3.365085640694154e-11
homozygous O 0 1.159871088063369e-09
deletion O 0 1.6383125966967782e-09
with O 0 3.928275066344966e-11
new O 0 2.686635081072808e-10
intragenic O 0 4.193921085970942e-06
markers O 0 2.680954347411557e-09
in O 0 6.330390378561646e-11
these O 0 2.159919985922354e-11
23 O 0 3.1299904335035933e-10
cases O 0 1.6695566804059148e-11
with O 0 4.639962372654516e-11
10q23 O 0 8.415445336140692e-06
loss O 0 8.588553868094095e-08
of O 0 5.600031158792262e-07
heterozygosity O 1 0.8523268103599548
. O 0 1.4104850379226264e-05

The O 0 5.237772437993726e-09
identification O 0 6.434590460457912e-08
of O 0 1.808177074735795e-08
the O 0 2.163682566447278e-09
second O 0 2.674015320280887e-08
mutational O 0 5.582584208241315e-07
event O 0 3.3690643608252913e-09
in O 0 2.592147607671791e-10
10 O 0 3.1992389293300505e-10
( O 0 2.647267648148155e-11
43 O 0 5.3910994779471366e-08
% O 0 6.698373056224227e-08
) O 0 1.3567492018751182e-08
tumors B-Disease 1 1.0
establishes O 0 7.598129627695016e-07
PTEN O 0 0.2556665241718292
/ O 0 0.000564183050300926
MMAC1 O 1 0.9999170303344727
as O 0 1.1454752701922644e-09
a O 0 1.921703907115102e-10
main O 0 5.622362020396565e-10
inactivation O 0 7.66287833187107e-09
target O 0 1.38076106104279e-09
of O 0 4.735282832513121e-09
10q O 0 4.0967021050164476e-05
loss O 0 8.620244074108996e-08
in O 0 2.51711771426244e-08
sporadic B-Disease 1 0.9999748468399048
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.307982509199064e-07
. O 0 1.9020022534732561e-07

Risk O 0 1.3403207958617713e-05
reversals O 0 1.308411128775333e-06
in O 0 1.8281089975147324e-09
predictive O 0 5.88563153769428e-08
testing O 0 2.386397746079183e-08
for O 0 3.8926739165390245e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.2530887235916452e-06

The O 0 5.958949333972896e-09
first O 0 4.739554859689576e-10
predictive O 0 9.38352595625247e-09
testing O 0 1.5725746260741857e-09
for O 0 8.575291587931133e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.1492527202404688e-10
HD B-Disease 0 1.2055064871674404e-05
) O 0 4.612535613873758e-12
was O 0 2.909851179455636e-11
based O 0 7.102713599563271e-13
on O 0 1.3854290110970613e-11
analysis O 0 2.284963052101574e-10
of O 0 8.938901008281874e-11
linked O 0 2.995279357875802e-09
polymorphic O 0 1.6656079848687e-09
DNA O 0 7.31512486140673e-08
markers O 0 5.787220147546179e-10
to O 0 1.2313104702510458e-10
estimate O 0 5.746336184664358e-10
the O 0 4.6800032599270125e-11
likelihood O 0 3.1721529847317242e-09
of O 0 1.4904237843893497e-09
inheriting O 0 1.7687187892079237e-07
the O 0 7.117781475329821e-09
mutation O 0 6.6872511972349e-09
for O 0 4.044095724964336e-09
HD B-Disease 0 0.0018354876665398479
. O 0 1.3787059742753627e-06

Limits O 0 2.373306706715539e-08
to O 0 2.661399156611566e-10
accuracy O 0 9.065954209575011e-09
included O 0 1.6699937266384524e-10
recombination O 0 6.293733312290328e-10
between O 0 5.551690218652539e-10
the O 0 2.775658314302376e-10
DNA O 0 4.7942755543317617e-08
markers O 0 2.159782130917165e-09
and O 0 5.507569747487118e-11
the O 0 1.9598901668249624e-10
mutation O 0 2.0632537900411307e-09
, O 0 2.9011008872981137e-11
pedigree O 0 1.7279194741703918e-09
structure O 0 7.568966786664078e-09
, O 0 2.5306217191212177e-11
and O 0 6.0569717644232135e-12
whether O 0 1.7748353134394712e-11
DNA O 0 5.760945498423098e-09
samples O 0 4.273386366993037e-10
were O 0 4.391519786706155e-11
available O 0 1.4688028571185896e-10
from O 0 2.5216695051510918e-11
family O 0 2.1506714464880616e-10
members O 0 1.4784810042911545e-09
. O 0 1.114774548227615e-07

With O 0 9.461700312130006e-10
direct O 0 1.1946984512789527e-09
tests O 0 1.4569945250286764e-10
for O 0 1.1721283665888649e-11
the O 0 7.65769808674932e-11
HD B-Disease 0 1.165434355243633e-06
mutation O 0 1.8565213255605784e-10
, O 0 1.224510293509895e-12
we O 0 1.9427157365442538e-12
have O 0 1.9549776565392502e-13
assessed O 0 1.1443019448664771e-10
the O 0 2.5830882571797886e-12
accuracy O 0 1.6198127283928443e-09
of O 0 4.936850234171786e-11
results O 0 1.965999411879249e-11
obtained O 0 1.290020867905639e-10
by O 0 1.1671467611829023e-11
linkage O 0 2.229939566333883e-09
approaches O 0 4.691427801795101e-10
when O 0 1.8710810678612688e-11
requested O 0 2.498928008964896e-10
to O 0 1.1415138279069481e-10
do O 0 1.4675204107472695e-10
so O 0 2.413345565055458e-11
by O 0 1.0346818020423587e-11
the O 0 6.117534950833559e-11
test O 0 3.033384099460079e-10
individuals O 0 1.2382634917429414e-09
. O 0 6.680178188389618e-08

For O 0 9.810958268019476e-09
six O 0 1.911334202020498e-09
such O 0 2.280024953560389e-11
individuals O 0 6.32713048620559e-11
, O 0 1.4116389480955949e-11
there O 0 3.1699965569176314e-11
was O 0 1.8062287221454199e-09
significant O 0 2.1083186307890855e-09
disparity O 0 2.546487642973716e-08
between O 0 1.0279123108247745e-09
the O 0 6.996048740326444e-10
tests O 0 8.502539117216656e-09
. O 0 1.1326450533033494e-07

Three O 0 2.70264752799676e-08
went O 0 3.028404194083123e-08
from O 0 8.932736217381887e-10
a O 0 2.775446539260429e-10
decreased O 0 1.1477266781412254e-07
risk O 0 2.2077801808961794e-09
to O 0 1.0048436388521154e-10
an O 0 1.924424508636946e-11
increased O 0 1.5730214908415974e-09
risk O 0 6.802851060250248e-10
, O 0 1.1835519543590411e-11
while O 0 3.011826552046237e-11
in O 0 1.1490693813120956e-11
another O 0 3.822112071283357e-11
three O 0 2.623181880045955e-11
the O 0 1.933089105454755e-10
risk O 0 9.424026892190795e-09
was O 0 2.3296145457152306e-08
decreased O 0 6.618888050979876e-07
. O 0 1.0771061198511234e-07

Knowledge O 0 5.659693488269113e-05
of O 0 1.6154267257206811e-07
the O 0 5.2468318578746675e-09
potential O 0 2.099322271575943e-09
reasons O 0 6.938295493696955e-10
for O 0 7.488583537995641e-12
these O 0 8.352270264300188e-12
changes O 0 3.0968946157505783e-11
in O 0 6.6075422043565535e-12
results O 0 1.3131729037496598e-10
and O 0 4.774848225141959e-11
impact O 0 5.563562388566368e-10
of O 0 1.3610582105805236e-10
these O 0 5.119382695539798e-11
risk O 0 5.029376359821924e-10
reversals O 0 2.3518962333213267e-09
on O 0 1.8101560528283045e-10
both O 0 1.2790178638422134e-10
patients O 0 1.0967519115112623e-09
and O 0 1.5234256564577997e-11
the O 0 5.651550408214412e-11
counseling O 0 3.391701808297398e-09
team O 0 6.545130409874034e-11
can O 0 1.2677984530251596e-11
assist O 0 2.064564741388608e-09
in O 0 3.711866924938079e-11
the O 0 3.574934445693678e-11
development O 0 2.2335235883019777e-09
of O 0 1.206488797755867e-10
strategies O 0 1.0642277059602634e-09
for O 0 1.403295535329363e-11
the O 0 1.043231195874128e-10
prevention O 0 7.338879282059452e-09
and O 0 2.9875393825484764e-11
, O 0 2.1918077162258465e-12
where O 0 6.082035482884995e-12
necessary O 0 1.5477719106371524e-09
, O 0 2.5573671652567853e-11
management O 0 2.5761006661184638e-09
of O 0 3.7627431725972826e-10
a O 0 5.50191336934347e-10
risk O 0 3.774014878388243e-09
reversal O 0 2.9648417054772835e-09
in O 0 3.536696976946807e-11
any O 0 6.535538082941272e-11
predictive O 0 2.477992921967598e-09
testing O 0 9.795433353332328e-10
program O 0 3.1891880247769677e-09
. O 0 1.1571730240689249e-09
. O 0 1.5678075726555107e-08

A O 0 5.354765448828402e-07
novel O 0 3.869368825348829e-09
common O 0 4.830612354567165e-09
missense O 0 5.156620659363398e-07
mutation O 0 1.7667447504976508e-09
G301C O 0 2.491402142368315e-07
in O 0 1.3450038305329315e-10
the O 0 5.338295361312362e-10
N O 0 8.893778868923619e-08
- O 0 1.3499376905201643e-07
acetylgalactosamine O 0 6.231510269572027e-06
- O 0 3.3193973081324657e-07
6 O 0 2.0361767383292317e-07
- O 0 1.2548865413464227e-07
sulfate O 0 8.34610816013992e-08
sulfatase O 0 9.218766763297026e-07
gene O 0 2.6403015329634627e-09
in O 0 4.176434309499655e-09
mucopolysaccharidosis B-Disease 0 8.286535739898682e-05
IVA I-Disease 1 0.9999910593032837
. O 0 1.1058604286517948e-05

Mucopolysaccharidosis B-Disease 1 0.9965325593948364
IVA I-Disease 1 1.0
( O 0 7.089929567882791e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.5199479008742856e-08
is O 0 6.868772772783416e-10
an O 0 1.2122814974091511e-09
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 7.375052518909797e-05
by O 0 8.288640329645602e-10
a O 0 1.5192494373650334e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 5.167398953176416e-09
N O 0 9.328566363819846e-08
- O 0 3.094973877182383e-08
acetylgalactosamine O 0 1.7233245444003842e-06
- O 0 6.714528666407205e-08
6 O 0 4.906077677446774e-08
- O 0 9.957329183407637e-08
sulfate O 0 2.436340018618921e-08
sulfatase O 0 9.434746175429609e-07
( O 0 3.427972572467297e-09
GALNS O 0 0.0002670203393790871
) O 0 4.051986746134162e-09
. O 0 9.926004196358917e-08

In O 0 2.3402185078680304e-08
previous O 0 2.4421604294389e-08
studies O 0 1.5812217091237812e-09
, O 0 1.587790489365748e-11
we O 0 1.1057829998883939e-11
have O 0 1.135543048480514e-12
found O 0 1.245035411573392e-11
two O 0 5.847597579766717e-12
common O 0 1.5467793712531375e-10
mutations O 0 1.0023232244193991e-09
in O 0 3.793122482775857e-10
Caucasians O 0 2.59531613977515e-08
and O 0 2.7225952048404167e-10
Japanese O 0 9.532550961921515e-07
, O 0 1.8223961228969188e-09
respectively O 0 4.168085183664516e-07
. O 0 2.797906688556395e-07

To O 0 7.30200667931058e-07
characterize O 0 1.0021765774581581e-05
the O 0 6.741605318438815e-08
mutational O 0 7.595371698698727e-06
spectrum O 0 3.335605924803531e-08
in O 0 2.2603840674206843e-11
various O 0 8.86450149395479e-11
ethnic O 0 1.7748498504222e-10
groups O 0 8.564653326825766e-12
, O 0 7.57552701124986e-12
mutations O 0 1.0058062716034044e-10
in O 0 8.749002217145474e-11
the O 0 3.222365263511051e-09
GALNS O 0 0.000999339739792049
gene O 0 3.0969504738465048e-09
in O 0 2.1399193528282012e-09
Colombian O 0 0.0012543589109554887
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 6.352375976348412e-07
were O 0 3.749477173187188e-09
investigated O 0 9.703057912702207e-09
, O 0 1.85592548274105e-11
and O 0 1.096788545401628e-11
genetic O 0 7.010983460453701e-10
backgrounds O 0 1.5747807502464184e-09
were O 0 6.303909616534042e-10
extensively O 0 1.584083419992055e-09
analyzed O 0 1.0297215302657037e-09
to O 0 1.550994402355066e-11
identify O 0 7.462256368384601e-10
racial O 0 1.2273945748653148e-10
origin O 0 1.9668480732981664e-10
, O 0 4.3226832703580076e-12
based O 0 2.050915210230486e-12
on O 0 9.916339277493691e-11
mitochondrial O 0 2.5967061834109018e-09
DNA O 0 9.784741905605188e-08
( O 0 9.09315567287905e-10
mtDNA O 0 1.1299349722548868e-07
) O 0 1.4676638793176267e-09
lineages O 0 5.142064907204258e-08
. O 0 2.2667863674996624e-07

Three O 0 2.807887078404292e-08
novel O 0 5.825908200307595e-09
missense O 0 8.446533001915668e-07
mutations O 0 4.925653218634807e-09
never O 0 3.828960704055362e-09
identified O 0 1.5715230006208003e-08
previously O 0 6.1396225881082955e-09
in O 0 6.186719886391856e-11
other O 0 3.116912283829265e-11
populations O 0 3.3812470184857446e-11
and O 0 9.889304652954678e-12
found O 0 4.463518790687182e-11
in O 0 1.4983488408337742e-11
16 O 0 6.847581390800883e-10
out O 0 1.476647623621652e-11
of O 0 7.77838182752788e-10
19 O 0 2.7365354426933663e-08
Colombian O 0 0.00017407380801159889
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 1.1320171324769035e-06
alleles O 0 3.2232503333062823e-09
account O 0 3.0403002337919816e-10
for O 0 4.421450983116415e-10
84 O 0 5.654933374898974e-07
. O 0 4.071294767982181e-07

2 O 0 3.2379824688177905e-07
% O 0 3.593178377059303e-08
of O 0 7.327378703791965e-10
the O 0 1.828694140559861e-10
alleles O 0 8.932118239490805e-11
in O 0 5.11697142990819e-11
this O 0 1.3141902843738507e-10
study O 0 4.835405853498287e-09
. O 0 6.71137883045958e-08

The O 0 5.284442181618942e-07
G301C O 0 0.00010808582737809047
and O 0 1.1867411053856358e-08
S162F O 0 1.4031194950803183e-05
mutations O 0 4.480694038022648e-09
account O 0 8.290522157672342e-10
for O 0 8.230650050400357e-10
68 O 0 3.64334050573234e-06
. O 0 1.082842459254607e-06

4 O 0 1.3015923059356282e-06
% O 0 2.1390964377587807e-07
and O 0 1.4950959359438798e-09
10 O 0 3.919083368941756e-08
. O 0 8.966473075133763e-08

5 O 0 1.805327798365397e-07
% O 0 2.9317050120880594e-08
of O 0 1.0498146796322771e-09
mutations O 0 3.443718643580951e-10
, O 0 3.381376081912357e-11
respectively O 0 3.566969164481293e-09
, O 0 1.324479154823921e-11
whereas O 0 5.855773088647709e-10
the O 0 4.869379344185631e-10
remaining O 0 1.08681319943571e-06
F69V O 1 0.9860299229621887
is O 0 6.748247100007987e-11
limited O 0 1.000761903902081e-10
to O 0 5.929205737498222e-11
a O 0 3.5873129466956755e-10
single O 0 9.727555649874375e-09
allele O 0 1.8278230129453732e-07
. O 0 4.154976238623931e-07

The O 0 1.780749130375625e-07
skewed O 0 2.0292966951274138e-07
prevalence O 0 2.9715973681732066e-08
of O 0 1.6119903190059404e-09
G301C O 0 3.6909898426529253e-07
in O 0 3.441464821452023e-11
only O 0 3.2307687775068317e-11
Colombian O 0 1.1692745971458862e-07
patients O 0 1.947682903846726e-09
and O 0 9.588321109310627e-11
haplotype O 0 1.4921018864910707e-09
analysis O 0 1.0076072615161635e-10
by O 0 6.977385249434809e-12
restriction O 0 1.581931981242679e-11
fragment O 0 1.942814104038959e-10
length O 0 1.0733439692600655e-09
polymorphisms O 0 6.616304837336884e-09
in O 0 4.0315861760120697e-10
the O 0 9.675078516124813e-09
GALNS O 1 0.8489857316017151
gene O 0 6.879894876021808e-09
suggest O 0 4.986044466193107e-09
that O 0 2.983917626875332e-11
G301C O 0 3.432653272739117e-07
originated O 0 3.384967639519232e-09
from O 0 3.8683781178328047e-10
a O 0 6.797598595120746e-10
common O 0 1.0785838888693888e-08
ancestor O 0 6.821028364356607e-06
. O 0 2.5279828150814865e-06

Investigation O 0 1.63214610893192e-06
of O 0 1.0425125651636336e-07
the O 0 2.9522073674570493e-09
genetic O 0 5.2711159881368985e-09
background O 0 1.9927304251154965e-09
by O 0 1.3899656599314358e-11
means O 0 2.4037649648533943e-09
of O 0 4.983553125725848e-09
mtDNA O 0 7.113414568493681e-08
lineages O 0 9.062215422517284e-10
indicate O 0 3.238815604600376e-10
that O 0 1.5166115975920325e-12
all O 0 2.4691301087065298e-11
our O 0 1.6613310727109365e-09
patients O 0 9.34198385316165e-10
are O 0 1.7088719328484103e-11
probably O 0 8.747271795783718e-10
of O 0 9.874331352577315e-10
native O 0 5.9150240261374165e-09
American O 0 1.7894242887450673e-07
descent O 0 0.0003740301763173193

Low O 0 9.992199920816347e-07
frequency O 0 9.356114816228e-08
of O 0 3.137112258855268e-08
BRCA1 O 0 1.3077982430331758e-07
germline O 0 7.372033223873586e-07
mutations O 0 6.72365996212676e-10
in O 0 2.394940357142161e-10
45 O 0 6.179675438033883e-08
German O 1 1.0
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3364254982661805e-06
. O 0 1.75585526562827e-07

In O 0 4.901024475145732e-09
this O 0 9.900445047117401e-11
study O 0 1.3842464674507227e-10
we O 0 1.3018575800716192e-11
investigated O 0 1.4214914800803058e-09
45 O 0 1.5914372042402647e-08
German O 1 0.9999219179153442
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.6295657024918455e-09
for O 0 2.4432900147530745e-10
germline O 0 1.6561500615352998e-06
mutations O 0 5.500895849941401e-10
in O 0 1.9462224887245583e-10
the O 0 2.5665760627902046e-09
BRCA1 O 0 1.4129562941889162e-07
gene O 0 2.1061090649254766e-08
. O 0 1.2424047213244194e-07

We O 0 5.703592265149382e-08
identified O 0 4.37842082590123e-08
four O 0 2.678230304198337e-09
germline O 0 1.1244347660976928e-05
mutations O 0 5.818412418534535e-09
in O 0 3.782488211534485e-10
three O 0 6.0562883597015116e-09
breast B-Disease 0 2.109629895130638e-05
cancer I-Disease 0 4.0864344441615685e-07
families O 0 1.3159064948808918e-09
and O 0 1.228050300339234e-10
in O 0 3.1028217772899325e-09
one O 0 4.121331130590988e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 5.5804772273404524e-05
. O 0 4.5843417950663934e-10
among O 0 4.2207448473774445e-12
these O 0 2.6597406460431017e-13
were O 0 2.7597988130900752e-11
one O 0 4.06531058816384e-12
frameshift O 0 7.095064535889151e-09
mutation O 0 3.59029778129738e-10
, O 0 2.791478680153059e-11
one O 0 2.5826621397051497e-10
nonsense O 0 5.694504352504737e-07
mutation O 0 9.255014532527639e-09
, O 0 2.1656673676595517e-10
one O 0 7.839714294410882e-11
novel O 0 5.335424879682193e-10
splice O 0 1.763490757866748e-07
site O 0 2.8722366707256697e-09
mutation O 0 2.5413331439239073e-09
, O 0 1.293213591768705e-10
and O 0 3.516130442360321e-10
one O 0 1.549875960904501e-08
missense O 0 5.580706420005299e-05
mutation O 0 2.5867079784802627e-06
. O 0 1.8780814343699603e-06

The O 0 2.318258935929407e-07
missense O 0 1.0079149433295242e-05
mutation O 0 1.682624706234037e-08
was O 0 3.485605049036167e-08
also O 0 2.1741643208006423e-10
found O 0 5.725483420704336e-10
in O 0 1.7752332936993298e-09
2 O 0 1.8337610185881204e-07
. O 0 3.2112285452967626e-07

8 O 0 3.7507453498619725e-07
% O 0 3.8352702347310696e-08
of O 0 9.44529232604907e-10
the O 0 1.4162783446014515e-10
general O 0 5.41853562019412e-10
population O 0 1.5198529934590255e-11
, O 0 2.742439522002149e-12
suggesting O 0 1.5310934464718429e-10
that O 0 7.864462119727689e-13
it O 0 1.0929204589948949e-12
is O 0 2.902473573984654e-11
not O 0 7.880014973871141e-10
disease O 0 1.8150276446249336e-06
associated O 0 4.782813448400702e-06
. O 0 4.459680894797202e-06

The O 0 1.928833448516798e-08
average O 0 2.9156430603194394e-09
age O 0 3.9377083815850256e-09
of O 0 2.0233972275462975e-09
disease O 0 7.157140657909622e-07
onset O 0 0.0003762874111998826
in O 0 2.98497782047491e-10
those O 0 2.658978870417883e-10
families O 0 3.237438372938328e-10
harbouring O 0 7.266252168847132e-07
causative O 0 1.6546346159884706e-07
mutations O 0 1.5518164531158618e-08
was O 0 8.14658349668207e-08
between O 0 2.668885201728699e-07
32 O 0 2.69349834525201e-06
. O 0 4.3458481968627893e-07

3 O 0 5.360585078051372e-07
and O 0 1.8886748165414247e-08
37 O 0 1.673198653406871e-06
. O 0 2.6469945169083076e-07

4 O 0 1.7004640540108085e-07
years O 0 6.626067250437018e-09
, O 0 5.1280021895472316e-11
whereas O 0 9.7217633943103e-10
the O 0 1.6216603060392742e-10
family O 0 3.566246464803413e-10
harbouring O 0 3.356575462021283e-07
the O 0 6.109771577555989e-10
missense O 0 1.459539049619707e-07
mutation O 0 6.913751238180055e-10
had O 0 9.196075845263607e-11
an O 0 1.0635178718590432e-12
average O 0 8.737729290109186e-11
age O 0 4.981051682229065e-10
of O 0 6.80132006269929e-10
onset O 0 8.94336244527949e-06
of O 0 8.676342986291274e-07
51 O 0 6.77457865094766e-06
. O 0 1.2674470326601295e-06

2 O 0 1.5941385527185048e-06
years O 0 6.308936804089171e-07
. O 0 6.995053922764782e-07

These O 0 1.4745194398813055e-08
findings O 0 6.665196394806117e-09
show O 0 8.368639670131017e-10
that O 0 4.5104003865148456e-11
BRCA1 O 0 6.051530831996388e-09
is O 0 2.876312556188143e-11
implicated O 0 5.6167735351664305e-08
in O 0 2.1483960443990924e-10
a O 0 2.2847015945792748e-10
small O 0 1.0366399405548066e-10
fraction O 0 2.268939880423204e-08
of O 0 5.578375748882536e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.795983166161477e-09
suggesting O 0 5.375342948532591e-10
the O 0 7.793045722626069e-12
involvement O 0 5.694825166990825e-10
of O 0 6.185708056882788e-10
another O 0 3.804614401303752e-10
susceptibility O 0 1.9585392863064044e-08
gene O 0 3.970242801187851e-09
( O 0 1.7731960344491426e-09
s O 0 3.873735749948537e-07
) O 0 3.1584954740537796e-07

Paternal O 0 0.0002127477346220985
transmission O 1 0.9998335838317871
of O 1 0.9962109327316284
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999910593032837

We O 0 5.980357542512138e-08
report O 0 1.072727906503701e-09
a O 0 5.6460232322752546e-11
rare O 0 4.247396878653831e-11
case O 0 4.5521267311166014e-11
of O 0 8.126034067856835e-09
paternally O 1 0.9999978542327881
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999263286590576
DM B-Disease 1 1.0
) O 0 4.6527215857850024e-08
. O 0 1.2077555311407195e-07

The O 0 4.982795758223801e-07
proband O 0 4.890215859632008e-05
is O 0 4.783428653176713e-10
a O 0 1.357141204971768e-10
23 O 0 1.0258636162774337e-09
year O 0 1.5351903082105878e-10
old O 0 4.413081100551608e-08
, O 0 1.5645535977881764e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 2.535762632760452e-06
who O 0 4.953807675178723e-08
suffers O 1 0.9652915000915527
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999991655349731

He O 0 7.449364858302943e-08
presented O 0 1.9208488311051042e-07
with O 0 4.169209333326762e-08
respiratory O 1 0.9999973773956299
and O 0 8.761606551388468e-08
feeding O 0 4.521752543951152e-06
difficulties O 1 0.8677693009376526
at O 0 2.0388563370943302e-07
birth O 0 2.4656242203491274e-06
. O 0 6.301330586211407e-07

His O 0 6.441553068725625e-07
two O 0 1.0397047134347304e-07
sibs O 0 0.2882208526134491
suffer O 0 2.7032563139073318e-06
from O 0 1.2650858138840704e-07
childhood O 1 0.9905608296394348
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 1.932621671585366e-05

Their O 0 4.807000575368647e-09
late O 0 2.5082227850248273e-08
father O 0 4.7931326463412915e-08
had O 0 3.495428391175892e-10
the O 0 1.8071951921050378e-11
adult O 0 2.444749125363188e-10
type O 0 4.943108700139476e-10
of O 0 5.9034963584281286e-08
DM B-Disease 1 1.0
, O 0 6.862879708968705e-10
with O 0 4.874255166154029e-11
onset O 0 0.0006880714208818972
around O 0 3.890103794645938e-09
30 O 0 3.224148281688599e-09
years O 0 6.25399598774834e-09
. O 0 2.4219078298415297e-08

Only O 0 4.642870532478582e-09
six O 0 6.239099792360037e-10
other O 0 2.9475215670982102e-12
cases O 0 1.7790473955114905e-12
of O 0 5.3935186178355465e-11
paternal O 0 2.2691094159199565e-07
transmission O 1 0.9999998807907104
of O 1 0.9998231530189514
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 5.2244256920630505e-08
been O 0 2.415563082891481e-09
reported O 0 1.1565111091016433e-09
recently O 0 4.254585128649069e-09
. O 0 1.452431774850993e-08

We O 0 1.564960250277636e-08
review O 0 3.6678757253660876e-10
the O 0 4.883989393467125e-11
sex O 0 6.057287310623494e-11
related O 0 2.514826125121772e-10
effects O 0 1.4224895705794438e-09
on O 0 4.232809658333281e-10
transmission O 1 0.6257601976394653
of O 0 1.1536360943864565e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0730597972869873

Decreased O 0 8.683405212650541e-06
fertility O 0 2.291464653580988e-07
of O 0 1.3586389790987141e-09
males O 0 8.566148346211833e-10
with O 0 9.579999120379323e-12
adult O 0 6.348230829900103e-09
onset O 1 0.9425485134124756
DM B-Disease 1 1.0
and O 0 2.2563544366249744e-09
contraction O 0 1.6987160122994283e-08
of O 0 7.796919776481559e-10
the O 0 1.0857244270301436e-10
repeat O 0 6.650056061374698e-10
upon O 0 2.7932586799117587e-10
male O 0 9.740490636289678e-10
transmission O 0 5.252709378567033e-09
contribute O 0 7.804265567123991e-11
to O 0 3.523809022354385e-11
the O 0 2.2794174880935714e-10
almost O 0 1.1863737769957083e-09
absent O 0 7.525851941636574e-09
occurrence O 0 1.944364669270726e-09
of O 0 4.518281027099391e-10
paternal O 0 1.6477012820814707e-07
transmission O 0 0.06640011817216873
of O 0 8.201695163734257e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.013756701722741127

Also O 0 5.465736752086059e-09
the O 0 1.4147105709128027e-09
fathers O 0 1.4177826024308615e-08
of O 0 9.25942433838145e-10
the O 0 8.312863730708386e-10
reported O 0 1.029710272604234e-08
congenitally O 0 4.0475206333212554e-05
affected O 0 4.438716505461571e-09
children O 0 1.5224736749086532e-10
showed O 0 1.3217500427487039e-09
, O 0 5.4273430367957065e-12
on O 0 1.6250104040160807e-10
average O 0 8.016451946701864e-10
, O 0 1.0107563397365738e-10
shorter O 0 1.006296912464677e-07
CTG O 0 8.982391591416672e-06
repeat O 0 6.149692666213014e-08
lengths O 0 7.084951221258962e-07
and O 0 4.711784296063115e-10
hence O 0 4.709648226963736e-09
less O 0 3.516843261053282e-09
severe O 0 3.132322845544877e-08
clinical O 0 2.4666704234732606e-07
symptoms O 0 3.972956719167087e-08
than O 0 1.1301073792047145e-11
the O 0 5.244865305953361e-11
mothers O 0 4.41605724210703e-10
of O 0 1.721510295427109e-10
children O 0 1.0509045855755517e-09
with O 0 3.9537855656135434e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8764277100563049

We O 0 1.894949619440922e-08
conclude O 0 2.3682879657371814e-07
that O 0 4.634690548011022e-11
paternal O 0 5.114286238949717e-08
transmission O 0 0.024625668302178383
of O 0 3.551406189217232e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.36558605593018e-07
rare O 0 3.024471340040691e-09
and O 0 8.517723332213123e-11
preferentially O 0 3.138407589364789e-10
occurs O 0 2.1881467471285276e-10
with O 0 4.979118246178915e-12
onset O 0 1.0790203305077739e-05
of O 0 2.2687422642775346e-06
DM B-Disease 1 1.0
past O 0 2.627893103124279e-08
30 O 0 7.756307263129258e-10
years O 0 1.8510257562831534e-11
in O 0 1.3857428659419524e-12
the O 0 7.973456096765918e-12
father O 0 3.633154221915902e-09
. O 0 2.8893800685381166e-09
. O 0 2.957506595180348e-08

The O 0 5.054703251516912e-07
RB1 O 0 0.0001744899054756388
gene O 0 5.86827653137334e-09
mutation O 0 7.325924866741218e-10
in O 0 1.0655636789591583e-10
a O 0 3.230143486021575e-09
child O 0 9.845762178883888e-06
with O 0 9.74567410594318e-06
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.34400036931037903

The O 0 5.005074967812106e-07
RB1 O 0 8.814928878564388e-05
gene O 0 2.8863618162233706e-09
mutation O 0 5.747727849225726e-10
was O 0 6.516608364037779e-10
investigated O 0 3.57024987351906e-09
in O 0 1.0516420373418711e-10
a O 0 2.99177210782986e-10
child O 0 5.156562110641971e-07
with O 0 3.6566749628264006e-08
ectopic B-Disease 1 0.9972025156021118
intracranial I-Disease 1 0.9890103936195374
retinoblastoma I-Disease 0 1.1365873433533125e-05
using O 0 8.433181930556088e-10
DNA O 0 5.812215064793236e-08
obtained O 0 1.7346857283939698e-09
from O 0 8.292747738503081e-11
both O 0 6.636179106234152e-11
the O 0 6.189850298987665e-10
pineal B-Disease 0 2.2549229470314458e-05
and I-Disease 0 2.8467352919392397e-08
retinal I-Disease 1 0.7485173940658569
tumours I-Disease 1 1.0
of O 0 0.0006568470853380859
the O 0 1.3221889503256534e-06
patient O 0 0.00019440232426859438
. O 0 1.055393568094587e-06

A O 0 4.951482424075948e-06
nonsense O 0 2.7346854039933532e-05
mutation O 0 7.8674524672806e-08
in O 0 9.040312498598269e-09
exon O 0 1.0548556872436166e-07
17 O 0 2.9560838221698305e-09
( O 0 8.334324202996513e-11
codon O 0 2.5678797754835614e-08
556 O 0 4.945223786023689e-09
) O 0 4.7671224606693485e-11
of O 0 9.944982615195386e-10
the O 0 7.712512406499172e-09
RB1 O 0 0.0001404560316586867
gene O 0 1.3154624056710418e-09
was O 0 2.5981281570608417e-09
found O 0 1.695567852788571e-10
to O 0 5.1794516592318374e-11
be O 0 2.2332882765319084e-10
present O 0 2.4403350451507322e-08
homozygously O 0 0.00015118546434678137
in O 0 1.1295094859420374e-09
both O 0 2.6158399890618966e-09
the O 0 1.0478168555039247e-08
retinal B-Disease 0 4.109498149773572e-06
and I-Disease 0 6.370053284854293e-08
the I-Disease 0 1.218153010995593e-05
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 5.888966188649647e-05

The O 0 6.442570921194601e-09
same O 0 1.2806905536066893e-09
mutation O 0 5.944494896326091e-10
was O 0 1.4133134662586144e-09
present O 0 1.2642090707615239e-09
heterozygously O 0 5.328784595803882e-07
in O 0 2.07389678347214e-11
the O 0 2.4233087758673832e-11
DNA O 0 1.3604108062281739e-08
from O 0 6.543594832653099e-11
the O 0 3.9766655246520344e-11
constitutional O 0 3.448437924102876e-10
cells O 0 1.3071587146029628e-09
of O 0 7.588825123860943e-10
the O 0 4.402139208714573e-10
patient O 0 1.0080450607574676e-07
, O 0 1.1430934671041726e-10
proving O 0 3.92295724793712e-08
it O 0 3.011750787998424e-12
to O 0 3.1556032092927566e-11
be O 0 5.582803108694634e-10
of O 0 4.475835879702572e-08
germline O 0 4.44308461737819e-05
origin O 0 4.4157548018119996e-07
. O 0 9.167958978650859e-07

The O 0 7.407846780438376e-09
initial O 0 1.2686929728999985e-08
mutation O 0 7.82888365247203e-10
was O 0 3.814700222370959e-10
shown O 0 4.0584355320838483e-10
to O 0 6.138644453868025e-11
have O 0 1.4471588857811746e-11
occurred O 0 3.6837084493868133e-09
in O 0 4.562305394584243e-11
the O 0 7.31133820153218e-10
paternally O 0 1.3219141692388803e-06
derived O 0 1.3278585697662493e-07
RB1 O 0 9.916265844367445e-05
allele O 0 2.7220900733482267e-07
. O 0 2.754087802259164e-07

The O 0 4.9023178405604995e-08
mutation O 0 8.979990973045915e-09
is O 0 4.0070904927524964e-11
in O 0 3.4604277776573156e-11
an O 0 6.776413197934206e-12
area O 0 2.905344020920353e-10
of O 0 3.258296410457717e-10
the O 0 2.4690233191293487e-10
gene O 0 5.856295309802917e-11
that O 0 5.175370548782254e-12
encodes O 0 4.7153510263076015e-11
the O 0 2.054440784160505e-10
protein O 0 9.558762670280885e-10
- O 0 9.193572569898834e-10
binding O 0 3.8394090684512605e-10
region O 0 4.152804677914901e-08
known O 0 2.897481810038016e-09
as O 0 4.696898425748941e-10
the O 0 2.514458197211411e-09
pocket O 0 1.845673796196934e-05
region O 0 1.135846332545043e-06
and O 0 2.96344526695691e-09
has O 0 1.2971093643621145e-10
been O 0 6.403083618877758e-10
detected O 0 1.870470356379883e-08
in O 0 5.0665870804378343e-11
other O 0 3.604265497170189e-11
cases O 0 6.169447175352616e-10
of O 0 3.143605198374644e-08
retinoblastoma B-Disease 0 0.00014095591905061156
. O 0 1.2142773186951672e-07
. O 0 4.6172277734513045e-07

Low O 0 2.0162094642728334e-06
levels O 0 2.275145583041649e-08
of O 0 8.480912083719261e-10
beta O 0 5.28476684635848e-09
hexosaminidase O 0 3.8741569596822956e-07
A O 0 4.2211856232654554e-09
in O 0 4.850383289456417e-11
healthy O 0 4.690425825515376e-10
individuals O 0 8.725933170472544e-12
with O 0 3.577090013084927e-11
apparent O 0 0.01801416650414467
deficiency O 1 0.9999465942382812
of O 0 2.137927913281601e-05
this O 0 1.312503083994443e-08
enzyme O 0 3.269006398909369e-08
. O 0 8.582462385220424e-08

Appreciable O 0 2.4264404601126444e-06
beta O 0 1.4138863946300262e-07
hexosaminidase O 0 1.108100786950672e-05
A O 0 2.46025905425995e-07
( O 0 4.5587242314404364e-10
hex O 0 5.295868987786889e-08
A O 0 1.792915327314404e-08
) O 0 1.0108368135586243e-11
activity O 0 1.2271862692703195e-10
has O 0 3.600510189473438e-13
been O 0 8.181775569549021e-12
detected O 0 7.273245117289662e-09
in O 0 2.727232883970032e-09
cultured O 1 0.9999996423721313
skin O 1 1.0
fibroblasts O 1 1.0
and O 0 8.9102286437992e-06
melanoma B-Disease 1 1.0
tissue O 1 0.9999791383743286
from O 0 2.8814072905447574e-08
healthy O 0 1.0256293592192378e-08
individuals O 0 4.461252547938166e-12
previously O 0 5.115859125215394e-11
reported O 0 1.9853041086093093e-11
as O 0 1.685255927863505e-11
having O 0 3.650318047832002e-09
deficiency B-Disease 0 3.1010341672299546e-07
of I-Disease 0 8.201337919899743e-08
hex I-Disease 0 2.4221532157753245e-07
A I-Disease 0 1.6107401634712915e-08
activity O 0 2.3962622996975824e-09
indistinguishable O 0 5.440099037912205e-09
from O 0 5.139720680308324e-12
that O 0 2.662684797042486e-13
of O 0 2.1609871878047748e-11
patients O 0 1.5430018374118504e-10
with O 0 1.8935262247055107e-08
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.0062519979546778e-05
TSD B-Disease 1 1.0
) O 0 2.32145325185229e-08
. O 0 1.2064673171607865e-07

Identification O 0 1.485241909904289e-06
and O 0 1.2957753092734947e-08
quantitation O 0 0.0006543322233483195
of O 0 4.3976974666293245e-06
hex O 0 5.3298231250664685e-06
A O 0 8.751433142606402e-07
, O 0 3.652077806837184e-10
amounting O 0 3.010378435419625e-08
to O 0 3.4318390351728567e-09
3 O 0 1.8618818842242035e-07
. O 0 2.3941876747812785e-07

5 O 0 1.3855112683813786e-06
% O 0 2.0785566903214203e-06
- O 0 4.769526640302502e-07
6 O 0 2.5233097744603583e-07
. O 0 1.2963691631284746e-07

9 O 0 1.965481715160422e-07
% O 0 5.433617999983653e-09
of O 0 5.410171199926594e-10
total O 0 6.196311241879471e-10
beta O 0 2.1786652482091995e-09
hexosaminidase O 0 5.7272703912758516e-08
activity O 0 1.0054768129208469e-09
, O 0 8.851639039797465e-12
has O 0 4.384911487728682e-13
been O 0 6.504010437863306e-12
obtained O 0 3.97886029679384e-10
by O 0 2.4775617668559846e-10
cellulose O 0 1.3486200600709708e-07
acetate O 0 4.3355651513365956e-08
gel O 0 3.004218172009132e-07
electrophoresis O 0 3.9498974047091906e-07
, O 0 1.1316319437071343e-08
DEAE O 0 0.006791706196963787
- O 0 8.130507467285497e-07
cellulose O 0 7.680622502448387e-07
ion O 0 2.421475073788315e-06
- O 0 9.236605365003925e-07
exchange O 0 7.577015992410452e-08
chromatography O 0 4.6852801460772753e-07
, O 0 6.379981543069846e-10
radial O 0 7.792254841376689e-09
immunodiffusion O 0 1.2523345276349573e-06
, O 0 6.381454253912011e-10
and O 0 2.41552156055036e-09
radioimmunoassay O 0 0.00011994143278570846
. O 0 1.0227654456684832e-06

Previous O 0 7.333197572734207e-06
family O 0 4.5748755894692295e-09
studies O 0 8.17608980518969e-10
suggested O 0 1.6037490779829966e-10
that O 0 3.4165424937955546e-13
these O 0 9.936418007838732e-13
individuals O 0 2.5038872884797225e-12
may O 0 1.2200649344984438e-11
be O 0 4.064242692392028e-11
compound O 0 4.954400001366821e-09
heterozygotes O 0 3.11004022535144e-08
for O 0 1.5266084230081134e-10
the O 0 4.373625350773125e-10
common O 0 2.701038503971631e-09
mutant O 0 1.7090114212692242e-08
TSD B-Disease 0 1.2080626220267732e-05
gene O 0 1.821899076048794e-09
and O 0 3.614952504005231e-10
a O 0 7.127505252668698e-10
rare O 0 1.4626532207628884e-09
( O 0 2.0552640145332646e-10
allelic O 0 5.957702242653795e-08
) O 0 2.1307218489585722e-10
mutant O 0 1.6183467010932873e-08
gene O 0 1.3152321898246555e-08
. O 0 8.261563522182769e-08

Thus O 0 4.011372141121683e-07
, O 0 1.5645953421739023e-09
the O 0 8.275781171462882e-10
postulated O 0 2.2993578596697262e-08
rate O 0 9.31513532975714e-10
mutant O 0 1.0047324777717748e-10
gene O 0 3.410029550399152e-11
appears O 0 4.223952090876004e-11
to O 0 6.840786184042491e-12
code O 0 8.076974852833096e-12
for O 0 4.726453603498548e-11
the O 0 2.4301696766038106e-10
expression O 0 1.1062671889661146e-09
of O 0 2.3188984066280227e-09
low O 0 5.135358360774944e-09
amounts O 0 2.423495015779764e-10
of O 0 1.8785639710472424e-09
hex O 0 3.6771893974218983e-07
A O 0 1.1658090670607635e-06
. O 0 7.540209026046796e-07

Heterozygotes O 0 1.2106551366741769e-05
for O 0 3.567513617852569e-09
the O 0 3.2291764817671265e-09
rare O 0 1.1340037797680225e-09
mutant O 0 2.8094231385722424e-09
may O 0 1.1245904207868307e-10
be O 0 8.386884242650439e-11
indistinguishable O 0 1.484401490614573e-08
from O 0 3.290585304238647e-10
heterozygotes O 0 2.684209832182205e-08
for O 0 3.2547681216854585e-10
the O 0 3.238570300823085e-09
common O 0 7.588614892029e-08
TSD B-Disease 0 0.000359660160029307
mutant O 0 1.1210642014702898e-06
. O 0 2.7594091989158187e-07

However O 0 4.68450274127008e-08
, O 0 2.5591154195758747e-10
direct O 0 1.7852876954549401e-09
visualization O 0 6.616861583097489e-07
and O 0 8.542930252097847e-10
quantitation O 0 0.0002962877042591572
of O 0 2.163073560268458e-07
hex O 0 1.6070922015387623e-07
A O 0 6.258494611444121e-09
by O 0 1.9246484614376946e-11
the O 0 1.2861481844816947e-11
methods O 0 1.1634766927670626e-08
described O 0 3.9539857499271136e-10
may O 0 4.265680170201236e-11
prevent O 0 5.778154621438603e-10
false O 0 2.536132637231958e-09
- O 0 2.7307931471654e-09
positive O 0 1.1733054805507237e-10
prenatal O 0 5.990826679180827e-08
diagnosis O 0 6.958924103628306e-08
of O 0 7.793251377563593e-09
TSD B-Disease 0 3.622353688115254e-05
in O 0 1.0190963628531335e-09
fetuses O 0 2.4048576463542304e-08
having O 0 2.7560337345633457e-10
the O 0 2.799120102370267e-10
incomplete O 0 6.059364210386775e-08
hex B-Disease 0 9.715215583128156e-07
A I-Disease 0 4.294801328796893e-06
deficiency I-Disease 0 6.87485808157362e-05
of O 0 6.962907406204977e-08
the O 0 3.892894451240636e-09
type O 0 1.568193965795217e-07
described O 0 9.202717698997276e-09
in O 0 3.2873295752189335e-10
the O 0 1.6955913340055417e-09
four O 0 6.916867079098665e-09
healthy O 0 2.920911299497675e-07
individuals O 0 7.312070238185697e-08

The O 0 2.690828466711537e-07
tumor B-Disease 0 3.4338524983468233e-06
suppressor O 0 1.8882265067077242e-06
gene O 0 3.663222969407798e-08
Smad4 O 0 0.0002522992726881057
/ O 0 1.6927732531257789e-06
Dpc4 O 0 9.911727829603478e-06
is O 0 6.996081665378018e-12
required O 0 9.993523369944413e-11
for O 0 2.4042852778127788e-11
gastrulation O 0 1.7803156424633926e-06
and O 0 1.6740377140056495e-10
later O 0 1.4900398692674344e-09
for O 0 1.214773698299254e-10
anterior O 0 3.346822197158872e-08
development O 0 7.49377022657427e-08
of O 0 2.3336347965141613e-08
the O 0 1.801320159700026e-08
mouse O 0 1.1778151076669019e-07
embryo O 0 1.4323331924970262e-06
. O 0 2.9593977046715736e-07

Mutations O 0 3.708985616412974e-07
in O 0 9.880289475461268e-09
the O 0 6.660598472763013e-08
SMAD4 O 1 0.9999991655349731
/ O 0 0.0018469257047399879
DPC4 O 1 0.9997602105140686
tumor B-Disease 0 1.1013096354872687e-06
suppressor O 0 7.582278271911491e-08
gene O 0 3.4990035868709413e-10
, O 0 3.0121943134231444e-11
a O 0 2.4946511523182835e-10
key O 0 3.0891413871358964e-08
signal O 0 1.7228315982720233e-06
transducer O 0 4.1259065142185136e-07
in O 0 1.951535377742175e-09
most O 0 3.461672282156769e-09
TGFbeta O 0 0.12826210260391235
- O 0 2.5588528274056443e-07
related O 0 7.015845682190047e-08
pathways O 0 1.2302622920401518e-08
, O 0 3.822358662225467e-12
are O 0 2.830215445684403e-13
involved O 0 6.486817333284378e-11
in O 0 1.0254874727166907e-10
50 O 0 1.543347849519705e-08
% O 0 8.280463248411252e-08
of O 0 8.829937314658309e-08
pancreatic B-Disease 1 0.9999892711639404
cancers I-Disease 1 0.9999963045120239
. O 0 7.44974531698972e-05

Homozygous O 0 1.2888909623143263e-05
Smad4 O 0 4.877031460637227e-05
mutant O 0 2.0879568296550133e-07
mice O 0 4.630112115933116e-08
die O 0 1.6707066663457226e-07
before O 0 1.5384543416985252e-08
day O 0 3.435711448673828e-08
7 O 0 1.7502779314781947e-07
. O 0 6.696341614542689e-08

5 O 0 4.5679635718443024e-07
of O 0 2.8881703428851324e-07
embryogenesis O 0 0.0013482235372066498
. O 0 5.447589956020238e-06

Mutant O 0 4.52326105460088e-07
embryos O 0 1.2380792213662062e-07
have O 0 1.546941741370489e-10
reduced O 0 4.6331283254374966e-10
size O 0 1.0046788401218976e-10
, O 0 9.384854872396264e-12
fail O 0 6.32472385575511e-09
to O 0 1.4129604153367836e-09
gastrulate O 0 8.91806666913908e-06
or O 0 1.9181272126189697e-09
express O 0 3.5410929744017494e-10
a O 0 1.6357513954456948e-10
mesodermal O 0 1.8144461364499875e-06
marker O 0 1.8680744062749e-08
, O 0 1.9455655142497363e-10
and O 0 4.298220113163609e-10
show O 0 5.0778268700923945e-08
abnormal O 0 1.4558537486664136e-06
visceral O 0 9.838233836489962e-07
endoderm O 0 3.6998702853452414e-05
development O 0 1.1366795433787047e-06
. O 0 4.0274409229823505e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 4.3957086859336414e-07
the O 0 8.571746690222426e-08
Smad4 O 1 0.9308297634124756
- O 0 8.414685908064712e-07
deficient O 0 4.569715272850772e-08
embryos O 0 2.0778623266437535e-09
results O 0 5.660237278881652e-10
from O 0 9.5909370723124e-11
reduced O 0 6.422384846160867e-10
cell O 0 3.969069517495427e-09
proliferation O 0 2.7027816429381346e-08
rather O 0 8.061423750760355e-10
than O 0 1.0262388161486058e-10
increased O 0 3.0017877072907595e-09
apoptosis O 0 3.2217712941928767e-07
. O 0 7.46345918400948e-08

Aggregation O 0 5.765922423961456e-07
of O 0 1.5870818970142864e-07
mutant O 0 2.6861749802264967e-07
Smad4 O 0 0.0003638716589193791
ES O 0 6.2317003539646976e-06
cells O 0 4.151891719317291e-09
with O 0 1.2706291574460238e-10
wild O 0 4.615472892766093e-09
- O 0 7.761432385677836e-09
type O 0 1.5346120818549025e-08
tetraploid O 0 3.91317098547006e-06
morulae O 0 2.7620848413789645e-05
rescues O 0 1.5131554391700774e-06
the O 0 2.8201567303653974e-08
gastrulation B-Disease 0 0.0011342511279508471
defect I-Disease 0 0.00024407987075392157
. O 0 7.501785148633644e-07

These O 0 1.199209620494912e-09
results O 0 6.337883551310597e-10
indicate O 0 1.573549734956714e-09
that O 0 1.3394604869709781e-11
Smad4 O 0 1.2192369069907727e-07
is O 0 2.3867025977092338e-12
initially O 0 2.1841969205516065e-11
required O 0 1.5536125164139492e-10
for O 0 2.441178682810463e-11
the O 0 2.454060288314963e-10
differentiation O 0 1.475485049695635e-07
of O 0 2.04445154139421e-08
the O 0 2.3564819429111594e-08
visceral O 0 2.5457984520471655e-07
endoderm O 0 3.5029149785259506e-06
and O 0 2.068619858741627e-10
that O 0 7.326784144667808e-12
the O 0 1.2386999759250727e-10
gastrulation B-Disease 0 1.659997178649064e-05
defect I-Disease 0 1.8006454638452851e-06
in O 0 1.3583280056295166e-09
the O 0 5.25064569600886e-09
epiblast O 0 8.544633601559326e-06
is O 0 3.4985231378570347e-10
secondary O 0 2.791030908610992e-07
and O 0 1.535193971946569e-09
non O 0 2.2303545392787782e-06
- O 0 2.102025291605969e-06
cell O 0 2.0939916794304736e-05
autonomous O 0 3.93764057662338e-05
. O 0 8.940011753111321e-07

Rescued O 0 7.392748375423253e-05
embryos O 0 1.6294882243528264e-06
show O 0 4.068359515940756e-08
severe O 0 1.7115664263656072e-07
anterior O 0 3.183202807122143e-06
truncations O 0 0.12713325023651123
, O 0 1.42193079533115e-09
indicating O 0 2.6931587626677356e-08
a O 0 1.0926589494308914e-10
second O 0 1.4452212759863414e-09
important O 0 1.9436861009580753e-09
role O 0 1.9247714533321414e-09
for O 0 3.240856694119998e-09
Smad4 O 1 0.9979947805404663
in O 0 2.393627696051226e-08
anterior O 0 7.252036539284745e-06
patterning O 0 0.00155991455540061
during O 1 0.5510401725769043
embryogenesis O 1 0.9997574687004089
. O 0 5.177176717552356e-06

Prevalence O 0 2.927817877207417e-05
of O 0 3.8070362506914535e-07
p16 O 0 1.2887975572084542e-05
and O 0 1.3742989324327937e-07
CDK4 O 1 0.9999940395355225
germline O 0 0.13387100398540497
mutations O 0 1.4391544311820326e-07
in O 0 5.033169880874766e-09
48 O 0 1.717278905744024e-06
melanoma B-Disease 1 0.999736487865448
- O 0 0.0007363197510130703
prone O 0 2.336158104299102e-05
families O 0 2.7393550539045464e-08
in O 0 3.4761043821163184e-08
France O 0 8.84130258782534e-06
. O 0 1.7346455933875404e-06

The O 0 4.133627953706309e-06
French O 0 0.004584849812090397
Familial B-Disease 1 0.9999816417694092
Melanoma I-Disease 1 1.0
Study O 0 5.242325642029755e-06
Group O 0 4.4503067897494475e-08
. O 0 1.476712441217387e-07

Germline O 0 0.002993588801473379
mutations O 0 3.105959081040055e-07
in O 0 4.032242095775018e-09
the O 0 1.1564985413770046e-08
p16 O 0 2.3806526314729126e-06
and O 0 8.452897048982777e-09
CDK4 O 1 0.9763743281364441
genes O 0 3.70569530616649e-09
have O 0 1.1347771680658703e-11
been O 0 2.2500303703543167e-11
reported O 0 3.093152123323506e-11
in O 0 1.370762097580025e-11
a O 0 1.2130442483826442e-10
subset O 0 1.604787946973829e-08
of O 0 3.266488590725203e-08
melanoma B-Disease 0 0.0008834220934659243
pedigrees O 0 8.160134825629939e-07
, O 0 2.8590083078761097e-10
but O 0 3.8502312449395504e-11
their O 0 1.721267434140472e-10
prevalence O 0 3.043790286483272e-08
is O 0 9.661307344421832e-12
not O 0 7.1404278323417e-11
well O 0 1.9996140299127774e-09
known O 0 2.957139777493012e-08
. O 0 3.4550322425275226e-07

We O 0 6.053737422462291e-08
searched O 0 4.9899760767857515e-08
for O 0 1.5848804213458578e-10
such O 0 2.6331986591188183e-10
germline O 0 8.740658813621849e-06
mutations O 0 7.72377362068255e-09
in O 0 1.1800682653273498e-09
48 O 0 9.98037194221979e-07
French O 0 5.419982335297391e-05
melanoma B-Disease 1 0.9999964237213135
- O 0 0.00286226742900908
prone O 0 2.472405640219222e-06
families O 0 2.368221729831532e-10
selected O 0 1.2334565313576462e-10
according O 0 1.7781696254326462e-11
to O 0 5.042559685780601e-12
two O 0 2.597024375064483e-12
major O 0 2.829775649915156e-11
criteria O 0 4.270379605486596e-10
families O 0 1.7001459268195518e-11
with O 0 1.2516588243291493e-12
at O 0 6.961370369040765e-11
least O 0 9.702376922715583e-12
three O 0 1.2730882320566295e-11
affected O 0 4.663734398668851e-10
members O 0 1.0207026196473734e-10
( O 0 8.544245866382028e-11
n O 0 1.7535642937716034e-09
= O 0 7.234625676311168e-10
20 O 0 8.506979010114435e-10
) O 0 4.052985377867024e-12
or O 0 9.135704345797357e-12
families O 0 1.3840371557161113e-11
with O 0 1.8893627981575456e-12
two O 0 1.069180854962326e-11
affected O 0 1.9658052963222872e-10
members O 0 1.0836631939015184e-11
, O 0 3.907975939382302e-12
one O 0 6.999512081051762e-12
of O 0 1.1018044115962411e-10
them O 0 1.7644023395102515e-11
affected O 0 2.9038871307562886e-10
before O 0 1.1347236344994016e-10
the O 0 2.0675537670822308e-11
age O 0 1.465568666425554e-09
of O 0 5.77546566127296e-10
50 O 0 1.0702898567416241e-09
( O 0 2.412107666383001e-11
n O 0 3.1114907872442643e-10
= O 0 1.3916535979152656e-10
28 O 0 1.3784270391781206e-09
) O 0 1.2299437510132627e-11
, O 0 8.439610121868668e-12
and O 0 8.323993404280028e-12
one O 0 1.4377058571435342e-11
additional O 0 3.757378574942294e-10
minor O 0 2.430978796041927e-08
criterion O 0 8.124446139845531e-06
. O 0 1.4559676628778107e-06

Sixteen O 0 4.52610174761503e-06
different O 0 5.8932368318664885e-08
p16 O 0 5.497939582710387e-06
germline O 0 5.499051439983305e-06
mutations O 0 1.2935208459907699e-08
were O 0 2.810596866353876e-09
found O 0 3.458285324775545e-10
in O 0 2.6181832743499278e-11
21 O 0 2.748401228824804e-10
families O 0 3.5622338412366616e-11
, O 0 1.517474861045809e-11
while O 0 9.962426023024662e-11
one O 0 1.726834647497455e-10
germline O 0 3.6135540995019255e-06
mutation O 0 2.7830299842435124e-08
, O 0 8.622702551974726e-10
Arg24His O 0 4.441924102138728e-05
, O 0 4.819933896449413e-10
was O 0 4.959799237980178e-09
detected O 0 1.210512223792648e-08
in O 0 2.0166344982808226e-10
the O 0 6.527645979303998e-09
CDK4 O 1 0.6516677737236023
gene O 0 2.493255806257366e-07
. O 0 2.687427809178189e-07

The O 0 8.711644738923496e-09
frequency O 0 3.336121423558325e-08
of O 0 6.7401368930575245e-09
p16 O 0 6.69752964199688e-08
gene O 0 2.536847398815212e-10
mutation O 0 9.111970900033128e-11
in O 0 3.690019817481627e-11
our O 0 1.1311522829515752e-09
sample O 0 6.073497815783924e-10
( O 0 1.1540574919310931e-11
44 O 0 2.7150359738215e-09
% O 0 1.5122927354838112e-09
) O 0 3.886352611254251e-12
is O 0 4.102129660260578e-12
among O 0 1.6753527384838485e-11
the O 0 4.953034857257954e-11
highest O 0 5.144946246815607e-09
rates O 0 1.4703285255990295e-09
yet O 0 7.399634377458497e-11
reported O 0 5.638027544829782e-11
and O 0 1.6087450815938098e-11
the O 0 3.820139204968598e-10
CDK4 O 0 0.0004410054534673691
mutation O 0 1.040421859777041e-09
is O 0 1.9662431405276237e-11
the O 0 1.304174546135073e-10
second O 0 7.079275832211351e-09
mutation O 0 8.902803827481875e-09
detected O 0 2.005325150378212e-08
in O 0 1.73889846966091e-10
this O 0 2.6638011241253423e-10
gene O 0 6.9384582523923655e-09
worldwide O 0 5.5025566325639375e-09
. O 0 1.2489718415054085e-07

In O 0 4.252956387063023e-08
summary O 0 7.990112038669395e-08
, O 0 3.361251277311794e-10
our O 0 1.4315041374501902e-09
results O 0 1.50055257108761e-09
show O 0 5.289806370711858e-10
frequent O 0 1.1101791708156838e-10
involvement O 0 5.73019542926545e-09
of O 0 1.6239889433222743e-09
the O 0 6.8396484032007265e-09
p16 O 0 1.8476197283234796e-06
gene O 0 7.681784985891227e-09
in O 0 4.426347732788827e-09
familial B-Disease 0 1.53920645971084e-05
melanoma I-Disease 1 0.9992750287055969
and O 0 1.2791654846466827e-08
confirm O 0 3.2872708288778085e-07
the O 0 2.460158743389229e-09
role O 0 6.421530418521115e-09
of O 0 3.185031616226297e-08
the O 0 4.530384245526875e-08
CDK4 O 1 0.9999831914901733
gene O 0 4.295288569267086e-09
as O 0 3.3962055390190926e-10
a O 0 3.4808464999258604e-09
melanoma B-Disease 0 0.148121178150177
- O 0 1.979557600861881e-05
predisposing O 0 2.695949888220639e-06
gene O 0 3.794993475025876e-08
. O 0 2.0896953500937343e-08
. O 0 1.5394603281038144e-07

Progression O 0 4.2942119762301445e-05
of O 0 2.1999055661581224e-06
somatic O 0 2.547504846006632e-05
CTG O 0 5.2316183428047225e-05
repeat O 0 2.8189951706281136e-08
length O 0 7.1435413140363835e-09
heterogeneity O 0 8.224988690130886e-09
in O 0 2.2788859341260626e-11
the O 0 1.0763920310630226e-10
blood O 0 3.517299340671798e-09
cells O 0 3.4126119885513617e-07
of O 0 0.00027547418721951544
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.809506893157959
. O 0 2.2025676571502117e-06

The O 0 1.1723201964741747e-08
genetic O 0 5.633743693778115e-09
basis O 0 4.134319198101366e-08
of O 0 2.4778109946055338e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.01275770366191864
DM B-Disease 1 1.0
) O 0 3.6945707604374434e-10
is O 0 3.3862797548661616e-12
the O 0 1.0098598172969542e-11
expansion O 0 7.648709998697711e-10
of O 0 1.263129156825471e-09
an O 0 8.466414791463706e-10
unstable O 0 0.0001261174911633134
CTG O 0 8.375592005904764e-05
repeat O 0 3.3862477266666247e-08
in O 0 4.188589752818217e-10
the O 0 4.848175749749828e-10
34 O 0 1.1301802160801344e-08
UTR O 0 1.1387191989342682e-05
of O 0 8.35763724893468e-09
the O 0 5.82808965532422e-08
DM B-Disease 1 0.9999998807907104
protein O 0 1.2194927023756463e-07
kinase O 0 1.4781152302134615e-08
gene O 0 6.365468707691946e-10
on O 0 3.7541640907079454e-09
chromosome O 0 3.431998152336746e-08
19 O 0 2.647777250786021e-07
. O 0 6.146339046608773e-07

One O 0 5.422167603796879e-09
of O 0 3.5401155340508694e-09
the O 0 6.943670638470678e-10
principal O 0 3.412637283872755e-08
features O 0 2.452726355350876e-10
of O 0 9.490800367828456e-10
the O 0 1.7853123424060868e-08
DM B-Disease 1 1.0
mutation O 0 7.000083623864839e-09
is O 0 3.703175960323435e-11
an O 0 9.60594451204777e-12
extraordinarily O 0 3.378564272793483e-08
high O 0 7.142274327520681e-09
level O 0 2.526331570606999e-07
of O 0 1.289409645721662e-08
somatic O 0 2.0357292669359595e-06
mosaicism O 0 8.71495867613703e-05
, O 0 1.5670376107834727e-10
due O 0 1.0760646595997514e-08
to O 0 1.1094763996410961e-10
an O 0 1.0740371265971493e-11
extremely O 0 1.777930691559959e-09
high O 0 6.432879229301136e-10
degree O 0 3.923653224546797e-08
of O 0 1.2200482402136004e-08
somatic O 0 2.2992364847596036e-06
instability O 0 1.2775910818163538e-06
both O 0 7.201955143365524e-10
within O 0 3.811938320552599e-09
and O 0 9.884200402598964e-11
between O 0 4.447147983199784e-09
different O 0 9.286453384049764e-09
tissues O 0 7.77927766648645e-07
. O 0 2.0702567837815877e-07

This O 0 1.0766850522259119e-07
instability O 0 1.1769457159971353e-05
appears O 0 2.2462804949441306e-09
to O 0 1.2916483160818615e-10
be O 0 2.2602945903837934e-10
biased O 0 1.3070869719911116e-08
towards O 0 4.01073441125277e-09
further O 0 1.482362704807727e-10
expansion O 0 5.724009599639146e-10
and O 0 6.670107608602871e-12
continuous O 0 1.5275478659759756e-08
throughout O 0 1.6568586780341121e-10
the O 0 1.3236406762318076e-11
life O 0 6.286388076759408e-11
of O 0 7.20148385369157e-11
an O 0 1.5275418733737278e-12
individual O 0 3.2008121847448834e-11
, O 0 6.3090275191635126e-12
features O 0 1.1585544155978678e-11
that O 0 4.442704884533022e-13
could O 0 3.4802436540276593e-12
be O 0 2.9867514711456877e-12
associated O 0 7.076936814343071e-10
with O 0 2.4681083565791795e-11
the O 0 2.3091575318545665e-09
progressive O 0 0.0006449967040680349
nature O 0 1.5445198897623413e-08
of O 0 8.87791085091294e-09
the O 0 2.137162979920504e-08
disease O 0 7.465205271728337e-06
. O 0 1.9648783222692146e-07

Although O 0 2.6359803229070167e-08
increasing O 0 2.9610272012092764e-09
measured O 0 6.765249471740731e-10
allele O 0 7.682571800948779e-10
size O 0 9.941469175656081e-11
between O 0 5.306905470625622e-10
patients O 0 1.1732188553992273e-09
clearly O 0 3.4488589761849653e-10
correlates O 0 7.570020166269842e-09
with O 0 6.642734973194564e-12
an O 0 6.49278070544157e-12
increased O 0 2.722050362891082e-10
severity O 0 2.3001780036224773e-08
of O 0 1.6464070107247153e-09
symptoms O 0 3.092713996011298e-08
and O 0 1.4403901682502607e-11
an O 0 6.637285664655435e-13
earlier O 0 7.133023338656841e-11
age O 0 3.8759628839812876e-10
of O 0 9.642497911244163e-11
onset O 0 3.578582763452687e-08
, O 0 2.8197208023356124e-12
this O 0 9.498881715919172e-13
correlation O 0 1.6854457066117767e-11
is O 0 3.3733400187779816e-13
not O 0 1.6750706724466546e-12
precise O 0 8.79468275982731e-10
and O 0 1.0906802370980184e-11
measured O 0 1.545022165760912e-10
allele O 0 9.096898234695061e-11
length O 0 3.4539540672007263e-10
cannot O 0 3.350210386887653e-10
be O 0 2.584543343231438e-11
used O 0 1.2861391118779153e-10
as O 0 1.1131024921229304e-11
an O 0 1.6938851580064473e-12
accurate O 0 6.373392924530208e-09
predictor O 0 4.049802839745098e-07
of O 0 1.8779835464499683e-09
age O 0 7.711574312452285e-08
of O 0 7.94720449448505e-08
onset O 0 0.12706983089447021
. O 0 2.7262049115961418e-06

In O 0 6.554706999395421e-09
order O 0 4.5642051249572546e-10
to O 0 2.1379843728741577e-10
further O 0 7.661309919804182e-10
characterize O 0 4.626404148666552e-08
the O 0 2.429957568494956e-09
dynamics O 0 1.8882084305005264e-06
of O 0 2.383974424446933e-05
DM B-Disease 1 1.0
CTG O 0 0.011595557443797588
repeat O 0 5.431008958112216e-07
somatic O 0 4.944499778503086e-06
instability O 0 1.7831583818406216e-06
, O 0 6.907921457077748e-11
we O 0 3.0532926881265965e-11
have O 0 8.281153540679043e-13
studied O 0 1.7246819250527068e-10
repeat O 0 5.456044296914264e-11
length O 0 1.0098737818209358e-10
changes O 0 1.679624148098746e-11
over O 0 1.1900349629334617e-11
time O 0 1.4775329570948514e-10
in O 0 4.950600485109646e-10
111 O 0 2.008544242926291e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.0220814061767669e-07
with O 0 4.976414766377779e-11
varying O 0 1.5436797395906865e-09
clinical O 0 1.8673761204013317e-08
severity O 0 9.76809033659265e-08
and O 0 7.987452921298654e-10
CTG O 0 1.1326444564474514e-06
repeat O 0 2.830879974879963e-09
size O 0 2.4830068556802587e-10
over O 0 2.6082842483066138e-11
time O 0 1.0600639810398604e-10
intervals O 0 6.10848172044598e-09
of O 0 1.136645555455118e-09
1 O 0 3.5608651582919038e-09
- O 0 1.3719255065325342e-08
7 O 0 5.014981763196147e-09
years O 0 7.398837542638148e-09
. O 0 2.1223847568307974e-08

We O 0 2.221941741709088e-08
have O 0 6.012659814480514e-11
found O 0 2.0450998533538822e-11
a O 0 4.699267884544778e-12
direct O 0 4.8011771641709444e-11
progression O 0 2.0479367535131132e-08
of O 0 3.6893124111259112e-09
the O 0 8.259633532681221e-10
size O 0 1.0827511109923194e-09
heterogeneity O 0 8.7500797718576e-09
over O 0 8.8045806756476e-11
time O 0 2.0265479572234568e-10
related O 0 2.1368684599565313e-09
to O 0 2.846536895084739e-10
initial O 0 3.622796995728095e-08
CTG O 0 3.990967798017664e-06
repeat O 0 9.462823413741717e-09
size O 0 3.6644351442127743e-10
and O 0 2.368979665212656e-11
the O 0 4.473977091579151e-11
time O 0 4.698555988724706e-10
interval O 0 7.219989939244442e-09
and O 0 2.965138551358493e-11
always O 0 2.8153063214020335e-10
biased O 0 2.0971850922535396e-09
towards O 0 1.8531612910877016e-09
further O 0 2.1416628470660726e-09
expansion O 0 3.113233404405946e-08
. O 0 8.085159919346552e-08

Attempts O 0 7.163750979088945e-07
to O 0 3.5511458218451253e-09
mathematically O 0 2.264221876657757e-07
model O 0 5.483498544123222e-09
the O 0 3.0741206802353815e-10
dynamics O 0 4.459602820361397e-08
have O 0 3.596546671591483e-11
proved O 0 1.2645546831890897e-08
only O 0 1.2820848549477404e-11
partially O 0 9.028951475364977e-10
successful O 0 7.190479878182998e-10
suggesting O 0 2.728235692917025e-10
that O 0 2.8020161603296845e-13
individual O 0 2.7407345056656984e-12
specific O 0 7.180307737275626e-11
genetic O 0 9.238030784786133e-09
and O 0 9.656785371348064e-10
/ O 0 6.843135906819953e-06
or O 0 3.939376380657222e-09
environmental O 0 7.964469972421284e-09
factors O 0 1.720310005559611e-09
also O 0 3.4232957180774237e-12
play O 0 1.0200940092630617e-09
a O 0 4.771291139959999e-10
role O 0 1.0773133496400078e-08
in O 0 2.4191653125171797e-08
somatic O 0 4.25323196395766e-05
mosaicism O 0 0.0015283855609595776
. O 0 7.970704274384843e-08
. O 0 2.3451028141607821e-07

Aspartylglucosaminuria B-Disease 1 0.9999998807907104
among O 0 1.6773128663771786e-07
Palestinian O 0 0.00031775591196492314
Arabs O 0 2.158244933525566e-05
. O 0 9.195629786518111e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.26908570528030396
AGU B-Disease 1 1.0
) O 0 4.728820446331383e-09
is O 0 2.6015928300537894e-10
a O 0 1.295908047538319e-09
rare O 0 1.576308932271786e-07
disorder B-Disease 1 0.9999839067459106
of I-Disease 1 0.9099859595298767
glycoprotein I-Disease 0 0.23420654237270355
metabolism I-Disease 1 0.9998030066490173
caused O 0 7.689660463938708e-08
by O 0 1.015413239602303e-10
the O 0 3.4798508519173765e-09
deficiency B-Disease 0 0.0008912868215702474
of I-Disease 0 1.2125508419558173e-07
the I-Disease 0 3.947569027218378e-08
lysosomal I-Disease 0 4.005311438959325e-06
enzyme I-Disease 0 6.008515907041101e-09
aspartylglucosaminidase I-Disease 0 2.241128640889656e-06
( O 0 1.0800552674439245e-09
AGA O 0 0.0001508628629380837
) O 0 8.788364702638773e-09
. O 0 1.422458382194236e-07

AGU B-Disease 1 1.0
is O 0 4.4345465965989206e-08
inherited O 0 0.0012090509990230203
as O 0 1.4138777260086499e-08
an O 0 2.7332267560353785e-09
autosomal O 1 0.9998103976249695
recessive O 1 0.9412214756011963
trait O 0 4.139914381084964e-05
and O 0 4.835689626503381e-10
occurs O 0 3.0825066943407364e-09
with O 0 1.592035878128506e-11
a O 0 1.007872604819049e-10
high O 0 1.60131374826733e-09
frequency O 0 1.6433771676815923e-08
in O 0 1.1373694347449614e-10
Finland O 0 2.7005400582424954e-08
because O 0 2.865754682168653e-11
of O 0 7.195666285042535e-10
a O 0 1.51727952424352e-09
founder O 0 1.5566757838314516e-07
effect O 0 1.9309462473415806e-08
. O 0 6.931450258207406e-08

While O 0 1.0436684760861681e-07
very O 0 8.302584397767987e-09
few O 0 1.4180009388908843e-09
patients O 0 1.3575898183404433e-09
with O 0 1.1520111531382327e-09
AGU B-Disease 1 1.0
have O 0 9.640916537323463e-11
been O 0 3.161645598104279e-11
reported O 0 1.6143116357558718e-11
from O 0 1.7535792262712846e-11
non O 0 8.759130309954344e-09
- O 0 2.407669841275606e-09
Finnish O 0 2.399564664301579e-06
origin O 0 6.743660296848475e-09
, O 0 9.045028614984574e-11
we O 0 3.35987959676487e-10
diagnosed O 0 0.009713558480143547
the O 0 1.0942576622596789e-08
disorder O 0 0.0019057064782828093
in O 0 5.740563024936307e-10
8 O 0 5.123852009347729e-09
patients O 0 3.5820280075427036e-10
originating O 0 6.320865164610723e-09
from O 0 3.248020741253299e-10
3 O 0 1.789928094630966e-09
unrelated O 0 6.417881337483777e-09
families O 0 5.56116194760925e-11
, O 0 3.355982158836923e-12
all O 0 2.190399337603788e-12
Palestinian O 0 7.395835268653173e-07
Arabs O 0 2.6773633976517885e-08
from O 0 1.7930365525664627e-10
the O 0 1.0631863445187406e-10
region O 0 6.829636411964657e-09
of O 0 7.932603018900863e-09
Jerusalem O 0 1.4503007150779013e-05
. O 0 1.2704008440778125e-06

The O 0 9.086229368904242e-08
clinical O 0 6.564157047250774e-06
diagnosis O 1 0.9999517202377319
of O 1 0.999783456325531
AGU B-Disease 1 1.0
is O 0 1.1669126109836725e-08
often O 0 7.633669252271602e-10
difficult O 0 3.094033047545963e-07
, O 0 5.2767939323628e-11
in O 0 1.5187488419665662e-11
particular O 0 3.178084878596721e-11
early O 0 5.665302671431505e-10
in O 0 6.582020952577983e-12
the O 0 2.590277992098322e-11
course O 0 1.2334789190049378e-08
of O 0 3.1747540707449673e-10
the O 0 5.726870644373605e-10
disease O 0 1.2383047476305364e-07
, O 0 7.908284270496946e-12
and O 0 9.92810608030359e-12
most O 0 6.5967253361221e-12
of O 0 8.940503892773677e-11
the O 0 1.2427964213301834e-10
patients O 0 5.193907526290786e-10
are O 0 1.2478859959252908e-11
diagnosed O 0 9.355308527858597e-09
after O 0 4.280736598527568e-10
the O 0 1.3019500755273583e-10
age O 0 6.47992415281351e-09
of O 0 2.1335451183546184e-09
5 O 0 4.814258325325227e-09
years O 0 9.228661390636717e-09
. O 0 4.2331450345045596e-08

However O 0 7.149282055252115e-07
, O 0 1.3279561894563585e-09
since O 0 4.770926986807922e-10
these O 0 1.2312446895368367e-10
patients O 0 2.882871996678915e-10
excrete O 0 2.997393888648503e-09
early O 0 1.9933679706873875e-10
large O 0 7.645186567151185e-12
amounts O 0 4.651561080759592e-11
of O 0 1.1507681474398623e-09
aspartylglucosamine O 0 2.394423518126132e-06
in O 0 5.14635978277056e-09
urine O 0 3.126479342085986e-08
, O 0 8.386148026007234e-11
biochemical O 0 1.1931590160330074e-09
screening O 0 5.591135887605958e-10
is O 0 3.170722018275285e-11
easy O 0 3.2755209655732642e-09
by O 0 7.665125201228307e-10
urine O 0 1.8605115315040166e-07
chromatography O 0 7.923780458440888e-07
. O 0 1.9497877090657312e-08
. O 0 8.34540756500246e-08

Detection O 0 3.025228579645045e-06
of O 0 1.856742670724998e-08
heterozygous O 0 8.063714695971669e-10
carriers O 0 3.220444744211903e-11
of O 0 4.672638387326344e-10
the O 0 5.971569549956257e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.429071284699603e-06
ATM O 1 0.999984860420227
) O 0 1.0900236963040655e-10
gene O 0 2.5512189583132283e-11
by O 0 2.908919286004341e-11
G2 O 0 2.984030089692169e-08
phase O 0 1.0486129298215019e-07
chromosomal O 0 7.594875910399423e-07
radiosensitivity O 0 9.31588510866277e-06
of O 0 5.358867838367587e-07
peripheral O 1 0.7352612018585205
blood O 0 3.6823788832407445e-05
lymphocytes O 0 5.163350579096004e-06
. O 0 6.3221486925613135e-06

In O 0 1.5723520846222527e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9219382405281067
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.740776825608918e-10
patients O 0 1.1262696331115762e-09
, O 0 2.6038691602198183e-12
mutations O 0 5.733225959952959e-12
in O 0 5.855049518138644e-13
a O 0 1.278499550151635e-12
single O 0 1.0293003428751835e-11
gene O 0 3.736921536101612e-11
, O 0 1.0481691035957308e-11
ATM O 0 9.66657580647734e-07
, O 0 8.526593493762835e-12
result O 0 2.4343446702879135e-10
in O 0 3.1886510098999565e-10
an O 0 1.6257407864372908e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 9.556671010102491e-09
embraces O 0 1.5622395599379502e-09
a O 0 4.3501948571167404e-11
variety O 0 2.5717397655888874e-10
of O 0 1.0123023530539399e-09
clinical O 0 2.017629086026318e-08
features O 0 3.3555633272008834e-10
and O 0 8.021892872189795e-11
manifests O 0 1.245084146894726e-09
extreme O 0 2.6104583383812496e-08
radiosensitivity O 0 3.872593879350461e-06
and O 0 5.083568010988415e-10
a O 0 8.947929619473882e-10
strong O 0 2.922948327821473e-09
pre O 0 3.4237057207064936e-06
- O 0 9.32825230393064e-07
disposition O 0 2.853166051863809e-06
to O 0 1.1630400109652328e-07
malignancy B-Disease 1 0.9880183935165405
. O 0 1.967669504665537e-06

Heterozygotes O 0 1.7889462924358668e-06
for O 0 1.1776668529250855e-09
the O 0 4.317679991316936e-09
ATM O 0 9.392961146659218e-06
gene O 0 8.229786851998711e-10
have O 0 8.422595954016288e-12
no O 0 6.167041270016549e-12
clinical O 0 1.4244001811380969e-10
expression O 0 3.201263906738028e-11
of O 0 9.513931864546521e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 4.960253097152645e-09
may O 0 2.9178226501613835e-10
be O 0 5.95291108074214e-11
cancer B-Disease 0 1.9899233372200342e-09
prone O 0 4.575329448641696e-09
with O 0 1.5110513534866143e-11
a O 0 6.424247245284676e-10
moderate O 0 2.2442518954335355e-08
increase O 0 1.184230602468972e-09
in O 0 1.706960683911518e-10
in O 0 2.421758571458099e-09
vitro O 0 6.15093028955016e-07
radiosensitivity O 0 6.672858035017271e-06
. O 0 3.287772472049255e-07

We O 0 2.641290031135668e-08
performed O 0 6.661919371708791e-08
a O 0 1.0284815665784208e-08
blind O 0 8.356420266864006e-07
chromosomal O 0 2.6386823037682916e-07
analysis O 0 9.395740185880186e-09
on O 0 4.509458584323056e-09
G2 O 0 3.1336799111159053e-07
- O 0 4.720556834314493e-09
phase O 0 5.950298032075807e-08
lymphocytes O 0 1.3543129950832622e-09
from O 0 2.6320939872093163e-10
7 O 0 8.359275494029816e-10
unrelated O 0 3.331003028961277e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.926430392515613e-06
, O 0 1.1113274189789024e-10
13 O 0 5.176876705093036e-10
obligate O 0 2.610388705193145e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999727010726929
T I-Disease 1 0.9999977350234985
heterozygotes O 0 4.403690581966657e-06
( O 0 6.986151240839789e-11
parents O 0 3.658469707734646e-11
of O 0 3.79591462429385e-11
the O 0 2.815712767112455e-11
patients O 0 1.767380686246156e-10
) O 0 1.1721971050066005e-12
, O 0 1.858290864936718e-12
and O 0 3.7612035881651185e-12
14 O 0 7.673137819574904e-11
normal O 0 4.249565144220924e-09
controls O 0 7.087905817826368e-10
following O 0 6.559690290952602e-11
X O 0 1.0282226625690782e-08
- O 0 1.8152254144254698e-09
irradiation O 0 3.8999750651136367e-10
with O 0 3.5074075588337195e-11
1 O 0 4.930183372664487e-09
Gy O 0 1.1150425649475437e-07
in O 0 2.925504239900678e-12
order O 0 4.073010158311963e-12
to O 0 2.285724734485406e-11
evaluate O 0 1.707987307142389e-09
this O 0 2.7480748579500336e-11
cytogenetic O 0 1.1778836039866292e-07
method O 0 8.352537328448761e-09
as O 0 1.252259407280576e-10
a O 0 1.5727898150519337e-10
tool O 0 2.173246116399241e-08
for O 0 9.10471004145208e-11
detection O 0 7.522662031078653e-07
of O 0 1.566227041394086e-07
ATM O 0 0.026934608817100525
carriers O 0 2.676174517546315e-07
. O 0 8.658174124320794e-07

Both O 0 1.7386137187713757e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
homozygotes O 0 0.00013355264673009515
and O 0 1.1184324577584448e-09
heterozygotes O 0 8.06276929665728e-08
showed O 0 1.117485770585347e-09
significantly O 0 1.265168525499405e-10
increased O 0 1.1684564774072648e-11
levels O 0 8.25715676389116e-11
of O 0 4.261931085824955e-11
radiation O 0 4.683582233155903e-07
- O 0 6.766506999156263e-08
induced O 0 1.80603720423278e-07
chromatid O 0 9.052373570739292e-06
damage O 0 1.5297878519504593e-07
relative O 0 8.18809908764706e-08
to O 0 9.778852033681673e-11
that O 0 1.033857287974227e-11
of O 0 6.5558286577172e-10
normal O 0 3.0872450906827e-07
controls O 0 3.3830980328275473e-07
. O 0 1.0624296464811778e-07

These O 0 4.365476424794679e-09
results O 0 3.881002630379271e-09
show O 0 8.097221226854856e-10
that O 0 6.803389449028252e-12
the O 0 1.5117901375205633e-10
G2 O 0 5.967892207081604e-07
- O 0 2.115094410726215e-08
phase O 0 7.213275239337236e-07
chromosomal O 0 1.3137249652572791e-06
radiosensitivity O 0 1.3513252952179755e-06
assay O 0 2.0012280721459774e-09
can O 0 1.3346635428790332e-11
be O 0 6.0251127004251614e-12
used O 0 9.97908006228343e-12
for O 0 4.245855837053947e-12
the O 0 2.6528579680218378e-11
detection O 0 1.3427501244223095e-07
of O 0 2.806779377806379e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.004189009312540293
. O 0 3.136641680612229e-06

In O 0 1.0757322144172576e-08
combination O 0 1.288642526020567e-08
with O 0 1.3567841294914729e-10
molecular O 0 2.0950469803437954e-08
genetic O 0 4.245716667128363e-09
analyses O 0 1.289812256999312e-09
, O 0 6.61424745269229e-13
this O 0 1.8182504113450904e-13
test O 0 8.488963004760208e-12
may O 0 5.03373818322439e-12
be O 0 4.873620604306517e-12
of O 0 7.513682731552507e-11
value O 0 3.0064331579815473e-10
in O 0 1.9481862303938335e-11
studies O 0 3.5332062275905685e-10
of O 0 3.1737490413519254e-10
familial B-Disease 0 1.0880306433591613e-08
and I-Disease 0 5.75237857347588e-10
sporadic I-Disease 0 2.0257962205505464e-06
cancers I-Disease 0 9.91134947980754e-06
aimed O 0 5.9184124268085725e-08
at O 0 9.58635171244282e-10
determination O 0 1.2660774650896656e-08
of O 0 2.3434645335385085e-09
the O 0 2.290461154075274e-10
potential O 0 2.483030447919532e-10
involvement O 0 1.59847655112344e-08
of O 0 4.9421426950857494e-08
ATM O 1 0.8386684656143188
mutations O 0 1.342686033467544e-07
in O 0 7.394689305328939e-09
tumor B-Disease 0 1.8400640328763984e-05
risk O 0 2.4692139888315978e-08
or O 0 7.237013210925625e-10
development O 0 1.3317163904957852e-07
. O 0 8.540474993878888e-09
. O 0 2.6742652536881906e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 4.85775819569767e-09
identification O 0 2.49041391953142e-07
and O 0 9.156852359692991e-11
detection O 0 3.0704677556059323e-07
of O 0 3.497025602428039e-08
founder O 0 3.5152294231011183e-07
- O 0 1.054627851715395e-08
effect O 0 3.7010314257734933e-10
mutations O 0 1.1222676954414368e-10
in O 0 2.6287713325579e-11
the O 0 3.634503809024636e-10
ATM O 0 1.0842791198228952e-05
gene O 0 1.1594442073104005e-09
in O 0 1.886181766330708e-10
ethnic O 0 2.88571211370936e-09
populations O 0 3.008729265729926e-09
. O 0 7.0531558371556e-09

To O 0 1.6542079706027835e-08
facilitate O 0 1.1345002093321455e-07
the O 0 6.986074496673211e-10
evaluation O 0 7.195453122221807e-08
of O 0 3.1431852676178096e-08
ATM O 0 0.0439666323363781
heterozygotes O 0 4.3370206981308e-07
for O 0 1.1453944459560716e-09
susceptibility O 0 1.9493923275604175e-07
to O 0 2.4702488943262324e-09
other O 0 3.425665529022126e-09
diseases O 1 0.7275274991989136
, O 0 4.296515365709297e-10
such O 0 3.4096345191692023e-10
as O 0 2.9683181423934e-07
breast B-Disease 1 0.9994392991065979
cancer I-Disease 0 0.1098419800400734
, O 0 2.352887884526922e-09
we O 0 1.8438137128207188e-10
have O 0 6.2573514078567705e-12
attempted O 0 1.4718913865507943e-09
to O 0 9.262351996497387e-11
define O 0 5.045780682166878e-09
the O 0 5.21351017912508e-10
most O 0 5.537959674173365e-11
common O 0 2.4283117183721004e-10
mutations O 0 1.3989615021969826e-10
and O 0 1.6973790428753688e-11
their O 0 8.604888329655225e-11
frequencies O 0 4.570011569171584e-08
in O 0 2.4838428203111107e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.001235498464666307
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
) O 0 1.1686828171875163e-09
homozygotes O 0 5.105538889438321e-07
from O 0 9.069629769431486e-11
10 O 0 9.270074985412435e-11
ethnic O 0 1.4324429142842376e-10
populations O 0 1.1627966645111343e-10
. O 0 2.761296968856186e-09

Both O 0 4.438608414147893e-08
genomic O 0 2.456367269587645e-07
mutations O 0 2.36206076920098e-09
and O 0 7.369956728231486e-11
their O 0 1.4880852106102793e-10
effects O 0 1.1098415519938953e-08
on O 0 4.286907717698796e-09
cDNA O 0 3.554590648491285e-07
were O 0 1.829739026959487e-08
characterized O 0 4.124891006540565e-08
. O 0 7.219978925832038e-08

Protein O 0 4.282676684397302e-07
- O 0 3.715889107525072e-08
truncation O 0 4.919121110447122e-08
testing O 0 2.6204540759522388e-09
of O 0 2.0058634753183924e-09
the O 0 2.51839271658838e-10
entire O 0 1.2567687335263145e-08
ATM O 0 1.8415035185626039e-07
cDNA O 0 6.155395482210224e-08
detected O 0 9.271074574712657e-09
92 O 0 4.981405510307013e-09
( O 0 6.508728972454136e-11
66 O 0 6.382677497640543e-08
% O 0 3.1763547347907206e-09
) O 0 7.175624677779879e-11
truncating O 0 9.60684189976746e-08
mutations O 0 9.79147318780349e-10
in O 0 2.364845264057891e-10
140 O 0 2.664584997091879e-09
mutant O 0 4.427766153725088e-09
alleles O 0 1.999270970998168e-09
screened O 0 1.5187329438504094e-07
. O 0 4.112256135613279e-07

The O 0 9.937180323049688e-08
haplotyping O 0 7.240456761792302e-05
of O 0 2.8586949696318698e-08
patients O 0 4.613994075697292e-09
with O 0 3.6005275150241545e-11
identical O 0 4.512134221812403e-09
mutations O 0 4.746674164834985e-10
indicates O 0 7.713449878821166e-10
that O 0 7.426222180598185e-13
almost O 0 9.503217657247376e-12
all O 0 1.6995323334420553e-12
of O 0 2.1044437026329632e-11
these O 0 1.3277166692471365e-11
represent O 0 1.246754227635094e-10
common O 0 2.879596838756271e-10
ancestry O 0 4.367258554793807e-09
and O 0 1.0249946724716352e-10
that O 0 2.1708398967312803e-11
very O 0 7.850701200240451e-10
few O 0 1.7116300599084866e-09
spontaneously O 0 6.956150855330634e-08
recurring O 0 1.5761675058456603e-06
ATM O 0 0.0007303323945961893
mutations O 0 5.329144983079459e-07
exist O 0 2.7584774215938523e-06
. O 0 1.301285692534293e-06

Assays O 0 4.667815005632292e-07
requiring O 0 8.287458719280494e-09
minimal O 0 4.117117313739982e-08
amounts O 0 5.866773733487207e-10
of O 0 2.6574983880145453e-10
genomic O 0 5.07388397963382e-09
DNA O 0 1.9837550269130588e-08
were O 0 2.2988073944407716e-10
designed O 0 1.581462183430915e-10
to O 0 3.0033770609394494e-11
allow O 0 2.2781483643985467e-10
rapid O 0 6.644607530859048e-09
screening O 0 1.7048367162431077e-09
for O 0 1.3585191305232058e-10
common O 0 6.420698195341856e-09
ethnic O 0 2.732837067753735e-08
mutations O 0 1.7151515407931583e-07
. O 0 1.4983460516759806e-07

These O 0 1.0351176804590523e-08
rapid O 0 5.160940119708357e-08
assays O 0 3.45236408350047e-08
detected O 0 1.4255268965257528e-08
mutations O 0 3.403377579758171e-10
in O 0 4.484981830366053e-11
76 O 0 5.911257261459468e-09
% O 0 2.8100233251393547e-09
of O 0 1.0888542290032888e-09
Costa O 0 1.7722375389439549e-07
Rican O 0 8.930748663260601e-06
patients O 0 2.1100419189679087e-07
( O 0 1.3803435824910615e-11
3 O 0 4.4622337075361784e-11
) O 0 1.1428830971882409e-12
, O 0 6.830886225585309e-13
50 O 0 2.123474833470862e-11
% O 0 4.722794724743018e-11
of O 0 7.994109540998551e-11
Norwegian O 0 2.5680334147182293e-05
patients O 0 4.840982228415669e-07
( O 0 1.3362715101106204e-10
1 O 0 4.969227807016807e-10
) O 0 4.325850441744272e-12
, O 0 1.8024814496878094e-12
25 O 0 3.492527794746181e-11
% O 0 1.0953925266843356e-10
of O 0 1.287705081454149e-10
Polish O 0 0.002265356481075287
patients O 0 3.2241980534308823e-06
( O 0 8.81930362073291e-11
4 O 0 6.254494144819489e-10
) O 0 3.90643333653129e-12
, O 0 2.1587245879750583e-12
and O 0 1.409257476339687e-12
14 O 0 1.0446329218316563e-10
% O 0 1.8818946401211178e-10
of O 0 1.1423175599878377e-10
Italian O 0 4.589596187543066e-07
patients O 0 6.974849497964897e-07
( O 0 8.180812971492202e-11
1 O 0 9.719242077821377e-10
) O 0 1.0291393605366128e-11
, O 0 5.783837818407189e-12
as O 0 9.637362956282924e-12
well O 0 7.916950428565883e-11
as O 0 2.74750899115217e-11
in O 0 4.901833106085718e-11
patients O 0 1.8113621713666817e-09
of O 0 1.4994432362414045e-08
Amish O 0 1.8489256490283879e-06
/ O 0 2.156593410518326e-07
Mennonite O 0 1.362830857942754e-06
and O 0 4.458146296570931e-09
Irish O 0 5.880604021513136e-07
English O 0 8.533621098649746e-07
backgrounds O 0 1.9011566791959922e-06
. O 0 6.393997296072484e-07

Additional O 0 9.948065127218797e-08
mutations O 0 1.0099248548556261e-08
were O 0 1.1019709589277227e-09
observed O 0 2.595531289895092e-10
in O 0 3.7830488741619206e-11
Japanese O 0 1.5033551292731318e-08
, O 0 1.0292654922805511e-10
Utah O 0 8.689705843778484e-09
Mormon O 0 1.1044693160044972e-08
, O 0 5.3066800953516235e-11
and O 0 1.392128773369805e-10
African O 0 6.835868759935693e-08
American O 0 7.151396630433737e-08
patients O 0 2.1037168096427195e-07
. O 0 3.434424797887914e-07

These O 0 1.107111513576342e-09
assays O 0 1.065342591921592e-09
should O 0 3.4823637029557375e-11
facilitate O 0 1.3383715247172745e-09
screening O 0 4.0461770045574497e-10
for O 0 7.287627168395261e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 6.212403604877181e-06
in O 0 2.167729606927793e-10
the O 0 1.9418064378662336e-10
populations O 0 3.209909421597601e-11
studied O 0 1.4394935243799978e-09
. O 0 3.2963332063928874e-10
. O 0 1.1344824635273199e-08

The O 0 1.2002134326394298e-06
von B-Disease 1 0.8655772805213928
Hippel I-Disease 1 0.9996284246444702
- I-Disease 0 0.2884717285633087
Lindau I-Disease 0 0.0006286824936978519
tumor I-Disease 0 1.2793432233593194e-06
suppressor O 0 3.793466873958096e-08
gene O 0 4.1514919973950626e-11
is O 0 6.93435597571429e-13
required O 0 6.062546298313265e-11
for O 0 2.0499307112897824e-11
cell O 0 5.872150765640072e-09
cycle O 0 9.457699512438467e-09
exit O 0 8.430483866561644e-09
upon O 0 2.767191586983131e-09
serum O 0 5.9499235760540614e-08
withdrawal O 0 1.971252174826077e-07
. O 0 2.9186000460867945e-07

The O 0 6.038008848463505e-08
inactivation O 0 1.379881950924755e-06
of O 0 2.4499890116658207e-08
the O 0 2.7770061805654223e-08
von B-Disease 1 0.9999552965164185
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.9999995231628418
( I-Disease 0 7.954193392833986e-07
VHL I-Disease 1 0.999931812286377
) I-Disease 0 1.6654180257091866e-08
tumor I-Disease 0 5.040040377934929e-06
suppressor O 0 5.660357146552997e-06
gene O 0 2.701204593336115e-08
predisposes O 0 1.0993221621902194e-06
affected O 0 1.384854453334583e-09
individuals O 0 2.1196185431837655e-11
to O 0 5.217377224697728e-11
the O 0 2.674983345940518e-09
human O 0 0.03445177152752876
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999995231628418
and O 0 2.781488095404683e-10
is O 0 7.365497968481183e-12
associated O 0 1.8249666222658334e-09
with O 0 1.4426097816322425e-10
sporadic B-Disease 1 0.9999994039535522
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 0.0020354909356683493
RCC B-Disease 1 0.9999996423721313
) O 0 6.956134779301237e-09
and O 0 5.6919422064538594e-08
brain B-Disease 1 0.9998772144317627
hemangioblastomas I-Disease 0 0.17991115152835846
. O 0 1.7043715843101381e-06

VHL O 0 0.007135498337447643
- O 0 7.027524407021701e-05
negative O 0 1.9776243220803735e-07
786 O 0 3.4765853342833e-05
- O 0 7.386090146610513e-06
0 O 0 9.470534578781553e-09
RCC B-Disease 0 7.529044978582533e-06
cells O 0 2.5124746727556158e-08
are O 0 2.375704910573262e-10
tumorigenic O 0 1.5642880271116155e-06
in O 0 2.639133134252347e-09
nude O 0 2.1041583408987208e-07
mice O 0 3.13666781437405e-09
which O 0 2.102957998711963e-12
is O 0 4.861319246457496e-12
suppressed O 0 1.0423301805007057e-10
by O 0 1.1623348117328902e-11
the O 0 3.7285224907535053e-10
reintroduction O 0 5.722475862057763e-07
of O 0 1.1732915083939588e-07
VHL B-Disease 0 0.0005557312979362905
. O 0 4.202276159048779e-06

Remarkably O 0 0.0003387745819054544
, O 0 9.515015442218555e-10
this O 0 3.092402722781884e-11
occurs O 0 1.8804593993060337e-10
without O 0 2.816304967012684e-10
affecting O 0 1.0792253757330172e-09
the O 0 1.3653170261029857e-10
growth O 0 2.3686521632981794e-09
rate O 0 9.516069043868924e-10
and O 0 8.630558941125077e-12
cell O 0 2.8127955520318437e-09
cycle O 0 1.108542502237242e-08
profile O 0 5.771127464804238e-10
of O 0 2.2735772986504088e-10
these O 0 4.045557291942892e-11
cells O 0 1.480905287287726e-09
in O 0 3.706880913334487e-10
culture O 0 1.1836592506142551e-07
. O 0 8.785988825366076e-08

The O 0 9.949429795597098e-07
786 O 0 7.07304134266451e-05
- O 0 4.4500711737782694e-06
0 O 0 1.3360453854360799e-09
cell O 0 1.0290745677821178e-07
line O 0 5.359296650908618e-08
, O 0 1.4708718965028567e-10
like O 0 4.77562295264633e-11
many O 0 3.758774541617882e-11
cancer B-Disease 0 5.8533085045553435e-09
cells O 0 1.1247503373112977e-08
, O 0 3.809826412681794e-11
fails O 0 8.808397899962017e-10
to O 0 1.768082069641963e-10
exit O 0 4.771150585725081e-08
the O 0 9.84274106663463e-10
cell O 0 2.41024888936181e-08
cycle O 0 1.2720319908510191e-08
upon O 0 7.245663180555084e-09
serum O 0 5.014113924062258e-08
withdrawal O 0 1.0359396895864847e-07
. O 0 1.980727262207438e-07

Here O 0 8.044410151342163e-07
, O 0 5.711272010877622e-10
it O 0 3.4183109901692044e-12
is O 0 2.06111104746054e-12
shown O 0 6.601726110222472e-11
that O 0 2.179942207650165e-12
reintroduction O 0 2.312754432409747e-09
of O 0 3.053853281365093e-10
the O 0 2.909952834251328e-10
wild O 0 6.611687641822073e-09
- O 0 6.519324102782775e-08
type O 0 1.0603323374880347e-07
VHL B-Disease 0 0.0002651602553669363
gene O 0 4.482044513309802e-09
restores O 0 2.2911263997116293e-09
the O 0 1.8521037481455949e-10
ability O 0 4.1158747521308214e-09
of O 0 5.961702953527492e-08
VHL O 1 0.9999608993530273
- O 0 0.1345086395740509
negative O 0 4.8711768840803416e-08
RCC B-Disease 0 0.00016564849647693336
cancer I-Disease 0 1.7078024328043284e-08
cells O 0 1.0747042145098362e-09
to O 0 9.867567180021908e-11
exit O 0 7.842443139338684e-09
the O 0 3.0389840643962884e-10
cell O 0 8.630374637164095e-09
cycle O 0 9.605409800883535e-09
and O 0 2.6680674336532206e-10
enter O 0 2.951978785858955e-07
G0 O 0 0.024514034390449524
/ O 0 7.151968020480126e-06
quiescence O 0 7.570820162072778e-05
in O 0 1.9497431225090622e-08
low O 0 5.776792590950208e-07
serum O 0 4.5055580244479643e-07
. O 0 1.0885354839729189e-07

Both O 0 1.340280050499132e-06
VHL O 0 0.0007690236088819802
- O 0 1.1880262036356726e-06
positive O 0 1.8260321033025662e-09
and O 0 9.950599233476964e-10
VHL O 0 0.03303932026028633
- O 0 5.161354010851937e-07
negative O 0 4.643762874234625e-10
RCC B-Disease 0 5.885187874810072e-07
cells O 0 8.211006985447966e-09
exit O 0 1.0601256761333389e-08
the O 0 1.2173738406229262e-10
cell O 0 3.044578367195072e-09
cycle O 0 3.1337494821315204e-09
by O 0 1.3296612422220022e-10
contact O 0 7.42279979704108e-08
inhibition O 0 5.265622462502506e-07
. O 0 2.2443680336436955e-07

The O 0 1.5195486184893525e-06
cyclin O 0 0.00014686674694530666
- O 0 5.145074464962818e-05
dependent O 0 6.9487446126004215e-06
kinase O 0 9.060754280199035e-08
inhibitor O 0 4.746106618824797e-09
, O 0 9.171224335524641e-10
p27 O 0 7.77637012561172e-07
, O 0 1.212859118693288e-10
accumulates O 0 1.2358261081146793e-09
upon O 0 4.967863342919543e-10
serum O 0 3.561788863848392e-09
withdrawal O 0 1.0930019556099069e-08
, O 0 2.5897445646294592e-11
only O 0 1.4550442448135747e-11
in O 0 5.37679406206748e-12
the O 0 1.9996462818916427e-11
presence O 0 2.3433024964880644e-10
of O 0 1.1892744566921465e-08
VHL B-Disease 0 0.32397574186325073
, O 0 4.352221916192889e-10
as O 0 2.8832552664836975e-11
a O 0 2.378804965508241e-11
result O 0 1.8374979315893825e-10
of O 0 6.320620138389188e-10
the O 0 3.676581816769442e-10
stabilization O 0 8.737981147532992e-07
of O 0 2.5475756615378486e-08
the O 0 4.5946933369123144e-08
protein O 0 3.569472823983233e-07
. O 0 8.977545462585113e-08

We O 0 1.9698799036405035e-08
propose O 0 4.788433205504816e-09
that O 0 2.376301586060059e-11
the O 0 1.6251096301989065e-10
loss O 0 1.9104158255345283e-09
of O 0 6.456902568174883e-09
wild O 0 1.0346222545365436e-08
- O 0 1.5606797632017333e-08
type O 0 1.3624958938862619e-08
VHL B-Disease 0 0.0001876948372228071
gene O 0 1.733345272869613e-10
results O 0 1.3101057738662547e-10
in O 0 6.19777102903174e-12
a O 0 3.881263366256604e-12
specific O 0 9.524816352302068e-11
cellular O 0 1.4176831086842867e-07
defect O 0 1.6091318855160353e-07
in O 0 8.538482698661198e-10
serum O 0 1.2066583110481588e-07
- O 0 3.037961846530379e-07
dependent O 0 4.6843285872455454e-07
growth O 0 8.060270784149282e-10
control O 0 2.230241546996581e-09
, O 0 7.486012677804244e-12
which O 0 3.6308421547115444e-12
may O 0 3.5832375955280327e-10
initiate O 0 5.7707143952256956e-08
tumor B-Disease 0 5.281744051899295e-06
formation O 0 9.646476428315509e-06
. O 0 8.828050340525806e-06

This O 0 4.361864203161758e-09
is O 0 3.791213176729258e-10
corrected O 0 3.0615723289884045e-08
by O 0 2.419807756948167e-11
the O 0 1.1529315696590103e-10
reintroduction O 0 1.6387321721822445e-08
of O 0 2.1907160530076908e-09
wild O 0 1.9990126887137194e-08
- O 0 3.127189245333284e-07
type O 0 2.9780542263324605e-06
VHL B-Disease 1 0.9999966621398926
, O 0 2.6250182827425306e-07
implicating O 1 0.9998948574066162
VHL B-Disease 1 0.9999430179595947
as O 0 4.5055981168218295e-09
the O 0 9.354965690988593e-10
first O 0 8.105704996097529e-10
tumor B-Disease 0 1.1188064696909805e-08
suppressor O 0 9.048368276864949e-09
involved O 0 9.229449426939595e-10
in O 0 1.2287273976063773e-10
the O 0 3.6612354814558046e-10
regulation O 0 3.1981364223554465e-09
of O 0 6.955096498728608e-10
cell O 0 4.840111866855068e-09
cycle O 0 2.5760920507877927e-08
exit O 0 3.623543420872011e-08
, O 0 4.764020775094302e-12
which O 0 4.32629382622271e-13
is O 0 1.3352536307534302e-12
consistent O 0 1.217576484080496e-09
with O 0 1.4237910329895076e-11
its O 0 3.035605100620842e-11
gatekeeper O 0 2.0168787528973553e-08
function O 0 3.559099681638145e-09
in O 0 7.479327157611237e-10
the O 0 4.258173369464657e-09
kidney O 0 2.0821851649088785e-05
. O 0 2.2179785119647022e-08
. O 0 6.28608560759858e-08

Piebaldism B-Disease 1 1.0
with O 0 0.0013851902913302183
deafness B-Disease 1 1.0
: O 0 4.006513787402355e-09
molecular O 0 1.2261277326786058e-08
evidence O 0 1.2354514078438683e-09
for O 0 4.456603142077853e-11
an O 0 1.1378423897534518e-10
expanded O 0 2.874875235647778e-07
syndrome O 1 0.7789899110794067
. O 0 1.2784516911779065e-06

In O 0 1.495165236065077e-08
a O 0 4.6156580779666e-09
South O 0 4.3928000792448074e-08
African O 0 3.77512563431992e-08
girl O 0 3.799144110416819e-07
of O 0 1.987277613579863e-07
Xhosa O 1 0.999990701675415
stock O 0 4.681222520730444e-09
with O 0 5.474798045468354e-11
severe O 0 3.1942872738000005e-06
piebaldism B-Disease 1 0.9999274015426636
and O 0 2.4187113467633026e-07
profound O 1 0.9986110925674438
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 3.181747274538793e-07
identified O 0 6.814829145440626e-09
a O 0 2.183139086175956e-11
novel O 0 3.897197668745189e-12
missense O 0 2.1417487783281786e-09
substitution O 0 5.496490484979688e-10
at O 0 5.682564419018377e-10
a O 0 1.431962187714575e-10
highly O 0 8.803296758230772e-09
conserved O 0 1.206004540676986e-08
residue O 0 7.936753121384754e-08
in O 0 4.723733626477156e-10
the O 0 2.749986016681305e-09
intracellular O 0 4.56497630807462e-08
kinase O 0 3.4636142842714435e-09
domain O 0 3.894179201324732e-09
of O 0 6.573875221960179e-09
the O 0 6.746184766370789e-08
KIT O 1 0.9999023675918579
proto O 1 0.5557908415794373
- O 0 0.0012056499253958464
oncogene O 0 7.036839087959379e-05
, O 0 1.9659161409890658e-08
R796G O 0 4.014377554995008e-05
. O 0 5.509804736902879e-07

Though O 0 2.2100284695625305e-06
auditory B-Disease 0 0.0006886151968501508
anomalies I-Disease 0 1.1747928510885686e-05
have O 0 2.556329592451334e-10
been O 0 4.109377282901505e-10
observed O 0 2.5997873298599927e-10
in O 0 8.419291652739247e-11
mice O 0 2.2725943349399813e-09
with O 0 1.5216375381932323e-10
dominant O 0 6.298096559476107e-05
white O 0 4.9312578909166405e-08
spotting O 1 0.9058139324188232
( O 0 1.6715633321950918e-08
W O 0 9.15614509722218e-06
) O 0 3.0244397264400646e-11
due O 0 3.381832769377979e-08
to O 0 1.1107177400049295e-09
KIT O 1 0.8718919157981873
mutations O 0 1.0824584251167835e-06
, O 0 1.5636594241641433e-08
deafness B-Disease 1 1.0
is O 0 4.830370547992402e-10
not O 0 1.054751563867029e-10
typical O 0 2.2423563450502115e-08
in O 0 6.478326208814167e-10
human O 0 3.154897498802711e-08
piebaldism B-Disease 0 7.41252806619741e-05
. O 0 5.110312599754252e-07

Thus O 0 1.6953406145603367e-07
, O 0 2.1342888567588147e-10
the O 0 1.3481063487752465e-10
occurrence O 0 1.663567985588088e-07
of O 0 6.878649855934782e-06
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 2.2146089122543344e-06
this O 0 2.4850879132287673e-09
patient O 0 1.5187416124717856e-07
extends O 0 1.9664653239104268e-10
considerably O 0 5.3974935632084e-10
the O 0 3.5161484834844714e-11
phenotypic O 0 1.3280372357371562e-09
range O 0 5.886423015688536e-10
of O 0 1.030149854308604e-09
piebaldism B-Disease 0 3.815039519849961e-07
due O 0 7.988587924501189e-08
to O 0 6.4498864027484615e-09
KIT O 0 0.0002299947664141655
gene O 0 4.5654807934170094e-08
mutation O 0 1.0983749909598828e-08
in O 0 1.8734712392554087e-10
humans O 0 4.409116183268225e-09
and O 0 2.289788358922351e-10
tightens O 0 1.047706366108514e-09
the O 0 1.59629962026564e-10
clinical O 0 1.602359489538685e-08
similarity O 0 2.3818766958783044e-09
between O 0 1.2322985298851563e-08
piebaldism B-Disease 0 1.1274178177700378e-06
and O 0 2.752990543863909e-11
the O 0 1.7997547896442256e-11
various O 0 1.4554252247833688e-10
forms O 0 2.135809085146434e-09
of O 0 2.2266694941208698e-06
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9941178560256958
. O 0 3.4467646514713124e-08
. O 0 1.3818451805036602e-07

Cycloheximide O 0 0.0001696080871624872
facilitates O 0 9.67796154327516e-08
the O 0 9.117887556087112e-10
identification O 0 5.350349496779927e-08
of O 0 4.644104478757072e-08
aberrant O 0 9.354527463756312e-08
transcripts O 0 1.9565946729471762e-07
resulting O 0 7.311578453794709e-09
from O 0 3.132241965797533e-10
a O 0 6.313966016691097e-11
novel O 0 4.0863512573707794e-10
splice O 0 2.2586125680845726e-07
- O 0 5.240320621879846e-09
site O 0 7.658038092550612e-10
mutation O 0 2.902829365769577e-10
in O 0 2.504066398678617e-10
COL17A1 O 0 0.29647213220596313
in O 0 1.1925128662326756e-09
a O 0 2.0430939162707773e-09
patient O 0 4.114740931981942e-06
with O 0 6.308221145445714e-08
generalized O 1 0.9775289297103882
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999984502792358
epidermolysis I-Disease 1 0.9999918937683105
bullosa I-Disease 1 0.9671899676322937
. O 0 1.0146136446564924e-05

Patients O 0 2.3137623429647647e-05
with O 0 1.4215333976608235e-07
generalized O 0 0.08193866908550262
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999954700469971
epidermolysis I-Disease 1 0.9999992847442627
bullosa I-Disease 1 0.998957633972168
often O 0 2.963863376947984e-09
show O 0 4.939386122337908e-10
decreased O 0 2.223645045873468e-09
expression O 0 1.7228013460268699e-10
of O 0 1.1573695335442835e-09
type O 0 5.0619874514268304e-08
XVII O 0 0.00016595268971286714
collagen O 0 3.3977621569647454e-06
, O 0 4.525493757512322e-09
a O 0 6.91300305888376e-09
transmembrane O 0 3.0166899023242877e-07
hemidesmosomal O 0 7.431993367390533e-07
protein O 0 8.073707036260203e-09
encoded O 0 4.228567274111583e-09
by O 0 4.11750766815544e-09
COL17A1 O 0 0.0040163579396903515
. O 0 9.654248742663185e-07

This O 0 1.4806433412672959e-08
report O 0 2.506872931462567e-09
documents O 0 6.180734590799375e-09
a O 0 4.292960154028691e-10
novel O 0 5.39319200409949e-10
splice O 0 6.376685064424237e-07
- O 0 7.412709113197025e-09
site O 0 5.952210391235724e-10
mutation O 0 2.850003011367619e-10
in O 0 1.1166755020663999e-10
COL17A1 O 1 0.9993999004364014
in O 0 1.215003764265532e-09
a O 0 1.8575742055659816e-09
patient O 0 4.877006176684517e-06
with O 0 4.875136383475365e-08
generalized O 1 0.99429851770401
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999904632568359
epidermolysis I-Disease 1 0.999984622001648
bullosa I-Disease 0 0.23784208297729492
, O 0 7.555563952266198e-10
and O 0 5.437915048811526e-11
applies O 0 3.491830158353082e-10
a O 0 3.7605245306604473e-11
new O 0 1.3702758545897087e-11
methodology O 0 8.22793833066271e-09
to O 0 7.927754286374267e-11
define O 0 7.438712756879795e-09
and O 0 4.3566739105216357e-10
characterize O 0 7.846487193319263e-08
the O 0 2.5848514439985593e-09
resulting O 0 2.643689001047278e-08
mRNA O 0 7.828285220057296e-07
splice O 0 1.8465909761289367e-06
variants O 0 1.5231293559736514e-07
. O 0 2.9977704230077507e-07

Mutational O 0 2.252799276902806e-05
analysis O 0 6.081618408870781e-08
of O 0 9.563184732996888e-08
COL17A1 O 1 0.7459701299667358
identified O 0 9.458190675104561e-08
a O 0 4.0632781583838096e-09
maternally O 0 7.643443495908286e-07
inherited O 0 2.83509893961309e-06
G O 0 6.670883863080235e-07
- O 0 1.3420792299712048e-07
to O 0 1.2544385974422312e-08
- O 0 1.5808597026989446e-06
T O 0 3.3056238635253976e-07
transversion O 0 4.63243959529791e-05
at O 0 1.0042085385464361e-08
the O 0 9.887222152116237e-10
- O 0 9.056599914458729e-10
1 O 0 1.6062103036507125e-10
position O 0 1.7960634091096495e-09
of O 0 5.637527777935247e-09
exon O 0 1.6113538947593042e-07
32 O 0 9.745144780026749e-08
. O 0 1.2188438347493502e-07

This O 0 7.012792568872328e-09
acceptor O 0 1.1584593551106082e-07
splice O 0 5.136745585332392e-06
- O 0 8.104413495857443e-08
site O 0 4.285239718626599e-09
mutation O 0 5.957662141398146e-10
led O 0 4.179540047388741e-10
to O 0 6.069234004257851e-11
the O 0 5.298975702672237e-10
formation O 0 1.216547389049083e-06
of O 0 1.129092083829164e-06
aberrant O 0 2.794312194964732e-07
transcripts O 0 1.1446740018072887e-06
present O 0 1.1764372587208527e-08
at O 0 2.8090012094139638e-08
extremely O 0 5.236726678958803e-07
low O 0 8.188706601686135e-07
levels O 0 8.233372454924393e-07
. O 0 8.427127795584965e-08

Based O 0 3.3136324795179917e-09
on O 0 2.275005739349467e-09
our O 0 1.3737997406337854e-09
recent O 0 3.4497914941367114e-11
finding O 0 3.4971020523855145e-10
that O 0 1.0892292276465376e-11
cycloheximide O 0 7.71088295437039e-08
stabilized O 0 2.1424521037261e-06
mutant O 0 3.471870257953924e-08
COL17A1 O 0 3.8263762689894065e-05
transcripts O 0 1.689704163254646e-07
in O 0 3.414001026325053e-10
keratinocytes O 0 1.9654967786664201e-07
homozygous O 0 2.407826160677473e-09
for O 0 8.432019665827184e-11
a O 0 9.519154353654358e-10
frameshift O 0 1.2382898830765043e-06
mutation O 0 2.5933899472363464e-09
, O 0 3.3854932746102406e-11
the O 0 9.239255194248841e-11
effects O 0 3.991883712473054e-09
of O 0 3.4522764646993664e-09
the O 0 4.624778782158501e-09
splice O 0 1.9054354538639018e-07
- O 0 2.45482434380051e-09
site O 0 1.933476295734593e-10
mutation O 0 2.3038760135762892e-11
on O 0 7.087077452672119e-11
splicing O 0 2.1676243022739072e-08
of O 0 7.227954235133893e-09
COL17A1 O 0 5.975244494038634e-05
transcripts O 0 3.154374184077824e-08
were O 0 1.7473798796796558e-10
determined O 0 1.24013715963045e-10
using O 0 1.835531900085119e-11
reverse O 0 1.790668169299181e-10
transcriptase O 0 4.893633831493105e-10
polymerase O 0 6.549804587585584e-10
chain O 0 9.260196776050833e-11
reaction O 0 2.570948662294903e-11
of O 0 2.835293388958604e-10
total O 0 1.2663182724637068e-09
RNA O 0 2.1249405790513265e-08
from O 0 3.5005540688359815e-09
keratinocytes O 0 4.254459781805053e-06
incubated O 0 4.488685760861699e-07
for O 0 1.197952292919524e-09
2 O 0 1.0252698245949432e-07
. O 0 1.1227724172613307e-07

5 O 0 1.317816611390299e-07
h O 0 9.443153814459038e-09
in O 0 2.1051671517113846e-10
the O 0 2.975990009979057e-10
presence O 0 3.1282895718298676e-10
or O 0 1.3721752900597295e-10
absence O 0 2.030558903243218e-07
of O 0 8.343147328560008e-08
10 O 0 4.1516564408539125e-08
microg O 0 3.248057510063518e-06
cycloheximide O 0 1.3766917845714488e-06
per O 0 2.206136002769199e-07
ml O 0 2.6154177703574533e-06
. O 0 1.7016482445342263e-07

Using O 0 4.282461940618987e-09
this O 0 1.4239928680659375e-10
approach O 0 4.535932962568268e-09
, O 0 7.73507369267179e-11
an O 0 1.2976085483895616e-11
abnormally O 0 1.8799619638798504e-09
spliced O 0 1.810955474468301e-08
transcript O 0 2.745025007300228e-08
was O 0 1.2606117261171335e-09
identified O 0 7.813698021941207e-10
that O 0 1.7812746720344275e-12
contains O 0 1.891616420793274e-12
an O 0 3.8112910180285176e-13
extra O 0 6.551451048331103e-11
264 O 0 2.035687618473503e-09
bases O 0 1.4251483326788161e-09
upstream O 0 6.804542262983659e-09
from O 0 1.1558011214773956e-09
exon O 0 3.2186445508841643e-08
32 O 0 1.5820400989241534e-08
, O 0 8.141942675621294e-11
resulting O 0 2.1983885822862703e-09
in O 0 1.6175578931854062e-10
a O 0 1.0338701006418205e-09
premature O 0 7.599797413604392e-08
termination O 0 4.85003965877695e-08
codon O 0 2.960120468742389e-07
27 O 0 1.1642196540151417e-07
bp O 0 2.2614919714669668e-07
downstream O 0 1.4824469474206126e-07
from O 0 3.043835405946993e-09
the O 0 2.725601433439806e-08
cryptic O 0 2.233613486168906e-06
splice O 0 6.502746600745013e-06
site O 0 2.2858291970351274e-07
. O 0 4.5360823719420296e-07

Three O 0 3.537134318776225e-08
other O 0 9.607328266270088e-10
splice O 0 8.170002274709987e-08
variants O 0 2.2971120561265934e-09
, O 0 1.0412804299364531e-11
including O 0 2.1522614419844377e-12
one O 0 3.718292167220749e-12
derived O 0 3.145431137774324e-10
from O 0 1.0500125074974775e-10
the O 0 2.2754863271412518e-10
skipping O 0 4.5715371044252606e-08
of O 0 8.187208777599153e-08
exon O 0 1.95722918761021e-07
32 O 0 7.694897874443996e-08
, O 0 3.513455637538243e-10
were O 0 5.887312859442773e-09
also O 0 7.532626744577442e-10
identified O 0 1.7703760590848105e-07
. O 0 4.1640686276878114e-07

These O 0 3.5404801312921563e-09
results O 0 4.056502689309127e-09
indicate O 0 2.9613431706820847e-09
the O 0 1.2061021625875412e-10
usefulness O 0 3.089323996618987e-08
of O 0 2.1215336154511988e-09
cycloheximide O 0 7.157427717174869e-07
treatment O 0 7.25764115472316e-09
in O 0 3.2171296876493116e-11
evaluating O 0 7.42040040524472e-10
the O 0 8.693824826710994e-11
abnormal O 0 5.785409928904528e-10
processing O 0 1.4331959619084955e-08
of O 0 8.433825304798859e-10
mRNA O 0 5.267387415130997e-09
due O 0 1.3090680539562527e-08
to O 0 1.346131206503287e-09
splice O 0 4.4499336127046263e-07
- O 0 6.107060634974459e-09
site O 0 9.330800576634601e-10
mutations O 0 1.3295503586974178e-09
, O 0 4.070340592354782e-11
because O 0 1.3084001937446743e-10
( O 0 1.1772216534922109e-10
i O 0 1.6983271677872835e-08
) O 0 1.0004870543145472e-10
aberrant O 0 4.6800261443991076e-09
splicing O 0 2.1020598595100637e-08
often O 0 7.591962475350655e-11
generates O 0 5.273001132954924e-11
a O 0 4.121251256927749e-11
premature O 0 5.741847441953496e-09
termination O 0 1.2407630478605824e-08
codon O 0 5.0185249733658566e-08
, O 0 6.888767334345403e-10
( O 0 1.0039394315874972e-10
ii O 0 3.2720075182623987e-07
) O 0 1.1668875865566974e-09
transcripts O 0 1.785268892717795e-07
with O 0 1.6361415000609725e-10
premature O 0 1.3536655352197613e-08
termination O 0 2.8245479288813158e-09
codons O 0 2.341096649871588e-09
can O 0 4.5327804010231176e-11
occur O 0 2.0026522662419666e-09
at O 0 3.5139868792555262e-09
low O 0 3.8120347767289786e-08
or O 0 5.22780929657074e-10
undetectable O 0 1.964952822675059e-08
levels O 0 2.256302700232027e-09
due O 0 2.1697617036409156e-09
to O 0 1.315045156102812e-10
nonsense O 0 3.116786118084747e-08
- O 0 3.5417500043877226e-09
mediated O 0 3.391949121578364e-08
mRNA O 0 3.340444720834057e-08
decay O 0 6.99773607948373e-08
, O 0 1.591659443134219e-11
and O 0 7.404120719312068e-12
( O 0 3.5330946068085067e-12
iii O 0 1.911397085052613e-08
) O 0 3.720308783261572e-11
the O 0 1.2235940038962667e-10
levels O 0 2.393375275744347e-09
of O 0 9.259578520603995e-11
these O 0 3.512777221881258e-11
transcripts O 0 1.2027103757361601e-08
can O 0 4.091777958126208e-11
be O 0 7.191957446250896e-11
increased O 0 1.1419477585761229e-09
by O 0 1.3786741748234022e-09
cycloheximide O 0 9.467516065342352e-06
. O 0 4.71274177016312e-07

A O 0 9.896585879687336e-07
deletion O 0 5.358734824767453e-07
mutation O 0 4.390427132960895e-09
in O 0 9.001679956988085e-10
COL17A1 O 1 0.9974517226219177
in O 0 1.6499207555753514e-10
five O 0 1.9084445135320038e-10
Austrian O 0 1.8508949040096923e-07
families O 0 2.5188695573774567e-09
with O 0 5.084423992940401e-09
generalized O 0 0.0003583525831345469
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999860525131226
epidermolysis I-Disease 1 0.9998894929885864
bullosa I-Disease 0 0.00038040895015001297
represents O 0 3.901859724209089e-09
propagation O 0 3.159896380111604e-07
of O 0 1.715507202959543e-08
an O 0 6.074552527657318e-10
ancestral O 0 2.6407340669720725e-07
allele O 0 3.6146391835245595e-07
. O 0 8.024733233469306e-07

Patients O 0 4.169543171883561e-05
with O 0 7.778270827429878e-08
generalized O 1 0.9287769198417664
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9996614456176758
, O 0 1.4456293939701936e-09
a O 0 4.1415681995005116e-10
usually O 0 6.675358599217418e-10
nonlethal O 0 2.00426654828334e-07
form O 0 1.5967404465300206e-07
of O 0 0.0007323731551878154
junctional B-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999990463256836
bullosa I-Disease 1 0.9924790859222412
, O 0 2.5209407894521974e-09
have O 0 8.850343374833258e-11
generalized O 0 6.81141099079241e-09
blistering B-Disease 0 2.6126349084165668e-08
, O 0 5.596708430033459e-09
nail B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
, O 0 1.3341815247258637e-05
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 2.304019290022552e-06
and O 0 7.44869394111447e-05
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.999935507774353

Skin B-Disease 1 1.0
fragility I-Disease 1 1.0
in O 0 3.805881476637296e-08
most O 0 9.42266958903204e-11
cases O 0 1.1186425917519838e-11
is O 0 1.0537190694645537e-12
due O 0 5.750184217667709e-10
to O 0 2.829522206815316e-11
mutations O 0 1.0674330169768709e-10
in O 0 8.36185027469627e-12
the O 0 4.155437105524129e-11
gene O 0 1.4437659401345115e-10
encoding O 0 3.377417101546598e-08
type O 0 6.630197049162234e-07
XVII O 1 0.9862733483314514
collagen O 0 0.009491920471191406
( O 0 4.919411722426048e-08
COL17A1 O 1 0.9999594688415527
) O 0 6.222204085304384e-09
. O 0 6.388329154560779e-08

Recently O 0 2.3096107781839237e-07
, O 0 3.2434149810356416e-10
we O 0 5.5434552781452595e-11
reported O 0 6.268057600733457e-11
five O 0 1.7368292568042953e-11
Austrian O 0 6.846791222869797e-08
families O 0 1.4038377127434387e-09
with O 0 4.553355914538315e-09
generalized O 0 0.0003512491821311414
atrophic B-Disease 1 0.9999997615814209
benign I-Disease 1 0.9999963045120239
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999722242355347
who O 0 2.5247294033192702e-08
share O 0 4.178601464843723e-09
the O 0 1.0320830856613838e-09
same O 0 2.4651905405903562e-08
COL17A1 O 1 0.9995205402374268
mutation O 0 3.919214748293598e-07
. O 0 1.2522779968549003e-07

Affected O 0 7.163764621509472e-07
individuals O 0 8.982710686389339e-10
in O 0 6.389831025410686e-11
three O 0 1.3816026447899254e-11
families O 0 7.494813797359612e-12
are O 0 1.079825031474746e-12
homozygous O 0 2.0301873029926476e-11
for O 0 1.1089892892890418e-11
4003delTC O 0 6.370539296085553e-08
, O 0 2.1712374953519742e-11
whereas O 0 1.1840814995167648e-09
those O 0 2.96429027157874e-11
in O 0 1.5301293218583645e-11
two O 0 2.3792360442920213e-11
others O 0 1.8599309592470803e-10
are O 0 4.9091970072412394e-11
compound O 0 2.933237297497726e-08
heterozygotes O 0 1.3789348258796963e-06
. O 0 4.373746946839674e-07

To O 0 2.4840797863134867e-08
determine O 0 2.850919322838763e-08
if O 0 2.806823939938141e-10
the O 0 1.0263406097221761e-10
occurrence O 0 1.2768254009642988e-08
of O 0 1.6210242037573153e-09
4003delTC O 0 3.3328969806234454e-08
in O 0 1.8879011201566875e-11
these O 0 5.9333310833964426e-12
unrelated O 0 1.0485660117964812e-09
families O 0 5.689325746627283e-12
signifies O 0 7.069526214431576e-11
propagation O 0 1.2031279972291031e-08
of O 0 1.2148252404031723e-09
an O 0 1.1310999359359641e-10
ancestral O 0 4.2230158925349315e-08
allele O 0 3.722252017723804e-08
or O 0 7.879853214376453e-09
a O 0 7.980668925711143e-08
mutational O 0 3.499097147141583e-05
hot O 0 1.3483927432389464e-06
spot O 0 1.0813568707135346e-07
, O 0 1.5447804146973e-10
haplotypes O 0 3.1439149061895932e-09
were O 0 3.527630687560901e-10
determined O 0 2.6645037287664763e-09
for O 0 2.9727054151607035e-10
polymorphisms O 0 7.660251100105597e-08
both O 0 4.998518488008585e-09
within O 0 4.457315228023617e-08
and O 0 1.269879312815192e-08
flanking O 0 0.00012343104754108936
COL17A1 O 1 0.9999990463256836
. O 0 2.1583642592304386e-05

Five O 0 2.7301237537358247e-07
intragenic O 0 3.62569107892341e-06
polymorphisms O 0 1.4418850113884218e-08
were O 0 5.535977232185019e-10
chosen O 0 5.131439162475715e-10
based O 0 2.750303457199621e-11
on O 0 6.575966438049363e-10
their O 0 4.257052488298996e-09
informativeness O 0 5.104595038574189e-05
. O 0 1.4999889117461862e-06

One O 0 6.020655263228036e-08
of O 0 7.994468198546656e-09
these O 0 4.1093226044175424e-10
, O 0 1.6625402443626314e-11
not O 0 3.2887876449949616e-12
previously O 0 2.3944379812235184e-10
reported O 0 1.2447867736575802e-10
, O 0 6.5951272221198565e-12
was O 0 1.5548702325673958e-09
2988 O 0 6.529130018861906e-07
A O 0 1.5219850979519833e-07
or O 0 2.596057369075311e-09
C O 0 9.808395589061547e-07
that O 0 8.377196158981803e-11
introduces O 0 4.057692515324618e-10
a O 0 3.422631622562733e-11
new O 0 7.405829421935906e-12
restriction O 0 4.3035009583691775e-11
site O 0 1.5718121249008732e-10
for O 0 2.448673763755238e-10
Eco0109 O 0 1.878431976365391e-05
I O 0 6.842338916612789e-05
. O 0 1.0642422694218112e-06

All O 0 4.604086889514747e-09
the O 0 6.400470708989303e-10
4003delTC O 0 2.103844742862293e-08
alleles O 0 1.221972939502436e-10
showed O 0 8.387939648413223e-11
the O 0 5.440028635894656e-12
same O 0 1.2323342866993325e-11
haplotype O 0 3.0394942118761037e-10
for O 0 1.7237570745787245e-11
these O 0 2.0543547418760966e-10
five O 0 1.8687362768332605e-09
polymorphic O 0 1.9140830431751965e-07
markers O 0 2.8910832838846545e-07
. O 0 1.240845676875324e-06

Fourteen O 0 1.3352839687286178e-06
microsatellite O 0 3.070327068144252e-07
polymorphisms O 0 1.2980362562586834e-08
were O 0 5.084120902054678e-10
selected O 0 3.799949244154277e-11
based O 0 2.5553669423528103e-12
on O 0 1.1672275646024133e-10
their O 0 1.9987209110006177e-10
high O 0 5.008032655240413e-09
heterozygosity O 0 9.061634045792744e-06
and O 0 7.313555316912357e-10
their O 0 8.82711681526871e-10
location O 0 2.4374880780442254e-08
within O 0 6.421998932637507e-08
10q23 O 0 2.490577935532201e-05
- O 0 1.772546397660335e-06
q25 O 0 5.843140388606116e-05
near O 0 6.14174859947525e-06
COL17A1 O 0 0.239443838596344
. O 0 3.6218825698597357e-06

Three O 0 2.0278568158005328e-08
families O 0 2.138377031002392e-09
shared O 0 3.499107492643816e-08
microsatellite O 0 7.165957640609122e-07
polymorphisms O 0 2.772180778265465e-07
covering O 0 1.731309140495796e-07
at O 0 1.1008392419853408e-08
most O 0 1.682007033654287e-10
19 O 0 3.6429315120045658e-09
cM O 0 2.3668830451128997e-08
, O 0 4.140050108292215e-11
whereas O 0 1.3568003387476324e-09
the O 0 8.163016929074729e-10
others O 0 1.4517302915351138e-09
shared O 0 5.627214694214899e-09
smaller O 0 1.718967607144961e-10
regions O 0 2.752860717158967e-10
consistent O 0 1.736258026241444e-09
with O 0 9.513917431647201e-12
cross O 0 8.861197109411023e-09
- O 0 3.67658579136787e-08
over O 0 1.8802764900627267e-10
events O 0 9.969858272285137e-11
during O 0 6.045712819258142e-10
passage O 0 1.5593987212625393e-10
of O 0 1.4079255990229189e-11
this O 0 6.064138774464212e-12
mutation O 0 1.0039776648929077e-10
through O 0 2.143259458797786e-10
several O 0 8.46538117382778e-10
generations O 0 1.9261612749232881e-07
. O 0 9.762688790715401e-08

These O 0 4.365168226883043e-09
results O 0 1.3878715954263043e-09
indicate O 0 1.5499904693072608e-09
that O 0 6.718897140045588e-12
4003delTC O 0 1.1902366203742076e-08
occurs O 0 1.66855473882066e-10
on O 0 1.235318930481455e-10
a O 0 7.584596145582267e-11
single O 0 1.924074011228072e-09
ancestral O 0 5.119361290439883e-08
allele O 0 3.401421011517414e-08
. O 0 1.530715465491994e-08
. O 0 2.834458996403555e-07

The O 0 2.927166065092024e-07
haptoglobin O 0 5.1918483222834766e-05
- O 0 4.918318836644175e-07
gene O 0 1.7171005728400246e-09
deletion O 0 1.0607163147824394e-08
responsible O 0 1.950851569176848e-08
for O 0 4.247476326213473e-08
anhaptoglobinemia B-Disease 1 0.996503472328186
. O 0 3.540918442013208e-06

We O 0 5.6240093471160435e-08
have O 0 1.4294788963642446e-10
found O 0 4.6639456185992856e-11
an O 0 1.5685491100425608e-12
allelic O 0 1.0382655624141535e-08
deletion O 0 1.770976432169391e-08
of O 0 5.078359421872847e-08
the O 0 8.779674232073376e-08
haptoglobin O 0 0.2676778733730316
( O 0 1.1907081987061474e-09
Hp O 0 8.249246619129735e-09
) O 0 1.183186361386479e-11
gene O 0 4.2535017175104883e-11
from O 0 2.916452496171118e-11
an O 0 5.50087926598497e-12
individual O 0 4.4705844581827137e-10
with O 0 4.9077319985713075e-09
anhaptoglobinemia B-Disease 0 0.3130229115486145
. O 0 2.327399897694704e-06

The O 0 1.901521642366788e-07
Hp O 0 5.0697266829047294e-08
gene O 0 1.0878926232082975e-10
cluster O 0 1.1869141780529446e-10
consists O 0 2.3384760794442627e-10
of O 0 3.5179166246734894e-09
coding O 0 0.00038616888923570514
regions O 0 2.0258580590848396e-08
of O 0 1.3659279929356671e-08
the O 0 1.6421449755554818e-09
alpha O 0 9.561043068373465e-10
chain O 0 5.5990306141451285e-11
and O 0 1.4389485263055501e-11
beta O 0 4.650091145474988e-10
chain O 0 8.566046483249323e-11
of O 0 2.426760459250943e-10
the O 0 4.902135364304172e-10
haptoglobin O 0 7.819637062311813e-07
gene O 0 1.9225552261303847e-09
( O 0 6.289182369334512e-11
Hp O 0 3.6290888072443295e-09
) O 0 1.918823953894755e-11
and O 0 4.4808434740417624e-11
of O 0 1.9733836786883785e-09
the O 0 1.0694143348644047e-09
alpha O 0 1.285077932955403e-09
chain O 0 1.055987519649193e-10
and O 0 7.058891665634448e-12
beta O 0 3.4919697688984286e-10
chain O 0 6.609916086697254e-11
of O 0 1.1151068957104826e-10
the O 0 5.243377398933546e-10
haptoglobin O 0 3.515240223350702e-06
- O 0 2.8780512195680785e-08
related O 0 1.3040664548213954e-08
gene O 0 1.2655794190408187e-09
( O 0 2.2582044567620585e-10
Hpr O 0 8.795300914243853e-07
) O 0 5.467326244512627e-11
, O 0 3.078625548935676e-11
in O 0 9.670198669597951e-11
tandem O 0 8.852838817574593e-08
from O 0 3.6481324627857248e-09
the O 0 9.924334243294197e-09
5 O 0 3.84128817643159e-08
side O 0 9.019389324294025e-08
. O 0 2.595552075490559e-07

Southern O 0 4.150744643993676e-06
blot O 0 2.342139623578987e-06
and O 0 9.366248887587858e-10
PCR O 0 4.733569625159362e-08
analyses O 0 2.083450079126692e-09
have O 0 3.039804302371052e-12
indicated O 0 3.7288120507961153e-11
that O 0 8.753094820138085e-14
the O 0 5.343136415085492e-13
individual O 0 2.0932814943225297e-12
with O 0 3.674320830232558e-12
anhaptoglobinemia B-Disease 0 7.632467458051906e-08
was O 0 1.4588861230180328e-09
homozygous O 0 2.1650849169052577e-10
for O 0 5.900310622031224e-12
the O 0 8.707316812017751e-11
gene O 0 3.341066034945328e-10
deletion O 0 1.7429437892957367e-09
and O 0 3.4799801928997454e-11
that O 0 2.5226880046719247e-12
the O 0 2.981624669384786e-11
gene O 0 5.2765628671958e-11
deletion O 0 2.6028537658540074e-10
was O 0 4.012936094532904e-10
included O 0 4.589484001171762e-11
at O 0 1.4838875961320497e-10
least O 0 6.065180042230667e-12
from O 0 1.3396674394816621e-11
the O 0 2.0889598384421504e-10
promoter O 0 4.452238613339432e-07
region O 0 6.417578788386891e-07
of O 0 2.4607706450296973e-07
Hp O 0 2.078284069284564e-07
to O 0 6.854157685864948e-09
Hpr O 0 7.209657724160934e-07
alpha O 0 1.5510462914036793e-09
but O 0 4.872990899684737e-11
not O 0 2.302900752038095e-11
to O 0 6.498808713395476e-10
Hpr O 0 2.2936956156627275e-06
beta O 0 5.8626412169360265e-08
( O 0 5.217820397973583e-09
Hpdel O 0 4.031576099805534e-05
) O 0 1.4803215542258386e-08
. O 0 3.105885184595536e-07

In O 0 7.14565384640764e-09
addition O 0 2.7081159537090116e-09
, O 0 9.600874956161576e-11
we O 0 3.735083423106467e-11
found O 0 2.0187499241708373e-11
seven O 0 1.811660890749245e-11
individuals O 0 4.9244900691969296e-12
with O 0 1.0915751809392749e-11
hypohaptoglobinemia B-Disease 0 8.547254992663511e-07
in O 0 1.9311063859106525e-10
three O 0 2.661485198895974e-10
families O 0 6.756644549410495e-11
, O 0 9.412587029244968e-12
and O 0 1.3858678094003096e-11
the O 0 1.5336068526217161e-10
genotypes O 0 5.032672945048944e-08
of O 0 1.5391580232559932e-09
six O 0 4.895649996505824e-10
of O 0 3.9518593952792003e-10
the O 0 8.989922001267914e-11
seven O 0 1.0740622974347858e-10
individuals O 0 1.4737102163597804e-11
were O 0 2.6676300057815183e-10
found O 0 1.038858860047398e-10
to O 0 3.029498596429647e-10
be O 0 2.014806455008511e-08
Hp2 O 1 0.9991194605827332
/ O 1 0.6350055932998657
Hpdel O 1 0.961155116558075
. O 0 4.675675427279202e-06

The O 0 4.819314085580118e-07
phenotypes O 0 7.288127221727336e-07
and O 0 1.7365726634466228e-09
genotypes O 0 4.069935144457304e-08
in O 0 8.22057352745098e-11
one O 0 1.0231932488780071e-11
of O 0 1.9463588726842396e-11
these O 0 1.0277107940701025e-12
three O 0 3.122450431894408e-12
families O 0 6.2364766129086036e-12
showed O 0 1.1890419204796387e-10
the O 0 7.848836164336959e-12
father O 0 9.380480836540528e-10
to O 0 1.6329645968760076e-10
be O 0 1.0838343555974461e-08
hypohaptoglobinemic B-Disease 0 0.010779302567243576
( O 0 1.2630118284562286e-08
Hp2 O 0 0.0032287791837006807
) O 0 7.440553728699228e-10
and O 0 2.319694658581284e-09
Hp2 O 0 0.02472965233027935
/ O 0 2.5712770366226323e-06
Hpdel O 0 0.0002628057263791561
, O 0 7.140223828860925e-11
the O 0 2.1529369953476873e-10
mother O 0 9.221284846816502e-10
to O 0 1.2791739889550513e-10
be O 0 3.375709045627673e-09
Hp2 O 1 0.8439143896102905
- O 0 6.72981116167648e-07
1 O 0 1.896754042718385e-08
and O 0 3.9691601116942365e-09
Hp1 O 0 0.019764427095651627
/ O 0 1.4202437341737095e-06
Hp2 O 0 1.5035670912766363e-05
, O 0 2.2606383778822625e-11
one O 0 5.8904825461780774e-12
of O 0 4.03507678659043e-11
the O 0 4.1107239140414364e-11
two O 0 4.943455367278915e-11
children O 0 1.473403864193923e-11
to O 0 4.2207470157817895e-11
be O 0 2.0572574754851303e-09
hypohaptoglobinemic B-Disease 0 0.00024802310508675873
( O 0 1.0820683016277144e-08
Hp2 O 0 0.007410628255456686
) O 0 1.2079423017397062e-09
and O 0 7.51010809096897e-09
Hp2 O 1 0.9976240992546082
/ O 0 0.0005482262931764126
Hpdel O 1 0.9956117272377014
, O 0 2.196639814489032e-10
and O 0 1.922271196386216e-11
the O 0 9.537323708563861e-11
other O 0 4.08732388212929e-11
child O 0 1.9195911526992404e-09
to O 0 1.5782197770874973e-10
be O 0 5.825385951396811e-09
Hp1 O 0 0.004936497658491135
and O 0 4.930844355044428e-08
Hp1 O 1 0.9992585778236389
/ O 0 0.0002902447013184428
Hpdel O 0 0.02072007767856121
, O 0 4.3600073551530727e-10
showing O 0 3.111474411454651e-09
an O 0 3.217135932653825e-11
anomalous O 0 8.082739100245817e-08
inheritance O 0 4.0075274228001945e-06
of O 0 6.363356078509241e-05
Hp O 0 1.0744468454504386e-05
phenotypes O 0 8.566728837422488e-08
in O 0 7.361011800099959e-10
the O 0 1.645000802241725e-09
child O 0 3.007164650625782e-08
with O 0 4.059350633411896e-09
Hp1 O 1 0.7090581655502319
. O 0 1.791698650777107e-06

The O 0 7.516387086070608e-07
Hp2 O 0 0.0044178348034620285
/ O 0 4.4924554458702914e-06
Hpdel O 0 9.516112913843244e-05
individuals O 0 1.4819706573021563e-09
had O 0 5.614742559778563e-10
an O 0 5.258696256227324e-12
extremely O 0 6.625599624499046e-09
low O 0 2.538085084324848e-07
level O 0 1.2038028216920793e-05
of O 0 1.1632752006107694e-07
Hp O 0 1.8618564467942633e-08
( O 0 5.5433914403213436e-11
mean O 0 9.757802343912658e-10
+ O 0 1.0252434456958781e-09
/ O 0 2.3920747604933013e-09
- O 0 7.618981001655811e-09
SD O 0 1.2058646348123148e-07
= O 0 4.0906328324652463e-10
0 O 0 4.3555086620683525e-11
. O 0 3.9712233501632e-11
049 O 0 1.0133923034061354e-08
+ O 0 1.316938447182281e-09
/ O 0 6.789684814378916e-09
- O 0 3.641000168030928e-09
0 O 0 4.162695535492311e-11
. O 0 1.0944423145531346e-10
043 O 0 7.245693467439196e-08
mg O 0 1.0954313012234707e-08
/ O 0 6.122117035545216e-09
ml O 0 4.50627712922369e-09
; O 0 1.719527471799598e-11
n O 0 2.431630174992705e-10
= O 0 3.975535872724478e-11
6 O 0 6.514740830132482e-11
) O 0 4.308785858490871e-13
, O 0 4.530087513877207e-13
compared O 0 1.0950075915450164e-11
with O 0 9.878876145938409e-13
the O 0 1.659081899640924e-10
level O 0 7.505685175601684e-07
( O 0 2.0741738188112535e-11
1 O 0 8.956854702368844e-11
. O 0 2.068796349508073e-11
64 O 0 1.1183748371834668e-09
+ O 0 1.4424013095037935e-09
/ O 0 6.995558354816467e-09
- O 0 3.6573359896152624e-09
1 O 0 3.3996272463809873e-10
. O 0 2.6614344061925976e-10
07 O 0 1.8422582570565282e-08
mg O 0 7.808740321024743e-09
/ O 0 1.8491220776795103e-09
ml O 0 1.8000002599549703e-09
) O 0 2.990063275101762e-12
obtained O 0 2.7871119301359215e-10
from O 0 4.1030806530173436e-10
52 O 0 1.584123410225402e-08
healthy O 0 8.653022298688029e-09
volunteers O 0 1.7377721484024278e-09
having O 0 1.3531407105915605e-09
phenotype O 0 2.6522650742322185e-08
Hp2 O 0 3.783931788348127e-06
, O 0 1.1070221822562232e-10
whereas O 0 1.8001273804912898e-09
the O 0 6.442014144347752e-10
serum O 0 9.029196945675722e-09
Hp O 0 6.702318700035903e-09
level O 0 2.2977049596306642e-08
of O 0 6.213969894197646e-10
an O 0 3.826822973090893e-12
individual O 0 6.128489382639657e-11
with O 0 7.468136664634528e-10
Hp1 O 1 0.930992066860199
/ O 0 6.850584759376943e-05
Hpdel O 0 0.018446333706378937
was O 0 3.1334286632045405e-07
0 O 0 1.43367451244103e-08
. O 0 2.622535433260964e-08

50 O 0 7.012674245743256e-07
mg O 0 4.2711417336249724e-07
/ O 0 1.2913250202473137e-07
ml O 0 8.54569321973031e-08
, O 0 3.934738992961151e-11
which O 0 1.9141660912574965e-12
was O 0 2.2468150950860633e-10
approximately O 0 6.702811222725202e-11
half O 0 1.9296841902161077e-11
the O 0 5.1959464508755104e-11
level O 0 1.0487470092357398e-07
of O 0 1.3527028386306483e-08
Hp O 0 1.536290206161084e-08
in O 0 8.812800489366168e-10
control O 0 8.76301058383433e-08
sera O 0 5.743329012375398e-08
from O 0 3.8921130207647536e-10
the O 0 1.986044440016599e-09
Hp1 O 0 9.023167513078079e-05
phenotype O 0 3.17086019663293e-08
( O 0 3.419897351419898e-11
1 O 0 4.4498951745630677e-10
. O 0 4.5188304487187025e-11
26 O 0 4.739825754107585e-10
+ O 0 8.649849170261348e-10
/ O 0 3.3837281865345403e-09
- O 0 2.2287531820097684e-09
0 O 0 4.363416225561245e-11
. O 0 1.1365843682886734e-10
33 O 0 3.16735260241785e-09
mg O 0 5.131666647173461e-09
/ O 0 6.062829793762603e-09
ml O 0 6.346910996768429e-09
; O 0 1.6861047280603003e-11
n O 0 3.085410815728551e-10
= O 0 1.0858941523750332e-10
9 O 0 2.934157916634206e-10
) O 0 3.8713711056348465e-12
, O 0 5.398538387157981e-12
showing O 0 2.6373103700905176e-10
a O 0 2.0756034391222755e-10
gene O 0 4.286826005284183e-09
- O 0 3.776479928774279e-08
dosage O 0 2.1857468368580157e-07
effect O 0 5.8425364102276944e-08
. O 0 1.5390978092000296e-07

The O 0 2.8384507189116448e-08
other O 0 6.625293091921947e-10
allele O 0 1.3065461601513562e-08
( O 0 2.7461166673958814e-10
Hp2 O 0 3.699584340211004e-05
) O 0 3.997327122085004e-11
of O 0 5.402581715330257e-10
individuals O 0 2.551259203897871e-10
with O 0 1.523444481676961e-09
Hp2 O 1 0.9999998807907104
/ O 1 0.985225260257721
Hpdel O 1 0.9999349117279053
was O 0 3.711567941877547e-08
found O 0 4.439787079646429e-11
to O 0 1.1352230787353701e-11
have O 0 5.132990386902403e-12
, O 0 1.6967825798921976e-12
in O 0 6.306019508656169e-12
all O 0 3.3862426751518626e-11
exons O 0 2.684701527755351e-08
, O 0 8.30151052066963e-12
no O 0 8.867877786256084e-12
mutation O 0 2.7179918038466866e-11
, O 0 1.9318229741577264e-12
by O 0 2.0320583757338362e-11
DNA O 0 9.533172118381117e-08
sequencing O 0 7.406570716739225e-07
. O 0 3.6582522966455144e-07

On O 0 2.483208128012393e-08
the O 0 2.743143212580179e-10
basis O 0 2.419224154337485e-09
of O 0 7.970845511406921e-11
the O 0 3.456008743074612e-11
present O 0 1.0059021671171564e-10
study O 0 1.70064864968289e-11
, O 0 7.043475503364094e-13
the O 0 5.9583150045783295e-12
mechanism O 0 2.726140646558406e-09
of O 0 4.787428675712135e-09
anhaptoglobinemia B-Disease 0 1.0970100447593722e-05
and O 0 4.354497318281858e-10
the O 0 1.0491242319332628e-09
mechanism O 0 4.108630093924148e-07
of O 0 2.5680268578298637e-08
anomalous O 0 9.162155834019359e-07
inheritance O 0 7.032497819636774e-07
of O 0 4.324716655901284e-07
Hp O 0 2.6039990075332753e-07
phenotypes O 0 3.100344869721994e-08
were O 0 4.782318097085181e-09
well O 0 3.807999693350439e-09
explained O 0 5.616752218884358e-08
. O 0 6.109463157599748e-08

However O 0 2.2639369490207173e-07
, O 0 5.782696543832344e-10
the O 0 2.3493620937564685e-10
mechanism O 0 2.175436293327948e-07
of O 0 7.449677497106677e-08
hypohaptoglobinemia B-Disease 0 0.47748756408691406
remains O 0 6.199619747349061e-06
unknown O 0 5.866120045538992e-05

ATM O 0 0.007015196140855551
mutations O 0 1.7268008889459452e-07
and O 0 2.822829969773011e-09
phenotypes O 0 2.3455434927655006e-07
in O 0 1.9774016379869863e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.00017705955542623997
in O 0 5.4657260939450225e-09
the O 0 1.020740048041091e-09
British O 0 1.7127185003573686e-08
Isles O 0 9.481617269102571e-08
: O 0 3.891314787757283e-12
expression O 0 5.8135482539078964e-11
of O 0 1.270563654287571e-10
mutant O 0 1.0725520471766004e-09
ATM O 0 8.443045658168558e-07
and O 0 1.608770477945498e-10
the O 0 6.607801528168977e-10
risk O 0 6.23115914422101e-09
of O 0 1.725446985290091e-08
leukemia B-Disease 1 1.0
, O 0 9.611690074962098e-06
lymphoma B-Disease 1 1.0
, O 0 0.06219640001654625
and O 0 0.03298991546034813
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9975341558456421

We O 0 2.920715225229742e-08
report O 0 8.20787104949261e-10
the O 0 1.0243497716722061e-10
spectrum O 0 4.2200745120624106e-09
of O 0 1.1653683573698004e-09
59 O 0 3.00503160133303e-08
ATM O 0 1.0933209523500409e-05
mutations O 0 3.7047127587896966e-09
observed O 0 2.76432188250908e-09
in O 0 1.4250103319568552e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9857063889503479
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.052013364257533e-10
patients O 0 2.769265095015072e-10
in O 0 1.3339305354742592e-11
the O 0 9.644245124729167e-11
British O 0 2.4132846832003452e-08
Isles O 0 2.448077111694147e-06
. O 0 1.9801530015683966e-07

Of O 0 5.770070856669918e-06
51 O 0 9.198618499794975e-06
ATM O 0 0.0007259103003889322
mutations O 0 2.5519916846405977e-08
identified O 0 1.5425031918425702e-08
in O 0 2.1048461584793898e-10
families O 0 2.0842319536917842e-10
native O 0 2.9706875848134473e-10
to O 0 6.036952188148703e-11
the O 0 5.95470839304113e-10
British O 0 8.624586200767226e-08
Isles O 0 2.186144001825596e-06
, O 0 8.16047507345985e-11
11 O 0 3.9706116172766315e-10
were O 0 6.635232918661416e-10
founder O 0 4.490147809121936e-09
mutations O 0 8.608734280990404e-10
, O 0 2.741970019093376e-11
and O 0 4.7278961995411706e-11
2 O 0 9.989735705318026e-10
of O 0 1.7308684485684012e-09
these O 0 6.544980529765709e-11
11 O 0 2.6848676060176047e-10
conferred O 0 6.0148912517377084e-09
a O 0 2.71569239318481e-10
milder O 0 4.360783290024983e-09
clinical O 0 3.787557822931831e-09
phenotype O 0 9.52353085281743e-10
with O 0 7.883990335577629e-12
respect O 0 1.574096075707132e-09
to O 0 4.323011726370396e-09
both O 0 1.1990368875558488e-07
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 5.574759597948287e-06
cellular O 0 0.000136601782287471
features O 0 4.955385790594846e-08
. O 0 1.4399533654341212e-07

We O 0 5.778600709049897e-08
report O 0 1.2384122616282411e-09
, O 0 1.0459423258057932e-11
in O 0 8.03677437100081e-12
two O 0 4.903778424991678e-11
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.979724645614624
T I-Disease 1 0.9999996423721313
families O 0 1.601570320808321e-09
, O 0 1.3477535060202328e-11
an O 0 5.505088572499428e-12
ATM O 0 2.725622891830426e-07
mutation O 0 1.2097153279100326e-09
( O 0 1.9831968012251622e-10
7271T O 0 1.7731379557517357e-05
- O 0 3.009006150023197e-06
- O 0 6.961525400583923e-07
> O 0 8.502948389832454e-08
G O 0 4.7763954569290945e-08
) O 0 3.0069807321203568e-12
that O 0 2.0450547993326046e-13
may O 0 4.528109387013507e-13
be O 0 6.266305833599328e-13
associated O 0 5.2113702242451154e-11
with O 0 4.433928918468055e-12
an O 0 2.952675647385772e-12
increased O 0 6.30496765907651e-10
risk O 0 8.604011725310556e-09
of O 0 7.260427281607917e-08
breast B-Disease 1 0.6124817132949829
cancer I-Disease 0 4.177650225756224e-06
in O 0 4.499380867883929e-09
both O 0 6.674330421674313e-09
homozygotes O 0 1.0416852092021145e-06
and O 0 7.342207952731883e-10
heterozygotes O 0 3.703224038531516e-08
( O 0 2.2313083325453675e-10
relative O 0 8.320834865571669e-08
risk O 0 5.829509763799479e-09
12 O 0 7.855793793254406e-10
. O 0 3.659481398465836e-11
7 O 0 4.978667478283683e-10
; O 0 2.844022760351006e-11
P O 0 2.977952107130477e-08
= O 0 2.6512406159362456e-10
. O 0 1.0337040251551244e-10
0025 O 0 9.486826968441164e-08
) O 0 7.427515200109092e-12
, O 0 2.575408853192074e-12
although O 0 1.9424130706657827e-11
there O 0 5.3888265377777245e-12
is O 0 1.6844773189153561e-12
a O 0 3.339955742531764e-11
less O 0 1.1930543220017853e-09
severe O 0 2.8440488222258864e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 0.9999939203262329
phenotype O 0 2.5738721376455942e-08
in O 0 4.8833187493713126e-11
terms O 0 1.4815318416516732e-10
of O 0 1.0382467108271953e-10
the O 0 7.684400338270336e-11
degree O 0 1.5124643937269866e-07
of O 0 2.6657258445084153e-07
cerebellar B-Disease 1 0.9999747276306152
degeneration I-Disease 1 0.9999998807907104
. O 0 1.6473461073474027e-05

This O 0 9.73343805554805e-09
mutation O 0 2.476769012105251e-09
( O 0 1.0332525807177362e-10
7271T O 0 1.1827570460809511e-06
- O 0 3.074282517445681e-07
- O 0 4.736848069342159e-08
> O 0 6.5158909379192664e-09
G O 0 4.9429038639914324e-09
) O 0 1.6071648135593253e-12
also O 0 2.77088302389622e-13
allows O 0 5.536179696098709e-13
expression O 0 8.264242588873483e-12
of O 0 3.901438894171605e-11
full O 0 2.2333095095472544e-10
- O 0 5.202890340783028e-10
length O 0 2.0394925748234982e-09
ATM O 0 3.0631781555712223e-06
protein O 0 3.4966705086958427e-09
at O 0 1.3218810490656097e-09
a O 0 1.866178045428768e-10
level O 0 1.926836823429312e-08
comparable O 0 4.951396181951395e-09
with O 0 8.815346889956555e-12
that O 0 1.1012617900929556e-11
in O 0 2.747966298954907e-10
unaffected O 0 1.7523822748444218e-07
individuals O 0 4.827978017374335e-09
. O 0 2.7317904027768236e-07

In O 0 9.202365980343075e-09
addition O 0 1.8328608630824306e-09
, O 0 4.322091989861221e-11
we O 0 2.4484343372210837e-11
have O 0 2.056759927301921e-12
studied O 0 1.3035384993642651e-09
18 O 0 4.869929792761241e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.8615850169444457e-05
, O 0 4.908082620880272e-11
in O 0 5.623128698784008e-12
15 O 0 2.972216570085173e-11
families O 0 3.2030641160252227e-12
, O 0 1.4212940720181866e-12
who O 0 3.633323850116277e-11
developed O 0 1.2308636598845624e-07
leukemia B-Disease 1 0.9999998807907104
, O 0 7.329516620302456e-07
lymphoma B-Disease 1 1.0
, O 0 8.137021723086946e-06
preleukemic O 1 0.9999996423721313
T O 1 0.9714411497116089
- O 0 2.4149843738996424e-05
cell O 0 7.408527744701132e-05
proliferation O 1 0.9980044960975647
, O 0 7.510809751920533e-09
or O 0 4.329509920353303e-06
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.2548390916199423e-05
mostly O 0 2.1581277209747896e-08
in O 0 1.30949939780578e-09
childhood O 0 2.8623396701732418e-06
. O 0 3.1306120717999875e-07

A O 0 3.8771381696278695e-06
wide O 0 1.294345679525577e-07
variety O 0 1.0079427958942233e-08
of O 0 6.757942827562147e-08
ATM O 0 0.011495840735733509
mutation O 0 5.717618378753286e-09
types O 0 4.823532684383736e-09
, O 0 8.453920896656086e-11
including O 0 9.251228255680033e-11
missense O 0 4.186102557923732e-07
mutations O 0 2.9414044533382366e-09
and O 0 4.5403103499097597e-10
in O 0 2.5547580051465957e-08
- O 0 1.4467108258031658e-06
frame O 0 6.044927886250662e-06
deletions O 0 3.494811906534778e-08
, O 0 5.195054456064163e-11
were O 0 7.799745849190742e-10
seen O 0 5.297823291172676e-10
in O 0 4.1327205546615176e-11
these O 0 4.5000822512797356e-10
patients O 0 1.9869320411203262e-08
. O 0 9.668828937492435e-08

We O 0 4.495891658962137e-08
also O 0 5.311186213052821e-11
show O 0 1.0618487339408844e-10
that O 0 1.074544750054307e-12
25 O 0 3.822863206548455e-11
% O 0 6.267913965629646e-11
of O 0 3.1813839757033335e-11
all O 0 1.8788927358404095e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.9999998807907104
patients O 0 1.3299394652221963e-07
carried O 0 2.7839415217556507e-09
in O 0 1.9738692902393495e-09
- O 0 5.297354022104628e-08
frame O 0 1.7787156991744268e-07
deletions O 0 2.1074752609706593e-08
or O 0 9.527909572426552e-10
missense O 0 3.5241515661255107e-07
mutations O 0 1.5331806935137138e-09
, O 0 1.2354785597357143e-11
many O 0 2.1347387833131615e-12
of O 0 2.924021788586195e-11
which O 0 5.284705507403731e-13
were O 0 3.2522162046744185e-11
also O 0 1.754267412758248e-12
associated O 0 1.3481013527716357e-10
with O 0 1.870595865705038e-11
expression O 0 1.4180523422169244e-09
of O 0 7.0191088497040255e-09
mutant O 0 8.514860638797472e-08
ATM O 0 0.00029961206018924713
protein O 0 1.0225528512819437e-06
. O 0 2.1197554644913907e-07

The O 0 4.392088044369302e-07
DMPK O 0 0.3084293305873871
gene O 0 2.3059062215224913e-08
of O 0 2.8593328593728984e-08
severely O 1 0.9969407916069031
affected O 1 0.9983336329460144
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.048882756382226944
is O 0 1.130444848840284e-09
hypermethylated O 0 1.7673339698376367e-06
proximal O 0 6.862374561933393e-07
to O 0 2.9769851028760286e-09
the O 0 2.30493863995207e-08
largely O 0 3.8133441648824373e-07
expanded O 0 9.674658230096611e-08
CTG O 0 4.709139102487825e-05
repeat O 0 8.735831329431676e-07
. O 0 6.283076459112635e-07

Using O 0 3.384182321042317e-07
methylation O 0 3.2018604088079883e-06
- O 0 4.865856226388132e-06
sensitive O 0 4.2260779764546896e-07
restriction O 0 8.450072308541223e-10
enzymes O 0 8.402927659245663e-11
, O 0 5.601003168209662e-12
we O 0 1.3887572515580704e-11
characterized O 0 3.306343393516542e-11
the O 0 3.729793904283518e-11
methylation O 0 2.0662784816494195e-09
pattern O 0 9.916274024135419e-09
on O 0 1.5442569445411891e-09
the O 0 3.385843827530266e-10
5 O 0 4.786056551076001e-10
side O 0 5.247769996330476e-10
of O 0 2.4556017219623527e-09
the O 0 1.2714837183125383e-08
CTG O 0 2.2891414118930697e-05
repeat O 0 1.1414322820257894e-08
in O 0 6.158334259209752e-11
the O 0 3.0236971260144685e-10
DMPK O 0 2.1339314116630703e-05
gene O 0 1.925372777877854e-10
of O 0 2.368899520988066e-10
normal O 0 8.393261197170432e-09
individuals O 0 2.290538418658894e-11
and O 0 1.5539347586468466e-11
of O 0 3.929386260814738e-10
patients O 0 2.368647500361476e-09
affected O 0 1.6182324813485138e-08
with O 0 1.1407815136976751e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 6.044010181227577e-09
showing O 0 1.1298785018709623e-08
expansions O 0 6.923387640966894e-09
of O 0 6.565488708254463e-10
the O 0 8.132169937447031e-10
repetitive O 0 6.455464074406336e-08
sequence O 0 2.410708610511847e-08
. O 0 1.3276306276566174e-07

The O 0 3.8373116240109084e-08
gene O 0 3.1379661091790467e-09
segment O 0 8.813695551168621e-09
analyzed O 0 6.355145298897469e-10
corresponds O 0 3.2054692233884907e-10
to O 0 4.6130481379247357e-11
the O 0 6.496825299961984e-10
genomic O 0 7.596029405476656e-08
SacI O 0 3.970930265495554e-06
- O 0 6.281158704268819e-08
HindIII O 0 6.698736569887842e-07
fragment O 0 5.755761645076518e-09
carrying O 0 1.7251048589628226e-08
exons O 0 5.266828111416544e-07
11 O 0 5.568281835621747e-08
- O 0 1.2985444186597306e-07
15 O 0 6.631038473869921e-08
. O 0 1.473510735650052e-07

There O 0 5.4302020657814865e-08
is O 0 4.924260443850415e-10
constitutive O 0 2.178517348738751e-07
methylation O 0 9.872908890429244e-08
in O 0 1.636414559413879e-08
intron O 0 6.068293032512884e-07
12 O 0 8.254692929199337e-09
at O 0 8.023580133631469e-10
restriction O 0 7.568613097364008e-11
sites O 0 1.037549907101365e-10
of O 0 7.288266656857445e-10
SacII O 0 8.142091246554628e-06
and O 0 1.0460016852675835e-08
HhaI O 0 0.005648190155625343
, O 0 1.2454214326496071e-09
localized O 0 6.379829642355617e-08
1 O 0 2.2142578881556574e-09
, O 0 4.93338599139026e-11
159 O 0 9.298719128025823e-09
- O 0 2.0285336077563443e-08
1 O 0 2.858780545622608e-09
, O 0 2.1021177853963735e-10
232 O 0 2.4354744887489232e-09
bp O 0 1.611357802744351e-08
upstream O 0 6.297329235849247e-08
of O 0 1.2827913842272665e-08
the O 0 4.3832002916133206e-08
CTG O 0 8.214469562517479e-05
repeat O 0 4.379715505820059e-07
, O 0 4.066431913418711e-10
whereas O 0 8.341011437096313e-09
most O 0 8.388451738783331e-11
, O 0 9.781738787018046e-12
if O 0 8.06499918931669e-12
not O 0 2.0494030084083903e-11
all O 0 6.128723917253609e-11
, O 0 2.378051748574972e-11
of O 0 2.8001506668928755e-10
the O 0 1.3825181277571374e-10
other O 0 2.0116276699955193e-11
sites O 0 3.1630403851679034e-10
of O 0 1.545058192498061e-09
SacII O 0 1.1416516827011947e-05
, O 0 1.630233059657371e-09
HhaI O 0 4.185829675407149e-05
, O 0 9.963950775571107e-10
and O 0 1.3516189278917068e-09
HpaII O 0 0.0001856670860433951
in O 0 3.2659616677754855e-10
this O 0 6.927898532627097e-11
region O 0 1.2140383809366995e-08
are O 0 1.6325908680503431e-10
unmethylated O 0 1.2105581390642328e-06
, O 0 3.604581563787512e-11
in O 0 2.1966555310837244e-11
normal O 0 7.68562458119959e-09
individuals O 0 5.6043190921339914e-11
and O 0 3.2552634199323194e-11
most O 0 1.4656819161129597e-11
of O 0 6.571728716764369e-10
the O 0 7.164172366458388e-09
patients O 0 9.702728220872814e-08
. O 0 1.6150754333921213e-07

In O 0 7.390769773962802e-09
a O 0 5.501588073997254e-10
number O 0 2.839866675152791e-10
of O 0 1.7270561647464433e-09
young O 0 1.703586249846012e-08
and O 0 1.1007967870568791e-09
severely O 0 0.000164915356435813
affected O 0 4.17576728750646e-08
patients O 0 2.313791158670142e-09
, O 0 5.179044259423504e-12
however O 0 2.6267366753929267e-11
, O 0 1.6887688079544882e-12
complete O 0 9.339240492067802e-10
methylation O 0 1.1036964231436741e-08
of O 0 8.805223217223102e-10
these O 0 2.334659895963931e-11
restriction O 0 1.65695270004651e-11
sites O 0 3.315146074323039e-11
was O 0 1.7516413319818014e-10
found O 0 6.12663114685219e-11
in O 0 3.223001379670798e-11
the O 0 9.313109727848712e-10
mutated O 0 6.31813108498136e-08
allele O 0 3.7696293020417215e-07
. O 0 4.6158359623404976e-07

In O 0 1.499237356483718e-08
most O 0 1.5827024413272994e-10
of O 0 5.006855485767403e-10
these O 0 7.850532723896464e-11
patients O 0 4.943778719734837e-10
, O 0 2.5330252218652705e-12
the O 0 2.8652245506743945e-11
onset O 0 1.2030084235448157e-06
of O 0 1.9424714281512934e-08
the O 0 6.87129499965522e-08
disease O 1 0.9981909394264221
was O 1 0.759266197681427
congenital O 1 1.0
. O 0 0.010088171809911728

Preliminary O 0 5.007844379179005e-07
in O 0 5.476863407238852e-08
vivo O 0 2.649550424393965e-06
footprinting O 0 2.910502917075064e-05
data O 0 1.4729002906221922e-08
gave O 0 1.589542664159893e-10
evidence O 0 3.6142699944008427e-10
for O 0 3.374250531762435e-11
protein O 0 1.1295051560722413e-09
- O 0 1.099621504963011e-09
DNA O 0 7.834254489580417e-08
contact O 0 2.539086452202355e-08
in O 0 1.7353864179003864e-10
normal O 0 6.92823860504177e-08
genes O 0 8.833988540679627e-10
at O 0 2.916420438481282e-10
an O 0 1.0150544467457667e-11
Sp1 O 0 3.416640970144158e-09
consensus O 0 1.0260788885219085e-09
binding O 0 8.721311867132542e-11
site O 0 3.928201930403219e-10
upstream O 0 1.2049301556515957e-09
of O 0 5.044469841841703e-10
the O 0 1.6352905696237485e-09
CTG O 0 1.7360956917400472e-05
repeat O 0 4.145926979504111e-08
and O 0 1.707983338095076e-10
for O 0 4.77527635489583e-11
a O 0 3.113180893632439e-11
significant O 0 1.3351658667559718e-10
reduction O 0 3.9472962676256884e-09
of O 0 4.295089839345678e-10
this O 0 1.0557131557842325e-11
interaction O 0 1.7323976697625199e-09
in O 0 2.3779520019751033e-11
cells O 0 2.2743580629924764e-10
with O 0 2.3205286650562762e-11
a O 0 1.917391800887458e-09
hypermethylated O 0 2.1726844352087937e-05
DMPK O 0 0.09267512708902359
gene O 0 1.4870255249377351e-08
. O 0 5.24102050647457e-09
. O 0 3.253257219171246e-08

The O 0 6.450924956880044e-06
hemochromatosis B-Disease 1 1.0
gene O 0 5.20793674851916e-09
product O 0 9.67274926821915e-10
complexes O 0 1.8146154023845895e-10
with O 0 7.880938956983385e-12
the O 0 4.68177330237296e-10
transferrin O 0 2.3683595529178092e-08
receptor O 0 1.3832038292527216e-10
and O 0 2.302269486165187e-10
lowers O 0 2.66155625316955e-10
its O 0 8.67176122576474e-12
affinity O 0 1.3122114506103344e-10
for O 0 1.9728746414315879e-10
ligand O 0 2.2506647212594544e-08
binding O 0 7.453401451584796e-08
. O 0 9.119057722273283e-07

We O 0 5.3088648144239414e-08
recently O 0 1.0715746068257204e-09
reported O 0 5.970718364167737e-11
the O 0 2.7268503427491098e-11
positional O 0 7.917019040348805e-09
cloning O 0 1.672685101539173e-09
of O 0 2.460762704714625e-10
a O 0 1.8595761042128345e-10
candidate O 0 1.4863677400001052e-08
gene O 0 5.057142971054418e-08
for O 0 1.3954831956652924e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999687671661377
HFE O 1 0.999998927116394
. O 0 9.874148645394598e-07

The O 0 3.389711267232087e-08
gene O 0 1.5560420729698876e-09
product O 0 1.5903074412904061e-09
, O 0 2.492890269212289e-11
a O 0 1.1891575224520778e-10
member O 0 2.0878059281415062e-09
of O 0 1.9671578144198065e-08
the O 0 1.7151245756963363e-08
major O 0 3.7468481650648755e-08
histocompatibility O 0 5.506390721166099e-07
complex O 0 5.5904699536313274e-08
class O 0 1.2547441974319895e-09
I O 0 3.5407904306339333e-06
- O 0 3.030518769264745e-08
like O 0 3.452319333185905e-11
family O 0 1.93457555530685e-10
, O 0 1.1384626748267568e-11
was O 0 4.688028298893698e-10
found O 0 3.58962477797764e-11
to O 0 2.0623469945690864e-11
have O 0 3.282847604868522e-11
a O 0 2.482197225539551e-10
mutation O 0 2.3526409709262452e-09
, O 0 7.478799246563028e-10
Cys O 0 2.580716500233393e-05
- O 0 2.563857606219244e-07
282 O 0 1.2700071465587826e-06
- O 0 0.04305403307080269
- O 0 0.0002405224513495341
> O 0 5.805716682516504e-06
Tyr O 0 5.214627435634611e-06
( O 0 2.4302299062028965e-10
C282Y O 0 2.9610745855279674e-07
) O 0 5.518386962666266e-12
, O 0 1.1198823986202644e-12
in O 0 4.206278988311274e-12
85 O 0 1.8307400040384891e-09
% O 0 1.7395793694419126e-09
of O 0 6.794733664605701e-10
patient O 0 3.0895219538251695e-07
chromosomes O 0 1.7729656747178524e-06
. O 0 1.0855587788682897e-06

This O 0 2.930530840217216e-08
mutation O 0 1.2180438879738631e-08
eliminates O 0 1.9128769679355173e-09
the O 0 2.128357906583389e-10
ability O 0 4.86975304525572e-09
of O 0 1.7952078934513338e-08
HFE O 0 0.04273613914847374
to O 0 3.210120835817065e-09
associate O 0 1.52589976210038e-08
with O 0 1.6645050615604617e-10
beta2 O 1 0.8157714605331421
- O 0 0.00011458298831712455
microglobulin O 0 0.37935110926628113
( O 0 1.9766988046399092e-09
beta2m O 0 0.0001545212435303256
) O 0 3.672396067799788e-11
and O 0 5.3373253733335346e-11
prevents O 0 1.815672168170579e-09
cell O 0 4.455056114238687e-06
- O 0 1.497313292020408e-06
surface O 0 8.374973731406499e-06
expression O 0 2.258793983855867e-06
. O 0 3.4775973745126976e-07

A O 0 3.1252099574885506e-07
second O 0 4.084119353819915e-08
mutation O 0 3.969447881502219e-09
that O 0 2.620776339001818e-11
has O 0 3.68993290783548e-12
no O 0 4.905478367261962e-12
effect O 0 1.978095812149583e-11
on O 0 4.642886075600927e-10
beta2m O 0 1.509387857367983e-06
association O 0 4.858932700635421e-10
, O 0 2.1126329852183545e-10
H63D O 0 0.06711968034505844
, O 0 1.0261918398368763e-10
was O 0 1.1946551525809923e-09
found O 0 4.3214570810690134e-11
in O 0 3.639988050557763e-12
eight O 0 3.5253286401193407e-11
out O 0 4.924527799432532e-12
of O 0 1.1490743079267673e-10
nine O 0 7.235233523417151e-10
patients O 0 2.8383395633824193e-10
heterozygous O 0 2.496683693120616e-10
for O 0 6.717055384131143e-11
the O 0 1.1794186072222601e-08
C282Y O 0 1.563124533277005e-05
mutant O 0 5.138574579177657e-07
. O 0 3.554851559783856e-07

In O 0 2.1854086540429307e-08
this O 0 4.182187651746716e-10
report O 0 3.0971913922428485e-10
, O 0 9.835205566632865e-12
we O 0 1.957681065867245e-11
demonstrate O 0 1.1393849197460781e-09
in O 0 1.115511683025261e-09
cultured O 0 3.553526255473116e-07
293 O 0 3.2557526452592356e-08
cells O 0 7.089331433007828e-08
overexpressing O 0 1.3159695981812547e-06
wild O 0 1.2436228047363329e-08
- O 0 1.5884440429658753e-08
type O 0 2.895868433938631e-09
or O 0 1.9094141823217115e-09
mutant O 0 2.985219893503199e-08
HFE O 0 3.9604087760380935e-06
proteins O 0 1.7341059144193594e-10
that O 0 2.3488175380365073e-12
both O 0 1.2118825908069564e-11
the O 0 6.279521347352102e-11
wild O 0 4.863411340316759e-10
- O 0 1.7525979556509697e-09
type O 0 4.717676915788616e-09
and O 0 5.042105399866159e-09
H63D O 1 0.9997144341468811
HFE O 0 0.00032680510776117444
proteins O 0 8.010826446636088e-10
form O 0 6.894130266665854e-10
stable O 0 2.6562855737211066e-07
complexes O 0 1.1492897744602715e-09
with O 0 3.359890837772994e-11
the O 0 1.6196920471500675e-09
transferrin O 0 1.4599621067645785e-07
receptor O 0 2.8291311515715734e-09
( O 0 1.0377344539236333e-09
TfR O 0 2.557601646913099e-06
) O 0 3.893674271893133e-09
. O 0 1.0127241978352686e-07

The O 0 1.780973377663031e-07
C282Y O 0 3.310743340989575e-05
mutation O 0 1.77658900923916e-08
nearly O 0 2.3836717044645184e-09
completely O 0 3.901874379153014e-09
prevents O 0 1.0639795294808962e-10
the O 0 5.079630813198399e-11
association O 0 6.269420399496184e-11
of O 0 1.5904857986193122e-10
the O 0 2.1160122265495573e-10
mutant O 0 9.19438303270681e-09
HFE O 0 3.1083618523553014e-05
protein O 0 1.2871784527135333e-08
with O 0 2.0502718967030376e-10
the O 0 1.5767742667094353e-08
TfR O 0 0.0001662653376115486
. O 0 8.444986860922654e-07

Studies O 0 3.528253955664695e-07
on O 0 1.7077049108138453e-08
cell O 0 1.655098600394922e-07
- O 0 2.1703463914946042e-08
associated O 0 9.671645706532672e-09
transferrin O 0 9.82830528073464e-08
at O 0 1.897766388481159e-09
37 O 0 1.0943489447967636e-09
degrees O 0 2.5807036507785597e-09
C O 0 9.84391057556877e-09
suggest O 0 4.710633549898091e-10
that O 0 8.137401343033535e-13
the O 0 1.0291634211512246e-10
overexpressed O 0 2.3339003973887884e-07
wild O 0 4.332355363345641e-09
- O 0 3.1252987753305206e-08
type O 0 9.511231269243581e-08
HFE O 0 9.095908171730116e-05
protein O 0 7.1129369061395664e-09
decreases O 0 4.480016912999929e-10
the O 0 4.318243679302114e-11
affinity O 0 2.1505811020894328e-10
of O 0 1.4803152037501377e-09
the O 0 7.191334194800447e-09
TfR O 0 6.952132025617175e-06
for O 0 1.4902028055985284e-08
transferrin O 0 7.260777238116134e-06
. O 0 8.528755301995261e-07

The O 0 3.0158291792758973e-06
overexpressed O 0 0.1717333048582077
H63D O 1 0.9999855756759644
protein O 0 4.395490549313763e-08
does O 0 8.324470453235921e-12
not O 0 5.600929008781064e-12
have O 0 3.9229548971266015e-13
this O 0 8.111491621616562e-13
effect O 0 9.619163104934714e-12
, O 0 5.47527247065499e-13
providing O 0 1.8591886710717098e-11
the O 0 6.050597956691606e-12
first O 0 1.411975657922282e-11
direct O 0 7.227367315731925e-11
evidence O 0 1.6449122619555112e-10
for O 0 1.0012463948216865e-11
a O 0 2.9372318466336367e-10
functional O 0 1.1751346562505205e-07
consequence O 0 3.807456749882476e-08
of O 0 9.749770768507915e-09
the O 0 3.8775418431669095e-08
H63D O 0 0.11526370048522949
mutation O 0 6.27324482138647e-07
. O 0 3.475223309123976e-07

Addition O 0 6.174268492031842e-07
of O 0 1.5417745089507662e-06
soluble O 0 3.753740656975424e-06
wild O 0 5.397179947408404e-08
- O 0 1.0087701696193108e-07
type O 0 2.8837280297011603e-07
HFE O 1 0.9999569654464722
/ O 0 0.00045739198685623705
beta2m O 0 5.795803008368239e-05
heterodimers O 0 3.624345765729231e-07
to O 0 1.5418053500582118e-09
cultured O 0 3.1520590937361703e-07
cells O 0 1.7083594983091643e-08
also O 0 3.833604267367008e-11
decreased O 0 6.924599227353667e-10
the O 0 7.042417864144834e-12
apparent O 0 5.314299555969626e-10
affinity O 0 3.61256746739258e-10
of O 0 1.720858011644566e-09
the O 0 1.3052899872079138e-09
TfR O 0 2.8815344421673217e-07
for O 0 1.9485727267842812e-11
its O 0 4.143499779396542e-12
ligand O 0 2.130916831877272e-10
under O 0 3.964446548820888e-09
steady O 0 7.322543638110801e-07
- O 0 4.138995812752455e-09
state O 0 7.009990504736052e-11
conditions O 0 1.0074603373766422e-08
, O 0 1.983858043119735e-11
both O 0 1.918121564359332e-11
in O 0 2.3292201500879628e-11
293 O 0 7.686939973439166e-10
cells O 0 1.72246050755831e-09
and O 0 4.12863326859636e-10
in O 0 9.029387015857537e-09
HeLa O 0 1.3184493582230061e-05
cells O 0 1.1876522876264062e-06
. O 0 4.776322271027311e-07

Furthermore O 0 2.060307451756671e-06
, O 0 1.3165617485100256e-09
at O 0 8.117370109417266e-10
4 O 0 3.123996616949398e-10
degrees O 0 4.763346606040386e-09
C O 0 5.417518522676801e-08
, O 0 7.977369459455375e-11
the O 0 5.176777895243845e-10
added O 0 8.212494684300964e-09
soluble O 0 4.476988735291343e-08
complex O 0 8.07036659722371e-09
of O 0 4.5926608294166726e-08
HFE O 0 0.0004692765942309052
/ O 0 1.150599473476177e-06
beta2m O 0 9.559041700413218e-07
inhibited O 0 1.510667502202523e-08
binding O 0 5.186799323375624e-10
of O 0 1.678970029672655e-08
transferrin O 0 2.3597300469191396e-07
to O 0 1.7769822946434033e-08
HeLa O 0 7.2384455052088015e-06
cell O 0 5.279147785586247e-07
TfR O 0 3.1564438813802553e-06
in O 0 3.116747138154352e-10
a O 0 9.29250898451528e-10
concentration O 0 1.9687020085257245e-06
- O 0 2.1035823749571136e-07
dependent O 0 1.808339646913737e-07
manner O 0 3.6271467251935974e-07
. O 0 2.213305094755924e-07

Scatchard O 0 6.198893242981285e-05
plots O 0 1.8638627352629555e-07
of O 0 6.730117352304887e-09
these O 0 1.1591297366386755e-10
data O 0 2.194873394145702e-09
indicate O 0 5.422847726421764e-10
that O 0 3.0225004356981833e-12
the O 0 1.6688093962269335e-10
added O 0 1.0034766351196822e-09
heterodimer O 0 8.015018870821677e-09
substantially O 0 5.967787153338122e-09
reduced O 0 1.2195683352089759e-09
the O 0 1.6573392658258967e-10
affinity O 0 1.8509923593867939e-09
of O 0 1.1064154037399021e-08
TfR O 0 6.661692623310955e-06
for O 0 1.5096016880988827e-08
transferrin O 0 3.5939506233262364e-06
. O 0 8.686650403433305e-07

These O 0 6.887010517431236e-09
results O 0 6.834940613487106e-09
establish O 0 6.2366520836576456e-09
a O 0 2.1756452195376141e-10
molecular O 0 5.665856672720793e-09
link O 0 1.4518030333476872e-08
between O 0 1.1178934222755288e-08
HFE O 1 0.5674282312393188
and O 0 4.8129087382164926e-09
a O 0 2.94210567020059e-09
key O 0 4.134517155307549e-07
protein O 0 6.467268054421993e-09
involved O 0 7.910860411186604e-09
in O 0 1.257895343442783e-09
iron O 0 1.203472663746652e-07
transport O 0 1.1165386126776866e-07
, O 0 1.7597752421938395e-10
the O 0 7.435148607903841e-10
TfR O 0 7.3081137088593096e-06
, O 0 5.031417643630576e-11
and O 0 1.5554470905732032e-11
raise O 0 7.868865975479977e-11
the O 0 2.4800991121898264e-11
possibility O 0 6.288046194846686e-10
that O 0 9.993003820263358e-12
alterations O 0 3.5441558576820853e-09
in O 0 4.367687461703795e-11
this O 0 1.6626987980883356e-11
regulatory O 0 2.040387414581346e-09
mechanism O 0 1.951242367681516e-08
may O 0 2.060000919845706e-10
play O 0 1.1490886464571304e-08
a O 0 1.8064043594279156e-09
role O 0 7.670072577070641e-09
in O 0 5.607690423126144e-10
the O 0 6.945978903161176e-09
pathogenesis O 1 0.9999984502792358
of O 1 0.9999845027923584
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.042035773396492004
. O 0 4.981712322660314e-07

Genomic O 0 2.046398094535107e-06
organization O 0 5.0995163647371555e-09
of O 0 3.380304391953359e-08
the O 0 9.105660581099073e-08
UBE3A O 1 0.9999761581420898
/ O 0 0.0006289787706919014
E6 O 0 0.0302179753780365
- O 0 3.409252485653269e-06
AP O 0 2.524876435927581e-05
gene O 0 1.1297055513281862e-09
and O 0 1.4392484426473118e-10
related O 0 4.486460269959025e-08
pseudogenes O 0 2.505450538592413e-06
. O 0 1.4624133370944037e-07

The O 0 4.4346907657200063e-07
UBE3A O 0 0.00015508629439864308
gene O 0 1.1511507302941482e-08
encodes O 0 8.971974829741214e-10
the O 0 1.4525142200128016e-09
E6 O 0 1.6951053112279624e-05
- O 0 7.031665518297814e-06
AP O 0 0.0005901359254494309
ubiquitin O 0 8.441201657660713e-07
- O 0 4.441657495135587e-07
protein O 0 9.26624388331021e-10
ligase O 0 2.488658445987113e-10
and O 0 3.9768931203720825e-11
has O 0 2.3708227221697076e-12
recently O 0 8.020633636418584e-12
been O 0 1.6078423314969115e-12
shown O 0 7.552717132264242e-12
to O 0 2.4603940846495975e-12
be O 0 3.7627127108530445e-11
mutated O 0 5.0384262095803933e-08
in O 0 3.2384889436798403e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.601467426506133e-07
who O 0 1.5633841998763387e-09
lack O 0 2.5219171675416874e-06
15q11 O 0 0.34789758920669556
- O 0 1.3607577784569003e-05
q13 O 0 0.0001248479966307059
deletions O 0 2.075887266528298e-07
or O 0 3.4619167532667916e-09
chromosome O 0 1.3975180479519622e-07
15 O 0 2.1929835725131852e-07
paternal O 0 3.5300326999276876e-05
uniparental B-Disease 1 0.9473835825920105
disomy I-Disease 0 0.004913330078125
. O 0 2.5084486878768075e-06

Previous O 0 2.58791214946541e-06
UBE3A O 0 6.177913746796548e-05
cDNA O 0 5.392939215198567e-07
analysis O 0 3.2659324133987866e-09
has O 0 2.987771488549562e-12
shown O 0 5.6757373106952613e-11
a O 0 9.778199083765315e-11
coding O 0 1.73471846665052e-06
region O 0 5.9085433434802326e-08
of O 0 6.303551902675508e-09
approximately O 0 3.757581357177742e-09
2 O 0 4.7236309086429173e-08
. O 0 1.0639830350100965e-07

6 O 0 1.0845994893315947e-06
kb O 0 5.489478553499794e-06
and O 0 1.4680306970049628e-09
a O 0 3.862400621557072e-09
3 O 0 1.2090427503608225e-07
- O 0 6.9235952651069965e-06
untranslated O 1 0.9998923540115356
region O 0 3.1572087664244464e-06
( O 0 3.782532953522377e-09
UTR O 0 9.406163007952273e-05
) O 0 2.343239768887173e-10
of O 0 6.56785958952355e-09
< O 0 2.7817253567263833e-07
50 O 0 1.8303010662634733e-08
bp O 0 1.36091422575646e-08
, O 0 7.258574991064748e-11
whereas O 0 3.405359771946337e-09
Northern O 0 6.917790784655153e-09
analysis O 0 2.2988477788032924e-09
has O 0 1.1306313524306333e-11
indicated O 0 4.12863326859636e-10
mRNA O 0 3.133600046112406e-09
sizes O 0 1.6380126144355245e-09
of O 0 4.552053400885825e-09
5 O 0 2.608099336498526e-08
- O 0 1.293817462055813e-07
8 O 0 8.034200504880573e-08
kb O 0 6.772912001906661e-06
. O 0 1.1103480090923767e-07

We O 0 8.82683863778766e-08
have O 0 2.491779005353578e-10
analyzed O 0 8.747504942618889e-10
additional O 0 1.3425971445713003e-10
cDNA O 0 7.233473553469594e-08
clones O 0 4.633219141680911e-09
and O 0 4.1675815576347475e-11
provide O 0 2.005170057772787e-10
evidence O 0 4.0302025605676306e-10
for O 0 4.107353693272309e-11
an O 0 2.989722705515341e-11
additional O 0 1.9230321779417636e-09
0 O 0 1.197518884055171e-08
. O 0 6.035625688127766e-08

5 O 0 3.498541047974868e-07
kb O 0 4.83004851048463e-06
of O 0 1.2734525967061927e-07
5 O 0 1.7037169186551182e-07
- O 0 1.4970163420002791e-06
UTR O 0 0.00021021273278165609
and O 0 9.169025538824371e-09
> O 0 2.9613447694032402e-08
2 O 0 4.692718658105832e-09
kb O 0 1.7101110927342233e-07
of O 0 1.950442474196734e-08
3 O 0 6.694604053336661e-07
- O 0 8.528807484253775e-06
UTR O 0 0.0008807783015072346
. O 0 7.844988090255356e-07

We O 0 3.0403207063045556e-08
have O 0 4.455124116842235e-11
established O 0 1.0228484031982177e-10
the O 0 1.0982119727498407e-11
genomic O 0 5.151287174598451e-10
organization O 0 3.241842558288077e-11
of O 0 1.4893836164375784e-09
UBE3A O 0 3.38871031999588e-05
and O 0 1.1353384898882268e-10
the O 0 2.6723812052154017e-10
sequence O 0 3.992538299968373e-09
of O 0 8.419319641461698e-08
intron O 0 1.1439993613748811e-05
- O 0 6.3789443629502784e-06
exon O 0 1.0967901289404836e-06
borders O 0 7.652554501191844e-08
. O 0 9.147836976808321e-07

We O 0 1.249312475692932e-07
have O 0 3.492762468138011e-10
also O 0 6.726183499061733e-11
mapped O 0 1.3846200630496242e-08
two O 0 1.745817518328252e-10
highly O 0 8.160825792913329e-09
homologous O 0 7.583229155727622e-09
processed O 0 2.9876009222107314e-08
pseudogenes O 0 1.2909900704016763e-07
, O 0 1.6144109660221062e-10
UBE3AP1 O 0 6.986816879361868e-05
and O 0 2.6091675486838994e-09
UBE3AP2 O 1 0.9997707009315491
, O 0 2.4505567020050023e-10
to O 0 1.6702995930817366e-10
chromosomes O 0 3.450518981651385e-09
2 O 0 7.911218347089743e-10
and O 0 6.325368701043388e-11
21 O 0 4.4218725903100164e-10
, O 0 5.114802678618524e-12
respectively O 0 3.877471399515997e-10
, O 0 4.6402786127441864e-12
and O 0 5.9845683096637625e-12
determined O 0 1.5739819447802006e-09
their O 0 9.68382485311281e-10
genomic O 0 1.3384007502281747e-07
organization O 0 3.324288044836976e-08
. O 0 2.3868037146712595e-07

These O 0 7.470334573156379e-09
results O 0 1.7080981074002466e-09
will O 0 2.782335820072923e-11
form O 0 4.6191498542791365e-11
the O 0 7.215605196675412e-11
basis O 0 6.519318418440889e-10
for O 0 6.211333097166927e-12
studies O 0 7.256457240645275e-11
of O 0 1.1440662306405613e-10
mutation O 0 2.335262261343729e-10
and O 0 2.834693035858038e-10
imprinting O 0 3.4064250939991325e-06
of O 0 5.277142008708324e-06
UBE3A O 1 0.998201847076416
. O 0 9.942516044247895e-06

Mutation O 0 5.530009161702765e-07
spectrum O 0 4.5673363047171733e-07
and O 0 5.334125141587265e-09
genotype O 0 2.504647682144423e-06
- O 0 6.135112471383763e-07
phenotype O 0 4.978625156581984e-08
analyses O 0 4.33433271496142e-08
in O 0 2.0337007633486337e-09
Cowden B-Disease 1 0.7724352478981018
disease I-Disease 0 1.515188500889053e-06
and O 0 3.444884910663859e-08
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.362231965591377e-09
two O 0 7.743156338335666e-09
hamartoma B-Disease 1 0.999278724193573
syndromes I-Disease 0 7.987672870513052e-05
with O 0 1.6150645478774095e-06
germline O 1 0.9999991655349731
PTEN O 1 0.9999444484710693
mutation O 0 4.357262241683202e-06
. O 0 8.526218380211503e-07

The O 0 1.379131390422117e-05
tumour B-Disease 1 1.0
suppressor O 0 0.003695302875712514
gene O 0 8.002760978342849e-07
PTEN O 0 4.385105421533808e-05
, O 0 1.2135069338281568e-10
which O 0 6.2031165794229626e-12
maps O 0 2.8253508421727247e-09
to O 0 1.2318896125407264e-08
10q23 O 0 0.0001047889090841636
. O 0 1.1554311640793458e-06

3 O 0 1.827224593853316e-08
and O 0 1.3134635046263554e-10
encodes O 0 3.8195543949903765e-11
a O 0 1.2931266300808542e-11
403 O 0 5.765611599262144e-11
amino O 0 2.5836918715604895e-10
acid O 0 4.848554890912737e-10
dual O 0 1.0698171593048755e-07
specificity O 0 8.709386634109251e-07
phosphatase O 0 5.6762011809041724e-05
( O 0 6.846412503591637e-08
protein O 0 1.2276110510356375e-06
tyrosine O 0 6.151136062726437e-07
phosphatase O 0 3.3550421107975126e-07
; O 0 3.4057281994570587e-10
PTPase O 0 4.220796199660981e-06
) O 0 2.1461343119311138e-11
, O 0 7.870753528094188e-12
was O 0 2.349828109871055e-10
shown O 0 2.559261691459369e-10
recently O 0 1.0287316831725235e-10
to O 0 5.907463407339719e-11
play O 0 2.4496992878653145e-08
a O 0 6.656950546357621e-09
broad O 0 1.04697175373758e-08
role O 0 2.167781509854194e-08
in O 0 1.3412956079150717e-08
human O 0 1.1171005098731257e-06
malignancy B-Disease 1 0.9999454021453857
. O 0 4.403237198857823e-06

Somatic O 0 0.12235313653945923
PTEN O 0 0.0017723223427310586
deletions O 0 7.791974212523201e-07
and O 0 3.0534121897574096e-09
mutations O 0 1.8398134127295407e-09
were O 0 6.054933776589166e-10
observed O 0 2.4693244671247783e-10
in O 0 3.597541362032608e-11
sporadic B-Disease 0 8.054689146774763e-07
breast I-Disease 0 5.253195558907464e-05
, I-Disease 0 1.0181875786940964e-08
brain I-Disease 1 1.0
, I-Disease 0 1.799222673071199e-07
prostate I-Disease 1 1.0
and I-Disease 1 0.9999971389770508
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 8.089353968898649e-07
and O 0 2.0765339447947895e-10
in O 0 1.0469666800183575e-10
several O 0 1.6636164668071274e-10
primary O 0 5.860829332959838e-07
tumours B-Disease 1 1.0
such O 0 2.2558896972668663e-09
as O 0 3.231778578083322e-07
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 1 0.9999954700469971
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9999719858169556

In O 0 1.559620521618399e-08
addition O 0 8.882517832375925e-09
, O 0 1.9329131628609275e-09
PTEN O 0 1.2242240700288676e-05
was O 0 6.392848472813739e-09
identified O 0 3.3906797369809283e-09
as O 0 6.634545690609173e-11
the O 0 1.0074555079064851e-10
susceptibility O 0 2.360934781009405e-09
gene O 0 8.399562989591658e-11
for O 0 1.5908679928955394e-10
two O 0 4.4610402483158396e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 0.9999998807907104
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9238115549087524
( O 0 2.616987737624754e-09
CD B-Disease 1 0.9161285758018494
; O 0 3.377183865893585e-09
MIM O 0 1.0718627891037613e-05
158350 O 0 3.3485309813841013e-07
) O 0 8.718285121611657e-11
and O 0 7.972522086951983e-10
Bannayan B-Disease 0 0.08395080268383026
- I-Disease 0 0.000206106822588481
Zonana I-Disease 1 0.9435117244720459
( I-Disease 0 1.3570391921291503e-08
BZS I-Disease 0 0.00011200605513295159
) I-Disease 0 2.1679652517647696e-10
or I-Disease 0 7.717246286453872e-10
Ruvalcaba I-Disease 0 5.132788828632329e-06
- I-Disease 0 2.753872649918776e-07
Riley I-Disease 0 6.982500781305134e-05
- I-Disease 1 0.9999682903289795
Smith I-Disease 1 0.9999693632125854
syndrome I-Disease 1 1.0
( O 0 6.819472559982387e-07
MIM O 1 0.9999974966049194
153480 O 0 0.12044315785169601
) O 0 9.30118471131891e-09
. O 0 1.358483388003151e-07

Constitutive O 0 4.378865469334414e-06
DNA O 0 7.913426429695392e-07
from O 0 5.369341860017585e-09
37 O 0 1.9126698447280432e-08
CD B-Disease 0 5.503681563823193e-07
families O 0 1.200692184566421e-10
and O 0 3.060732570170366e-11
seven O 0 7.168843851879103e-10
BZS B-Disease 0 1.5137965419853572e-05
families O 0 2.8298205445587143e-10
was O 0 1.719932640753541e-09
screened O 0 7.19630133261262e-09
for O 0 1.2389445025462464e-08
germline O 0 0.0009444020688533783
PTEN O 0 0.0016951682046055794
mutations O 0 2.70783903033589e-06
. O 0 9.472323654335923e-07

PTEN O 0 0.00016585490084253252
mutations O 0 3.708956697323629e-08
were O 0 4.72231320713945e-09
identified O 0 2.5404318648725166e-09
in O 0 4.127418892774237e-11
30 O 0 5.608556397085351e-10
of O 0 9.028848224623687e-10
37 O 0 8.242955651383e-09
( O 0 8.691056208043335e-11
81 O 0 3.688730032536114e-08
% O 0 1.6054729767844833e-09
) O 0 7.658073827854217e-12
CD B-Disease 0 4.9436795990231985e-08
families O 0 2.8977218194392584e-11
, O 0 4.326766375739588e-12
including O 0 1.7160314835784618e-11
missense O 0 6.712812705700344e-08
and O 0 1.952071393418464e-09
nonsense O 0 9.298948498326354e-06
point O 0 2.4349515115318354e-07
mutations O 0 1.1598983107319327e-08
, O 0 1.937603688606515e-10
deletions O 0 4.794044716760482e-09
, O 0 1.8418348790572026e-10
insertions O 0 5.894135668427225e-08
, O 0 3.7341521541556233e-10
a O 0 3.258298075792254e-09
deletion O 0 1.7107421399487066e-06
/ O 0 6.1768159866915084e-06
insertion O 0 2.321870852028951e-06
and O 0 1.728684253521351e-07
splice O 0 4.3237319914624095e-05
site O 0 3.749972847799654e-07
mutations O 0 4.189417097677506e-07
. O 0 3.3245927966163435e-07

These O 0 1.0418641060994105e-08
mutations O 0 3.641764223516475e-09
were O 0 7.265462675931644e-10
scattered O 0 5.049706208737348e-10
over O 0 4.437129136336537e-11
the O 0 6.339355429485494e-11
entire O 0 9.740384498968524e-09
length O 0 6.329913482261418e-09
of O 0 1.6115391687776537e-08
PTEN O 0 1.4735318245584494e-06
, O 0 2.7367920429899328e-11
with O 0 2.774343038289273e-12
the O 0 4.453866789266847e-11
exception O 0 1.2216280764754117e-10
of O 0 3.877745069491567e-10
the O 0 3.265638037763807e-10
first O 0 9.533090983282477e-10
, O 0 1.3750257876754546e-10
fourth O 0 1.7268002139303462e-08
and O 0 1.3865936177026583e-09
last O 0 8.3967556463449e-08
exons O 0 1.4333116268971935e-05
. O 0 4.894516223430401e-07

A O 0 1.624926517251879e-05
hot O 0 1.2532460686998093e-06
spot O 0 8.97528522614266e-08
for O 0 5.522604595853409e-10
PTEN O 0 1.0117797728526057e-06
mutation O 0 2.465644077798146e-10
in O 0 6.738459096267135e-11
CD B-Disease 0 4.332820537911175e-07
was O 0 6.6908105722518485e-09
identified O 0 1.4620067823045702e-08
in O 0 8.887512392696806e-10
exon O 0 1.1198355132080451e-08
5 O 0 3.6258765434560303e-10
that O 0 6.346598593887087e-12
contains O 0 1.207623150784043e-11
the O 0 2.2734775173560706e-10
PTPase O 0 9.474723810853902e-06
core O 0 5.19498314588418e-07
motif O 0 8.410183660600978e-09
, O 0 3.476006288360978e-11
with O 0 1.0264242580881877e-11
13 O 0 9.090884156570667e-10
of O 0 2.014136857297899e-09
30 O 0 1.2277909799962572e-09
( O 0 2.3770178533832897e-11
43 O 0 1.1644845976377383e-08
% O 0 7.026753068295477e-10
) O 0 1.2120166849316494e-11
CD B-Disease 0 1.173043102653537e-07
mutations O 0 1.011404848760833e-09
identified O 0 3.155558037093442e-09
in O 0 4.4766598761292187e-10
this O 0 4.839908473996957e-09
exon O 0 3.4869665341830114e-06
. O 0 5.931351552135311e-07

Seven O 0 1.94273880538276e-07
of O 0 2.7975429972570964e-08
30 O 0 4.662313646264238e-09
( O 0 7.039668847852454e-11
23 O 0 3.1167073366589193e-09
% O 0 4.180608359494187e-10
) O 0 2.4506197852242062e-12
were O 0 1.1054249876574218e-10
within O 0 7.805013857442589e-10
the O 0 4.690496879788952e-10
core O 0 8.970766884885961e-08
motif O 0 1.5787776641573714e-09
, O 0 1.799589990914008e-11
the O 0 5.502036326543447e-11
majority O 0 9.16445253018594e-11
( O 0 1.0352285868819866e-11
five O 0 7.994673673072938e-11
of O 0 2.2546582656435277e-10
seven O 0 2.6934537933342995e-10
) O 0 1.0824093357730824e-11
of O 0 1.2297192431010018e-10
which O 0 9.24189457601754e-12
were O 0 4.612217274768682e-09
missense O 0 6.183661298564402e-07
mutations O 0 3.3488192219266466e-09
, O 0 6.092407134339339e-11
possibly O 0 7.157507475596958e-09
pointing O 0 8.299516451870659e-08
to O 0 1.3238239393587037e-09
the O 0 6.904082194836292e-09
functional O 0 1.5921420981612755e-06
significance O 0 8.420938613085127e-09
of O 0 4.168030365292452e-09
this O 0 5.66924784894951e-10
region O 0 1.828574340834166e-07
. O 0 2.9673108770111867e-07

Germline O 0 0.044949427247047424
PTEN O 0 0.00028108537662774324
mutations O 0 4.1821518692586324e-08
were O 0 1.8365176046586384e-09
identified O 0 1.486902712066751e-09
in O 0 1.2415210352834105e-11
four O 0 1.82653874664096e-11
of O 0 2.699198364819466e-10
seven O 0 4.922184881905878e-10
( O 0 5.7526060304180504e-11
57 O 0 6.498888183159579e-08
% O 0 1.5549334264619574e-08
) O 0 7.475390861877429e-10
BZS B-Disease 0 2.2148044081404805e-05
families O 0 5.3888964401949124e-09
studied O 0 6.463120598709793e-07
. O 0 2.743968252616469e-07

Interestingly O 0 1.1484311244203127e-06
, O 0 6.107057082260781e-10
none O 0 2.248059294274185e-09
of O 0 3.5085337413143236e-10
these O 0 4.0027592351776775e-11
mutations O 0 2.7159668958276484e-10
was O 0 7.026056403347525e-10
observed O 0 2.3428198270281086e-10
in O 0 1.83976334167113e-10
the O 0 6.807683305964929e-09
PTPase O 0 0.002734114183112979
core O 0 1.3488195691024885e-05
motif O 0 9.86357918009162e-07
. O 0 3.5952973576058866e-07

It O 0 1.709675734318239e-09
is O 0 7.247590722014863e-11
also O 0 8.820241412244023e-12
worthy O 0 3.2927844895169756e-09
of O 0 2.0166124325982082e-09
note O 0 4.750387860852356e-10
that O 0 2.9129817048084705e-12
a O 0 1.9151824223739844e-11
single O 0 1.0041563136553577e-09
nonsense O 0 2.783768593417335e-07
point O 0 1.8766023401894927e-08
mutation O 0 2.2573101166045717e-09
, O 0 1.4518264368490463e-10
R233X O 0 8.798891144579102e-07
, O 0 5.163640001693004e-11
was O 0 6.145735031992672e-10
observed O 0 1.7024703868884217e-10
in O 0 2.1150831086558242e-11
the O 0 1.486678002926567e-10
germline O 0 4.548297738438123e-07
DNA O 0 8.983729316014433e-08
from O 0 3.4096278578310546e-10
two O 0 7.593933121219365e-11
unrelated O 0 1.126837378961909e-08
CD B-Disease 0 4.8387109927716665e-06
families O 0 9.826721658612314e-10
and O 0 7.527428125264635e-10
one O 0 1.1172581970697593e-08
BZS B-Disease 0 0.004469984211027622
family O 0 5.145704662368189e-08
. O 0 4.787367515746155e-07

Genotype O 0 1.1316358722979203e-05
- O 0 2.1762332380603766e-07
phenotype O 0 3.937084880334396e-09
studies O 0 2.928935427526369e-10
were O 0 6.1176980148403e-11
not O 0 2.3481095540178742e-12
performed O 0 8.844711629762969e-10
on O 0 1.2680240191187409e-10
this O 0 1.1230657896710294e-11
small O 0 4.8703242827574655e-11
group O 0 1.3548473454250143e-10
of O 0 6.849429468047674e-08
BZS B-Disease 1 0.9847864508628845
families O 0 8.974241438863828e-08
. O 0 5.856376219526283e-07

However O 0 1.4860394514926156e-07
, O 0 6.254950779549517e-09
genotype O 0 2.7271360636405007e-07
- O 0 8.151496189157115e-08
phenotype O 0 9.449117044368904e-09
analysis O 0 2.6881896708630393e-09
inthe O 0 6.503688041448186e-07
group O 0 8.886084923442894e-11
of O 0 1.8275999602579418e-09
CD B-Disease 0 0.046108171343803406
families O 0 3.154954353323802e-10
revealed O 0 1.3153920175312805e-09
two O 0 3.6383847323850915e-12
possible O 0 4.865941677367758e-11
associations O 0 3.0007028112288836e-11
worthy O 0 2.136786969586524e-09
of O 0 1.6407517566818797e-09
follow O 0 1.9940012307984034e-08
- O 0 6.686871500960478e-08
up O 0 7.93188736913919e-10
in O 0 4.981687840022175e-10
independent O 0 6.3484852930173474e-09
analyses O 0 1.0085238955070963e-07
. O 0 5.709981820700705e-08

The O 0 2.104262186719552e-08
first O 0 4.9427999471163275e-09
was O 0 2.2863952509055707e-08
an O 0 1.8712453461744438e-11
association O 0 1.052289991254618e-10
noted O 0 7.397743528869682e-11
in O 0 5.644857411363224e-12
the O 0 1.2611659980232837e-11
group O 0 6.738378952042545e-12
of O 0 5.942953351656399e-10
CD B-Disease 0 0.02495458908379078
families O 0 5.711710659994651e-09
with O 0 1.3985067326416356e-08
breast B-Disease 1 0.999987006187439
disease I-Disease 1 0.9999797344207764
. O 0 2.5552180886734277e-05

A O 0 6.251190143302665e-07
correlation O 0 2.109277019712863e-08
was O 0 4.243037032836128e-09
observed O 0 4.830195132754511e-10
between O 0 6.931391571818324e-10
the O 0 1.2549254690963352e-10
presence O 0 3.3788702391568393e-10
/ O 0 3.985662289096581e-08
absence O 0 1.6441869377104013e-07
of O 0 4.43615384426721e-08
a O 0 5.830688376562421e-09
PTEN O 0 3.947053301089909e-06
mutation O 0 2.840701007755797e-10
and O 0 9.068102171938541e-12
the O 0 2.3221050082788963e-11
type O 0 6.333294777505216e-09
of O 0 7.743351204680948e-08
breast O 0 0.008005478419363499
involvement O 1 0.8649946451187134
( O 0 1.0823949025962065e-07
unaffected O 0 0.1557457000017166
versus O 1 0.9990159273147583
benign O 0 0.36264920234680176
versus O 0 0.3327842354774475
malignant O 0 0.0004152613109908998
) O 0 1.5429593602789282e-08
. O 0 3.009999716141465e-07

Specifically O 0 1.1760221241274849e-08
and O 0 2.026466772164781e-10
more O 0 8.346633280365001e-12
directly O 0 1.589057496698132e-10
, O 0 1.115885075314571e-11
an O 0 2.583398555841554e-12
association O 0 7.611870855850356e-11
was O 0 2.8634519200210207e-09
also O 0 1.0335260425264892e-11
observed O 0 9.529176753231283e-11
between O 0 1.7109275107785038e-10
the O 0 7.022998155248317e-11
presence O 0 8.532975714903301e-11
of O 0 1.3732704973179466e-09
a O 0 1.0542296813298435e-08
PTEN O 1 0.6282756924629211
mutation O 0 3.382250724826008e-06
and O 0 1.4687884686281905e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0016258817631751299

Secondly O 0 1.6373738617403433e-05
, O 0 3.106054746737641e-09
there O 0 3.5243621909764045e-10
appeared O 0 2.8531849105561946e-10
to O 0 3.679000160072832e-11
be O 0 3.8147365821750157e-10
an O 0 4.0635630971230796e-10
interdependent O 0 6.041268079570727e-06
association O 0 4.108290152515792e-09
between O 0 3.9313167832233376e-08
mutations O 0 4.414013154985241e-09
upstream O 0 2.37473640751773e-09
and O 0 3.8042569094898226e-11
within O 0 2.5549806714764145e-09
the O 0 5.066640440531955e-09
PTPase O 0 4.63435280835256e-05
core O 0 1.29398176795803e-06
motif O 0 1.6205087050025213e-08
, O 0 1.4232733047681023e-10
the O 0 9.924954191831148e-10
core O 0 6.938223151564671e-08
motif O 0 2.097453100091684e-09
containing O 0 6.226043985924079e-11
the O 0 5.3718557380122434e-11
majority O 0 5.474307118724653e-11
of O 0 2.1740327316166486e-09
missense O 0 1.1945255664613796e-06
mutations O 0 1.2714157726634312e-08
, O 0 1.5219045468306547e-10
and O 0 1.2771943225242666e-10
the O 0 1.7050124645479059e-09
involvement O 0 2.07521952688694e-06
of O 0 1.3958131717117794e-07
all O 0 9.495960684446914e-10
major O 0 5.529943614135391e-09
organ O 1 0.9881155490875244
systems O 1 0.9972385168075562
( O 0 2.003853083465401e-08
central O 0 0.06307142227888107
nervous O 0 6.992575799813494e-05
system O 0 5.250641152088065e-06
, O 0 6.406385200108389e-09
thyroid O 1 0.9999843835830688
, O 0 1.1584969428213299e-07
breast O 1 0.9999997615814209
, O 0 0.0005947513272985816
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 0.9999996423721313
) O 0 6.703305643895874e-07
. O 0 1.2293484360270668e-05

However O 0 1.6799782542875619e-07
, O 0 1.8730818285295214e-10
these O 0 2.409638287514948e-11
observations O 0 6.198155322323373e-10
would O 0 1.4339074198843615e-11
need O 0 1.3451552371979147e-10
to O 0 1.2008519179040889e-11
be O 0 2.1253304671731144e-11
confirmed O 0 2.119098091446503e-10
by O 0 8.058202542737813e-12
studying O 0 5.95479943132915e-10
a O 0 2.091953346661235e-11
larger O 0 2.8652245506743945e-11
number O 0 6.204232266826537e-11
of O 0 1.0248916160193744e-09
CD B-Disease 0 3.52362417288532e-06
families O 0 7.455530415256817e-09
. O 0 1.1817407141734293e-07

Molecular O 0 0.00019147820421494544
defects O 1 0.9958884119987488
leading O 0 1.2799934268059587e-07
to O 0 9.027350533763467e-10
human O 0 5.0814698226986366e-08
complement B-Disease 1 0.9998210072517395
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.518557140618327e-09
an O 0 2.679208591094273e-11
African O 0 1.527839366133321e-08
- O 0 2.9195401651804787e-08
American O 0 2.850640612450661e-09
family O 0 6.388704232307418e-09
. O 0 4.63306264464336e-08

Complement B-Disease 0 0.001771350740455091
component I-Disease 1 0.9999997615814209
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.8598238444033086e-08
C6D B-Disease 1 0.9999988079071045
) O 0 3.053911568073886e-10
was O 0 1.424379991732394e-08
diagnosed O 0 4.1410754647586145e-07
in O 0 7.078984620711992e-11
a O 0 2.4123193026470702e-11
16 O 0 2.263776388566896e-10
- O 0 7.06647934611837e-11
year O 0 7.877876129214201e-11
- O 0 1.6864795115978382e-09
old O 0 6.766687477011146e-08
African O 0 1.3081100291856274e-07
- O 0 5.371707967327666e-09
American O 0 2.2935256471789955e-10
male O 0 2.5758710719969713e-08
with O 0 4.720962287763086e-09
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.3603373190562706e-05

The O 0 8.47804102477312e-08
patients O 0 5.476456266251262e-08
father O 0 6.533701935040881e-08
and O 0 1.778798081053523e-10
two O 0 1.677883249007195e-10
brothers O 0 2.1073468303711707e-08
also O 0 7.79328754307862e-11
had O 0 3.7721656909184276e-09
C6D B-Disease 1 0.9999903440475464
, O 0 5.208984979465647e-11
but O 0 1.0375949231755666e-11
gave O 0 2.2762099496920207e-11
no O 0 6.1661713061933465e-12
history O 0 8.671621753997272e-10
of O 0 1.7953860620423256e-08
meningitis B-Disease 1 1.0
or O 0 4.11397707011929e-08
other O 0 4.9147132585858344e-08
neisserial B-Disease 1 0.9989883303642273
infection I-Disease 1 0.9998337030410767
. O 0 7.2239013206854e-06

By O 0 2.2547927969185366e-09
using O 0 1.6556718218652122e-09
exon O 0 1.2458830411787858e-08
- O 0 1.348281347679503e-10
specific O 0 1.0859185078926359e-11
polymerase O 0 8.936173329088248e-11
chain O 0 3.14202379392281e-11
reaction O 0 4.08400223361749e-12
( O 0 6.871985619438803e-13
PCR O 0 2.4558441391597796e-10
) O 0 2.8183388782465624e-12
/ O 0 6.101151528437043e-11
single O 0 1.3448782365532708e-10
- O 0 2.7610216890572303e-10
strand O 0 9.847506143856322e-11
conformation O 0 1.0457214261183623e-10
polymorphism O 0 5.668080449439117e-10
as O 0 1.3938843135274936e-11
a O 0 9.595854492949751e-12
screening O 0 1.0443898523782025e-10
step O 0 4.2667078203884046e-10
and O 0 2.0593438412874754e-11
nucleotide O 0 5.47093870206794e-10
sequencing O 0 7.618457864566608e-09
of O 0 1.072695265946777e-09
target O 0 1.9209205337489266e-09
exons O 0 1.611911137899824e-08
, O 0 7.890896269735492e-12
we O 0 1.1359985001291317e-11
determined O 0 3.962388195333233e-10
that O 0 3.063692528837425e-12
the O 0 8.493162423350853e-11
proband O 0 4.6484734639307135e-07
was O 0 4.1438696918305595e-09
a O 0 2.3204016486033652e-10
compound O 0 1.0211359757761329e-08
heterozygote O 0 1.5387192320304166e-07
for O 0 1.2033362084551413e-09
two O 0 2.411389132817021e-08
C6 O 1 0.5357162356376648
gene O 0 2.9845315907550685e-07
mutations O 0 1.345693476650922e-07
. O 0 2.149009503682464e-07

The O 0 9.873398454374183e-08
first O 0 1.2043585684295977e-08
, O 0 5.20654408475707e-10
1195delC O 0 1.240858296114311e-07
located O 0 1.4351291266478938e-09
in O 0 1.7604567803530813e-10
exon O 0 1.5275713138862557e-08
7 O 0 8.97923690956759e-09
, O 0 7.73821701161026e-11
is O 0 1.1755539250368763e-11
a O 0 2.8890355385779998e-11
novel O 0 4.652608506794387e-11
mutation O 0 4.71098382526236e-10
, O 0 3.3707706764696255e-11
while O 0 2.532168086322173e-10
the O 0 8.267987405830013e-10
second O 0 2.275527677397804e-08
, O 0 8.668661344302109e-10
1936delG O 0 1.6081915532595303e-07
in O 0 2.863015158283133e-09
exon O 0 4.9913182920136023e-08
12 O 0 3.795382674809389e-09
, O 0 8.98082164191294e-11
has O 0 2.7682433168668696e-12
been O 0 2.1856887827409466e-11
described O 0 1.851471614910949e-10
before O 0 1.2048543274190138e-09
to O 0 1.4534092818152544e-09
cause O 0 3.1852570714363537e-07
C6D B-Disease 1 0.9999995231628418
in O 0 1.6037284833458898e-09
an O 0 5.426320850987487e-11
unrelated O 0 4.5149343463890546e-07
African O 0 1.958780558197759e-06
- O 0 2.0212618778714386e-07
American O 0 4.378702289642433e-09
individual O 0 8.330517609067556e-09
. O 0 1.4459422459367488e-07

Both O 0 1.6315597406446614e-07
mutations O 0 1.949702088666072e-08
result O 0 1.0996913601957203e-08
in O 0 2.0901089747837887e-09
premature O 0 1.8610724339396256e-07
termination O 0 8.624125769074453e-08
codons O 0 1.033648260317932e-07
and O 0 2.5256829516706603e-08
C6 O 0 0.0002137334377039224
null O 0 1.4458597661359818e-06
alleles O 0 6.331630686418066e-08
. O 0 3.6541308645610115e-07

Allele O 0 2.1601090338663198e-07
- O 0 3.469154741253533e-09
specific O 0 7.706696392162371e-11
PCR O 0 3.383347380037094e-09
indicated O 0 3.637048717752833e-10
that O 0 1.3031712211078461e-12
the O 0 1.6367556615604073e-11
probands O 0 7.602262286354744e-08
two O 0 6.157735432665845e-11
brothers O 0 3.806968518205167e-09
also O 0 3.1576380399300774e-11
inherited O 0 9.556015534428752e-09
the O 0 6.735404456392757e-10
1195delC O 0 4.7527397128988014e-08
mutation O 0 1.5657529439661033e-10
from O 0 4.637431758047761e-11
their O 0 1.40622749555952e-10
heterozygous O 0 2.026908418883977e-09
mother O 0 2.6925821572376663e-09
and O 0 1.175323588453736e-10
the O 0 6.999492097037319e-10
1936delG O 0 6.174597899644141e-08
mutation O 0 2.8316127220762155e-10
from O 0 2.138236289417339e-11
their O 0 4.7659768492858134e-11
homozygous O 0 2.6856681323295106e-09
father O 0 3.325048680835607e-08
. O 0 1.583362241319719e-08
. O 0 2.7669349833558954e-07

PAX6 O 0 0.01729007624089718
mutations O 0 3.7640966183971614e-06
reviewed O 0 2.8666286198131274e-06
. O 0 1.1600994866967085e-06

Mutations O 0 4.336344318289775e-06
in O 0 4.8444551481452436e-08
PAX6 O 0 0.00044001147034578025
are O 0 4.6291537270093386e-10
responsible O 0 3.431171569090452e-09
for O 0 4.040393020154909e-10
human O 0 5.173891395315877e-07
aniridia B-Disease 1 1.0
and O 0 1.9790677985298544e-09
have O 0 1.0952874891778652e-11
also O 0 5.698499398049117e-13
been O 0 6.559111760673364e-12
found O 0 4.768902286955701e-12
in O 0 2.006660245953973e-12
patients O 0 1.1394755972116144e-10
with O 0 6.708399807875409e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 9.56905665816521e-09
with O 0 1.0557388350207475e-06
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.09155669063329697
with O 0 0.0002764590026345104
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 8.475728918710956e-08
and O 0 2.5283627635985795e-08
with O 0 8.773594117883476e-07
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9918689727783203

No O 0 1.5206995840344462e-07
locus O 0 1.9469856837872612e-08
other O 0 1.8874521390266352e-10
than O 0 7.730663331706467e-11
chromosome O 0 1.9880884494227757e-08
11p13 O 0 7.382723651971901e-06
has O 0 6.549925879451024e-11
been O 0 5.422909343799631e-10
implicated O 0 1.083330062101595e-06
in O 0 6.065434376978374e-08
aniridia B-Disease 1 1.0
, O 0 3.563541906004275e-09
and O 0 4.028552158530374e-09
PAX6 O 1 0.9991042017936707
is O 0 6.320307055496244e-10
clearly O 0 4.345238058256484e-10
the O 0 6.578371181120701e-11
major O 0 6.834767751762172e-10
, O 0 1.3476147281421547e-11
if O 0 1.683745851077667e-11
not O 0 2.8747604990941866e-11
only O 0 1.33644484368034e-10
, O 0 3.1360680718961476e-10
gene O 0 3.2224758417243038e-09
responsible O 0 3.850406642413873e-07
. O 0 1.2240500382176833e-06

Twenty O 0 3.122596126559074e-06
- O 0 6.807868402347594e-08
eight O 0 2.2043971092955417e-09
percent O 0 4.329742675501791e-10
of O 0 9.504817072292226e-11
identified O 0 3.5777212303855777e-09
PAX6 O 0 4.669855115935206e-06
mutations O 0 1.4079190036042633e-09
are O 0 8.682971008866502e-11
C O 0 7.927650358396932e-07
- O 0 8.467680459034455e-07
T O 0 6.04551075866766e-08
changes O 0 1.807658911445742e-09
at O 0 7.929926049143887e-09
CpG O 0 3.3910927754732256e-07
dinucleotides O 0 2.2945479827285453e-07
, O 0 3.4955198457975456e-11
20 O 0 2.2254642573216188e-10
% O 0 1.3225613659795243e-10
are O 0 1.2872741067537774e-12
splicing O 0 1.538988492200133e-08
errors O 0 3.3370957908118726e-07
, O 0 2.123548697996469e-10
and O 0 5.543476094826971e-11
more O 0 4.707162611083948e-12
than O 0 1.7282111505756426e-11
30 O 0 7.433177962035131e-10
% O 0 1.3010322819084763e-09
are O 0 1.6873079322632378e-11
deletion O 0 3.989455432673594e-09
or O 0 1.3946409582743513e-09
insertion O 0 1.2358248113741865e-07
events O 0 2.2139236932616768e-07
. O 0 1.8535175740908016e-06

There O 0 4.2797939414640496e-08
is O 0 2.96172031344355e-10
a O 0 1.476905486796909e-09
noticeably O 0 3.178050747010275e-07
elevated O 0 1.0740408562526227e-08
level O 0 1.9454709843103046e-08
of O 0 4.451847501751871e-10
mutation O 0 1.5328846525441975e-10
in O 0 2.1428333066286775e-11
the O 0 5.6977339513153424e-11
paired O 0 7.787615552423688e-10
domain O 0 9.321408089846273e-10
compared O 0 1.6102563726860808e-10
with O 0 2.69729659614637e-12
the O 0 5.2905704123196173e-11
rest O 0 5.144043413451982e-09
of O 0 1.8818633318318234e-09
the O 0 4.736285141859753e-09
gene O 0 2.111953989469839e-08
. O 0 9.186043570252878e-08

Increased O 0 6.701618815441179e-08
mutation O 0 3.289934324968158e-09
in O 0 1.3360651474059182e-10
the O 0 3.794772551746206e-10
homeodomain O 0 2.3763831791256962e-07
is O 0 2.7553282572201354e-11
accounted O 0 2.025895673440914e-09
for O 0 9.428921185494765e-12
by O 0 5.2149895513053934e-11
the O 0 2.195015724737459e-09
hypermutable O 0 3.3099813663284294e-06
CpG O 0 1.6393595387853566e-06
dinucleotide O 0 2.5211165848304518e-06
in O 0 1.1763250817864446e-08
codon O 0 8.94726895239728e-07
240 O 0 2.243135526214246e-07
. O 0 6.371730592036329e-07

Very O 0 1.379142418045376e-07
nearly O 0 7.813597768802083e-09
all O 0 1.3451655067608925e-10
mutations O 0 7.216295894174607e-10
appear O 0 7.610989061213047e-10
to O 0 3.3245509123425165e-10
cause O 0 2.3361108603126013e-08
loss O 0 2.9833415737812174e-08
of O 0 4.9414172309525384e-08
function O 0 9.652190158249141e-08
of O 0 1.2509286051454183e-08
the O 0 1.8142623514627587e-10
mutant O 0 1.5518031304395663e-10
allele O 0 3.039210272337556e-10
, O 0 3.0211343409608515e-12
and O 0 1.6512319940195641e-12
more O 0 5.202585324354247e-13
than O 0 1.6510052873452974e-12
80 O 0 1.6348718212544355e-10
% O 0 3.0410887696952216e-10
of O 0 1.62999586050816e-10
exonic O 0 9.496204711467726e-08
substitutions O 0 8.488570735210033e-09
result O 0 4.6267016884371515e-09
in O 0 6.254723849963284e-09
nonsense O 0 2.289628355356399e-06
codons O 0 1.9066475260842708e-06
. O 0 1.309854383180209e-06

In O 0 1.6493686416652054e-08
a O 0 2.815984334603172e-09
gene O 0 9.775146248003352e-10
with O 0 4.187613450445937e-11
such O 0 6.3760739743568e-11
extraordinarily O 0 9.491387231719273e-08
high O 0 1.1881470252106396e-09
sequence O 0 1.916626579667735e-10
conservation O 0 9.112770260610858e-11
throughout O 0 1.175704065353722e-11
evolution O 0 9.248828786168062e-11
, O 0 3.73534493267047e-12
there O 0 9.443714907297895e-12
are O 0 2.5614288468034374e-11
presumed O 0 1.5312198229366913e-06
undiscovered O 0 6.141120684333146e-05
missense O 0 4.921354047837667e-06
mutations O 0 5.068566366617233e-08
, O 0 3.601078601978003e-10
these O 0 3.658171265907839e-10
are O 0 1.7955416320436512e-10
hypothesized O 0 4.057199021190172e-09
to O 0 2.806004872901724e-10
exist O 0 4.651985463510755e-08
in O 0 1.4243140000758103e-09
as O 0 4.4970298596069824e-09
- O 0 3.4053549313739495e-08
yet O 0 1.1059618110209612e-08
unidentified O 0 9.227351256413385e-07
phenotypes O 0 2.9361825681917253e-07
. O 0 9.925621213824343e-09
. O 0 1.7115796424604923e-07

Genetic O 0 7.265875410666922e-06
heterogeneity O 0 1.624338665351388e-06
and O 0 4.143735576889185e-09
penetrance O 0 7.554931016784394e-06
analysis O 0 1.2989031183963107e-08
of O 0 1.031510876714492e-08
the O 0 2.109759833501812e-08
BRCA1 O 0 4.043388912577939e-07
and O 0 1.0900746971742592e-08
BRCA2 O 0 2.3162313027569326e-06
genes O 0 4.30386073446698e-08
in O 0 1.1700639568346105e-08
breast B-Disease 0 0.00017695422866381705
cancer I-Disease 0 4.892975539405597e-06
families O 0 6.542343555793195e-08
. O 0 8.849341384120635e-07

The O 0 0.0005748675321228802
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9990960359573364
Consortium O 0 6.989172334215255e-07
. O 0 7.667969725844159e-08

The O 0 2.053866943185767e-08
contribution O 0 1.065892405449631e-07
of O 0 1.6356383980564715e-07
BRCA1 O 0 7.631011271769239e-07
and O 0 1.3971444445814996e-08
BRCA2 O 0 6.128316272224765e-06
to O 0 1.047808723342314e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.0009897343115881085
assessed O 0 8.208689727950969e-09
by O 0 6.595005097587148e-11
linkage O 0 6.384891282351646e-09
and O 0 2.0832372285561895e-11
mutation O 0 7.666334927991514e-11
analysis O 0 1.5306612921595075e-10
in O 0 1.5040238152130847e-11
237 O 0 3.005068693884283e-10
families O 0 2.3370522531096505e-11
, O 0 1.8723226094530254e-12
each O 0 3.3747121850474793e-12
with O 0 5.2532227699797485e-12
at O 0 1.8115962896469995e-10
least O 0 1.3869254703036127e-11
four O 0 1.0060013586055128e-11
cases O 0 4.449646553994491e-11
of O 0 6.906295091368975e-09
breast B-Disease 0 1.4975504427638953e-06
cancer I-Disease 0 3.986255237009573e-08
, O 0 1.7888921247100065e-11
collected O 0 1.006558517091527e-10
by O 0 5.298467567471654e-11
the O 0 8.433752896053193e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.013836970552802086
Consortium O 0 2.3300928830849443e-07
. O 0 5.640821854058231e-08

Families O 0 8.927119488078006e-09
were O 0 2.9166150050663475e-10
included O 0 5.1218144309084224e-11
without O 0 9.020219293720544e-11
regard O 0 1.1787029130516657e-09
to O 0 5.042841144664578e-11
the O 0 5.071559283642557e-10
occurrence O 0 2.2514246666105464e-05
of O 1 0.5862960815429688
ovarian B-Disease 1 1.0
or I-Disease 0 5.7469031162327155e-05
other I-Disease 0 2.1445391666929936e-06
cancers I-Disease 1 1.0
. O 0 0.04778711870312691

Overall O 0 0.00011544654262252152
, O 0 6.447133671372285e-08
disease O 0 2.3789460101397708e-05
was O 0 2.5560308358762995e-07
linked O 0 2.627011781441979e-07
to O 0 2.8567148646629903e-09
BRCA1 O 0 1.0379946502325765e-07
in O 0 1.318664621940968e-10
an O 0 2.6030894020173667e-12
estimated O 0 2.5260356306677778e-11
52 O 0 4.620693827561695e-10
% O 0 1.8160417614154767e-10
of O 0 4.5504860296530225e-11
families O 0 1.0271670319861315e-10
, O 0 6.69826138999241e-11
to O 0 5.059906937887604e-10
BRCA2 O 0 2.5721053731331267e-08
in O 0 6.936456964368176e-10
32 O 0 1.4031559025795559e-08
% O 0 1.5570753575389062e-09
of O 0 1.2241564706361174e-10
families O 0 3.871358095208777e-11
, O 0 6.037398879443767e-12
and O 0 6.163466004932561e-12
to O 0 4.5071928828077645e-11
neither O 0 6.550557429818582e-09
gene O 0 2.721365077729132e-10
in O 0 1.4055007158120247e-10
16 O 0 8.787807703747319e-10
% O 0 2.385239505908743e-10
( O 0 3.1962351602216055e-12
95 O 0 1.8721542094368715e-09
% O 0 1.1340383077040883e-09
confidence O 0 4.0885694829739805e-08
interval O 0 7.197608198339367e-08
[ O 0 7.336573304428384e-08
CI O 0 4.011535111203557e-06
] O 0 1.7020239440057594e-08
6 O 0 3.325567377032712e-09
% O 0 2.743981930564132e-09
- O 0 9.696448088902798e-10
28 O 0 1.7473441582538385e-09
% O 0 7.880420205275129e-10
) O 0 1.0838120331757573e-11
, O 0 2.604992957455643e-11
suggesting O 0 2.1618098422493404e-09
other O 0 8.644043814065583e-10
predisposition O 0 7.550757459284796e-07
genes O 0 8.308605856655049e-07
. O 0 2.822357828335953e-06

The O 0 5.59134427646768e-08
majority O 0 4.279791632200158e-09
( O 0 6.156795906431256e-11
81 O 0 1.5126857988434494e-08
% O 0 1.9475863144435834e-09
) O 0 3.7778122644049894e-12
of O 0 4.513732998479014e-10
the O 0 1.9726701339095598e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.162693313323416e-08
were O 0 1.104237035143285e-09
due O 0 8.300478526734878e-09
to O 0 2.1822575690944035e-10
BRCA1 O 0 4.717775947682412e-09
, O 0 8.488428709929607e-12
with O 0 6.308762540152557e-12
most O 0 4.8086735982000306e-11
others O 0 3.138970472438274e-10
( O 0 2.7044276540433287e-11
14 O 0 2.0176742498989597e-09
% O 0 8.070685231231778e-10
) O 0 1.2027269805092722e-11
due O 0 1.8927895695242114e-08
to O 0 4.37611653580916e-08
BRCA2 O 0 7.4535028034006245e-06
. O 0 9.419767934559786e-07

Conversely O 0 1.6529737649761955e-06
, O 0 3.121364000602256e-10
the O 0 8.840929377473827e-11
majority O 0 3.6326167768274686e-11
of O 0 4.105810830212775e-11
families O 0 1.6162987614976032e-11
with O 0 9.670451071863706e-12
male B-Disease 0 4.545141223388782e-07
and I-Disease 0 4.6958280819353604e-08
female I-Disease 1 0.9999985694885254
breast I-Disease 1 0.9999979734420776
cancer I-Disease 1 0.999987006187439
were O 1 0.9874787330627441
due O 1 0.9999933242797852
to O 0 1.5029199573746155e-07
BRCA2 O 0 2.2447706271577772e-07
( O 0 2.574885860084919e-10
76 O 0 3.097815124419867e-07
% O 0 1.5760917904117377e-08
) O 0 3.808411641603726e-10
. O 0 1.532836435558238e-08

The O 0 1.0618017398655866e-07
largest O 0 5.424991567082316e-09
proportion O 0 5.721371376665729e-09
( O 0 5.233832464646149e-11
67 O 0 2.646782775173051e-07
% O 0 8.373194582134147e-09
) O 0 3.971441231431783e-12
of O 0 8.123824529748802e-11
families O 0 2.4648482907507763e-11
due O 0 9.00470631393091e-09
to O 0 1.1148985207265483e-10
other O 0 3.5591772584719905e-11
genes O 0 5.758976628911228e-10
was O 0 1.5169900891010002e-09
found O 0 6.68904306944107e-11
in O 0 5.5844161760132405e-12
families O 0 9.224706068455824e-12
with O 0 1.454061480596347e-12
four O 0 1.82399043785475e-11
or O 0 1.394004009447336e-11
five O 0 1.785629630268737e-11
cases O 0 3.00704530720175e-11
of O 0 1.528002435691178e-08
female O 0 0.0010468433611094952
breast B-Disease 0 0.07629368454217911
cancer I-Disease 0 7.375326822511852e-05
only O 0 3.42261813557343e-07
. O 0 2.2314802663458977e-06

These O 0 4.264285369259824e-09
estimates O 0 1.8755925701441356e-09
were O 0 5.188323104476922e-10
not O 0 2.3299489074202206e-11
substantially O 0 1.3926685360488023e-09
affected O 0 7.506677918156512e-11
either O 0 5.8146796405589285e-11
by O 0 9.951158820575845e-12
changing O 0 7.282014435894268e-10
the O 0 1.0215927409573666e-10
assumed O 0 1.0318494503280817e-08
penetrance O 0 8.219581815183119e-08
model O 0 5.31271859838256e-10
for O 0 1.4355801269960722e-10
BRCA1 O 0 1.0397557481667263e-08
or O 0 5.576244327398783e-11
by O 0 3.301081630269209e-11
including O 0 1.0889992380080926e-10
or O 0 2.8669768781242055e-09
excluding O 0 2.529550044982898e-07
BRCA1 O 0 7.959976073834696e-07
mutation O 0 3.3893879702873164e-08
data O 0 2.1104807501615142e-07
. O 0 1.3621171035538282e-07

Among O 0 2.017551992139488e-08
those O 0 3.6523148394529414e-10
families O 0 2.0404408718199818e-10
with O 0 6.636469151999336e-11
disease O 0 2.386312644375721e-06
due O 0 0.040217820554971695
to O 0 5.952168091738486e-09
BRCA1 O 0 1.787554282373094e-08
that O 0 5.151026740563003e-12
were O 0 1.8372445925729508e-11
tested O 0 4.782329046659761e-12
by O 0 3.8482449648755135e-13
one O 0 6.54391308935881e-13
of O 0 1.1563688374904846e-11
the O 0 8.328663279877357e-12
standard O 0 7.47960790525859e-11
screening O 0 2.6273379305497002e-11
methods O 0 1.5197354485962933e-09
, O 0 1.3438774398855102e-11
mutations O 0 6.044303252350502e-11
were O 0 2.0187049254438705e-10
detected O 0 1.0985565790377905e-09
in O 0 1.2509291345830231e-11
the O 0 1.5964092547893216e-10
coding O 0 5.677629246747529e-07
sequence O 0 6.900870097581446e-09
or O 0 8.272199591985441e-10
splice O 0 1.6001695968270724e-08
sites O 0 1.3530523923499516e-10
in O 0 2.087334124989404e-11
an O 0 3.3402215455363704e-12
estimated O 0 1.5246298668003533e-10
63 O 0 1.2271688554221782e-08
% O 0 1.3030114764944756e-09
( O 0 2.4713399729425767e-11
95 O 0 2.1914402736911143e-08
% O 0 9.242560494726604e-09
CI O 0 7.526745093855425e-07
51 O 0 7.0013676634062e-08
% O 0 2.154303047063877e-08
- O 0 1.9457976563330703e-08
77 O 0 2.394445175468718e-08
% O 0 1.8366447918083395e-08
) O 0 1.1883102279952595e-09
. O 0 4.69771848088385e-08

The O 0 1.2434947294082122e-08
estimated O 0 2.0581758519711e-09
sensitivity O 0 8.557758945926253e-09
was O 0 1.868183108211241e-10
identical O 0 4.021484881211457e-11
for O 0 1.1895102958181525e-12
direct O 0 4.524574465092357e-11
sequencing O 0 3.7623859583391095e-09
and O 0 1.3291540090776266e-10
other O 0 3.847186735850272e-10
techniques O 0 6.570169716724195e-06
. O 0 6.12488804563327e-07

The O 0 2.89203455849929e-07
penetrance O 0 9.792611672310159e-05
of O 0 5.625724952551536e-07
BRCA2 O 0 1.7373794491959416e-07
was O 0 5.290192284235218e-09
estimated O 0 8.256652306304346e-11
by O 0 2.5489279090185057e-11
maximizing O 0 1.480770528416997e-08
the O 0 2.108885732710064e-09
LOD O 0 2.1295725673553534e-05
score O 0 2.992003445001501e-08
in O 0 2.7018989268157156e-09
BRCA2 O 0 2.935242093826673e-07
- O 0 2.5234440315102802e-08
mutation O 0 7.614647801190699e-10
families O 0 5.866401808773958e-11
, O 0 1.213617401019107e-11
over O 0 3.458547684354052e-11
all O 0 4.307705928074945e-11
possible O 0 1.2002239202502096e-08
penetrance O 0 7.179219664976699e-06
functions O 0 6.90583590312599e-07
. O 0 4.1220130242436426e-07

The O 0 7.3254540211564745e-09
estimated O 0 3.143267424121632e-09
cumulative O 0 1.0930227389849279e-08
risk O 0 7.330513529524296e-09
of O 0 5.249967927056787e-08
breast B-Disease 0 4.237899702275172e-05
cancer I-Disease 0 2.9830055154889124e-06
reached O 0 4.940352027915651e-06
28 O 0 3.166514517261021e-08
% O 0 3.307511764472082e-10
( O 0 1.3195112320493751e-12
95 O 0 2.3292534567787015e-09
% O 0 6.657747686489301e-10
CI O 0 4.526497576762267e-08
9 O 0 7.854969452658622e-10
% O 0 2.426325529381046e-10
- O 0 7.940284540985942e-11
44 O 0 1.2807656324387295e-10
% O 0 4.1871821981898094e-11
) O 0 1.369762322230711e-13
by O 0 9.222817821952223e-13
age O 0 2.130197546135193e-10
50 O 0 9.082352925293691e-11
years O 0 6.948953912289113e-11
and O 0 1.4618263197152537e-11
84 O 0 2.6592845703277135e-09
% O 0 6.134012742187167e-10
( O 0 6.4195120573484754e-12
95 O 0 3.124885905592123e-09
% O 0 1.4961886174447159e-09
CI O 0 1.2539868521344033e-07
43 O 0 7.637298793383707e-09
% O 0 6.908043581610457e-10
- O 0 2.7444096994955203e-10
95 O 0 7.878992458465461e-10
% O 0 9.379741428006128e-11
) O 0 2.438411885602454e-13
by O 0 1.3000504535745638e-12
age O 0 1.2336359711540013e-09
70 O 0 3.4723455222263055e-09
years O 0 3.2858893384002386e-09
. O 0 3.7807755148833166e-08

The O 0 2.5539991383993765e-06
corresponding O 1 0.9999992847442627
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 1.0895761079154909e-05
were O 0 2.840227075751045e-08
0 O 0 4.274904874534968e-09
. O 0 1.1601882121681228e-08

4 O 0 1.492262668989497e-07
% O 0 1.4879050880267641e-08
( O 0 8.932015543861027e-11
95 O 0 4.007585729937091e-08
% O 0 9.936153233525147e-09
CI O 0 6.23777282271476e-07
0 O 0 1.562706769542288e-10
% O 0 1.49815315708679e-09
- O 0 4.3669068361396057e-10
1 O 0 4.168996398101754e-11
% O 0 2.9880067170529045e-11
) O 0 1.176505995490601e-13
by O 0 5.452699381423842e-13
age O 0 1.016178599599904e-10
50 O 0 8.707216891945535e-11
years O 0 5.401630531753909e-11
and O 0 1.2877904471964019e-11
27 O 0 8.443530874480132e-10
% O 0 3.984997054562456e-10
( O 0 7.714355196308809e-12
95 O 0 1.4181991581097009e-08
% O 0 6.2046763282808115e-09
CI O 0 2.48636069954955e-07
0 O 0 1.5114902385260365e-10
% O 0 7.135639856770126e-10
- O 0 6.305400646056114e-10
47 O 0 1.7828953868814779e-09
% O 0 2.868758564034124e-10
) O 0 8.296899950931136e-13
by O 0 5.940748760979719e-12
age O 0 2.4136010967623633e-09
70 O 0 7.539530777478376e-09
years O 0 5.709183792390604e-09
. O 0 4.5219238131721795e-08

The O 0 2.7551328329877833e-08
lifetime O 0 1.6920358802963165e-07
risk O 0 4.0972904002956057e-07
of O 0 1.406736714670842e-06
breast B-Disease 1 0.9996210336685181
cancer I-Disease 0 2.0557445168378763e-05
appears O 0 2.103249796547857e-09
similar O 0 5.0229032738657864e-11
to O 0 1.2680603789227973e-10
the O 0 1.1728898963170309e-09
risk O 0 1.0955941931456437e-08
in O 0 1.0986110909882996e-09
BRCA1 O 0 5.314586548621492e-09
carriers O 0 5.530633936934315e-11
, O 0 7.079683193855768e-12
but O 0 4.1410824422327686e-12
there O 0 2.369675636271218e-11
was O 0 2.0077151052788622e-10
some O 0 4.902691100316936e-12
suggestion O 0 4.005159537356917e-10
of O 0 2.3267003879112735e-09
a O 0 3.804493164949463e-09
lower O 0 2.4116795316331263e-07
risk O 0 3.424354488856807e-08
in O 0 3.3959093315161226e-09
BRCA2 O 0 3.18954249678427e-08
carriers O 0 1.2736578458572012e-09
< O 0 7.71397168364274e-08
50 O 0 2.703713475327163e-09
years O 0 1.0243287329458894e-09
of O 0 2.7432962568241237e-09
age O 0 1.637900055584396e-07
. O 0 1.5076039971972932e-07

Eye B-Disease 1 0.9854238629341125
movement I-Disease 0 1.5426820027641952e-05
abnormalities I-Disease 1 0.9524707198143005
correlate O 0 3.684983084895066e-06
with O 0 1.735400378954921e-09
genotype O 0 1.4310128335637273e-06
in O 0 2.419543676523972e-08
autosomal O 1 0.9816198348999023
dominant O 1 0.999052107334137
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 6.415122334146872e-05

We O 0 9.613165730115725e-08
compared O 0 1.088479493205341e-07
horizontal O 0 8.589452136220643e-07
eye O 0 9.784909707377665e-06
movements O 0 8.14083421118994e-07
( O 0 4.065821457288621e-09
visually O 0 9.832954361854718e-08
guided O 0 1.6771080879607325e-07
saccades O 0 1.2212029105285183e-05
, O 0 1.2035817897881884e-09
antisaccades O 0 1.0754285995062673e-06
, O 0 7.741199348210159e-11
and O 0 1.5584412926816782e-10
smooth O 0 6.307776061476034e-07
pursuit O 0 3.4250538760716154e-07
) O 0 8.029883702409535e-11
in O 0 1.2105155766661824e-10
control O 0 2.964339884670153e-08
subjects O 0 3.463124471636547e-07
( O 0 4.1479382428821765e-11
n O 0 3.364490352986138e-10
= O 0 7.937907275934464e-11
14 O 0 9.415285912028892e-11
) O 0 1.4647839148215769e-12
and O 0 2.2712302958499686e-12
patients O 0 8.794237039977393e-12
with O 0 7.986008772678521e-13
three O 0 4.100064471962428e-12
forms O 0 4.294286870543118e-10
of O 0 3.575928886334623e-08
autosomal O 0 0.49293580651283264
dominant O 1 0.9411669373512268
cerebellar B-Disease 1 0.9999992847442627
ataxias I-Disease 1 0.9967340230941772
type I-Disease 0 0.39073124527931213
I I-Disease 1 0.9999997615814209
spinocerebellar B-Disease 1 0.9999973773956299
ataxias I-Disease 0 0.05551286041736603
1 I-Disease 0 1.945081606891108e-08
and I-Disease 0 5.83705028756043e-10
2 I-Disease 0 1.73307845852122e-09
( O 0 2.3158254480737384e-10
SCA1 B-Disease 0 3.5138837120030075e-05
, O 0 1.4757445265800584e-10
n O 0 3.641623391725801e-10
= O 0 2.3307589192000933e-10
11 O 0 4.074475201676364e-10
; O 0 2.9063237927395846e-11
SCA2 B-Disease 0 3.86872534363647e-06
, O 0 7.480250446834091e-11
n O 0 1.0328230631850843e-10
= O 0 7.864155160408615e-11
10 O 0 1.3233637796705722e-10
) O 0 8.75600980609903e-12
and O 0 4.3166567542662904e-10
SCA3 B-Disease 1 1.0
/ O 0 1.036986986946431e-06
Machado B-Disease 0 9.241538236892666e-07
- I-Disease 0 2.7423226356404484e-07
Joseph I-Disease 0 1.6914462321437895e-05
disease I-Disease 1 0.7764258980751038
( O 0 8.935978179636095e-09
MJD B-Disease 1 1.0
) O 0 1.6047934092711102e-09
( O 0 1.3651425823102414e-10
n O 0 1.6574601691132784e-09
= O 0 4.5125453373984215e-10
16 O 0 1.3827614608885597e-09
) O 0 2.66687671945931e-10
. O 0 1.0880825129788718e-08

In O 0 3.455711237165815e-07
SCA1 B-Disease 0 0.000566067174077034
, O 0 1.3159642264781723e-09
saccade O 0 6.863427870484884e-07
amplitude O 0 8.866830114584445e-08
was O 0 9.423595237478821e-09
significantly O 0 2.1875095068679684e-09
increased O 0 6.739336311234467e-10
, O 0 2.1716102874269616e-11
resulting O 0 1.273033678472757e-09
in O 0 3.953640526077606e-09
hypermetria B-Disease 0 2.2639056624029763e-05
. O 0 8.855808459884429e-07

The O 0 5.02799593959935e-07
smooth O 0 4.6856803237460554e-05
pursuit O 0 1.8232496586279012e-05
gain O 0 2.280503849760862e-06
was O 0 3.0241389481489023e-07
decreased O 0 2.609515604490298e-06
. O 0 8.179623023352178e-08

In O 0 3.5257247077424836e-07
SCA2 B-Disease 0 0.0008739944896660745
, O 0 1.4874785847496241e-09
saccade O 0 4.0523758570998325e-07
velocity O 0 3.940265571600321e-07
was O 0 4.452591042536369e-07
markedly O 0 6.927471986273304e-06
decreased O 0 1.610951130714966e-06
. O 0 1.324633274180087e-07

The O 0 2.6412195097691438e-08
percentage O 0 4.618927462729516e-08
of O 0 8.059824474493382e-10
errors O 0 1.1547855365279247e-06
in O 0 3.991145192117074e-09
antisaccades O 0 0.00013587818830274045
was O 0 2.0395752642343723e-08
greatly O 0 9.65918367512586e-09
increased O 0 8.847596544292458e-10
and O 0 2.9053702152448402e-11
was O 0 4.852301338509335e-10
significantly O 0 5.982279671634672e-10
correlated O 0 2.4920652208493266e-09
with O 0 1.551663138255055e-11
age O 0 1.6030870853001034e-08
at O 0 2.446626723440204e-08
disease O 0 3.944983291148674e-06
onset O 0 0.0011925901053473353
. O 0 6.277098805185233e-07

In O 0 1.523027037819702e-08
addition O 0 1.8866574968967598e-09
, O 0 6.441261413137056e-11
a O 0 6.721156270428352e-11
correlation O 0 3.548902560712719e-10
between O 0 1.7536077034918662e-09
smooth O 0 2.4640633000672096e-06
pursuit O 0 5.086201895210252e-07
gain O 0 3.2326475718491565e-08
and O 0 4.53866319527485e-11
the O 0 4.498715289180666e-11
number O 0 1.1067498306704948e-10
of O 0 6.983902900437045e-10
trinucleotide O 0 1.7929311297848471e-06
repeats O 0 2.659164266560765e-08
was O 0 4.4640110274940525e-08
found O 0 1.2198341003966107e-08
. O 0 1.1839041746952716e-07

In O 0 3.728071760633611e-06
SCA3 B-Disease 1 1.0
, O 0 2.8560359055518347e-07
gaze B-Disease 0 0.0006920468294993043
- I-Disease 0 5.12612587044714e-06
evoked I-Disease 0 4.153446298005292e-08
nystagmus I-Disease 0 4.3573347596748135e-08
was O 0 6.2499894148970725e-09
often O 0 7.567385607032406e-11
present O 0 9.900597008893897e-11
as O 0 3.4481667521291115e-11
was O 0 1.1855233461588455e-09
saccade O 0 6.659060431957187e-07
hypometria O 0 2.311619255124242e-06
and O 0 2.6227942040435437e-09
smooth O 0 1.0029367331299e-05
pursuit O 0 7.547830136900302e-06
gain O 0 3.216593768229359e-06
was O 0 3.717087508903205e-07
markedly O 0 5.899325969949132e-06
decreased O 0 1.2969321687705815e-06
. O 0 9.65870938784974e-08

Three O 0 2.789369801803332e-08
major O 0 5.101598254952933e-09
criteria O 0 9.662058708670429e-09
, O 0 1.5326302726936802e-10
saccade O 0 1.5782613616011076e-07
amplitude O 0 3.585476449075031e-08
, O 0 1.7728976620112746e-10
saccade O 0 8.20118088995514e-08
velocity O 0 3.8154173154225646e-08
, O 0 2.3407026317201485e-10
and O 0 9.51363154921836e-11
presence O 0 1.641230706894703e-09
of O 0 4.393487245124561e-07
gaze B-Disease 1 0.9143193960189819
- I-Disease 0 0.0005250053363852203
evoked I-Disease 0 2.356033235173527e-07
nystagmus I-Disease 0 4.4793118547659105e-08
, O 0 4.250557891771756e-11
permitted O 0 1.4747711385432183e-10
the O 0 1.4401016837362057e-11
correct O 0 7.024006376532554e-10
assignment O 0 2.620344163872801e-09
of O 0 6.756892823034377e-10
90 O 0 3.826434280540525e-09
% O 0 6.662879692420631e-10
of O 0 1.645828473506583e-10
the O 0 2.4774954310302633e-10
SCA1 B-Disease 0 1.0662381100701168e-05
, O 0 3.8544119285166545e-11
90 O 0 1.1199503546777123e-09
% O 0 4.649222118402463e-10
of O 0 8.130613543544385e-11
the O 0 5.127535618321133e-10
SCA2 B-Disease 0 0.00010262559226248413
, O 0 5.7090252664204755e-11
and O 0 1.736723265199913e-11
93 O 0 2.589608749659078e-09
% O 0 4.484368154589191e-10
of O 0 3.858060051986634e-11
the O 0 3.677014942526924e-11
patients O 0 4.2044143166997117e-10
with O 0 2.549804534179856e-10
SCA3 B-Disease 1 1.0
to O 0 1.1512555353476728e-09
their O 0 2.2472951277663356e-10
genetically O 0 2.484195904539632e-10
confirmed O 0 7.37877980938606e-10
patient O 0 2.2604822902394517e-08
group O 0 5.128070537652185e-11
and O 0 1.7609472213742094e-10
, O 0 4.517365648215588e-11
therefore O 0 4.273380316277553e-09
, O 0 2.5628960065304796e-10
may O 0 1.1759520024412495e-09
help O 0 2.7426750648373854e-08
orient O 0 1.5458822417713236e-06
diagnoses O 0 1.3693918390345061e-06
of O 0 1.7046381799445953e-06
SCA1 B-Disease 1 0.9999990463256836
, O 0 1.057726173314677e-08
SCA2 B-Disease 1 0.9998468160629272
, O 0 8.703269771537236e-10
and O 0 2.1375166081583075e-09
SCA3 B-Disease 1 1.0
at O 0 1.2424609785455232e-08
early O 0 1.2084147016366842e-09
clinical O 0 2.4219526384428036e-09
stages O 0 2.3173081231675496e-08
of O 0 4.558152522093906e-09
the O 0 6.317393719257325e-09
diseases O 0 2.5988836114265723e-06
. O 0 3.43558710369507e-08
. O 0 1.9078720470133703e-07

Genetic O 0 3.870094644753408e-07
basis O 0 4.713991330618228e-08
and O 0 2.2298364543704707e-10
molecular O 0 8.788415328808696e-09
mechanism O 0 1.938143441293505e-06
for O 0 2.945847938917723e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999983310699463

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999958276748657
causes O 0 1.121260993386386e-06
more O 0 1.574365499079633e-10
than O 0 1.09385738314427e-11
300 O 0 1.0181186449464974e-10
, O 0 4.776786171473146e-12
000 O 0 3.3112126374135187e-09
sudden O 0 6.684136577561617e-10
deaths O 0 2.1809593020449825e-10
each O 0 1.3104574717037742e-11
year O 0 5.6059549363718375e-11
in O 0 6.660233475841437e-11
the O 0 2.0289390167960164e-09
USA O 0 5.6485951915874466e-08
alone O 0 9.473374262825018e-08
. O 0 9.576618964501904e-08

In O 0 5.2832774599664845e-08
approximately O 0 4.2640251329828516e-09
5 O 0 2.144033395268252e-09
- O 0 1.394827142675581e-09
12 O 0 4.732986780275894e-10
% O 0 2.6851904033620144e-10
of O 0 8.152396292759878e-12
these O 0 2.023764619427104e-12
cases O 0 6.267085808642214e-12
, O 0 2.0459103161618586e-12
there O 0 3.894841914264813e-12
are O 0 4.484431923024168e-12
no O 0 9.140257994921797e-11
demonstrable O 0 1.696244453341933e-06
cardiac O 1 0.5637193322181702
or O 0 7.48140251971563e-08
non O 1 0.9999983310699463
- O 1 0.9999995231628418
cardiac O 1 1.0
causes O 0 1.6034333327752393e-07
to O 0 2.73556177710077e-10
account O 0 1.2706145857688256e-10
for O 0 1.7119876696836123e-11
the O 0 2.7575799976808923e-10
episode O 0 1.8249388666902178e-09
, O 0 1.6556440463402766e-12
which O 0 6.68142096011716e-14
is O 0 3.3082765043060403e-13
therefore O 0 4.727048266706113e-11
classified O 0 4.503415862444626e-09
as O 0 2.6960471188886004e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999446868896484
IVF B-Disease 1 1.0
) O 0 1.0654452609060172e-07
. O 0 1.3644391572142922e-07

A O 0 1.452396389822752e-07
distinct O 0 9.292283387196676e-09
group O 0 2.9372262955185136e-10
of O 0 6.630633464510538e-08
IVF B-Disease 1 1.0
patients O 0 7.315068728530605e-08
has O 0 1.505351941190336e-12
been O 0 2.299616443449115e-12
found O 0 1.250220088046261e-12
to O 0 1.6816909193320684e-12
present O 0 1.381983000259268e-10
with O 0 4.402523484658971e-11
a O 0 4.086634142197454e-09
characteristic O 0 9.588569582774653e-07
electrocardiographic O 0 0.029306119307875633
pattern O 0 8.319521293742582e-05
. O 0 2.078184024867369e-06

Because O 0 5.081217580027442e-08
of O 0 3.649386925985709e-08
the O 0 4.975167389176249e-09
small O 0 3.7991756962618695e-10
size O 0 4.155661093019347e-10
of O 0 8.600315459794672e-10
most O 0 7.312296601558188e-11
pedigrees O 0 1.5435862366075526e-08
and O 0 1.0388628152169233e-10
the O 0 5.72130287590511e-10
high O 0 1.0555737617323757e-08
incidence O 0 6.159928744864374e-08
of O 0 3.0547870899511054e-09
sudden B-Disease 0 1.0971291430905694e-08
death I-Disease 0 2.570877732921417e-09
, O 0 3.06987699150163e-11
however O 0 1.0238711267707146e-10
, O 0 7.418242235768258e-12
molecular O 0 3.768431677819706e-10
genetic O 0 2.471501614476068e-10
studies O 0 4.1467929090543976e-10
of O 0 3.014617222518723e-09
IVF B-Disease 1 1.0
have O 0 7.593643075454182e-11
not O 0 2.408613759830036e-11
yet O 0 3.1425945179464065e-10
been O 0 6.826989529251648e-10
done O 0 3.366194789578003e-08
. O 0 1.36125876792903e-07

Because O 0 5.042660177423386e-06
IVF B-Disease 1 1.0
causes O 0 0.00012954964768141508
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 0 0.0009689484722912312
, O 0 1.351275480399039e-10
we O 0 4.364373099030594e-11
investigated O 0 2.185345016059159e-09
whether O 0 1.5399294339690783e-10
malfunction O 0 1.6067350543380599e-06
of O 0 1.1703936708684637e-09
ion O 0 4.3743642663685023e-07
channels O 0 3.747838377421431e-07
could O 0 3.0011909624150235e-10
cause O 0 1.1983247727442858e-09
the O 0 2.1994905896605133e-10
disorder O 0 3.4533895743038556e-09
by O 0 9.70518977683188e-12
studying O 0 2.0260619848500028e-09
mutations O 0 2.102514828905555e-10
in O 0 5.397336397261476e-11
the O 0 1.2817390482311453e-09
cardiac O 0 0.0002932263014372438
sodium O 0 2.5244025891879573e-07
channel O 0 1.946002328168106e-07
gene O 0 4.408470388739261e-08
SCN5A O 0 0.00014880414528306574
. O 0 4.76475747746008e-07

We O 0 5.5958572886538605e-08
have O 0 1.1654166520713716e-10
now O 0 4.572358464072224e-11
identified O 0 2.873846161044469e-10
a O 0 1.6832618632278695e-10
missense O 0 8.988733668502391e-08
mutation O 0 8.273162155347791e-10
, O 0 3.028665165882849e-11
a O 0 3.0486968505272216e-10
splice O 0 5.578161790253944e-07
- O 0 3.6647048062832255e-08
donor O 0 2.4845299151365907e-08
mutation O 0 3.83714171547922e-09
, O 0 8.290722969261921e-11
and O 0 5.999555019453595e-11
a O 0 8.982436461302257e-10
frameshift O 0 7.008595730439993e-07
mutation O 0 4.4781456320919233e-10
in O 0 5.077228221184171e-11
the O 0 3.46406181517267e-10
coding O 0 7.898650437709875e-06
region O 0 6.846895672651954e-08
of O 0 5.8878548259144736e-08
SCN5A O 1 0.9919660091400146
in O 0 1.1947440814452648e-09
three O 0 4.158398514420014e-09
IVF B-Disease 1 1.0
families O 0 1.9371288573211132e-08
. O 0 8.42441210124889e-08

We O 0 5.4243429303824087e-08
show O 0 1.3414126476263277e-09
that O 0 1.0092474599099344e-11
sodium O 0 1.4962191208223174e-10
channels O 0 8.557146657928172e-11
with O 0 5.921333302155718e-13
the O 0 5.651894924296741e-11
missense O 0 6.18307112176808e-08
mutation O 0 1.3700917067538398e-09
recover O 0 2.1798371108161518e-07
from O 0 1.889873812999099e-09
inactivation O 0 2.575189057552052e-07
more O 0 1.8195705359103087e-11
rapidly O 0 2.7480864805973226e-10
than O 0 1.1489241632731129e-12
normal O 0 1.6587307916093863e-10
and O 0 2.4890072641836625e-12
that O 0 1.1108791837799448e-12
the O 0 8.715658056379638e-11
frameshift O 0 2.5077045506805007e-07
mutation O 0 1.1493598295331253e-09
causes O 0 3.011897398152996e-10
the O 0 3.193837139203737e-10
sodium O 0 1.4646854840094647e-09
channel O 0 7.192166862068916e-10
to O 0 5.783090326061391e-11
be O 0 4.965949318425089e-10
non O 0 5.674857561643876e-07
- O 0 8.598311751484289e-07
functional O 0 5.00954365634243e-06
. O 0 2.386748860772059e-07

Our O 0 3.5738088399739354e-07
results O 0 6.276187125564547e-09
indicate O 0 2.5372068890305854e-09
that O 0 4.804417714360243e-12
mutations O 0 2.853036210059834e-11
in O 0 1.7896566173458694e-11
cardiac O 0 4.859586510974623e-07
ion O 0 2.378024873905815e-06
- O 0 5.7594056670495775e-06
channel O 0 7.092631904015434e-08
genes O 0 1.1498262758591338e-10
contribute O 0 7.014590991394343e-11
to O 0 1.4492057727466534e-11
the O 0 4.2912881581536055e-11
risk O 0 6.75199673949578e-10
of O 0 1.0541949535536332e-09
developing O 0 4.7197940489240864e-07
IVF B-Disease 1 1.0
. O 0 3.5478098681096526e-08
. O 0 5.526856483584197e-08

Molecular O 0 7.389394340862054e-06
heterogeneity O 0 5.981481081107631e-06
in O 0 1.0196630029213338e-07
mucopolysaccharidosis B-Disease 1 0.9994627833366394
IVA I-Disease 1 1.0
in O 0 1.0075606837744999e-07
Australia O 0 4.474835169077096e-09
and O 0 1.791792131333736e-10
Northern O 0 1.2801467441647674e-08
Ireland O 0 1.7649334438374353e-08
: O 0 1.1089511253725703e-11
nine O 0 1.290148682331349e-10
novel O 0 7.861361735195249e-12
mutations O 0 6.381840889080337e-11
including O 0 1.7590999837335808e-11
T312S O 0 5.12936026098032e-07
, O 0 5.575393619006164e-11
a O 0 5.542820716297747e-11
common O 0 4.3987399833689267e-10
allele O 0 1.0085600798959149e-08
that O 0 6.432434446201896e-11
confers O 0 1.610531441542662e-08
a O 0 1.2091599721486546e-08
mild O 0 4.882087978330674e-07
phenotype O 0 1.009404059004737e-06
. O 0 6.829118319728877e-07

Mucopolysaccharidosis B-Disease 1 0.9908158779144287
IVA I-Disease 1 1.0
( O 0 2.3849246645113453e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 5.769434707758592e-09
is O 0 2.2248318465312167e-10
an O 0 9.52040779544916e-10
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
caused O 0 4.5233400669530965e-06
by O 0 6.918420836221628e-10
a O 0 1.4325974184714596e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.2653896536439788e-08
N O 0 3.670861303817219e-07
- O 0 7.670660551184483e-08
acetylgalactosamine O 0 3.4136317026423058e-06
- O 0 1.5926798369036987e-07
6 O 0 1.4229698308554362e-07
- O 0 2.9008239721406426e-07
sulfate O 0 1.5433573707923642e-07
sulfatase O 0 2.3861261979618575e-06
( O 0 3.3791167641794573e-09
GALNS O 0 0.0005674251588061452
) O 0 4.3298520324697165e-09
. O 0 5.964603388974865e-08

Previous O 0 9.554852908877365e-08
studies O 0 4.686484089688747e-09
of O 0 9.031345671317581e-10
patients O 0 3.5782721230503967e-10
from O 0 7.23598819751814e-11
a O 0 1.0494739105526563e-10
British O 0 3.3060391757544494e-08
- O 0 9.508202936103771e-08
Irish O 0 1.743883188964901e-07
population O 0 4.368695682988033e-11
showed O 0 5.022538981935831e-11
that O 0 1.5667721568919657e-13
the O 0 2.2823224213319726e-11
I113F O 0 6.61507115751192e-08
mutation O 0 4.585539725709964e-10
is O 0 6.564730963692922e-12
the O 0 3.451838467838364e-11
most O 0 1.0065235103717818e-11
common O 0 7.385154293659824e-11
single O 0 6.691892595611648e-10
mutation O 0 2.709583224458356e-09
among O 0 5.275521353098611e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.8552116418723017e-05
and O 0 1.2137205684936703e-09
produces O 0 5.804775549123065e-10
a O 0 1.2581280461887445e-09
severe O 0 2.9082974606353673e-07
clinical O 0 2.2094129690231057e-06
phenotype O 0 7.250615112752712e-07
. O 0 2.3615986322056415e-07

We O 0 1.0361728897123612e-07
studied O 0 1.2020812789614865e-07
mutations O 0 1.6645821387939463e-09
in O 0 6.951777348218613e-11
the O 0 4.79450812385096e-10
GALNS O 0 0.00021021372231189162
gene O 0 3.178601548636806e-10
from O 0 8.638814663619598e-11
23 O 0 6.667761343059908e-10
additional O 0 5.990413054490773e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.15345823764801e-05
( O 0 3.189289665694872e-10
15 O 0 2.3156232487053785e-09
from O 0 4.676347642451617e-10
Australia O 0 3.963711026067074e-10
, O 0 1.2018829508020357e-11
8 O 0 1.6188790585847102e-10
from O 0 6.522772599826254e-11
Northern O 0 5.5451740976764086e-09
Ireland O 0 1.8775654808678155e-08
) O 0 5.288754503784965e-11
, O 0 1.6281493514513912e-11
with O 0 9.584824253727753e-12
various O 0 2.023914369431168e-09
clinical O 0 5.3738665428682e-07
phenotypes O 0 6.970986419219116e-07
( O 0 2.0539365763738715e-09
severe O 0 4.234138373249152e-07
, O 0 3.0620248003820905e-10
16 O 0 1.1376845021615622e-09
cases O 0 2.621021281956626e-11
; O 0 2.2725213637969643e-12
intermediate O 0 2.051888658982648e-09
, O 0 9.700786181288112e-12
4 O 0 1.4320604424522543e-10
cases O 0 6.948741582135654e-11
; O 0 6.12998610205473e-11
mild O 0 4.318964741401032e-09
, O 0 6.617761894034402e-11
3 O 0 2.5628960065304796e-10
cases O 0 8.532601708521881e-11
) O 0 2.834179557709149e-10
. O 0 1.713659436575199e-08

We O 0 1.1306894975859905e-07
found O 0 1.2449321573626548e-09
two O 0 6.141314540242249e-11
common O 0 6.999021501252756e-11
mutations O 0 1.1988705861387672e-10
that O 0 1.9875574710365163e-12
together O 0 1.1256419407690288e-10
accounted O 0 1.0584629173138183e-08
for O 0 1.8012074470830086e-11
32 O 0 3.068359433200385e-08
% O 0 5.017794624251337e-09
of O 0 2.1746371370312545e-10
the O 0 1.7979302768811323e-10
44 O 0 1.4500366463110481e-09
unrelated O 0 3.055631969672845e-09
alleles O 0 1.9997734024279623e-10
in O 0 9.361654507156203e-11
these O 0 6.247352635213588e-10
patients O 0 6.178614597729393e-08
. O 0 1.8295337156359892e-07

One O 0 1.615694067425011e-08
is O 0 3.3439351287967156e-10
the O 0 8.246600069483634e-10
T312S O 0 7.631602784385905e-06
mutation O 0 4.494243199815173e-09
, O 0 1.8929094403041802e-11
a O 0 1.493392909335256e-11
novel O 0 6.29170188171102e-11
mutation O 0 5.821495507873919e-10
found O 0 6.618367659472213e-11
exclusively O 0 2.6418629506252955e-09
in O 0 6.126166796072141e-10
milder O 0 1.4487883959191095e-07
patients O 0 2.6083685611411056e-07
. O 0 5.257172688288847e-07

The O 0 4.0422083458224733e-08
other O 0 5.026355998083432e-10
is O 0 4.8524746720790546e-11
the O 0 1.1383764070282965e-10
previously O 0 3.741275733659677e-09
described O 0 3.1683435874896304e-09
I113F O 0 1.519973125141405e-06
that O 0 1.7858646852997317e-11
produces O 0 2.0728063709896105e-10
a O 0 6.667355001432895e-10
severe O 0 5.198461963118461e-07
phenotype O 0 2.686392463147058e-06
. O 0 1.0932437817245955e-06

The O 0 2.9285845926096954e-07
I113F O 0 1.862993485701736e-05
and O 0 6.536279517632693e-09
T312S O 0 3.926666522602318e-06
mutations O 0 5.011835835233569e-09
accounted O 0 1.966714968659744e-08
for O 0 3.40555118827357e-11
8 O 0 1.0555973872783397e-09
( O 0 1.187962141852017e-11
18 O 0 1.2543996952274483e-09
% O 0 2.0191399940916455e-10
) O 0 1.2782946359410352e-12
and O 0 9.848365178921625e-12
6 O 0 4.4437287183285434e-10
( O 0 1.3402322654454402e-11
14 O 0 7.111156108408068e-10
% O 0 2.2465281024341976e-10
) O 0 1.7007127043472403e-12
of O 0 1.0070289740982119e-10
44 O 0 9.584285587393993e-10
unrelated O 0 5.068380382056148e-09
alleles O 0 8.622275116110245e-10
, O 0 1.2490660727948466e-09
respectively O 0 6.34302921298513e-07
. O 0 5.890241254746797e-07

The O 0 1.0857590382329363e-07
relatively O 0 1.3980246649225592e-07
high O 0 2.39283348690833e-08
residual O 0 5.871783059774316e-07
GALNS O 0 3.4768509067362174e-05
activity O 0 3.8277923053442464e-09
seen O 0 5.13474818220061e-10
when O 0 3.454618188736269e-11
the O 0 7.826118225695566e-11
T312S O 0 4.7627764843127807e-08
mutant O 0 5.233256605841063e-10
cDNA O 0 2.7111047629091445e-08
is O 0 7.185307904222782e-11
overexpressed O 0 1.899594934684501e-07
in O 0 8.761944642055042e-11
mutant O 0 7.411404268076183e-10
cells O 0 1.0868561606258709e-09
provides O 0 1.8921440803065792e-11
an O 0 5.788800970692176e-13
explanation O 0 3.797297892793594e-11
for O 0 1.0067403508062789e-11
the O 0 3.314142849042412e-10
mild O 0 2.5301367667651675e-09
phenotype O 0 2.71462163858871e-09
in O 0 2.7868500909744576e-11
patients O 0 2.144895233646693e-10
with O 0 1.0828594965150984e-11
this O 0 5.015677317921075e-10
mutation O 0 4.543398901546425e-08
. O 0 9.777185994153115e-08

The O 0 1.193457865866776e-08
distribution O 0 2.8804825191741656e-09
and O 0 3.422592417812176e-11
relative O 0 3.245743895874398e-09
frequencies O 0 3.807418824663955e-09
of O 0 4.2333828109697436e-10
the O 0 3.9775321925006324e-10
I113F O 0 1.0433057013869984e-06
and O 0 5.558640769898204e-10
T312S O 0 8.921290941543703e-07
mutations O 0 1.5221839344548016e-09
in O 0 1.2091748435860694e-10
Australia O 0 1.2911458013853405e-10
corresponded O 0 5.306540762362033e-10
to O 0 4.977478151868553e-11
those O 0 1.2091817824799733e-10
observed O 0 5.590347074146962e-10
in O 0 1.9320348099149953e-10
Northern O 0 4.0752407670652246e-08
Ireland O 0 4.987682800106086e-08
and O 0 1.991072862139731e-10
are O 0 3.291525038640053e-11
unique O 0 2.0767440545021998e-10
to O 0 3.0753035534791806e-11
these O 0 4.5389920988458954e-11
two O 0 5.52658474539669e-11
populations O 0 3.598906936352897e-11
, O 0 2.2854313927456182e-12
suggesting O 0 9.748385432217788e-11
that O 0 8.401220799765519e-13
both O 0 1.9706019802057106e-11
mutations O 0 2.4739635340331745e-10
were O 0 1.047093078909711e-09
probably O 0 5.595829910554073e-10
introduced O 0 1.2795692283518179e-10
to O 0 8.180640886923385e-11
Australia O 0 2.449042912910926e-10
by O 0 1.0958271789984764e-10
Irish O 0 5.286866411324809e-08
migrants O 0 6.181936740290439e-09
during O 0 1.3728154613090737e-08
the O 0 1.2884476818797452e-09
19th O 0 5.8372791045258055e-08
century O 0 6.414445863356377e-08
. O 0 1.6022593740672164e-07

Haplotype O 0 2.398812057435862e-06
analysis O 0 4.2874656713820514e-08
using O 0 1.4539090820164802e-08
6 O 0 3.5474315041028603e-07
RFLPs O 0 1.4858999747957569e-05
provides O 0 2.1745749645418755e-10
additional O 0 9.125450395330859e-11
data O 0 8.471195966919254e-10
that O 0 1.830548733428028e-12
the O 0 1.1868983573748437e-10
I113F O 0 8.729651881367317e-07
mutation O 0 2.5696034189337524e-09
originated O 0 3.4043596830457545e-09
from O 0 5.273345649037253e-10
a O 0 8.382506355708585e-10
common O 0 3.883411281435656e-08
ancestor O 0 4.2195165406155866e-06
. O 0 1.743960979183612e-06

The O 0 1.441555497194713e-07
other O 0 1.4333892961460037e-09
9 O 0 2.970394374912644e-09
novel O 0 4.1581408455337865e-11
mutations O 0 8.711935339800192e-11
identified O 0 9.750132645702791e-11
in O 0 3.911428472780365e-12
these O 0 5.706964848611884e-12
23 O 0 3.051925934194344e-10
patients O 0 5.470643729688085e-11
were O 0 3.551351920871859e-11
each O 0 2.8856305366031787e-12
limited O 0 3.5399634612520714e-11
to O 0 4.856594987279195e-11
a O 0 3.787043456604522e-10
single O 0 1.374434699386029e-08
family O 0 2.7331500618288374e-08
. O 0 3.406778148473677e-07

These O 0 3.3060267412565736e-08
data O 0 3.211965804439387e-08
provide O 0 6.800153218300409e-10
further O 0 1.4600574915757392e-10
evidence O 0 2.8464064438793457e-10
for O 0 3.514613253208232e-11
extensive O 0 1.4369924805635037e-08
allelic O 0 1.536649989475336e-07
heterogeneity O 0 3.6840620509792643e-07
in O 0 3.2001089778077585e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 3.574544393813994e-08
British O 0 2.0567090359691065e-06
- O 0 2.4829278117977083e-05
Irish O 0 1.5458924735867186e-06
patients O 0 1.2471526922297471e-08
and O 0 2.639075243060507e-11
provide O 0 5.148818871258953e-11
evidence O 0 7.938921742223215e-11
for O 0 3.758664820358026e-12
their O 0 2.989865299785066e-11
transmission O 0 5.072822659712983e-07
to O 0 7.566332282937793e-11
Australia O 0 8.44115957687741e-11
by O 0 1.5966398342337484e-11
British O 0 3.1897066321562306e-08
- O 0 3.0259325711767815e-08
Irish O 0 2.664240916772087e-08
migrants O 0 1.209958178094439e-08
. O 0 1.116222447805626e-09
. O 0 1.3536578080675099e-08

Identification O 0 4.642174644686747e-06
of O 0 3.986415606505034e-07
constitutional O 0 2.345320126551087e-06
WT1 O 1 0.9993112087249756
mutations O 0 7.551032865649177e-08
, O 0 4.811995246711831e-11
in O 0 2.9077596233606506e-11
patients O 0 1.3807927023989919e-09
with O 0 5.851854556482294e-10
isolated O 0 0.055047739297151566
diffuse B-Disease 1 0.9999996423721313
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 8.13938527688407e-10
and O 0 2.508032496961743e-11
analysis O 0 7.1837352733084e-10
of O 0 1.1097605057130977e-09
genotype O 0 9.1235632382336e-09
/ O 0 5.446099571315699e-09
phenotype O 0 2.424262457445536e-10
correlations O 0 5.666736871412503e-11
by O 0 2.908457112302254e-12
use O 0 4.247007953650517e-11
of O 0 5.366400102069235e-10
a O 0 5.007743664187103e-10
computerized O 0 4.217293110286846e-07
mutation O 0 4.061381986275592e-08
database O 0 1.762614800782103e-07
. O 0 1.4887885413372715e-07

Constitutional O 0 9.579960078553995e-07
mutations O 0 1.5537594322267978e-08
of O 0 9.983321724860161e-09
the O 0 4.675136722198658e-09
WT1 O 0 5.4796500990050845e-06
gene O 0 1.7462505053078559e-10
, O 0 4.6850023860400825e-12
encoding O 0 6.847402200804709e-09
a O 0 5.478031361860758e-09
zinc O 0 1.0554247182881227e-06
- O 0 3.184386741850176e-06
finger O 0 4.6812783693894744e-07
transcription O 0 6.056371262275206e-07
factor O 0 3.9033780652175665e-09
involved O 0 1.4086610988783832e-08
in O 0 1.2130661808384957e-08
renal O 1 1.0
and O 0 2.813130095091765e-06
gonadal O 1 1.0
development O 0 0.0062403189949691296
, O 0 8.488271197037989e-11
are O 0 3.762911423427218e-12
found O 0 1.8594547776529247e-11
in O 0 5.262137947603662e-12
most O 0 3.1633027360727928e-12
patients O 0 6.304123195688405e-11
with O 0 1.7276813313316097e-10
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.244942154698947e-06
DDS B-Disease 1 1.0
) O 0 7.60550733502896e-09
, O 0 6.051608658630414e-10
or O 0 2.332201987087501e-08
diffuse B-Disease 1 0.999953031539917
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.615188350318931e-07
DMS B-Disease 0 0.0001312726817559451
) O 0 2.9803683826434835e-11
associated O 0 2.9015629898765383e-09
with O 0 7.081135677822203e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.3618643751888158e-07
/ O 0 0.02274565026164055
or O 0 1.2983887245354708e-06
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.778214693069458
( O 0 1.382686178885706e-07
WT B-Disease 1 1.0
) O 0 7.025148907047196e-09
. O 0 1.0589540266892072e-07

Most O 0 4.393914565525847e-08
mutations O 0 1.006744199116838e-07
in O 0 4.1623604118967705e-08
DDS B-Disease 1 1.0
patients O 0 0.00030464291921816766
lie O 0 0.0014253793051466346
in O 0 3.536553805361109e-08
exon O 0 9.652668353510307e-08
8 O 0 9.276221568654819e-09
or O 0 2.4728230574311283e-09
exon O 0 2.600529214191738e-08
9 O 0 3.5767524497742897e-09
, O 0 3.636868584067088e-10
encoding O 0 1.1431380926296697e-06
zinc O 0 3.173046025040094e-06
finger O 0 4.2744490201584995e-05
2 O 0 5.392425350692065e-07
or O 0 1.0321543868485605e-06
zinc O 0 1.1387137419660576e-05
finger O 0 9.447204320167657e-06
3 O 0 3.5513556539967794e-09
, O 0 2.5722484905954524e-11
respectively O 0 7.366193766067397e-10
, O 0 4.096406373832462e-12
with O 0 4.632823638606176e-12
a O 0 3.8670797120055056e-10
hot O 0 8.620754243793272e-08
spot O 0 6.772705063440299e-08
( O 0 6.189342371953899e-10
R394W O 0 1.532514147584152e-06
) O 0 1.698318846665714e-10
in O 0 2.4227380102104235e-09
exon O 0 2.732473092237342e-07
9 O 0 2.348876506630404e-07
. O 0 4.660369086195715e-07

We O 0 3.305282803012233e-08
analyzed O 0 7.676102420361985e-09
a O 0 6.481746389619403e-11
series O 0 2.6662703295210477e-11
of O 0 9.930573030558776e-11
24 O 0 8.797199080312623e-10
patients O 0 5.080951215319374e-10
, O 0 4.925589016518961e-12
10 O 0 9.47399311779229e-11
with O 0 1.2156428641496575e-10
isolated B-Disease 0 0.00022680276015307754
DMS I-Disease 1 0.9999377727508545
( O 0 6.495469051515101e-08
IDMS B-Disease 1 0.9999674558639526
) O 0 3.162805295442439e-10
, O 0 2.9596009670784795e-11
10 O 0 1.7439372168581713e-10
with O 0 1.6785714485045844e-10
DDS B-Disease 1 1.0
, O 0 4.717656265640358e-10
and O 0 7.755682207566394e-11
4 O 0 1.0980328868370748e-09
with O 0 2.6953453358125046e-10
urogenital B-Disease 0 0.006582658272236586
abnormalities I-Disease 1 0.9999983310699463
and O 0 1.421179945282347e-06
/ O 1 0.9997358918190002
or O 0 0.009325915947556496
WT B-Disease 1 1.0
. O 0 3.5536522773327306e-06

We O 0 4.972779379386338e-07
report O 0 2.9117156685742884e-08
WT1 O 0 2.1268389900797047e-05
heterozygous O 0 1.3813465926659774e-08
mutations O 0 9.276340806607664e-10
in O 0 1.0910491954341239e-10
16 O 0 4.495546157556873e-09
patients O 0 3.581230423321813e-09
, O 0 3.853691671329429e-11
4 O 0 9.220932906117696e-10
of O 0 1.0730533128722186e-09
whom O 0 7.709423321955455e-09
presented O 0 5.024405425047007e-08
with O 0 6.173843303258764e-08
IDMS B-Disease 1 0.9999983310699463
. O 0 8.43718953547068e-06

One O 0 2.929502507242887e-08
male O 0 1.6359777532670705e-08
and O 0 1.3157577805067433e-10
two O 0 7.722061323711671e-10
female O 0 2.8562749321281444e-06
IDMS B-Disease 1 1.0
patients O 0 2.3615940847321326e-07
with O 0 2.996760883888783e-08
WT1 O 1 0.9999998807907104
mutations O 0 1.8346721617490402e-06
underwent O 0 3.1738138204673305e-05
normal O 0 9.523810149403289e-05
puberty O 0 0.00012279197108000517
. O 0 2.785569108709751e-07

Two O 0 2.9418661284807968e-08
mutations O 0 1.2347853406424747e-08
associated O 0 1.987948117232463e-08
with O 0 1.4961314409589477e-09
IDMS B-Disease 1 0.9999982118606567
are O 0 3.098454479100177e-11
different O 0 1.2529158266438856e-11
from O 0 2.7051602277672337e-11
those O 0 2.2354137638180838e-11
described O 0 1.6166488148172675e-09
in O 0 8.889720959359693e-09
DDS B-Disease 1 1.0
patients O 0 4.598236046149395e-06
. O 0 6.64473702727264e-07

No O 0 1.9023973436560482e-06
WT1 O 0 0.00037840945878997445
mutations O 0 5.6814862148257816e-08
were O 0 3.282663030290678e-09
detected O 0 5.030060368227396e-09
in O 0 1.992606774026129e-11
the O 0 1.1620362311282051e-10
six O 0 1.4528022118653894e-09
other O 0 1.2208717370398858e-09
IDMS B-Disease 1 0.9999997615814209
patients O 0 5.85087782667415e-08
, O 0 2.834476819923992e-10
suggesting O 0 1.1883153128167123e-08
genetic O 0 1.954926531766432e-08
heterogeneity O 0 2.8313411348790396e-07
of O 0 6.432848209669828e-08
this O 0 2.0012482337961046e-08
disease O 0 0.0003647503035608679
. O 0 7.744746426396887e-07

We O 0 1.2712295927030937e-07
analyzed O 0 2.2573935609671025e-07
genotype O 0 2.7799484314527945e-07
/ O 0 7.889075703815251e-08
phenotype O 0 3.4918317126653164e-09
correlations O 0 6.592496326618402e-09
, O 0 1.480234511352929e-11
on O 0 5.0200298779001784e-11
the O 0 1.2945579504208826e-11
basis O 0 8.674896911919916e-10
of O 0 1.0330929167690073e-10
the O 0 1.8324709805117578e-11
constitution O 0 6.433657859933328e-12
of O 0 1.790797926615184e-10
a O 0 6.897102888814288e-10
WT1 O 0 8.662057553010527e-06
mutation O 0 2.716558755722076e-09
database O 0 1.0756003865353136e-09
of O 0 1.4325912678359032e-09
84 O 0 8.909755422337184e-08
germ O 0 0.389020174741745
- O 0 2.7587628210312687e-05
line O 0 3.4639734280972334e-07
mutations O 0 5.460161656145601e-09
, O 0 2.090625242368027e-11
to O 0 2.1610407907601825e-11
compare O 0 3.1203295502990613e-09
the O 0 4.884138579686059e-11
distribution O 0 2.3799862081119727e-10
and O 0 4.301308007687021e-12
type O 0 1.3819466682107873e-09
of O 0 1.3039139767911934e-09
mutations O 0 5.153380500111382e-10
, O 0 2.1735152740121055e-12
according O 0 3.571806392321797e-11
to O 0 1.7989209080693236e-11
the O 0 1.3362384809756378e-10
different O 0 1.184134124088132e-08
symptoms O 0 4.149312189838383e-06
. O 0 1.4488713873106462e-07

This O 0 2.7506118271958258e-08
demonstrated O 0 2.6415173692839744e-07
( O 0 2.0577116399689288e-10
1 O 0 9.086152386039714e-10
) O 0 1.8790637448806713e-11
the O 0 5.87935117257743e-11
association O 0 9.155437519225984e-11
between O 0 2.1154242801912915e-09
mutations O 0 6.900405802312548e-10
in O 0 2.6162977340149496e-10
exons O 0 1.5773006012409496e-08
8 O 0 3.889359667663683e-10
and O 0 2.6607986647331217e-11
9 O 0 2.0094439445728085e-09
and O 0 3.2531377591737964e-09
DMS B-Disease 0 0.0004044259840156883
; O 0 3.8997743923019357e-10
( O 0 1.706628588449277e-10
2 O 0 1.4861032404667185e-09
) O 0 2.2178186370735986e-11
among O 0 4.664292910239176e-11
patients O 0 1.1219123546846177e-10
with O 0 6.456871148863286e-11
DMS B-Disease 0 1.420766693627229e-05
, O 0 1.089481144189719e-10
a O 0 5.232505054242331e-11
higher O 0 1.077863576171012e-09
frequency O 0 2.6162640942573034e-09
of O 0 3.544399218569083e-09
exon O 0 9.827026303810271e-09
8 O 0 1.0833666186371715e-09
mutations O 0 5.029424654523496e-10
among O 0 2.917342409314294e-11
46 O 0 4.311483170482688e-09
, O 0 3.440632778684005e-10
XY O 0 0.0011672598775476217
patients O 0 8.820709496148993e-09
with O 0 2.5691757055135156e-10
female O 0 3.4020047223748406e-08
phenotype O 0 3.943533499750629e-09
than O 0 1.840197612346106e-11
among O 0 3.142041488102265e-11
46 O 0 3.072381016266945e-09
, O 0 1.0872806821549119e-10
XY O 1 0.7378522157669067
patients O 0 1.611345545882159e-08
with O 0 7.4686166973148e-11
sexual O 0 1.2148368977449309e-09
ambiguity O 0 1.5049932855504267e-08
or O 0 1.32767763449948e-09
male O 0 4.601349701260915e-08
phenotype O 0 1.1083395534683405e-08
; O 0 5.910303496614588e-11
and O 0 3.1102878050859317e-09
( O 0 1.635954288703445e-10
3 O 0 9.274289114458156e-10
) O 0 1.2400632604103734e-11
statistically O 0 1.4651200391790908e-11
significant O 0 1.4034286970401877e-12
evidence O 0 1.7696467555228246e-11
that O 0 1.959977969853699e-12
mutations O 0 1.5973077027719995e-10
in O 0 3.4869115927982364e-10
exons O 0 1.260224564703094e-07
8 O 0 4.720313917516705e-09
and O 0 4.170072065434738e-10
9 O 0 9.354167218589282e-09
preferentially O 0 1.1250292253350835e-08
affect O 0 2.3141099703138934e-08
amino O 0 3.4434051165987967e-09
acids O 0 2.2705047564297587e-10
with O 0 4.7568021570298935e-12
different O 0 1.6598035446069304e-10
functions O 0 8.575340437744217e-09
. O 0 3.3805800381259132e-09
. O 0 2.4135703213801207e-08

The O 0 3.760645199690771e-07
185delAG O 0 6.136269348644419e-06
BRCA1 O 0 2.0719139115499274e-07
mutation O 0 2.699203638378833e-10
originated O 0 2.029011680892978e-10
before O 0 1.0941542810671834e-10
the O 0 4.064398123615476e-11
dispersion O 0 5.2480224610462756e-09
of O 0 4.49170656224851e-09
Jews O 0 1.1570324254250863e-08
in O 0 2.214167876823936e-10
the O 0 3.2419922302295845e-10
diaspora O 0 1.0359491042777336e-08
and O 0 1.1456165877055113e-10
is O 0 5.053153034895175e-11
not O 0 1.3379215790809695e-10
limited O 0 4.0176630911048505e-09
to O 0 3.167722795183181e-08
Ashkenazim O 0 0.0022792057134211063
. O 0 2.8609479159058537e-06

The O 0 1.207937430081074e-07
185delAG O 0 5.573101134359604e-06
mutation O 0 1.5803783171008945e-08
in O 0 1.7866740309457896e-09
BRCA1 O 0 4.27412452097542e-08
is O 0 8.315793886826128e-11
detected O 0 5.8863474095005586e-09
in O 0 1.6709975070305916e-10
Ashkenazi O 0 2.928810545199667e-07
Jews O 0 8.92293172682912e-09
both O 0 1.033672925032647e-09
in O 0 3.730103781407479e-09
familial B-Disease 1 0.9994078874588013
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.03400319069623947
in O 0 3.663018555144504e-09
the O 0 7.341788288428575e-10
general O 0 7.637280252659195e-10
population O 0 1.030705520932429e-10
. O 0 1.5944837672421386e-09

All O 0 3.5212480042901007e-08
tested O 0 3.687541294539187e-08
Ashkenazi O 0 2.3286601447125577e-07
mutation O 0 3.774603685169353e-10
carriers O 0 6.732113477792012e-11
share O 0 1.526911375115958e-10
the O 0 3.739032000682485e-11
same O 0 2.011367877807757e-10
allelic O 0 4.673730558124589e-08
pattern O 0 7.899856058202204e-08
at O 0 3.585497054814368e-08
the O 0 4.6165666844899533e-08
BRCA1 O 0 6.043747475814598e-07
locus O 0 6.32920347243271e-08
. O 0 9.506516107649077e-08

Our O 0 4.047679169616458e-07
previous O 0 2.975879453970265e-08
study O 0 5.517908352459244e-10
showed O 0 1.836390761678075e-10
that O 0 2.639631406248927e-13
this O 0 3.7299343301488985e-12
Ashkenazi O 0 1.7083326042666158e-07
mutation O 0 1.860353981975038e-09
also O 0 2.00398777433497e-11
occurs O 0 1.3616424654472326e-10
in O 0 2.741138739603688e-11
Iraqi O 0 3.085222260779119e-06
Jews O 0 9.583375870647615e-09
with O 0 4.2264906852107487e-11
a O 0 1.1606252070528456e-10
similar O 0 3.3753722039620015e-10
allelic O 0 3.6680268067357247e-07
pattern O 0 9.180856181956187e-07
. O 0 5.064522383690928e-07

We O 0 3.669208581413841e-08
extended O 0 9.390903166206499e-09
our O 0 1.884539191365775e-09
analysis O 0 2.8102042914923686e-10
to O 0 3.388310118590532e-11
other O 0 8.534457168751786e-11
non O 0 1.8364596598985372e-07
- O 0 4.138982134804792e-08
Ashkenazi O 0 1.995245781927224e-07
subsets O 0 8.505896431643123e-09
354 O 0 2.691442180235981e-09
of O 0 6.071690927811346e-10
Moroccan O 0 4.3788887182927283e-07
origin O 0 4.610985371300558e-09
, O 0 4.1962964353325916e-11
200 O 0 4.5561338035682297e-10
Yemenites O 0 6.880329692648957e-07
and O 0 8.678931184835648e-11
150 O 0 1.3837191392696013e-09
Iranian O 0 2.91502857407977e-07
Jews O 0 3.892997142429522e-07
. O 0 6.048314276085875e-07

Heteroduplex O 0 4.3965530494460836e-05
analysis O 0 2.5294385253005203e-08
complemented O 0 4.038361200997542e-09
by O 0 1.3404241258618832e-11
direct O 0 8.866089806769395e-11
DNA O 0 1.231588786509974e-08
sequencing O 0 6.232374261117002e-08
of O 0 8.844260435125761e-09
abnormally O 0 8.881738011723428e-09
migrating O 0 7.912818178468228e-10
bands O 0 1.0731378452533136e-08
were O 0 1.4158207939374279e-08
employed O 0 1.5760248288643197e-06
. O 0 3.4267787896169466e-07

Four O 0 2.2874553806673248e-08
of O 0 3.328037223582214e-08
Moroccan O 0 0.21018490195274353
origin O 0 1.749513529603064e-07
( O 0 1.701499635631265e-10
1 O 0 9.918842414080586e-10
. O 0 3.651902044654598e-11
1 O 0 2.554609024318921e-10
% O 0 7.797421042177177e-11
) O 0 3.536639568441774e-13
and O 0 2.326816690711997e-12
none O 0 2.286580647048453e-10
of O 0 5.793271973253411e-10
the O 0 9.270097467428684e-10
Yemenites O 0 4.14975147577934e-06
or O 0 5.116837509255845e-10
Iranians O 0 7.857419603851667e-08
was O 0 9.118739652258512e-10
a O 0 4.298169112293415e-11
carrier O 0 3.14500536724438e-10
of O 0 1.176678976477774e-09
the O 0 8.034120035915748e-09
185delAG O 0 8.779873496678192e-06
mutation O 0 3.4133802273572655e-07
. O 0 2.86876513655443e-07

BRCA1 O 0 9.262465027859434e-06
allelic O 0 6.504916427729768e-07
patterns O 0 2.1383046444611864e-08
were O 0 6.863665191758628e-10
determined O 0 6.037519928447921e-10
for O 0 8.36255283770404e-12
four O 0 1.3401837799242866e-11
of O 0 2.7639446287253122e-11
these O 0 6.373116010621738e-12
individuals O 0 1.0990900030372064e-11
and O 0 8.249863465981111e-12
for O 0 1.5896145511007376e-11
12 O 0 4.3048742348616997e-10
additional O 0 2.683147592996704e-10
non O 0 2.102521001745572e-08
- O 0 9.67760627190728e-09
Ashkenazi O 0 1.0531307736982853e-07
185delAG O 0 6.160739474125876e-08
mutation O 0 5.261961977254259e-10
carriers O 0 1.6213387576957672e-10
who O 0 3.730558972847575e-09
had O 0 0.0001237411197507754
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9998340606689453

Six O 0 5.840726089445525e-07
non O 0 9.164793482341338e-06
- O 0 6.392216960193764e-07
Ashkenazi O 0 2.273446625622455e-06
individuals O 0 1.8146473212965475e-09
shared O 0 2.481887051430931e-08
the O 0 6.086126047577523e-10
common O 0 1.7636437865675703e-09
Ashkenazi O 0 1.099084215638868e-06
haplotype O 0 2.7332593077744605e-08
, O 0 9.385915655801824e-11
four O 0 1.8627746567467796e-10
had O 0 5.52520695862313e-10
a O 0 9.087672281360426e-11
closely O 0 1.0003101680311488e-09
related O 0 2.9533349987787005e-08
pattern O 0 0.006550251971930265
, O 0 3.3500316409806885e-10
and O 0 1.650758141291675e-10
the O 0 1.524445281120279e-08
rest O 0 1.2145802429586183e-05
( O 0 2.2782351005723456e-10
n O 0 2.3749537891859518e-09
= O 0 7.526049783379563e-10
6 O 0 8.874435630801258e-10
) O 0 3.677931657147804e-12
displayed O 0 1.6270884639624228e-10
a O 0 2.5198917952273803e-10
distinct O 0 4.65561367235523e-09
BRCA1 O 0 9.510506515653105e-08
allelic O 0 4.147019581068889e-07
pattern O 0 1.330043915004353e-06
. O 0 1.450009222025983e-06

We O 0 5.42103286704787e-08
conclude O 0 2.8490339332165604e-07
that O 0 1.0331303867960884e-10
the O 0 9.160927016971243e-10
185delAG O 0 5.499625785887474e-07
BRCA1 O 0 2.3652771119486715e-07
mutation O 0 5.628478239039225e-10
occurs O 0 2.6568394706494303e-10
in O 0 3.367043796553837e-11
some O 0 6.366789734313372e-11
non O 0 1.0511596428841585e-06
- O 0 2.9695802368223667e-06
Ashkenazi O 0 7.745400216663256e-05
populations O 0 7.657529721427636e-09
at O 0 1.0465179833829552e-09
rates O 0 6.322380396994731e-10
comparable O 0 1.1221912288306157e-09
with O 0 7.458819152594831e-12
that O 0 5.4682650768578256e-11
of O 0 4.1745249035329834e-08
Ashkenazim O 0 0.00045953429071232677
. O 0 2.74217086371209e-06

The O 0 4.8543800090783407e-08
majority O 0 1.9704951004229088e-09
of O 0 2.7600437491059893e-09
Jewish O 0 1.6773567423911118e-08
185delAG O 0 2.557528091529093e-07
mutation O 0 1.1447871539616017e-09
carriers O 0 5.576457351441633e-11
have O 0 5.685810763184085e-12
a O 0 2.6242426634515148e-11
common O 0 3.2829183815863416e-10
allelic O 0 1.6529659774278116e-07
pattern O 0 4.576431535951997e-07
, O 0 4.2893755214379325e-10
supporting O 0 5.792115231884054e-09
the O 0 4.5486512334491636e-09
founder O 0 9.309707138527301e-08
effect O 0 1.2607319632707004e-09
notion O 0 1.8068212481736623e-09
, O 0 1.071724826939846e-11
but O 0 4.623325160213465e-12
dating O 0 9.765250830184868e-10
the O 0 2.161881784701336e-11
mutations O 0 2.7667717075741116e-11
origin O 0 1.1886200357302812e-10
to O 0 4.527665048437157e-11
an O 0 1.0757347269907402e-11
earlier O 0 3.7995309676297495e-10
date O 0 2.206632032653033e-08
than O 0 1.1664530452648592e-10
currently O 0 1.3613056237815613e-09
estimated O 0 7.508819344081985e-09
. O 0 1.1731012961035958e-07

However O 0 1.0290764862475044e-07
, O 0 1.9550028262926844e-10
the O 0 6.04960942451882e-11
different O 0 1.8268464518911287e-10
allelic O 0 1.187015499226618e-07
pattern O 0 1.450870712460528e-07
at O 0 1.622964695968676e-08
the O 0 7.870705864831962e-09
BRCA1 O 0 1.1730498528095268e-07
locus O 0 4.131825992459426e-09
even O 0 5.237327585505547e-11
in O 0 1.6642057523719167e-11
some O 0 6.767475035224235e-12
Jewish O 0 9.538183576296433e-10
mutation O 0 1.953665673681826e-09
carriers O 0 4.0633227338382483e-10
, O 0 1.5779128004211884e-10
might O 0 1.0472788192217308e-09
suggest O 0 5.569776639902102e-09
that O 0 5.870263303231482e-11
the O 0 1.4408174653368633e-09
mutation O 0 8.083692826232891e-09
arose O 0 3.595070552364632e-08
independently O 0 9.049061588939367e-08
. O 0 6.792962192747609e-09
. O 0 1.3252599728730274e-07

Crystal O 0 1.7198412024299614e-05
structure O 0 5.473111286846688e-06
of O 0 1.1955003174080048e-05
the O 0 3.729040327016264e-05
hemochromatosis B-Disease 1 1.0
protein O 0 1.4638311540693394e-06
HFE O 0 0.00010101553925778717
and O 0 1.5864894120642958e-10
characterization O 0 3.9185956701714986e-09
of O 0 1.061500998211784e-09
its O 0 3.330502540421776e-11
interaction O 0 6.455178613862245e-09
with O 0 1.1679630596006518e-09
transferrin O 0 1.283390474782209e-06
receptor O 0 3.807042858738896e-08
. O 0 1.1046424219784967e-07

HFE O 0 0.0028238450177013874
is O 0 8.60903437427396e-09
an O 0 8.846904875348116e-10
MHC O 0 2.3986904125194997e-05
- O 0 4.807296591025079e-06
related O 0 1.1144721611344721e-05
protein O 0 7.207004415477059e-08
that O 0 5.768369722852773e-12
is O 0 1.1183327484551309e-12
mutated O 0 2.2171545849269947e-11
in O 0 1.8244985383608636e-11
the O 0 5.114527468208507e-09
iron B-Disease 1 0.9998470544815063
- I-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9915701150894165

HFE O 0 0.00014932577323634177
binds O 0 2.244928332117979e-08
to O 0 1.5027989519467155e-08
transferrin O 0 2.6696486088439997e-07
receptor O 0 2.269449517200428e-09
( O 0 1.6867006402687679e-10
TfR O 0 7.058722530928208e-07
) O 0 1.8454206912599247e-11
and O 0 3.581609314684542e-11
reduces O 0 3.0152139118833077e-10
its O 0 1.4661683325756236e-11
affinity O 0 2.375953878086534e-10
for O 0 5.901869548630145e-10
iron O 0 2.824781972776691e-07
- O 0 6.777667493906847e-08
loaded O 0 1.7984707056939442e-08
transferrin O 0 6.599280482078029e-07
, O 0 9.821030211298876e-09
implicating O 0 7.546039705630392e-05
HFE O 0 0.05274353176355362
in O 0 4.093993766218773e-07
iron O 0 0.0008734313887543976
metabolism O 0 0.0035250845830887556
. O 0 2.1571088382188464e-06

The O 0 2.003023837460205e-06
2 O 0 3.668989165817038e-06
. O 0 1.08721337710449e-06

6 O 0 5.379130470828386e-06
A O 0 3.5338512134330813e-06
crystal O 0 8.82700624060817e-06
structure O 0 3.5359987577976426e-06
of O 0 4.57098849437898e-06
HFE O 1 0.999972939491272
reveals O 0 3.853499208616995e-08
the O 0 1.6267844016315536e-10
locations O 0 1.4848197116279493e-09
of O 0 2.7853610973238574e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 9.137654899404879e-08
and O 0 1.8298393911209132e-09
a O 0 8.898728864892291e-09
patch O 1 0.9970901012420654
of O 0 0.1854834258556366
histidines O 1 0.999948263168335
that O 0 9.077451290639971e-11
could O 0 1.1022711216002179e-10
be O 0 4.837144226832457e-11
involved O 0 7.708996996314e-09
in O 0 5.539489578154644e-08
pH O 0 0.09610208868980408
- O 0 4.055285899084993e-06
dependent O 0 3.3619651276239892e-06
interactions O 0 7.646017365914304e-07
. O 0 4.312637145176268e-07

We O 0 1.382699394980591e-07
also O 0 1.460757292903736e-09
demonstrate O 0 1.1332426197441237e-07
that O 0 4.420660726367487e-09
soluble O 0 6.842469133516715e-07
TfR O 0 2.378405952185858e-06
and O 0 3.3083971118230693e-09
HFE O 0 8.861461537890136e-06
bind O 0 8.899034398268668e-09
tightly O 0 1.5003307396455057e-07
at O 0 2.5931228275766216e-09
the O 0 3.266728276773989e-10
basic O 0 1.8187549244430556e-07
pH O 0 6.473836577924885e-08
of O 0 5.604845476625542e-10
the O 0 9.061156686085425e-11
cell O 0 4.464315139784958e-09
surface O 0 5.776471301288666e-09
, O 0 5.1572811993194634e-11
but O 0 1.5994256266638196e-11
not O 0 3.4129702536356277e-11
at O 0 4.9301647209176735e-09
the O 0 4.270237496939444e-08
acidic O 0 1.1290530892438255e-05
pH O 0 2.2673844796372578e-05
of O 0 2.948294877569424e-06
intracellular O 0 4.9586178647587076e-05
vesicles O 0 8.670610986882821e-05
. O 0 3.7474023883987684e-06

TfR O 0 0.0019471787381917238
HFE O 0 0.0024450563360005617
stoichiometry O 0 7.84653821028769e-06
( O 0 3.0599069944514667e-09
2 O 0 3.971356132836945e-09
1 O 0 1.1013889800182142e-09
) O 0 1.5224526500601243e-11
differs O 0 6.590305523523909e-10
from O 0 3.844751461645757e-10
TfR O 0 5.891775458621851e-07
transferrin O 0 8.153314468017925e-08
stoichiometry O 0 1.9642826032395533e-07
( O 0 3.223654676531851e-10
2 O 0 5.549932180493045e-10
2 O 0 2.9070568174915934e-10
) O 0 1.170564426639098e-11
, O 0 4.754063028661326e-12
implying O 0 1.2138727523147708e-10
a O 0 3.874237302498029e-12
different O 0 1.4803784934014352e-11
mode O 0 1.000266802719807e-08
of O 0 6.768385296673785e-10
binding O 0 6.150953635319922e-10
for O 0 1.3733437720375719e-09
HFE O 0 0.00013283912267070264
and O 0 1.2727526588207638e-08
transferrin O 0 3.0181172405718826e-07
to O 0 6.104905914128267e-09
TfR O 0 4.10307984566316e-06
, O 0 5.0927855682614265e-11
consistent O 0 1.0196096189574178e-09
with O 0 1.2558706678766907e-11
our O 0 7.091732756592251e-10
demonstration O 0 3.873814158339428e-09
that O 0 8.007645241336903e-11
HFE O 0 5.0058570195687935e-06
, O 0 5.712416095704498e-10
transferrin O 0 9.886061747010899e-08
, O 0 3.725963149125988e-10
and O 0 1.0642702275021065e-09
TfR O 0 6.91278819431318e-06
form O 0 8.415335095435239e-09
a O 0 1.2517449299309646e-08
ternary O 0 1.9183997210348025e-05
complex O 0 1.4028278201294597e-05
. O 0 2.239434252260253e-06

Identification O 0 2.1192595340835396e-06
of O 0 3.579402019227018e-08
three O 0 2.3498594736715006e-10
novel O 0 2.0454157464988576e-11
mutations O 0 5.108097972383874e-11
and O 0 6.2238443565565404e-12
a O 0 2.043099717186081e-11
high O 0 1.2360919232623502e-10
frequency O 0 2.2880213279563577e-09
of O 0 2.966769052648033e-10
the O 0 7.003992941179149e-10
Arg778Leu O 0 1.169238430520636e-06
mutation O 0 5.474278252926013e-10
in O 0 5.247576678746313e-11
Korean O 0 1.236494568956914e-07
patients O 0 5.605500508210071e-09
with O 0 6.870763957778081e-10
Wilson B-Disease 0 1.582012919243425e-05
disease I-Disease 0 3.0166233045747504e-05
. O 0 2.596089245798794e-07

Four O 0 2.921161978974851e-07
mutations O 0 1.192798322335875e-07
- O 0 6.6528025399748e-07
- O 0 5.482726805894345e-07
R778L O 0 1.3225876500655431e-05
, O 0 6.286235421093522e-10
A874V O 0 6.307012085926544e-07
, O 0 4.4555317768590896e-11
L1083F O 0 4.452607527127839e-08
, O 0 5.176901008568935e-12
and O 0 1.288729106069253e-11
2304delC O 0 1.1456287474231885e-08
- O 0 8.789605487891095e-09
- O 0 4.835618128140595e-09
in O 0 6.844239064385249e-10
the O 0 8.084571234689975e-09
copper O 0 3.625874001045304e-07
- O 0 2.821887834514314e-09
transporting O 0 5.9918185968399484e-09
enzyme O 0 4.536501729823783e-10
, O 0 3.042156526689155e-10
P O 0 7.91360162111232e-06
- O 0 1.6478443853884528e-07
type O 0 1.246168750412835e-07
ATPase O 0 1.160013835033169e-05
( O 0 1.8676102886416857e-09
ATP7B O 1 0.9936787486076355
) O 0 2.873801023539624e-11
, O 0 3.6917847251460856e-12
were O 0 1.7076012479022573e-11
identified O 0 1.2072851052202793e-10
in O 0 1.8148255467864693e-11
Korean O 0 1.599712646793705e-07
Patients O 0 2.1603433708605735e-08
with O 0 1.4581601481822304e-09
Wilson B-Disease 0 0.0003906603087671101
disease I-Disease 0 0.04581911861896515
. O 0 2.0833772396144923e-06

Arg778Leu O 1 0.9409149885177612
, O 0 1.1701421165355441e-08
the O 0 1.0397592786759446e-09
most O 0 9.937469597209869e-11
frequently O 0 2.2535534549561476e-10
reported O 0 1.3737544435343807e-10
mutation O 0 3.0333263678627986e-10
of O 0 4.41651215599137e-10
this O 0 1.2333147524079546e-11
enzyme O 0 5.941159370026483e-11
, O 0 4.48912400308199e-11
was O 0 1.6261152424590364e-09
found O 0 3.6162746408496815e-11
in O 0 6.660585711443234e-12
six O 0 5.280791082196146e-11
of O 0 4.919723309293467e-11
eight O 0 2.2804350074956403e-10
unrelated O 0 3.5148783883443002e-09
patients O 0 4.5758941080720206e-10
studied O 0 1.9298296294323336e-09
, O 0 5.632252910586777e-12
an O 0 4.887152965302177e-13
allele O 0 2.586443281771267e-10
frequency O 0 1.577571495658958e-08
of O 0 2.2026497958904656e-08
37 O 0 8.959983119893877e-07
. O 0 3.615728587647027e-07

5 O 0 4.291286472835054e-07
% O 0 1.3033967150022363e-07
, O 0 7.437456900349915e-11
which O 0 1.7995238545814862e-12
is O 0 5.542500920024951e-12
considerably O 0 2.8182731703907393e-09
higher O 0 1.7625878534488493e-09
than O 0 1.1700087079735688e-11
those O 0 2.729082411445649e-11
in O 0 9.83159109679832e-11
other O 0 5.933892266440921e-10
Asian O 0 5.1381235266489966e-08
populations O 0 7.063993834321991e-09
. O 0 3.167994577779609e-08

The O 0 1.463834475856629e-08
novel O 0 4.0359102171372285e-10
single O 0 1.0995334642771581e-09
nucleotide O 0 2.047202585231389e-08
deletion O 0 3.1081646145736386e-09
, O 0 6.523768331101465e-11
2304delC O 0 6.428812326930711e-08
, O 0 1.2334165633287597e-10
was O 0 2.7439923666605637e-09
found O 0 1.73299166683627e-10
in O 0 2.1486132317782847e-10
one O 0 1.1248890707804549e-09
patient O 0 2.694441263884073e-06
. O 0 1.1134926580780302e-06

Since O 0 4.818973664555415e-08
a O 0 1.8143531121950218e-09
mutation O 0 1.607538213654891e-09
at O 0 2.600106130401514e-09
cDNA O 0 3.735146094641095e-07
nucleotide O 0 3.2053446830104804e-07
2302 O 0 3.892379936587531e-06
( O 0 2.467737680866833e-10
2302insC O 0 7.816313285502474e-08
) O 0 5.49993765808221e-11
had O 0 1.9235740778000832e-10
been O 0 1.0204690564785679e-10
previously O 0 2.073669458368954e-09
described O 0 5.587426077369173e-10
, O 0 5.401277949207417e-12
this O 0 2.3827634743761594e-12
region O 0 1.6312720063638153e-09
of O 0 2.710394797489357e-09
the O 0 1.4833656081236768e-08
ATP7B O 1 0.9999997615814209
gene O 0 9.78313341448711e-09
may O 0 6.665497598312697e-10
be O 0 7.280958058686338e-10
susceptible O 0 2.9447747351696307e-07
to O 0 8.680793861515212e-09
gene O 0 1.2396179727147683e-06
rearrangements O 1 0.9989379048347473
causing O 0 0.0008016328210942447
Wilson B-Disease 0 0.025049731135368347
disease I-Disease 0 0.0039468929171562195
. O 0 8.783959515312745e-07

Disruption O 0 1.3191373000154272e-05
of O 0 1.0338868605686002e-07
splicing O 0 2.1614897605104488e-07
regulated O 0 5.892424326248147e-09
by O 0 2.886055977535662e-11
a O 0 1.227772217227141e-09
CUG O 0 0.00018618760805111378
- O 0 9.382474530639229e-08
binding O 0 1.7456860845754818e-08
protein O 0 4.616871080997953e-07
in O 0 1.4335108744489844e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00011153018567711115

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9580704569816589
DM B-Disease 1 1.0
) O 0 1.0690029306203996e-08
is O 0 1.7437443156076426e-10
caused O 0 1.172713259833813e-09
by O 0 9.856375438044296e-11
a O 0 1.1753936712821655e-09
CTG O 0 2.642943627506611e-06
expansion O 0 6.2658886967881244e-09
in O 0 1.180945896628316e-10
the O 0 2.926187903096178e-10
3 O 0 1.1173669989261725e-08
untranslated O 0 5.412162499851547e-05
region O 0 1.740001742689401e-08
of O 0 1.3974055690368914e-08
the O 0 2.876619475955522e-07
DM B-Disease 1 1.0
gene O 0 6.452675620494119e-07
. O 0 9.498901363258483e-07

One O 0 1.771672231143384e-08
model O 0 6.790904905074058e-08
of O 0 2.6333279947721167e-06
DM B-Disease 1 1.0
pathogenesis O 1 0.7432129383087158
suggests O 0 1.2520744441246734e-08
that O 0 2.436155097096382e-11
RNAs O 0 2.2755786144301737e-09
from O 0 1.9765469816412917e-10
the O 0 5.41579524282465e-11
expanded O 0 1.7829081266906854e-10
allele O 0 1.0581126252962036e-10
create O 0 3.819437821572791e-11
a O 0 1.2088957612732543e-10
gain O 0 1.1031050739518378e-08
- O 0 6.09014705332811e-09
of O 0 1.212298261776823e-08
- O 0 7.611660635120643e-09
function O 0 1.2409636651611322e-09
mutation O 0 5.417665274731753e-11
by O 0 4.597524617955262e-12
the O 0 1.1003926068953174e-11
inappropriate O 0 7.137201246676383e-11
binding O 0 2.2376746289243243e-11
of O 0 9.186507665681631e-10
proteins O 0 1.16816292750066e-10
to O 0 2.742264193500432e-10
the O 0 1.7443280597717603e-08
CUG O 1 0.9982154369354248
repeats O 0 4.202240234008059e-06
. O 0 5.951148409621965e-07

Data O 0 3.4963261441589566e-07
presented O 0 9.798913680469923e-09
here O 0 4.084966143125257e-09
indicate O 0 3.4934906079087114e-09
that O 0 1.6592709844998055e-11
the O 0 3.0577232412731803e-10
conserved O 0 1.606426280886808e-08
heterogeneous O 0 1.1144875600166415e-07
nuclear O 0 3.5109277973788267e-07
ribonucleoprotein O 0 3.566713360214635e-07
, O 0 8.898826675540761e-10
CUG O 0 5.101387796457857e-05
- O 0 3.483013344407482e-08
binding O 0 2.387229525169232e-09
protein O 0 5.421960658225089e-09
( O 0 2.511034713492677e-10
CUG O 1 0.9787798523902893
- O 0 3.5501630009093788e-06
BP O 0 9.992886589316186e-07
) O 0 1.9265666839629603e-10
, O 0 1.1834080937411784e-10
may O 0 6.118868189908255e-10
mediate O 0 5.933150077908067e-07
the O 0 7.478006835981432e-08
trans O 0 5.276480123939109e-07
- O 0 5.432350462797331e-07
dominant O 0 4.0666148493073706e-07
effect O 0 7.808453328372877e-10
of O 0 3.0371372083948245e-09
the O 0 5.3722302162384494e-09
RNA O 0 8.438272516286816e-07
. O 0 2.2840814040137047e-07

CUG O 1 0.9994356036186218
- O 0 0.0007011102861724794
BP O 0 4.615762463799911e-06
was O 0 1.513874892111744e-08
found O 0 9.355210356387644e-11
to O 0 1.4030065303982653e-11
bind O 0 1.3953027622193304e-10
to O 0 3.882392740628404e-10
the O 0 1.9823584995748433e-09
human O 0 1.0071207157125173e-07
cardiac O 1 1.0
troponin O 1 0.8719329833984375
T O 0 2.4871479809007724e-07
( O 0 1.1752071538140285e-10
cTNT O 0 3.207246024317101e-08
) O 0 8.942476967255253e-12
pre O 0 8.728076927866368e-09
- O 0 2.3475579258303014e-09
messenger O 0 5.269946701247363e-10
RNA O 0 6.479504044420992e-09
and O 0 3.51195461600895e-10
regulate O 0 2.1790132198606926e-10
its O 0 2.374190427589795e-11
alternative O 0 8.563032949382432e-09
splicing O 0 5.114588930155151e-07
. O 0 5.407308378835296e-08

Splicing O 0 5.356529527489329e-06
of O 0 5.460143484015134e-07
cTNT O 0 0.000176791480043903
was O 0 6.723537353536813e-07
disrupted O 0 1.226921631314326e-05
in O 0 7.318236328046623e-08
DM B-Disease 1 1.0
striated O 0 0.0019980946090072393
muscle O 0 7.313087166949117e-07
and O 0 2.5965625205515153e-09
in O 0 9.513527743365557e-10
normal O 0 1.6080825560038647e-07
cells O 0 2.0609972395391196e-08
expressing O 0 1.1596189564144765e-09
transcripts O 0 1.815247152592292e-08
that O 0 1.5809426684443295e-11
contain O 0 1.0811682660261113e-09
CUG O 0 1.7881849998957478e-05
repeats O 0 2.5997263719546027e-07
. O 0 1.3664315190453635e-07

Altered O 0 8.257576382675325e-07
expression O 0 5.050848272958319e-08
of O 0 3.373148871332887e-08
genes O 0 5.671457525835422e-09
regulated O 0 7.447074512612062e-09
posttranscriptionally O 0 4.1807002304494745e-08
by O 0 8.719669430945487e-10
CUG O 1 0.9999198913574219
- O 0 1.6347978089470416e-05
BP O 0 1.2429680964487488e-06
therefore O 0 6.228687343678985e-09
may O 0 1.3894263517499894e-09
contribute O 0 3.5924038854773244e-08
to O 0 4.192174856143538e-07
DM B-Disease 1 1.0
pathogenesis O 1 0.9989551305770874
. O 0 4.3983337150166335e-07
. O 0 7.537778401456308e-07

Identification O 0 5.5383054586855e-07
of O 0 1.7212954617207288e-08
a O 0 3.755966926366483e-10
novel O 0 1.8234173893016958e-10
nonsense O 0 3.643641832695721e-08
mutation O 0 7.367595422635986e-11
and O 0 1.219385703521425e-11
a O 0 6.300744648246592e-11
missense O 0 6.221824389029962e-09
substitution O 0 1.500512492036421e-09
in O 0 2.371801921530192e-10
the O 0 1.5255149365955845e-09
vasopressin O 0 7.737799023743719e-07
- O 0 1.8107454025084735e-07
neurophysin O 0 3.9187628431136545e-07
II O 0 1.3982440577819943e-05
gene O 0 3.2293653862147664e-10
in O 0 1.7081322467582538e-11
two O 0 1.0575753814356936e-11
Spanish O 0 8.677549345748048e-09
kindreds O 0 5.148453965375666e-07
with O 0 1.1107516018071806e-09
familial B-Disease 0 0.09159442782402039
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999988079071045
. O 0 2.1676632968592457e-05

Familial B-Disease 1 0.9999995231628418
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.1251084970353986e-06
FNDI B-Disease 1 1.0
) O 0 2.645552665825335e-10
is O 0 6.893281952191632e-12
an O 0 3.4078056349029495e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.21393261849880219
by O 0 2.6590271318127634e-08
deficiency O 1 0.9980736970901489
in O 0 1.769170232535089e-08
the O 0 6.800107144044887e-08
antidiuretic O 0 8.068458896559605e-07
hormone O 0 1.3007699806166784e-08
arginine O 0 8.380052207712652e-08
vasopressin O 0 1.816809884758186e-07
( O 0 2.9613980712106525e-10
AVP O 0 2.226523676540637e-08
) O 0 5.522725072398815e-12
encoded O 0 1.5189408064664178e-10
by O 0 4.3645233260836136e-11
the O 0 3.1380678056081024e-09
AVP O 0 1.298797633353388e-05
- O 0 4.095448730367934e-06
neurophysin O 0 1.7788388504413888e-05
II O 1 0.9999165534973145
( O 0 1.251661814194449e-07
AVP O 0 0.0018911886727437377
- O 0 1.667414471739903e-05
NPII O 0 0.22551937401294708
) O 0 2.1630459923205336e-10
gene O 0 3.7905409366878473e-10
on O 0 3.350633992482699e-09
chromosome O 0 1.9570612153074762e-07
20p13 O 0 8.230072853621095e-05
. O 0 7.126926675482537e-07

In O 0 1.1932302257378069e-08
this O 0 3.5732389269682585e-10
study O 0 2.0503813924488412e-10
, O 0 4.264995041164399e-12
we O 0 8.024535896877794e-12
analyzed O 0 2.148510674926385e-10
two O 0 2.3531356984490825e-12
families O 0 8.969791923107984e-12
with O 0 1.2297841564534728e-11
FNDI B-Disease 1 1.0
using O 0 1.560119478050126e-09
direct O 0 3.733085840451622e-09
automated O 0 1.295553460067822e-07
fluorescent O 0 4.371742523545663e-09
, O 0 2.2712401404056948e-11
solid O 0 1.0016371065901808e-09
phase O 0 3.429823536293952e-09
, O 0 6.211925505233973e-12
single O 0 3.586592828286328e-11
- O 0 5.1888552482504124e-11
stranded O 0 1.500088248063136e-10
DNA O 0 4.814494358740262e-10
sequencing O 0 1.244414682410877e-09
of O 0 2.6094313376745504e-09
PCR O 0 2.1957376361569914e-07
- O 0 1.5236189483402995e-06
amplified O 0 1.8534786931923009e-06
AVP O 0 0.00011466594150988385
- O 0 1.3229874639364425e-05
NPII O 0 0.008084896020591259
DNA O 0 2.9788221581839025e-05
. O 0 1.0021813068306074e-06

In O 0 8.822576447187203e-09
one O 0 3.407508442077045e-10
of O 0 5.263939839572629e-10
the O 0 1.7953361020062175e-10
families O 0 1.4512423207602154e-10
, O 0 7.693900204441828e-12
affected O 0 3.389764510752791e-11
individuals O 0 7.652364852894777e-12
presented O 0 4.2066522487616e-10
a O 0 6.888396103521544e-11
novel O 0 8.203641238546666e-11
nonsense O 0 5.132559977027995e-08
mutation O 0 4.4310077829123884e-10
in O 0 4.278752907538319e-10
exon O 0 5.446432194133877e-09
3 O 0 6.382281925176869e-10
of O 0 9.4122554195053e-10
the O 0 2.9937927137346776e-10
gene O 0 9.83494813366903e-11
, O 0 9.939417344728696e-12
consisting O 0 9.752346152858138e-11
in O 0 6.901310772855496e-11
a O 0 5.25505139403748e-10
G O 0 2.0222598706709505e-08
to O 0 4.725655866621992e-09
T O 0 1.1285241896530351e-07
transition O 0 6.700674475723645e-06
at O 0 2.574024193791047e-08
nucleotide O 0 2.344520844133058e-08
2101 O 0 1.4298707640136854e-07
, O 0 6.167111959998195e-12
which O 0 1.9586128508983225e-13
produces O 0 3.9904519033746866e-13
a O 0 3.1510722850458528e-12
stop O 0 9.950385654322602e-11
signal O 0 2.8765583692802466e-08
in O 0 1.2834098228609037e-09
codon O 0 7.296981863191832e-08
82 O 0 1.104170621601952e-07
( O 0 4.669308939497796e-09
Glu O 0 2.6935447749565355e-05
) O 0 3.708629847665179e-09
of O 0 3.6149768334325927e-07
NPII O 1 0.9998470544815063
. O 0 6.934148132131668e-06

The O 0 1.7011419117807236e-07
premature O 0 1.0618761052683112e-06
termination O 0 1.9229271686072025e-07
eliminates O 0 1.6199184216247886e-08
part O 0 7.305231974896742e-10
of O 0 5.478125508773246e-09
the O 0 7.063064355605775e-09
C O 0 8.692909432284068e-06
- O 0 1.7190619416851405e-07
terminal O 0 1.57891104635155e-08
domain O 0 9.969088665684467e-09
of O 0 5.7574633949286635e-09
NPII O 1 0.7157579064369202
, O 0 4.141068390972613e-11
including O 0 1.2251556540110453e-11
a O 0 7.973870869149025e-11
cysteine O 0 8.436371601305837e-09
residue O 0 3.3143231803478557e-07
in O 0 5.927195401156382e-10
position O 0 3.515248891972078e-08
85 O 0 3.859979713638495e-08
, O 0 2.0505994471897715e-11
which O 0 8.278295041651285e-13
could O 0 1.1315569141412407e-11
be O 0 4.0974244830405127e-11
involved O 0 3.1603466510432554e-09
in O 0 4.160927713492413e-10
the O 0 2.313133684594959e-09
correct O 0 1.997644176299218e-06
folding O 0 8.366171755369578e-07
of O 0 4.453669433246432e-08
the O 0 1.2026374918150395e-07
prohormone O 0 0.0032813013531267643
. O 0 1.238360709976405e-06

In O 0 2.2517724573845044e-08
the O 0 5.2557056484658915e-09
second O 0 4.142188458899909e-08
family O 0 5.240997635880262e-10
, O 0 9.93791941100719e-12
a O 0 2.911405838634806e-11
G279A O 0 1.6636434452266258e-08
substitution O 0 9.079810792123055e-10
at O 0 1.0703203878748013e-09
position O 0 1.3939980725297119e-08
- O 0 2.4329349646023957e-09
1 O 0 2.2422728951365656e-10
of O 0 3.1550687062953386e-10
the O 0 6.77679162786049e-11
signal O 0 2.2668322774421767e-09
peptide O 0 1.141733860232641e-10
was O 0 1.6198672958545046e-10
observed O 0 8.730332429207621e-11
in O 0 3.354934385857433e-11
all O 0 7.353107706054018e-11
affected O 0 1.8550072589107458e-09
individuals O 0 4.635941852626502e-09
. O 0 1.628801697961535e-07

This O 0 4.360901684208329e-08
missense O 0 9.84172584139742e-06
mutation O 0 9.055913352540301e-09
, O 0 1.6850222606112908e-10
which O 0 6.162435145506961e-11
replaces O 0 1.6465169210277963e-06
Ala O 0 1.534877810627222e-05
with O 0 1.7647820982347184e-08
Thr O 1 0.9999911785125732
, O 0 3.3145597377881586e-10
is O 0 3.317246130563056e-11
frequent O 0 1.0244010084647925e-09
among O 0 1.155191142743206e-08
FNDI B-Disease 1 1.0
patients O 0 3.741029286175035e-05
and O 0 7.003178037479074e-10
is O 0 1.3261430842348432e-10
thought O 0 9.294317537822394e-10
to O 0 9.152364283115944e-11
reduce O 0 1.3379988228479078e-09
the O 0 2.8617905267758204e-10
efficiency O 0 8.772509119125971e-08
of O 0 1.8529633383224109e-09
cleavage O 0 7.573573768127062e-09
by O 0 3.0594618505297433e-10
signal O 0 7.422318049066234e-07
peptidases O 0 1.9156444977852516e-05
. O 0 5.332419306114389e-08
. O 0 2.5670530590105045e-07

Genetic O 0 3.942234343412565e-06
heterogeneity O 0 2.0890970517939422e-06
of O 0 1.247925752068113e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.266235892862568e-10
due O 0 3.4677125313464785e-06
to O 0 5.930477886550989e-09
TWIST O 0 0.3922646939754486
and O 0 1.3303530010944087e-07
FGFR O 1 0.9999996423721313
mutations O 0 1.4750531818208401e-06
. O 0 5.577533670475532e-07

Thirty O 0 4.116577474633232e-05
- O 0 1.564253579999786e-07
two O 0 1.231683921520954e-10
unrelated O 0 4.353453153527198e-09
patients O 0 7.568699833537806e-11
with O 0 7.759432744773587e-13
features O 0 1.0530529920282916e-10
of O 0 8.163880949041413e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.917421110775308e-09
a O 0 1.945188232710393e-09
common O 0 2.2123861072032014e-06
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
condition I-Disease 1 1.0
of O 1 0.9999998807907104
craniosynostosis B-Disease 1 1.0
and O 0 0.16783203184604645
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999994039535522
, O 0 5.325565766156615e-09
were O 0 1.3623868255763227e-08
screened O 0 2.5157727012725672e-09
for O 0 1.9322927979903426e-10
mutations O 0 1.30457566971387e-09
in O 0 1.088216960987154e-09
TWIST O 0 6.515603217849275e-06
, O 0 3.585119090487865e-09
FGFR2 O 1 0.9256139397621155
, O 0 2.6850637269149047e-09
and O 0 9.367861153464219e-09
FGFR3 O 1 0.9994022846221924
. O 0 1.2102949540349073e-06

Nine O 0 2.533417671202187e-07
novel O 0 1.4859729002836275e-09
and O 0 1.5668732977758282e-10
three O 0 2.9988908578637563e-10
recurrent O 0 6.068351012800122e-07
TWIST O 0 3.001382765432936e-06
mutations O 0 1.5021704991013962e-09
were O 0 6.94308777138275e-10
found O 0 4.532278718993865e-11
in O 0 3.761033498528299e-11
12 O 0 1.5470811298712306e-09
families O 0 9.344746088046918e-10
. O 0 5.768150401763705e-08

Seven O 0 5.4042565977852064e-08
families O 0 6.425104892571198e-10
were O 0 8.024804154516119e-10
found O 0 3.036277132495435e-11
to O 0 2.4941028409219967e-11
have O 0 1.7810175209631574e-11
the O 0 1.367321922352005e-09
FGFR3 O 1 0.9993732571601868
P250R O 0 1.6597581634414382e-05
mutation O 0 2.09761297220723e-09
, O 0 2.1678856626516918e-11
and O 0 1.0092609040168732e-11
one O 0 9.90204532952399e-12
individual O 0 1.8051076258740473e-11
was O 0 3.7217460224781007e-09
found O 0 1.1040048042421091e-10
to O 0 6.425027870848865e-11
have O 0 1.008014852144079e-10
an O 0 4.4468065341085605e-10
FGFR2 O 0 0.02161731757223606
VV269 O 0 0.00026795349549502134
- O 0 1.9526257801771862e-06
270 O 0 7.52324297081941e-07
deletion O 0 2.8457636744860793e-06
. O 0 6.275303690017608e-07

To O 0 1.862382070783042e-08
date O 0 1.1004765099187352e-07
, O 0 3.663492009753355e-10
our O 0 1.3924135178200459e-09
detection O 0 1.433849945442489e-07
rate O 0 1.70762892715004e-09
for O 0 4.495584460251223e-11
TWIST O 0 1.4915711687990552e-07
or O 0 2.8418729591805914e-09
FGFR O 0 0.0009951916290447116
mutations O 0 6.162276910970377e-09
is O 0 7.022998155248317e-11
68 O 0 4.1705376929712656e-08
% O 0 1.6487136100806765e-09
in O 0 5.309241588036251e-11
our O 0 3.5616004367966525e-08
Saethre B-Disease 1 0.9999935626983643
- I-Disease 1 0.9999995231628418
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.4686705185340543e-07
, O 0 3.966529882326597e-11
including O 0 6.604194274784092e-11
our O 0 9.569038006418396e-09
five O 0 5.840647410160216e-10
patients O 0 1.3917464403156998e-10
elsewhere O 0 8.231226117372259e-11
reported O 0 4.502707234843584e-11
with O 0 2.795783916875738e-11
TWIST O 0 7.173087851697346e-06
mutations O 0 1.932958895167758e-07
. O 0 4.211762529848784e-07

More O 0 1.7061575485755043e-09
than O 0 7.722072287164039e-11
35 O 0 9.817709978321432e-10
different O 0 3.09988618107937e-10
TWIST O 0 1.848153914352224e-07
mutations O 0 7.405342450361729e-10
are O 0 6.5310977112598145e-12
now O 0 3.2626727708429115e-11
known O 0 3.5361845396320035e-11
in O 0 5.875326614113163e-11
the O 0 8.235784831889248e-10
literature O 0 5.967663696537784e-08
. O 0 1.115153125397228e-07

The O 0 9.481635743213701e-08
most O 0 6.836932131548679e-10
common O 0 8.630963166389449e-10
phenotypic O 0 7.571465232558694e-09
features O 0 2.5085550303671766e-10
, O 0 9.044230642185624e-12
present O 0 1.548845912635599e-10
in O 0 1.8919168315312263e-11
more O 0 1.2388049570530302e-12
than O 0 8.58088556807135e-13
a O 0 7.015122857612077e-12
third O 0 1.645870217892309e-09
of O 0 1.2461794929308212e-09
our O 0 1.4947630688766367e-08
patients O 0 6.23610496575111e-09
with O 0 2.0407210643558216e-10
TWIST O 0 4.984961833542911e-06
mutations O 0 6.623022130725076e-09
, O 0 6.727415152729677e-11
are O 0 8.985259064564488e-11
coronal B-Disease 0 2.1514414072498766e-07
synostosis I-Disease 0 3.935303993785055e-06
, O 0 3.812461901731012e-09
brachycephaly B-Disease 0 6.988132554397453e-06
, O 0 5.2447504117481e-09
low B-Disease 0 7.386034212686354e-06
frontal I-Disease 0 0.2975947856903076
hairline I-Disease 1 0.9999985694885254
, O 0 6.50883930575219e-06
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 0 1.1294644536974374e-05
ptosis B-Disease 1 0.9999998807907104
, O 0 1.546147530007147e-07
hypertelorism B-Disease 0 0.23607699573040009
, O 0 7.029130166813502e-09
broad B-Disease 0 8.369525517082366e-08
great I-Disease 0 3.869610736728646e-06
toes I-Disease 0 0.030723178759217262
, O 0 7.325607231933873e-09
and O 0 8.014854557814033e-08
clinodactyly B-Disease 1 0.9273906350135803
. O 0 7.70349561207695e-06

Significant O 0 6.2734638959227595e-06
intra O 0 0.0010554826585575938
- O 0 1.1154971616633702e-05
and O 0 9.598834616042495e-09
interfamilial O 0 0.02418651059269905
phenotypic O 0 2.93776110993349e-06
variability O 0 2.2564982771200448e-07
is O 0 1.238422819155316e-11
present O 0 1.3738199466928336e-10
for O 0 5.2209511020029353e-11
either O 0 3.768873568787967e-08
TWIST O 0 6.946239591343328e-05
mutations O 0 1.9485985092160263e-07
or O 0 4.8993261003715816e-08
FGFR O 1 0.9994137287139893
mutations O 0 9.492670187682961e-07
. O 0 6.313023845905263e-07

The O 0 3.928918204110232e-07
overlap O 0 3.428851584885706e-07
in O 0 1.4116835478361622e-09
clinical O 0 7.210138619484496e-08
features O 0 1.6451703332975853e-09
and O 0 1.5021840715778723e-10
the O 0 7.519965761204617e-10
presence O 0 5.588065565831357e-10
, O 0 1.5058867347539362e-11
in O 0 7.724632565542233e-12
the O 0 1.6669061964069698e-11
same O 0 4.747975970720297e-11
genes O 0 9.437003956058732e-11
, O 0 4.0400343660762505e-12
of O 0 3.802668249730523e-11
mutations O 0 2.0902503686248686e-11
for O 0 8.745594526349265e-12
more O 0 1.7582536988858255e-12
than O 0 4.897102254958208e-12
one O 0 2.690258953108593e-11
craniosynostotic B-Disease 0 1.3226943451627449e-07
condition I-Disease 0 8.945571607910097e-06
- O 0 5.4641443369973786e-08
such O 0 4.012117305052243e-10
as O 0 1.0696597385617679e-08
Saethre B-Disease 1 0.9645956754684448
- I-Disease 0 1.1485775758046657e-05
Chotzen I-Disease 0 0.002295602113008499
, I-Disease 0 1.941148353168387e-09
Crouzon I-Disease 0 0.009421453811228275
, I-Disease 0 1.3828220790657042e-09
and I-Disease 0 5.4762345769177045e-09
Pfeiffer I-Disease 0 8.082298882072791e-05
syndromes I-Disease 0 0.00011592375085456297
- O 0 1.3058182730674162e-06
support O 0 5.190961616108325e-08
the O 0 8.846032351073063e-09
hypothesis O 0 6.779862893324662e-09
that O 0 1.7798221230158617e-11
TWIST O 0 1.1719406245447317e-07
and O 0 1.450229519806001e-10
FGFRs O 0 1.4701519148729858e-06
are O 0 6.394997812547709e-12
components O 0 8.675728579987663e-09
of O 0 2.4254045993821194e-10
the O 0 4.165713954340511e-11
same O 0 3.932143152751699e-11
molecular O 0 7.800607937369364e-10
pathway O 0 3.3823069345295664e-10
involved O 0 1.0545886386381653e-10
in O 0 3.336332946024534e-11
the O 0 2.996809189692584e-10
modulation O 0 7.120620011846768e-06
of O 0 2.5133072085736785e-06
craniofacial O 1 1.0
and O 0 3.4336073440499604e-05
limb O 1 0.9995691180229187
development O 0 0.00015466363402083516
in O 0 3.4537717130689316e-09
humans O 0 3.984360841258194e-09
. O 0 1.2343797095581976e-09
. O 0 1.7571407440186704e-08

Mutation O 0 2.708820012742308e-08
analysis O 0 6.2993570359992646e-09
of O 0 4.354783911253435e-08
UBE3A O 1 1.0
in O 1 0.5479905605316162
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.00027193388086743653
. O 0 6.978003739277483e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.413728937739506e-05
AS B-Disease 1 1.0
) O 0 6.643768313274734e-10
is O 0 3.57612793544515e-11
caused O 0 2.7469443386607395e-10
by O 0 8.577327043068905e-11
chromosome O 0 5.1515382182287794e-08
15q11 O 0 0.0001071992955985479
- O 0 5.567049470300844e-07
q13 O 0 3.4224390219605993e-06
deletions O 0 5.649195777834848e-09
of O 0 6.075907554858873e-10
maternal O 0 7.595867046461535e-09
origin O 0 1.020714845978432e-09
, O 0 2.089042827613241e-11
by O 0 1.655206804951348e-10
paternal O 0 4.190243089396972e-06
uniparental B-Disease 1 0.99937903881073
disomy I-Disease 1 0.9999263286590576
( O 0 5.42316229257267e-07
UPD B-Disease 1 1.0
) O 0 1.517846737186801e-09
15 O 0 1.4619948585092857e-09
, O 0 1.0042031442503152e-11
by O 0 6.93823956621209e-11
imprinting O 0 1.624091419216711e-05
defects O 0 6.672027666354552e-05
, O 0 1.0127865213149789e-10
and O 0 6.679468783632458e-11
by O 0 2.0104971854006948e-10
mutations O 0 3.1445868131640964e-09
in O 0 1.2204572907847933e-09
the O 0 5.9549645214929114e-08
UBE3A O 0 0.00330556882545352
gene O 0 2.42139549300191e-07
. O 0 3.1422925417246006e-07

UBE3A O 0 0.0026938910596072674
encodes O 0 3.3858512438200705e-07
a O 0 2.8935509988059493e-08
ubiquitin O 0 5.582147650784464e-07
- O 0 1.8447744878358208e-06
protein O 0 8.455574018739753e-09
ligase O 0 5.342983833145354e-09
and O 0 7.109460242737953e-10
shows O 0 1.1380996589593906e-08
brain O 0 7.066643320285948e-06
- O 0 2.0718873727787468e-08
specific O 0 1.0623097956852234e-08
imprinting O 0 6.202541499078507e-06
. O 0 2.652475643571961e-07

Here O 0 8.94003676421562e-07
we O 0 1.5663040642266424e-08
describe O 0 2.6638957706381916e-07
UBE3A O 0 0.0038382732309401035
coding O 0 0.0016605888959020376
- O 0 4.4828249201600556e-07
region O 0 7.020434011906218e-09
mutations O 0 3.1605434935855214e-10
detected O 0 6.787078676850911e-10
by O 0 2.32813646833252e-11
SSCP O 0 0.02527516335248947
analysis O 0 2.4530553144330725e-09
in O 0 3.144577653824143e-11
13 O 0 1.39635503160207e-09
AS B-Disease 1 0.9318938255310059
individuals O 0 7.578743188574322e-10
or O 0 1.158560025693589e-09
families O 0 4.15056167213379e-09
. O 0 1.5669560582409758e-07

Two O 0 2.0661692801127174e-08
identical O 0 5.0278757157684595e-08
de O 0 2.1131995708856266e-07
novo O 0 3.5036492818107945e-07
5 O 0 1.1536349120433442e-07
- O 0 1.8260563194871793e-07
bp O 0 6.432517096754964e-08
duplications O 0 4.027889985991351e-07
in O 0 5.05632025138425e-09
exon O 0 7.978233185212957e-08
16 O 0 8.68198579695445e-09
were O 0 1.4226586131371732e-08
found O 0 1.2821112171934601e-08
. O 0 1.429587257462117e-07

Among O 0 5.475255449027827e-08
the O 0 1.8481206565112984e-09
other O 0 1.9295454123380296e-10
11 O 0 8.164480203021185e-10
unique O 0 4.443669598952482e-10
mutations O 0 5.341748154918946e-10
, O 0 2.0611004222792495e-11
8 O 0 1.2321286213534677e-09
were O 0 3.629199607502187e-09
small O 0 2.9710500726309874e-10
deletions O 0 1.9653902949556823e-09
or O 0 4.403339914915705e-10
insertions O 0 1.490419379024388e-07
predicted O 0 8.803686313285652e-08
to O 0 2.277754207469229e-09
cause O 0 3.083825959038222e-07
frameshifts O 0 0.03129825368523598
, O 0 3.8093925236459825e-10
1 O 0 1.685225514691524e-09
was O 0 9.928911026690912e-10
a O 0 1.8566974346878595e-11
mutation O 0 2.7585409650976445e-11
to O 0 2.5189005395387376e-11
a O 0 5.346219994484258e-11
stop O 0 9.331940775680891e-10
codon O 0 4.240814277522986e-08
, O 0 1.658850973251802e-10
1 O 0 6.509874861393428e-10
was O 0 1.346303291072104e-09
a O 0 1.4496460976065606e-10
missense O 0 4.324712321590596e-08
mutation O 0 1.9936730044634032e-09
, O 0 5.282100798420508e-11
and O 0 6.274887554003072e-11
1 O 0 3.78451048277384e-09
was O 0 1.0134561634345118e-08
predicted O 0 3.318749275393884e-09
to O 0 8.727069761294004e-11
cause O 0 3.720970476184249e-10
insertion O 0 6.933007945519876e-09
of O 0 1.8730693440716095e-08
an O 0 8.775413173900404e-10
isoleucine O 0 9.088027582038194e-05
in O 0 4.561196753627428e-09
the O 0 9.354220509294464e-09
hect O 0 1.7116184380938648e-06
domain O 0 8.888788372019008e-09
of O 0 3.4665288417556894e-09
the O 0 1.0861604060607988e-08
UBE3A O 0 0.0009994222782552242
protein O 0 8.111910254626764e-09
, O 0 1.4015248163412597e-11
which O 0 1.6615629228403095e-12
functions O 0 1.0692472462991987e-09
in O 0 6.293745524743599e-10
E2 O 0 3.023088623876902e-08
binding O 0 3.2410976125163415e-09
and O 0 3.687891325654391e-09
ubiquitin O 0 4.350608833192382e-07
transfer O 0 6.59281568005099e-06
. O 0 3.0224139209167333e-06

Eight O 0 1.6377315148474736e-07
of O 0 5.514270817741362e-09
the O 0 2.911751395551221e-10
cases O 0 1.5299403410828916e-10
were O 0 1.796673254617076e-09
familial O 0 1.640721336571005e-08
, O 0 2.0510423914821274e-10
and O 0 1.7025351961574842e-10
five O 0 1.2714927999368797e-09
were O 0 9.17560338820067e-09
sporadic O 0 1.219023374687822e-06
. O 0 2.884999048546888e-07

In O 0 2.2165153268360882e-08
two O 0 1.6415563353078255e-09
familial O 0 1.0206651523958499e-07
cases O 0 1.6142671643848416e-09
and O 0 5.716797590871181e-10
one O 0 1.4814244275740407e-10
sporadic O 0 1.330279388866984e-07
case O 0 3.2564570484616695e-10
, O 0 1.2092971068966563e-10
mosaicism O 0 6.491926569651696e-07
for O 0 1.6298444815987523e-09
UBE3A O 0 0.000595802441239357
mutations O 0 4.1180574505972345e-09
was O 0 2.5020432392608427e-09
detected O 0 2.8052411504830843e-09
in O 0 2.039805477305201e-11
the O 0 5.124804747236311e-11
mother O 0 1.3047424252121687e-09
of O 0 1.1953001921582995e-09
three O 0 1.1286910295282837e-09
AS B-Disease 1 1.0
sons O 0 6.375560133164981e-07
, O 0 2.644023021358688e-11
in O 0 6.8239233708133895e-12
the O 0 4.200876799198561e-11
maternal O 0 1.3158394374102045e-08
grandfather O 0 3.904251144604132e-08
of O 0 6.440727506884514e-09
two O 0 4.965021727088015e-10
AS B-Disease 1 1.0
first O 0 8.210834678834544e-09
cousins O 0 3.278610094525902e-08
, O 0 1.432406710605294e-11
and O 0 1.0029589138371708e-11
in O 0 2.054651414284958e-11
the O 0 2.528046660899008e-10
mother O 0 5.274716663450363e-09
of O 0 1.8761548759016478e-08
an O 0 1.5700870603652106e-09
AS B-Disease 1 1.0
daughter O 0 0.04081348329782486
. O 0 1.05788822111208e-05

The O 0 1.7924639550415122e-08
frequencies O 0 2.6037403344503218e-08
with O 0 1.8146940547469903e-11
which O 0 1.658102691606822e-12
we O 0 1.108135024713297e-11
detected O 0 3.894088107525562e-10
mutations O 0 2.962837614139957e-11
were O 0 6.695722865046605e-10
5 O 0 1.1949485845264007e-10
( O 0 2.959864991991523e-12
14 O 0 1.1793926946168654e-10
% O 0 1.1676037914298831e-10
) O 0 6.98100214788222e-13
of O 0 2.7842521690968347e-11
35 O 0 6.88290979766748e-10
in O 0 4.516701943013679e-11
sporadic O 0 2.314220637344988e-08
cases O 0 5.197475227980419e-10
and O 0 1.7056261958359187e-10
8 O 0 1.2233238866343754e-09
( O 0 3.0204561074498315e-11
80 O 0 2.5530759728553676e-09
% O 0 3.999556241751634e-10
) O 0 3.013221616665618e-12
of O 0 9.847242465887973e-11
10 O 0 2.6327215407739857e-10
in O 0 1.4472011089505799e-10
familial O 0 2.7490960619047655e-08
cases O 0 3.4890088596029045e-09
. O 0 2.8814016062028713e-08
. O 0 2.1055473098385846e-07

The O 0 6.075837063690415e-06
hemochromatosis B-Disease 1 1.0
845 O 0 6.439086973841768e-06
G O 0 1.288099042540125e-06
- O 0 1.5124628589546774e-06
- O 0 1.078530829090596e-07
> O 0 1.2103391178186484e-08
A O 0 8.661541706089793e-09
and O 0 4.682646631559706e-11
187 O 0 1.7280273045816585e-10
C O 0 1.1176487646480382e-07
- O 0 7.67247399835469e-07
- O 0 6.964739895920502e-07
> O 0 5.473928581523069e-07
G O 0 1.0872755638047238e-06
mutations O 0 1.1435526303671395e-08
: O 0 4.1398363903599744e-11
prevalence O 0 4.98319208119824e-09
in O 0 2.0035453851541263e-10
non O 0 6.76135869071004e-07
- O 0 3.075407676078612e-06
Caucasian O 0 0.00013611887698061764
populations O 0 1.6680733949669957e-07
. O 0 3.0863472488817933e-07

Hemochromatosis B-Disease 1 0.999995231628418
, O 0 5.510383616069703e-08
the O 0 4.8663478082744405e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 9.400042522145213e-09
leads O 0 2.9339087603830194e-08
, O 0 2.347015082282411e-10
if O 0 3.039849261199379e-09
untreated O 1 0.999991774559021
, O 0 7.908744215079366e-10
to O 0 7.529632028990818e-08
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 0.9999814033508301
and O 0 7.590193007445123e-08
premature B-Disease 0 4.16752664023079e-06
death I-Disease 0 6.526695983666286e-07
. O 0 3.4616419952726574e-07

The O 0 2.7613554266281426e-05
hemochromatosis B-Disease 1 1.0
gene O 0 2.847849316367501e-07
, O 0 4.647176421457289e-09
HFE O 1 0.8064672946929932
, O 0 7.786635225492944e-10
recently O 0 4.234553818704967e-10
has O 0 9.840135433911157e-13
been O 0 4.106333328923739e-12
identified O 0 1.1212213796296666e-10
, O 0 3.3202195333370543e-12
and O 0 6.637428454081551e-12
characterization O 0 3.3059495141429807e-09
of O 0 1.2522338721510096e-09
this O 0 5.918335960197751e-11
gene O 0 1.2263602633399984e-10
has O 0 9.966006969328034e-13
shown O 0 1.727631059045276e-11
that O 0 1.2596479035623803e-13
it O 0 2.5651356039269047e-14
contains O 0 3.642116312317298e-14
two O 0 2.58805319839836e-13
mutations O 0 4.827381550054355e-12
that O 0 3.1504757570105513e-13
result O 0 4.064553207894228e-11
in O 0 1.4822723604090982e-10
amino O 0 2.180335217927265e-10
acid O 0 8.394374084730316e-11
substitutions O 0 7.406613655724925e-10
- O 0 1.1810455946559273e-09
cDNA O 0 8.345149460353696e-09
nucleotides O 0 8.043745114427736e-10
845 O 0 9.757807895027781e-09
G O 0 2.2011127143173326e-08
- O 0 2.1506784264602175e-07
- O 0 2.222942896423774e-07
> O 0 2.756683237237212e-08
A O 0 1.4025197003775247e-07
( O 0 1.331671301008086e-10
C282Y O 0 1.4066131370782387e-07
) O 0 5.2551665276345805e-12
and O 0 1.231988729782918e-11
187 O 0 1.7407038310768286e-10
C O 0 1.291159890115523e-07
- O 0 8.998766816148418e-07
- O 0 1.1066645129176322e-06
> O 0 4.939560653838271e-07
G O 0 1.5339309129558387e-06
( O 0 6.406458918917224e-09
H63D O 1 0.980655312538147
) O 0 5.853241447084656e-09
. O 0 4.4273289034890695e-08

Although O 0 0.000202803363208659
hemochromatosis B-Disease 1 1.0
is O 0 1.423527162813798e-08
common O 0 9.51748901911742e-09
in O 0 8.910482129920183e-09
Caucasians O 0 1.2541006071842276e-05
, O 0 3.5638003659244077e-09
affecting O 0 5.122975110793959e-08
> O 0 4.721549728969876e-08
= O 0 3.646469792784046e-09
1 O 0 4.3469894350778304e-09
/ O 0 2.1647061920759825e-09
300 O 0 1.367135987750956e-10
individuals O 0 1.59435138702424e-11
of O 0 3.6843952888609977e-10
northern O 0 6.335212909824861e-10
European O 0 1.9195434131091815e-09
origin O 0 5.806085390247517e-09
, O 0 1.5695024446760186e-10
it O 0 3.9777330734791505e-12
has O 0 1.3401523814293714e-12
not O 0 3.319098685131139e-12
been O 0 9.61146578992711e-11
recognized O 0 2.323968129047671e-09
in O 0 1.7397676355113134e-10
other O 0 6.366209781560883e-10
populations O 0 8.525208095022663e-09
. O 0 5.4121791492889315e-08

The O 0 7.110861233172727e-09
present O 0 7.237110355440279e-10
study O 0 1.4002448506245102e-11
used O 0 7.602319815336323e-12
PCR O 0 3.2096172941642465e-10
and O 0 1.5119277357866778e-11
restriction O 0 9.447449766941673e-11
- O 0 3.62472191151042e-10
enzyme O 0 2.8807928265095484e-11
digestion O 0 2.7797921742234166e-09
to O 0 4.8430249394160185e-11
analyze O 0 8.146887053861462e-10
the O 0 4.23317075837204e-11
frequency O 0 1.3177474667003253e-09
of O 0 2.600784310136106e-10
the O 0 1.842080654679279e-10
845 O 0 3.0009290608035144e-09
G O 0 9.34371691130309e-09
- O 0 5.634617394889574e-08
- O 0 1.9081516811070287e-08
> O 0 3.662955494476705e-09
A O 0 5.1786566146461155e-09
and O 0 4.8675660724306624e-11
187 O 0 8.365508286090062e-11
C O 0 3.227226130775307e-08
- O 0 5.495804344946009e-08
- O 0 3.5252533336915803e-08
> O 0 2.474296145749122e-08
G O 0 3.737982368079429e-08
mutations O 0 5.462044705417668e-10
in O 0 4.87377416202861e-10
HLA O 0 2.784447517001354e-08
- O 0 2.5118362945164563e-09
typed O 0 1.1179867032140578e-09
samples O 0 3.693386985137437e-10
from O 0 1.1977643876726063e-10
non O 0 1.7991848721976567e-07
- O 0 1.5533659336597339e-07
Caucasian O 0 7.033073870843509e-06
populations O 0 1.0685642370944493e-09
, O 0 1.1464117849468991e-11
comprising O 0 3.5702074629995195e-10
Australian O 0 4.693723809623407e-08
Aboriginal O 0 5.909512310608989e-07
, O 0 3.7038823397228526e-11
Chinese O 0 3.6928606839126132e-09
, O 0 1.7928176998527334e-10
and O 0 1.0230342128991765e-09
Pacific O 0 3.5433195932910166e-08
Islanders O 0 1.3313346016730065e-06
. O 0 7.29201360627485e-07

Results O 0 2.532871690164029e-07
showed O 0 2.9295136982909753e-08
that O 0 2.224741571521527e-11
the O 0 1.577434294297575e-10
845 O 0 3.2900033808402895e-09
G O 0 2.243815266922411e-08
- O 0 8.413798013862106e-08
- O 0 3.37460974719761e-08
> O 0 1.1039553271530167e-08
A O 0 6.755272341507634e-09
mutation O 0 1.4110690393920322e-10
was O 0 2.0537042899615443e-10
present O 0 3.3095550605599655e-11
in O 0 2.999002088333036e-12
these O 0 3.1466459212564635e-12
populations O 0 2.0960381867662914e-12
( O 0 1.8242669202507555e-13
allele O 0 4.7655043106109574e-11
frequency O 0 5.759734356125534e-10
0 O 0 1.8149362221442367e-11
. O 0 2.8510778807278037e-11
32 O 0 2.8969955323532304e-09
% O 0 5.224708998774474e-10
) O 0 4.168128082265854e-12
, O 0 7.811752113229264e-12
and O 0 1.149788424192888e-11
, O 0 5.81139433450395e-12
furthermore O 0 4.4386122555195584e-10
, O 0 9.141735111961591e-12
it O 0 1.0774735053828421e-12
was O 0 4.90649409989885e-10
always O 0 4.554899790676359e-10
seen O 0 9.484250051983167e-10
in O 0 1.1191766957630023e-10
conjunction O 0 4.5695469630402386e-09
with O 0 7.690404757454417e-09
HLA O 0 1.2446011169231497e-05
haplotypes O 0 2.1255330295844033e-07
common O 0 6.5664194082160066e-09
in O 0 4.445638079886294e-09
Caucasians O 0 1.4374069223777042e-07
, O 0 2.364150819555988e-10
suggesting O 0 1.7748779113091473e-09
that O 0 1.6289103746403022e-11
845 O 0 4.759522997943577e-09
G O 0 1.9029639020118339e-07
- O 0 9.751605830388144e-06
- O 0 3.348305472172797e-05
> O 0 4.72899455417064e-06
A O 0 8.832512321532704e-07
may O 0 2.9586544325610475e-10
have O 0 6.791604171413335e-12
been O 0 1.0306401565518541e-11
introduced O 0 1.0874730803356325e-11
into O 0 1.1887691352130414e-11
these O 0 4.712983475707588e-12
populations O 0 1.7599826110381578e-11
by O 0 1.170672309092069e-10
Caucasian O 0 2.647888322826475e-06
admixture O 0 1.223582057718886e-05
. O 0 2.9221250770206098e-06

187 O 0 8.52553796448774e-08
C O 0 2.4823425519571174e-06
- O 0 1.382806431138306e-06
- O 0 1.6850341921781364e-07
> O 0 1.7464254042920402e-08
G O 0 2.221725736717417e-08
was O 0 7.520610800781924e-10
present O 0 1.0566443553461369e-10
at O 0 1.3289455473575185e-11
an O 0 7.254688793060723e-14
allele O 0 2.9440280074899405e-11
frequency O 0 3.560932881896406e-09
of O 0 1.2788727410395495e-08
2 O 0 2.8221134584782703e-07
. O 0 3.214773585114017e-07

68 O 0 1.7371919966535643e-05
% O 0 9.000297040984151e-08
in O 0 5.379309844788516e-11
the O 0 3.7580792644487104e-11
two O 0 8.675947113512272e-12
populations O 0 5.972264349729528e-12
analyzed O 0 5.465608521326715e-10
( O 0 1.8918590652394762e-11
Australian O 0 5.178906548053419e-08
Aboriginal O 0 5.835275374010962e-07
and O 0 3.324690522887863e-10
Chinese O 0 4.186445323739463e-08
) O 0 3.038904461405423e-09
. O 0 6.727013612817245e-08

In O 0 6.144404096630751e-08
the O 0 1.3793140851703356e-08
Australian O 0 1.784159167073085e-07
Aboriginal O 0 9.33191230956254e-08
samples O 0 6.152596765396368e-10
, O 0 3.3999352812286165e-12
187 O 0 2.2723664963586465e-11
C O 0 2.133131360437801e-08
- O 0 1.345624127679912e-07
- O 0 1.5120274099444941e-07
> O 0 8.886164692967213e-08
G O 0 9.766264952304482e-08
was O 0 4.0243897103664494e-09
found O 0 5.667915789486777e-11
to O 0 7.861181323953748e-12
be O 0 4.100403003248765e-11
associated O 0 2.2221241735564945e-08
with O 0 2.9897597730865755e-09
HLA O 0 7.192615157691762e-05
haplotypes O 0 1.0207454579358455e-06
common O 0 1.1219649209692761e-08
in O 0 2.7224513754475765e-09
Caucasians O 0 2.0497701314070582e-07
, O 0 1.164296853373159e-10
suggesting O 0 1.8843486770947493e-09
that O 0 1.8460322246532934e-12
it O 0 6.285638242536917e-13
was O 0 1.1438350266956832e-10
introduced O 0 9.417404356337755e-11
by O 0 8.543447893583078e-11
recent O 0 2.977632362899385e-09
admixture O 0 4.903056378680049e-07
. O 0 2.4721975933061913e-07

In O 0 3.021964545268929e-08
the O 0 3.019451133567941e-09
Chinese O 0 7.1446311089573555e-09
samples O 0 1.4355397981447027e-09
analyzed O 0 1.083486522723831e-09
, O 0 4.136314554759046e-12
187 O 0 1.7782612188321778e-11
C O 0 2.6264800112585363e-08
- O 0 8.842611265436062e-08
- O 0 7.34713196948178e-08
> O 0 3.878473719964859e-08
G O 0 6.689077736155014e-08
was O 0 5.0974167109529844e-09
present O 0 1.5218117044302204e-10
in O 0 1.974620467137811e-11
association O 0 2.4667058326488522e-11
with O 0 1.0556567772712633e-11
a O 0 1.5937776098873258e-10
wide O 0 1.0520477822240082e-09
variety O 0 1.6138238523311088e-09
of O 0 2.6063091240757785e-08
HLA O 0 8.563662845517683e-07
haplotypes O 0 3.746061949527757e-08
, O 0 5.8085827814302604e-11
showing O 0 4.953859544798433e-10
this O 0 1.2588852703332432e-11
mutation O 0 8.388483657695289e-11
to O 0 4.019023655543741e-11
be O 0 7.831736925645316e-10
widespread O 0 1.1533748178749192e-08
and O 0 2.3194414444649425e-10
likely O 0 2.121440578761735e-09
to O 0 7.765870169151867e-10
predate O 0 7.870871741033625e-07
the O 0 2.352914751924118e-09
more O 0 5.28570902325054e-11
genetically O 0 3.3383140696230384e-10
restricted O 0 8.865384537593002e-10
845 O 0 1.9730647338178642e-08
G O 0 4.88515240704146e-07
- O 0 7.3579963100200985e-06
- O 0 3.222273790015606e-06
> O 0 7.950970370984578e-07
A O 0 5.124172730575083e-07
mutation O 0 2.494673481123755e-07
. O 0 1.0714876452766475e-07

Genotype O 0 0.00014781845675315708
- O 0 1.5525483831879683e-05
phenotype O 0 9.364092647956568e-07
correlations O 0 2.2300355340121314e-06
in O 0 6.553109415108338e-07
attenuated B-Disease 1 0.9992917776107788
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 9.436016262043267e-05

Germ O 0 0.2619529366493225
- O 0 1.9939627236453816e-05
line O 0 6.793119666781422e-08
mutations O 0 3.3964664414298795e-09
of O 0 1.035666663540269e-08
the O 0 1.6703999961009686e-08
tumor B-Disease 0 4.643236934498418e-06
suppressor O 0 1.4121495723884436e-06
APC O 0 6.102428073972987e-08
are O 0 1.7334478297215128e-10
implicated O 0 3.6338192330731545e-06
in O 0 7.077043733261235e-07
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 6.734685484843794e-06
AAPC B-Disease 1 1.0
) O 0 1.0337630751422466e-10
, O 0 9.63172076817731e-12
a O 0 2.2221885789819318e-11
variant O 0 6.09925194794414e-08
of O 0 8.479879397782497e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.439776471874211e-05
FAP B-Disease 0 5.028196392231621e-05
) O 0 2.3609809218783084e-08
. O 0 2.3778112279160268e-07

AAPC B-Disease 1 1.0
is O 0 3.2751710232759024e-09
recognized O 0 1.0043536002868336e-09
by O 0 3.3205695137983327e-11
the O 0 1.351326966991806e-10
occurrence O 0 1.8693645742473564e-08
of O 0 1.2194107945617816e-08
< O 0 1.0423221965538687e-06
100 O 0 7.441781235684175e-08
colonic B-Disease 0 4.252707185514737e-06
adenomas I-Disease 0 1.2306962844377267e-06
and O 0 6.978985445105224e-11
a O 0 3.8031251758940954e-11
later O 0 2.9994298156310606e-09
onset O 1 0.9998513460159302
of O 1 0.9999943971633911
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.435985052036017e-09
age O 0 3.723302910429993e-08
> O 0 3.400543624465513e-09
40 O 0 2.913662644488113e-10
years O 0 8.577670518317149e-11
) O 0 5.707458117232278e-11
. O 0 6.028443966243913e-09

The O 0 4.9977391114452985e-08
aim O 0 1.4163911998821277e-07
of O 0 3.1575748682399762e-09
this O 0 1.2353519596164375e-10
study O 0 1.6181286865979416e-10
was O 0 4.321541735574641e-10
to O 0 1.506953589691662e-10
assess O 0 1.42251806778404e-07
genotype O 0 4.217641162540531e-06
- O 0 1.5126951211641426e-06
phenotype O 0 2.0336462114300957e-07
correlations O 0 1.0547505553404335e-06
in O 0 8.360574810239996e-08
AAPC B-Disease 1 1.0
families O 0 2.0122107002862322e-07
. O 0 4.769876795762684e-07

By O 0 2.2519831333056572e-08
protein O 0 1.7259408124914444e-08
- O 0 8.085095259957598e-09
truncation O 0 1.7749303538039385e-07
test O 0 1.3259750630822964e-08
( O 0 1.3701048073855304e-09
PTT O 0 8.094115173662431e-07
) O 0 2.0577850187719626e-11
assay O 0 4.6198567194011275e-10
, O 0 8.227203640576164e-12
the O 0 1.3452878568076532e-11
entire O 0 4.04544620025149e-09
coding O 0 9.609478865968413e-07
region O 0 8.18931322754679e-09
of O 0 1.2211207600643093e-09
the O 0 1.327110421556199e-09
APC B-Disease 0 1.1157381862858529e-07
gene O 0 8.474945190073413e-10
was O 0 2.0617196838657037e-09
screened O 0 1.0563183661105313e-09
in O 0 3.211128238311822e-11
affected O 0 2.2359648854664016e-10
individuals O 0 1.4575894657919974e-10
from O 0 2.436185475573893e-09
11 O 0 4.73540296752617e-07
AAPC B-Disease 1 1.0
kindreds O 0 1.895726381917484e-05
, O 0 3.454276864545136e-10
and O 0 1.4521449320792357e-10
their O 0 1.044980213471547e-09
phenotypic O 0 3.0789186666879687e-07
differences O 0 4.221111566948821e-07
were O 0 6.868346247301815e-08
examined O 0 2.193482714574202e-06
. O 0 2.1802777894208702e-07

Five O 0 8.325867639769058e-08
novel O 0 4.389975050145267e-09
germ O 0 8.158924174495041e-05
- O 0 1.0148748970095767e-06
line O 0 4.952022081283758e-08
APC B-Disease 0 1.843766881393094e-07
mutations O 0 1.085981748971676e-09
were O 0 8.719985844507505e-10
identified O 0 1.8519952238449378e-09
in O 0 2.047157582341086e-10
seven O 0 7.940247570559222e-09
kindreds O 0 1.0650633157638367e-05
. O 0 5.865028356311086e-07

Mutations O 0 5.826128131047881e-07
were O 0 2.6483574444569058e-08
located O 0 7.968584125883638e-10
in O 0 5.615733572605919e-12
three O 0 1.210288054671882e-12
different O 0 7.2547514870513474e-12
regions O 0 6.835493976398155e-11
of O 0 3.4413416560852284e-10
the O 0 1.501377133727999e-09
APC B-Disease 0 8.75539214462151e-08
gene O 0 1.5618344395562644e-09
( O 0 3.768645465140885e-11
1 O 0 2.2558768186797806e-09
) O 0 5.29957917827506e-11
at O 0 2.4240001117448173e-09
the O 0 4.2529604837859836e-10
5 O 0 3.6977715334174377e-10
end O 0 4.029766298430104e-09
spanning O 0 2.3032775686715468e-08
exons O 0 1.2982689590046448e-08
4 O 0 1.0276295092648269e-10
and O 0 2.1208883607681805e-11
5 O 0 2.4153545830074563e-10
, O 0 6.076032732504899e-11
( O 0 1.438125486752373e-11
2 O 0 1.5152457066847091e-10
) O 0 1.994363355017903e-11
within O 0 3.5243101770277008e-09
exon O 0 3.908071199987262e-09
9 O 0 1.945718697271559e-09
, O 0 1.6860156326625741e-10
and O 0 2.8159560794271954e-10
( O 0 8.228981385194345e-11
3 O 0 1.339111932452397e-09
) O 0 5.666888833188999e-11
at O 0 7.85993048424416e-10
the O 0 2.3823479300411066e-10
3 O 0 2.680284882927708e-09
distal O 0 4.184257917927425e-08
end O 0 3.623170385935737e-08
of O 0 5.881569009602572e-08
the O 0 8.411278429321101e-08
gene O 0 2.7356227860764193e-07
. O 0 5.066536914455355e-07

Variability O 0 2.1683537852368318e-05
in O 0 2.0756638630103907e-09
the O 0 1.5209795645176882e-09
number O 0 8.587615951682892e-09
of O 0 7.979563633853104e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 5.3885573834122624e-06
most O 0 4.6789322416529444e-11
apparent O 0 1.5263413866151154e-09
in O 0 1.7200359192504067e-11
individuals O 0 4.114802942822848e-11
with O 0 9.258607075457448e-11
mutations O 0 3.1392310972933046e-08
in O 0 2.2057356829918717e-08
region O 0 3.5146444133715704e-05
1 O 0 1.3927734698881977e-07
, O 0 7.093221010556761e-10
and O 0 4.453565072282117e-09
upper O 1 0.9994920492172241
- O 0 0.0216594859957695
gastrointestinal O 0 1.507866272731917e-05
manifestations O 0 1.5516188796027564e-05
were O 0 3.84686103416243e-07
more O 0 6.682718267647658e-11
severe O 0 3.436751994101428e-09
in O 0 6.491387982698882e-10
them O 0 5.12805620189738e-09
. O 0 1.829708224931892e-07

In O 0 7.933602219623026e-09
individuals O 0 8.962721675942475e-10
with O 0 9.81558931356652e-11
mutations O 0 1.2549644656800751e-09
in O 0 4.433459432906517e-10
either O 0 2.809832722050487e-07
region O 0 0.00016712983779143542
2 O 0 6.127750395990006e-08
or O 0 3.747003596288323e-09
region O 0 1.5137514708385424e-07
3 O 0 4.649186591265675e-10
, O 0 5.245232633649399e-12
the O 0 5.958928663007956e-12
average O 0 2.7233470686893746e-11
number O 0 4.9323885253915734e-11
of O 0 2.472936078135035e-09
adenomas B-Disease 0 1.8543026953921071e-06
tended O 0 2.9921174871105904e-08
to O 0 9.043135684727588e-10
be O 0 1.5711444367738636e-09
lower O 0 2.0123369637303767e-08
than O 0 5.0231523801569367e-11
those O 0 1.5844020540001225e-11
in O 0 2.002703732018052e-11
individuals O 0 1.883283459735985e-11
with O 0 6.368452987182138e-11
mutations O 0 7.4399610916486836e-09
in O 0 9.860855465504414e-10
region O 0 8.359299386029306e-08
1 O 0 3.3543103850064426e-09
, O 0 1.9224141376006365e-11
although O 0 5.30561740375024e-11
age O 0 5.353335552626959e-10
at O 0 2.9980670723794844e-10
diagnosis O 0 7.183166417235043e-08
was O 0 3.921017732722021e-09
similar O 0 4.551775845129669e-09
. O 0 1.1833149926587794e-07

In O 0 6.026371579537226e-07
all O 0 5.931985356255609e-07
AAPC B-Disease 1 1.0
kindreds O 0 5.043987403041683e-05
, O 0 2.031327189788712e-10
a O 0 2.8155208720015423e-10
predominance O 0 3.507825283577404e-07
of O 0 4.846201591135468e-07
right O 0 0.02924506366252899
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999914169311523
rectal B-Disease 1 1.0
polyp I-Disease 0 0.008953004144132137
sparing O 0 2.7531478963283007e-07
was O 0 4.390245322838382e-08
observed O 0 1.5572721778767118e-08
. O 0 2.131114129610978e-08

No O 0 1.7419830328435637e-05
desmoid B-Disease 1 0.9996837377548218
tumors I-Disease 1 1.0
were O 0 4.929546548737562e-07
found O 0 2.519345176921206e-09
in O 0 4.716459445219812e-10
these O 0 5.613685960526027e-09
kindreds O 0 1.3722935364057776e-05
. O 0 6.408490094145236e-07

Our O 0 1.745939584907319e-06
data O 0 1.3162440382075147e-07
suggest O 0 4.30250413074873e-09
that O 0 8.202479494234804e-12
, O 0 2.680890232031885e-11
in O 0 1.0665849314861475e-09
AAPC B-Disease 1 1.0
families O 0 2.6173121447925496e-09
, O 0 1.206435212147694e-11
the O 0 1.3292168581091612e-11
location O 0 9.92540827304822e-10
of O 0 1.1004944733272737e-09
the O 0 7.305472671248481e-09
APC B-Disease 0 5.992808837618213e-06
mutation O 0 4.4181764025097436e-08
may O 0 3.1145264145493456e-09
partially O 0 1.1556037549098619e-07
predict O 0 1.930684767614821e-08
specific O 0 1.0805318417794751e-08
phenotypic O 0 9.971638519346016e-07
expression O 0 3.8166768945302465e-07
. O 0 6.487915698016877e-07

This O 0 7.841935101282616e-09
should O 0 6.103959560022076e-10
help O 0 1.0228782265642167e-09
in O 0 3.43166536853623e-11
the O 0 2.7108832539868288e-11
design O 0 1.870733568054561e-09
of O 0 7.926533318602935e-10
tailored O 0 7.775434518464408e-09
clinical O 0 2.2056521231661463e-07
- O 0 5.341967934668901e-08
management O 0 7.057785023079077e-09
protocols O 0 3.627367206604504e-08
in O 0 6.090269261127546e-11
this O 0 1.3192953673968333e-11
subset O 0 1.0424598961833453e-09
of O 0 2.6326778534979667e-09
FAP B-Disease 0 3.2811067285365425e-07
patients O 0 1.1626780427320682e-08
. O 0 5.466581409763194e-09
. O 0 1.085057235172826e-07

Wilms B-Disease 1 0.9999598264694214
' I-Disease 0 1.713544588710647e-05
tumor I-Disease 0 6.419049896067008e-06
1 O 0 5.910493428018526e-08
and O 0 1.6538230340756854e-08
Dax O 1 0.9948256015777588
- O 0 1.6223787042690674e-06
1 O 0 2.0178521964453466e-08
modulate O 0 2.9984704497110215e-08
the O 0 1.8509499488672532e-09
orphan O 0 1.8623245168214453e-09
nuclear O 0 2.3163579498941544e-08
receptor O 0 2.8710467336878764e-10
SF O 0 1.2441576018318301e-06
- O 0 2.4731354741902578e-08
1 O 0 1.4167403361575737e-10
in O 0 1.6718255252401448e-11
sex O 0 9.387741972677333e-11
- O 0 1.545343436548663e-10
specific O 0 1.233600027683579e-10
gene O 0 1.253792070166071e-09
expression O 0 2.3305833707354395e-08
. O 0 4.373830364556852e-08

Products O 0 1.904234295579954e-06
of O 0 1.4588141539206845e-06
steroidogenic O 0 0.00011950212501687929
factor O 0 2.0757122243253434e-08
1 O 0 2.582678293450158e-09
( O 0 2.225205297801125e-10
SF O 0 4.138282292842632e-06
- O 0 7.772101895398009e-08
1 O 0 9.503172693214879e-10
) O 0 5.690630952570608e-11
and O 0 1.809866811974814e-09
Wilms B-Disease 1 0.9999929666519165
tumor I-Disease 0 0.00017267491784878075
1 O 0 2.6471859371213213e-08
( O 0 3.536698711670283e-10
WT1 O 0 3.148650876028114e-06
) O 0 3.147361885003086e-11
genes O 0 5.998593982647904e-11
are O 0 3.1201465022778763e-12
essential O 0 9.453582361373947e-10
for O 0 7.518800165806638e-11
mammalian O 0 1.3528554632102896e-07
gonadogenesis O 0 4.3765172108578554e-07
prior O 0 6.924684470277498e-08
to O 0 3.4133840198791177e-09
sexual O 0 3.573916984578318e-08
differentiation O 0 2.1234106952761067e-06
. O 0 7.824008321222209e-07

In O 0 3.982546559200273e-08
males O 0 1.2235817337113986e-07
, O 0 2.240068353032143e-09
SF O 0 0.0005520232953131199
- O 0 1.6866883925104048e-06
1 O 0 5.39473798966128e-09
participates O 0 1.3361727280170044e-09
in O 0 1.6093373161885083e-11
sexual O 0 2.638707828628295e-11
development O 0 1.541404642813049e-10
by O 0 3.3783381907931398e-12
regulating O 0 8.700443837605931e-11
expression O 0 8.000988760414884e-11
of O 0 3.1442673464887605e-10
the O 0 1.0383640614008982e-09
polypeptide O 0 2.4622963223919214e-07
hormone O 0 4.625186988960195e-08
Mullerian O 0 2.002691417146707e-06
inhibiting O 0 4.3644465819170364e-08
substance O 0 2.8859895451205375e-07
( O 0 2.6659996876787773e-08
MIS O 0 0.0004076035984326154
) O 0 1.6734389873818145e-08
. O 0 2.2798117527145223e-07

Here O 0 6.335623083941755e-07
, O 0 1.6517921475056596e-09
we O 0 7.575462479536554e-10
show O 0 2.2184047931972373e-09
that O 0 3.8016692571751776e-10
WT1 O 0 6.169811240397394e-05
- O 0 1.6829125115691568e-06
KTS O 0 0.000169132646988146
isoforms O 0 1.3387351316396234e-07
associate O 0 1.716505515503286e-08
and O 0 1.718079289947383e-10
synergize O 0 1.9053517519296292e-07
with O 0 3.0385740590332944e-09
SF O 0 0.1313973218202591
- O 0 1.9662631984829204e-06
1 O 0 1.0803463013075998e-08
to O 0 3.052294195171612e-09
promote O 0 1.5990506199159427e-06
MIS O 0 0.0028189027216285467
expression O 0 3.4278903626727697e-07
. O 0 1.436171004343123e-07

In O 0 4.0150882796297083e-07
contrast O 0 4.812516749552742e-07
, O 0 2.4551910726700044e-08
WT1 O 0 0.0002762271324172616
missense O 0 1.867887590378814e-06
mutations O 0 1.7410366481840356e-09
, O 0 1.2960995991739832e-11
associated O 0 7.122014644700414e-10
with O 0 4.518953544696558e-10
male B-Disease 0 0.002280074404552579
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.0498359188204631e-05
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.893350892207991e-09
fail O 0 9.154111921816366e-07
to O 0 6.064425850382804e-09
synergize O 0 7.227408787002787e-06
with O 0 5.347258280608003e-08
SF O 1 0.9999996423721313
- O 0 0.02115190029144287
1 O 0 1.2219484233355615e-06
. O 0 1.4894801836362603e-07

Additionally O 0 4.138517226692784e-07
, O 0 4.716657620029707e-10
the O 0 5.765108945787745e-10
X O 0 4.646744855563156e-06
- O 0 4.117102037071163e-07
linked O 0 1.6513021705577557e-07
, O 0 9.425491637182759e-11
candidate O 0 2.3704327389850732e-09
dosage O 0 5.1589420735354e-08
- O 0 1.6453908457947364e-08
sensitive O 0 3.072998211450795e-08
sex O 0 1.8190934314432639e-09
- O 0 7.215570807517224e-09
reversal O 0 1.3819632549427752e-08
gene O 0 1.4790055846702899e-09
, O 0 6.630855309275319e-10
Dax O 0 0.0005192043608985841
- O 0 2.438153785533359e-07
1 O 0 1.962645335140678e-08
, O 0 1.3747957217091766e-09
antagonizes O 0 2.0208803164223355e-07
synergy O 0 5.891303445082485e-08
between O 0 5.2108809711626236e-08
SF O 0 2.56646908383118e-05
- O 0 1.6412761283390864e-07
1 O 0 1.395428439465718e-09
and O 0 4.254923913205033e-10
WT1 O 0 1.5663150406908244e-05
, O 0 3.553709757020407e-11
most O 0 2.0983301901589257e-12
likely O 0 1.9531645398251918e-11
through O 0 2.8798479226321838e-11
a O 0 3.443099624855783e-11
direct O 0 5.318416262944936e-10
interaction O 0 1.4487049782019312e-08
with O 0 6.101716465423124e-09
SF O 1 0.998641312122345
- O 0 3.591236236388795e-05
1 O 0 3.965806456562859e-07
. O 0 1.5097494099336473e-07

We O 0 9.438385006887984e-08
propose O 0 3.7417059672861797e-08
that O 0 1.1907059782600982e-09
WT1 O 0 6.19409402133897e-05
and O 0 8.099515014237113e-08
Dax O 1 0.834944486618042
- O 0 1.2309239991736831e-06
1 O 0 1.1191863436010863e-08
functionally O 0 1.2519483050255076e-07
oppose O 0 2.853211833464542e-10
each O 0 1.616006113647206e-11
other O 0 1.75961346188247e-11
in O 0 1.2605870514104112e-10
testis O 0 1.1969211755058495e-07
development O 0 1.7621542003354307e-09
by O 0 1.7049009426450823e-10
modulating O 0 3.503588175135519e-08
SF O 0 6.272279733821051e-06
- O 0 3.728000308456103e-07
1 O 0 2.140598098776536e-08
- O 0 9.983421023207484e-08
mediated O 0 1.721497937978711e-06
transactivation O 0 1.5508761862292886e-05
. O 0 1.698962215357369e-08
. O 0 6.03805503374133e-08

A O 0 7.163573059187911e-07
mouse O 0 3.314430330192408e-08
model O 0 1.8865577544602274e-08
for O 0 6.867809787536316e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9974849224090576
centre O 0 6.03323587711202e-06
mutations O 0 7.058137896365224e-08
. O 0 4.6017802901587856e-08

Imprinting O 0 5.256602889858186e-05
in O 0 1.3742930349280869e-08
the O 0 2.502288154460075e-08
15q11 O 0 5.915668225497939e-05
- O 0 6.512849495265982e-07
q13 O 0 2.5200972686434397e-06
region O 0 5.4556856809995224e-09
involves O 0 2.1727890597844635e-09
an O 0 7.390522221983886e-11
imprinting O 0 8.59568353916984e-06
centre O 0 1.7791343225326273e-06
( O 0 8.63389415517446e-10
IC O 0 0.0029542120173573494
) O 0 8.854665611846002e-11
, O 0 7.484956231207374e-12
mapping O 0 1.3251476582709643e-09
in O 0 3.4659101977307927e-11
part O 0 1.4206262555216398e-10
to O 0 2.929767817239082e-10
the O 0 2.24952612093432e-09
promoter O 0 2.0138784293521894e-06
and O 0 5.639506639454339e-09
first O 0 1.7769916382803785e-07
exon O 0 1.7137450640802854e-06
of O 0 6.470855282714183e-07
SNRPN O 1 0.9999860525131226
. O 0 5.194000095798401e-06

Deletion O 0 3.3576011446712073e-06
of O 0 1.3833457046530384e-07
this O 0 6.027248478090996e-09
IC O 0 0.00011951489432249218
abolishes O 0 4.6801357456160986e-08
local O 0 4.176768708674672e-09
paternally O 0 3.727538100406491e-08
derived O 0 3.342570387143695e-10
gene O 0 8.656182715061078e-11
expression O 0 6.417692072213654e-11
and O 0 5.908790384062668e-12
results O 0 6.477782199532101e-10
in O 0 4.508024886717976e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997226595878601
PWS B-Disease 1 1.0
) O 0 1.3440235591133387e-07
. O 0 9.228470787547849e-08

We O 0 6.938778795984035e-08
have O 0 6.01977426240019e-11
created O 0 9.284851359980806e-11
two O 0 1.1175465067236878e-11
deletion O 0 1.685566353160084e-09
mutations O 0 4.0076200691352426e-10
in O 0 2.898961626307539e-10
mice O 0 1.0756891377639022e-08
to O 0 1.5074056447517137e-09
understand O 0 9.515151759842411e-05
PWS B-Disease 1 1.0
and O 0 5.701772831656626e-09
the O 0 8.867397371936647e-10
mechanism O 0 6.938183361171468e-08
of O 0 3.781854829298936e-09
this O 0 2.2757868922695934e-09
IC O 0 0.00014509781613014638
. O 0 5.543087695514259e-07

Mice O 0 4.497909321798943e-05
harbouring O 0 0.00010043280781246722
an O 0 5.503521638416942e-09
intragenic O 0 3.9613383705727756e-05
deletion O 0 6.962933412069106e-07
in O 0 3.2594169585564714e-09
Snrpn O 0 0.00011770351557061076
are O 0 4.432892941608202e-10
phenotypically O 0 1.6352466900571017e-06
normal O 0 1.2383496539314365e-07
, O 0 4.628586403043755e-11
suggesting O 0 2.681142252658475e-10
that O 0 2.465791893585534e-12
mutations O 0 1.8336815399422335e-10
of O 0 1.886952594176705e-09
SNRPN O 1 0.9589691162109375
are O 0 1.7590773282449845e-10
not O 0 2.802854337513594e-10
sufficient O 0 1.9951468743784062e-07
to O 0 6.154608911401738e-08
induce O 0 0.00017188332276418805
PWS B-Disease 1 1.0
. O 0 3.3910178899532184e-05

Mice O 0 4.272311002750939e-07
with O 0 2.1531629257331986e-10
a O 0 1.7131644713952454e-10
larger O 0 5.07446196174044e-10
deletion O 0 3.730772579757513e-09
involving O 0 4.586871771294909e-09
both O 0 5.256918900187202e-09
Snrpn O 0 0.0004820897593162954
and O 0 7.112838096290375e-10
the O 0 6.93225388204155e-09
putative O 0 4.47699812866631e-06
PWS O 1 1.0
- O 0 6.293197657214478e-05
IC O 0 0.03846689686179161
lack O 0 9.432587262381276e-07
expression O 0 2.721682879069931e-09
of O 0 7.380088762332093e-10
the O 0 6.196642643452321e-10
imprinted O 0 3.2259336535389593e-08
genes O 0 1.124441428856926e-08
Zfp127 O 0 1.6420164001829107e-06
( O 0 2.670271781468614e-10
mouse O 0 6.798470675306589e-09
homologue O 0 7.36686160962563e-08
of O 0 2.4534361386940873e-07
ZNF127 O 1 0.9999990463256836
) O 0 2.0561875757607595e-08
, O 0 2.3303611484948306e-08
Ndn O 0 0.00043438939610496163
and O 0 1.4245321366956887e-08
Ipw O 0 9.521043466520496e-06
, O 0 4.79423445387539e-10
and O 0 1.7555377984646015e-10
manifest O 0 6.746956415781824e-08
several O 0 2.7165640847925943e-09
phenotypes O 0 1.1412673472932511e-07
common O 0 1.905416802117088e-08
to O 0 1.5538637399004074e-06
PWS B-Disease 1 1.0
infants O 1 0.9154889583587646
. O 0 2.3014608814264648e-06

These O 0 3.4225566825085707e-09
data O 0 2.183974112668352e-09
demonstrate O 0 8.477790691685527e-10
that O 0 2.0598848148034588e-12
both O 0 4.1079548616929085e-12
the O 0 1.1822478759859756e-11
position O 0 1.059393461844138e-09
of O 0 7.291019454847003e-10
the O 0 8.851563371159443e-10
IC O 0 0.0003681139787659049
and O 0 1.2867304444164063e-10
its O 0 7.867481839618495e-12
role O 0 2.414157207475398e-10
in O 0 2.7503506416781676e-11
the O 0 7.127555490260562e-11
coordinate O 0 2.850966795975296e-09
expression O 0 3.430170369966845e-09
of O 0 3.98461130757255e-09
genes O 0 4.2380768339178587e-10
is O 0 2.0199208625171217e-11
conserved O 0 1.7213012126759963e-09
between O 0 2.6934552366242315e-09
mouse O 0 2.424282108393072e-09
and O 0 5.238686567876627e-11
human O 0 3.4836408757676907e-10
, O 0 1.930858598009344e-11
and O 0 2.679984272696556e-12
indicate O 0 2.422029798943015e-10
that O 0 7.886784216155907e-13
the O 0 2.913983637720108e-11
mouse O 0 3.835522455197804e-10
is O 0 2.724644728585579e-12
a O 0 6.561564225987526e-12
suitable O 0 4.377917584008628e-09
model O 0 1.2003470439836406e-09
system O 0 2.00653693660513e-09
in O 0 3.520900238029867e-11
which O 0 5.6493382021016725e-12
to O 0 7.111247701807599e-11
investigate O 0 2.838660417836536e-09
the O 0 6.9624495058207e-10
molecular O 0 1.4950339632946452e-08
mechanisms O 0 7.586111649970917e-08
of O 0 6.278749076216172e-09
imprinting O 0 6.127353344709263e-07
in O 0 1.5894789651138552e-10
this O 0 2.3176623814569197e-11
region O 0 3.973152029601579e-09
of O 0 1.2361844881070283e-09
the O 0 7.619965214367141e-10
genome O 0 7.962146497675349e-09
. O 0 2.519508601750431e-09
. O 0 3.7287183118905887e-08

Mutations O 0 1.922483505722994e-07
of O 0 3.0388076055487545e-08
the O 0 1.908482971657577e-08
ATM O 0 0.00046601842041127384
gene O 0 2.8767597193279926e-09
detected O 0 1.136321081673941e-08
in O 0 4.565972877568214e-10
Japanese O 1 0.9982193112373352
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9995934367179871
: O 0 9.270092332647195e-11
possible O 0 8.004030216390845e-10
preponderance O 0 4.94676122286819e-09
of O 0 8.63082660895742e-11
the O 0 3.1555126567273106e-11
two O 0 5.245585563140587e-11
founder O 0 7.127155754460546e-09
mutations O 0 6.273410235735355e-09
4612del165 O 0 7.685465561735327e-07
and O 0 1.1027095681015453e-08
7883del5 O 0 6.34583193459548e-05
. O 0 1.0068976052934886e-06

The O 0 3.593319490846625e-07
ATM O 0 0.08554981648921967
( O 0 7.98235859633678e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 6.858482670679678e-10
mutated O 0 1.5045469037300307e-10
) O 0 2.9271396504576552e-12
gene O 0 2.571807176943164e-11
on O 0 5.2890365698221586e-11
human O 0 8.541871654443867e-10
chromosome O 0 7.841758531412779e-08
11q22 O 0 3.0572824471164495e-05
. O 0 2.2316984882309043e-07

3 O 0 8.565633891066682e-08
has O 0 9.399746953020482e-11
recently O 0 2.153042674701844e-11
been O 0 6.4008061004261485e-12
identified O 0 6.004053504371498e-11
as O 0 1.4639348761003035e-12
the O 0 3.267491095401698e-12
gene O 0 1.078705701151872e-11
responsible O 0 1.2266831994622862e-10
for O 0 2.8092970658089023e-11
the O 0 6.988259970697186e-10
human O 0 2.727838364080526e-07
recessive B-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999979734420776
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.132044236129559e-08
. O 0 4.966911149040243e-08

In O 0 1.132633808964556e-08
order O 0 5.169545347349924e-10
to O 0 4.787006346873568e-10
define O 0 4.979657575177043e-09
the O 0 2.719066638512402e-10
types O 0 2.851227698386083e-09
of O 0 2.541950294698836e-08
disease O 0 5.9080906794406474e-05
- O 0 6.149246445374956e-08
causing O 0 6.593150914113721e-09
ATM O 0 2.8292512070038356e-05
mutations O 0 1.1966477808655895e-10
in O 0 5.134490749236775e-11
Japanese O 0 4.4402429466572357e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.334056822903221e-07
as O 0 1.8673956825310256e-10
well O 0 8.606448193004823e-11
as O 0 1.0362657780482731e-11
to O 0 2.0923485166690625e-11
look O 0 1.981049491117659e-10
for O 0 6.185669337854804e-11
possible O 0 1.2165951801534902e-08
mutational O 0 1.94650510820793e-06
hotspots O 0 2.55523069370156e-08
, O 0 3.3519728659392456e-11
reverse O 0 2.7335134156203367e-09
- O 0 5.596281660302793e-09
transcribed O 0 4.824627364286016e-09
RNA O 0 2.2955179979078366e-09
derived O 0 4.2898745666875016e-10
from O 0 3.781980978390109e-11
ten O 0 5.764503874239324e-10
patients O 0 9.811659124059346e-11
belonging O 0 1.5704374467517823e-09
to O 0 9.06874714212691e-11
eight O 0 3.840720241843343e-10
unrelated O 0 1.5789501262020167e-08
Japanese O 0 5.476735168485902e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
families O 0 3.361189104822415e-09
was O 0 8.234434245579791e-10
analyzed O 0 1.5364147454288712e-10
for O 0 7.324097383264172e-13
mutations O 0 6.885266662370881e-12
by O 0 1.5338336070008785e-12
the O 0 2.0014207305352194e-11
restriction O 0 6.91538354358201e-11
endonuclease O 0 4.887560911548405e-10
fingerprinting O 0 1.1450214998376396e-08
method O 0 1.88677418577754e-07
. O 0 5.109908443046152e-07

As O 0 3.951908311705665e-08
has O 0 5.822425874768555e-11
been O 0 2.775455906767199e-11
reported O 0 6.8946758025045796e-12
by O 0 1.9147758465593023e-12
others O 0 5.643223735529723e-11
, O 0 6.89830614505893e-12
mutations O 0 6.912481698151396e-11
that O 0 1.0314188739202201e-11
lead O 0 2.933213449907157e-09
to O 0 4.880958748287867e-09
exon O 0 4.4124752207608253e-07
skipping O 0 7.81143796757533e-07
or O 0 4.9477549168841506e-08
premature O 0 3.6439903396967566e-06
protein O 0 1.0538280292848867e-07
truncation O 0 4.100184924027417e-06
were O 0 9.550789314971553e-08
also O 0 7.33939409247597e-10
predominant O 0 6.553796794150912e-08
in O 0 7.057485706951638e-10
our O 0 1.5261448993442173e-07
mutants O 0 3.2970854135783156e-07
. O 0 3.316770573746908e-07

Six O 0 2.1451512566272868e-08
different O 0 2.737101378880169e-10
mutations O 0 1.1589219167662534e-10
were O 0 5.5848870667007944e-11
identified O 0 1.3593198788797167e-10
on O 0 6.978879280028494e-11
12 O 0 3.9134395724005344e-10
of O 0 4.65714744546375e-10
the O 0 8.090290104512121e-10
16 O 0 1.3983361135672112e-08
alleles O 0 3.2676332750725123e-09
examined O 0 4.906789285996638e-07
. O 0 5.853025868418626e-07

Four O 0 3.406290360885578e-08
were O 0 8.752415681101411e-09
deletions O 0 7.489052045173139e-09
involving O 0 1.2385900305389441e-08
a O 0 1.834823071256153e-09
loss O 0 1.8739615370577667e-07
of O 0 6.375234534061747e-06
a O 0 6.068859903507473e-08
single O 0 5.782679863841622e-07
exon O 0 5.790543582406826e-07
exon O 0 1.0725059240712653e-07
7 O 0 3.12659267365234e-08
, O 0 2.0888335505730993e-09
exon O 0 3.2767847102377345e-08
16 O 0 1.0307400266640343e-08
, O 0 2.267026788516091e-09
exon O 0 1.2158649553839496e-07
33 O 0 2.2140102373668924e-07
or O 0 9.485144403242884e-08
exon O 0 5.541060545510845e-06
35 O 0 4.012262252217624e-06
. O 0 2.1642156298185e-06

The O 0 5.795068602765241e-08
others O 0 9.577638238056352e-09
were O 0 6.601015289930956e-09
minute O 0 2.129793408300884e-08
deletions O 0 4.65792293624645e-09
, O 0 2.2401397403726264e-10
4649delA O 0 8.762710024257103e-08
in O 0 6.9807768454666075e-09
exon O 0 1.677028222957233e-07
33 O 0 8.66883453909395e-08
and O 0 5.515943257705658e-09
7883del5 O 0 1.1619259566941764e-05
in O 0 6.340936664628316e-08
exon O 0 1.9682177025970304e-06
55 O 0 1.326589426753344e-06
. O 0 6.3227122382159e-07

The O 0 2.880287013340421e-07
mutations O 0 1.7374522087720834e-07
4612del165 O 0 1.5055206858960446e-06
and O 0 7.528777601351067e-10
7883del5 O 0 4.156686372880358e-06
were O 0 3.483104471513343e-09
found O 0 3.964147760049386e-11
in O 0 1.5601646493820787e-12
more O 0 1.310861141856634e-13
than O 0 3.5190231804926864e-13
two O 0 1.2460325739954703e-12
unrelated O 0 7.05296376857234e-10
families O 0 2.9071607968167434e-11
; O 0 2.702569938672905e-12
44 O 0 2.145559285793297e-09
% O 0 1.0415813767039594e-09
( O 0 8.177860298663742e-12
7 O 0 8.160417341862569e-10
of O 0 3.6164626848744774e-10
16 O 0 5.811776615516351e-10
) O 0 4.299117919298601e-12
of O 0 5.2280957341110934e-11
the O 0 2.1858639898120202e-11
mutant O 0 1.4578646623242264e-10
alleles O 0 5.6187363789428346e-11
had O 0 6.263181639987181e-11
one O 0 7.513763916611182e-12
of O 0 1.3074571980631333e-10
the O 0 7.224035813990781e-10
two O 0 3.2294782403852196e-09
mutations O 0 1.3315893454546313e-07
. O 0 3.3365452623002056e-07

The O 0 8.40596783291403e-07
4612del165 O 0 3.358933099661954e-05
mutations O 0 2.248423891515472e-09
in O 0 1.4905387688002314e-11
three O 0 4.176053600146723e-12
different O 0 3.877564068444084e-12
families O 0 4.33184477871551e-12
were O 0 3.30992733221791e-11
all O 0 3.0966980282126633e-12
ascribed O 0 5.977672246082477e-10
to O 0 2.007622193489489e-11
the O 0 1.1338387867487754e-10
same O 0 5.448954065734313e-10
T O 0 2.1532347460606616e-08
- O 0 1.9711281140644132e-07
- O 0 5.0522931616114874e-08
> O 0 6.241697825259962e-09
A O 0 2.43914244357768e-09
substitution O 0 1.247939640514062e-09
at O 0 3.0774821579981904e-10
the O 0 2.5356139410348533e-10
splice O 0 8.50267269925098e-08
donor O 0 3.584004870660351e-09
site O 0 3.469234233222096e-09
in O 0 3.753305222176095e-09
intron O 0 5.731854798796121e-06
33 O 0 1.885915594357357e-06
. O 0 8.452552151538839e-07

Microsatellite O 0 2.1473149899975397e-05
genotyping O 0 4.704924322140869e-06
around O 0 3.4470457599411475e-09
the O 0 4.466257141899632e-09
ATM O 0 7.391225517494604e-05
locus O 0 8.536859219532289e-09
also O 0 4.0865522771271756e-11
indicated O 0 5.972794481223787e-10
that O 0 1.6557861852450895e-12
a O 0 1.4493274635984932e-11
common O 0 5.324659047012403e-10
haplotype O 0 2.698032908199366e-08
was O 0 2.1284655815634324e-08
shared O 0 3.873636966744698e-09
by O 0 1.8306264490397517e-11
the O 0 4.871178807541732e-11
mutant O 0 3.316747987369695e-10
alleles O 0 9.336564854578455e-11
in O 0 7.466110368836709e-11
both O 0 3.7186664858523955e-09
mutations O 0 2.9754312791396842e-08
. O 0 2.123328641800981e-07

This O 0 8.545754326405586e-09
suggests O 0 3.260996361831303e-09
that O 0 3.528488265458485e-12
these O 0 1.988032308219978e-11
two O 0 7.66462379675481e-11
founder O 0 2.6006382825016772e-08
mutations O 0 4.320118041079013e-09
may O 0 1.8450485583798582e-10
be O 0 3.8434827542843664e-10
predominant O 0 7.537376944810603e-08
among O 0 2.867751869306545e-10
Japanese O 0 1.2442686170288653e-07
ATM O 0 1.110116772906622e-05
mutant O 0 1.0293376107028962e-07
alleles O 0 2.3296855999888066e-08
. O 0 3.756938724563952e-07

W474C O 0 2.165508340112865e-05
amino O 0 5.2097082203772516e-08
acid O 0 4.707223055788745e-09
substitution O 0 9.578350557148951e-09
affects O 0 2.2762242091189933e-10
early O 0 3.4424249562015063e-10
processing O 0 1.2942340532617891e-08
of O 0 4.167972911250928e-10
the O 0 1.5894575933206312e-10
alpha O 0 1.8409146429476664e-10
- O 0 1.5229324745735795e-10
subunit O 0 7.251006045594366e-11
of O 0 4.855865709529894e-10
beta O 0 4.695440480873003e-09
- O 0 2.0647116016903055e-08
hexosaminidase O 0 2.092276361054246e-07
A O 0 2.333487891803543e-08
and O 0 5.853258155941177e-11
is O 0 2.279546690298062e-11
associated O 0 2.1892123669431385e-09
with O 0 2.4844148960312396e-09
subacute O 1 0.9974867105484009
G B-Disease 0 0.00037904834607616067
( I-Disease 0 2.0068824824193143e-08
M2 I-Disease 0 1.3940631106379442e-05
) I-Disease 0 1.1156100931941637e-08
gangliosidosis I-Disease 0 1.5799878383404575e-05
. O 0 3.2825903417688096e-07

Mutations O 0 1.9253238292549213e-07
in O 0 2.8738040835918355e-09
the O 0 5.990389961851861e-09
HEXA O 0 1.1054692549805623e-05
gene O 0 2.407659349668023e-10
, O 0 8.956731190057354e-12
encoding O 0 3.3489647166540237e-10
the O 0 1.8041859672912608e-10
alpha O 0 1.0692833424252868e-10
- O 0 1.3732567860635925e-10
subunit O 0 7.312687261284978e-11
of O 0 4.0421041513916123e-10
beta O 0 1.9107329052303612e-09
- O 0 1.2349903322217415e-08
hexosaminidase O 0 3.587248897929385e-07
A O 0 6.5863908105257e-08
( O 0 1.3284494337906239e-10
Hex O 0 5.9046904254955734e-08
A O 0 1.4616833965419573e-08
) O 0 4.4013979960677574e-11
, O 0 1.694635751170459e-11
that O 0 9.295566920364262e-12
abolish O 0 8.209816826365568e-09
Hex O 0 7.179276906299492e-08
A O 0 5.469334762864264e-09
enzyme O 0 2.619084948918271e-09
activity O 0 2.9509420684803445e-08
cause O 0 0.000933396106120199
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.3900240958264476e-07
TSD B-Disease 1 0.9999990463256836
) O 0 1.6357451504411813e-10
, O 0 1.877895755564296e-11
the O 0 2.0312110327047606e-10
fatal O 0 4.139709233186295e-07
infantile B-Disease 0 1.7871608406494488e-06
form I-Disease 0 2.1585599085938156e-08
of I-Disease 0 4.137412543059327e-05
G I-Disease 0 3.0468333989119856e-06
( I-Disease 0 1.948232908333125e-09
M2 I-Disease 0 9.54019014898222e-07
) I-Disease 0 6.271660413226243e-10
gangliosidosis I-Disease 0 7.171727816057683e-07
, I-Disease 0 5.625698240585564e-10
Type I-Disease 0 9.64482822496393e-08
1 I-Disease 0 1.792549966239676e-07
. O 0 1.3354963357414817e-07

Less O 0 5.0815456233976875e-06
severe O 0 9.500544547336176e-05
, O 0 3.2197927879451527e-08
subacute O 1 0.9987364411354065
( O 0 3.9951206787236515e-09
juvenile O 0 0.003615018678829074
- O 0 6.949904673092533e-06
onset O 1 0.9999924898147583
) O 0 2.6600250890851385e-09
and O 0 8.109717697379892e-08
chronic O 1 1.0
( O 0 2.5328117381206994e-09
adult O 0 0.00034783771843649447
- O 0 2.689955280743561e-08
onset O 0 1.9671469431159494e-07
) O 0 2.636553302071132e-12
variants O 0 1.2133959115256943e-10
are O 0 2.3055233937252506e-12
characterized O 0 9.380631688093999e-12
by O 0 2.66558758572899e-12
a O 0 3.022328914914496e-11
broad O 0 1.0984618076248509e-10
spectrum O 0 1.3805030452118672e-09
of O 0 2.4566876311027386e-10
clinical O 0 5.46531975231801e-09
manifestations O 0 6.98799729192956e-09
and O 0 4.4437859642032507e-11
are O 0 5.616590092322182e-12
associated O 0 4.0989972527327723e-10
with O 0 5.390433238661174e-11
residual O 0 1.5576590328691964e-07
levels O 0 3.7441974853891224e-08
of O 0 4.37035874156777e-09
Hex O 0 7.84347946591879e-08
A O 0 2.6817023268677076e-08
enzyme O 0 6.0364175880067705e-09
activity O 0 3.588877106608379e-08
. O 0 5.3739032779276386e-08

We O 0 8.200837697813768e-08
identified O 0 3.203198772894211e-08
a O 0 1.3730321324345596e-09
1422 O 0 3.9399836282427714e-07
G O 0 2.5544613890815526e-07
- O 0 1.0131316230399534e-06
- O 0 1.3701294676593534e-07
> O 0 1.7848833522293717e-08
C O 0 4.078374260529927e-08
( O 0 2.120184409981629e-11
amino O 0 1.4490461608396288e-10
acid O 0 9.076031592947231e-11
W474C O 0 7.407648716650783e-09
) O 0 3.895961786688773e-13
substitution O 0 1.098019800083172e-10
in O 0 1.3086241291981882e-11
the O 0 3.15489891156151e-11
first O 0 2.558002698549444e-10
position O 0 1.3042032342980292e-08
of O 0 2.467392157257109e-08
exon O 0 1.2626162515516626e-07
13 O 0 6.674597763378642e-09
of O 0 1.792846937576087e-08
HEXA O 0 0.00018990620446857065
of O 0 9.090146591006487e-08
a O 0 3.14010373259066e-09
non O 0 5.640966378450685e-07
- O 0 7.52244062596219e-08
Jewish O 0 2.4284206645575068e-08
proband O 0 7.563539111288264e-05
who O 0 1.7281535091839828e-09
manifested O 0 1.913162606115293e-08
a O 0 7.060810824910391e-10
subacute O 0 1.4112474673311226e-06
variant O 0 5.276218573158076e-08
of O 0 7.284157618414611e-06
G B-Disease 0 5.717662861570716e-05
( I-Disease 0 1.8992484029922707e-08
M2 I-Disease 0 2.1211935745668598e-05
) I-Disease 0 1.2374802516035288e-08
gangliosidosis I-Disease 0 1.2432749826984946e-05
. O 0 2.527582410039031e-07

On O 0 1.0018251828114444e-07
the O 0 4.92274132568582e-09
second O 0 2.3132232129796648e-08
maternally O 0 9.93427761386556e-07
inherited O 0 4.747847128783178e-07
allele O 0 1.1935648913663499e-08
, O 0 3.7967906596492185e-11
we O 0 5.1655998922761626e-11
identified O 0 2.52688625579367e-09
the O 0 9.489858898703574e-10
common O 0 1.527232484477281e-06
infantile O 1 0.9999998807907104
disease O 1 1.0
- O 0 0.034958887845277786
causing O 0 3.94603432596341e-07
4 O 0 1.5419228702739929e-06
- O 0 3.4199229048681445e-07
bp O 0 1.4741959653008507e-08
insertion O 0 1.8515933675189444e-08
, O 0 1.0442948727984458e-09
+ O 0 8.064753131975522e-08
TATC O 0 0.00014699787425342947
1278 O 0 6.752711669832934e-06
, O 0 1.3112538832515952e-09
in O 0 2.9837499138096746e-09
exon O 0 2.3023470419047953e-07
11 O 0 1.0888552992582845e-07
. O 0 6.090313036111183e-07

Pulse O 0 5.3274161473382264e-05
- O 0 2.7529063117981423e-07
chase O 0 1.1902774765815138e-08
analysis O 0 1.2002898674978724e-09
using O 0 1.410671468526914e-09
proband O 0 1.157930796580331e-06
fibroblasts O 0 4.867429765909037e-07
revealed O 0 9.779961729350362e-09
that O 0 6.286601014066084e-12
the O 0 5.580043024866477e-11
W474C O 0 2.9784180455294518e-08
- O 0 1.793580423070651e-10
containing O 0 2.8493384734984417e-11
alpha O 0 1.1142840816713573e-10
- O 0 4.459734248563052e-10
subunit O 0 3.07558090106852e-10
precursor O 0 1.0040318576542973e-09
was O 0 2.7325959273127864e-09
normally O 0 1.4527191671831474e-09
synthesized O 0 8.510975924025388e-09
, O 0 2.6573651265571208e-11
but O 0 1.2690734747800025e-11
not O 0 3.8418757758451605e-11
phosphorylated O 0 2.5867468167461993e-08
or O 0 1.5059543612139237e-09
secreted O 0 6.477983927055675e-09
, O 0 9.026553809965421e-11
and O 0 1.238988217577841e-10
the O 0 1.95012894721458e-09
mature O 0 3.082326429648674e-07
lysosomal O 0 6.672041195088241e-07
alpha O 0 7.891871156573416e-09
- O 0 8.019346076082456e-09
subunit O 0 4.381776719242225e-09
was O 0 1.367249513606339e-08
not O 0 1.1776040143018918e-09
detected O 0 2.84736586309009e-07
. O 0 1.5144243548093073e-07

When O 0 2.3239518753825905e-08
the O 0 5.151466364594626e-09
W474C O 0 6.328225481411209e-07
- O 0 3.1245639409149817e-09
containing O 0 1.8150791980531267e-10
alpha O 0 4.436538914021071e-10
- O 0 4.677319642709676e-10
subunit O 0 3.5785385765763067e-10
was O 0 6.243579431242097e-09
transiently O 0 5.779746814482678e-08
co O 0 2.1359962687483858e-09
- O 0 5.949508663505299e-10
expressed O 0 7.299281318262629e-11
with O 0 1.887579719264676e-12
the O 0 2.7920428122274465e-11
beta O 0 8.409758306404669e-11
- O 0 2.739460915057723e-11
subunit O 0 7.594276769939956e-12
to O 0 1.693982974726449e-11
produce O 0 2.854044778288767e-10
Hex O 0 7.218491759886092e-08
A O 0 1.0423038077078672e-07
( O 0 1.5596434144171667e-09
alphabeta O 0 4.520898983173538e-06
) O 0 2.3998195097796327e-10
in O 0 4.274594900266493e-09
COS O 0 1.6165706256288104e-05
- O 0 2.4138054754985205e-07
7 O 0 6.043249012321894e-09
cells O 0 3.086601418900159e-09
, O 0 1.0939534000886653e-11
the O 0 3.794560846093198e-11
mature O 0 1.3335300641514891e-09
alpha O 0 1.9511882387579504e-10
- O 0 2.4149077182400447e-10
subunit O 0 1.8421650316291505e-10
was O 0 4.947089404794269e-10
present O 0 3.376293133960928e-10
, O 0 1.1578386686916797e-11
but O 0 4.485706944779011e-12
its O 0 1.6594378865822379e-12
level O 0 2.3277667793308865e-08
was O 0 3.004617443735924e-09
much O 0 3.5796307584767817e-10
lower O 0 3.7745315206727525e-10
than O 0 1.686988547987267e-12
that O 0 3.4692135774359867e-13
from O 0 2.7454868239962238e-11
normal O 0 4.123795527277707e-09
alpha O 0 3.0601055023282697e-09
- O 0 8.856059885431478e-09
subunit O 0 2.3955812888942773e-09
transfections O 0 1.4928660618807044e-07
, O 0 2.511110243352821e-11
although O 0 3.283311122981303e-11
higher O 0 3.6954445059578234e-10
than O 0 1.4359813251679787e-12
in O 0 3.5493658793323e-12
those O 0 3.3677036853640985e-12
cells O 0 1.1303924463135218e-10
transfected O 0 4.178378532060378e-09
with O 0 5.483835174152629e-12
an O 0 7.28318707426956e-12
alpha O 0 8.859839528696511e-10
- O 0 4.065681569187518e-09
subunit O 0 2.7991373663383e-09
associated O 0 7.581887473406823e-08
with O 0 5.731335406267135e-08
infantile O 1 0.9616250395774841
TSD B-Disease 1 0.9840894937515259
. O 0 2.4115699943649815e-06

Furthermore O 0 1.527346057628165e-06
, O 0 7.182639483183095e-10
the O 0 1.984805236832088e-10
precursor O 0 2.318464975559209e-09
level O 0 4.9718497763251435e-08
of O 0 1.6706573902069977e-09
the O 0 2.991623615500316e-10
W474C O 0 5.265230385020914e-08
alpha O 0 5.314431672509556e-10
- O 0 5.515267131883661e-10
subunit O 0 2.6332538927142934e-10
was O 0 1.0850169651632768e-09
found O 0 1.8600400733537192e-11
to O 0 3.4556395939189244e-11
accumulate O 0 1.0300903185989085e-10
in O 0 1.743770058904026e-11
comparison O 0 1.1647056930019772e-10
to O 0 2.7514419562169046e-11
the O 0 4.3193579268852034e-10
normal O 0 1.8731128648141748e-07
alpha O 0 3.2045129216839996e-08
- O 0 1.0940994599195619e-07
subunit O 0 5.493414789725648e-08
precursor O 0 1.9808594231562893e-07
levels O 0 4.325174529640208e-07
. O 0 7.505242649585853e-08

We O 0 9.31549735128101e-08
conclude O 0 4.3450771158859425e-07
that O 0 1.5430724753517921e-10
the O 0 5.032044225750099e-10
1422 O 0 4.5365928258433996e-07
G O 0 3.4767978718264203e-07
- O 0 2.387223275945871e-06
- O 0 3.972533022533753e-07
> O 0 9.775676090839625e-08
C O 0 1.2967339557690138e-07
mutation O 0 1.9576223975192875e-10
is O 0 9.392926974410853e-13
the O 0 5.774435183486526e-12
cause O 0 7.668576329500354e-10
of O 0 5.984693274285746e-08
Hex B-Disease 0 0.0024479294661432505
A I-Disease 1 0.9849053025245667
enzyme I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 0 9.234913278532986e-09
the O 0 3.488198885293059e-08
proband O 0 6.15675890003331e-05
. O 0 3.369873127212486e-07

The O 0 2.16797158003601e-08
resulting O 0 5.2650499071660306e-08
W474C O 0 4.4987910996496794e-07
substitution O 0 8.04267585863272e-09
clearly O 0 6.584877643156517e-10
interferes O 0 1.5009418152800436e-09
with O 0 2.2737454280497005e-11
alpha O 0 4.173716650068826e-10
- O 0 3.960491656851417e-10
subunit O 0 2.580446412103754e-10
processing O 0 1.573736518878377e-08
, O 0 5.277878828424676e-12
but O 0 1.4945406023869623e-12
because O 0 5.864494003263165e-13
the O 0 4.320507059757395e-12
base O 0 2.4142859933462546e-10
substitution O 0 1.8126168344068105e-09
falls O 0 1.915638137006681e-08
at O 0 3.749267840635895e-10
the O 0 9.840483289336177e-11
first O 0 4.291536015443853e-10
position O 0 1.7539564467483615e-08
of O 0 3.722252017723804e-08
exon O 0 1.0005514639033208e-07
13 O 0 4.123174246473127e-09
, O 0 3.446471996682021e-10
aberrant O 0 1.0455149634935879e-08
splicing O 0 9.385767896219477e-08
may O 0 8.316067279245942e-10
also O 0 4.536326175808014e-11
contribute O 0 7.431211201947008e-09
to O 0 3.0146303231504135e-08
Hex B-Disease 0 0.03870010003447533
A I-Disease 0 0.4720820486545563
deficiency I-Disease 1 0.5784968137741089
in O 0 3.771784218287166e-09
this O 0 1.0311307363508604e-09
proband O 0 1.1173806342412718e-05
. O 0 8.313723931507866e-09
. O 0 7.41182120123085e-08

Two O 0 3.336961640343361e-08
frequent O 0 3.784606406043167e-08
missense O 0 8.075732694123872e-06
mutations O 0 1.0683770597097464e-06
in O 0 2.1744167497672606e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0004066810361109674

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.0698600760861154e-07
an O 0 2.6603163405525265e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.057752832770347595
by O 0 5.266831970551777e-10
early O 0 2.1560786990448833e-05
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999994039535522
goiter B-Disease 1 1.0
. O 1 0.9997249245643616

A O 0 8.33182483006567e-08
century O 0 3.9288110542656796e-09
after O 0 1.8901505360879867e-10
its O 0 1.4399197979797496e-12
recognition O 0 1.6120478563141916e-10
as O 0 7.193905887659113e-11
a O 0 1.0948750794881335e-09
syndrome O 0 3.3149558475997765e-07
by O 0 1.6202257591135805e-10
Vaughan O 0 3.3054095638362924e-07
Pendred O 0 0.026291251182556152
, O 0 5.5940242021934594e-11
the O 0 1.4276588244932498e-10
disease O 0 3.860347774775619e-08
gene O 0 1.2847691799322547e-09
( O 0 3.410447479978984e-10
PDS O 0 1.874148438218981e-05
) O 0 5.572948352794427e-11
was O 0 3.004961168784348e-09
mapped O 0 8.226024306168256e-09
to O 0 1.0586299614701034e-09
chromosome O 0 4.526238228663715e-07
7q22 O 0 0.005164650734513998
- O 0 8.390669245272875e-05
q31 O 0 0.0003172564320266247
. O 0 1.0992299621648272e-06

1 O 0 1.2939482019191928e-07
and O 0 3.705143969412461e-09
, O 0 2.0202803319158136e-10
recently O 0 2.5106614010006467e-10
, O 0 9.97483692866119e-12
found O 0 1.8150644182091114e-11
to O 0 4.3171400482266975e-11
encode O 0 1.3177280600018548e-08
a O 0 1.8046488747813783e-08
putative O 0 6.00279008722282e-06
sulfate O 0 8.464575330435764e-06
transporter O 0 1.2028171113342978e-05
. O 0 1.928436176967807e-06

We O 0 1.0413316431368003e-08
performed O 0 5.81372017194326e-09
mutation O 0 2.4756721672680726e-10
analysis O 0 1.1093938268036396e-10
of O 0 1.376852382106719e-10
the O 0 9.130364797549362e-10
PDS B-Disease 0 0.09664967656135559
gene O 0 3.215991695171283e-09
in O 0 1.6800671964745106e-10
patients O 0 4.144391496652133e-09
from O 0 6.471546076802781e-10
14 O 0 4.9996051743050884e-09
Pendred B-Disease 0 1.707456135591201e-06
families O 0 1.1066907806833726e-10
originating O 0 2.8156403875101432e-09
from O 0 6.090733473129717e-11
seven O 0 1.3632509010541582e-10
countries O 0 9.327041916584733e-11
and O 0 4.554150112578981e-11
identified O 0 8.69048477625256e-09
all O 0 1.4262060421543765e-09
mutations O 0 4.372086692683297e-08
. O 0 7.460867834652163e-08

The O 0 5.409908254705442e-08
mutations O 0 3.755560751272924e-09
include O 0 8.204845830528384e-11
three O 0 9.547006241117373e-11
single O 0 1.1343801453733704e-09
base O 0 1.639107338746726e-08
deletions O 0 7.746288055443529e-09
, O 0 1.709185709630745e-10
one O 0 3.424122096973292e-10
splice O 0 3.348476695919089e-07
site O 0 5.164777938659881e-09
mutation O 0 2.478545813033861e-09
and O 0 5.922878298925127e-10
10 O 0 5.118950952009982e-08
missense O 0 1.2617242646228988e-05
mutations O 0 2.486400774159847e-07
. O 0 9.021503046824364e-07

One O 0 1.0935069383322116e-07
missense O 0 4.173429260845296e-06
mutation O 0 2.2901138763131712e-08
( O 0 7.998124385011351e-10
L236P O 0 1.5872872609179467e-05
) O 0 1.6524087653735364e-10
was O 0 7.366141918652147e-09
found O 0 1.0205975647936683e-10
in O 0 9.821502985896124e-12
a O 0 1.559385953697756e-11
homozygous O 0 2.071660204494563e-10
state O 0 1.3742569582309017e-11
in O 0 7.556117190277156e-12
two O 0 4.07184702622132e-11
consanguineous O 0 1.2059099390171468e-06
families O 0 1.7268676766324376e-10
and O 0 2.28460878687331e-11
in O 0 2.220506417627277e-11
a O 0 2.0921009716290406e-11
heterozygous O 0 9.01444127676676e-11
state O 0 8.742659374227912e-12
in O 0 9.693553251755027e-12
five O 0 1.9646687055008272e-11
additional O 0 2.5756274890653685e-10
non O 0 1.3178340907415986e-07
- O 0 2.3831324824641342e-07
consanguineous O 0 1.836946830735542e-05
families O 0 4.082328075583064e-08
. O 0 4.3174679831281537e-07

Another O 0 9.061287187250855e-07
missense O 0 1.3510466487787198e-05
mutation O 0 2.8659997042268515e-08
( O 0 1.368657742695234e-09
T416P O 0 1.0843039490282536e-05
) O 0 1.3520720654192075e-10
was O 0 4.084693472350409e-09
found O 0 9.595346739388333e-11
in O 0 1.624628383212201e-11
a O 0 2.1456062621050265e-11
homozygous O 0 5.105402212102206e-10
state O 0 9.960810648523832e-11
in O 0 6.30551791336309e-11
one O 0 1.0810584372134002e-10
family O 0 1.1840221858516742e-10
and O 0 1.5921300736132515e-11
in O 0 2.2496613946709765e-11
a O 0 2.962865716660268e-11
heterozygous O 0 8.115415284226657e-11
state O 0 2.087015456286867e-11
in O 0 3.056369046738894e-11
four O 0 1.7106534244692995e-10
families O 0 5.261149294000234e-10
. O 0 3.457464359257756e-08

Pendred B-Disease 0 0.09001980721950531
patients O 0 1.8266258905441646e-07
in O 0 7.091110476586948e-10
three O 0 1.1484220241442245e-09
non O 0 1.4796052028032136e-07
- O 0 4.0341518570130575e-08
consanguineous O 0 4.231984348734841e-06
families O 0 1.5107927409108157e-10
were O 0 1.5716952739275314e-10
shown O 0 2.3022080075651985e-10
to O 0 4.250833365859741e-11
be O 0 1.1642903308128894e-10
compound O 0 6.506650773729916e-09
heterozygotes O 0 1.1076426176259702e-07
for O 0 6.413794828574737e-09
L236P O 0 4.387418448459357e-05
and O 0 1.1333106897382095e-07
T416P O 0 0.0001588411396369338
. O 0 8.056587148530525e-07

In O 0 2.8084549796858482e-08
total O 0 3.6475288567316966e-08
, O 0 1.860111786822216e-10
one O 0 2.5868564235143054e-11
or O 0 2.4851896582300803e-11
both O 0 2.362707252068219e-11
of O 0 8.898177333849233e-11
these O 0 8.847537286138518e-12
mutations O 0 4.108098236588198e-11
were O 0 9.145785517805649e-11
found O 0 2.3925011277681207e-11
in O 0 4.354874967582578e-12
nine O 0 3.140916693400442e-10
of O 0 3.716055518854233e-10
the O 0 5.644076872535209e-10
14 O 0 2.858862480081825e-09
families O 0 5.457306273548568e-10
analyzed O 0 1.339723638693613e-07
. O 0 7.173117211323188e-08

The O 0 4.248308815846258e-09
identification O 0 1.4155000371829374e-07
of O 0 1.0812389206193984e-08
two O 0 1.7875058100358387e-09
frequent O 0 3.1291637725416876e-08
PDS B-Disease 0 0.006295543629676104
mutations O 0 1.432440943638369e-09
will O 0 5.621233686858851e-11
facilitate O 0 1.1940429978096745e-08
the O 0 1.2934781024043218e-09
molecular O 0 2.9107059162925e-07
diagnosis O 0 0.014151934534311295
of O 1 0.5479966402053833
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.560832167044282e-05

Insertional O 0 0.00011362051009200513
mutation O 0 3.048921115578196e-08
by O 0 1.0336353994944147e-09
transposable O 0 3.579106532924925e-06
element O 0 1.1023041679436574e-07
, O 0 1.6479277942238468e-09
L1 O 0 0.0002936120727099478
, O 0 6.733757301757848e-11
in O 0 7.54563703186939e-11
the O 0 1.6360081067645638e-09
DMD B-Disease 1 1.0
gene O 0 6.394832996470257e-10
results O 0 2.8264113272058466e-10
in O 0 2.692724654362877e-10
X B-Disease 1 0.9106152653694153
- I-Disease 0 0.15821915864944458
linked I-Disease 0 0.01043147686868906
dilated I-Disease 0 0.3107759952545166
cardiomyopathy I-Disease 1 1.0
. O 0 1.9010600226465613e-05

X B-Disease 1 0.9918632507324219
- I-Disease 1 0.9985666871070862
linked I-Disease 1 0.6236456036567688
dilated I-Disease 1 0.9997660517692566
cardiomyopathy I-Disease 1 1.0
( O 0 1.3283022326504579e-06
XLDCM B-Disease 1 1.0
) O 0 4.6569144374064564e-11
is O 0 4.528923243374283e-12
a O 0 6.536942862012118e-12
clinical O 0 1.4108975099347276e-09
phenotype O 0 1.6374941402830245e-09
of O 0 7.302491944471967e-09
dystrophinopathy B-Disease 0 1.5745224573038286e-06
which O 0 1.1032443188174756e-11
is O 0 5.729246937979937e-12
characterized O 0 1.4886983312756286e-10
by O 0 1.7716807187984074e-10
preferential O 0 1.6747458175814245e-07
myocardial B-Disease 1 0.9990788698196411
involvement I-Disease 0 2.151615035472787e-06
without O 0 4.824848520712521e-09
any O 0 1.3234098261705185e-09
overt O 0 2.284878242164723e-08
clinical O 0 1.4896122024765646e-07
signs O 0 6.173973332579408e-08
of O 0 3.9805487176636234e-05
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9820199608802795

To O 0 1.0755701218556624e-08
date O 0 9.211764506744657e-08
, O 0 1.412997358007928e-10
several O 0 8.30192650735917e-11
mutations O 0 9.006763113106331e-10
in O 0 2.951856814537024e-10
the O 0 7.991259849404742e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9009142518043518
, O 0 3.636626615843852e-06
DMD O 1 1.0
, O 0 1.0150883467119343e-09
have O 0 4.496679938126302e-12
been O 0 8.199601587988159e-12
identified O 0 4.323996369293148e-11
in O 0 6.363192524977412e-12
patients O 0 1.6311871298135827e-10
with O 0 6.153156456578657e-11
XLDCM B-Disease 1 0.9999960660934448
, O 0 3.7834840815875737e-10
but O 0 1.6114568013314567e-11
a O 0 2.1606903766180352e-11
pathogenic O 0 2.3596156140115454e-09
correlation O 0 4.344326565153267e-10
of O 0 3.4005545601623055e-10
these O 0 9.922166560594192e-11
cardiospecific O 0 1.3773113494153222e-07
mutations O 0 1.4492902433715926e-09
in O 0 1.3359485739883326e-09
DMD O 1 1.0
with O 0 1.2370501289993285e-09
the O 0 3.7563648191962784e-08
XLDCM B-Disease 1 0.9999796152114868
phenotype O 0 2.429574976758886e-07
has O 0 7.271545171549931e-11
remained O 0 3.513519430953238e-08
to O 0 9.183967475401289e-10
be O 0 1.9323868727383342e-08
elucidated O 0 0.00011727552919182926
. O 0 1.0939007779597887e-06

We O 0 3.289214589585754e-08
report O 0 2.981239699550997e-10
here O 0 5.663873536843056e-11
the O 0 6.118664169080246e-12
identification O 0 1.1352632167671572e-09
of O 0 4.164913414150817e-10
a O 0 3.0091237834817264e-10
unique O 0 1.351046718944815e-09
de O 0 1.762615653433386e-08
novo O 0 3.143856730503103e-08
L1 O 0 1.056778387464874e-06
insertion O 0 1.0502639646858825e-08
in O 0 1.2652512371147395e-09
the O 0 8.856194888551272e-09
muscle O 0 9.12581157308523e-08
exon O 0 1.258900823586373e-07
1 O 0 1.457863429976669e-08
in O 0 6.8565633171147056e-09
DMD O 1 1.0
in O 0 4.283303045582443e-09
three O 0 2.6683895093526644e-09
XLDCM B-Disease 1 0.9937993884086609
patients O 0 3.0497453451516776e-09
from O 0 1.476671007694108e-10
two O 0 4.349755278187928e-11
unrelated O 0 6.8637993067000025e-09
Japanese O 0 9.027753833379393e-08
families O 0 3.5250362628858056e-09
. O 0 8.785285388057673e-08

The O 0 3.7234379135497875e-08
insertion O 0 9.100833864295055e-08
was O 0 6.196411561631976e-08
a O 0 1.2714393982093952e-09
5 O 0 1.935801963171002e-09
- O 0 1.3583176805553876e-09
truncated O 0 1.2615810618399337e-09
form O 0 2.05082339999052e-10
of O 0 2.3402395576965773e-09
human O 0 2.375198482340579e-09
L1 O 0 8.419912091994775e-07
inversely O 0 3.138901405463912e-08
integrated O 0 8.806676277117731e-08
in O 0 2.1210026790452474e-10
the O 0 2.1193242993877703e-10
5 O 0 5.296835858814575e-09
- O 0 6.445056044412922e-08
untranslated O 0 0.0006125193322077394
region O 0 2.9855275585077834e-08
in O 0 7.694347936570978e-10
the O 0 4.4889230110811695e-09
muscle O 0 7.182646299952467e-08
exon O 0 6.841151645176069e-08
1 O 0 1.853528885931155e-09
, O 0 1.8169417359548135e-11
which O 0 1.0924641183004957e-12
affected O 0 2.3490157735617245e-11
the O 0 1.668464845450135e-11
transcription O 0 4.0144290669452687e-10
or O 0 1.7639178312434112e-11
the O 0 2.7281107928267545e-10
stability O 0 4.124075530853588e-06
of O 0 1.2376998093088787e-08
the O 0 3.2434970265171614e-09
muscle O 0 3.861730490939408e-09
form O 0 1.0948457696002833e-09
of O 0 8.430938436276847e-08
dystrophin O 0 1.9397687083255732e-06
transcripts O 0 4.16105834233349e-08
but O 0 3.626841448695073e-12
not O 0 1.398456003776083e-12
that O 0 9.429725880347184e-13
of O 0 3.207524246207072e-10
the O 0 4.741681713937851e-09
brain O 1 0.8853724002838135
or O 0 8.594859046695547e-09
Purkinje O 0 0.3571963310241699
cell O 0 9.569957001076546e-06
form O 0 1.0658960825082886e-08
, O 0 4.053716251561923e-10
probably O 0 3.153067140715393e-09
due O 0 4.612236637058231e-08
to O 0 1.567288659964916e-10
its O 0 1.4538070400305081e-11
unique O 0 2.4512814000843264e-10
site O 0 1.4352440347309425e-09
of O 0 3.0455600263934457e-09
integration O 0 2.1450709937198553e-06
. O 0 7.457026072188455e-07

We O 0 5.112374523719154e-08
speculate O 0 2.0364227637514887e-08
that O 0 1.6000199212426458e-12
this O 0 9.739194043248411e-13
insertion O 0 9.952307866711863e-10
of O 0 1.2898049295273495e-09
an O 0 1.0946573508752167e-10
L1 O 0 1.0425666005176026e-05
sequence O 0 1.9360502534482293e-08
in O 0 1.4658182223570293e-08
DMD O 1 1.0
is O 0 2.217773326096406e-10
responsible O 0 8.203738799394955e-10
for O 0 2.575557475625878e-11
some O 0 6.068894518873602e-12
of O 0 3.4961800815525024e-11
the O 0 1.6632252866632946e-11
population O 0 2.506534476504063e-12
of O 0 1.3328700122772208e-11
Japanese O 0 4.700162481441339e-09
patients O 0 1.038348185211646e-09
with O 0 4.1248160442819426e-10
XLDCM B-Disease 1 0.8291842341423035
. O 0 5.3415600831385746e-08
. O 0 1.4258564817737351e-07

Severe O 0 0.0002645612694323063
early O 0 0.4944493770599365
- O 1 0.9997497200965881
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.2225611928661237e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.157568037044257e-05
red O 1 0.5226781964302063
hair O 1 1.0
pigmentation O 1 0.9999998807907104
caused O 1 0.7607609033584595
by O 0 1.4962583350097702e-07
POMC O 1 0.9998995065689087
mutations O 0 1.3423148459423828e-07
in O 0 3.3834055557235843e-09
humans O 0 3.69928514487583e-08
. O 0 3.8834627957839984e-08

Sequential O 0 1.6744787671996164e-06
cleavage O 0 3.0597689715250453e-07
of O 0 6.419500664378575e-08
the O 0 7.0047585509769306e-09
precursor O 0 6.497126392446262e-09
protein O 0 7.893914966139448e-10
pre O 0 5.846761652605892e-08
- O 0 3.849980245718143e-08
pro O 0 2.0510562990239123e-06
- O 0 1.8605929653858766e-05
opiomelanocortin O 0 0.00019075750606134534
( O 0 1.6795586033069299e-09
POMC O 0 1.3615547686640639e-05
) O 0 4.780279644345242e-11
generates O 0 8.421861125151864e-11
the O 0 3.8701767485216365e-11
melanocortin O 0 7.41292396355675e-08
peptides O 0 1.2079306443979476e-09
adrenocorticotrophin O 0 4.8917070216703e-07
( O 0 7.356085185428185e-10
ACTH O 0 1.561709268571576e-06
) O 0 3.586916041964372e-10
, O 0 2.2619217610042597e-09
melanocyte O 0 1.8819302567862906e-05
- O 0 4.61372037534602e-05
stimulating O 0 3.579741132853087e-06
hormones O 0 6.660521734147551e-08
( O 0 3.702867179544711e-10
MSH O 0 4.819737000616442e-07
) O 0 9.192755931475283e-12
alpha O 0 3.4058044579010627e-11
, O 0 1.2150853240244786e-12
beta O 0 8.379876653696883e-12
and O 0 2.171836929049098e-12
gamma O 0 3.4490282158072816e-11
as O 0 2.062795594059974e-11
well O 0 1.000658861327608e-10
as O 0 6.128326318632915e-11
the O 0 3.355211108946321e-10
opioid O 0 2.2770123564441747e-08
- O 0 2.5909786316447025e-08
receptor O 0 4.825296828769865e-10
ligand O 0 1.811808836293949e-08
beta O 0 8.154665351867152e-07
- O 0 3.859902790281922e-06
endorphin O 0 1.3531251170206815e-05
. O 0 1.3588669389719144e-07

While O 0 1.5141759490688855e-07
a O 0 1.9512376159269706e-09
few O 0 6.588621870307065e-10
cases O 0 4.175970125253059e-10
of O 0 5.6937015102676014e-08
isolated O 0 0.009963813237845898
ACTH B-Disease 1 1.0
deficiency I-Disease 0 0.017721742391586304
have O 0 3.7137296710065826e-11
been O 0 8.541997664757162e-11
reported O 0 1.337426697167743e-10
( O 0 8.786160687890288e-11
OMIM O 0 1.1500901564431842e-05
201400 O 0 4.037069913920277e-07
) O 0 9.50942311006564e-11
, O 0 6.978186778416884e-11
an O 0 1.5209759840484338e-10
inherited O 1 0.9983614087104797
POMC O 1 1.0
defect O 1 0.9999951124191284
has O 0 1.6694874649392233e-10
not O 0 4.143581311399913e-11
been O 0 3.681774884967126e-10
described O 0 2.7928446222347247e-09
so O 0 9.278853796423903e-10
far O 0 3.281104721253314e-09
. O 0 3.1295339653070187e-08

Recent O 0 6.965816368165179e-08
studies O 0 4.49810233504877e-09
in O 0 6.32261881738927e-11
animal O 0 4.781747567350614e-11
models O 0 4.1329747957341567e-10
elucidated O 0 7.956608527592834e-08
a O 0 1.6737630725849328e-10
central O 0 2.768553608589741e-09
role O 0 7.519850853121568e-10
of O 0 2.138729016110119e-08
alpha O 0 1.3943335375188326e-07
- O 0 3.936872872145614e-06
MSH O 0 6.527824007207528e-05
in O 0 2.731031234493031e-10
the O 0 8.182825250724335e-11
regulation O 0 4.659111429994311e-10
of O 0 1.466969046237665e-10
food O 0 1.6660893151221323e-11
intake O 0 4.492659282789857e-12
by O 0 1.6319533072996217e-13
activation O 0 2.61669557549693e-11
of O 0 9.70072133732458e-10
the O 0 5.083046872300656e-09
brain O 0 7.504893801524304e-06
melanocortin O 0 9.947845683200285e-06
- O 0 5.931730697739113e-07
4 O 0 2.894666017994041e-08
- O 0 3.1682244383546276e-08
receptor O 0 9.746265600130144e-11
( O 0 5.492526572448142e-11
MC4 O 0 1.2497237548814155e-05
- O 0 1.6395458146689634e-07
R O 0 2.798743992116215e-08
; O 0 2.553954964179539e-11
refs O 0 1.178539399404599e-08
3 O 0 5.383541390457935e-10
- O 0 6.216021031235641e-10
5 O 0 1.1920386552843887e-11
) O 0 7.755999618594411e-13
and O 0 1.7131919797727657e-12
the O 0 4.27666235758295e-11
linkage O 0 2.908732881223841e-07
of O 0 1.5630629235374727e-08
human O 0 8.375001243621227e-07
obesity B-Disease 1 1.0
to O 0 1.1947948408419506e-08
chromosome O 0 1.9671727358172575e-08
2 O 0 1.5006613729440232e-09
in O 0 2.6377430795143653e-10
close O 0 1.0998130406392193e-08
proximity O 0 1.2905931434659124e-08
to O 0 7.320729022985972e-10
the O 0 1.6708524341879638e-08
POMC O 0 6.168893742142245e-05
locus O 0 5.806229275151509e-09
, O 0 5.3702577107461735e-11
led O 0 7.576686500421204e-11
to O 0 3.208954282851728e-11
the O 0 1.0449915932575493e-10
proposal O 0 3.177474117155299e-10
of O 0 7.802096746445386e-10
an O 0 7.604673141203833e-11
association O 0 1.0132507055615747e-09
of O 0 1.2457979892133153e-07
POMC O 1 0.9995288848876953
with O 0 1.2870066790071633e-08
human O 0 2.8994436434004456e-05
obesity B-Disease 1 1.0
. O 0 1.6053045328590088e-06

The O 0 5.517914303254656e-08
dual O 0 7.828397201592452e-07
role O 0 1.3654856445555197e-07
of O 0 5.5362011153192725e-06
alpha O 0 5.3740121074952185e-05
- O 1 0.8646903038024902
MSH O 1 0.9982342720031738
in O 0 2.3276458538390443e-09
regulating O 0 1.2628937895442505e-08
food O 0 8.245341631685221e-10
intake O 0 2.4432864620393957e-09
and O 0 2.4328780656723836e-10
influencing O 0 5.535593572858488e-06
hair O 0 0.026773903518915176
pigmentation O 0 0.00013613195915240794
predicts O 0 6.620546333380162e-09
that O 0 3.977695343243548e-12
the O 0 3.431390588337635e-11
phenotype O 0 4.42108016862619e-10
associated O 0 3.218094957180284e-10
with O 0 3.323141761768511e-11
a O 0 3.454615038478437e-09
defect O 0 0.07350002974271774
in O 0 6.23264782007027e-08
POMC O 1 0.6894126534461975
function O 0 1.2309246244512906e-07
would O 0 8.362416870077993e-10
include O 0 7.940005097850644e-09
obesity B-Disease 1 1.0
, O 0 4.906756112532662e-10
alteration O 0 9.974177373806015e-06
in O 0 1.3820270794440148e-07
pigmentation O 1 0.9999982118606567
and O 0 0.3796345591545105
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999958276748657
. O 0 1.0446963642607443e-05

The O 0 5.99147824686952e-08
observation O 0 3.205191774213745e-07
of O 0 7.792938738759858e-09
these O 0 8.203520085459104e-10
symptoms O 0 2.186870773357441e-07
in O 0 2.521733100113721e-10
two O 0 5.507205247390345e-10
probands O 0 1.8995292521140072e-06
prompted O 0 4.247771856480398e-10
us O 0 6.744554220672327e-11
to O 0 2.6745317766030396e-11
search O 0 4.746142590050795e-09
for O 0 3.2816913075883747e-10
mutations O 0 8.854624589105242e-09
within O 0 2.407818122662775e-08
their O 0 3.484534971676112e-08
POMC O 0 0.0008957769023254514
genes O 0 3.449639507380198e-07
. O 0 3.8100071719782136e-07

Patient O 0 0.05474406108260155
1 O 0 1.457761129586288e-07
was O 0 2.6318959456261837e-08
found O 0 2.2909721342223577e-10
to O 0 2.2667220531125132e-11
be O 0 5.431529531696455e-11
a O 0 1.0805966538240952e-10
compound O 0 3.293487926825378e-09
heterozygote O 0 1.5647154683051667e-08
for O 0 4.51293898084959e-11
two O 0 1.400571464360567e-10
mutations O 0 8.814985963390143e-10
in O 0 8.026932452054325e-10
exon O 0 1.2410541927465601e-08
3 O 0 1.3599092962834902e-09
( O 0 3.9013439701029995e-10
G7013T O 0 2.7200812837691046e-06
, O 0 4.473518500081042e-10
C7133delta O 0 3.763324912142707e-06
) O 0 1.6954698062177087e-11
which O 0 1.4728692441026703e-12
interfere O 0 5.267917213558349e-10
with O 0 7.82283092470859e-12
appropriate O 0 5.015766468829952e-09
synthesis O 0 1.9481525725950632e-07
of O 0 6.728155454993612e-08
ACTH O 0 8.221765710914042e-06
and O 0 2.0911786080546335e-08
alpha O 0 1.363794240205607e-06
- O 0 1.8776010620058514e-05
MSH O 0 0.00029724996420554817
. O 0 4.0132471212928067e-07

Patient O 0 0.00023718641023151577
2 O 0 1.9653574767630744e-08
was O 0 3.729733855095674e-09
homozygous O 0 3.870200826483483e-10
for O 0 1.3476481215690672e-11
a O 0 8.365746984040356e-11
mutation O 0 4.258374208809812e-10
in O 0 9.522024280173014e-10
exon O 0 3.183701480224954e-08
2 O 0 5.255164747808294e-09
( O 0 1.9820938224057727e-09
C3804A O 0 2.9313973755051848e-06
) O 0 3.293649519786612e-10
which O 0 2.770348117575594e-10
abolishes O 0 1.6220415943735134e-07
POMC O 0 6.379299884429201e-05
translation O 0 4.279731001588516e-06
. O 0 1.7867655515146907e-06

These O 0 4.125006558552968e-09
findings O 0 3.731652764571436e-10
represent O 0 4.385100269010955e-11
the O 0 1.1915453866639947e-11
first O 0 1.6586286163966513e-11
examples O 0 1.4123130442911247e-10
of O 0 3.2658620252590254e-10
a O 0 1.743422517463955e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 2.909705720810507e-08
the O 0 1.4608241283298184e-09
POMC O 0 1.9199167581973597e-05
gene O 0 3.7424444099265486e-10
and O 0 1.803521047782919e-11
define O 0 1.2871458343610698e-09
a O 0 2.995597936372718e-10
new O 0 4.218344340500835e-09
monogenic B-Disease 1 1.0
endocrine I-Disease 1 0.9999997615814209
disorder I-Disease 0 0.046451881527900696
resulting O 0 1.602063015582189e-08
in O 0 3.4618555244669835e-10
early O 0 3.914895387424622e-06
- O 0 0.00024142605252563953
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.7640868438538746e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.00015050999354571104
red O 0 0.06558575481176376
hair O 1 0.9999998807907104
pigmentation O 1 0.9999953508377075
. O 0 1.6403041627199855e-06
. O 0 5.342288886822644e-07

A O 0 8.484364002470102e-07
European O 0 1.0730236255085401e-07
multicenter O 0 1.9059085389017127e-05
study O 0 6.179639910897095e-08
of O 0 9.467840754950885e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.63052937607722e-10
classification O 0 1.1875466165989224e-09
of O 0 1.1370770991447898e-09
105 O 0 2.652435604488801e-09
mutations O 0 3.221919606111179e-11
and O 0 7.677935544292414e-12
a O 0 1.462278041708398e-11
general O 0 5.253114609971021e-11
system O 0 4.1454964461173915e-10
for O 0 2.5252841484579847e-11
genotype O 0 7.292581649664953e-09
- O 0 1.3661123343666759e-09
based O 0 1.097375038061621e-10
prediction O 0 1.3502312867785804e-07
of O 0 1.3665247600158636e-08
metabolic O 0 1.2026875083392952e-05
phenotype O 0 2.920198198808066e-07
. O 0 3.212879562397575e-07

Phenylketonuria B-Disease 1 0.9945460557937622
( O 0 1.910278939476484e-07
PKU B-Disease 0 0.0028316043317317963
) O 0 2.9448399274656367e-09
and O 0 1.1158654444898275e-08
mild B-Disease 0 0.18128089606761932
hyperphenylalaninemia I-Disease 1 1.0
( O 0 3.243290848331526e-06
MHP B-Disease 1 1.0
) O 0 8.941326568034924e-10
are O 0 2.0082933926968138e-10
allelic B-Disease 0 7.803992616572941e-07
disorders I-Disease 0 1.2026733884340501e-06
caused O 0 2.2360897578010963e-09
by O 0 2.91998127066595e-11
mutations O 0 3.477352433778336e-11
in O 0 8.970801532171002e-12
the O 0 6.597961760279603e-11
gene O 0 6.23218976425477e-10
encoding O 0 2.4327559344783367e-07
phenylalanine O 0 5.560985300689936e-06
hydroxylase O 0 3.380433554411866e-05
( O 0 1.6425224202976096e-07
PAH O 0 0.0005930555053055286
) O 0 1.7390727080623947e-08
. O 0 2.445164852815651e-07

Previous O 0 3.3961967460527376e-07
studies O 0 3.3155793666139743e-09
have O 0 7.321727425735336e-12
suggested O 0 4.755072030571128e-11
that O 0 2.4044893680297275e-13
the O 0 8.523065066212698e-12
highly O 0 5.646825229632668e-09
variable O 0 4.4763484652321495e-07
metabolic O 0 0.0019227381562814116
phenotypes O 0 2.1769483282696456e-05
of O 1 0.9901414513587952
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999898672103882
correlate O 0 0.27931034564971924
with O 0 8.376291589229368e-06
PAH O 1 0.999995231628418
genotypes O 0 7.153297337936237e-05
. O 0 1.1509627029226976e-06

We O 0 5.563313365541944e-08
identified O 0 4.594798497237207e-08
both O 0 5.210559983481744e-09
causative O 0 1.22274187219773e-07
mutations O 0 5.038644612653798e-09
in O 0 4.719626911509067e-10
686 O 0 7.688032610531081e-08
patients O 0 5.71351943534637e-09
from O 0 1.5126908614604417e-09
seven O 0 4.078006821117697e-09
European O 0 5.327661511955739e-08
centers O 0 5.212521614339494e-08
. O 0 4.649891849339838e-08

On O 0 6.340561498063835e-08
the O 0 8.677875640294985e-10
basis O 0 1.1408859634798318e-08
of O 0 6.282400155654955e-10
the O 0 3.7864439361712243e-10
phenotypic O 0 1.7340017421929588e-08
characteristics O 0 5.127332780574534e-09
of O 0 5.387160051384399e-09
297 O 0 3.153044758619217e-08
functionally O 0 1.9341366623848444e-06
hemizygous O 0 1.993736759686726e-06
patients O 0 2.3874802135281925e-09
, O 0 5.673179807874629e-12
105 O 0 7.191399142847388e-10
of O 0 1.9827732511412677e-10
the O 0 1.1434445751357103e-10
mutations O 0 7.9228415494903e-11
were O 0 8.889830538372223e-11
assigned O 0 4.034117206952459e-10
to O 0 6.94667448564168e-11
one O 0 5.917229206620078e-11
of O 0 1.0874720013376304e-09
four O 0 6.72106981181031e-10
arbitrary O 0 2.2533233945409847e-08
phenotype O 0 3.5271096265887536e-08
categories O 0 4.8318316459017296e-08
. O 0 1.3423351674646256e-07

We O 0 8.831247733098735e-09
proposed O 0 5.024247129448156e-10
and O 0 2.222476890023639e-11
tested O 0 1.709961755524958e-10
a O 0 4.865076223825593e-12
simple O 0 1.9407316032005184e-11
model O 0 5.061554994578721e-11
for O 0 7.716782941813438e-12
correlation O 0 2.4819035715495374e-10
between O 0 2.966859813380296e-10
genotype O 0 1.655056891536333e-08
and O 0 8.285431785104436e-10
phenotypic O 0 9.066234696319952e-08
outcome O 0 2.316456630069297e-06
. O 0 1.6487040284118848e-06

The O 0 3.296405637343014e-08
observed O 0 2.076044935961363e-08
phenotype O 0 1.450103770395117e-08
matched O 0 2.652239849965099e-08
the O 0 1.503990931794874e-09
predicted O 0 8.44877057204485e-09
phenotype O 0 7.339519547677753e-10
in O 0 3.055296640686045e-11
79 O 0 6.4431482371674065e-09
% O 0 3.4598439668798164e-09
of O 0 1.6108706035744547e-10
the O 0 3.244861324080972e-11
cases O 0 4.0081455515705855e-11
, O 0 1.3824198730194581e-11
and O 0 1.5918719467600262e-11
in O 0 2.988263109182654e-11
only O 0 1.3792094202824678e-11
5 O 0 8.93067009233306e-11
of O 0 9.584134180729009e-11
184 O 0 1.0449782150701026e-09
patients O 0 8.008108065560293e-10
was O 0 7.169199123246983e-10
the O 0 8.784417637741626e-11
observed O 0 3.6466138442214913e-10
phenotype O 0 4.807080289381815e-10
more O 0 2.995057543989099e-12
than O 0 2.5554595332183405e-12
one O 0 2.388341911394032e-12
category O 0 9.371819292836037e-11
away O 0 2.0942818312885692e-10
from O 0 7.811175317673502e-11
that O 0 2.7772244573509575e-11
expected O 0 2.6098510019778587e-08
. O 0 3.571315119188512e-07

Among O 0 4.323417357454673e-08
the O 0 1.1933001253794373e-09
seven O 0 1.3381699082160026e-09
contributing O 0 1.5328415203796908e-09
centers O 0 2.8858263001474427e-10
, O 0 2.562492752711254e-12
the O 0 1.2960971705611168e-11
proportion O 0 2.733668291732272e-10
of O 0 1.2944845195761445e-10
patients O 0 1.4506390533242097e-10
for O 0 1.0728543053950546e-10
whom O 0 1.107502711761299e-08
the O 0 4.1707481912567346e-10
observed O 0 1.0203371481054546e-09
phenotype O 0 4.6552739441096946e-10
did O 0 4.1040022075167215e-11
not O 0 1.9253350649894863e-11
match O 0 4.2540171385496706e-09
the O 0 1.1676489775069854e-09
predicted O 0 9.741053297318558e-09
phenotype O 0 2.1575834452391973e-09
was O 0 6.02876304434119e-10
4 O 0 3.3311078895259527e-10
% O 0 7.646754895951346e-10
- O 0 3.2080135770051754e-10
23 O 0 6.393101048551841e-10
% O 0 1.940970717484447e-09
( O 0 2.2127621956968824e-10
P O 0 9.911527740769088e-07
< O 0 8.750784274980106e-08
. O 0 2.543388000209035e-10
0001 O 0 1.0455971732881153e-07
) O 0 2.3571391366550287e-11
, O 0 8.225321465604729e-12
suggesting O 0 2.865728765399922e-10
that O 0 1.7961769224750235e-12
differences O 0 6.264260221655604e-10
in O 0 3.90043986692179e-12
methods O 0 3.1472808803556518e-09
used O 0 1.888863787602446e-10
for O 0 6.575561622979009e-11
mutation O 0 5.131353564280516e-09
detection O 0 2.3807208435755456e-06
or O 0 3.4400373660758987e-09
phenotype O 0 2.4760336003737393e-08
classification O 0 5.448988371625774e-09
may O 0 1.7596846202394545e-10
account O 0 6.377387506972809e-11
for O 0 1.6013792722424647e-11
a O 0 9.031857900465567e-11
considerable O 0 1.6893255683214647e-09
proportion O 0 1.6413715941965279e-09
of O 0 3.959799155239807e-09
genotype O 0 2.102548478433164e-06
- O 0 1.4056843610887881e-05
phenotype O 0 5.5036580306477845e-06
inconsistencies O 0 2.5001778340083547e-05
. O 0 1.8465805169398664e-06

Our O 0 5.205397997087857e-07
data O 0 4.640004647171736e-08
indicate O 0 3.3000715493614052e-09
that O 0 1.9095650408140763e-11
the O 0 2.8644571159475163e-09
PAH O 0 5.639856317429803e-05
- O 0 5.762784027751877e-08
mutation O 0 1.7764425486177515e-09
genotype O 0 1.0619653600940637e-08
is O 0 2.1482761750069024e-11
the O 0 1.6500184552015185e-10
main O 0 1.4488652055888451e-08
determinant O 0 9.995043370736312e-08
of O 0 3.456462138728966e-08
metabolic O 0 2.903920722019393e-05
phenotype O 0 3.42539294706512e-08
in O 0 3.734123565912739e-10
most O 0 8.157382547224756e-10
patients O 0 6.744267579961161e-07
with O 0 4.6227261918829754e-05
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.00392442662268877

In O 0 9.64076019016602e-09
the O 0 1.1481613437780425e-09
present O 0 1.2505630975212512e-09
study O 0 7.119295430957351e-11
, O 0 3.018749746702687e-12
the O 0 1.6242474379368765e-11
classification O 0 1.433061225242227e-09
of O 0 1.8046282690420412e-08
105 O 0 5.3506428230321035e-06
PAH O 0 0.4347032904624939
mutations O 0 7.461633977356996e-09
may O 0 1.4833273498382482e-10
allow O 0 1.7349957581735964e-10
the O 0 1.568691287978652e-10
prediction O 0 4.1963744479289744e-08
of O 0 2.0586155002888518e-09
the O 0 3.6805478664803104e-09
biochemical O 0 1.4538861137225467e-07
phenotype O 0 3.011228244531594e-08
in O 0 2.916121566443053e-09
> O 0 4.587968049918345e-08
10 O 0 1.2775287494548593e-09
, O 0 2.5057995609034656e-11
000 O 0 1.302281837922692e-08
genotypes O 0 3.60984344638382e-08
, O 0 3.937148870813978e-11
which O 0 2.985646669131925e-12
may O 0 1.3048630752299228e-11
be O 0 2.6072697820178625e-11
useful O 0 1.4317443897127191e-09
for O 0 8.773600596034825e-11
the O 0 1.0825157437110988e-09
management O 0 3.5105460938211763e-07
of O 0 3.278879603385576e-07
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.9158179043188284e-07
newborns O 0 1.589471935403708e-06
. O 0 1.7314378908395156e-07

Somatic O 0 0.0036438065581023693
instability O 0 0.004119421821087599
of O 0 4.266624728188617e-06
the O 0 6.659384439444693e-07
CTG O 0 0.00871217530220747
repeat O 0 8.913987414871372e-08
in O 0 9.564088410130012e-10
mice O 0 1.977656705065556e-09
transgenic O 0 1.5303848188708002e-09
for O 0 2.7204552846549213e-11
the O 0 1.6189732221505437e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 2.2602357603318524e-06
is O 0 8.069633850027458e-11
age O 0 1.4707941531355573e-09
dependent O 0 1.3400087706116892e-09
but O 0 1.3817495325002538e-12
not O 0 1.2579533768819484e-12
correlated O 0 1.3418834932110713e-09
to O 0 5.7692857435842626e-11
the O 0 6.454780598907917e-10
relative O 0 7.129713708309282e-07
intertissue O 0 1.070076359610539e-05
transcription O 0 4.6634190198346914e-07
levels O 0 1.9311494270368712e-07
and O 0 1.4519276447799712e-08
proliferative O 0 0.0003129963588435203
capacities O 0 5.943374344496988e-05
. O 0 1.2729392437904608e-06

A O 0 4.301892840885557e-05
( O 0 1.0209922862713938e-07
CTG O 0 0.00010731272050179541
) O 0 1.339055755167351e-09
nexpansion O 0 1.8500174974178663e-06
in O 0 6.404647368007943e-10
the O 0 9.023355951320866e-10
3 O 0 1.4722683516765755e-08
- O 0 6.095530693528417e-07
untranslated O 1 0.992867112159729
region O 0 1.7598485158032418e-07
( O 0 3.868968201370393e-10
UTR O 0 3.354512227815576e-05
) O 0 3.67964582415059e-11
of O 0 1.5433234690220843e-09
the O 0 6.102381888695163e-08
DM O 1 1.0
protein O 0 8.480303677060874e-07
kinase O 0 2.0933613953388885e-08
gene O 0 2.407518406855047e-09
( O 0 4.42044761905791e-10
DMPK O 1 0.9824997186660767
) O 0 5.114970946795694e-11
is O 0 9.848477068585826e-12
responsible O 0 1.5602383829360633e-09
for O 0 2.534537024700967e-09
causing O 1 0.9999603033065796
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.2136133462190628
DM B-Disease 1 1.0
) O 0 3.4263074155660433e-08
. O 0 1.2184860054276214e-07

Major O 0 7.542570074292598e-06
instability O 0 0.008449182845652103
, O 0 1.9304482457016547e-09
with O 0 1.692168904998681e-10
very O 0 1.9481103397112065e-09
large O 0 1.1333371741084619e-10
expansions O 0 3.1839610947770325e-09
between O 0 5.897177191016567e-10
generations O 0 1.7783579053798348e-09
and O 0 7.343699433282058e-12
high O 0 1.3180560809455955e-10
levels O 0 3.180099239497025e-10
of O 0 2.8073166014053186e-10
somatic O 0 6.019576659355153e-08
mosaicism O 0 4.363520474726101e-06
, O 0 8.056039862980313e-11
is O 0 3.47129582023431e-11
observed O 0 9.955268831518538e-10
in O 0 1.448908659718029e-09
patients O 0 1.008160452897755e-07
. O 0 1.6835228677791747e-07

There O 0 4.809625764323755e-08
is O 0 3.318064156765388e-10
a O 0 5.231470256994442e-10
good O 0 1.2216176514812105e-08
correlation O 0 6.1729585887349e-09
between O 0 4.159723232532997e-09
repeat O 0 3.4494149758756976e-08
size O 0 1.7285788356247167e-09
( O 0 2.7342355810033858e-11
at O 0 1.3830983580653822e-10
least O 0 1.482062389479566e-11
in O 0 4.1050982058088437e-11
leucocytes O 0 1.5434368094702222e-07
) O 0 4.8341008279662034e-11
, O 0 2.0742371362181267e-11
clinical O 0 2.207443339230508e-09
severity O 0 4.33313438463756e-08
and O 0 1.8141965707485497e-10
age O 0 4.335374725883412e-08
of O 0 5.894371923886865e-08
onset O 0 0.01284309197217226
. O 0 1.0177068361372221e-06

The O 0 4.200092917017173e-06
trinucleotide O 1 0.9884549379348755
repeat O 0 1.7907159417518415e-05
instability O 0 5.347240585251711e-05
mechanisms O 0 3.627178330134484e-06
involved O 0 7.977944704862239e-08
in O 0 5.395728663870614e-08
DM B-Disease 1 1.0
and O 0 5.0285180464015866e-08
other O 0 3.8806549085279585e-09
human O 0 9.140841939370148e-06
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 5.500706556915702e-10
unknown O 0 3.5105526308143453e-07
. O 0 3.515456725722288e-08

We O 0 1.7088949277876964e-07
studied O 0 7.408831379507319e-07
somatic O 0 3.0300504931801697e-06
instability O 0 3.317093444366037e-07
by O 0 3.5854730295881154e-10
measuring O 0 2.936697107713826e-08
the O 0 1.2101376567486e-09
CTG O 0 2.3396037249767687e-06
repeat O 0 4.3212389222446745e-09
length O 0 2.372554375185132e-09
at O 0 1.2881889999150076e-10
several O 0 7.73865607012203e-12
ages O 0 6.874434355097492e-10
in O 0 9.22870026925926e-12
various O 0 4.134914355358177e-10
tissues O 0 8.837701237496276e-09
of O 0 5.649475998126263e-09
transgenic O 0 1.4251137159249083e-08
mice O 0 5.97693117221354e-10
carrying O 0 6.046012579474791e-10
a O 0 1.0579577214286928e-09
( O 0 1.6160262017450577e-09
CTG O 0 5.491913725563791e-06
) O 0 3.813725168999582e-10
55expansion O 0 3.0542182116732874e-07
surrounded O 0 6.7732059960690094e-09
by O 0 2.5576209553013207e-11
45 O 0 3.0114162274941236e-09
kb O 0 9.135372636137618e-08
of O 0 7.546662739166266e-10
the O 0 9.117296362326499e-10
human O 0 7.331215812200753e-08
DM B-Disease 1 1.0
region O 0 3.102285290879081e-07
, O 0 4.173451861877453e-11
using O 0 3.7565187072097217e-10
small O 0 2.357487760562549e-09
- O 0 5.7222145244395506e-08
pool O 0 1.60798748538582e-07
PCR O 0 7.454252681782236e-07
. O 0 2.2100401508851064e-07

These O 0 3.4802571491354684e-08
mice O 0 6.904108396099673e-09
have O 0 9.86028099447811e-12
been O 0 1.3445518136367962e-11
shown O 0 4.656381530354636e-11
to O 0 2.585312519620686e-11
reproduce O 0 5.599302799197403e-09
the O 0 5.044046291757809e-10
intergenerational O 0 2.2001604804700037e-07
and O 0 1.9710175713782974e-09
somatic O 0 5.259426870907191e-06
instability O 0 8.697204975760542e-06
of O 0 5.516146472928085e-08
the O 0 3.2996766208270856e-08
55 O 0 7.378187660833646e-07
CTG O 0 2.4708670025574975e-05
repeat O 0 5.315927253946029e-08
suggesting O 0 1.1121682241821418e-08
that O 0 1.1414283580812867e-11
surrounding O 0 4.745407400363888e-10
sequences O 0 4.258301489201699e-10
and O 0 7.472392843377307e-11
the O 0 4.95896435026566e-10
chromatin O 0 3.960525774004964e-08
environment O 0 3.017172645058963e-08
are O 0 4.5204770482421e-11
involved O 0 7.80516717924229e-09
in O 0 8.001196150075884e-09
instability O 0 2.6190964490524493e-05
mechanisms O 0 3.3785523555707186e-05
. O 0 9.264392701879842e-07

As O 0 6.01704863711916e-09
observed O 0 2.024304501802021e-09
in O 0 5.0196662798596137e-11
some O 0 5.231764240581915e-12
of O 0 2.2208210270768802e-10
the O 0 3.712229967867131e-10
tissues O 0 8.400488837878584e-08
of O 0 1.1641458286248962e-06
DM B-Disease 1 1.0
patients O 0 1.7675181140930363e-07
, O 0 2.3005783042484573e-11
there O 0 8.497532538731534e-12
is O 0 8.012587446835917e-13
a O 0 4.616469966717274e-12
tendency O 0 2.425417332252433e-11
for O 0 5.975557288567801e-12
repeat O 0 8.064637846416645e-10
length O 0 1.4443670703911948e-09
and O 0 1.0006626777192551e-10
somatic O 0 8.813044161115613e-08
mosaicism O 0 6.091079285397427e-07
to O 0 1.3307877022583625e-10
increase O 0 4.667327288543355e-11
with O 0 2.7176689718078073e-12
the O 0 4.0507458498595383e-11
age O 0 2.2892305828747794e-09
of O 0 5.068455100065705e-10
the O 0 1.227062895736708e-09
mouse O 0 4.7784180168264356e-08
. O 0 7.12707617367414e-08

Furthermore O 0 6.203962357176351e-07
, O 0 3.1824173851724424e-10
we O 0 4.4016078976083506e-11
observed O 0 7.61965698869993e-11
no O 0 9.326006113197227e-12
correlation O 0 4.8353921561217206e-11
between O 0 3.933426154234532e-11
the O 0 3.216571453634742e-11
somatic O 0 5.4319936992897055e-08
mutation O 0 9.314019777661997e-09
rate O 0 6.610000724549536e-08
and O 0 2.043429203624214e-09
tissue O 0 3.175940491928486e-06
proliferation O 0 2.8214963094796985e-05
capacity O 0 6.657856374658877e-06
. O 0 2.2126172893877083e-07

The O 0 4.5663520609195984e-07
somatic O 0 1.535571936983615e-05
mutation O 0 4.9117421241362536e-08
rates O 0 2.750516037153261e-09
in O 0 1.636799376592002e-11
different O 0 6.560353649209816e-11
tissues O 0 2.586913128155288e-09
were O 0 1.0554765950132605e-09
also O 0 3.2366388215410158e-12
not O 0 2.357255016183224e-12
correlated O 0 6.451285616826397e-10
to O 0 4.616577606308958e-11
the O 0 4.706637302120953e-10
relative O 0 1.2288385278225178e-06
inter O 0 0.00016539722855668515
- O 0 5.399821020546369e-05
tissue O 0 6.770739855710417e-05
difference O 0 1.0201532774090083e-07
in O 0 1.2117977454817463e-10
transcriptional O 0 1.542764360706883e-09
levels O 0 5.603327801750879e-10
of O 0 3.490949196383042e-11
the O 0 1.1784543826887095e-11
three O 0 1.9116786278972064e-11
genes O 0 1.9799389905372777e-10
( O 0 6.038679972730776e-11
DMAHP O 0 3.606718382798135e-05
, O 0 8.519612237911645e-10
DMPK O 0 0.004241633228957653
and O 0 3.0280618013023286e-09
59 O 0 1.8769000575957762e-07
) O 0 4.2074224659849335e-10
surrounding O 0 7.67235519560927e-09
the O 0 1.1197109905936031e-09
repeat O 0 1.1110216036058773e-07
. O 0 1.2098797519399795e-08
. O 0 7.457524731080412e-08

A O 0 2.8752151592925657e-07
novel O 0 9.16180464827221e-09
missense O 0 2.0472787127800984e-06
mutation O 0 4.277922904805109e-09
in O 0 1.2114903524818033e-10
patients O 0 2.146095523514191e-09
from O 0 3.104714818569221e-10
a O 0 1.4183282326385438e-09
retinoblastoma B-Disease 0 5.381931259762496e-05
pedigree O 0 2.3947814042912796e-07
showing O 0 3.089518330057217e-08
only O 0 2.552193456573093e-10
mild O 0 2.04412287097e-09
expression O 0 2.5577111539831776e-09
of O 0 3.4509137769589415e-09
the O 0 7.761372877723716e-09
tumor B-Disease 0 6.495815796370152e-07
phenotype O 0 8.65375184844197e-08
. O 0 1.0126739624638503e-07

We O 0 5.856647167234996e-09
have O 0 1.003609521876836e-11
used O 0 1.7633963733665325e-11
single O 0 1.267315558051152e-10
strand O 0 2.8890259629044124e-10
conformation O 0 2.2897096718654808e-10
polymorphism O 0 2.8720721356734202e-09
analysis O 0 1.0490941448892954e-09
to O 0 7.941980406656057e-11
study O 0 1.4035612949658827e-10
the O 0 1.2028468499014622e-10
27 O 0 8.824394548412329e-09
exons O 0 7.010294211795554e-08
of O 0 7.000280355384803e-10
the O 0 5.269524816498006e-10
RB1 O 0 7.042121069389395e-06
gene O 0 1.2113217373599383e-10
in O 0 8.932623737911705e-12
individuals O 0 1.8472166504746035e-11
from O 0 1.2220825740261176e-10
a O 0 1.118566905766727e-09
family O 0 3.3963625245547746e-09
showing O 0 1.740998385457715e-07
mild O 0 1.5550757126447934e-08
expression O 0 9.822604063458584e-09
of O 0 1.732946941501723e-08
the O 0 2.1246407300168357e-08
retinoblastoma B-Disease 0 1.3178182598494459e-05
phenotype O 0 5.598322445621307e-07
. O 0 2.319068386213985e-07

In O 0 1.9136077611392466e-08
this O 0 8.754615921091613e-10
family O 0 8.11659572885759e-10
affected O 0 7.162283544026593e-10
individuals O 0 4.4125439413456036e-11
developed O 0 1.8873809182196055e-09
unilateral B-Disease 0 3.6168387396173785e-08
tumors I-Disease 1 1.0
and O 0 3.160812411806546e-08
, O 0 2.543761590256821e-10
as O 0 7.801854995381774e-11
a O 0 3.4296173540004915e-11
result O 0 1.762231582880247e-09
of O 0 8.507146098679641e-09
linkage O 0 4.161607023434044e-07
analysis O 0 9.737746609062015e-09
, O 0 8.098854226146202e-11
unaffected O 0 3.777493429168999e-09
mutation O 0 9.400284023408645e-11
carriers O 0 3.2559524520969774e-11
were O 0 4.912384388155999e-10
also O 0 6.531263030407075e-11
identified O 0 4.436600420376635e-09
within O 0 1.418109896178521e-08
the O 0 8.628629366569385e-09
pedigree O 0 1.6410739362981985e-06
. O 0 4.709560528226575e-07

A O 0 6.759115223076151e-08
single O 0 5.3382369635812665e-09
band O 0 1.8342641183721753e-08
shift O 0 2.192995829375377e-08
using O 0 2.5572917117244742e-09
SSCP O 0 0.0016380667220801115
was O 0 1.742140298688355e-08
identified O 0 7.719973993403073e-09
in O 0 9.271582945835632e-10
exon O 0 1.2943303318024846e-08
21 O 0 6.738282709584098e-10
which O 0 2.7524902929815243e-12
resulted O 0 6.455310175290663e-10
in O 0 6.623987469644987e-11
a O 0 2.6105950734489625e-10
missense O 0 7.539217250496222e-08
mutation O 0 6.666095453411458e-10
converting O 0 2.9645097043839996e-08
a O 0 1.155742079816946e-08
cys O 0 0.0006717824726365507
- O 0 0.00027419417165219784
- O 0 1.8602344425744377e-05
> O 0 5.851156856806483e-07
arg O 0 3.7279573206205896e-08
at O 0 3.5852218971399452e-09
nucleotide O 0 6.1782121640874266e-09
position O 0 1.3688621791629885e-08
28 O 0 9.747930462822296e-09
in O 0 8.725326572367464e-10
the O 0 1.0525882387923957e-08
exon O 0 1.4799539940213435e-06
. O 0 4.833555067307316e-07

The O 0 7.79911317749793e-08
mutation O 0 1.5318310175871375e-08
destroyed O 0 9.932613664886958e-08
an O 0 2.2854686199114127e-10
NdeI O 0 2.8576755539688747e-06
restriction O 0 5.094160204777154e-09
enzyme O 0 6.841318622718973e-09
site O 0 2.984178237852575e-08
. O 0 1.4483573806955974e-07

Analysis O 0 1.9465703360310727e-07
of O 0 2.998533332743136e-08
all O 0 1.2757097600513134e-09
family O 0 7.686499770009902e-10
members O 0 7.595164080997918e-11
demonstrated O 0 9.456251337525146e-10
that O 0 4.317640429213343e-12
the O 0 2.7057500684435354e-10
missense O 0 3.968901296502736e-07
mutation O 0 8.177996946301391e-09
co O 0 7.944022684114316e-08
- O 0 2.763670465810719e-07
segregated O 0 1.2926896886256145e-08
with O 0 1.7466627103002175e-11
patients O 0 1.964446738611514e-08
with O 0 2.3055004572114512e-09
tumors B-Disease 1 1.0
or O 0 0.3559671640396118
who O 0 4.1244825865760504e-07
, O 0 2.687614020224771e-10
as O 0 5.424075424920183e-11
a O 0 3.1828650826071225e-11
result O 0 1.7281007735903131e-09
of O 0 6.834393495580571e-09
linkage O 0 9.681801316219207e-08
analysis O 0 1.621534462259433e-09
had O 0 1.4464973663308456e-10
been O 0 7.805917717762512e-11
predicted O 0 3.8417163894521877e-10
to O 0 1.8825543554590318e-11
carry O 0 1.6302206251594953e-09
the O 0 9.945064327609998e-09
predisposing O 0 7.284685125341639e-06
mutation O 0 4.815473175767693e-07
. O 0 6.249586590456602e-07

These O 0 9.710426240872039e-09
observations O 0 3.2048244946736304e-08
point O 0 3.033628681592404e-09
to O 0 4.590429425466169e-11
another O 0 1.6581233608370383e-10
region O 0 9.618554841495097e-09
of O 0 8.771033677135165e-09
the O 0 2.425994694021938e-08
RB1 O 0 0.0004803672491107136
gene O 0 7.630524545554351e-10
where O 0 7.41878364296511e-11
mutations O 0 7.910972571467667e-11
only O 0 6.407279654757625e-12
modify O 0 2.1028156993452285e-10
the O 0 1.3510563501295536e-10
function O 0 5.045992512719977e-09
of O 0 4.972747547071776e-09
the O 0 2.207624527628127e-09
gene O 0 1.3232533957463488e-09
and O 0 1.2452261444195756e-10
raise O 0 5.507793110481884e-10
important O 0 4.318838897621191e-10
questions O 0 1.6544524084061152e-10
for O 0 2.0452207635801578e-11
genetic O 0 4.9732031826010825e-09
counseling O 0 4.1002272688217545e-09
in O 0 5.103167454584279e-12
families O 0 5.711756154852532e-12
with O 0 3.4275425379870494e-12
these O 0 9.334463063614962e-11
distinctive O 0 4.635517303341885e-09
phenotypes O 0 5.051079554618809e-08
. O 0 1.532824889238782e-08
. O 0 1.6464683483263798e-07

Maternal B-Disease 0 0.0002022200496867299
disomy I-Disease 0 0.0005074060172773898
and O 0 5.0674630074354354e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.997612476348877
with O 0 5.316347917450059e-10
gamete O 0 4.9143191063194536e-06
complementation O 0 2.692016823857557e-05
in O 0 3.761344014030499e-10
a O 0 4.309982232220122e-11
case O 0 9.174998955030489e-11
of O 0 6.452888889896258e-09
familial O 0 5.281530093270703e-07
translocation O 0 6.298401785898022e-06
( O 0 4.0520617416994753e-10
3 O 0 2.513039110141335e-09
; O 0 1.0008912101899803e-11
15 O 0 1.9079568480684372e-10
) O 0 3.0624712835103374e-12
( O 0 9.320013510949465e-12
p25 O 0 3.4118173175556876e-08
; O 0 4.316835430784316e-11
q11 O 0 1.0785102233512589e-07
. O 0 3.35474398260871e-10
2 O 0 1.6412713410574042e-09
) O 0 5.861394147821386e-10
. O 0 1.5730913460743068e-08

Maternal B-Disease 1 0.6236992478370667
uniparental I-Disease 1 0.9998341798782349
disomy I-Disease 1 0.9997729659080505
( I-Disease 0 4.575611001200741e-07
UPD I-Disease 1 1.0
) I-Disease 0 5.556700655162672e-10
for I-Disease 0 1.5577815426492947e-10
chromosome I-Disease 0 9.888848850891918e-09
15 I-Disease 0 2.1219939694283596e-10
is O 0 1.5445991924725733e-12
responsible O 0 4.516710616631059e-11
for O 0 2.8608395166718203e-11
an O 0 9.427536008799198e-12
estimated O 0 1.1765527441198742e-10
30 O 0 5.281630133247006e-10
% O 0 1.2319024966789272e-10
of O 0 6.285413595846778e-12
cases O 0 1.1496656057707888e-11
of O 0 1.3233631079856423e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999548196792603
PWS B-Disease 1 1.0
) O 0 1.0044176690371387e-07
. O 0 7.871639695622434e-08

We O 0 4.151466370672097e-08
report O 0 1.0022428442724163e-09
on O 0 2.7906707500413575e-10
an O 0 5.531317157775328e-12
unusual O 0 7.424020426194389e-11
case O 0 1.933240234563982e-10
of O 0 7.146948366454353e-09
maternal B-Disease 0 0.00013718944683205336
disomy I-Disease 0 0.21246890723705292
15 I-Disease 0 2.3679442406887574e-08
in O 0 2.087817918550172e-09
PWS B-Disease 1 1.0
that O 0 6.980157424285593e-11
is O 0 1.2852188063794401e-11
most O 0 6.595328883723939e-12
consistent O 0 1.9341190871102754e-09
with O 0 2.294648845935221e-11
adjacent O 0 1.0737069899846574e-08
- O 0 2.4277431176500386e-09
1 O 0 3.2352717727057723e-10
segregation O 0 2.9141085100548025e-09
of O 0 2.521507447283966e-10
a O 0 2.954154698642242e-10
paternal O 0 2.3090228751243558e-07
t O 0 1.372531976961966e-09
( O 0 5.7337318920547276e-11
3 O 0 4.0479988805408595e-10
; O 0 3.834392438978318e-12
15 O 0 2.4163315792691265e-10
) O 0 3.5315450650635904e-12
( O 0 4.96158019183679e-12
p25 O 0 2.0224760532983055e-08
; O 0 1.8939893056679757e-11
q11 O 0 7.406677582366683e-08
. O 0 3.3917368913449764e-11
2 O 0 1.965557057392875e-11
) O 0 4.3680499755421875e-13
with O 0 9.53585843101179e-13
simultaneous O 0 2.7715916228743254e-09
maternal O 0 4.08971715160078e-07
meiotic O 0 5.261839396553114e-05
nondisjunction O 0 3.116676089121029e-05
for O 0 1.1818732659207853e-08
chromosome O 0 2.1326863475223945e-07
15 O 0 1.2554396278119384e-07
. O 0 2.1292984797582903e-07

The O 0 7.43131238323258e-07
patient O 0 0.002236027969047427
( O 0 1.4419666571896528e-09
J O 0 1.8497603093692305e-07
. O 0 1.6954319892459324e-10
B O 0 1.803842741843198e-09
. O 0 5.304208461343052e-12
) O 0 2.583417149908812e-13
, O 0 4.2747004395417287e-13
a O 0 3.2130929861207136e-12
17 O 0 6.936294594250825e-11
- O 0 8.346542207382512e-11
year O 0 1.0054801435899208e-10
- O 0 1.2716316888372603e-08
old O 0 6.074106408959778e-07
white O 0 1.5748888859690169e-09
male O 0 1.3184773273167139e-08
with O 0 9.950162915828287e-10
PWS B-Disease 1 1.0
, O 0 1.8943532964499354e-08
was O 0 7.735675211506532e-08
found O 0 4.170700729222432e-10
to O 0 9.268536632633939e-11
have O 0 3.349160879184687e-11
47 O 0 2.19594542549828e-09
chromosomes O 0 1.155671114361212e-09
with O 0 1.380178471510618e-10
a O 0 3.287575767174644e-09
supernumerary O 0 1.3852264601155184e-05
, O 0 1.433361984659598e-09
paternal O 0 1.2420343864505412e-06
der O 0 1.3275399396661669e-05
( O 0 1.038142238840578e-09
15 O 0 1.6076394659947368e-09
) O 0 3.5654129388468236e-12
consisting O 0 4.6529453900934215e-11
of O 0 1.2867697185559024e-10
the O 0 1.2945117200402478e-10
short O 0 1.1390243193076799e-09
arm O 0 7.589859762902051e-08
and O 0 5.26858001670405e-10
the O 0 5.2864197463975415e-09
proximal O 0 5.010858876630664e-05
long O 0 1.7150892972495058e-07
arm O 0 1.6295600289595313e-05
of O 0 1.9211472590541234e-06
chromosome O 0 8.256117325800005e-06
15 O 0 2.081650336549501e-07
, O 0 3.5601024905851375e-10
and O 0 1.305576424748267e-09
distal O 0 3.51796325048781e-06
chromosome O 0 0.0005800740327686071
arm O 1 0.999969482421875
3p O 1 0.9999974966049194
. O 0 0.012748565524816513

The O 0 9.950388630386442e-06
t O 0 9.426474889551173e-08
( O 0 7.235191334942215e-10
3 O 0 1.7067139923554464e-09
; O 0 5.040079031209954e-12
15 O 0 5.5037051305273366e-11
) O 0 1.7392385275039057e-12
was O 0 9.44319830664675e-11
present O 0 1.1114037468118454e-10
in O 0 7.013143104445119e-12
the O 0 2.602604243229223e-11
balanced O 0 6.438403143960159e-10
state O 0 2.2013613154570066e-11
in O 0 1.2812122023031502e-11
the O 0 5.519042514667838e-11
patients O 0 6.335635349685731e-10
father O 0 1.0093510027786579e-08
and O 0 6.740159541607227e-10
a O 0 1.5172801681728743e-08
sister O 0 5.312984285410494e-06
. O 0 1.6552137367398245e-06

Fluorescent O 0 1.1091897249571048e-06
in O 0 7.664588075328993e-09
situ O 0 1.2195129102110513e-06
hybridization O 0 4.3131858085132535e-09
analysis O 0 4.518763696559347e-10
demonstrated O 0 4.167806100241478e-10
that O 0 7.242874702773072e-12
the O 0 4.720491220133738e-10
PWS B-Disease 1 1.0
critical O 0 1.2264871429579216e-07
region O 0 4.5326661535227686e-08
resided O 0 6.261649332373054e-08
on O 0 2.1140517114659474e-10
the O 0 9.313656096354705e-11
derivative O 0 6.745242586703171e-09
chromosome O 0 3.0899354186431083e-09
3 O 0 3.0341942847122993e-10
and O 0 1.6612532530158042e-11
that O 0 3.890557580960019e-12
there O 0 2.4132902273765744e-11
was O 0 3.074871191000028e-10
no O 0 1.8859433112417e-11
deletion O 0 2.065986937083153e-09
of O 0 2.907502016924468e-09
the O 0 3.5157516009576284e-08
PWS B-Disease 1 1.0
region O 0 3.3396536309737712e-06
on O 0 4.169175227275446e-09
the O 0 4.898900729521927e-10
normal O 0 4.0734768447237e-08
pair O 0 2.3433495144331573e-08
of O 0 2.9673211443537184e-08
15s O 0 6.397073775588069e-06
present O 0 6.465038637770704e-08
in O 0 3.4573851337427186e-08
J O 0 1.592756416357588e-05
. O 0 4.5678851279262744e-07

B O 0 0.0011082094861194491
. O 0 1.568784318806138e-05

Methylation O 0 1.2688789183812332e-06
analysis O 0 7.466762497188029e-08
at O 0 2.2482749884034092e-08
exon O 0 1.518032810565728e-08
alpha O 0 4.446942258873321e-10
of O 0 1.3528672626605953e-09
the O 0 1.4896847089218568e-09
small O 0 9.748575280354999e-10
nuclear O 0 2.018353200128331e-07
ribonucleoprotein O 0 2.9926452498330036e-06
- O 0 4.4157751233342424e-08
associated O 0 3.735716092023722e-08
polypeptide O 0 6.254916939951727e-08
N O 0 5.8412776837712954e-08
( O 0 6.08505537624815e-11
SNRPN O 0 3.3435289878980257e-06
) O 0 8.765584612324684e-12
gene O 0 2.774132659699724e-11
showed O 0 1.1213262957054937e-10
a O 0 6.965776479933572e-12
pattern O 0 3.857651975636145e-09
characteristic O 0 3.564921913223884e-09
of O 0 4.97720797909551e-09
only O 0 2.1039027464642146e-10
the O 0 3.909232104692961e-10
maternal O 0 5.5598974313397775e-08
chromosome O 0 1.005375693807764e-08
15 O 0 9.741814466224241e-09
in O 0 7.63533325454091e-09
J O 0 1.1967985301453155e-05
. O 0 6.828310006312677e-07

B O 0 0.0005059368559159338
. O 0 1.0812752407218795e-05

Maternal B-Disease 0 0.00014292393461801112
disomy I-Disease 0 3.713333353516646e-05
was O 0 1.6836553484722572e-08
confirmed O 0 4.3326753296213383e-10
by O 0 7.871835128181459e-12
polymerase O 0 6.429027310517199e-10
chain O 0 2.9918161698061496e-11
reaction O 0 5.411094315677101e-12
analysis O 0 7.375512006690954e-11
of O 0 1.2236872626303352e-10
microsatellite O 0 7.104326904538993e-09
repeats O 0 1.7034683663652572e-09
at O 0 2.2502590069084505e-10
the O 0 8.066633472303408e-11
gamma O 0 3.734887510375984e-09
- O 0 4.952844179229032e-08
aminobutyric O 0 7.399524974971428e-07
acid O 0 1.975632990536269e-08
receptor O 0 7.105434574050662e-10
beta3 O 0 2.104886789311422e-07
subunit O 0 9.875917861279504e-09
( O 0 2.247532160382093e-09
GABRB3 O 0 0.0002430930471746251
) O 0 4.208925208359915e-09
locus O 0 6.686042297587846e-08
. O 0 1.2642439628507418e-07

A O 0 7.199635001597926e-05
niece O 0 0.0002937719691544771
( O 0 6.784739436938025e-09
B O 0 2.743172728969512e-07
. O 0 1.413142936002032e-10
B O 0 1.749765554670546e-09
. O 0 2.7317685873801123e-12
) O 0 1.7610049432136704e-13
with O 0 5.537520854186073e-13
45 O 0 7.505689819664596e-11
chromosomes O 0 2.451033542794079e-10
and O 0 4.5042448937326895e-11
the O 0 2.3467286447420577e-10
derivative O 0 1.610588884481956e-09
3 O 0 1.2098369528423802e-10
but O 0 3.1793866584611807e-12
without O 0 3.647822668928491e-11
the O 0 1.4029430395190445e-10
der O 0 3.5242456419837254e-07
( O 0 1.4984553875496687e-10
15 O 0 8.590314570788848e-10
) O 0 1.2265000647049273e-11
demonstrated O 0 9.105773912665427e-10
a O 0 1.313979758332806e-10
phenotype O 0 9.301056036470357e-10
consistent O 0 3.6270959569151273e-09
with O 0 1.3563591222398586e-11
that O 0 2.5462637640721875e-12
reported O 0 3.37513905712683e-11
for O 0 5.349647461128093e-11
haploinsufficiency O 0 5.616768703475827e-06
of O 0 7.907620158675854e-08
distal O 0 4.523693860392086e-06
3 O 0 4.706212166638579e-06
p O 0 2.0635461623896845e-05
. O 0 6.360061775012582e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999940395355225
associated O 0 1.0827619689735002e-06
with O 0 7.2839347886599626e-09
unbalanced O 0 3.880556505464483e-06
segregation O 0 2.110072188088452e-07
of O 0 9.585427562797122e-08
non O 0 2.3167207473306917e-05
- O 0 2.8246736292203423e-06
Robertsonian O 0 0.009059654548764229
translocations O 0 1.0777982879517367e-06
has O 0 1.1817023054527809e-11
been O 0 3.6192968760895283e-11
reported O 0 4.269408437895805e-11
previously O 0 7.919733202577106e-10
but O 0 5.953112135193006e-12
has O 0 3.164193896048467e-13
not O 0 1.7480083136164892e-12
, O 0 6.041453361887994e-12
to O 0 5.275898468104501e-11
our O 0 8.735571377371798e-09
knowledge O 0 6.697158596580266e-07
, O 0 6.364506838218986e-11
been O 0 4.952231680288577e-11
observed O 0 1.1235570113177218e-10
in O 0 2.5983038637322764e-11
a O 0 1.1057497278921247e-10
case O 0 2.6987572177006314e-09
of O 0 4.736414496164798e-07
PWS B-Disease 1 1.0
. O 0 8.942236490838695e-06

Furthermore O 0 5.051964762969874e-06
, O 0 2.9112421362498253e-09
our O 0 3.821037708462427e-09
findings O 0 2.717366054394432e-10
are O 0 2.2861725533507293e-12
best O 0 9.034886554182275e-12
interpreted O 0 3.6815623466468494e-11
as O 0 1.9328188355371978e-11
true O 0 2.328191861522555e-09
gamete O 0 2.112813945132075e-06
complementation O 0 1.3091927030473016e-05
resulting O 0 1.299163727708219e-07
in O 0 1.8038091909033938e-08
maternal B-Disease 0 0.0020804565865546465
UPD I-Disease 1 1.0
15 I-Disease 0 1.1003712643287145e-05
and O 0 3.724692078321823e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9996654987335205
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
type I-Disease 0 2.7721409878722625e-06
2 I-Disease 0 9.9007991138933e-08
and O 0 6.054232226659906e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 8.61086479897466e-11
a O 0 6.197869301116654e-11
case O 0 3.2315143616568065e-11
for O 0 1.528192676569784e-11
" O 0 1.5902802408263028e-09
lumping O 0 3.25102433862412e-08
" O 0 1.91886346811998e-08
. O 0 6.198776247856586e-08

Recent O 0 4.699158395737868e-09
studies O 0 9.516414323229583e-10
demonstrated O 0 3.6012159920773e-10
the O 0 1.1188837183151445e-11
existence O 0 3.082152311151276e-10
of O 0 2.339533289319462e-10
a O 0 3.777331225585101e-11
genetically O 0 3.740182330513875e-10
distinct O 0 1.705736801804747e-10
, O 0 1.5002725624324587e-12
usually O 0 1.657976165213293e-12
lethal O 0 1.5307539957820637e-11
form O 0 2.2737192337252132e-11
of O 0 1.336896815473665e-09
the O 0 4.560413380261252e-09
Schwartz B-Disease 1 0.9997915625572205
- I-Disease 1 0.9999998807907104
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.028101040556066e-08
SJS B-Disease 1 1.0
) O 0 1.1115696141317244e-09
of O 0 3.9005968233141175e-07
myotonia B-Disease 1 0.9999998807907104
and O 0 1.1115214874735102e-05
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 4.707324308128591e-08
which O 0 3.851547969446756e-10
we O 0 3.702374629099836e-09
called O 0 1.3564677203703468e-07
SJS B-Disease 1 0.9999982118606567
type I-Disease 0 1.7636601796766627e-06
2 I-Disease 0 1.2683719887718325e-06
. O 0 2.146436912653371e-07

This O 0 1.567138383506972e-07
disorder O 0 0.03530818223953247
is O 0 2.4790802743979157e-09
reminiscent O 0 4.697588451563206e-07
of O 0 4.978995349347315e-08
another O 0 1.5887734461372816e-09
rare O 0 1.3659977593505346e-09
condition O 0 0.12923331558704376
, O 0 2.408040711276982e-10
the O 0 1.9088178149218038e-08
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0023697782307863235
SWS B-Disease 1 1.0
) O 0 1.9865967204601986e-10
, O 0 9.887362630023322e-12
which O 0 2.1224005625902764e-12
comprises O 0 1.7115933670375227e-10
campomelia B-Disease 0 3.735345543987023e-08
at O 0 6.910903516121891e-10
birth O 0 3.09399403874977e-08
with O 0 8.97043861414204e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 5.234589366409637e-07
contractures B-Disease 1 0.9999988079071045
, O 0 1.22202790109327e-08
and O 0 2.1544785955285306e-09
early B-Disease 0 9.466670007896028e-07
death I-Disease 0 9.601178589946358e-07
. O 0 3.922314419924078e-07

To O 0 8.139001472784457e-09
test O 0 1.2618386335816467e-09
for O 0 2.1529533711373006e-10
possible O 0 1.8570082360724882e-08
nosologic O 0 8.352893200935796e-05
identity O 0 1.478716455949325e-07
between O 0 3.4746264532259374e-08
these O 0 1.7209236258253213e-09
disorders O 0 2.7274427338852547e-06
, O 0 2.6208462483578998e-11
we O 0 1.6276558226224758e-11
reviewed O 0 1.415425138207027e-10
the O 0 1.153914377244325e-11
literature O 0 2.3735746007558234e-11
and O 0 5.279678061929916e-13
obtained O 0 2.655961561792708e-11
a O 0 6.353636367029125e-12
follow O 0 3.217394961563258e-10
- O 0 2.1841572994674152e-09
up O 0 1.0742425698984093e-10
of O 0 2.0763755992359023e-10
the O 0 3.9279152846960486e-11
only O 0 1.081499299837585e-11
two O 0 7.965354070771369e-12
surviving O 0 2.8218678949087916e-08
patients O 0 8.271331397580184e-10
, O 0 1.3580001706481326e-11
one O 0 3.1107415254805204e-11
with O 0 5.037873451740893e-10
SJS B-Disease 1 0.9995425939559937
type I-Disease 0 5.703842020921002e-07
2 I-Disease 0 6.403163155255243e-08
at O 0 4.8629962279278516e-09
age O 0 2.0186405880195935e-09
10 O 0 1.7327264623112626e-11
years O 0 1.1384626748267568e-11
and O 0 1.3186607838652775e-12
another O 0 1.4943844772741244e-11
with O 0 1.4192529096401785e-10
SWS B-Disease 1 0.7566472291946411
at O 0 6.763949400578895e-09
age O 0 1.78322956401189e-08
7 O 0 2.026793310960784e-08
years O 0 6.122292450783107e-09
. O 0 3.1325200211540505e-08

Patients O 0 6.258831604100124e-07
reported O 0 5.09526820735573e-09
as O 0 1.642498220766342e-10
having O 0 2.9020503777843487e-09
either O 0 2.4904570636863355e-06
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 8.397162218898302e-07
SWS B-Disease 1 0.9999575614929199
presented O 0 1.1506101627034582e-09
a O 0 1.0423435552187055e-11
combination O 0 9.500249198435284e-11
of O 0 1.3036398349708378e-10
a O 0 1.0507637815404536e-10
severe O 0 2.495843531846731e-08
, O 0 4.2721717830040973e-10
prenatal O 1 0.943466067314148
- O 0 8.164208702510223e-05
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 2.5385682889123018e-08
with O 0 3.864614086523943e-07
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999966621398926
respiratory O 1 1.0
and O 0 0.06286828964948654
feeding O 1 0.9982602000236511
difficulties O 1 1.0
, O 0 8.171167742432317e-09
tendency O 0 5.599145680434958e-08
to O 0 1.1974183422580609e-08
hyperthermia B-Disease 1 0.9458531737327576
, O 0 5.449525830591995e-10
and O 0 9.279946949769524e-11
frequent O 0 3.0860580757519074e-10
death O 0 6.474681901735835e-10
in O 0 1.1157536700112658e-10
infancy O 0 8.979412058351954e-08
) O 0 1.9475239563387925e-12
with O 0 1.2694432094048635e-12
a O 0 5.796894908538519e-11
distinct O 0 1.631593171680379e-08
campomelic B-Disease 0 0.0009952812688425183
- I-Disease 0 0.0020830114372074604
metaphyseal I-Disease 1 0.8671473264694214
skeletal I-Disease 1 0.9999973773956299
dysplasia I-Disease 1 0.9999995231628418
. O 0 0.0006900181178934872

The O 0 4.1543575690639045e-08
similarity O 0 5.027568761306611e-08
of O 0 1.363775048446314e-08
the O 0 3.699226480691209e-09
clinical O 0 2.8733839485539647e-07
and O 0 9.631840880430786e-10
radiographic O 0 2.741410071394057e-06
findings O 0 1.1307597080900678e-09
is O 0 9.109777168725408e-12
so O 0 7.229528174029776e-12
extensive O 0 8.768085146826365e-10
that O 0 6.174432926747686e-12
these O 0 1.537012600527632e-10
disorders O 0 7.851441807815718e-08
appear O 0 1.5337686676275553e-09
to O 0 1.5846687850817887e-10
be O 0 3.2446897946236675e-10
a O 0 1.3194829673324193e-09
single O 0 3.46261188610697e-08
entity O 0 9.724661822474445e-07
. O 0 1.4565647461495246e-06

The O 0 3.5944534459986244e-08
follow O 0 5.3496048479928504e-08
- O 0 3.647563673325749e-08
up O 0 1.254978204690005e-10
observation O 0 6.211555714230599e-09
of O 0 2.1149189344260577e-10
an O 0 1.2837654116831798e-12
identical O 0 9.134175360525632e-11
and O 0 1.1267303930140304e-11
unique O 0 6.157242077309277e-11
pattern O 0 9.838132086770202e-08
of O 0 2.906763256760314e-06
progressive O 1 0.9999996423721313
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999998807907104
in O 0 1.6387446066801203e-08
the O 0 3.2882467859707276e-09
two O 0 3.6335404129950177e-10
patients O 0 1.5542357401088225e-09
( O 0 1.627093945688607e-11
one O 0 7.158045683963721e-11
with O 0 5.132486657899449e-10
SJS B-Disease 1 0.9990044236183167
type I-Disease 0 8.389967831590184e-08
2 I-Disease 0 9.584820048758047e-09
, O 0 3.570273590658424e-11
one O 0 1.743527371089737e-11
with O 0 2.185148034739015e-10
SWS B-Disease 1 0.9995144605636597
) O 0 3.270674564515019e-10
surviving O 0 3.057015476315428e-07
beyond O 0 3.163315511756082e-07
infancy O 0 1.9465737750579137e-06
adds O 0 6.264977425729512e-10
to O 0 9.269367912123627e-11
the O 0 3.083263644398926e-10
evidence O 0 2.898913553650573e-09
in O 0 1.143603822750805e-10
favor O 0 2.0086583507605837e-09
of O 0 7.2088850444629315e-09
identity O 0 7.019981467237812e-07
. O 0 1.3509619520846172e-06

The O 0 1.0122143123680871e-07
hypothesis O 0 1.0292728802596685e-07
that O 0 1.9353736391281018e-09
SWS B-Disease 1 0.9937404990196228
and O 0 2.4556825906074664e-08
SJS B-Disease 1 0.9998549222946167
type I-Disease 0 1.7151481301880267e-07
2 I-Disease 0 5.469271702196465e-09
are O 0 2.5481599469356908e-11
the O 0 1.0962201979491937e-10
same O 0 2.0004762291137013e-09
disorder O 0 2.0584359106123884e-08
should O 0 4.86968347590544e-11
be O 0 5.009871337224858e-11
testable O 0 1.0669959360498638e-09
by O 0 6.13166678889443e-12
molecular O 0 7.029207216291411e-10
methods O 0 1.751001654781703e-08
. O 0 3.3088134454573037e-09
. O 0 6.983976419405735e-08

A O 0 3.08368186097141e-07
mouse O 0 9.41012423538723e-09
model O 0 4.802033881645684e-09
of O 0 1.2639397084512893e-08
severe O 1 0.9999185800552368
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 7.473126061086077e-06
defects O 1 0.9999997615814209
in O 0 1.0387552151769341e-07
hemostasis O 1 0.9999972581863403
and O 0 5.473751230056223e-07
thrombosis B-Disease 1 0.999606192111969
. O 0 8.308429823955521e-05

von B-Disease 1 0.999995231628418
Willebrand I-Disease 1 0.9999990463256836
factor I-Disease 0 0.001796373981051147
( I-Disease 0 1.0756382835097611e-05
vWf I-Disease 1 0.9999985694885254
) I-Disease 0 0.0001411921257385984
deficiency I-Disease 1 1.0
causes O 1 0.999985933303833
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.6044960021972656
humans O 0 5.827178483741591e-06
. O 0 1.0157245355912892e-07

We O 0 2.1413821826854473e-08
generated O 0 1.2390100057046993e-09
a O 0 1.1202744981675394e-10
mouse O 0 4.962654731599514e-10
model O 0 1.612155409169702e-10
for O 0 2.7651362102809607e-11
this O 0 1.8176418703497177e-11
disease O 0 2.1831900176572105e-10
by O 0 2.2485490032420063e-12
using O 0 1.4877617193764792e-10
gene O 0 1.1539772470925413e-09
targeting O 0 5.197478003537981e-09
. O 0 3.023307826310884e-08

vWf B-Disease 0 0.004528960213065147
- I-Disease 0 0.27359697222709656
deficient I-Disease 0 0.0008345846435986459
mice O 0 1.9006006368726958e-07
appeared O 0 4.684902243923261e-09
normal O 0 1.306937402745234e-08
at O 0 1.5065253211599128e-10
birth O 0 3.332550346790697e-10
; O 0 1.3738343145400234e-12
they O 0 5.6223350627937485e-12
were O 0 2.680252686459994e-10
viable O 0 6.114604502727161e-07
and O 0 2.541609589457039e-09
fertile O 0 1.612167397979647e-05
. O 0 2.596693491341284e-07

Neither O 0 0.00010689235205063596
vWf O 0 0.00029863475356251
nor O 0 2.8796361220884137e-05
vWf O 0 0.00033928625634871423
propolypeptide O 0 0.0007722445297986269
( O 0 6.177012323860254e-08
von B-Disease 0 0.0041504548862576485
Willebrand I-Disease 0 0.00026306419749744236
antigen O 0 1.3761639650056168e-07
II O 1 0.9999951124191284
) O 0 1.180354836094466e-08
were O 0 1.3027715795033146e-07
detectable O 0 3.1785506848791556e-07
in O 0 6.699960725109477e-11
plasma O 0 1.0223110358253962e-08
, O 0 6.607142610803862e-11
platelets O 0 2.0015917812088446e-08
, O 0 5.723223561737711e-10
or O 0 1.2278073002747192e-09
endothelial O 0 5.634238409157888e-09
cells O 0 2.825557210428542e-08
of O 0 4.070160741775908e-08
the O 0 1.4210964849326047e-08
homozygous O 0 1.6202646335727877e-08
mutant O 0 2.8791381723181075e-08
mice O 0 5.3439144664935156e-08
. O 0 3.371656731587791e-08

The O 0 1.4290228023128293e-07
mutant O 0 4.076749462456064e-07
mice O 0 6.081861414486411e-08
exhibited O 0 1.030732033058257e-08
defects O 0 1.400551013830409e-06
in O 0 3.2115154979805993e-10
hemostasis O 0 0.0001887967373477295
with O 0 6.588014855868352e-11
a O 0 7.894215281467609e-10
highly O 0 5.337738002708647e-06
prolonged O 1 0.9996528625488281
bleeding O 1 0.9999997615814209
time O 0 2.0703253085230244e-06
and O 0 8.407520901698717e-09
spontaneous O 0 1.4907776630934677e-06
bleeding O 0 0.029061852023005486
events O 0 3.1798463862031667e-09
in O 0 1.2411571770343244e-10
approximately O 0 9.892744262662845e-11
10 O 0 1.5651975548980346e-10
% O 0 3.712300744584951e-10
of O 0 3.136678139448179e-10
neonates O 0 3.6786835266866547e-07
. O 0 2.3404957971706608e-07

As O 0 4.251593921367203e-08
in O 0 2.5873720943536682e-09
the O 0 2.6626849614075354e-09
human O 0 7.258585554836827e-08
disease O 0 0.0015874245436862111
, O 0 9.875531642444813e-11
the O 0 2.5322066665722787e-10
factor O 0 5.970391403486985e-10
VIII O 0 2.0833613234572113e-06
level O 0 1.487609324613004e-06
in O 0 8.155619929395286e-11
these O 0 2.9561145198364613e-11
mice O 0 3.4115013591851095e-10
was O 0 1.173710711954712e-10
reduced O 0 7.616896002815565e-11
strongly O 0 8.849646709885306e-12
as O 0 2.1774739129842846e-12
a O 0 6.203435768542542e-12
result O 0 1.8874952989467175e-10
of O 0 7.10004277593157e-10
the O 0 4.0211189933359037e-10
lack O 0 2.25708731704799e-08
of O 0 1.5354927329624957e-09
protection O 0 5.894481347468172e-09
provided O 0 2.8020861186917045e-09
by O 0 2.2721435843919835e-09
vWf O 0 3.88724947697483e-06
. O 0 5.403957175076357e-07

Defective O 0 0.003912091255187988
thrombosis B-Disease 0 8.668874215800315e-05
in O 0 3.886434640776315e-08
mutant O 0 5.057374252714908e-08
mice O 0 9.796577771226112e-09
was O 0 9.439924397725008e-10
also O 0 4.287506114031281e-12
evident O 0 4.4917665142918395e-09
in O 0 9.87793787737834e-12
an O 0 7.172936290072984e-13
in O 0 1.9564790759707407e-11
vivo O 0 5.882015319258471e-09
model O 0 1.8068050167130423e-08
of O 0 7.353320370384608e-07
vascular B-Disease 1 0.9999902248382568
injury I-Disease 1 0.9999972581863403
. O 0 0.00025660317623987794

In O 0 5.2430499941635844e-09
this O 0 1.060597859536827e-10
model O 0 1.045422859391465e-09
, O 0 2.814472613299479e-11
the O 0 2.3481883104636836e-10
exteriorized O 0 7.907014492047892e-07
mesentery O 0 2.6130694550374756e-06
was O 0 2.9600855100397894e-08
superfused O 0 1.4712178426634637e-06
with O 0 9.552165725068562e-10
ferric O 0 4.6144774387357756e-05
chloride O 0 2.025096819124883e-06
and O 0 2.7141881631109754e-08
the O 0 5.255768797951532e-08
accumulation O 0 2.752235195657704e-05
of O 0 1.932738996401895e-06
fluorescently O 0 2.3942591269587865e-06
labeled O 0 5.988802342926647e-09
platelets O 0 1.1130723009955545e-08
was O 0 4.260472419304051e-09
observed O 0 7.929543133222694e-10
by O 0 8.544853158376498e-10
intravital O 0 2.009469653785345e-06
microscopy O 0 3.1562351068714634e-05
. O 0 2.693724582059076e-06

We O 0 9.394992162015114e-08
conclude O 0 1.0007821629187674e-06
that O 0 1.7399137686169297e-10
these O 0 3.840727458293003e-10
mice O 0 6.89540957665713e-09
very O 0 3.8425665427332945e-10
closely O 0 1.690013533561796e-07
mimic O 0 1.5241335859172978e-05
severe O 0 0.00010160726378671825
human O 1 0.9976546168327332
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 2.166597568020734e-07
will O 0 3.080019017609459e-10
be O 0 8.984453458982244e-11
very O 0 4.884846693808953e-11
useful O 0 9.380886345500272e-11
for O 0 5.4432773392842915e-12
investigating O 0 7.526164691462611e-10
the O 0 5.531586300122626e-10
role O 0 7.296254267430413e-09
of O 0 2.8454216760565032e-08
vWf O 0 9.54972961153544e-07
in O 0 1.6066707964057514e-09
normal O 0 2.200037670263555e-06
physiology O 0 2.4088392365229083e-06
and O 0 1.4519795366041421e-09
in O 0 1.021567941350554e-09
disease O 0 4.004048292927109e-08
models O 0 6.927825868530135e-09
. O 0 1.3554268818438686e-09
. O 0 9.303278147854144e-09

Oral O 0 0.0043298122473061085
contraceptives O 0 0.0004082931554876268
and O 0 9.790501742656943e-10
the O 0 2.2780235475750032e-09
risk O 0 3.001560116899782e-06
of O 1 0.9988559484481812
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999958276748657

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9967858791351318
Study O 0 1.0501861424927483e-07
Group O 0 4.457729740892091e-09
. O 0 1.4838748896295328e-08

BACKGROUND O 0 0.0007064550882205367
Women O 0 9.03693297971131e-09
with O 0 1.0193836053051797e-10
mutations O 0 4.842122813819572e-10
in O 0 4.343868667544548e-11
either O 0 7.624476161538496e-09
the O 0 1.6509675404563495e-08
BRCA1 O 0 1.2688727224485774e-07
or O 0 5.274632952634306e-10
the O 0 1.1224030593837142e-09
BRCA2 O 0 7.90175125331416e-09
gene O 0 4.586788587834789e-11
have O 0 1.9129433280473673e-12
a O 0 7.1584105830468925e-12
high O 0 2.81174805660811e-10
lifetime O 0 5.44304690208719e-09
risk O 0 2.895340571740235e-07
of O 0 0.0003768079332076013
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.667881098110229e-05

Oral O 1 0.998274564743042
contraceptives O 1 0.9999463558197021
protect O 0 1.09229968074942e-05
against O 1 0.9999997615814209
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 7.442589549100376e-07
general O 0 8.928788375328622e-09
, O 0 9.720010386848887e-12
but O 0 5.874300611913297e-13
it O 0 2.9014784959412523e-14
is O 0 8.92631305785159e-14
not O 0 3.0397678731780564e-13
known O 0 3.1402321715168213e-11
whether O 0 3.593325637041289e-10
they O 0 3.4781899582725373e-10
also O 0 1.359400370049002e-10
protect O 0 1.7573043020746582e-09
against O 0 6.6849428215221e-09
hereditary B-Disease 1 1.0
forms I-Disease 1 0.9999970197677612
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7647859454154968

METHODS O 0 1.1210931006644387e-05
We O 0 2.0047554727398165e-08
enrolled O 0 7.820802494507006e-08
207 O 0 6.5117040648488e-09
women O 0 3.521358760139037e-10
with O 0 1.665046411858384e-08
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.823263269481686e-08
161 O 0 1.0131681271730031e-08
of O 0 4.238073003648424e-08
their O 0 6.212326209009689e-09
sisters O 0 1.3385303532231774e-08
as O 0 2.2525477316737152e-10
controls O 0 9.85469306158393e-09
in O 0 1.0743245876243535e-10
a O 0 1.8649538857662407e-10
case O 0 1.6760001164684013e-09
- O 0 2.6740613279230274e-08
control O 0 4.6059774660989206e-08
study O 0 7.429326043251194e-09
. O 0 1.4812959747700916e-08

All O 0 1.1867365756756953e-08
the O 0 7.437120363995575e-10
patients O 0 6.564838117562033e-10
carried O 0 1.342102956547464e-10
a O 0 1.5147451001840118e-11
pathogenic O 0 1.1285296031005032e-09
mutation O 0 6.78439970869249e-10
in O 0 4.1606257328297147e-10
either O 0 7.962453452137197e-08
BRCA1 O 0 1.5302256883842347e-07
( O 0 9.441757098382908e-11
179 O 0 5.519553258892529e-09
women O 0 1.3058678582922312e-09
) O 0 1.1979746361578947e-10
or O 0 3.4877447596670663e-09
BRCA2 O 0 1.5900042171779205e-07
( O 0 1.9258281080958284e-10
28 O 0 2.3748011557245263e-08
women O 0 1.3728775893895317e-09
) O 0 6.5365007850815e-10
. O 0 4.094266259357937e-08

The O 0 8.570340526148357e-08
control O 0 1.6455233264878188e-07
women O 0 3.8638209298724746e-10
were O 0 2.0910249920458313e-10
enrolled O 0 1.8538436341586362e-09
regardless O 0 1.6358957521944717e-09
of O 0 2.432841150756815e-10
whether O 0 3.2558532259141515e-11
or O 0 2.3174767660449902e-11
not O 0 1.844322784771979e-11
they O 0 1.1866425897455457e-10
had O 0 9.800517064562086e-10
either O 0 3.837209305856959e-08
mutation O 0 2.96016281708944e-07
. O 0 3.3288694112343364e-07

Lifetime O 0 1.005039280244091e-06
histories O 0 3.8652555645057873e-07
of O 0 3.161692774256153e-08
oral O 0 5.068651717010653e-06
- O 0 5.887720178066047e-08
contraceptive O 0 1.5763172100946576e-08
use O 0 2.4818312335805892e-11
were O 0 1.6102431887876634e-11
obtained O 0 3.8519059469832584e-11
by O 0 2.7243225036999164e-12
interview O 0 2.870044757408152e-10
or O 0 1.761113282115756e-12
by O 0 6.749900660109331e-13
written O 0 2.472819258386716e-12
questionnaire O 0 1.0326865231002902e-11
and O 0 1.1202433295234848e-12
were O 0 3.672732257209432e-11
compared O 0 3.0856109334287396e-10
between O 0 2.926662523439205e-10
patients O 0 2.7384697287580195e-10
and O 0 2.523892553285556e-11
control O 0 1.6556567672409983e-08
women O 0 4.949729515146828e-11
, O 0 3.375884207595936e-12
after O 0 9.051984856123241e-11
adjustment O 0 2.050031433498134e-08
for O 0 4.6183543100930535e-12
year O 0 1.131487785410723e-11
of O 0 1.1728445992176262e-10
birth O 0 7.385457134745366e-09
and O 0 2.379111352368568e-09
parity O 0 2.63300648839504e-06
. O 0 1.668878581995159e-07

RESULTS O 0 1.0871054882954923e-06
The O 0 1.0552295037769e-08
adjusted O 0 6.478357761352527e-08
odds O 0 1.1798285726172253e-07
ratio O 0 7.112085143035074e-08
for O 0 1.548693973063564e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 3.5844031742726656e-08
with O 0 8.057526000582182e-12
any O 0 1.7839821633836017e-11
past O 0 9.065201367342013e-11
use O 0 2.1737072211647224e-11
of O 0 6.35827335226935e-10
oral O 0 1.086842189579329e-06
contraceptives O 0 3.4501501886552433e-06
was O 0 2.0847746640129117e-08
0 O 0 2.496989726097354e-09
. O 0 1.3375197838172426e-08

5 O 0 5.0285567709806855e-08
( O 0 1.0761462831965218e-09
95 O 0 7.436488402845498e-08
percent O 0 9.840306347541627e-09
confidence O 0 5.4525781223446756e-08
interval O 0 7.994471928896019e-08
, O 0 5.6104690338010244e-11
0 O 0 1.7755227843530008e-11
. O 0 1.6019231080521834e-11
3 O 0 3.61384776270679e-11
to O 0 4.423642008255513e-11
0 O 0 4.8722938877920896e-11
. O 0 4.177083332002063e-11
8 O 0 1.1215728346058995e-09
) O 0 5.675794279014212e-10
. O 0 1.6644907674390197e-08

The O 0 1.0511961789916313e-07
risk O 0 5.099548516795949e-08
decreased O 0 1.5727252389297064e-08
with O 0 3.1157337994358603e-12
increasing O 0 1.098497404150578e-10
duration O 0 2.21016609458502e-08
of O 0 2.648238572877659e-10
use O 0 6.865009949397205e-11
( O 0 5.7390384111677406e-11
P O 0 3.519629743209407e-08
for O 0 1.0460265986722561e-10
trend O 0 1.7327214107965005e-09
, O 0 1.0233396595393796e-11
< O 0 8.893871750181859e-10
0 O 0 9.628818575802e-12
. O 0 1.09011038043616e-11
001 O 0 4.646529383478537e-09
) O 0 5.42694686932188e-13
; O 0 1.4039606337310634e-13
use O 0 2.7358772799329634e-12
for O 0 8.088290454066893e-12
six O 0 2.059391962516699e-10
or O 0 2.451135128200832e-11
more O 0 1.7546356078160241e-12
years O 0 3.7042920814078784e-11
was O 0 3.9053701245128636e-11
associated O 0 5.944605918628554e-11
with O 0 2.960130187842913e-12
a O 0 1.1904260910355902e-10
60 O 0 1.7074311742248938e-08
percent O 0 3.938467330044659e-09
reduction O 0 1.4382319335481952e-08
in O 0 2.316113523193053e-09
risk O 0 1.8602844420456677e-07
. O 0 2.415548578937887e-07

Oral O 0 0.0015960625605657697
- O 0 1.1633827853074763e-05
contraceptive O 0 1.2972748208994744e-06
use O 0 3.1918778731210296e-09
protected O 0 3.7408751722978195e-06
against O 1 0.9854114651679993
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 2.9394092493362223e-08
for O 0 1.7659106815726133e-11
carriers O 0 8.16498604838678e-12
of O 0 3.497936107432764e-10
the O 0 2.8065578749902897e-09
BRCA1 O 0 2.6643730777209385e-08
mutation O 0 4.211516968499751e-10
( O 0 2.876861422695942e-11
odds O 0 7.629818554732992e-08
ratio O 0 5.0596677958480996e-09
, O 0 2.3870906987188967e-11
0 O 0 8.539939588825263e-12
. O 0 3.2576530448885643e-12
5 O 0 7.665541812418297e-12
; O 0 2.600482763154277e-13
95 O 0 6.020925980010361e-10
percent O 0 4.2548264911346223e-10
confidence O 0 1.5155507071540342e-08
interval O 0 2.430144263598777e-08
, O 0 1.0241504172503468e-10
0 O 0 2.095659409895312e-11
. O 0 1.3042211408076376e-11
3 O 0 6.060581203559678e-11
to O 0 7.683843145089853e-11
0 O 0 2.3951495300988945e-11
. O 0 9.6005590630166e-12
9 O 0 1.5096578154238927e-10
) O 0 2.0021300155964594e-12
and O 0 7.940746042482683e-13
for O 0 1.9424490228098223e-12
carriers O 0 4.487600221980692e-11
of O 0 1.7547385766647494e-09
the O 0 1.0681143969293316e-08
BRCA2 O 0 2.8918412908751634e-07
mutation O 0 3.904182310776605e-09
( O 0 2.0725296479007227e-10
odds O 0 7.533696475547913e-07
ratio O 0 2.9169129334150057e-08
, O 0 1.0758870877536353e-10
0 O 0 3.009156812616709e-11
. O 0 1.0963158332544243e-11
4 O 0 1.9444963000880833e-11
; O 0 6.018023536100148e-13
95 O 0 7.546202551722558e-10
percent O 0 2.832412360209702e-10
confidence O 0 4.3617478517887776e-09
interval O 0 1.0149804552384012e-08
, O 0 4.0960956848579144e-11
0 O 0 2.6745930123417416e-11
. O 0 2.4012652977134508e-11
2 O 0 9.708749776349279e-11
to O 0 1.279622935390634e-10
1 O 0 7.392697565222761e-10
. O 0 1.8387179279155674e-10
1 O 0 1.5049350654550153e-09
) O 0 3.600927611646654e-10
. O 0 2.1655415238797104e-08

CONCLUSIONS O 0 2.2267535314313136e-05
Oral O 0 0.02999548800289631
- O 0 1.9564544345485047e-05
contraceptive O 0 1.1393188970032497e-06
use O 0 2.535256171665168e-10
may O 0 2.60531235474204e-10
reduce O 0 2.160317702504244e-09
the O 0 8.78981942786794e-10
risk O 0 1.3058231616014382e-06
of O 1 0.9999815225601196
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.243986140295419e-08
women O 0 9.897047070772658e-11
with O 0 1.0504966688196227e-11
pathogenic O 0 9.843529324982114e-10
mutations O 0 3.533752179762928e-10
in O 0 3.746586652031425e-10
the O 0 1.2426316864377895e-08
BRCA1 O 0 1.3604181958726258e-06
or O 0 1.9152953711909504e-07
BRCA2 O 0 1.5429734048666432e-05
gene O 0 3.3219796478078933e-06

A O 0 2.534152372390963e-07
Japanese O 0 5.534989782063349e-07
family O 0 2.0417538770800547e-09
with O 0 4.668914144190239e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.844598056052973e-10
a O 0 2.7603005992027363e-10
codon O 0 2.889491845792236e-08
291 O 0 2.75873857091824e-09
deletion O 0 1.613673816791561e-08
: O 0 2.8914610289421105e-11
a O 0 9.948241536106295e-11
clinical O 0 4.395498720555224e-08
, O 0 1.6499397681446482e-10
biochemical O 0 6.675796981880922e-08
, O 0 5.040766692943066e-10
pathological O 0 4.6081049731583335e-06
, O 0 3.589112895774349e-10
and O 0 9.423051228196755e-10
genetic O 0 1.4500048450827308e-07
report O 0 1.3714388735763805e-08
. O 0 9.600119454944434e-08

We O 0 1.5385834828407496e-08
report O 0 3.0399696648863994e-10
a O 0 4.3596640186827074e-11
Japanese O 0 1.3724646308332922e-08
family O 0 1.0697652763624887e-09
with O 0 2.345275529336277e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.00022024045756552368
ALD B-Disease 1 1.0
) O 0 1.4349532673207932e-10
with O 0 4.6182836201114075e-12
a O 0 2.47904457378878e-11
three O 0 2.3452417091673894e-11
base O 0 3.8980191297000033e-10
pair O 0 4.1472936196385035e-09
deletion O 0 2.1727320387299187e-08
( O 0 7.509588506593445e-10
delGAG O 0 2.2459275896835607e-06
291 O 0 5.471515240884628e-09
) O 0 6.931096668827408e-11
in O 0 3.0934479977595686e-10
the O 0 7.189033368604214e-08
ALD B-Disease 1 1.0
gene O 0 1.5533732948824763e-06
. O 0 1.2036763337164302e-06

A O 0 5.54030236799008e-07
variety O 0 1.6712380812577976e-08
of O 0 8.00606514417268e-09
phenotypes O 0 2.0751027562937452e-08
were O 0 7.398918699941248e-10
observed O 0 1.7707213473272532e-10
within O 0 2.3702145801607344e-10
this O 0 9.06212396789563e-11
family O 0 2.6122002338979655e-09
. O 0 1.160772882258243e-07

While O 0 5.3292570356688884e-08
the O 0 9.703871484134652e-09
proband O 1 0.637424886226654
( O 0 2.492854589419835e-09
patient O 0 1.3204526112531312e-05
1 O 0 5.377376766091402e-09
) O 0 1.2061452531186845e-11
was O 0 2.587602909720488e-10
classified O 0 2.1515249304382422e-10
as O 0 2.006129463938411e-11
having O 0 3.244813306935157e-10
a O 0 2.366577073198428e-11
rare O 0 3.204972398584971e-11
intermediate O 0 1.2606909960410917e-09
type O 0 5.526946122991205e-10
of O 0 3.723102270924983e-09
adult O 0 1.789036900845531e-07
cerebral O 0 8.632981007394847e-06
and O 0 2.086381911681201e-08
cerebello O 1 0.9999996423721313
- O 1 0.9957222938537598
brain O 1 0.998246431350708
stem O 0 3.4161024586865096e-07
forms O 0 9.630370945146183e-10
, O 0 1.799154054904495e-11
his O 0 3.313169461005572e-10
younger O 0 3.022172734290507e-07
brother O 0 6.813636446167948e-06
( O 0 7.88852649868943e-10
patient O 0 0.00029649821226485074
2 O 0 6.299681221122455e-09
) O 0 2.6655176330048214e-11
and O 0 2.74991140969405e-10
nephew O 0 6.0444317568908446e-06
( O 0 5.81053538617482e-10
patient O 0 6.228814299902297e-07
3 O 0 3.686801086644209e-09
) O 0 3.1253537952080634e-11
had O 0 2.0318928484197585e-10
a O 0 1.6003732783431701e-09
childhood O 0 3.337485759402625e-05
ALD B-Disease 1 1.0
type O 0 3.997759267804213e-05
. O 0 2.36799064623483e-06

Another O 0 3.4398695447634964e-07
nephew O 0 0.003848079824820161
( O 0 1.3375860419273522e-08
patient O 0 0.0010783434845507145
4 O 0 1.7487286285700065e-08
) O 0 2.774016259754486e-11
of O 0 1.4721580621213093e-09
patient O 0 3.0318196877487935e-06
1 O 0 1.1530866927955685e-08
was O 0 4.659379992943968e-09
classified O 0 5.604930963798438e-10
as O 0 2.1564784680183635e-11
having O 0 8.541219398416899e-10
an O 0 1.7744335167879655e-10
adolescent O 0 4.09992878758203e-07
form O 0 3.430950457072868e-08
. O 0 1.4789154647587566e-06

The O 0 3.7994698232068913e-07
tau O 0 1.311337598508544e-07
level O 0 1.2948249832334113e-06
in O 0 1.9287109687127213e-09
the O 0 1.0992635246509508e-08
cerebrospinal O 0 0.005613083019852638
fluid O 0 0.0017650735098868608
( O 0 8.735308654195251e-08
CSF O 1 0.9999994039535522
) O 0 1.7026237086881224e-09
in O 0 4.076459170221369e-09
patient O 0 0.014501208439469337
1 O 0 2.3856788544662777e-08
was O 0 9.053115590518246e-09
as O 0 6.8651373648365155e-12
high O 0 4.159560890171221e-11
as O 0 6.368288600448746e-13
that O 0 1.0712904088133746e-13
of O 0 2.4676658286204578e-11
patients O 0 2.529321196931278e-09
with O 0 1.2547880068325412e-08
Alzheimers B-Disease 1 1.0
disease I-Disease 0 0.016494084149599075
( O 0 1.2723126996405654e-09
AD B-Disease 0 3.119272662388539e-07
) O 0 1.6030862193261441e-09
. O 0 3.513546076305829e-08

His O 0 1.3358757655623776e-07
brain O 0 1.3647244259118452e-06
magnetic O 0 7.122958578520411e-08
resonance O 0 6.531720941893582e-08
image O 0 8.009211072135258e-09
( O 0 1.4304907258733124e-10
MRI O 0 2.7501469958224334e-05
) O 0 1.4194803665823486e-10
showed O 0 8.802339301894335e-09
abnormalities B-Disease 0 3.9164163467830804e-07
in I-Disease 0 5.919498224926656e-11
the I-Disease 0 5.927568436092656e-10
bilateral I-Disease 0 0.45735418796539307
cerebellar I-Disease 1 1.0
hemispheres I-Disease 0 0.0010261681163683534
and O 0 3.399261316872071e-08
brain O 0 0.030955098569393158
stem O 0 1.4612714949180372e-07
, O 0 1.4533052712650818e-11
but O 0 2.873125348745731e-12
not O 0 4.46971062592616e-12
in O 0 9.460415090201124e-11
the O 0 6.148458187027472e-09
cerebral O 0 0.03204621747136116
white O 0 4.242381557162389e-09
matter O 0 3.451455299341433e-08
, O 0 7.731073593808535e-12
where O 0 1.8244279784834783e-12
marked O 0 1.5112531018268704e-11
reductions O 0 2.712365221313462e-09
of O 0 9.123141131439638e-10
the O 0 2.9488307351499543e-09
cerebral O 0 2.159727046091575e-06
blood O 0 5.5408737154039045e-08
flow O 0 3.329834896703687e-07
and O 0 1.041563502113263e-09
oxygen O 0 2.4151082911316735e-08
metabolism O 0 5.488094600991644e-08
were O 0 6.001205643535457e-10
clearly O 0 4.443667309117494e-11
demonstrated O 0 2.4059506123497165e-11
by O 0 1.513915186789061e-12
positron O 0 1.215439415780395e-09
emission O 0 1.0190943644516892e-09
tomography O 0 1.3240195073649375e-07
( O 0 1.0387309679060763e-08
PET O 0 8.489078027196229e-06
) O 0 1.0142064077456325e-08
. O 0 2.3486302325181896e-07

In O 0 5.748868261434836e-07
patients O 0 1.2804882771888515e-06
2 O 0 3.212180388345587e-08
and O 0 5.20948451043779e-10
3 O 0 9.210368578926875e-10
, O 0 3.9899971347734375e-12
the O 0 7.967648242568348e-12
autopsy O 0 4.427428645925602e-09
findings O 0 5.251805101913476e-10
showed O 0 2.6350037707345564e-09
massive O 0 3.120700142744681e-08
demyelination B-Disease 1 1.0
of I-Disease 0 1.421054003003519e-05
the I-Disease 0 7.5460739026311785e-06
cerebral I-Disease 1 0.9999949932098389
white I-Disease 0 6.360644277947358e-08
matter I-Disease 0 8.181932287243399e-08
with O 0 4.9184285116909976e-11
sparing O 0 1.3903442841467495e-08
of O 0 3.2446433095856264e-08
the O 0 8.117424243891946e-08
U O 1 0.8399182558059692
- O 0 3.126997626168304e-06
fibers O 0 3.562999850714732e-08
, O 0 5.809125402933546e-11
compatible O 0 3.923578262288174e-08
with O 0 1.3217940630916303e-11
the O 0 1.5826691346365607e-10
findings O 0 7.112309075019141e-10
of O 0 6.689700793316433e-09
childhood O 0 0.00020893827604595572
ALD B-Disease 1 1.0
. O 0 1.1911552974197548e-05

Oleic O 0 0.0043075853027403355
and O 0 1.6991392612908385e-06
erucic O 1 0.9997469782829285
acids O 0 8.280176757580193e-07
( O 0 6.9391066226387466e-09
Lorenzos O 0 0.00017388287233188748
Oil O 0 1.0207001821527228e-07
) O 0 6.843174030907173e-12
were O 0 3.880154877955455e-11
administered O 0 5.177963058322632e-10
to O 0 7.653521566508559e-11
patients O 0 2.2356718698546274e-09
1 O 0 1.0307472653181549e-09
and O 0 1.019574147331781e-10
4 O 0 8.969784359713628e-10
, O 0 5.0719116406749976e-12
but O 0 1.808028553262897e-12
sufficient O 0 3.6003644510174126e-10
effectiveness O 0 9.798516442671712e-10
was O 0 5.016739801355641e-10
not O 0 7.047621514155722e-11
obtained O 0 2.5824579807931514e-08
. O 0 1.1322152460024881e-07

The O 0 7.135033541771918e-08
findings O 0 3.447236274212173e-09
in O 0 4.8272549152406086e-11
this O 0 3.334277992594892e-11
family O 0 9.086267849234275e-11
suggest O 0 2.1530684179982273e-10
that O 0 2.1196458217104253e-12
delGAG291 O 0 4.8733954649549105e-09
is O 0 5.304511604270479e-12
part O 0 1.1321467374703076e-10
of O 0 1.788839298910716e-09
the O 0 1.8598538265024445e-09
cause O 0 9.644714360490525e-09
of O 0 5.0078536872888435e-08
Japanese O 0 0.025027766823768616
ALD B-Disease 1 1.0
with O 0 8.23886825429554e-09
phenotypic O 0 4.7263705482691876e-07
variations O 0 8.266544426760447e-08
. O 0 1.3789016861665004e-07

Moreover O 0 1.328041207671049e-06
, O 0 1.3460510484009092e-10
although O 0 6.011295627939006e-11
the O 0 1.60019462958072e-11
scale O 0 1.1415646206103247e-09
of O 0 1.9782592231010199e-10
the O 0 5.220473012212956e-11
study O 0 1.2490313471003045e-11
is O 0 9.669118804234156e-13
limited O 0 1.2035874900895305e-11
, O 0 2.305536620991755e-12
there O 0 4.720126199619923e-12
is O 0 1.5861338934983205e-12
a O 0 2.3268401094789226e-11
possibility O 0 1.9153998387366755e-09
that O 0 1.6852279294266026e-10
PET O 0 6.155924552331271e-07
can O 0 1.4280679971889754e-09
detect O 0 1.2144665788582643e-06
an O 0 6.496928328658669e-09
insidious B-Disease 0 3.31161049871298e-06
lesion I-Disease 0 4.391960465000011e-05
which O 0 1.457080844868841e-10
is O 0 4.67060452813417e-11
undetectable O 0 1.5719118229284845e-09
by O 0 4.38338384686765e-12
computed O 0 6.841109456701133e-09
tomogram O 0 6.169412927192752e-07
( O 0 1.0635899799771309e-10
CT O 0 1.7209893599101633e-07
) O 0 2.8067156238043012e-11
or O 0 9.502768710811793e-11
MRI O 0 5.822067805638653e-07
analysis O 0 3.852438812401715e-09
, O 0 9.489650384941761e-12
and O 0 5.73686887925251e-12
that O 0 1.111640076864595e-12
the O 0 1.708826309620992e-11
higher O 0 2.6262985119984705e-09
level O 0 1.2690462902753552e-08
of O 0 8.528033834664939e-10
tau O 0 8.265638173909906e-10
reflects O 0 1.2605438914903289e-10
the O 0 1.3651835738259788e-11
process O 0 4.487638705086283e-09
of O 0 2.3043629227004203e-08
neuronal B-Disease 0 0.0005862385150976479
degeneration I-Disease 1 0.9999995231628418
in O 0 3.4489330573705956e-05
ALD B-Disease 1 1.0
. O 0 6.009565186104737e-05

Lorenzos O 0 0.004784088581800461
Oil O 0 6.457507879531477e-07
should O 0 2.5432667083435945e-10
be O 0 3.689695771136314e-11
given O 0 2.374027537055401e-11
in O 0 1.1721238563078273e-11
the O 0 2.135489181320782e-11
early O 0 1.6837508054479144e-09
stage O 0 1.4468051645621927e-08
. O 0 5.346184828169953e-09
. O 0 4.8106258532243373e-08

Nonsense O 0 0.0001672849612077698
mutation O 0 1.3093756479065632e-07
in O 0 1.9408233242756978e-08
exon O 0 2.003364443226019e-07
4 O 0 6.175242983630369e-09
of O 0 4.470561254521499e-09
human O 0 5.803582947550012e-09
complement O 0 1.0650978055082305e-07
C9 O 1 0.7055550813674927
gene O 0 1.937168425669711e-09
is O 0 1.1354332404844847e-11
the O 0 3.615667834577785e-11
major O 0 4.1627851166126106e-10
cause O 0 2.0888895058135404e-09
of O 0 3.0300970621510714e-08
Japanese O 0 3.088720768573694e-05
complement B-Disease 0 0.00019792624516412616
C9 I-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9813050627708435
. O 0 5.5212371989910025e-06

Deficiency B-Disease 1 0.9937533736228943
of I-Disease 0 3.4543675155873643e-06
the I-Disease 0 6.255334739080354e-08
ninth I-Disease 0 3.900432147929678e-06
component I-Disease 0 3.1705823744232475e-07
of I-Disease 0 1.1480940642627502e-08
human I-Disease 0 2.795002895794596e-09
complement I-Disease 0 7.729421724889107e-08
( O 0 1.868622145906329e-09
C9 O 1 0.9997978806495667
) O 0 1.02593739059742e-10
is O 0 1.702365505507064e-11
the O 0 6.013588238484857e-11
most O 0 5.710877257203428e-11
common O 0 8.028946041349627e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.041605799505078e-09
Japan O 0 2.3825638351127054e-08
but O 0 3.7611053160802044e-11
is O 0 9.647975127147213e-12
rare O 0 6.079823450244604e-11
in O 0 8.01522459514814e-11
other O 0 1.9132846695857353e-10
countries O 0 5.835862459946384e-09
. O 0 2.433219776776241e-07

We O 0 5.984899331679117e-08
studied O 0 7.013584735204859e-08
the O 0 4.354422655783452e-10
molecular O 0 4.056084801362658e-09
basis O 0 5.2938691652570924e-08
of O 0 1.4151598293210554e-07
C9 B-Disease 1 0.9999996423721313
deficiency I-Disease 0 0.0004700635909102857
in O 0 1.1669253341395347e-09
four O 0 3.0029259634467564e-10
Japanese O 0 1.362483459388386e-07
C9 B-Disease 1 0.9992626309394836
- I-Disease 0 5.778523700428195e-06
deficient I-Disease 0 1.210214236380125e-06
patients O 0 2.4822941924185216e-08
who O 0 6.013683995220731e-10
had O 0 8.753851865606066e-09
suffered O 0 0.20215879380702972
from O 0 5.603508907370269e-05
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.919440248660976e-06

Direct O 0 4.54372823810445e-08
sequencing O 0 2.2317836112506484e-07
of O 0 8.461159239914195e-08
amplified O 0 1.8339079588258755e-07
C9 O 0 3.48010962625267e-06
cDNA O 0 1.439396015712191e-07
and O 0 3.3402122734393913e-10
DNA O 0 3.336064224868096e-08
revealed O 0 5.664689606277307e-09
a O 0 1.9226864544918953e-10
nonsense O 0 1.6095516031100487e-08
substitution O 0 2.092015449761675e-09
( O 0 2.4933669018345483e-10
CGA O 0 1.8440234725858318e-06
- O 0 4.730383807327598e-06
- O 0 1.1175235385962878e-06
> O 0 1.0995156429771669e-07
TGA O 0 1.383129415444273e-07
) O 0 2.0057200691980803e-11
at O 0 3.7809588793180637e-10
codon O 0 1.702367247169434e-09
95 O 0 8.580608223951458e-09
in O 0 1.1169934976962281e-09
exon O 0 1.6812132130894497e-08
4 O 0 1.3602777793053633e-09
in O 0 1.3639558926747952e-10
the O 0 1.1599042837318052e-09
four O 0 2.9110548638300315e-08
C9 B-Disease 1 0.9988340735435486
- I-Disease 0 0.0006574959843419492
deficient I-Disease 0 4.011996497865766e-05
individuals O 0 5.2189879085062785e-08
. O 0 9.636256663725362e-07

An O 0 2.8362412418658778e-09
allele O 0 9.28572774228087e-09
- O 0 2.524588094132696e-09
specific O 0 3.027043893322201e-10
polymerase O 0 2.605472726457947e-09
chain O 0 6.4238425689922e-10
reaction O 0 5.4865476745158404e-11
system O 0 3.1551589119160894e-10
designed O 0 6.425432408363463e-11
to O 0 2.3099305454521435e-11
detect O 0 1.2021365014547314e-09
exclusively O 0 9.39817446088398e-10
only O 0 6.200963787589275e-12
one O 0 2.1844375266977245e-12
of O 0 3.2502129460043605e-11
the O 0 3.723332753224895e-11
normal O 0 2.4112407626120103e-09
and O 0 6.2497893145441186e-12
mutant O 0 2.944421095829597e-11
alleles O 0 6.460391249740738e-12
indicated O 0 2.3728550374579882e-11
that O 0 2.1304340941125793e-13
all O 0 1.4409500068840453e-12
the O 0 4.3211992144243094e-12
four O 0 6.9937072626202745e-12
patients O 0 2.1808376285403774e-11
were O 0 5.7915020001964024e-11
homozygous O 0 2.1625180812723244e-10
for O 0 1.419842542149663e-11
the O 0 4.772301442912408e-10
mutation O 0 4.122222563296418e-09
in O 0 2.886802130674937e-09
exon O 0 9.776477583045562e-08
4 O 0 2.43136710764702e-09
and O 0 9.689362506781762e-11
that O 0 8.354436933921683e-12
the O 0 1.2532988535873812e-10
parents O 0 2.26022117688629e-10
of O 0 1.8152843672680774e-09
patient O 0 1.0140540496195172e-07
2 O 0 3.0903020586947605e-08
were O 0 3.679637217146592e-08
heterozygous O 0 3.6337450382006864e-08
. O 0 3.913727297799596e-08

The O 0 7.909369514891296e-08
common O 0 1.1634567087526193e-08
mutation O 0 1.3277585697579752e-09
at O 0 2.224646244997075e-09
codon O 0 1.5709055389834248e-08
95 O 0 1.1178939018918754e-07
in O 0 4.149682819587497e-09
exon O 0 3.700336392853387e-08
4 O 0 1.9562909070458545e-09
might O 0 1.8025761439055543e-10
be O 0 1.3922880903738388e-10
responsible O 0 3.9716363531283605e-09
for O 0 8.056673661549496e-10
most O 0 4.819715737625074e-09
Japanese O 0 0.0004526619741227478
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.7638645768165588
. O 0 8.222514225053601e-08
. O 0 2.4252548769254645e-07

BRCA1 O 0 1.2533102733414125e-07
required O 0 1.893258883001181e-08
for O 0 2.1039920916621213e-09
transcription O 0 9.441497468287707e-07
- O 0 5.653369612446113e-07
coupled O 0 3.211841033134988e-07
repair O 0 0.0002533939841669053
of O 0 1.695997156048179e-07
oxidative O 0 8.222173164540436e-06
DNA O 0 0.00011502677807584405
damage O 0 2.1861065761186182e-05
. O 0 5.004339982406236e-07

The O 0 2.16289731724828e-06
breast B-Disease 1 0.999988317489624
and I-Disease 1 0.998889148235321
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 0.008744267746806145
gene O 0 1.3297995593575251e-08
BRCA1 O 0 1.3324018333094045e-08
encodes O 0 1.2788177461420247e-10
a O 0 1.8323496886463175e-10
zinc O 0 8.83025386144709e-09
finger O 0 3.7736789693099126e-08
protein O 0 4.476380155438164e-09
of O 0 7.428008430565569e-09
unknown O 0 1.426059270670521e-06
function O 0 6.457323706854368e-07
. O 0 2.8631401960410585e-07

Association O 0 8.124131056774786e-08
of O 0 2.7866631668871378e-08
the O 0 7.191169437703593e-09
BRCA1 O 0 1.3193628412011549e-08
protein O 0 1.6266943347886809e-10
with O 0 2.348848763059075e-12
the O 0 1.0391124766195858e-10
DNA O 0 1.2618520486284979e-06
repair O 0 0.09351053088903427
protein O 0 5.33063939656131e-08
Rad51 O 0 4.955329586664448e-07
and O 0 9.484945814874912e-12
changes O 0 9.59287163593281e-12
in O 0 4.0003152700085476e-12
the O 0 5.777244134475001e-12
phosphorylation O 0 1.4776881107625428e-10
and O 0 1.3057767540847198e-11
cellular O 0 1.056129583787424e-08
localization O 0 5.702612497771042e-07
of O 0 1.1769736296685096e-08
the O 0 2.0480332985073346e-09
protein O 0 2.125665199415039e-09
after O 0 1.5007814990752877e-09
exposure O 0 1.2283114969591225e-08
to O 0 2.608001870019194e-10
DNA O 0 6.9510638240899425e-06
- O 0 3.0703097309014993e-07
damaging O 0 5.665316660241615e-09
agents O 0 2.001994403588725e-10
are O 0 5.811915185227612e-12
consistent O 0 9.851944815508773e-10
with O 0 1.7269712136031012e-12
a O 0 1.6734749003211036e-11
role O 0 1.5385555329761047e-10
for O 0 1.521965470319131e-10
BRCA1 O 0 5.273652803339246e-08
in O 0 3.0517004478980425e-09
DNA O 0 7.952517989906482e-06
repair O 0 0.000619931670371443
. O 0 1.1108580793006695e-06

Here O 0 8.291144126815198e-07
, O 0 3.797567260654944e-10
it O 0 2.1272111676295946e-12
is O 0 1.810723879863696e-12
shown O 0 8.885965574467747e-11
that O 0 1.0127512543867123e-11
mouse O 0 3.0130307138165335e-09
embryonic O 0 9.947420664957463e-08
stem O 0 2.1671225169939135e-07
cells O 0 3.2512295433662075e-07
deficient B-Disease 0 1.8643956991581945e-06
in I-Disease 0 2.3558741624185586e-09
BRCA1 I-Disease 0 1.3980001156710387e-08
are O 0 9.525284207223539e-12
defective O 0 1.0034230113475928e-09
in O 0 1.4622946950537674e-11
the O 0 2.4458905387159113e-11
ability O 0 2.0509484388586685e-10
to O 0 2.1217378548543664e-11
carry O 0 7.209651209372225e-10
out O 0 2.579157165616408e-10
transcription O 0 2.6360515903434134e-07
- O 0 1.675100520515116e-07
coupled O 0 3.444872334057436e-07
repair O 0 8.234116648964118e-06
of O 0 1.7049741174446353e-08
oxidative O 0 9.707615333809372e-08
DNA O 0 3.5123082398058614e-06
damage O 0 2.5277174131588254e-07
, O 0 7.231518162065242e-11
and O 0 3.118434330207087e-11
are O 0 9.382263715940198e-11
hypersensitive O 0 1.1545616729335961e-07
to O 0 1.0070319689248208e-08
ionizing O 0 2.779999158519786e-05
radiation O 0 2.2656357032246888e-05
and O 0 1.2093698487092297e-08
hydrogen O 0 5.562405931414105e-07
peroxide O 0 5.298715677781729e-06
. O 0 5.500816655512608e-07

These O 0 1.2631106827143412e-08
results O 0 1.4834108164052395e-08
suggest O 0 1.4802058245777516e-08
that O 0 2.2559833168234178e-10
BRCA1 O 0 9.987893179186358e-09
participates O 0 1.8660151201999042e-09
, O 0 1.7832685328400544e-10
directly O 0 1.697932106026201e-08
or O 0 3.373173074194824e-09
indirectly O 0 1.1356519991068126e-07
, O 0 1.1394191146152366e-10
in O 0 3.853428964806227e-10
transcription O 0 2.981771842769376e-07
- O 0 1.4157214422994002e-07
coupled O 0 1.7321877976428368e-07
repair O 0 3.668520321298274e-06
of O 0 1.4072700338374489e-08
oxidative O 0 2.460331813836092e-07
DNA O 0 4.2592296267685015e-06
damage O 0 7.274954327840533e-07
. O 0 1.514363034971211e-08
. O 0 8.701302789404508e-08

Truncation O 0 0.0002913756179623306
mutations O 0 1.2005244798274362e-07
in O 0 1.8224447506653974e-09
the O 0 5.821298998398561e-09
transactivation O 0 3.9821057725930586e-05
region O 0 2.0731808092477877e-07
of O 0 8.35376852137415e-08
PAX6 O 0 0.3714103102684021
result O 0 4.654328478181924e-08
in O 0 3.282650595792802e-09
dominant O 0 2.259630264234147e-06
- O 0 1.7961640708108462e-07
negative O 0 1.0328846666851632e-09
mutants O 0 3.104599599623725e-08
. O 0 2.9624068531575176e-08

PAX6 O 0 0.0009994040010496974
is O 0 4.695995592385316e-09
a O 0 9.85064807501601e-10
transcription O 0 7.830575299294651e-09
factor O 0 1.0515376763775564e-10
with O 0 1.4346452628308248e-12
two O 0 1.0652074708406012e-11
DNA O 0 1.9070347079264138e-08
- O 0 2.45482434380051e-09
binding O 0 3.045651508770675e-10
domains O 0 6.513878325620226e-09
( O 0 3.485719698992362e-11
paired O 0 5.000883263051037e-09
box O 0 4.405022124842617e-09
and O 0 7.930495704577822e-10
homeobox O 0 8.451933553033086e-08
) O 0 1.796054624469967e-11
and O 0 5.123827404029946e-11
a O 0 1.1763064966530123e-09
proline O 0 1.341098368357052e-06
- O 0 3.9632240600440127e-07
serine O 0 8.819869776743872e-07
- O 0 2.101961172229494e-06
threonine O 0 2.2927813461137703e-06
( O 0 2.676570742821127e-09
PST O 1 0.8283712267875671
) O 0 1.0822190255055375e-08
- O 0 2.7812581038233475e-07
rich O 0 4.382690477200413e-08
transactivation O 0 3.849610220640898e-05
domain O 0 6.79836205108586e-07
. O 0 1.54145098463232e-07

PAX6 O 1 0.9999924898147583
regulates O 0 1.0220019248663448e-05
eye O 0 7.193102646851912e-05
development O 0 1.8362965192864067e-06
in O 0 1.9076775714665928e-09
animals O 0 3.553860816740695e-10
ranging O 0 9.241996501430094e-09
from O 0 7.209871588642613e-10
jellyfish O 0 9.080759061363963e-11
to O 0 2.6273241915397705e-10
Drosophila O 0 2.897859019412863e-08
to O 0 9.541790468858835e-09
humans O 0 1.7107636551827454e-07
. O 0 2.103201239833652e-07

Heterozygous O 0 8.749021844778326e-07
mutations O 0 1.859053000430322e-08
in O 0 3.7652414519584454e-10
the O 0 9.348400942243984e-10
human O 0 1.3691545674987537e-08
PAX6 O 1 0.5632712841033936
gene O 0 3.049175356650835e-09
result O 0 8.101144755023881e-10
in O 0 1.4258537059386178e-11
various O 0 2.71091565862136e-10
phenotypes O 0 2.3056367925988752e-09
, O 0 7.304765299587235e-12
including O 0 1.2261311410632914e-10
aniridia B-Disease 1 1.0
, O 0 5.502422339986879e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.3653346775963655e-08
autosomal B-Disease 1 0.9975430965423584
dominant I-Disease 1 0.9989035129547119
keratitis I-Disease 1 1.0
, O 0 1.2764289181177446e-07
and O 0 8.104720450319292e-07
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 1.0

It O 0 5.644066325416475e-10
is O 0 6.688826575951268e-11
believed O 0 7.667040891057297e-10
that O 0 7.207275683381031e-13
the O 0 6.282225174097933e-12
mutated O 0 5.003893133181947e-11
allele O 0 5.327584484682291e-10
of O 0 3.967147055305986e-09
PAX6 O 0 0.0003161495551466942
produces O 0 3.897840661348795e-10
an O 0 2.8603376611702203e-11
inactive O 0 2.1575926822947622e-08
protein O 0 3.38303252078731e-08
and O 0 5.570318428738119e-09
aniridia B-Disease 1 1.0
is O 0 2.0757588981012987e-09
caused O 0 2.1768842728420168e-08
due O 0 1.812549044188927e-07
to O 0 1.0821219476042643e-08
genetic O 0 1.8041640714727691e-06
haploinsufficiency O 0 7.064236706355587e-05
. O 0 7.472965535271214e-07

However O 0 1.3886963756704063e-07
, O 0 4.394295760601352e-10
several O 0 1.0885444629016305e-10
truncation O 0 2.2680623601445404e-07
mutations O 0 2.3552586547737064e-09
have O 0 2.5603737879853483e-11
been O 0 6.3669104710673e-11
found O 0 1.8545526225821618e-11
to O 0 9.438798700966977e-12
occur O 0 1.2923536685249815e-09
in O 0 7.766029486155901e-11
the O 0 4.343332360434715e-10
C O 0 9.725830523166223e-07
- O 0 3.692932892818135e-08
terminal O 0 1.6709545747062293e-08
half O 0 6.756660786422231e-10
of O 0 6.793243745306654e-10
PAX6 O 0 6.45860745862592e-06
in O 0 2.0329085637094124e-10
patients O 0 3.815806282059242e-10
with O 0 7.099497378870723e-11
Aniridia B-Disease 1 1.0
resulting O 0 5.539296576984043e-09
in O 0 3.6985102480624477e-11
mutant O 0 6.405743296911126e-11
proteins O 0 2.800671370165042e-12
that O 0 3.892663643680072e-13
retain O 0 7.276761831986889e-11
the O 0 6.298666449522372e-11
DNA O 0 7.763655673898029e-08
- O 0 2.2795925147534035e-09
binding O 0 1.6449591688783016e-10
domains O 0 7.800939449964517e-09
but O 0 7.152777675711874e-11
have O 0 3.835644649119452e-11
lost O 0 3.7105472028287068e-09
most O 0 1.925650784662114e-11
of O 0 8.63315252619401e-10
the O 0 7.836925774995507e-09
transactivation O 0 0.00017070129979401827
domain O 0 8.437531846539059e-07
. O 0 2.994315764226485e-07

It O 0 2.1543224981712683e-09
is O 0 1.223729312327393e-10
not O 0 1.3683960908839055e-10
clear O 0 1.437457819442045e-09
whether O 0 2.0761063701524307e-10
such O 0 8.649102961610922e-11
mutants O 0 1.381004022249499e-08
really O 0 4.4489296691097024e-09
behave O 0 1.5554546539675584e-09
as O 0 4.4577441737914114e-10
loss O 0 1.4619232047152764e-08
- O 0 3.417248706227838e-08
of O 0 6.05619845828187e-07
- O 0 6.116738973105385e-07
function O 0 5.55784076539112e-08
mutants O 0 1.1600952198875802e-08
as O 0 4.871151051966116e-11
predicted O 0 1.897216161950155e-09
by O 0 2.684862610013994e-10
haploinsufficiency O 0 2.9146219731046585e-06
. O 0 1.8115501632109954e-07

Contrary O 0 6.188747079249879e-07
to O 0 9.90485138352426e-10
this O 0 1.0078572004745823e-10
theory O 0 1.116474290796532e-08
, O 0 1.522844697565695e-11
our O 0 1.563115054059594e-10
data O 0 1.1860999959978358e-09
showed O 0 1.4591972075095327e-10
that O 0 2.1753307705499325e-13
these O 0 1.0201352566505117e-12
mutants O 0 9.261468675303419e-11
are O 0 9.197053708887015e-12
dominant O 0 4.513685780693777e-08
- O 0 9.17735309968748e-09
negative O 0 3.080712351888337e-10
in O 0 1.530345988820514e-10
transient O 0 2.3327714870902128e-08
transfection O 0 2.3161950934991182e-07
assays O 0 2.4853059610308037e-09
when O 0 1.624712864245481e-10
they O 0 4.2273212708110464e-11
are O 0 1.9144337157217528e-11
coexpressed O 0 6.062380464300077e-08
with O 0 5.292498383990818e-11
wild O 0 1.620672485103114e-08
- O 0 3.3890688655446866e-07
type O 0 3.5160182960680686e-06
PAX6 O 1 0.9463766813278198
. O 0 3.1406618745677406e-06

We O 0 2.612749661068392e-08
found O 0 5.909247535740292e-10
that O 0 1.9635699316511435e-12
the O 0 7.182088257451369e-11
dominant O 0 1.3211335669893742e-07
- O 0 4.281792254090533e-09
negative O 0 3.3279372313455013e-11
effects O 0 5.073436115665686e-10
result O 0 5.730550062255091e-11
from O 0 1.4061651149033239e-11
the O 0 8.110149704587677e-12
enhanced O 0 4.866463898522966e-10
DNA O 0 2.5501609712819118e-09
binding O 0 7.939118806810086e-11
ability O 0 1.565246043888635e-09
of O 0 2.288388145643694e-09
these O 0 1.9088424174640295e-09
mutants O 0 1.973434109459049e-07
. O 0 1.032857923632946e-07

Kinetic O 0 6.398963137144165e-07
studies O 0 4.070825898594421e-09
of O 0 5.589003704287165e-10
binding O 0 2.127018561282057e-10
and O 0 6.848962369465639e-11
dissociation O 0 1.1098077123961048e-08
revealed O 0 3.6443073003766813e-09
that O 0 2.3843182202915036e-12
various O 0 8.773801130068648e-11
truncation O 0 6.267600127785045e-08
mutants O 0 2.1324997323546313e-09
have O 0 1.7174919472728867e-11
3 O 0 1.7435347610117446e-10
- O 0 6.652631778791829e-10
5 O 0 3.860255726184647e-10
- O 0 1.2823773154480023e-09
fold O 0 2.7649268985463493e-10
higher O 0 5.251845625053875e-10
affinity O 0 1.7237010430104505e-11
to O 0 5.430739625361669e-12
various O 0 9.241317433517082e-11
DNA O 0 1.5261298003110824e-08
- O 0 4.712502610360048e-10
binding O 0 1.954498542178218e-11
sites O 0 4.450181195769787e-11
when O 0 1.0227933083806207e-11
compared O 0 7.509928789950493e-11
with O 0 2.4756884910159815e-12
the O 0 2.4868601622429765e-10
wild O 0 1.6108108624734996e-08
- O 0 2.1630467017530464e-07
type O 0 1.9669566881930223e-06
PAX6 O 0 0.24848823249340057
. O 0 2.792258101180778e-06

These O 0 8.551591434979855e-09
results O 0 7.207358709848677e-09
provide O 0 1.0834845243223867e-09
a O 0 8.183496935654233e-11
new O 0 3.2746992617571635e-11
insight O 0 1.6081823650537785e-09
into O 0 7.151222669588009e-11
the O 0 8.582367455600703e-11
role O 0 3.1482776385871603e-09
of O 0 2.6123659679910816e-08
mutant O 0 3.979843938850536e-07
PAX6 O 0 0.00907281506806612
in O 0 1.67254565752728e-08
causing O 0 1.0475858971403795e-06
aniridia B-Disease 1 1.0
. O 0 9.699915892724675e-08
. O 0 1.2401294213759684e-07

Reversal O 0 3.0858077479933854e-06
of O 0 2.9517030952774803e-07
severe O 1 0.9897332787513733
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 6.025065431458643e-06
excellent O 0 1.281184381696221e-06
neuropsychologic O 0 1.268508640350774e-06
outcome O 0 3.4553153227534494e-08
in O 0 6.256877654875481e-11
very B-Disease 0 2.537108578781755e-10
- I-Disease 0 2.0204238282417464e-09
long I-Disease 0 1.8098496035179323e-09
- I-Disease 0 1.2539098648289837e-08
chain I-Disease 0 4.8637844862753354e-09
acyl I-Disease 0 7.972163729164095e-08
- I-Disease 0 1.8304709215044568e-07
coenzyme I-Disease 0 6.859665973024676e-07
A I-Disease 0 0.0004487309488467872
dehydrogenase I-Disease 0 0.0019761936273425817
deficiency I-Disease 0 0.011357061564922333
. O 0 1.033787725646107e-06

Very B-Disease 0 2.438916339997377e-07
- I-Disease 0 2.407717545338528e-07
long I-Disease 0 2.3287171302399656e-08
- I-Disease 0 9.881740758999058e-09
chain I-Disease 0 7.936760693105782e-10
acyl I-Disease 0 1.4832403083531176e-09
- I-Disease 0 1.109062286452911e-09
coenzyme I-Disease 0 9.062647854385375e-10
A I-Disease 0 1.408682503978298e-08
dehydrogenase I-Disease 0 1.7129078599964487e-08
( I-Disease 0 2.988276015525315e-10
VLCAD I-Disease 1 0.9999994039535522
) I-Disease 0 2.980763413873433e-09
deficiency I-Disease 0 1.2716822084257728e-06
is O 0 3.0275275342273034e-11
a O 0 7.793350964568901e-10
disorder O 1 0.5761488676071167
of O 0 0.05160565301775932
fatty O 0 7.469880642929638e-07
acid O 0 4.273309173186135e-08
beta O 0 3.59135410299416e-09
oxidation O 0 6.629126581003675e-09
that O 0 3.869246936738513e-11
reportedly O 0 7.936987733714318e-10
has O 0 4.79005203557481e-12
high O 0 5.262855706789082e-10
rates O 0 3.437001128148154e-09
of O 0 1.5364448602284142e-09
morbidity O 0 1.5686741789977532e-06
and O 0 8.831887221560919e-09
mortality O 0 3.653925523394719e-05
. O 0 6.402308372344123e-07

We O 0 5.67212019575436e-08
describe O 0 1.946915162420737e-08
the O 0 6.823708820213881e-10
outcome O 0 9.124889288614213e-08
of O 0 1.511114078311948e-08
a O 0 3.6791844570949195e-10
5 O 0 4.210055359887832e-10
- O 0 1.190839510334385e-10
year O 0 3.049253904929827e-11
- O 0 4.922870444623584e-10
old O 0 6.0565077397711775e-09
girl O 0 6.816222253291926e-08
with O 0 1.0354967550085803e-08
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 3.363422251823067e-08
was O 0 3.034151063729951e-08
first O 0 1.0239946668377797e-09
seen O 0 3.0512172788377256e-09
at O 0 2.6982360790128723e-10
5 O 0 5.6394364872369707e-11
months O 0 5.161257185526402e-11
of O 0 2.294075866771106e-11
age O 0 9.243684151449827e-10
with O 0 1.007757211013427e-10
severe O 0 0.00027289666468277574
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999713897705078
hepatomegaly B-Disease 1 1.0
, O 1 0.997697651386261
encephalopathy B-Disease 1 0.9999592304229736
, O 0 1.561448037534774e-08
and O 0 1.56790690652997e-07
hypotonia B-Disease 0 0.18073582649230957
. O 0 1.1982270734733902e-05

Biochemical O 0 7.213093795144232e-06
studies O 0 5.478064508679381e-07
indicated O 1 0.8757980465888977
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 2.2729992110726016e-07
by O 0 1.2747096433951555e-10
a O 0 4.781987028579238e-10
stable O 0 5.8002156038128305e-06
yet O 0 1.1914221609288234e-08
inactive O 0 1.8352970698742865e-07
enzyme O 0 3.952933624873367e-08
. O 0 1.9371073278762196e-07

Molecular O 0 6.172548978611303e-07
genetic O 0 8.863445088991284e-09
analysis O 0 2.499463080951614e-09
of O 0 3.299435835657505e-09
her O 0 1.2629444157141734e-08
VLCAD O 1 0.9999994039535522
gene O 0 1.2121017078925433e-08
revealed O 0 9.306867099212468e-08
a O 0 6.916257011546634e-10
T1372C O 0 1.1830604762508301e-06
( O 0 2.875995830375899e-10
F458L O 0 4.917948217553203e-07
) O 0 1.7091433823779312e-10
missense O 0 1.4132716330550465e-07
mutation O 0 3.272180082447562e-09
and O 0 4.035558109904969e-09
a O 0 1.7779527183847676e-07
1668 O 0 0.0006861416040919721
ACAG O 1 0.9997338652610779
1669 O 0 0.0004573069454636425
splice O 0 8.211148815462366e-05
site O 0 6.433240855585609e-07
mutation O 0 3.6438163419916236e-07
. O 0 5.628386929856788e-07

After O 0 1.4537150150317757e-08
initial O 0 1.4684682803078886e-08
treatment O 0 1.5756324955873424e-07
with O 0 1.7675266805738943e-09
intravenous O 0 5.601481007033726e-06
glucose O 0 3.4083391255990136e-06
and O 0 1.556202500196946e-09
carnitine O 0 4.2361900653986595e-08
, O 0 1.5135320080572612e-11
the O 0 6.123442031213955e-11
patient O 0 1.128754067991622e-08
has O 0 7.826486854434211e-12
thrived O 0 8.741951607049714e-10
on O 0 8.486458064060898e-11
a O 0 2.009876154396295e-10
low O 0 3.3907727470250393e-07
- O 0 2.425491061330831e-07
fat O 0 1.4134974968271763e-08
diet O 0 8.842063192737726e-10
supplemented O 0 9.72918301478387e-10
with O 0 1.7174527425223296e-11
medium O 0 8.921778515968981e-08
- O 0 4.5115601920997506e-08
chain O 0 1.1640893582409717e-08
triglyceride O 0 4.307572680772864e-07
oil O 0 3.3680894517829074e-08
and O 0 1.5047857404582032e-09
carnitine O 0 9.875073914145105e-08
and O 0 4.3705400409876916e-10
avoidance O 0 4.600577767632785e-07
of O 0 1.559844235998753e-07
fasting O 0 4.687354703492019e-06
. O 0 7.070587457747024e-07

Her O 0 8.195619739126414e-05
ventricular O 1 0.9999167919158936
hypertrophy O 1 0.9999988079071045
resolved O 1 0.9987860321998596
significantly O 0 3.5825922850563074e-07
over O 0 5.035414307741348e-10
1 O 0 2.0611760909172716e-10
year O 0 2.6867001678976266e-11
, O 0 2.987435169035657e-12
and O 0 1.1155446358324106e-11
cognitively O 0 4.149503922690201e-07
, O 0 2.002934068601192e-10
she O 0 1.404702049123685e-10
is O 0 3.724050234854559e-11
in O 0 4.9032174154195474e-11
the O 0 1.6909429412237387e-10
superior O 0 8.403417517399703e-09
range O 0 7.14855685757243e-09
for O 0 8.950301610965994e-10
age O 0 3.398814669708372e-07
. O 0 3.899708076460229e-07

Clinical O 0 4.014646492578322e-06
recognition O 0 5.509560651262291e-06
of O 1 0.9999911785125732
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 5.532169389255159e-09
important O 0 1.6778295419683786e-09
because O 0 1.4462621204802684e-11
it O 0 1.3154196698908494e-13
is O 0 6.299127885966982e-13
one O 0 4.4364837324673e-12
of O 0 2.467869797406763e-10
the O 0 6.629274906799765e-10
few O 0 5.848108219907999e-09
directly O 0 8.650748384297913e-08
treatable O 0 0.04846235737204552
causes O 0 2.0954712454113178e-07
of O 0 6.98999838277814e-06
cardiomyopathy B-Disease 1 1.0
in O 0 1.8687930491978477e-07
children O 0 4.549119747565555e-09
. O 0 1.8192184425558366e-09
. O 0 2.1330418320530953e-08

Cloning O 0 5.586684892477933e-07
of O 0 2.3037607377318636e-08
a O 0 4.879076032082708e-10
novel O 0 1.1612674016836522e-10
member O 0 7.586465899933614e-10
of O 0 1.7907203497813384e-09
the O 0 4.715292600820931e-09
low O 0 1.2438123349056696e-06
- O 0 4.244973794698126e-08
density O 0 5.894256194238778e-09
lipoprotein O 0 1.9505917236983805e-07
receptor O 0 5.758264975952443e-09
family O 0 8.495406156328045e-09
. O 0 8.207409507576813e-08

A O 0 2.886567642690352e-07
gene O 0 5.4727573584045786e-09
encoding O 0 5.109762213351132e-08
a O 0 1.0389227256268896e-09
novel O 0 7.506795740575001e-10
transmembrane O 0 2.956197953096762e-08
protein O 0 7.80593228943971e-11
was O 0 1.824074051526292e-11
identified O 0 3.729066534730041e-12
by O 0 7.737349172823316e-14
DNA O 0 4.651951740486382e-11
sequence O 0 1.135604284219216e-11
analysis O 0 2.308089656899437e-11
within O 0 3.728051548024247e-11
the O 0 1.0053459453818192e-10
insulin B-Disease 1 0.5803512930870056
- I-Disease 1 0.7776427865028381
dependent I-Disease 1 0.9999775886535645
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 2.7655676859694722e-08
IDDM B-Disease 0 0.025391971692442894
) O 0 2.7027222126996264e-10
locus O 0 4.704620248929814e-09
IDDM4 O 0 2.030870064118062e-06
on O 0 1.405622995775957e-08
chromosome O 0 4.1450465460002306e-07
11q13 O 0 5.03077644680161e-05
. O 0 1.4176035847413004e-06

Based O 0 3.138139748060098e-09
on O 0 2.2293695778330402e-09
its O 0 1.1989506609744183e-10
chromosomal O 0 1.3835384038429765e-07
position O 0 1.4363024547492387e-07
, O 0 6.68565064421145e-11
this O 0 1.2806234371554037e-11
gene O 0 3.951329541340698e-11
is O 0 4.627127240391937e-12
a O 0 2.0943049378052692e-11
candidate O 0 2.143326183201566e-09
for O 0 1.0256420018839307e-10
conferring O 0 5.906858291382378e-07
susceptibility O 0 1.6349038560292684e-05
to O 0 6.121407523096423e-07
diabetes B-Disease 1 0.9999985694885254
. O 0 2.4792509066173807e-05

The O 0 3.483551225258452e-08
gene O 0 1.9783206184342816e-09
, O 0 7.807451907204666e-11
termed O 0 8.911213100759596e-09
low O 0 3.752684563096409e-07
- O 0 1.1517699682883631e-08
density O 0 6.787712614197972e-10
lipoprotein O 0 9.811027545936213e-10
receptor O 0 3.9535309054317125e-11
related O 0 3.6132101755015356e-09
protein O 0 1.0280143403207376e-09
5 O 0 1.9934821848810458e-10
( O 0 1.5357898980328244e-11
LRP5 O 0 1.9006382672159816e-06
) O 0 5.829311859606445e-12
, O 0 5.286633977807931e-12
encodes O 0 2.013896688302097e-11
a O 0 8.596555411966023e-11
protein O 0 1.952302319807586e-09
of O 0 3.3329907722645657e-09
1615 O 0 4.978131755706272e-07
amino O 0 2.3850782682188765e-08
acids O 0 9.061195682669165e-10
that O 0 8.343450062786584e-12
contains O 0 5.070074134833069e-12
conserved O 0 7.397602669323433e-11
modules O 0 8.929822437053758e-10
which O 0 5.550072120635852e-13
are O 0 9.719931023249861e-13
characteristic O 0 3.107048784922739e-10
of O 0 1.0976225484071733e-09
the O 0 1.8824017899987666e-09
low O 0 4.4277939537096245e-07
- O 0 8.101338266897073e-08
density O 0 1.1955379797257137e-08
lipoprotein O 0 1.5390479290999792e-07
( O 0 7.807995139330615e-09
LDL O 0 1.0388339433120564e-06
) O 0 2.158633050086678e-09
receptor O 0 5.406439740340829e-09
family O 0 1.1449538206420584e-08
. O 0 1.7256485307370895e-07

These O 0 5.1490500752038315e-09
modules O 0 6.908194905008713e-08
include O 0 1.4191069153124403e-10
a O 0 1.268205401805389e-10
putative O 0 5.601332286886418e-09
signal O 0 1.3099596962717897e-08
peptide O 0 1.0549895401723575e-09
for O 0 4.432791633757205e-10
protein O 0 2.0033017467113723e-09
export O 0 2.6600568858725637e-08
, O 0 1.4864001696146545e-10
four O 0 2.1439843234105638e-09
epidermal O 0 1.1685121847904156e-07
growth O 0 1.1289586154816789e-08
factor O 0 3.2457685428255445e-09
( O 0 6.640917260547496e-10
EGF O 0 3.2942631378318765e-07
) O 0 4.559382385527222e-11
repeats O 0 1.3591054948136616e-09
with O 0 1.1604127381215079e-10
associated O 0 9.404512013588828e-08
spacer O 0 3.2067564461613074e-05
domains O 0 8.961703201748605e-08
, O 0 2.922991571008282e-10
three O 0 1.07258268933208e-09
LDL O 0 1.5093087313289288e-07
- O 0 7.098099530367108e-08
receptor O 0 1.8166791682094896e-10
( O 0 3.4428979112099967e-10
LDLR O 1 0.8265429735183716
) O 0 9.06540884026974e-11
repeats O 0 1.3634025020081708e-09
, O 0 4.5446029751927686e-12
a O 0 1.9470643847219193e-11
single O 0 1.625609646893622e-09
transmembrane O 0 6.052271572798418e-08
spanning O 0 3.1018412727235045e-08
domain O 0 7.82696218948331e-09
, O 0 1.0747876894035002e-10
and O 0 2.3970153639751857e-10
a O 0 1.4029284400862707e-08
cytoplasmic O 0 3.630133733167895e-06
domain O 0 4.250688107276801e-06
. O 0 1.9261315173935145e-06

The O 0 7.996743534022244e-08
encoded O 0 1.7760952175649436e-07
protein O 0 1.1561324342324042e-08
has O 0 8.94793700939589e-12
a O 0 1.3333048207164744e-11
unique O 0 9.711194348671626e-11
organization O 0 3.0013341811852e-10
of O 0 6.708435051905326e-08
EGF O 0 5.612889435724355e-05
and O 0 1.0102967351599546e-08
LDLR O 1 0.9997256398200989
repeats O 0 3.579490837068988e-08
; O 0 1.6558089968587986e-11
therefore O 0 4.046431800741601e-10
, O 0 2.40984177057868e-10
LRP5 O 0 0.0002577934938017279
likely O 0 3.3855163117380016e-09
represents O 0 7.924247369395232e-11
a O 0 2.902711578045558e-11
new O 0 7.771092797037582e-12
category O 0 4.1206954515260463e-10
of O 0 4.636525385848245e-09
the O 0 5.167332517430623e-08
LDLR O 1 0.9999687671661377
family O 0 5.304866590449819e-07
. O 0 1.1864376574521884e-06

Both O 0 1.0494733260202338e-07
human O 0 3.67490997632558e-08
and O 0 1.387943804331826e-08
mouse O 0 9.636551112635061e-07
LRP5 O 1 0.9999943971633911
cDNAs O 0 0.00016087651601992548
have O 0 6.619504250293673e-11
been O 0 8.962374592469402e-11
isolated O 0 2.9997829220640426e-10
and O 0 6.335629069986748e-12
the O 0 1.910961389128829e-10
encoded O 0 4.1859724575488144e-09
mature O 0 7.381500299885602e-09
proteins O 0 1.7360442944314158e-11
are O 0 3.3543181253425924e-12
95 O 0 1.0410808881644584e-09
% O 0 5.739421438111236e-11
identical O 0 5.6649220037119363e-11
, O 0 2.413882895652142e-12
indicating O 0 9.366744185834719e-11
a O 0 1.6553985612843825e-11
high O 0 3.6476016651576515e-10
degree O 0 2.5566590622361218e-08
of O 0 7.4151409457101636e-09
evolutionary O 0 4.546996734688946e-08
conservation O 0 9.556817559541742e-09
. O 0 1.7094278215168401e-09
. O 0 3.671722126341592e-08

The O 0 4.780605991072662e-07
APC B-Disease 0 4.316448666941142e-06
variants O 0 4.1089040792030573e-07
I1307K O 0 2.517257416911889e-05
and O 0 1.5004609776880784e-09
E1317Q O 0 5.591108447333681e-07
are O 0 2.8034519150565984e-11
associated O 0 4.6093697392279864e-07
with O 0 0.009806107729673386
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 6.152872629172634e-07
but O 0 1.2732200016518647e-10
not O 0 1.8611152549641297e-11
always O 0 2.5097995903777814e-10
with O 0 2.233491516734354e-11
a O 0 9.639816722639694e-10
family O 0 2.178328850632738e-09
history O 0 2.1716844855745876e-07
. O 0 1.7886769398955948e-07

Classical O 1 0.9926820397377014
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.5174153986663441e-06
FAP B-Disease 0 3.7464876641024603e-06
) O 0 7.61685228778397e-11
is O 0 1.2261866001728183e-11
a O 0 1.9599012690552087e-10
high O 0 2.1461883079609834e-06
- O 1 0.8975080251693726
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9979549646377563
that O 0 3.8338329733100807e-10
predisposes O 0 4.3177726638532476e-07
to O 0 2.6964661059558637e-10
hundreds O 0 5.797804458751443e-10
or O 0 2.666668275086437e-10
thousands O 0 2.2216863904134243e-09
of O 0 0.17610712349414825
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 1.9852823243127204e-06
that O 0 7.315030525756328e-11
results O 0 1.444554365015449e-09
from O 0 5.737673114403208e-10
truncating O 0 2.000278875868844e-08
mutations O 0 2.2335139293616635e-10
in O 0 1.1683479184121381e-10
the O 0 3.3392328901982182e-09
APC B-Disease 0 9.60753595791175e-07
gene O 0 8.574085086365812e-08
. O 0 4.938223128192476e-07

A O 0 2.809355805766245e-07
variant O 0 3.1010725365376857e-07
of O 0 2.5218133714588475e-07
FAP B-Disease 0 1.143314420914976e-05
is O 0 1.0066348465898045e-07
attenuated B-Disease 1 0.9918414354324341
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
, O 0 1.290983875357199e-09
which O 0 6.517471458356017e-12
results O 0 2.719107716764313e-10
from O 0 6.7290223393357e-10
germ O 0 5.8929545048158616e-05
- O 0 3.7897208926551684e-07
line O 0 6.357890924846288e-08
mutations O 0 2.5355813004779293e-09
in O 0 4.733817782209826e-10
the O 0 4.4804868148951016e-10
5 O 0 5.467829522487477e-10
and O 0 1.491818647780807e-11
3 O 0 1.3585786662329014e-10
regions O 0 1.9249504767948622e-10
of O 0 3.377136903459643e-10
the O 0 3.5764182726438776e-09
APC B-Disease 0 9.86236614153313e-07
gene O 0 8.69027374506004e-08
. O 0 4.611286783529067e-07

Attenuated B-Disease 1 0.999995231628418
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999991655349731
patients O 0 4.1882148593685997e-07
have O 0 2.5808388412484895e-11
" O 0 1.4740961229442462e-10
multiple O 0 1.5995624380593654e-08
" O 0 0.0520847924053669
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 4.2319781012878366e-10
typically O 0 6.13698258877804e-11
fewer O 0 4.088982624717019e-12
than O 0 7.753455538196674e-13
100 O 0 4.155040894682216e-11
) O 0 1.3513179290824961e-12
without O 0 6.132301610950464e-11
the O 0 2.373005680844642e-10
florid O 0 1.436099807961e-07
phenotype O 0 4.080381899029817e-08
of O 0 2.964967471541513e-08
classical O 0 5.804022748634452e-06
FAP B-Disease 0 6.777047474315623e-06
. O 0 5.567245580095914e-07

Another O 0 4.834919664631343e-08
group O 0 7.303546101233849e-10
of O 0 5.394408475467571e-09
patients O 0 3.512608159894626e-08
with O 0 3.58973600844692e-10
multiple O 0 0.08103128522634506
adenomas B-Disease 1 0.9999997615814209
has O 0 1.353470530096601e-10
no O 0 2.758251786694199e-11
mutations O 0 1.0880581158279057e-11
in O 0 9.553831684105951e-12
the O 0 1.4306682227793743e-10
APC B-Disease 0 2.4745698823380735e-08
gene O 0 2.8698038390118086e-10
, O 0 1.788605548391775e-11
and O 0 1.7808442220879073e-11
their O 0 1.1338863875609562e-10
phenotype O 0 9.54981538292543e-10
probably O 0 3.121453095999982e-10
results O 0 2.997529724435566e-10
from O 0 3.2043018238780974e-10
variation O 0 4.429928424087848e-09
at O 0 4.07168787575074e-09
a O 0 1.0197592770211372e-09
locus O 0 3.2359892543354363e-09
, O 0 1.1007352668235271e-10
or O 0 2.4885776772620716e-10
loci O 0 5.955392623491207e-09
, O 0 2.1007710848675032e-10
elsewhere O 0 8.141357588087317e-10
in O 0 2.1078189194057018e-10
the O 0 2.3876760568697364e-09
genome O 0 1.4419791227737733e-07
. O 0 1.9234444437188358e-07

Recently O 0 2.5223235411431233e-07
, O 0 2.5938981518258686e-10
however O 0 1.8259406486809127e-10
, O 0 5.393412712967338e-12
a O 0 2.1409377742864777e-11
missense O 0 2.446813596179709e-08
variant O 0 6.3729674870671715e-09
of O 0 1.383010612698854e-07
APC B-Disease 0 4.263492883183062e-06
( O 0 5.624832155604054e-09
I1307K O 0 5.24146125826519e-05
) O 0 6.902337035263884e-11
was O 0 1.471071819914016e-09
described O 0 3.17482679035308e-10
that O 0 2.476226905814838e-12
confers O 0 1.75066586227679e-10
an O 0 8.741092051567367e-12
increased O 0 1.1428761270693144e-09
risk O 0 1.6087069809600507e-07
of O 1 0.9921650886535645
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.2561437756630767e-07
including O 0 8.115001448594228e-10
multiple O 0 2.7462037905934267e-06
adenomas B-Disease 1 0.9954805374145508
, O 0 1.3766910278434352e-08
in O 0 9.657512123339984e-08
Ashkenazim O 0 0.0015616859309375286
. O 0 3.484792387098423e-06

We O 0 3.563346595569783e-08
have O 0 1.1017162182547224e-10
studied O 0 1.3312555502409396e-09
a O 0 1.7951813646721604e-11
set O 0 7.197858975516169e-11
of O 0 9.119691113390616e-11
164 O 0 2.863747017300966e-09
patients O 0 1.8485252217814718e-10
with O 0 5.6723171298900255e-11
multiple O 1 0.9999417066574097
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999895095825195
/ I-Disease 1 1.0
or I-Disease 1 0.9997594952583313
carcinoma I-Disease 1 1.0
and O 0 5.060518560640048e-06
analyzed O 0 1.2151547252869932e-06
codons O 0 7.800080226161299e-08
1263 O 0 3.034770088561345e-06
- O 0 4.2372084863018245e-07
1377 O 0 7.072745802361169e-07
( O 0 4.9364974330501354e-09
exon O 0 3.0628109470853815e-07
15G O 0 1.0818660030054161e-06
) O 0 6.634748306311167e-11
of O 0 8.341580759463341e-10
the O 0 3.060554920608638e-09
APC B-Disease 0 2.1305213238065335e-07
gene O 0 1.9673742635006874e-09
for O 0 3.901904133130074e-09
germ O 1 0.9999161958694458
- O 0 0.0002153835230274126
line O 0 6.671634196209197e-07
variants O 0 9.555797078064643e-07
. O 0 3.268791886057443e-07

Three O 0 5.5158938749855224e-08
patients O 0 7.115827038717271e-09
with O 0 6.540513269870374e-11
the O 0 7.194307372060393e-10
I1307K O 0 2.1666410532361624e-07
allele O 0 5.058382046563281e-10
were O 0 1.1435252744718127e-10
detected O 0 9.607987738746715e-10
, O 0 1.7844711168793492e-12
each O 0 1.1353942092062752e-11
of O 0 3.2516178638530846e-09
Ashkenazi O 0 2.983154627145268e-05
descent O 0 0.07368534803390503
. O 0 5.647040597978048e-05

Four O 0 1.0468603761637496e-07
patients O 0 5.564639948829608e-08
had O 0 1.8669763512946247e-09
a O 0 1.2040204389052178e-09
germ O 0 0.00033948326017707586
- O 0 5.080792107037269e-07
line O 0 7.633588694488935e-08
E1317Q O 0 1.5738589809188852e-06
missense O 0 4.7767777289209334e-08
variant O 0 1.844064345668528e-09
of O 0 6.6966454603800685e-09
APC O 0 5.5943203847164114e-08
that O 0 1.7650655242951174e-11
was O 0 6.458869550307611e-10
not O 0 1.3154509599655473e-11
present O 0 4.5587761343668376e-10
in O 0 1.164252583230052e-10
controls O 0 4.1054311061827775e-09
; O 0 2.5886367702177004e-12
one O 0 7.202043648957268e-12
of O 0 4.686166385492463e-11
these O 0 1.514785519241002e-11
individuals O 0 4.715692766832369e-11
had O 0 4.2883771533830384e-10
an O 0 2.2950034234137107e-11
unusually O 0 8.17640177785961e-10
large O 0 1.0740991429614155e-10
number O 0 5.060196706097031e-10
of O 0 2.334547488658245e-08
metaplastic B-Disease 0 0.00015483834431506693
polyps I-Disease 0 1.6282955073165795e-07
of I-Disease 0 5.644201195309506e-08
the I-Disease 0 3.9055626643857977e-07
colorectum I-Disease 0 0.00032646965701133013
. O 0 2.96653729492391e-06

There O 0 3.893267574994752e-08
is O 0 4.3976577934756733e-10
increasing O 0 1.188144693742288e-09
evidence O 0 2.8859858947072325e-10
that O 0 2.07524514066193e-12
there O 0 1.234861258386788e-11
exist O 0 1.1042349257195383e-09
germ O 0 9.38637299441325e-07
- O 0 4.4284247380232955e-09
line O 0 4.204374071115069e-10
variants O 0 8.99790297825831e-10
of O 0 1.592881826439907e-09
the O 0 1.4443010121212296e-09
APC B-Disease 0 1.081868603591829e-07
gene O 0 3.76331743545677e-10
that O 0 1.3670648814356756e-11
predispose O 0 8.481903179813344e-09
to O 0 7.789706379934813e-11
the O 0 2.395378895236888e-10
development O 0 3.7275665221159215e-08
of O 0 3.050514862934506e-08
multiple O 1 0.9999892711639404
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
carcinoma I-Disease 1 1.0
, O 0 2.4669967402246584e-08
but O 0 2.315613395476035e-10
without O 0 1.4782639556898403e-09
the O 0 2.8584534739195533e-09
florid O 0 2.855883565189288e-07
phenotype O 0 7.976708182866332e-09
of O 0 1.315766695597631e-08
classical O 0 1.0785323638629052e-06
FAP B-Disease 0 2.3755265488034638e-07
, O 0 7.297193405086944e-11
and O 0 1.2663846533922385e-11
possibly O 0 1.5508569983779807e-09
with O 0 9.06215935625454e-11
importance O 0 1.8735393041424686e-06
for O 0 5.585103644989431e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 7.887953688623384e-05
in O 0 2.1627613588925954e-10
the O 0 1.0164052932637446e-10
general O 0 2.298548573698156e-10
population O 0 1.364954503590976e-11
. O 0 8.311258625770535e-11
. O 0 3.506381185403029e-09

Genomic O 0 1.4723364074598067e-06
structure O 0 1.0459243071636593e-07
of O 0 4.348832760570076e-08
the O 0 6.632809146367435e-08
human O 1 0.9999527931213379
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.4035332202911377
CLD B-Disease 1 1.0
) O 0 3.845369356270112e-09
gene O 0 8.103111959201215e-09
. O 0 1.7356397208345697e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9764362573623657
CLD B-Disease 1 1.0
) O 0 3.036683682289265e-10
is O 0 4.900970688309636e-12
caused O 0 3.1878590045497646e-11
by O 0 1.9986922273479424e-12
mutations O 0 3.5946811499654174e-11
in O 0 1.1518297600432437e-11
a O 0 2.5315100710132654e-11
gene O 0 4.27977896177989e-11
which O 0 8.313520878655556e-12
encodes O 0 2.149015854158165e-09
an O 0 1.360669465988451e-09
intestinal O 0 0.00014886005374137312
anion O 0 4.033057120977901e-05
transporter O 0 2.159900395781733e-05
. O 0 3.2265543268295005e-06

We O 0 6.864888746349607e-08
report O 0 1.1119153375815927e-09
here O 0 3.221859723456788e-10
the O 0 1.6865004184851706e-11
complete O 0 6.009830966213769e-10
genomic O 0 2.6344610937201196e-09
organization O 0 5.630644561716025e-11
of O 0 3.472687970518251e-10
the O 0 6.198451196759436e-10
human O 0 2.917246710865129e-08
CLD B-Disease 1 0.9999996423721313
gene O 0 2.459534576004785e-09
which O 0 8.90428442784641e-12
spans O 0 3.3207483984831754e-10
approximately O 0 1.1706924318843903e-10
39kb O 0 8.49004848646473e-08
, O 0 1.792650194953893e-10
and O 0 5.66103608434787e-10
comprises O 0 9.555741975475485e-09
21 O 0 2.751706631443085e-07
exons O 0 1.0297455446561798e-05
. O 0 8.550173333787825e-07

All O 0 2.811451167872292e-06
exon O 0 1.0945333087875042e-05
/ O 0 1.6700836340532987e-06
intron O 0 1.3134319942764705e-06
boundaries O 0 4.648550433472565e-09
conform O 0 4.7952354975677736e-08
to O 0 4.117264307268442e-09
the O 0 4.089021743425292e-08
GT O 0 5.3907042456557974e-05
/ O 0 6.422086880775169e-05
AG O 0 3.381616988917813e-05
rule O 0 6.850656859569426e-07
. O 0 9.514948828837078e-07

An O 0 2.0847099602150365e-09
analysis O 0 1.6538610481120486e-08
of O 0 3.066538356577553e-09
the O 0 2.2998389859196777e-09
putative O 0 8.53575556902797e-08
promoter O 0 4.1309937159894616e-07
region O 0 2.667215248663979e-08
sequence O 0 1.0616514778405417e-08
shows O 0 2.402142706969812e-09
a O 0 2.063643700367379e-09
putative O 0 1.032656541610777e-06
TATA O 0 1.9081055143033154e-05
box O 0 4.928850927399253e-08
and O 0 1.1705901803438223e-09
predicts O 0 9.834264069752408e-09
multiple O 0 9.758440278062608e-09
transcription O 0 4.0322440497675416e-08
factor O 0 2.6377542372557627e-09
binding O 0 3.007484261630111e-09
sites O 0 3.9950847963154956e-08
. O 0 1.3566928203090356e-07

The O 0 2.0205096262770894e-08
genomic O 0 1.386102894684882e-07
structure O 0 7.79888598145817e-09
was O 0 5.519634749262536e-10
determined O 0 1.8144560853805558e-10
using O 0 1.2064059473626543e-10
DNA O 0 1.0350425405647457e-08
from O 0 1.9264737374791174e-11
several O 0 3.661706788476993e-12
sources O 0 1.208483174641728e-10
including O 0 2.09034504115857e-12
multiple O 0 5.499206090497921e-10
large O 0 2.700049517301295e-09
- O 0 5.4377988334408656e-08
insert O 0 7.703547311166403e-08
libaries O 0 2.1388570985436672e-06
and O 0 2.2652837938785808e-10
genomic O 0 1.5047779911014914e-08
DNA O 0 1.1335377081422848e-07
from O 0 3.879663257322363e-09
Finnish O 1 0.875154972076416
CLD B-Disease 1 1.0
patients O 0 1.565317802487698e-06
and O 0 1.6956018811242757e-08
controls O 0 3.6368141991260927e-06
. O 0 1.0859034773602616e-06

Exon O 0 3.64663646905683e-05
- O 0 8.61661177964379e-08
specific O 0 1.2271588190060356e-09
primers O 0 7.415678293654082e-09
developed O 0 1.1020172552278495e-09
in O 0 1.1258775162170664e-11
this O 0 2.5421437958167425e-12
study O 0 5.293273198231363e-12
will O 0 1.4227967762292515e-12
facilitate O 0 1.9905155301813693e-09
mutation O 0 1.6409795744465328e-10
screening O 0 1.75162120918948e-10
studies O 0 2.60167221100005e-10
of O 0 7.960301168230544e-11
patients O 0 2.2434408497584712e-10
with O 0 3.406441101416746e-11
the O 0 1.770351687468974e-08
disease O 0 0.00019109448476228863
. O 0 2.6533939490036573e-07

Genomic O 0 9.784032783954899e-08
sequencing O 0 1.1857369486278913e-07
of O 0 4.586025781350145e-08
a O 0 8.237363857688251e-08
BAC O 0 0.0038272582460194826
clone O 0 1.9746023099287413e-05
H O 1 0.9999988079071045
_ O 0 2.0623096563809895e-09
RG364P16 O 0 7.262393069140671e-07
revealed O 0 2.5733994934995508e-09
the O 0 2.436136535555189e-11
presence O 0 1.2116445867460524e-11
of O 0 2.1858651000350449e-10
another O 0 3.148582228273966e-10
, O 0 8.551028635173097e-11
highly O 0 2.895625295096238e-09
homologous O 0 7.264080892355196e-09
gene O 0 6.317390499610553e-10
3 O 0 3.906347745274985e-10
of O 0 4.504977502151064e-10
the O 0 9.723433169739337e-10
CLD B-Disease 0 0.4359171986579895
gene O 0 6.481082337472799e-10
, O 0 4.6347413754088684e-12
with O 0 7.416200899917902e-13
a O 0 1.4276852269845541e-11
similar O 0 6.44164235841238e-11
genomic O 0 8.805193907335251e-09
structure O 0 3.2201903366058104e-09
, O 0 1.081872699065789e-11
recently O 0 2.1580586276326308e-11
identified O 0 1.8257002853960813e-10
as O 0 5.204436881456331e-11
the O 0 2.0497813224551464e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.7855107614650478e-07
( O 0 6.2934604194708754e-09
PDS B-Disease 0 0.0010272881481796503
) O 0 1.3810876886566348e-09
. O 0 1.0367596559035519e-08
. O 0 1.5027077893137175e-07

The O 0 5.579273647526861e-07
APCI1307K O 1 0.9819460511207581
allele O 0 1.2270047591300681e-06
and O 0 1.0972212471926923e-08
cancer B-Disease 0 3.2214409202424577e-06
risk O 0 4.446717838391123e-08
in O 0 2.3812482541352153e-10
a O 0 9.06281646950724e-11
community O 0 1.8358198294876615e-10
- O 0 1.1074974270997018e-10
based O 0 2.6687721043500146e-12
study O 0 4.6209560483623235e-11
of O 0 6.383645834162621e-10
Ashkenazi O 0 6.107785566200619e-07
Jews O 0 3.5092841699224664e-07
. O 0 6.135458079370437e-07

Mutations O 0 9.141828627434734e-07
in O 0 9.383866128587215e-09
APC O 0 2.409118735613447e-07
are O 0 1.700004303994973e-10
classically O 0 1.7057361390016013e-07
associated O 0 1.708578736270283e-07
with O 0 4.823751282856392e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.000163803284522146
FAP B-Disease 0 1.0226210179098416e-05
) O 0 1.1571372332541685e-10
, O 0 2.930906906062347e-11
a O 0 3.37892797075412e-10
highly O 0 6.990344900259515e-06
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.0004675301315728575
by O 0 4.671233178044076e-09
multiple O 0 0.0017275704303756356
intestinal O 1 1.0
polyps B-Disease 0 1.7961023957013822e-07
and O 0 1.4423208460900838e-10
, O 0 7.990491948661749e-12
without O 0 4.008682552569809e-10
surgical O 1 0.9791820049285889
intervention O 1 0.8294759392738342
, O 0 1.7727352918939232e-10
the O 0 5.75422209880827e-10
development O 0 0.0004641999548766762
of O 1 0.9999996423721313
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.1337186707532965e-06
CRC B-Disease 0 0.0001226431195391342
) O 0 2.2915371822307407e-09
. O 0 3.006166693353407e-08

APC B-Disease 0 1.518403132649837e-05
is O 0 1.0459538124507617e-08
a O 0 7.512117150554332e-08
tumour O 1 1.0
- O 0 0.00015325783169828355
suppressor O 0 5.081246854388155e-07
gene O 0 7.999161888427864e-10
, O 0 2.360274996282552e-11
and O 0 1.279935463172066e-10
somatic O 0 5.957297616987489e-06
loss O 0 4.672473892242124e-07
occurs O 0 1.2805737696908182e-06
in O 0 4.575296941311535e-07
tumours B-Disease 1 1.0
. O 0 3.0248358598328196e-05

The O 0 5.050761728853104e-07
germline O 0 7.982059287314769e-06
T O 0 1.2340841237801214e-07
- O 0 2.6572932299018248e-08
to O 0 9.58883861201798e-10
- O 0 5.7142415244015865e-08
A O 0 5.2106326364764755e-08
transversion O 0 6.065579327696469e-07
responsible O 0 4.954416876756795e-10
for O 0 2.0415998752687514e-11
the O 0 2.4231527895324234e-10
APC O 0 8.939114337636056e-09
I1307K O 0 2.846062230332791e-08
allele O 0 5.427949201219917e-10
converts O 0 3.2030733621013496e-10
the O 0 7.795993711701144e-11
wild O 0 1.3085799110967855e-10
- O 0 7.341896535173476e-11
type O 0 9.331792977240738e-11
sequence O 0 3.8283451408993585e-10
to O 0 4.794261654339493e-10
a O 0 1.5873567349444784e-08
homopolymer O 1 0.9999268054962158
tract O 0 3.215097967768088e-05
( O 0 2.8453874811873447e-09
A8 O 0 8.729562068765517e-06
) O 0 1.682568528948991e-10
that O 0 1.1257594682845262e-11
is O 0 1.060626170223955e-10
genetically O 0 2.169858070999453e-08
unstable O 0 4.487151818466373e-05
and O 0 1.5470082104229732e-08
prone O 0 1.6656360458000563e-05
to O 0 1.4989062435688538e-07
somatic O 0 0.034938178956508636
mutation O 0 6.863592261652229e-06
. O 0 1.5463673435078817e-06

The O 0 2.800202310027089e-07
I1307K O 0 1.1165998330397997e-05
allele O 0 1.300341381238468e-07
was O 0 2.936590526303462e-08
found O 0 1.5877494874416698e-09
in O 0 1.4631330591541314e-09
6 O 0 2.418787516944576e-07
. O 0 2.777833572054078e-07

1 O 0 9.124433972829138e-07
% O 0 1.7622467396449792e-07
of O 0 2.2088174844725472e-08
unselected O 0 0.005959334317594767
Ashkenazi O 0 3.247856147936545e-05
Jews O 0 9.968255909598156e-08
and O 0 2.179163960391861e-09
higher O 0 2.435220380903047e-08
proportions O 0 2.84799361871535e-09
of O 0 5.405945024961056e-09
Ashkenazim O 0 0.0002408152213320136
with O 0 7.378315181050255e-10
family O 0 5.476892717126702e-09
or O 0 2.6139146402925917e-09
personal O 0 4.472618968520692e-07
histories O 0 0.010845046490430832
of O 1 0.9958621263504028
CRC B-Disease 1 0.9998283386230469
( O 0 3.390487179899537e-08
ref O 0 7.041880394353939e-07
. O 0 8.108070326251493e-10
2 O 0 4.4519090636185865e-09
) O 0 4.355793226107352e-10
. O 0 1.759250345401142e-08

To O 0 2.8358208226109127e-08
evaluate O 0 1.1753364503874764e-07
the O 0 2.461073789206125e-09
role O 0 1.3954291944173747e-08
of O 0 2.4885241600713925e-07
I1307K O 1 0.9888654351234436
in O 0 4.7611301567940245e-09
cancer B-Disease 0 1.1082956064001337e-07
, O 0 1.333392007918377e-10
we O 0 7.036033977669831e-10
genotyped O 0 1.2797727322322316e-06
5 O 0 5.348969711604923e-09
, O 0 2.1250681769835467e-10
081 O 0 2.989972244904493e-06
Ashkenazi O 0 5.282461756905832e-07
volunteers O 0 1.404749117028814e-08
in O 0 2.3518817449108553e-10
a O 0 3.773667767159594e-10
community O 0 2.52485787832768e-09
survey O 0 1.8966309411894144e-08
. O 0 3.599584985636284e-08

Risk O 0 1.7533817299408838e-05
of O 0 3.3105939110100735e-06
developing O 1 0.9999960660934448
colorectal B-Disease 1 1.0
, I-Disease 1 0.8184992671012878
breast I-Disease 1 0.9999788999557495
and I-Disease 0 6.271378794053817e-08
other I-Disease 0 2.5907365142074923e-08
cancers I-Disease 1 0.9999991655349731
were O 0 0.0010237094247713685
compared O 0 2.6934830543723365e-07
between O 0 2.9316153060676697e-08
genotyped O 0 1.0575970463833073e-06
I1307K O 0 1.8573206261862651e-07
carriers O 0 4.1802953459901815e-11
and O 0 5.919645329477419e-11
non O 0 1.8437804172322103e-08
- O 0 1.4155472349841602e-09
carriers O 0 3.6368043992984767e-11
and O 0 1.1942734128023158e-11
their O 0 5.0426197939490436e-11
first O 0 1.4747493226607844e-09
- O 0 7.548941027835099e-09
degree O 0 2.9686438551834726e-07
relatives O 0 3.257107152876415e-07
. O 0 1.433557343943903e-07

Sperm O 0 5.709202355319576e-07
DNA O 0 2.3042008479023934e-07
analysis O 0 8.059998002352131e-09
in O 0 2.9335589513124205e-10
a O 0 1.0010245077296531e-08
Friedreich B-Disease 1 0.9949637651443481
ataxia I-Disease 1 0.999919056892395
premutation O 1 0.7207177877426147
carrier O 0 1.4123230585028068e-07
suggests O 0 3.1406084843865756e-08
both O 0 3.238477708222831e-09
meiotic O 0 1.792527109500952e-05
and O 0 9.443874127157414e-09
mitotic O 0 8.44833721203031e-07
expansion O 0 1.6045132156250475e-07
in O 0 1.6440786509974714e-09
the O 0 1.2070723087731494e-08
FRDA B-Disease 0 0.0017237162683159113
gene O 0 2.029602512720885e-07
. O 0 2.114606729719526e-07

Friedreich B-Disease 1 0.999997615814209
ataxia I-Disease 1 0.9999995231628418
is O 0 4.2126139021547715e-08
usually O 0 1.3463989922968267e-08
caused O 0 1.2207326705038213e-08
by O 0 3.531695422220871e-11
an O 0 6.328382696346724e-12
expansion O 0 2.345320160301867e-09
of O 0 6.6828138578500784e-09
a O 0 2.2404069710546537e-08
GAA O 0 2.408866203040816e-05
trinucleotide O 0 3.1347219191957265e-05
repeat O 0 2.0148875989889348e-07
in O 0 1.0000817063371414e-08
intron O 0 2.566406749338057e-07
1 O 0 5.429556804159574e-09
of O 0 4.290613198065785e-09
the O 0 2.4854731606183122e-08
FRDA B-Disease 0 0.41614407300949097
gene O 0 3.0517315963152214e-07
. O 0 3.9792976735952834e-07

Occasionally O 0 5.387130954659369e-07
, O 0 7.240851807033266e-10
a O 0 4.725337898747739e-10
fully O 0 7.714708516459723e-08
expanded O 0 1.4612756560339335e-09
allele O 0 1.4375179935299798e-09
has O 0 1.9296428604292926e-12
been O 0 1.5188357516127127e-11
found O 0 6.417675852549154e-12
to O 0 1.0969056392362564e-11
arise O 0 8.966230424789501e-09
from O 0 4.2412146017412056e-10
a O 0 6.678427810768994e-10
premutation O 0 1.956622327270452e-06
of O 0 1.9568590303720157e-08
100 O 0 3.7624598547836285e-08
or O 0 1.1172960334704385e-09
less O 0 3.011670557384605e-08
triplet O 0 3.0304319807328284e-05
repeats O 0 4.697494659922086e-06
. O 0 7.649693429812032e-07

We O 0 5.773775058059982e-08
have O 0 9.84874543030756e-11
examined O 0 2.6243354156463283e-09
the O 0 4.289299818105441e-11
sperm O 0 8.401009332636988e-10
DNA O 0 4.0643655552230484e-08
of O 0 8.054465538975819e-09
a O 0 5.795397495234056e-09
premutation O 0 1.5877565601840615e-05
carrier O 0 3.6318957086223236e-07
. O 0 6.024607728249975e-07

This O 0 1.5229892014190227e-08
mans O 0 9.899061836904366e-08
leucocyte O 0 2.1972144281789951e-07
DNA O 0 7.742657004428111e-08
showed O 0 1.7501694538069046e-09
one O 0 4.8810348124428415e-12
normal O 0 4.908675133030727e-10
allele O 0 1.842734437262905e-10
and O 0 1.2057106181517785e-11
one O 0 1.3144050951818809e-11
allele O 0 4.2921086129688035e-10
of O 0 1.15142673173807e-09
approximately O 0 2.2508954700128925e-09
100 O 0 1.937176818955777e-08
repeats O 0 1.6737271835154388e-07
. O 0 1.1835068391974346e-07

His O 0 3.002270716478961e-07
sperm O 0 2.4637668616378505e-07
showed O 0 1.2728473386403039e-08
an O 0 8.288141874202015e-12
expanded O 0 1.4687692728720947e-10
allele O 0 1.7696273613143632e-10
in O 0 6.352209730442482e-11
a O 0 5.532113656059323e-10
tight O 0 1.2621936207324325e-07
range O 0 1.7317344003231483e-08
centering O 0 5.520335477626759e-08
on O 0 1.9683576990559004e-09
a O 0 6.278590425345953e-10
size O 0 9.888523333501098e-10
of O 0 1.9792831817966317e-09
approximately O 0 5.376638245735421e-09
320 O 0 3.593041242311301e-08
trinucleotide O 0 2.1499643480638042e-05
repeats O 0 1.1025559842892108e-06
. O 0 9.484707561568939e-07

His O 0 1.2991182529731304e-06
affected O 0 2.4020580440264894e-06
son O 0 5.007257277611643e-05
has O 0 3.8414016412247065e-10
repeat O 0 6.8041008383090684e-09
sizes O 0 2.0651438337182526e-09
of O 0 2.9918421073915624e-09
1040 O 0 1.6183874151920463e-07
and O 0 8.387212702132274e-09
540 O 0 6.601533186767483e-07
. O 0 3.09231921846731e-07

These O 0 3.875057785762692e-08
data O 0 4.105480044813703e-08
suggest O 0 1.6427746940550492e-09
that O 0 2.3074194464844933e-12
expansion O 0 5.00098573663621e-10
occurs O 0 5.7048130108761086e-11
in O 0 4.589245216485294e-12
two O 0 2.8349876699668153e-12
stages O 0 2.7283670878119892e-09
, O 0 7.453031247717234e-12
the O 0 9.88312036376282e-12
first O 0 2.7309677089193407e-11
during O 0 4.827091504289172e-10
meiosis O 0 1.0202131583980645e-08
followed O 0 1.0181069182157998e-10
by O 0 1.0672207909068199e-11
a O 0 4.7185266111027246e-11
second O 0 1.48295187241132e-09
mitotic O 0 1.2479852102842415e-06
expansion O 0 1.9048409285460366e-06
. O 0 7.787501772327232e-07

We O 0 1.0850013865137953e-07
also O 0 3.124377701002601e-10
show O 0 6.027705001798722e-10
that O 0 2.6228004143535877e-12
in O 0 7.385713568508478e-12
all O 0 1.2944048610741277e-11
informative O 0 1.7567236554327792e-10
carrier O 0 1.2770749735491194e-10
father O 0 9.45135170127287e-09
to O 0 5.803004188287275e-10
affected O 0 8.306464849283657e-09
child O 0 1.8709911842051952e-08
transmissions O 0 1.164065906777978e-06
, O 0 5.015873567187912e-12
with O 0 1.074471024306578e-12
the O 0 2.6225214708186506e-11
notable O 0 3.890054944832855e-11
exception O 0 7.059958867516869e-11
of O 0 2.272203120101679e-10
the O 0 5.751171761048113e-10
premutation O 0 3.961622212500515e-07
carrier O 0 2.563953493961435e-09
, O 0 2.3264419557467164e-10
the O 0 5.496196830989675e-10
expansion O 0 2.2071203531481842e-08
size O 0 2.6843980371893394e-09
decreases O 0 9.700947600776999e-09
. O 0 3.238119328230482e-09
. O 0 6.077397074477631e-08

The O 0 1.9216770397179062e-07
R496H O 0 1.3969885003461968e-05
mutation O 0 2.5853656993035656e-08
of O 0 2.461563397559985e-08
arylsulfatase O 0 0.01637687347829342
A O 0 1.237744413629116e-06
does O 0 1.0572779318707148e-09
not O 0 3.2699962737581245e-09
cause O 0 0.03197774663567543
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 4.5490542106563225e-06

Deficiency B-Disease 1 0.6431035399436951
of I-Disease 0 3.501694300211966e-05
arylsulfatase I-Disease 1 0.9999977350234985
A I-Disease 1 0.9553832411766052
( O 0 8.698133768803018e-08
ARSA O 1 0.9999774694442749
) O 0 3.0095487213444017e-10
enzyme O 0 1.972401575400795e-09
activity O 0 3.464652920115441e-08
causes O 0 8.552522103855154e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 9.13470785235404e-07
MLD B-Disease 1 1.0
) O 0 4.983384727097473e-08
. O 0 1.7739691315910022e-07

A O 0 2.9501438802981284e-07
number O 0 9.206667428429682e-09
of O 0 6.585612055687307e-08
ARSA O 1 0.9446497559547424
gene O 0 2.4999122771873772e-08
mutations O 0 2.5831068395376633e-09
responsible O 0 4.3542751626546305e-09
for O 0 7.739583196553212e-09
MLD B-Disease 1 1.0
have O 0 7.50892958922833e-10
been O 0 5.785244505673859e-10
identified O 0 8.846437360432446e-09
. O 0 1.7289258025243726e-08

Recently O 0 1.0991255550152346e-07
, O 0 4.793667129909807e-10
the O 0 5.085013521366477e-10
R496H O 0 1.1303342262181104e-06
mutation O 0 4.59098536964575e-09
of O 0 2.88823009952921e-08
ARSA O 1 0.9993355870246887
was O 0 2.1131466354518125e-08
proposed O 0 1.194515597546797e-10
to O 0 3.595229669528521e-11
be O 0 8.759488273613059e-11
a O 0 3.324075459332221e-10
cause O 0 2.4354712024887704e-08
of O 0 5.384950782172382e-06
MLD B-Disease 1 1.0
( O 0 8.266118811661727e-08
Draghia O 0 2.7649575713439845e-05
et O 0 1.6659652146699955e-07
al O 0 1.3143726107500697e-07
. O 0 1.4883576315849467e-10
, O 0 3.5077822591045305e-11
1997 O 0 9.8452013208572e-10
) O 0 1.0595955224346199e-09
. O 0 4.532371988830164e-08

We O 0 1.1962751500504964e-07
have O 0 3.7567193800214227e-10
investigated O 0 4.573855072464994e-09
the O 0 4.0933875733450975e-10
R496H O 0 4.183627879683627e-07
mutation O 0 3.2252414627897963e-10
and O 0 9.807313815224372e-12
found O 0 1.46080335328147e-11
this O 0 3.3922658519008886e-12
mutation O 0 1.1722318948859112e-10
at O 0 3.455232489013582e-10
a O 0 5.525235477477075e-11
relatively O 0 5.173175221528936e-10
high O 0 7.166570115124671e-11
frequency O 0 6.348022107971474e-10
in O 0 2.1441907277486294e-11
an O 0 1.397637994920986e-11
African O 0 3.895657574304323e-09
American O 0 2.253618847092298e-09
population O 0 1.2500425694561557e-10
( O 0 2.8095314703185936e-12
f O 0 2.0041225623490533e-10
= O 0 3.625883482349934e-10
0 O 0 5.76617295577897e-11
. O 0 7.771733950834303e-11
09 O 0 6.639578220557496e-09
, O 0 1.1325766019476546e-10
n O 0 5.374933276236504e-10
= O 0 9.67715907407296e-10
61 O 0 1.0998486565938492e-08
subjects O 0 1.0454196797127224e-07
) O 0 2.987160518941323e-09
. O 0 8.202495394016296e-08

The O 0 3.954694420826854e-06
ARSA O 0 0.0047692665830254555
enzyme O 0 1.064745891454777e-08
activity O 0 2.872510673768147e-09
in O 0 2.8299215401594857e-11
subjects O 0 6.004277075533082e-09
with O 0 3.519575689919785e-12
and O 0 4.9310785489586895e-12
without O 0 1.6878205777448585e-10
the O 0 1.4061415920529896e-10
R496H O 0 2.086161714487389e-07
mutation O 0 1.1424918650027038e-10
was O 0 2.4973076384604553e-10
determined O 0 1.0574634501381297e-09
and O 0 8.944870538707406e-11
found O 0 9.373463810691263e-11
to O 0 1.46434961378894e-10
be O 0 1.6458042706446463e-09
normal O 0 4.1684647840156686e-06
. O 0 3.6545699799717113e-07

It O 0 1.4624941258034596e-09
is O 0 5.497075017402153e-11
therefore O 0 2.5606533560207367e-10
concluded O 0 1.578862041107243e-09
that O 0 3.6255479955032976e-12
the O 0 4.931391406337582e-11
R496H O 0 3.274539039921365e-07
mutation O 0 3.6275662473883585e-09
of O 0 3.46467317058341e-08
ARSA O 1 0.9705074429512024
does O 0 5.178081297074755e-10
not O 0 3.008859827957622e-10
negatively O 0 1.223695544894099e-08
influence O 0 2.7171496164157816e-09
the O 0 3.672495918483065e-10
activity O 0 1.2077793876130727e-08
of O 0 2.0269402156714023e-08
ARSA O 1 0.9996241331100464
and O 0 1.0491821855751482e-09
is O 0 7.020159453752228e-11
not O 0 1.0100702912962944e-10
a O 0 2.9893665320912532e-09
cause O 0 7.95464927705325e-07
of O 0 2.534866871428676e-05
MLD B-Disease 1 1.0

Down O 0 5.473805686051492e-06
- O 0 4.6483799565066874e-07
regulation O 0 3.2042436259871465e-08
of O 0 3.8711357319698436e-07
transmembrane O 0 0.00015732402971480042
carbonic O 0 0.10645241290330887
anhydrases O 1 0.8070529699325562
in O 0 3.7889330428697576e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999992847442627
lines O 0 3.658377067949914e-08
by O 0 4.206098525028068e-10
wild O 0 5.612850628722299e-09
- O 0 1.4054728048051857e-08
type O 0 8.361101322407194e-08
von B-Disease 1 0.9992436170578003
Hippel I-Disease 1 0.9999499320983887
- I-Disease 0 0.11041927337646484
Lindau I-Disease 0 0.001842919853515923
transgenes O 0 0.00018330258899368346
. O 0 2.2155149963509757e-06

To O 0 2.91945752906031e-07
discover O 0 1.9734906686608156e-07
genes O 0 4.475603443410137e-09
involved O 0 7.999791939994338e-09
in O 0 4.124975472308279e-09
von B-Disease 1 0.9997634291648865
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999978542327881
Lindau I-Disease 1 0.9999247789382935
( O 0 1.8376509558493126e-07
VHL B-Disease 1 0.9979531764984131
) O 0 2.4217690963723726e-08
- O 0 3.4048099450956215e-07
mediated O 0 2.5352561351610348e-05
carcinogenesis O 1 0.9999991655349731
, O 0 7.017271208553666e-10
we O 0 1.218526113344609e-10
used O 0 1.7557807652224255e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999774694442749
lines O 0 1.512794597147149e-06
stably O 0 2.380534397161682e-06
transfected O 0 2.178982754230674e-07
with O 0 1.4911252788074592e-10
wild O 0 3.4633234058389917e-09
- O 0 3.9498964099493605e-08
type O 0 1.353098042500278e-07
VHL O 0 0.03251533955335617
- O 0 2.5459908101765905e-06
expressing O 0 5.650761281117411e-08
transgenes O 0 4.5813931137672625e-06
. O 0 1.0226469271401584e-07

Large O 0 9.418926083526458e-08
- O 0 3.2401413108118504e-08
scale O 0 2.57972576633847e-08
RNA O 0 7.139090030250372e-08
differential O 0 7.874838559018826e-08
display O 0 2.1758579382691323e-09
technology O 0 1.608330357782961e-08
applied O 0 8.545587015795775e-10
to O 0 3.229604084165061e-11
these O 0 1.4154810136501883e-11
cell O 0 1.902789925622983e-09
lines O 0 1.298356838708159e-10
identified O 0 1.3013963517938265e-10
several O 0 1.5882810691647542e-11
differentially O 0 1.0882445167226251e-08
expressed O 0 1.5172874068269948e-10
genes O 0 1.12187391321239e-10
, O 0 4.782930995705925e-12
including O 0 1.59374336644591e-11
an O 0 7.58550722235185e-11
alpha O 0 4.425944410968441e-08
carbonic O 0 8.5722704170621e-06
anhydrase O 0 1.091356261895271e-05
gene O 0 1.0336147227008041e-07
, O 0 1.7327817403156587e-08
termed O 0 1.4243292753235437e-05
CA12 O 1 0.9996134638786316
. O 0 9.263613719667774e-06

The O 0 3.796564485014642e-08
deduced O 0 9.380004684089727e-08
protein O 0 4.823198507253323e-10
sequence O 0 2.397788079200325e-10
was O 0 3.4080804844904833e-10
classified O 0 1.4803963610532378e-10
as O 0 9.075611789866045e-12
a O 0 1.9561208555729515e-11
one O 0 1.1551481993166135e-10
- O 0 3.01909537370193e-08
pass O 0 1.3099301554575504e-07
transmembrane O 0 4.532550974545302e-06
CA O 0 4.767439349961933e-06
possessing O 0 1.9252828664662047e-08
an O 0 1.4634114753331318e-10
apparently O 0 8.946912544161023e-08
intact O 0 2.578934299890534e-06
catalytic O 0 3.249821389772478e-08
domain O 0 2.8564112852791368e-08
in O 0 3.3718865477538884e-09
the O 0 4.466659930812966e-08
extracellular O 0 8.431134119746275e-06
CA O 0 9.815714292926714e-05
module O 0 5.161055742064491e-05
. O 0 6.964248200347356e-07

Reintroduced O 0 3.902378466591472e-06
wild O 0 1.404006297889282e-07
- O 0 5.139819450050709e-07
type O 0 2.4252921093648183e-07
VHL B-Disease 0 0.0016363809118047357
strongly O 0 6.771320393283986e-09
inhibited O 0 7.703764737243546e-09
the O 0 1.3125343867326222e-10
overexpression O 0 1.1833686919260344e-08
of O 0 9.597108663328413e-10
the O 0 1.370794810995335e-09
CA12 O 0 0.00022264933795668185
gene O 0 1.3101432438933358e-10
in O 0 4.200580508428864e-11
the O 0 4.419444254999405e-10
parental O 0 2.2379433062269527e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.04629676789045334
. O 0 1.9092310594714945e-06

Similar O 0 3.449860619397782e-09
results O 0 1.6739043484648164e-09
were O 0 2.0428046754172868e-10
obtained O 0 7.727542494784245e-10
with O 0 5.324635871106764e-11
CA9 O 0 7.748570351395756e-05
, O 0 3.0958327568164634e-10
encoding O 0 9.306316428592254e-08
another O 0 4.743237358439956e-09
transmembrane O 0 1.0049003549283952e-06
CA O 0 2.4208468403230654e-06
with O 0 2.7617380604638697e-10
an O 0 4.33804187016662e-10
intact O 0 2.8251477033336414e-06
catalytic O 0 2.4688426947250264e-07
domain O 0 9.799998679227429e-07
. O 0 5.604123884950241e-07

Although O 0 2.2995946480364182e-08
both O 0 2.0388584154318323e-09
domains O 0 1.26396138000473e-08
of O 0 5.18927611992126e-09
the O 0 1.0035326347690443e-08
VHL B-Disease 0 0.0008688022498972714
protein O 0 4.032988165647566e-09
contribute O 0 5.725888096996812e-10
to O 0 8.424656805505748e-11
regulation O 0 4.40119274358608e-09
of O 0 2.573037782838128e-08
CA12 O 1 0.99994957447052
expression O 0 1.656579229347699e-08
, O 0 5.6264791437055095e-11
the O 0 8.470384116332497e-11
elongin O 0 3.7584143797175784e-08
binding O 0 1.1171085168015793e-09
domain O 0 1.663494231252116e-08
alone O 0 4.384928864453741e-09
could O 0 1.1605350014320948e-09
effectively O 0 3.699920512190147e-07
regulate O 0 1.0199095186180784e-06
CA9 O 0 0.2374081015586853
expression O 0 4.28613520853105e-06
. O 0 5.707846639779746e-07

We O 0 1.2515155276560108e-06
mapped O 0 2.1972067770548165e-05
CA12 O 0 0.12928175926208496
and O 0 1.108572575958533e-07
CA9 O 0 0.0019152957247570157
loci O 0 1.1568806002060228e-07
to O 0 1.8362025233642498e-09
chromosome O 0 3.575430795876855e-08
bands O 0 6.788832251913846e-07
15q22 O 0 0.00014646255294792354
and O 0 1.2080745648290758e-07
17q21 O 0 0.0006623832741752267
. O 0 1.6077344753284706e-06

2 O 0 2.7956608050772047e-07
respectively O 0 2.7228404064771894e-07
, O 0 8.382937677353652e-10
regions O 0 9.940076317604962e-09
prone O 0 4.92615335190294e-08
to O 0 1.3082760430549456e-09
amplification O 0 2.6830741717276396e-06
in O 0 3.3364571105920504e-09
some O 0 1.2109456770659222e-09
human O 0 1.8793467404520925e-07
cancers B-Disease 1 0.9997444748878479
. O 0 4.375404841994168e-06

Additional O 0 2.3516957270430794e-08
experiments O 0 1.9178902022076727e-08
are O 0 4.193120156648078e-11
needed O 0 1.978094354981863e-09
to O 0 8.588787320240598e-11
define O 0 6.013468833998559e-09
the O 0 6.745921043993519e-10
role O 0 7.857655859311308e-09
of O 0 1.819292663185479e-07
CA O 0 0.0015731046441942453
IX O 0 2.472781307005789e-05
and O 0 4.4508755792094234e-08
CA O 0 7.601487141073449e-06
XII O 0 3.339407044222753e-07
enzymes O 0 1.2499376533803286e-10
in O 0 3.286443686634222e-11
the O 0 8.131327555727097e-11
regulation O 0 1.5349889137539208e-09
of O 0 2.7854021311668475e-09
pH O 0 1.21790975526892e-07
in O 0 3.12392500756431e-10
the O 0 3.2939402316856103e-09
extracellular O 0 2.5659909397290903e-07
microenvironment O 0 1.008664071378007e-06
and O 0 2.538381727035244e-10
its O 0 1.6610124733973386e-11
potential O 0 1.0079307388721759e-09
impact O 0 7.2939725370702035e-09
on O 0 1.6921285705961964e-08
cancer B-Disease 0 1.3438367432172527e-06
cell O 0 1.3696158930542879e-05
growth O 0 1.784584497954711e-07
. O 0 1.6782344403054594e-07

A O 0 5.5334069770651695e-08
gene O 0 2.0425017233094422e-09
encoding O 0 1.0584431464621957e-07
a O 0 9.502778119951927e-09
transmembrane O 0 3.152762531044573e-07
protein O 0 1.308196218019475e-09
is O 0 1.4995631689510014e-12
mutated O 0 4.554124091726841e-11
in O 0 8.08107400440683e-12
patients O 0 4.299100186955229e-09
with O 0 1.1666833721335479e-08
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.999998927116394
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9986364245414734
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 8.14867817666709e-09
. O 0 6.595114854235362e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.455959085840732e-05
WFS B-Disease 1 0.9999988079071045
; O 0 1.8617500430195832e-08
OMIM O 1 0.7812294960021973
222300 O 0 3.7641145809175214e-06
) O 0 1.185323783570169e-10
is O 0 8.893798891795868e-11
an O 0 2.0528554411924915e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 2.1061895338903014e-08
by O 0 2.631692364030158e-10
young O 0 4.098483330494673e-09
- O 0 9.771403242098131e-09
onset O 1 0.9998904466629028
non O 1 0.9999644756317139
- O 0 0.0027139007579535246
immune O 0 0.000637377961538732
insulin B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
dependent I-Disease 1 0.9999834299087524
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 8.092325151665136e-05
progressive O 1 0.9999998807907104
optic B-Disease 1 0.9999997615814209
atrophy I-Disease 0 0.09226130694150925
. O 0 1.2488670108723454e-05

Linkage O 0 6.051984746591188e-05
to O 0 2.478013172435567e-08
markers O 0 4.0433803860651096e-08
on O 0 2.0924472821093332e-08
chromosome O 0 5.507188802766905e-07
4p O 0 0.00011610740330070257
was O 0 1.5235791295253875e-08
confirmed O 0 2.192229286990255e-09
in O 0 1.2713126384955586e-10
five O 0 3.841775231272493e-10
families O 0 6.283957798558504e-10
. O 0 3.6670680714223636e-08

On O 0 4.7659845847647375e-08
the O 0 1.094584756167194e-09
basis O 0 2.8268022589372777e-08
of O 0 7.473013319270194e-09
meiotic O 0 0.0011342247016727924
recombinants O 1 0.9881531596183777
and O 0 3.6393217328622995e-08
disease O 0 0.00012205837992951274
- O 0 1.3602218018604617e-07
associated O 0 2.396419631622848e-07
haplotypes O 0 2.9892058250879927e-07
, O 0 1.0658501858884506e-10
the O 0 1.9673140894127528e-09
WFS B-Disease 0 9.548317757435143e-05
gene O 0 4.11481293483007e-10
was O 0 4.404862696816281e-09
localized O 0 1.4269089021468062e-08
to O 0 1.566829110899448e-09
a O 0 5.040954320634228e-08
BAC O 0 0.0012574788415804505
/ O 0 3.9408546399499755e-06
P1 O 0 0.00014525174628943205
contig O 0 7.633320819877554e-06
of O 0 1.623240208914467e-08
less O 0 2.378054420049125e-09
than O 0 1.2644835178932112e-10
250 O 0 1.0762144952991548e-08
kb O 0 5.434591002995148e-06
. O 0 3.502413221667666e-07

Mutations O 0 1.7156553155928123e-07
in O 0 9.014823887376622e-10
a O 0 2.9167429582699356e-10
novel O 0 2.045167091235811e-10
gene O 0 5.533180025274476e-10
( O 0 1.591726889182965e-10
WFS1 O 0 0.0003268013533670455
) O 0 1.7773194027626005e-10
encoding O 0 1.6421434168023552e-07
a O 0 6.594307322416171e-09
putative O 0 1.3187523109081667e-06
transmembrane O 0 3.5138552334501583e-07
protein O 0 3.735129983084562e-09
were O 0 7.583601524530081e-10
found O 0 4.340919984580083e-11
in O 0 1.3540586187021919e-11
all O 0 4.747305326624485e-11
affected O 0 3.1316688131610704e-10
individuals O 0 2.7288536014191678e-11
in O 0 1.6143494874221176e-10
six O 0 1.2475571686820786e-08
WFS B-Disease 0 0.0011024688137695193
families O 0 1.022566031849692e-09
, O 0 3.146047658497686e-11
and O 0 1.3099151971451839e-11
these O 0 9.574025600089797e-12
mutations O 0 2.5139534898244165e-10
were O 0 7.912692723266446e-11
associated O 0 1.7202836932739274e-09
with O 0 6.93543486529613e-11
the O 0 1.9817470331418008e-08
disease O 0 0.00010380015010014176
phenotype O 0 9.760358352650655e-07
. O 0 2.520490909319051e-07

WFS1 O 1 0.9909343123435974
appears O 0 3.852889207678345e-08
to O 0 6.825414122779705e-10
function O 0 8.898355829956017e-09
in O 0 4.985585277950122e-10
survival O 0 1.9247818272560835e-06
of O 0 1.6284717574421848e-08
islet O 0 1.5906881856153632e-07
beta O 0 1.0737115019310295e-07
- O 0 3.0273067608277415e-08
cells O 0 5.648808087954649e-09
and O 0 8.07596656215992e-10
neurons O 0 1.9854552135711856e-07
. O 0 4.942885212244619e-09
. O 0 3.286969274540752e-08

Stable O 1 0.8349602222442627
interaction O 0 1.6044704409523547e-07
between O 0 5.67892621816668e-09
the O 0 7.613946972906405e-11
products O 0 6.972174226849148e-11
of O 0 2.335360238525652e-10
the O 0 1.2448372332940494e-09
BRCA1 O 0 2.206981442043343e-08
and O 0 1.4733632092145399e-09
BRCA2 O 0 1.0574522946171783e-07
tumor B-Disease 0 1.8625247832915193e-07
suppressor O 0 9.630545605432417e-08
genes O 0 1.2317714626064458e-09
in O 0 4.780291162909123e-10
mitotic O 0 2.947283803678147e-07
and O 0 4.9075190133862634e-08
meiotic O 0 0.000607677036896348
cells O 0 5.667893128702417e-05
. O 0 4.742914370581275e-06

BRCA1 O 0 4.198863098281436e-05
and O 0 1.401343041607106e-07
BRCA2 O 0 1.2207091231175582e-06
account O 0 8.605188228649752e-10
for O 0 3.4689660866060734e-11
most O 0 1.1157914002468683e-11
cases O 0 1.2324047164724572e-11
of O 0 1.0147903628521249e-09
familial O 0 6.395497820221863e-08
, O 0 2.675390187167892e-10
early O 0 2.357440251898879e-07
onset O 1 0.9999998807907104
breast B-Disease 1 0.9999097585678101
and I-Disease 0 0.0009026391780935228
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.980514169503294e-07
encode O 0 4.956612009721084e-09
products O 0 2.914518626440099e-10
that O 0 1.4510249555718668e-12
each O 0 5.4522441249316156e-12
interact O 0 5.870993691203807e-10
with O 0 1.5273950160210603e-10
hRAD51 O 0 1.047944692800229e-06
. O 0 2.9037303761469957e-07

Results O 0 6.642215311103428e-08
presented O 0 1.4178636931205801e-08
here O 0 8.166026077560673e-09
show O 0 3.324717612329664e-09
that O 0 8.117025107612363e-11
BRCA1 O 0 1.2755620559801173e-08
and O 0 8.274013696407678e-10
BRCA2 O 0 7.165267845721246e-08
coexist O 0 4.8728033164024964e-08
in O 0 1.8873333451630003e-10
a O 0 4.932221853160002e-10
biochemical O 0 2.888191552585795e-08
complex O 0 3.03011411517673e-08
and O 0 3.627988132137716e-09
colocalize O 0 1.3548193237511441e-05
in O 0 5.845387285319248e-09
subnuclear O 0 4.151445409661392e-06
foci O 0 2.3766368428823625e-07
in O 0 7.602051765864815e-10
somatic O 0 5.187190765809646e-08
cells O 0 5.394130919711415e-09
and O 0 8.72716898747683e-11
on O 0 3.69923869314448e-10
the O 0 3.512187415899426e-11
axial O 0 2.477727190086654e-10
elements O 0 1.6524537294060337e-09
of O 0 6.110450812002455e-09
developing O 0 1.925386214907121e-07
synaptonemal O 0 1.6352298189303838e-05
complexes O 0 3.478671999346261e-07
. O 0 1.6046816142534226e-07

Like O 0 1.262455157302611e-06
BRCA1 O 0 8.167545274773147e-06
and O 0 3.744319201359758e-07
RAD51 O 1 0.9996898174285889
, O 0 5.3410506239970346e-08
BRCA2 O 0 2.1669178806860145e-07
relocates O 0 1.988668607566524e-08
to O 0 6.311263067715345e-09
PCNA O 0 5.83059445489198e-05
+ O 0 2.3933081294558178e-08
replication O 0 3.3897098461466157e-09
sites O 0 7.676152768976152e-11
following O 0 8.539146473252046e-11
exposure O 0 3.047099683683996e-09
of O 0 1.012897210550534e-09
S O 0 2.0452938898074535e-08
phase O 0 9.41428993428417e-07
cells O 0 1.0994610732950605e-07
to O 0 1.4125406622156333e-08
hydroxyurea O 0 2.2951987830310827e-06
or O 0 6.996028645289698e-08
UV O 0 5.1877166697522625e-05
irradiation O 0 8.032007485780923e-07
. O 0 9.264838496392258e-08

Thus O 0 2.1671712602255866e-06
, O 0 3.6247463697236526e-08
BRCA1 O 0 1.0081681267593012e-07
and O 0 6.845649047626523e-10
BRCA2 O 0 3.4969638296189487e-09
participate O 0 1.7038225275101126e-09
, O 0 5.767030603065493e-11
together O 0 4.0666336964534366e-10
, O 0 2.4585283461830976e-11
in O 0 5.430959501562249e-11
a O 0 4.2948933298703196e-10
pathway O 0 2.1455961451977146e-09
( O 0 2.081656375052532e-11
s O 0 1.7726947687535244e-10
) O 0 5.4322106708692974e-12
associated O 0 3.244287338777241e-10
with O 0 3.865940553793301e-12
the O 0 6.652754735991806e-11
activation O 0 5.639998468254248e-10
of O 0 1.1462532034656192e-09
double O 0 9.58572998754903e-10
- O 0 1.2207605593061999e-08
strand O 0 2.408629740102697e-09
break O 0 1.0587196896949536e-07
repair O 0 0.0019193051848560572
and O 0 1.2343567945549694e-08
/ O 0 7.718901429143443e-07
or O 0 7.826215231432343e-09
homologous O 0 1.7341945124371705e-07
recombination O 0 3.427138324241241e-07
. O 0 3.294633756922849e-07

Dysfunction O 1 0.9969848990440369
of O 0 6.696011041640304e-06
this O 0 1.9738552126113973e-08
pathway O 0 5.406390712892062e-08
may O 0 9.060793781934251e-11
be O 0 3.7362231364301834e-11
a O 0 3.992267974539665e-11
general O 0 2.1706961228495913e-10
phenomenon O 0 3.962327688178391e-10
in O 0 3.469189128676997e-12
the O 0 4.91051513687446e-12
majority O 0 4.769648218050371e-12
of O 0 7.909837715369683e-12
cases O 0 1.4807910106440225e-11
of O 0 6.719419687328809e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999946355819702
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.43204206228256226
. O 0 5.823411584060523e-07

A O 0 5.028806526752305e-07
novel O 0 8.54983017717359e-09
Arg362Ser O 0 7.6061573963670526e-06
mutation O 0 2.101028684364792e-09
in O 0 9.70269628530751e-11
the O 0 2.653972874799848e-10
sterol O 0 3.637794776523151e-08
27 O 0 5.6508905998953196e-08
- O 0 9.427824210206381e-08
hydroxylase O 0 6.399402536771959e-07
gene O 0 7.173278859795573e-09
( O 0 1.1931317045466017e-09
CYP27 O 1 0.9999905824661255
) O 0 1.1809750399827124e-10
: O 0 1.840561557331366e-12
its O 0 1.031020971722918e-12
effects O 0 5.6293771727444764e-11
on O 0 1.0473302780589222e-10
pre O 0 1.754535361442322e-08
- O 0 3.75237441119225e-09
mRNA O 0 2.093836748429112e-08
splicing O 0 2.9080137409209783e-08
and O 0 3.708549856096255e-10
enzyme O 0 1.2375434010891695e-09
activity O 0 2.2003991517749455e-08
. O 0 5.7524612628867544e-08

A O 0 3.8535361568392545e-07
novel O 0 1.83239601270202e-09
C O 0 8.66852118974748e-08
to O 0 5.941457326130717e-10
A O 0 1.7485787040527612e-08
mutation O 0 6.482664960394402e-10
in O 0 3.795415023932769e-11
the O 0 2.2081497741410772e-10
sterol O 0 2.263182885542392e-08
27 O 0 1.759256917921448e-08
- O 0 3.609637033719082e-08
hydroxylase O 0 1.8283371616689692e-07
gene O 0 1.1650750364466944e-09
( O 0 2.5717541984882075e-10
CYP27 O 0 0.0058556790463626385
) O 0 2.4111278945637693e-11
was O 0 2.2414434197592925e-10
identified O 0 9.138200612879288e-11
by O 0 1.0698519327390077e-11
sequencing O 0 3.706304951833772e-08
amplified O 0 6.646119032893694e-08
CYP27 O 0 6.997348464210518e-06
gene O 0 1.4151983751542474e-10
products O 0 1.3574701085428131e-10
from O 0 2.781699003084892e-11
a O 0 7.405959873141299e-11
patient O 0 8.665991657608174e-08
with O 0 1.9802468997909273e-08
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 3.0180481758179667e-07
CTX B-Disease 0 0.0007245018496178091
) O 0 1.0777901238157028e-08
. O 0 1.2585707054313389e-07

The O 0 9.084011054483199e-08
mutation O 0 2.1619344536816243e-08
changed O 0 7.614056940496994e-09
the O 0 1.9410966167754395e-09
adrenodoxin O 0 2.0574847781063e-07
cofactor O 0 5.1235100606561446e-09
binding O 0 1.5807573028325805e-09
residue O 0 1.7587846912192617e-07
362Arg O 0 1.088761862888532e-07
to O 0 2.318089276087676e-09
362Ser O 0 1.019042315419938e-06
( O 0 1.289714646190987e-08
CGT O 0 1.693310150585603e-05
362Arg O 0 1.2586010598170105e-06
to O 0 2.6475595049646472e-08
AGT O 1 0.999947190284729
362Ser O 0 4.904580919173895e-07
) O 0 3.525510092194928e-11
, O 0 5.901762585580617e-12
and O 0 2.9701688157579564e-12
was O 0 1.8490021735928508e-09
responsible O 0 1.7098068738619077e-08
for O 0 1.5622164895034985e-08
deficiency O 1 0.9906898736953735
in O 0 2.1713070452733518e-08
the O 0 3.0071188206193256e-08
sterol O 0 2.126729299334329e-07
27 O 0 4.9570498816819963e-08
- O 0 2.3963959705497473e-08
hydroxylase O 0 7.424809922440545e-08
activity O 0 1.833346807700309e-09
, O 0 7.674904982379882e-12
as O 0 2.0390577247508812e-12
confirmed O 0 1.66468210743842e-11
by O 0 2.968668063110802e-12
expression O 0 1.0684922391313023e-10
of O 0 1.4958195793113305e-10
mutant O 0 2.1204039912792183e-10
cDNA O 0 3.1542356282443507e-08
into O 0 2.774115870352034e-08
COS O 0 4.827469092560932e-05
- O 0 2.673541985132033e-06
1 O 0 6.311061184760547e-08
cells O 0 1.7771796478882607e-07
. O 0 1.4241048518215393e-07

Quantitative O 0 7.466675810974266e-07
analysis O 0 6.188401791007436e-09
showed O 0 5.470228714443692e-10
that O 0 5.433513881880625e-13
the O 0 4.97186796941107e-12
expression O 0 2.7355356868596914e-10
of O 0 1.3667794673821732e-09
CYP27 O 0 6.007377578498563e-06
gene O 0 1.3049110403340336e-10
mRNA O 0 2.889716244069973e-09
in O 0 3.7806972830178864e-11
the O 0 1.3124241970974282e-10
patient O 0 1.5002498798821762e-08
represented O 0 3.2841036556874315e-09
52 O 0 3.909206895968964e-07
. O 0 2.0673445533248014e-07

5 O 0 7.70633974411794e-08
% O 0 2.294468615104961e-08
of O 0 1.0053406995780279e-09
the O 0 1.2186149866977303e-09
normal O 0 6.918110102560604e-07
level O 0 7.327165803872049e-06
. O 0 1.2528202830708324e-07

As O 0 8.624121861089407e-09
the O 0 6.833203447520475e-10
mutation O 0 4.178296597601161e-10
occurred O 0 8.714868826587008e-09
at O 0 5.032907979263257e-10
the O 0 1.2153091033528796e-10
penultimate O 0 7.007272984083102e-08
nucleotide O 0 3.963125294603742e-08
of O 0 2.0682871593180607e-07
exon O 0 1.0624539470427408e-07
6 O 0 2.503739437997865e-08
( O 0 7.579639138555194e-10
- O 0 2.9921174871105904e-08
2 O 0 2.7825084458754645e-09
position O 0 8.09861901984732e-08
of O 0 1.2272019489500963e-07
exon O 0 9.233753672788225e-08
6 O 0 1.572390146975522e-07
- O 0 4.2040016978717176e-07
intron O 0 2.2526795362409757e-07
6 O 0 1.4309233797860088e-08
splice O 0 5.219505183617912e-08
site O 0 1.6143278380731374e-10
) O 0 3.8787029144060625e-12
of O 0 1.996769971590595e-10
the O 0 3.0347557800070035e-10
gene O 0 7.286014569451993e-10
, O 0 7.040527882917758e-11
we O 0 1.9329231271125735e-10
hypothesized O 0 1.7139332175730715e-09
that O 0 3.4895363508480326e-12
the O 0 1.738003213569428e-10
mutation O 0 1.7531662788172753e-09
may O 0 4.0494196884566236e-10
partially O 0 1.5800768693452483e-08
affect O 0 1.6315208073436338e-09
the O 0 2.7427976556637645e-10
normal O 0 2.7406304781152357e-08
splicing O 0 5.258275237451926e-08
efficiency O 0 6.20974560661125e-08
in O 0 7.942863589072147e-10
exon O 0 3.958637861956049e-08
6 O 0 3.32610650133347e-09
and O 0 1.7433120225174292e-10
cause O 0 3.7267025576603885e-10
alternative O 0 4.5856474173433526e-09
splicing O 0 4.43118999271519e-08
elsewhere O 0 1.1593690452116334e-09
, O 0 4.398920030318498e-12
which O 0 2.3510796716592897e-13
resulted O 0 3.077182952893054e-10
in O 0 4.3739817323640295e-11
decreased O 0 5.983561646161206e-09
transcript O 0 2.546905264466659e-08
in O 0 1.5062955049938154e-10
the O 0 3.4668661275105705e-09
patient O 0 3.3767264540074393e-06
. O 0 1.042540930029645e-06

Transfection O 0 0.0002641589962877333
of O 0 1.1056980611101608e-06
constructed O 0 2.2215619992493885e-06
minigenes O 0 7.471180651918985e-06
, O 0 5.387863419303862e-11
with O 0 4.845526757613072e-12
or O 0 3.1197790878456644e-11
without O 0 1.7695531151495913e-10
the O 0 4.4498185691743686e-10
mutation O 0 9.562246550132159e-10
, O 0 4.634796713087752e-11
into O 0 4.955893473379547e-09
COS O 0 3.7026547943241894e-05
- O 0 1.3226413386746572e-07
1 O 0 5.080388887357401e-10
cells O 0 1.721835590773324e-10
confirmed O 0 3.686094138255491e-11
that O 0 7.235936161234871e-14
the O 0 1.2394241449137366e-12
mutant O 0 1.1347041362075316e-10
minigene O 0 1.9936893025374047e-08
was O 0 7.006010771526405e-10
responsible O 0 6.250295836451869e-10
for O 0 6.604018026878933e-11
a O 0 2.506087559694947e-10
mRNA O 0 1.4978740026094783e-08
species O 0 3.616831443717383e-12
alternatively O 0 1.301886265459018e-09
spliced O 0 7.782188049532124e-08
at O 0 7.042415095526167e-09
an O 0 4.333972902781369e-10
activated O 0 2.915890604526794e-07
cryptic O 0 1.463394170286847e-07
5 O 0 1.1532121035884302e-08
splice O 0 1.6736473185119394e-07
site O 0 3.552927285710439e-09
88 O 0 1.7752171288520913e-08
bp O 0 2.6122812357698422e-08
upstream O 0 9.564694813946062e-09
from O 0 6.007619401948716e-10
the O 0 8.197857948033516e-10
3 O 0 1.0566494346164745e-08
end O 0 1.3063845472061075e-07
of O 0 2.951933879558055e-07
exon O 0 4.788007117895177e-06
6 O 0 1.601139729245915e-06
. O 0 8.831113973428728e-07

Our O 0 5.039776738158253e-07
data O 0 4.7905643896228867e-08
suggest O 0 5.90880788742254e-10
that O 0 1.252977322591109e-12
the O 0 1.3820216672455476e-11
C O 0 2.568005808001317e-09
to O 0 4.603915512713108e-11
A O 0 5.7271254405577565e-09
mutation O 0 3.6541125680855657e-10
at O 0 6.691994736129914e-10
the O 0 1.4345646892621744e-10
penultimate O 0 3.941595494438843e-08
nucleotide O 0 2.1303907971059743e-08
of O 0 2.232400397872425e-08
exon O 0 5.062740271455368e-08
6 O 0 3.4581881802608905e-09
of O 0 1.5391286023458406e-09
the O 0 2.242025898269162e-09
CYP27 O 0 0.2973989248275757
gene O 0 4.866027580874288e-10
not O 0 5.5535406134898935e-11
only O 0 2.2521011444620598e-10
causes O 0 5.555230941922673e-09
the O 0 1.9371990234162695e-08
deficiency B-Disease 0 7.59018666940392e-06
in I-Disease 0 1.1006707767435842e-09
the I-Disease 0 3.2336633370988466e-09
sterol I-Disease 0 1.2575269181525073e-07
27 I-Disease 0 3.5019581900996855e-08
- I-Disease 0 2.6221751880939337e-08
hydroxylase I-Disease 0 6.545464259488654e-08
activity I-Disease 0 4.088029470494803e-09
, O 0 6.119974665930172e-11
but O 0 2.7516624395707012e-11
also O 0 4.213812979103615e-11
partially O 0 1.3185728064968316e-08
leads O 0 1.4184195484823192e-10
to O 0 4.680217671748643e-11
alternative O 0 4.175103818226944e-09
pre O 0 7.539922108890096e-08
- O 0 7.78061171047284e-09
mRNA O 0 1.99451459792499e-08
splicing O 0 4.062024672180087e-08
of O 0 3.786828628449257e-09
the O 0 4.174825374292368e-09
gene O 0 2.4440428347816123e-08
. O 0 1.1292110002614208e-07

To O 0 4.524676100459146e-08
our O 0 6.707820432438893e-08
knowledge O 0 1.0938423429251998e-06
, O 0 3.703840359414734e-11
this O 0 1.863344764943542e-12
is O 0 1.1823465383836718e-12
the O 0 5.850843681071138e-12
first O 0 3.333820372541929e-11
report O 0 7.829369097489547e-12
regarding O 0 1.6245270406667345e-10
effects O 0 4.171480383341475e-10
on O 0 1.5503739958511176e-10
pre O 0 1.328564813718458e-08
- O 0 1.0285752249927782e-09
mRNA O 0 2.8347810765438908e-09
splicing O 0 6.8514127704588645e-09
of O 0 3.6779357337479723e-10
a O 0 5.670715980121699e-11
mutation O 0 1.7236986837865231e-10
at O 0 8.215436664293918e-10
the O 0 1.4072826237665481e-09
- O 0 3.5464296388454386e-08
2 O 0 3.245867352674736e-09
position O 0 3.8789696787944195e-08
of O 0 9.816798041129005e-09
a O 0 3.2298845820122324e-09
5 O 0 2.91374906424835e-08
splice O 0 4.686978343215742e-07
site O 0 2.5921599089429037e-08
. O 0 7.341094487856026e-08

ATM O 0 0.008587262593209743
germline O 0 0.0002622990868985653
mutations O 0 1.634624737789636e-07
in O 0 4.966264732786385e-09
classical O 1 0.8977956771850586
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9998725652694702
in O 0 3.6961231852927767e-09
the O 0 2.3465416276735596e-09
Dutch O 0 6.355914479172498e-07
population O 0 3.863010467064498e-10
. O 0 3.20673065878907e-09

Germline O 0 0.0009693445754237473
mutations O 0 4.8831399368509665e-08
in O 0 6.403010344158133e-10
the O 0 1.9829258235404268e-09
ATM O 0 5.909314495511353e-06
gene O 0 1.5153120425104305e-10
are O 0 2.0028939444471927e-12
responsible O 0 7.02527619411697e-11
for O 0 3.505106968559879e-11
the O 0 5.351559480004653e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999364614486694
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1712072200964485e-08
. O 0 4.999722236220805e-08

In O 0 6.403749353012245e-08
our O 0 5.484798393240453e-08
study O 0 6.162508836560221e-10
, O 0 1.145561510235149e-11
we O 0 7.775377564023245e-12
have O 0 3.388242106588252e-13
determined O 0 9.618360968799422e-11
the O 0 1.8045334670979685e-10
ATM O 0 2.2537356016982812e-06
mutation O 0 2.4384214647454883e-09
spectrum O 0 3.6663105884571223e-09
in O 0 2.4515278695957932e-11
19 O 0 3.013460314615912e-10
classical O 0 2.1922016912867548e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.383590402947448e-07
, O 0 1.6815345990628394e-11
including O 0 2.2912758929766186e-12
some O 0 7.83877845446368e-13
immigrant O 0 4.8402917091072695e-11
populations O 0 1.721174591740038e-11
, O 0 2.1067598620500005e-12
as O 0 7.365652358870545e-12
well O 0 8.261819700594586e-11
as O 0 2.49538289337492e-11
12 O 0 4.024003630309636e-10
of O 0 4.3590175913266194e-10
Dutch O 0 4.1833004615909886e-08
ethnic O 0 2.037843671587325e-09
origin O 0 3.3309266456171827e-08
. O 0 1.611195727946324e-07

Both O 0 3.288367622644728e-08
the O 0 4.515113172232077e-09
protein O 0 1.0844748432603524e-09
truncation O 0 5.9280381492499146e-08
test O 0 4.887116045182438e-09
( O 0 1.054011988799175e-09
PTT O 0 1.027645225804008e-06
) O 0 2.0440002121424605e-11
and O 0 1.6286524212594244e-11
the O 0 4.066817368975073e-11
restriction O 0 3.580735360997345e-11
endonuclease O 0 1.8823864689210268e-10
fingerprinting O 0 2.998308712420794e-09
( O 0 3.3748959182844374e-10
REF O 0 1.5493918681386276e-07
) O 0 1.3215715414377494e-12
method O 0 3.4861999398394516e-10
were O 0 1.015432668505234e-10
used O 0 7.331792811759996e-11
and O 0 1.7997582590911776e-11
compared O 0 1.2000328508676716e-10
for O 0 6.096227689322831e-12
their O 0 3.1431805075365915e-11
detection O 0 1.8754573005708153e-08
efficiency O 0 6.133325403112622e-09
, O 0 4.669301837539885e-12
identifying O 0 6.629843896099885e-10
76 O 0 1.1862183235678003e-08
% O 0 8.738783585648946e-10
and O 0 8.026082402856627e-12
60 O 0 1.2571829133278811e-09
% O 0 3.524966984969069e-10
of O 0 4.396649017079923e-11
the O 0 8.30867527557011e-11
mutations O 0 1.067411270483376e-09
, O 0 1.8664342293917002e-10
respectively O 0 1.3721721359161165e-07
. O 0 2.76047245506561e-07

Most O 0 2.6118028628729917e-08
patients O 0 1.537201832491064e-08
were O 0 2.237805052374142e-09
found O 0 1.8284429526005397e-10
to O 0 7.833704518400708e-11
be O 0 8.286838437676636e-10
compound O 0 3.2452504683533334e-07
heterozygote O 0 9.917401257553138e-06
. O 0 8.356411740351177e-07

Seventeen O 0 2.0038758066220907e-06
mutations O 0 1.1321089843363552e-08
were O 0 2.165193579983793e-09
distinct O 0 6.663667395656603e-10
, O 0 7.69422286300836e-12
of O 0 8.342801449678916e-11
which O 0 1.6518903215786973e-12
10 O 0 3.579246274365566e-11
were O 0 9.576989895565546e-11
not O 0 9.722086850849632e-12
reported O 0 9.822749280630205e-10
previously O 0 8.546165730649591e-08
. O 0 1.636381057323888e-07

Mutations O 0 2.28116959988256e-06
are O 0 4.5898209677375235e-09
small O 0 1.264414706270145e-08
deletions O 0 1.9593507261106424e-07
or O 0 5.804117364505146e-08
point O 0 5.776303169113817e-06
mutations O 0 6.3548964135407e-07
frequently O 0 1.0617611678753747e-07
affecting O 0 9.337858841718116e-08
splice O 0 1.8427630266160122e-06
sites O 0 7.014440228658714e-08
. O 0 2.352912105152427e-07

Moreover O 0 1.0865419426409062e-05
, O 0 1.0346635548330596e-08
a O 0 1.1558303647518642e-08
16 O 0 2.3834599005567725e-07
. O 0 3.347853976265469e-07

7 O 0 2.0315947040216997e-06
- O 0 4.7632036626055196e-07
kb O 0 4.425581607847562e-07
genomic O 0 3.010872262620978e-08
deletion O 0 2.4107729146294332e-08
of O 0 2.9041116178518678e-08
the O 0 3.759014877147138e-09
3 O 0 2.627135176069828e-09
end O 0 4.1415151308399345e-09
of O 0 1.7940057217558092e-09
the O 0 3.153895478114066e-10
gene O 0 1.6095193233756078e-10
, O 0 7.512575631030138e-12
most O 0 3.0272717926188575e-12
likely O 0 6.013130271487199e-11
a O 0 3.409619808714126e-11
result O 0 9.381284638010357e-10
of O 0 1.0051622867379706e-09
recombination O 0 5.620646725823519e-10
between O 0 1.6970699290297375e-09
two O 0 1.3216686078898476e-10
LINE O 0 1.1591004067668109e-07
elements O 0 4.95994090243812e-09
, O 0 1.2612412503276715e-10
was O 0 5.220488041857152e-09
identified O 0 6.711404409998067e-08
. O 0 1.1442774905390252e-07

The O 0 6.795348639343501e-08
most O 0 8.10371048043379e-10
frequently O 0 8.203817625229703e-10
found O 0 1.4225023936553782e-10
mutation O 0 1.1248092735005599e-10
, O 0 4.330308247396664e-12
identified O 0 3.3158623069518e-10
in O 0 1.3292649099494458e-11
three O 0 1.745523690865891e-11
unrelated O 0 2.6209439063507034e-09
Turkish O 0 2.9297232231328962e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
individuals O 0 1.689996764753232e-08
, O 0 1.3228389217356806e-10
was O 0 1.808383109924705e-09
previously O 0 5.24387755440614e-10
described O 0 4.2821881457433264e-11
to O 0 4.122672255663096e-12
be O 0 1.0048431704767768e-11
a O 0 2.3689659608971958e-11
Turkish O 0 6.012450626258214e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
founder O 0 3.954480052925646e-05
mutation O 0 6.304858857220097e-07
. O 0 1.4614428778259025e-07

The O 0 6.775495364763628e-08
presence O 0 8.674239104777826e-09
of O 0 1.9042358800902548e-08
a O 0 1.0669557681808328e-08
founder O 0 4.998215672458173e-07
mutation O 0 1.3209844773598434e-08
among O 0 4.868438638339079e-11
relatively O 0 1.7649554040488624e-10
small O 0 6.769411420304294e-12
ethnic O 0 5.003387287816352e-11
population O 0 4.546666862448312e-12
groups O 0 7.698637192153635e-13
in O 0 1.3830844455831048e-11
Western O 0 3.808493520551792e-09
Europe O 0 2.765603301924102e-09
could O 0 3.294617079152573e-10
indicate O 0 4.07438349725453e-09
a O 0 5.736980682180537e-11
high O 0 4.637956130260079e-10
carrier O 0 4.027866373768063e-10
frequency O 0 2.313655578234375e-08
in O 0 3.3561392553949077e-10
such O 0 7.263716850225421e-10
communities O 0 8.160514930466434e-09
. O 0 8.240239424139872e-08

In O 0 1.3392812192591919e-08
patients O 0 6.4540950361902105e-09
of O 0 6.873178914901246e-09
Dutch O 0 6.62152046970732e-07
ethnic O 0 1.794803083932095e-09
origin O 0 1.877181521336979e-09
, O 0 1.470029827033148e-11
however O 0 8.336072804260297e-11
, O 0 6.0819539508816245e-12
no O 0 1.133639362937977e-11
significant O 0 1.5490646265714503e-10
founder O 0 3.553957572677291e-09
effect O 0 4.2825573642879533e-10
could O 0 1.5597972913283797e-10
be O 0 1.337809973911419e-09
identified O 0 5.803983640362276e-07
. O 0 6.253885089790856e-07

The O 0 4.295896971484581e-08
observed O 0 1.3499216855450413e-08
genetic O 0 1.0370958314354084e-08
heterogeneity O 0 1.0175410736223967e-08
including O 0 1.941635047186807e-11
the O 0 1.4741016740593693e-10
relative O 0 7.630910658917855e-08
high O 0 5.54436985211737e-09
percentage O 0 2.51188425615112e-09
of O 0 2.8893457071355044e-10
splice O 0 7.051020389781115e-08
- O 0 4.076793569396386e-09
site O 0 8.215200741901185e-10
mutations O 0 5.192342666937577e-10
had O 0 4.094262429088502e-10
no O 0 1.0047535720092426e-10
reflection O 0 8.675298701632528e-09
on O 0 3.5980185497663797e-09
the O 0 1.4804824921554882e-08
phenotype O 0 6.758315294064232e-07
. O 0 4.5476036802938324e-07

All O 0 1.2868494714268763e-08
patients O 0 4.015150878444729e-09
manifested O 0 2.802267973223138e-09
classical O 0 5.378409468903556e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999707937240601
T I-Disease 1 0.999997615814209
and O 0 3.343949339651431e-09
increased O 0 1.384300585272058e-08
cellular O 0 5.8650346801414344e-08
radioresistant O 0 8.595715428327821e-08
DNA O 0 4.558250452646462e-07
synthesis O 0 7.621294457749173e-07
. O 0 1.2029046558836853e-07

Determination O 0 3.0626990792370634e-06
of O 0 5.1686630087033336e-08
the O 0 1.4973819961738855e-09
genomic O 0 1.2313069674974031e-08
structure O 0 2.1386625803643255e-09
of O 0 7.841078342174512e-10
the O 0 8.687679464713938e-10
COL4A4 O 0 0.46154606342315674
gene O 0 4.347725235387401e-10
and O 0 2.2575833563687198e-11
of O 0 5.353549270559199e-10
novel O 0 1.4671404091615159e-09
mutations O 0 2.580649152150727e-07
causing O 0 4.438440555531997e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.000492209626827389

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.1829039081590054e-08
a O 0 3.7088362603299174e-08
progressive O 1 0.9999973773956299
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.7359633445739746
by O 0 3.453164652000851e-07
glomerular B-Disease 1 0.9999916553497314
basement I-Disease 1 0.9999592304229736
membrane I-Disease 0 2.6749887183541432e-05
abnormalities I-Disease 1 0.902529776096344
and O 0 8.54825987772756e-10
associated O 0 1.1972258562309435e-07
with O 0 3.172187790223546e-10
mutations O 0 1.1138384659048484e-09
in O 0 1.1932768662070714e-10
either O 0 2.2962887147315314e-09
the O 0 6.348824133084463e-09
COL4A3 O 1 0.9993405938148499
or O 0 3.6097019817660225e-10
the O 0 1.455445430842417e-09
COL4A4 O 0 0.00028742977883666754
gene O 0 3.53547136011656e-10
, O 0 4.180684010784974e-12
which O 0 1.3378786468433435e-13
encode O 0 1.4960679917130904e-10
the O 0 4.146745724575851e-10
alpha3 O 0 1.6571138985455036e-06
and O 0 3.616478227996822e-09
alpha4 O 0 1.6249248801614158e-05
type O 0 1.1328032087476458e-05
IV O 1 0.9999998807907104
collagen O 1 0.9943075776100159
chains O 0 6.634465989918681e-07
, O 0 2.519892960961556e-09
respectively O 0 3.799542582783033e-07
. O 0 1.590648821547802e-07

To O 0 5.404563019340003e-09
date O 0 7.257699508045334e-08
, O 0 1.960978185389095e-10
mutation O 0 6.409996838874221e-11
screening O 0 1.2807217786292568e-10
in O 0 1.6458371124294935e-11
the O 0 8.266343165530543e-11
two O 0 5.124804747236311e-11
genes O 0 3.4535194148865855e-10
has O 0 2.0282820561989823e-12
been O 0 2.4999181544305138e-11
hampered O 0 9.570337056175049e-08
by O 0 7.732149989725379e-12
the O 0 1.4483775290230483e-10
lack O 0 1.4689389260524877e-08
of O 0 1.7451060596584966e-09
genomic O 0 4.687702670480576e-08
structure O 0 5.291931159945307e-08
information O 0 7.900775500502277e-08
. O 0 1.010555408242908e-07

We O 0 4.7161133664985755e-08
report O 0 1.1966392321483e-09
here O 0 1.831654272699268e-10
the O 0 1.1392446881697271e-11
complete O 0 7.546288594006967e-10
characterization O 0 1.0807579275962098e-09
of O 0 3.1594105109888915e-10
the O 0 2.3587370945321595e-10
48 O 0 1.4968343009513774e-08
exons O 0 3.526725933511443e-08
of O 0 5.433625216433313e-10
the O 0 1.1575725933354875e-09
COL4A4 O 0 0.042688775807619095
gene O 0 9.199852546437626e-10
, O 0 1.7539069155358966e-11
a O 0 1.5901360089776162e-11
comprehensive O 0 1.7571366583979398e-09
gene O 0 2.3518142988621094e-10
screen O 0 3.295618000720424e-09
, O 0 7.214764896623649e-11
and O 0 3.0990866123348226e-11
the O 0 6.382339795552028e-11
subsequent O 0 1.3351360017566094e-09
detection O 0 1.3118578578996676e-07
of O 0 4.719735158253968e-10
10 O 0 6.05614378090813e-11
novel O 0 4.693212832251881e-12
mutations O 0 2.431753930165481e-11
in O 0 7.374930527381807e-12
eight O 0 3.543255133742207e-10
patients O 0 4.24338475468744e-09
diagnosed O 0 3.515374601192889e-06
with O 0 3.0385351124095905e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00043500022729858756

Furthermore O 0 7.963863595250587e-07
, O 0 4.779124318510242e-10
we O 0 1.2104094115894526e-10
identified O 0 5.70763492024895e-10
a O 0 6.358549103913091e-11
glycine O 0 9.557359348377759e-10
to O 0 2.623168071647086e-10
alanine O 0 2.855717884386877e-09
substitution O 0 8.735304923845888e-09
in O 0 5.78102010706516e-10
the O 0 1.8817771785251125e-09
collagenous O 0 1.6033889096433995e-06
domain O 0 3.07522474152222e-09
that O 0 3.686640836358945e-12
is O 0 5.559992570514094e-12
apparently O 0 3.386465774468661e-09
silent O 0 3.22039905853444e-09
in O 0 5.573394870617143e-11
the O 0 2.4077467797312124e-10
heterozygous O 0 1.1862562043774005e-09
carriers O 0 1.2781155300789493e-10
, O 0 1.6348968012724896e-10
in O 0 1.19377363549944e-09
11 O 0 1.3423326095107768e-07
. O 0 2.61084977637438e-07

5 O 0 5.6414460658515964e-08
% O 0 1.075174260734002e-08
of O 0 3.704513085178718e-10
all O 0 8.729233308413242e-11
control O 0 5.183904416838914e-09
individuals O 0 4.4084805250754755e-11
, O 0 1.3069977392032861e-11
and O 0 8.91323993779114e-12
in O 0 2.6437810274337892e-11
one O 0 1.283670478940957e-11
control O 0 3.1607125250410206e-10
individual O 0 2.548461268403468e-11
homozygous O 0 1.2861807452413387e-10
for O 0 2.293161320554571e-11
this O 0 2.0246740395357676e-10
glycine O 0 6.661500151494693e-08
substitution O 0 3.8643929656245746e-07
. O 0 3.4121174508072727e-07

There O 0 1.9081516811070287e-08
has O 0 1.9974317339022107e-11
been O 0 2.402841120519028e-11
no O 0 3.0600483084952668e-12
previous O 0 2.6684833162593513e-11
finding O 0 9.188115546177045e-11
of O 0 3.695527564517853e-11
a O 0 1.1178192919902852e-11
glycine O 0 2.4669047360426077e-10
substitution O 0 1.5137529008057982e-09
that O 0 1.9613802769435917e-12
is O 0 2.2744425700466087e-12
not O 0 3.986057144078625e-12
associated O 0 5.451178952675662e-10
with O 0 2.124827917782124e-11
any O 0 1.1269055688600815e-09
obvious O 0 2.02483825262334e-08
phenotype O 0 5.412547743333107e-09
in O 0 2.806792021026183e-10
homozygous O 0 2.266647491921958e-08
individuals O 0 5.930794966246822e-09
. O 0 2.537620389375661e-07

Founder O 0 0.00040094158612191677
BRCA1 O 0 8.67358085088199e-06
and O 0 1.3439768409284625e-08
BRCA2 O 0 2.422204090635205e-07
mutations O 0 2.2234625252082196e-09
in O 0 5.677158187999964e-10
French O 0 4.512206487561343e-06
Canadian O 1 0.9999229907989502
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.1386437058245065e-06
. O 0 5.202147690397396e-07

We O 0 6.527785245680207e-08
have O 0 1.375676378367885e-10
identified O 0 7.890362252460648e-10
four O 0 2.578585261980848e-11
mutations O 0 1.9629830746992205e-11
in O 0 1.8267191145143746e-12
each O 0 1.016005508891471e-11
of O 0 3.3100191476620466e-09
the O 0 2.0126830690969655e-07
breast B-Disease 1 0.9999929666519165
cancer I-Disease 1 0.9999960660934448
- O 1 0.9985082745552063
susceptibility O 0 2.7110172595712356e-05
genes O 0 1.8921042510555708e-07
, O 0 2.9794731126742136e-09
BRCA1 O 0 3.6818835980056974e-08
and O 0 2.5190327601620766e-09
BRCA2 O 0 1.8703348203530368e-08
, O 0 2.3233897444852047e-11
in O 0 3.994720526590001e-11
French O 0 5.0843876664430354e-08
Canadian O 0 1.528652137494646e-05
breast B-Disease 0 0.030409377068281174
cancer I-Disease 0 0.044902775436639786
and O 0 0.006246063858270645
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.5748204279807396e-07
from O 0 4.892892135899274e-08
Quebec O 0 2.01847001335409e-06
. O 0 7.917414990288307e-08

To O 0 4.94883124702028e-07
identify O 0 2.5569381705281558e-06
founder O 0 2.249807948828675e-06
effects O 0 8.890858680388192e-07
, O 0 3.167399398318338e-10
we O 0 9.112736260030729e-11
examined O 0 3.662431691253687e-09
independently O 0 5.3223971896443345e-09
ascertained O 0 1.0913045400684496e-07
French O 0 3.0743581902470396e-08
Canadian O 0 8.515201699310637e-08
cancer B-Disease 0 1.2561264917110293e-08
families O 0 1.9393478142837317e-11
for O 0 2.9551209569655956e-12
the O 0 2.827342526767751e-11
distribution O 0 3.7947003872496055e-10
of O 0 2.9347452246142325e-10
these O 0 1.4219653232672158e-10
eight O 0 4.48450743206763e-09
mutations O 0 1.9663437100803094e-08
. O 0 4.130984976313812e-08

Mutations O 0 2.9326622552616755e-07
were O 0 1.2672999538665408e-08
found O 0 1.006202010600532e-09
in O 0 1.2910940372368174e-10
41 O 0 1.0272209749473404e-08
of O 0 2.8950013497563987e-09
97 O 0 3.364571625752433e-07
families O 0 9.877877182873362e-09
. O 0 2.0734219674523047e-07

Six O 0 6.921106887602946e-08
of O 0 4.625193561480501e-09
eight O 0 2.141732347027414e-09
mutations O 0 2.0614826512499462e-10
were O 0 2.0336221595584902e-10
observed O 0 6.390053486349245e-10
at O 0 1.204686572719993e-09
least O 0 6.306939970279757e-10
twice O 0 1.51906984768857e-08
. O 0 8.012759877829012e-08

The O 0 4.460513309823e-07
BRCA1 O 0 1.9211067865398945e-06
C4446T O 0 6.078926617192337e-06
mutation O 0 5.649690937303831e-09
was O 0 2.087312322984758e-09
the O 0 1.3854983826888656e-10
most O 0 7.786835412582072e-12
common O 0 6.895178872312613e-11
mutation O 0 3.8361150367371977e-10
found O 0 1.6311994810447317e-10
, O 0 1.1845185422798554e-11
followed O 0 1.8352527830778342e-10
by O 0 5.815245160412097e-11
the O 0 7.914452204715872e-09
BRCA2 O 0 9.807907872527721e-07
8765delAG O 0 2.7638941446639365e-06
mutation O 0 2.750001613094355e-07
. O 0 3.283767853190511e-07

Together O 0 2.5680054704935174e-07
, O 0 3.836488349229228e-10
these O 0 2.888716002513725e-11
mutations O 0 2.965377388086665e-10
were O 0 4.337785686203688e-10
found O 0 4.188891594703037e-11
in O 0 1.0205444996025381e-11
28 O 0 6.133205054936752e-10
of O 0 4.452866686488477e-10
41 O 0 5.3200630567573626e-09
families O 0 6.507996919147274e-11
identified O 0 8.27426627214578e-10
to O 0 1.6796602997359855e-10
have O 0 2.0023610547426074e-10
a O 0 1.3025767131580324e-09
mutation O 0 9.672978507069274e-08
. O 0 4.1646762838354334e-07

The O 0 5.253633972301941e-08
odds O 0 2.5407197767890466e-07
of O 0 1.5468865077750138e-09
detection O 0 1.5767840011449152e-07
of O 0 3.966587058812365e-09
any O 0 2.654509390076498e-10
of O 0 2.2786450504241884e-09
the O 0 8.432410325553974e-10
four O 0 9.079637597331214e-10
BRCA1 O 0 7.3973556169448784e-09
mutations O 0 5.097899880013301e-10
was O 0 4.749366233625096e-09
18 O 0 2.1049123333227726e-08
. O 0 6.228297877441946e-08

7x O 0 0.00019494634761940688
greater O 0 9.28950498746417e-08
if O 0 1.271429739269081e-09
one O 0 9.387312455144681e-11
or O 0 3.728406819392127e-11
more O 0 3.935224975742946e-12
cases O 0 1.7733339796599523e-10
of O 0 5.822260209242813e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 2.985040282510454e-06
also O 0 1.759073095519703e-11
present O 0 5.2953353507634304e-11
in O 0 6.547902497988645e-11
the O 0 6.981519251603174e-10
family O 0 6.60977095279236e-09
. O 0 7.449733629982802e-08

The O 0 1.0452362175783492e-07
odds O 0 5.210871449889964e-07
of O 0 2.814196209399711e-09
detection O 0 4.073011155014683e-07
of O 0 6.891162751543334e-09
any O 0 1.0029140851131046e-09
of O 0 7.103162058541557e-09
the O 0 2.1559625196232446e-09
four O 0 2.889755101875835e-09
BRCA2 O 0 4.967489175555784e-08
mutations O 0 1.4526166935979745e-09
was O 0 1.2988088826659805e-08
5 O 0 3.169414952708394e-08
. O 0 4.8291134646660794e-08

3x O 0 4.9351809138897806e-05
greater O 0 1.6509613232074116e-08
if O 0 1.8148853253574515e-10
there O 0 3.156734595943789e-11
were O 0 4.3560734880321306e-11
at O 0 1.9541408421974715e-11
least O 0 1.195462565745098e-12
five O 0 1.181733313634914e-12
cases O 0 6.906626746211453e-12
of O 0 1.3962672129608222e-09
breast B-Disease 0 1.2864594282291364e-05
cancer I-Disease 0 1.0423578942209133e-06
in O 0 1.2801760540526175e-08
the O 0 1.453872329193473e-07
family O 0 1.2313108754824498e-07
. O 0 6.406547186088574e-07

Interestingly O 0 7.337384317906981e-07
, O 0 2.311655034059612e-10
the O 0 1.0762975233280514e-10
presence O 0 1.8865883855134769e-10
of O 0 3.90537593375484e-08
a O 0 8.400053275181563e-07
breast B-Disease 1 0.9999505281448364
cancer I-Disease 0 0.00032649521017447114
case O 0 2.0688545987468387e-08
< O 0 3.288666050593747e-07
36 O 0 2.7476949604476886e-09
years O 0 4.576468023986813e-11
of O 0 3.8097101862089033e-11
age O 0 5.663293722868445e-10
was O 0 7.50337084132191e-11
strongly O 0 9.530589858974814e-12
predictive O 0 1.0484459966875193e-09
of O 0 1.5640276573858358e-10
the O 0 5.382768536454918e-11
presence O 0 3.7166349858841485e-11
of O 0 2.998988002378411e-10
any O 0 1.7255834261487024e-10
of O 0 2.694184875196015e-09
the O 0 1.2401000226702763e-09
eight O 0 6.715012546010257e-09
mutations O 0 6.074161618130347e-09
screened O 0 3.0370923553846296e-08
. O 0 7.302480753423879e-08

Carriers O 0 1.6052746687478248e-08
of O 0 2.4222761574321794e-09
the O 0 4.3316508713253654e-10
same O 0 2.337267601681958e-10
mutation O 0 3.116366886768418e-10
, O 0 2.3423884359941027e-12
from O 0 6.5868933571411326e-12
different O 0 6.769040189480435e-11
families O 0 9.045684340458493e-11
, O 0 6.096657900744873e-12
shared O 0 1.2488700351642734e-10
similar O 0 4.817036700077715e-11
haplotypes O 0 3.777601342846992e-09
, O 0 1.9132653794606824e-11
indicating O 0 6.285575948616895e-10
that O 0 2.915839011213839e-12
the O 0 1.1777825242864637e-11
mutant O 0 1.5900337990704116e-10
alleles O 0 3.220346558863163e-11
were O 0 1.3198320214513615e-10
likely O 0 7.098305970787422e-11
to O 0 4.937864787196711e-12
be O 0 4.319501787503066e-12
identical O 0 5.3598809418575755e-11
by O 0 9.584294295705842e-12
descent O 0 2.9221473241136664e-08
for O 0 7.04271710394444e-11
a O 0 4.402122277813447e-10
mutation O 0 1.2453644782084439e-09
in O 0 2.0662775657154242e-10
the O 0 1.8670192059033752e-09
founder O 0 1.8290486991645594e-07
population O 0 8.98159713269564e-10
. O 0 1.961298323749361e-08

The O 0 4.03735977982933e-09
identification O 0 5.6768719502997556e-08
of O 0 9.039832349344579e-08
common O 0 3.6676422610071313e-07
BRCA1 O 0 2.502141114746337e-06
and O 0 3.890120225946703e-08
BRCA2 O 0 9.048716265169787e-08
mutations O 0 1.9393264771849772e-10
will O 0 1.9101695919454542e-11
facilitate O 0 2.3592241493730626e-09
carrier O 0 3.4686434280395417e-10
detection O 0 6.119300337559253e-07
in O 0 2.7813833458623094e-09
French O 0 4.257897671777755e-06
Canadian O 1 0.7454626560211182
breast B-Disease 1 0.9999407529830933
cancer I-Disease 1 0.9999661445617676
and O 1 0.9987738728523254
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.889427138252358e-07
. O 0 2.558986977874156e-07

Are O 0 6.773531424641988e-08
Dp71 O 0 0.00037465663626790047
and O 0 8.359203462759979e-08
Dp140 O 0 0.0025194413028657436
brain O 0 0.012955396436154842
dystrophin O 0 6.939440027053934e-06
isoforms O 0 2.1699159802324175e-08
related O 0 3.773244827698363e-09
to O 0 1.11564779636808e-09
cognitive B-Disease 0 0.0011475759092718363
impairment I-Disease 1 0.9986839890480042
in O 0 0.0003253018076065928
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999942779541016

Molecular O 0 5.180250468583836e-07
study O 0 2.087415795770653e-09
and O 0 5.0894448377913903e-11
neuropsychological O 0 4.81848427824616e-09
analysis O 0 1.4568667106029665e-10
were O 0 3.029866982307006e-11
performed O 0 8.825462582962018e-11
concurrently O 0 5.515467527139606e-10
on O 0 4.385485030677927e-11
49 O 0 1.0298276675868578e-09
patients O 0 6.097408133953763e-10
with O 0 4.409612230915627e-09
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DMD B-Disease 1 1.0
) O 0 2.8616611302823003e-09
in O 0 2.943837187907583e-11
order O 0 7.455818080981391e-12
to O 0 1.18886888181291e-11
find O 0 2.0994012084329938e-10
a O 0 1.4614358334608113e-11
molecular O 0 4.536916953234993e-10
explanation O 0 8.456887967689397e-11
for O 0 5.9798554996604025e-12
the O 0 2.0903789810233775e-10
cognitive B-Disease 0 1.1690020755850128e-06
impairment I-Disease 0 2.43586441683874e-07
observed O 0 1.9756170033247145e-09
in O 0 7.472539809150192e-10
most O 0 7.714925587265498e-09
DMD B-Disease 1 1.0
patients O 0 6.262548595259432e-06
. O 0 4.296348095067515e-07

Complete O 0 9.388184452063797e-08
analysis O 0 5.374177547423642e-09
of O 0 1.641230706894703e-09
the O 0 4.954709975635296e-10
dystrophin O 0 1.0592307120305122e-07
gene O 0 2.3629337375652426e-10
was O 0 6.342611436060963e-10
performed O 0 2.5864492769755998e-09
to O 0 2.722709557811953e-10
define O 0 7.63183827245939e-09
the O 0 1.9320098854080925e-09
localization O 0 3.312432818347588e-05
of O 0 4.7079797838023296e-08
deletions O 0 1.2718717634641052e-08
and O 0 3.495135014741635e-10
duplications O 0 3.935075767458329e-07
in O 0 2.1898460822455945e-10
relation O 0 1.1100363295213356e-08
to O 0 3.865103515021673e-10
the O 0 2.600259785268122e-09
different O 0 1.056613569971887e-07
DMD B-Disease 1 1.0
promoters O 0 3.887750062858686e-05
. O 0 6.304672410806234e-07

Qualitative O 0 1.6093387102955603e-06
analysis O 0 1.080733813552115e-08
of O 0 4.737658709785819e-09
the O 0 3.796678527123731e-09
Dp71 O 0 1.1214341611776035e-05
transcript O 0 3.8020864678856015e-08
and O 0 1.5974319089728795e-11
testing O 0 1.1463750781981474e-10
for O 0 1.5644257807603812e-12
the O 0 8.443876674257833e-12
specific O 0 5.6359094474656146e-11
first O 0 3.0985503052249896e-10
exon O 0 1.3660686803973476e-08
of O 0 2.8369446791742803e-09
Dp140 O 0 3.5427526654530084e-06
were O 0 2.43127873389426e-09
also O 0 2.4235398410343834e-11
carried O 0 1.0142058304296597e-09
out O 0 5.212784093266976e-10
. O 0 4.7042188811019514e-08

Neuropsychological O 0 1.1736741726053879e-05
analysis O 0 3.827647887533203e-08
assessed O 0 4.733677982926565e-08
verbal O 0 1.1954608680753154e-07
and O 0 4.41022640629285e-09
visuospatial O 1 0.7498852014541626
intelligence O 0 2.278864712934592e-06
, O 0 3.391331104829476e-10
verbal O 0 1.042411099660967e-07
memory O 1 0.83548903465271
, O 0 1.4956121896503305e-09
and O 0 1.1669943900116664e-09
reading O 0 1.1398185506550362e-07
skills O 0 8.974178490461782e-05
. O 0 4.444021612926008e-07

Comparison O 0 1.3368601230467902e-06
of O 0 6.798706664312704e-08
molecular O 0 1.0754454393691049e-07
and O 0 4.099703243554131e-09
psychometric O 0 4.2932350652336027e-07
findings O 0 3.684657023939053e-09
demonstrated O 0 5.33331112606561e-09
that O 0 1.5180247683876935e-11
deletions O 0 8.469257517518258e-10
and O 0 6.16191819791112e-11
duplications O 0 5.876355402278932e-08
that O 0 2.0782209286807074e-11
were O 0 5.880733122687332e-10
localized O 0 1.9063399747665244e-08
in O 0 1.1127294224921869e-10
the O 0 6.945353181464498e-10
distal O 0 1.5318464363645035e-07
part O 0 4.204440351429639e-09
of O 0 1.4814321502854e-07
the O 0 2.669021981205333e-08
gene O 0 9.293683156386123e-09
seemed O 0 5.84825299299041e-09
to O 0 3.349167471133896e-11
be O 0 2.7568157826007855e-11
preferentially O 0 4.2432532487701735e-10
associated O 0 3.94430088590525e-09
with O 0 2.1474424460876662e-09
cognitive B-Disease 1 0.9999558925628662
impairment I-Disease 1 0.9998278617858887
. O 0 3.5918608318752376e-06

Two O 0 9.344897478058556e-08
altered O 0 1.554619615262709e-07
Dp71 O 0 3.161639688187279e-05
transcripts O 0 1.8306471361029253e-07
and O 0 1.381666725475128e-10
two O 0 3.1102370678937064e-11
deleted O 0 6.480266323549699e-10
Dp140 O 0 6.0645994892638555e-09
DNA O 0 5.729678398402882e-10
sequences O 0 2.104993609974848e-11
were O 0 1.8228567960631992e-11
found O 0 3.4914267657559783e-12
in O 0 7.315469844476619e-13
four O 0 7.833940093848746e-12
patients O 0 5.784318024559809e-10
with O 0 5.443209771804902e-10
severe O 1 0.9999933242797852
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9987829327583313

These O 0 2.575463220466645e-08
findings O 0 3.4731335585291845e-09
suggest O 0 9.799432376667028e-10
that O 0 1.6038483475339094e-12
some O 0 9.833719125454388e-13
sequences O 0 6.164680571574266e-11
located O 0 1.8634392640048958e-10
in O 0 2.5595582944792916e-11
the O 0 5.078877873820886e-10
distal O 0 3.313027718832018e-07
part O 0 1.1943072308895353e-08
of O 0 2.1944104844351386e-07
the O 0 2.7248425737980142e-08
gene O 0 4.8704218436057545e-09
and O 0 8.108565485720476e-10
, O 0 1.861640702705003e-11
in O 0 1.692955844956323e-11
particular O 0 1.9450721588931685e-10
, O 0 1.187613288960998e-11
some O 0 1.6123330101591726e-11
DMD B-Disease 1 0.9999802112579346
isoforms O 0 2.075906202492206e-08
expressed O 0 1.7434782784153668e-10
in O 0 5.614151157851133e-11
the O 0 3.442497120698107e-10
brain O 0 5.76875493152329e-07
may O 0 6.773909905222197e-11
be O 0 2.1829640525772298e-11
related O 0 1.5418200050021369e-09
to O 0 2.111529007198243e-10
the O 0 2.168590862439146e-09
cognitive B-Disease 0 0.00021833446226082742
impairment I-Disease 0 6.400399342965102e-06
associated O 0 3.736364817541471e-07
with O 0 6.037927846591629e-08
DMD B-Disease 1 1.0
. O 0 5.622624712486868e-07
. O 0 2.1193231702909543e-07

I1307K O 0 0.0005072039202786982
APC O 0 5.105317995912628e-06
and O 0 1.1641071218093657e-08
hMLH1 O 0 9.431273610971402e-07
mutations O 0 4.285615862187342e-09
in O 0 1.0242774683977274e-10
a O 0 1.5279544296475933e-10
non O 0 1.0104108838504544e-07
- O 0 9.560609193215441e-09
Jewish O 0 1.4787714386343964e-09
family O 0 1.9329600420281423e-10
with O 0 1.1584069120607055e-10
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999960660934448

We O 0 4.825918153983366e-08
describe O 0 6.414959585754332e-08
a O 0 1.873911914529458e-09
French O 0 1.4076087495595857e-07
Canadian O 0 6.0579936871363316e-06
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.16537955403327942
HNPCC B-Disease 1 1.0
) O 0 1.1830092461195818e-09
kindred O 0 2.7180114159364166e-08
which O 0 6.559361994534774e-12
carries O 0 1.1322822887627204e-11
a O 0 6.7102395688578564e-12
novel O 0 3.775516010939839e-11
truncating O 0 5.2834490560371705e-08
mutation O 0 4.112633344988126e-09
in O 0 3.6604483888424966e-09
hMLH1 O 0 6.3063357629289385e-06
. O 0 8.290654136544617e-07

Interestingly O 0 4.198659098619828e-06
, O 0 2.325706516259629e-09
the O 0 2.6031579114516035e-09
I1307K O 0 1.9983358470199164e-06
APC O 0 8.218484737199105e-08
polymorphism O 0 1.801471150031375e-08
, O 0 1.8996838824225648e-11
associated O 0 4.776727347000076e-10
with O 0 2.233470353107947e-11
an O 0 1.4712217555334917e-11
increased O 0 1.063469312612142e-08
risk O 0 1.1995474551440566e-06
of O 1 0.999994158744812
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.464274295263749e-07
is O 0 2.313643200635429e-11
also O 0 1.3470023707551348e-12
present O 0 4.351904600574663e-11
in O 0 2.3735746007558234e-11
this O 0 1.2453614528507018e-10
family O 0 3.318837871191249e-09
. O 0 6.984535616538778e-08

The O 0 1.3634726769851113e-07
I1307K O 0 1.3361856872506905e-05
polymorphism O 0 2.6841439648706e-07
has O 0 3.518248192779794e-11
previously O 0 1.7643629612873468e-10
only O 0 1.6541477389220294e-12
been O 0 6.580326561422822e-12
identified O 0 7.905044674405559e-11
in O 0 2.8270231208077368e-12
individuals O 0 1.3666894872754742e-11
of O 0 3.729178743583361e-09
self O 0 7.76137426328205e-07
- O 0 2.7512948008734384e-07
reported O 0 3.5710485235540546e-08
Ashkenazi O 0 3.381463784535299e-06
Jewish O 0 9.686049651236317e-08
origins O 0 2.5339904823340476e-06
. O 0 4.177372545655089e-07

In O 0 1.2900615686817218e-08
addition O 0 3.846616358771371e-09
, O 0 6.826048754016156e-11
in O 0 2.0752897664233494e-11
this O 0 2.465064437295883e-11
family O 0 1.7792867179622363e-10
, O 0 6.572248387876067e-12
there O 0 3.851117775371948e-12
appears O 0 1.221413161583973e-11
to O 0 8.067321984051024e-12
be O 0 1.1680426070803662e-10
no O 0 3.1014948942420517e-10
relationship O 0 2.4820041577555685e-09
between O 0 6.175973510380572e-09
the O 0 1.0763535618352194e-09
I1307K O 0 1.944588774449585e-07
polymorphism O 0 2.6697602351077876e-08
and O 0 4.542871981372265e-11
the O 0 1.2308713770448065e-10
presence O 0 1.7153582720919047e-10
or O 0 2.920071962009274e-10
absence O 0 2.2046678793685714e-07
of O 0 1.3530491571600578e-07
cancer B-Disease 0 3.48600906363572e-06
. O 0 2.6894012350453522e-08
. O 0 7.85643052836349e-08

Identification O 0 1.9739827621378936e-06
of O 0 4.737941239341126e-08
a O 0 7.659206047172518e-10
novel O 0 8.48312392554007e-11
mutation O 0 4.693218036422309e-10
of O 0 1.4199956765992283e-09
the O 0 2.6441111522501615e-09
CPO O 0 1.1595319620028022e-06
gene O 0 2.7286986559182935e-10
in O 0 4.5825909039676205e-11
a O 0 6.638650185131212e-10
Japanese O 0 6.025157745170873e-06
hereditary B-Disease 1 0.9999997615814209
coproporphyria I-Disease 1 0.9999963045120239
family O 0 8.478314157400746e-07
. O 0 9.370291991217528e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 2.9781234843540005e-05
HCP B-Disease 1 1.0
) O 0 2.056002035288884e-09
is O 0 4.964121891326556e-10
an O 0 1.014101469465345e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
characterized O 0 5.442529982246924e-07
by O 0 7.225565146207202e-10
a O 0 5.5290469980207035e-09
deficiency B-Disease 1 0.6004360318183899
of I-Disease 1 0.6118510961532593
coproporphyrinogen I-Disease 1 0.9057213068008423
oxidase I-Disease 0 1.2665695159341794e-09
( O 0 1.8073477436875152e-10
CPO O 0 1.207931745739188e-07
) O 0 5.966309911398238e-12
caused O 0 3.1096795277685274e-11
by O 0 5.148452844605522e-12
a O 0 2.420370848188469e-11
mutation O 0 7.938391610728956e-11
in O 0 9.060811129169011e-11
the O 0 7.83069520338131e-09
CPO O 0 5.2405766837182455e-06
gene O 0 8.975696630386665e-08
. O 0 1.3332208936844836e-07

Only O 0 2.1869766442250693e-08
11 O 0 3.990764607664232e-09
mutations O 0 7.79654785176831e-10
of O 0 9.910691156633789e-10
the O 0 7.745263874703312e-10
gene O 0 5.685794612908524e-10
have O 0 1.1767585170185946e-11
been O 0 1.824854295451317e-10
reported O 0 1.0010126061388291e-09
in O 0 4.8191552970422435e-09
HCP B-Disease 1 0.9999896287918091
patients O 0 7.1744493652659e-06
. O 0 1.8966962898048223e-06

We O 0 5.366948130358651e-08
report O 0 1.5934834562969513e-09
another O 0 3.479324606203704e-10
mutation O 0 6.308022437728766e-10
in O 0 8.79085415572689e-11
a O 0 8.381387250899763e-10
Japanese O 0 7.714662615398993e-07
family O 0 3.327503961259026e-08
. O 0 3.9757128433848266e-07

Polymerase O 0 1.404216618539067e-07
chain O 0 2.572270840772717e-09
reaction O 0 9.168530934466901e-10
- O 0 2.344635818829488e-09
single O 0 1.8918673572176914e-10
strand O 0 4.177515555703337e-10
conformational O 0 1.702048224583308e-10
polymorphism O 0 5.230222921426275e-10
and O 0 3.3001359891343673e-12
direct O 0 1.622946742274589e-11
sequence O 0 7.343912977741951e-11
analyses O 0 3.7777295180951853e-10
demonstrated O 0 7.472326091217951e-10
a O 0 9.081971980018366e-11
C O 0 6.985225731170885e-09
to O 0 6.117467643562691e-10
T O 0 5.9054872103558864e-09
substitution O 0 5.374341416342077e-09
in O 0 2.2246333664099893e-09
exon O 0 5.448000717223067e-09
1 O 0 2.5543947512751686e-10
of O 0 7.727778417176978e-10
the O 0 1.4552761218311616e-09
CPO O 0 1.2212291267132969e-07
gene O 0 1.905036822735795e-10
at O 0 9.390540567366656e-10
nucleotide O 0 3.599158082678855e-09
position O 0 1.7584651956781272e-08
85 O 0 5.250227985698075e-08
, O 0 7.531991697007356e-11
which O 0 1.2103695649912094e-11
lies O 0 3.3189264669886143e-09
in O 0 1.0045331927388546e-10
the O 0 1.1728698012802852e-09
putative O 0 3.6132882996753324e-07
presequence O 0 1.3494604900188278e-06
for O 0 2.338057747408584e-09
targeting O 0 8.726033939865374e-08
to O 0 4.492368788078238e-08
mitochondria O 0 2.1343383195926435e-05
. O 0 2.600373591121752e-06

This O 0 1.006624228416797e-09
mutation O 0 3.678574111987132e-10
changes O 0 3.71224231909828e-11
the O 0 1.792957102231263e-11
codon O 0 5.713396422635242e-10
for O 0 6.167891197783604e-11
glutamine O 0 6.825834120149921e-09
to O 0 1.193008192235112e-10
a O 0 4.506000017556744e-10
termination O 0 3.693390837611332e-08
codon O 0 2.4067674075922696e-07
at O 0 3.2295908169999166e-08
amino O 0 8.778786053653675e-08
acid O 0 2.2906556651491883e-08
position O 0 2.9434610837597575e-07
29 O 0 1.9262765817984473e-06
. O 0 1.1495596936583752e-06

MaeI O 0 2.1242381990305148e-05
restriction O 0 4.719917789941519e-09
analysis O 0 4.249994578486849e-09
showed O 0 1.5642431794304912e-09
two O 0 6.521189404445904e-12
other O 0 3.728767728611304e-12
carriers O 0 2.8116235034625348e-11
in O 0 4.597333971845252e-11
the O 0 1.2984441299934701e-09
family O 0 1.4759657496199452e-08
. O 0 3.917798494512681e-07

The O 0 3.6777362311113393e-07
C O 0 0.00012770280591212213
- O 0 4.1154784412356094e-05
T O 0 2.4109112928272225e-07
mutation O 0 9.767820996486876e-10
is O 0 2.3482809446973008e-11
located O 0 5.686789580905405e-11
within O 0 6.344629682741854e-11
a O 0 2.2679760847132968e-11
recently O 0 2.283628668109383e-11
proposed O 0 1.9029475911702676e-11
putative O 0 3.6144628956513714e-10
alternative O 0 4.810272180577613e-10
translation O 0 1.9143697738144283e-09
initiation O 0 5.9727294221545435e-09
codon O 0 7.11553127530351e-08
( O 0 9.442072901322263e-09
TIC O 0 0.00011971873027505353
- O 0 2.8565639240696328e-06
1 O 0 5.947650816295891e-09
) O 0 4.209089674023225e-11
, O 0 1.5284142007576662e-11
supporting O 0 3.25406035450726e-10
that O 0 3.2329153243360054e-10
TIC O 0 2.8448399461922236e-05
- O 0 2.2682266376250482e-07
1 O 0 4.145743304206917e-09
is O 0 2.2809906741194652e-11
the O 0 1.5498714811545966e-10
real O 0 1.174226849087745e-08
TIC O 0 3.123246301584004e-07
rather O 0 3.173980633874862e-09
than O 0 2.195149839678834e-09
TIC O 0 1.3587865396402776e-05
- O 0 3.1467189387512917e-07
2 O 0 1.6354411158658877e-08
. O 0 6.333028768068516e-09
. O 0 2.6303151656748014e-08

Human B-Disease 0 1.324104459854425e-06
complement I-Disease 0 1.3304142157721799e-05
factor I-Disease 0 0.00016775523545220494
H I-Disease 1 1.0
deficiency I-Disease 1 0.5348258018493652
associated O 0 0.00026277618599124253
with O 0 0.0012810650514438748
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999713897705078

This O 0 1.7661416773506744e-09
study O 0 1.7294717047366959e-10
reports O 0 4.410154533229793e-11
on O 0 1.9918696900211863e-11
six O 0 1.3417823276073992e-11
cases O 0 1.5501456021582705e-11
of O 0 6.217316439460774e-09
deficiency B-Disease 0 0.0005786935216747224
in I-Disease 0 1.3906883422620808e-09
the I-Disease 0 1.0114916682013586e-09
human I-Disease 0 7.200512408545023e-10
complement I-Disease 0 4.344594017879899e-09
regulatory I-Disease 0 5.009735559724504e-08
protein I-Disease 0 6.807332919578357e-09
Factor I-Disease 0 4.5723282937615295e-09
H I-Disease 0 0.0001875154412118718
( O 0 1.8164783566199105e-10
FH O 0 1.1970870446020854e-06
) O 0 1.1162554387766921e-11
in O 0 4.851963449070684e-12
the O 0 1.0488510233941373e-11
context O 0 1.6597062613143976e-09
of O 0 2.1321702181609226e-09
an O 0 1.8625881281764123e-08
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.011256273835897446

Five O 0 2.9297819281737247e-08
of O 0 1.3887322403149938e-09
the O 0 8.986253408060918e-11
cases O 0 1.5910826475784567e-11
were O 0 3.845468041219213e-11
observed O 0 5.363253244294874e-12
in O 0 1.1269254843529475e-12
children O 0 3.975730768907004e-12
presenting O 0 3.3234366370038515e-09
with O 0 9.64600221919909e-09
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999990701675415
HUS B-Disease 1 1.0
) O 0 3.1554836823488586e-06
. O 0 3.4328015772189246e-06

Two O 0 4.173336787260951e-09
of O 0 2.6183157864068107e-09
the O 0 4.89133789027818e-10
children O 0 2.120909559089057e-10
exhibited O 0 7.579422645065392e-10
a O 0 1.2042500330267103e-09
homozygous O 0 1.7873914259780577e-07
deficiency O 0 2.1593316432699794e-06
characterized O 0 5.701044525352472e-09
by O 0 2.580505253924059e-10
the O 0 2.1877639699852125e-09
absence O 0 2.0620910845536855e-07
of O 0 7.936522550267e-09
the O 0 5.978014194774062e-10
150 O 0 2.4723372238355523e-09
- O 0 3.428947126238313e-09
kD O 0 2.944774024626895e-08
form O 0 1.6721428686139461e-09
of O 0 7.27341458173214e-08
Factor O 0 2.793209148421738e-07
H O 1 0.9945181012153625
and O 0 3.1322838767167127e-10
the O 0 1.78887599178168e-10
presence O 0 2.379163359378378e-11
, O 0 2.180150157626848e-12
upon O 0 3.7460723412152674e-10
immunoblotting O 0 7.85563614158491e-08
, O 0 1.4617900639946058e-11
of O 0 1.447063024961892e-10
the O 0 2.078340832767367e-10
42 O 0 1.0631712399344906e-08
- O 0 3.9091596626406044e-09
kD O 0 7.58101990072646e-08
Factor O 0 1.6826600557351412e-08
H O 1 0.7848467826843262
- O 0 5.954725565970875e-07
like O 0 4.824615706944257e-10
protein O 0 4.899816663517242e-10
1 O 0 2.35598512920987e-10
( O 0 2.0708296188942654e-11
FHL O 0 3.029576646440546e-06
- O 0 6.423404919075892e-09
1 O 0 1.2911852143027147e-10
) O 0 2.3348144164575535e-12
and O 0 6.327610310719045e-12
other O 0 5.4598648518977555e-11
FH O 0 1.2404088920447975e-05
- O 0 5.4298908480632235e-08
related O 0 2.1339212707971456e-07
protein O 0 4.008082754580755e-08
( O 0 6.203619840050578e-10
FHR O 0 0.0005325875827111304
) O 0 1.4387661062542634e-09
bands O 0 4.670388591421215e-07
. O 0 4.398228554691741e-07

Southern O 0 2.0707871044578496e-06
blot O 0 9.650741503719473e-07
and O 0 1.9572973797288284e-10
PCR O 0 6.533550145348954e-09
analysis O 0 1.2422322892557958e-10
of O 0 1.8669246704128284e-11
DNA O 0 4.058576585919127e-09
of O 0 2.27558610843559e-10
one O 0 3.0311503307345333e-11
patient O 0 1.553175543733687e-08
with O 0 5.857649920670838e-10
homozygous O 0 1.1371729442544165e-06
deficiency O 0 5.2260293159633875e-05
ruled O 0 1.8560770698172746e-08
out O 0 2.2760971926660822e-11
the O 0 1.9726515559925772e-11
presence O 0 1.9876872717206062e-11
of O 0 2.267207255268744e-10
a O 0 4.241293080631259e-11
large O 0 3.059145298189847e-11
deletion O 0 8.10177813725943e-10
of O 0 2.6336020031436647e-09
the O 0 2.9213209629119774e-09
FH O 0 2.3364498701994307e-05
gene O 0 5.767979982529425e-10
as O 0 5.6211049703769334e-11
the O 0 4.0056483130435083e-10
underlying O 0 9.439593668503221e-06
defect O 0 9.068168765224982e-06
for O 0 3.826325034594902e-09
the O 0 1.5348953184002312e-06
deficiency O 1 0.9999209642410278
. O 0 9.563625098962802e-06

The O 0 3.680255034055335e-08
other O 0 2.0994572746957374e-10
four O 0 8.284463393071206e-11
children O 0 4.756294316732301e-12
presented O 0 1.6088594345653462e-10
with O 0 1.0350811180392938e-10
heterozygous O 0 8.298660958416804e-08
deficiency O 0 2.372878043388482e-06
and O 0 2.5735222841660743e-09
exhibited O 0 7.521851586034245e-08
a O 0 1.7584308453777453e-09
normal O 0 3.0291316761577036e-06
immunoblotting O 0 1.6584797776886262e-05
pattern O 0 1.1704907620924132e-07
of O 0 1.2067706833818193e-08
proteins O 0 6.943167707440523e-10
of O 0 3.3827471934699815e-09
the O 0 3.3384704778427476e-08
FH O 0 0.0010246406309306622
family O 0 5.3523297793844904e-08
. O 0 1.9612875234997773e-07

Factor B-Disease 1 0.8609198927879333
H I-Disease 1 1.0
deficiency I-Disease 1 0.9108215570449829
is O 0 7.575650107227716e-10
the O 0 1.1799107246801555e-09
only O 0 8.53570281122984e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 0.0006339879473671317
with O 0 4.690170953836059e-07
HUS B-Disease 1 1.0
. O 0 0.00017013517208397388

These O 0 1.3857323288846146e-08
observations O 0 2.7693101145587207e-08
suggest O 0 3.4612630539498923e-09
a O 0 1.057583950969665e-10
role O 0 2.338392368628206e-09
for O 0 3.5713123569536265e-09
FH O 1 0.9992291927337646
and O 0 1.0794116889201177e-07
/ O 0 0.0005658347508870065
or O 0 1.0570328612402591e-07
FH O 1 0.7047208547592163
receptors O 0 3.497884426550968e-09
in O 0 3.75973002730845e-10
the O 0 2.4371149542901094e-09
pathogenesis O 0 2.387059066677466e-05
of O 0 1.2028018545606756e-06
idiopathic O 1 0.7590970396995544
HUS B-Disease 1 1.0
. O 0 1.30541241105675e-06
. O 0 7.993684221219155e-07

Further O 0 7.457823869572167e-08
evidence O 0 9.467680861519057e-09
for O 0 7.998089690541832e-11
a O 0 1.0828249408234569e-10
major O 0 7.325505757549422e-10
ancient O 0 1.1009236544623491e-07
mutation O 0 1.6693189536454156e-05
underlying O 1 0.9999902248382568
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.2637564143224154e-06
linkage O 0 2.7524663892108947e-05
disequilibrium O 0 8.57038758113049e-05
studies O 0 1.6958209281270342e-09
in O 0 1.4251767301021179e-11
the O 0 4.112566537317619e-11
Japanese O 0 1.5389240104468627e-08
population O 0 1.6669132740787518e-10
. O 0 7.3338979333925636e-09

The O 0 0.00018828239990398288
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.4349747289088555e-05
DM B-Disease 1 1.0
) O 0 1.5877464898395033e-09
mutation O 0 1.4072317755520203e-09
is O 0 4.133090744651291e-11
an O 0 1.578707581328942e-10
unstable O 1 0.9789263606071472
( O 0 1.8169791005107072e-08
CTG O 0 0.0013135418994352221
) O 0 1.136571323168134e-10
n O 0 5.297985383734272e-10
repeat O 0 2.573703916652903e-09
, O 0 1.2161779396058225e-11
present O 0 5.90955964718809e-11
at O 0 7.802003487711318e-11
a O 0 6.480494960103833e-12
copy O 0 7.078462260778906e-10
number O 0 1.1076009553967481e-10
of O 0 2.5423113614309045e-10
5 O 0 8.834561970871846e-10
- O 0 1.5396541819256981e-09
37 O 0 1.2683124550605385e-09
repeats O 0 7.271424018462369e-10
on O 0 3.594799458106479e-10
normal O 0 9.55027612548065e-09
chromosomes O 0 1.8812318369754166e-09
but O 0 8.481991498054953e-11
amplified O 0 1.629738788366808e-09
to O 0 6.54338319638903e-11
50 O 0 6.756432302523763e-09
- O 0 3.113183932867969e-09
3000 O 0 2.194864956450715e-09
copies O 0 2.518451447386383e-09
on O 0 5.991307006070201e-08
DM B-Disease 1 0.9996500015258789
chromosomes O 0 3.56131613443722e-06
. O 0 1.086002953343268e-06

Previous O 0 4.798332611244405e-07
findings O 0 5.8325460017272235e-09
in O 0 6.985355072153254e-10
Caucasian O 0 9.75940906755568e-07
populations O 0 2.1352468682067638e-09
of O 0 1.4150350224895192e-08
a O 0 4.91167270411097e-07
DM B-Disease 1 1.0
founder O 0 6.811753701185808e-05
chromosome O 0 1.3277866628413904e-06
raise O 0 3.667842696231105e-09
a O 0 1.322649489932104e-10
question O 0 2.4513993057695416e-09
about O 0 5.974041573930666e-12
the O 0 1.3384619801382058e-11
molecular O 0 7.677664615179935e-10
events O 0 2.6821805887422556e-10
involved O 0 3.731043030086312e-09
in O 0 4.633473049686643e-10
the O 0 3.3558207324091427e-09
expansion O 0 3.0344639867507794e-07
mutation O 0 1.1268164712419093e-07
. O 0 2.1920469350789062e-07

To O 0 4.5340406984450965e-08
investigate O 0 3.3099574636707985e-08
whether O 0 1.5590485569205725e-09
a O 0 5.947602410572017e-10
founder O 0 1.0258582427979945e-08
chromosome O 0 1.0343854661698515e-08
for O 0 7.314447936224155e-10
the O 0 1.3577853508195403e-07
DM B-Disease 1 1.0
mutation O 0 1.2586038877770989e-08
exists O 0 2.8113836259002767e-10
in O 0 6.394241039431314e-12
the O 0 6.756692427778432e-12
Japanese O 0 1.5378198714444125e-09
population O 0 9.070489151441485e-12
, O 0 1.1610358941621657e-12
we O 0 1.8502139056963962e-11
genotyped O 0 2.5775468870392615e-08
families O 0 2.1790952722811063e-11
using O 0 8.114718619278705e-11
polymorphic O 0 1.939771454573247e-09
markers O 0 3.994168551457733e-09
near O 0 1.0920541626546765e-07
the O 0 8.974305742981414e-09
( O 0 1.4239997625509204e-08
CTG O 0 2.7773996407631785e-05
) O 0 6.763158921785362e-10
n O 0 1.436674601507093e-08
repeat O 0 6.229819149439209e-08
region O 0 5.371146727384257e-08
and O 0 3.0884623747340356e-09
constructed O 0 7.429753736687417e-07
haplotypes O 0 8.809547011878749e-07
. O 0 2.1570376418367232e-07

Six O 0 5.124411828205666e-08
different O 0 2.4763910921876686e-09
haplotypes O 0 3.429334682891749e-08
were O 0 1.2502434643124616e-09
found O 0 5.351936116504419e-10
and O 0 1.134999094709599e-09
DM B-Disease 1 0.9999953508377075
alleles O 0 5.957755622176819e-09
were O 0 1.1569573743486217e-08
always O 0 6.72901290243999e-09
haplotype O 0 2.2247986919410323e-07
A O 0 2.2437354800786125e-06
. O 0 2.2512158466270193e-06

To O 0 2.8887313874292886e-08
find O 0 8.028758102796019e-09
an O 0 1.862745374614505e-11
origin O 0 1.9376193982623136e-09
of O 0 1.376108205164428e-08
the O 0 2.2119879261595088e-08
( O 0 3.2806288796649596e-09
CTG O 0 6.407386536011472e-06
) O 0 8.259188472026224e-11
n O 0 7.697034121179058e-10
repeat O 0 2.5194892838698024e-09
mutation O 0 1.619033379585133e-10
and O 0 1.2818330598352023e-11
to O 0 4.452694463141782e-11
investigate O 0 9.036428272324315e-10
the O 0 2.408031551937029e-10
mechanism O 0 2.8407852070699846e-08
of O 0 1.0966557661973297e-09
the O 0 1.1411219885681945e-10
expansion O 0 5.878120212798876e-10
mutation O 0 1.8728378223253905e-11
in O 0 1.103397429848274e-12
the O 0 2.0718596109581267e-12
Japanese O 0 1.0269148864594513e-09
population O 0 5.825707754744669e-13
we O 0 1.9618544798687826e-13
have O 0 9.172902644708977e-14
studied O 0 6.721476847326713e-11
90 O 0 5.669832381371975e-10
Japanese O 0 4.888526206059396e-08
DM B-Disease 1 0.9996287822723389
families O 0 6.900826576838881e-10
comprising O 0 7.17393200400096e-10
190 O 0 6.600457402861082e-10
affected O 0 9.63904511763758e-10
and O 0 1.2374791469316193e-10
130 O 0 3.098825374081571e-08
unaffected O 0 9.004672847368056e-07
members O 0 3.452982966223317e-08
. O 0 4.973898626303708e-07

The O 0 4.563609579122385e-08
results O 0 1.9133704398655027e-08
suggest O 0 5.5775473128960584e-09
that O 0 6.39230248594691e-12
a O 0 4.9737106794234265e-11
few O 0 1.8908138943452002e-10
common O 0 5.70494651519482e-10
ancestral O 0 2.8446239141999285e-08
mutations O 0 2.0103063658183373e-09
in O 0 1.360448143028492e-10
both O 0 2.6544397790928542e-09
Caucasian O 0 0.00012603492359630764
and O 0 1.5665931885067153e-09
Japanese O 0 4.5716157615061093e-07
populations O 0 4.627438709992049e-11
have O 0 1.8739151127090264e-13
originated O 0 6.868634567364085e-12
by O 0 3.1979041810459297e-13
expansion O 0 2.9028016101939613e-10
of O 0 3.730685205205475e-10
an O 0 6.789211554059094e-11
ancestral O 0 1.769939750317917e-08
n O 0 1.2358686296565224e-09
= O 0 5.836282568338902e-10
5 O 0 4.0794750910677635e-10
repeat O 0 2.4200779158434216e-09
to O 0 2.6182844781175163e-10
n O 0 1.420285555830958e-09
= O 0 1.350000888855618e-09
19 O 0 1.026339635501472e-08
- O 0 9.806186973548847e-09
37 O 0 5.157896776353255e-09
copies O 0 9.003985113054114e-09
. O 0 4.022035682282876e-08

These O 0 4.438030387632352e-09
data O 0 2.731246340204052e-09
support O 0 2.2671640953486616e-10
multistep O 0 2.2920891851185843e-08
models O 0 8.297756259878497e-09
of O 0 1.2603767807206623e-08
triplet O 0 4.6294330786622595e-06
repeat O 0 4.196118652544101e-08
expansion O 0 8.559358555260133e-09
that O 0 7.54665514107744e-12
have O 0 2.4935355429772654e-12
been O 0 5.373103004191471e-12
proposed O 0 2.7897738372889558e-12
for O 0 2.3590598224876302e-11
both O 0 2.1712159181674906e-08
DM B-Disease 1 1.0
and O 0 3.838187012661365e-07
Friedreichs B-Disease 1 0.9998661279678345
ataxia I-Disease 1 0.998893678188324
. O 0 2.998322088387795e-07
. O 0 8.404829259234248e-07

The O 0 2.79015193171972e-08
molecular O 0 8.038875165539139e-08
basis O 0 2.3283810151042417e-06
of O 1 0.953787624835968
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.530297559313112e-08
the O 0 3.2111007186585994e-09
western O 0 1.3632289963538824e-08
Cape O 0 3.558856676022515e-08
, O 0 3.5594099889735276e-10
South O 0 1.857791254167296e-08
Africa O 0 4.833149347405197e-08
. O 0 2.6753937731882615e-07

Deficiency B-Disease 1 0.9993529915809631
of I-Disease 0 6.884373306093039e-06
the I-Disease 0 1.0536631833701904e-07
sixth I-Disease 0 2.2064252789277816e-06
component I-Disease 0 1.9751777813326044e-07
of I-Disease 0 2.3361153012046998e-08
human I-Disease 0 1.500825241862458e-08
complement I-Disease 0 3.4183681236754637e-06
( O 0 1.4627906885777975e-08
C6 O 1 0.9999958276748657
) O 0 7.338073898521813e-11
has O 0 7.756784038866205e-13
been O 0 3.485804310129903e-12
reported O 0 6.049306021382872e-12
in O 0 4.934868160812178e-13
a O 0 2.497428912978661e-12
number O 0 2.0285849389178878e-11
of O 0 1.0513651754751052e-10
families O 0 8.552267921624335e-11
from O 0 1.1675971300917354e-10
the O 0 7.316848238403395e-10
western O 0 3.34407239677148e-08
Cape O 0 1.885989888705808e-07
, O 0 2.5397828284923207e-09
South O 0 6.698155630147085e-08
Africa O 0 2.253487565440082e-07
. O 0 4.23476819833013e-07

Meningococcal B-Disease 1 0.9999817609786987
disease I-Disease 1 0.9953097701072693
is O 0 2.033507762178033e-08
endemic O 0 9.394580047228374e-08
in O 0 2.9088650932429516e-10
the O 0 1.7072903091275293e-09
Cape O 0 2.0035855641253875e-08
and O 0 2.4640350523852383e-11
almost O 0 1.103617475184393e-10
all O 0 1.0826385794804327e-11
pedigrees O 0 4.771712358575542e-09
of O 0 1.656474779565542e-08
total O 0 0.0007312851375900209
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.4805932835315616e-07
C6Q0 O 1 0.9996349811553955
) O 0 1.6682619174979152e-10
have O 0 6.182988582931204e-12
been O 0 3.213437849147738e-11
ascertained O 0 2.1507966962985847e-08
because O 0 1.1152558043736605e-10
of O 0 1.362285484418635e-08
recurrent O 1 0.9588037729263306
disease O 1 0.6656230688095093
. O 0 6.49352659820579e-06

We O 0 2.893771622325403e-08
have O 0 1.2138311189513473e-10
sequenced O 0 5.007077419350026e-09
the O 0 9.04406272095315e-11
expressed O 0 1.1737381067078445e-09
exons O 0 1.2387252468215593e-07
of O 0 2.846505919862352e-09
the O 0 2.273418120424253e-09
C6 O 0 6.796375964768231e-05
gene O 0 7.581403282941324e-10
from O 0 1.26948562773066e-10
selected O 0 5.61908186647031e-10
cases O 0 6.190627177549146e-11
and O 0 2.3003458513026764e-11
have O 0 7.728301505693924e-12
found O 0 2.3229113077505303e-11
three O 0 1.8236565035856245e-11
molecular O 0 7.243828292757826e-08
defects O 0 1.6619471352896653e-05
leading O 0 1.363733481696272e-08
to O 0 1.6409958947249947e-09
total O 0 2.5154006380034843e-06
deficiency O 1 0.8801981806755066
879delG O 0 0.00028935831505805254
, O 0 1.4644502277505467e-10
which O 0 2.2703640183141527e-12
is O 0 7.084343962154849e-12
the O 0 1.0669078814862232e-10
common O 0 1.0194273869501558e-08
defect O 0 0.00023646565387025476
in O 0 4.470654957344777e-09
the O 0 2.2022717871550412e-08
Cape O 0 9.059922376764007e-07
and O 0 9.442234549794648e-09
hitherto O 0 3.63500453204324e-06
unreported O 0 2.6756029569696693e-07
, O 0 1.3512058139042438e-10
and O 0 1.5074423653782532e-10
1195delC O 0 9.239267484417724e-08
and O 0 1.4985676033418827e-09
1936delG O 0 4.846432943850232e-07
, O 0 3.6720876339657593e-11
which O 0 1.3236047457718114e-12
have O 0 4.731547185304885e-12
been O 0 6.801368496178739e-11
previously O 0 5.961208748850311e-10
reported O 0 1.3810053101082076e-10
in O 0 1.872003246861098e-10
African O 0 1.1945924427436694e-07
- O 0 2.688166205189191e-07
Americans O 0 2.3742084920286288e-07
. O 0 3.7899957305853604e-07

We O 0 7.539562574265801e-08
also O 0 1.9310585075427156e-10
show O 0 5.862903496023364e-10
that O 0 2.12412596192757e-12
the O 0 3.5822105698413154e-11
879delG O 0 3.139638238280895e-08
and O 0 2.023241713056123e-10
1195delC O 0 6.498102038676734e-07
defects O 0 1.057036456586502e-06
are O 0 4.151238380822875e-11
associated O 0 2.989242275930337e-08
with O 0 1.8110281274630324e-08
characteristic O 1 0.9999998807907104
C6 O 1 1.0
/ O 1 1.0
C7 O 1 0.9999998807907104
region O 0 4.699636974692112e-06
DNA O 0 3.848581854981603e-06
marker O 0 3.9298473808457857e-08
haplotypes O 0 1.8678891322565505e-08
, O 0 2.9783508992409224e-11
although O 0 9.457312016847297e-11
small O 0 3.688317012917608e-11
variations O 0 1.7141613128934807e-10
were O 0 3.4560647677039924e-09
observed O 0 5.976207262392563e-08
. O 0 2.034020383234747e-07

The O 0 1.1590738324684935e-07
1936delG O 0 7.123649993445724e-06
defect O 0 1.674262784945313e-05
was O 0 1.3639832374678917e-08
observed O 0 1.2240030100585386e-09
only O 0 4.412013809851345e-11
once O 0 1.3692523503916476e-10
in O 0 1.5191138277859118e-11
the O 0 1.687434358910167e-10
Cape O 0 1.880812661170239e-08
, O 0 1.4568743780807303e-11
but O 0 7.7721457741875e-12
its O 0 6.405275615462003e-12
associated O 0 4.534738806682981e-09
haplotype O 0 8.606427570612141e-08
could O 0 3.513705548741086e-09
be O 0 1.0509091374899526e-08
deduced O 0 3.903852302755695e-06
. O 0 5.069621238362743e-07

The O 0 4.552932608703486e-08
data O 0 5.007538206314166e-08
from O 0 3.7436437283489e-10
the O 0 4.155518429360683e-10
haplotypes O 0 7.626308473618337e-09
indicate O 0 8.278023266861112e-10
that O 0 1.2063493650196766e-12
these O 0 8.32475581524772e-12
three O 0 3.1096319963452856e-11
molecular O 0 6.499521276737141e-08
defects O 0 1.8857467694033403e-06
account O 0 3.110808277639876e-10
for O 0 1.0292753455098946e-10
the O 0 2.9685383040600755e-08
defects O 1 0.9967118501663208
in O 0 9.000873379960694e-10
all O 0 1.870575361273552e-10
the O 0 3.9260897310988696e-10
38 O 0 2.4716076296726897e-08
unrelated O 0 4.731294822590826e-08
C6Q0 O 0 0.0014239309821277857
individuals O 0 5.232248523334704e-10
we O 0 2.281910077561733e-10
have O 0 2.2161905990913944e-11
studied O 0 4.3311820796532174e-09
from O 0 4.3003686722720147e-10
the O 0 5.079654918915821e-09
Cape O 0 8.307449093081232e-07
. O 0 3.828239982794912e-07

We O 0 7.324464945668296e-08
have O 0 1.5963208532809858e-10
also O 0 1.0607874821599861e-11
observed O 0 6.573906696782927e-11
the O 0 6.483823894454233e-11
879delG O 0 1.4925585389846674e-07
defect O 0 4.7062695784916286e-07
in O 0 8.876043788852428e-10
two O 0 7.349763908592877e-09
Dutch O 1 0.9999994039535522
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 1 0.9918302893638611
, O 0 3.316355801086246e-10
but O 0 1.65589122275156e-11
the O 0 1.5438436640202724e-10
879delG O 0 2.8418210717973125e-07
defect O 0 1.2371295952107175e-06
in O 0 8.298511322557545e-10
the O 0 4.190206404075525e-09
Cape O 0 1.0176210452073065e-07
probably O 0 2.9184028527140526e-09
did O 0 7.733184925751146e-11
not O 0 1.6939378719160736e-11
come O 0 6.410207364915266e-10
from O 0 6.872573066196708e-10
The O 0 9.70781499631812e-09
Netherlands O 0 1.0394791161161265e-06
. O 0 4.2706446379270346e-08
. O 0 2.19859586536586e-07

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 8.436435550152055e-09
seven O 0 3.825923577949197e-09
further O 0 8.843395460367276e-10
molecular O 0 3.3746289318514755e-08
defects O 0 4.157521118486329e-07
and O 0 3.1812399936548275e-10
their O 0 1.7102073091024295e-09
associated O 0 4.782589712704066e-06
marker O 0 2.903203494497575e-06
haplotypes O 0 9.03500313143013e-06
. O 0 1.5397818060591817e-06

Seven O 0 1.3996107384173229e-07
further O 0 5.499607880210533e-09
molecular O 0 2.3938834914360996e-08
bases O 0 6.430554577718794e-08
of O 0 0.008085202425718307
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.154143317056878e-07
described O 0 4.0684770397092507e-07
. O 0 1.88639646125921e-07

All O 0 8.908918935901511e-09
these O 0 1.0899488256388423e-10
new O 0 2.6443456799252196e-11
molecular O 0 1.7226575721451809e-09
defects O 0 5.239841005533208e-09
involve O 0 2.251264730190883e-09
single O 0 1.2926797410273139e-08
- O 0 4.3092821755408295e-08
nucleotide O 0 3.9445886557132326e-08
events O 0 3.7732590385530784e-09
, O 0 1.5496881555776554e-10
deletions O 0 1.925314796480393e-09
and O 0 1.2131134985438052e-10
substitutions O 0 1.2473143407021325e-08
, O 0 8.352322999893858e-11
some O 0 1.8751398003780118e-11
of O 0 2.852896530125548e-10
which O 0 5.0474409374334783e-11
alter O 0 5.2291710517238243e-08
splice O 0 2.0543221523894317e-07
sites O 0 1.9600256973006935e-09
, O 0 1.4090842381797586e-10
and O 0 4.438451273180988e-10
others O 0 1.912578717622182e-08
codons O 0 1.6234682789217914e-06
. O 0 1.3408707673079334e-06

They O 0 3.896861500152227e-09
are O 0 2.551384277460489e-11
distributed O 0 4.460378941195664e-11
along O 0 1.2479414723820526e-10
the O 0 4.5649364843747264e-10
C7 O 0 5.4259708122117445e-05
gene O 0 2.7914599520784122e-09
, O 0 5.1710712101193934e-11
but O 0 4.3022863049912985e-11
predominantly O 0 3.6423108973338003e-10
towards O 0 2.7354694065451213e-09
the O 0 1.9339196910550527e-09
3 O 0 1.976959751459617e-08
end O 0 2.2424168832912983e-07
. O 0 2.8853622779934085e-07

All O 0 2.2650786135613998e-08
were O 0 5.310036410577368e-09
found O 0 2.071640498035876e-10
in O 0 3.528005665387468e-11
compound O 0 3.2850309139575984e-09
heterozygous O 0 5.5052962188995025e-09
individuals O 0 1.5826790988882067e-09
. O 0 1.782108256520587e-07

The O 0 0.0003010563086718321
C6 O 1 0.9999992847442627
/ O 1 0.995873749256134
C7 O 1 0.963523805141449
marker O 0 4.701312832366966e-07
haplotypes O 0 2.0270492484542046e-07
associated O 0 5.408072212276238e-08
with O 0 4.422904265055649e-09
most O 0 1.1713215997133375e-07
C7 B-Disease 1 1.0
defects I-Disease 1 0.985906720161438
are O 0 1.2103452684542049e-09
tabulated O 0 2.888856158733688e-07
. O 0 1.1403768596096597e-08
. O 0 5.8128584612404666e-08

A O 0 1.2117201322325855e-06
genome O 0 3.139285524866864e-07
- O 0 9.625090768849986e-08
wide O 0 9.408576140401692e-10
search O 0 3.385574487424492e-09
for O 0 2.727189862827828e-10
chromosomal O 0 6.171310815261677e-06
loci O 0 3.085847026795818e-07
linked O 0 3.128029675281141e-06
to O 0 1.7159621279461135e-08
mental O 1 0.9888057708740234
health O 0 5.164445724403777e-07
wellness O 0 2.504998803942726e-07
in O 0 7.554910863571962e-11
relatives O 0 2.073139659941603e-09
at O 0 2.18385656780562e-10
high O 0 7.622363851211844e-10
risk O 0 9.353947616475011e-10
for O 0 3.935223258366705e-09
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9980751276016235
disorder I-Disease 1 0.9929046034812927
among O 0 8.039791943303953e-09
the O 0 3.854673025216471e-09
Old O 0 9.398904694535304e-07
Order O 0 2.664921971984313e-08
Amish O 0 2.153852619812824e-06
. O 0 1.4351222432651412e-07

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.055705513805150986
BPAD B-Disease 1 1.0
; O 0 0.00011541551066329703
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 8.534868367604531e-10
is O 0 2.7605834285182596e-11
characterized O 0 1.0202744898935023e-10
by O 0 2.1322167989556995e-11
episodes O 0 1.1048063797147734e-08
of O 0 7.420885683728784e-09
mania B-Disease 0 8.204904844433258e-08
and O 0 2.410817767639628e-09
/ O 0 8.694283337717934e-07
or O 0 5.988893825303876e-09
hypomania B-Disease 0 8.665237692184746e-05
interspersed O 0 6.549660724886053e-08
with O 0 1.3088662098592607e-11
periods O 0 7.237158428097246e-08
of O 0 3.802383830020517e-08
depression B-Disease 0 1.1122594969492638e-06
. O 0 8.532337858468964e-08

Compelling O 0 1.6419428447989048e-06
evidence O 0 2.6022657806379357e-08
supports O 0 2.446952196422103e-09
a O 0 2.0553540813761373e-10
significant O 0 9.430224379158858e-10
genetic O 0 1.0775866421397495e-08
component O 0 1.1672509181437363e-08
in O 0 8.125498190958425e-11
the O 0 1.5445249523793336e-09
susceptibility O 0 5.225421872978586e-08
to O 0 1.925231529753546e-08
develop O 0 0.07994978874921799
BPAD B-Disease 1 1.0
. O 0 5.946481178398244e-05

To O 0 1.7889631109824222e-08
date O 0 1.3601881221347867e-07
, O 0 2.4636742645967047e-10
however O 0 3.729375974703686e-10
, O 0 2.4293804815056497e-11
linkage O 0 1.5747454895631563e-08
studies O 0 2.990083181053649e-10
have O 0 2.3951253307064047e-12
attempted O 0 2.730230708181125e-09
only O 0 1.4118228808257527e-10
to O 0 5.886636178509264e-10
identify O 0 2.942422270280076e-07
chromosomal O 0 0.00010700432176236063
loci O 0 1.8780100674575806e-07
that O 0 1.778648756056711e-10
cause O 0 6.078948011634111e-09
or O 0 1.2821491091052906e-10
increase O 0 1.5494074079303033e-10
the O 0 1.5951551191051294e-10
risk O 0 2.429225265387913e-09
of O 0 1.4400792558433295e-08
developing O 0 9.578292520018294e-05
BPAD B-Disease 1 1.0
. O 0 1.1998748959740624e-05

To O 0 2.6482968706886822e-08
determine O 0 7.071154328741613e-08
whether O 0 2.6430624355811005e-09
there O 0 3.0507676940239037e-10
could O 0 9.984987836553216e-11
be O 0 9.161324476814059e-11
protective O 0 2.4406781040653414e-09
alleles O 0 2.3125236447985031e-10
that O 0 1.4836744680057912e-11
prevent O 0 7.188619033371424e-09
or O 0 1.9563206610229145e-09
reduce O 0 2.1022323437591695e-08
the O 0 9.725212857247811e-10
risk O 0 6.5426539741508805e-09
of O 0 1.1365377972083479e-08
developing O 0 0.00023065776622388512
BPAD B-Disease 1 1.0
, O 0 7.308419841534075e-11
similar O 0 1.3055426531516368e-11
to O 0 1.1441878694506968e-11
what O 0 5.530694392047453e-12
is O 0 3.273766891256913e-12
observed O 0 1.0342463691026538e-10
in O 0 4.834608061110579e-11
other O 0 1.1374545749731624e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.1193175553092516e-10
we O 0 8.619179675539712e-11
used O 0 5.269889413739293e-09
mental O 0 0.006790976971387863
health O 0 3.3464200299704316e-08
wellness O 0 3.706099960254505e-08
( O 0 3.3346704304132446e-12
absence O 0 3.1413599499430234e-10
of O 0 1.2310051589192739e-10
any O 0 4.231849037861224e-10
psychiatric B-Disease 0 0.0633181631565094
disorder I-Disease 0 5.830282680108212e-05
) O 0 6.015665049430297e-11
as O 0 8.665664713580767e-11
the O 0 3.0083777136091783e-10
phenotype O 0 2.702599921633464e-09
in O 0 1.359371781806118e-10
our O 0 4.6900523464898924e-09
genome O 0 1.4637591583266385e-08
- O 0 2.4153294475581788e-08
wide O 0 3.851182484027049e-09
linkage O 0 6.357260673439669e-08
scan O 0 2.2144911682175916e-08
of O 0 2.2396495769072544e-09
several O 0 2.0845580817052678e-10
large O 0 3.0970850883882406e-10
multigeneration O 0 1.9379794480300916e-07
Old O 0 5.622347032385733e-08
Order O 0 1.7428972709510049e-09
Amish O 0 1.8652160349574842e-07
pedigrees O 0 3.695166483907997e-08
exhibiting O 0 6.851712974764723e-09
an O 0 1.2524624393162043e-10
extremely O 0 6.012094644347599e-08
high O 0 1.4570467499197548e-07
incidence O 0 3.341106321386178e-06
of O 0 1.944501491379924e-05
BPAD B-Disease 1 1.0
. O 0 2.5077668396988884e-05

We O 0 8.015068431177497e-08
have O 0 1.867046656167659e-10
found O 0 1.8503207299680469e-10
strong O 0 4.409884957201626e-11
evidence O 0 1.7437674915132817e-10
for O 0 1.6291216639596762e-11
a O 0 1.6604147223819865e-10
locus O 0 9.77121161760408e-10
on O 0 1.764047463659324e-09
chromosome O 0 2.2280188360923603e-08
4p O 0 9.223768756783102e-06
at O 0 1.9955535890403553e-08
D4S2949 O 0 2.126907787669552e-07
( O 0 1.414650480091595e-10
maximum O 0 2.46836648898352e-08
GENEHUNTER O 0 4.670596536016092e-05
- O 0 4.832365974039021e-08
PLUS O 0 3.9741919977132056e-08
nonparametric O 0 3.1120939070206077e-07
linkage O 0 6.392643570052314e-08
score O 0 3.026040973352906e-09
= O 0 3.536442527707351e-10
4 O 0 6.22493112611977e-10
. O 0 1.425824597278691e-10
05 O 0 3.850729157761634e-08
, O 0 3.658477965018392e-10
P O 0 5.295161997764808e-08
= O 0 3.0431718256451745e-10
5 O 0 1.4102080614364354e-10
. O 0 9.33837555894268e-12
22 O 0 2.5569234229916304e-11
x O 0 2.5378055212854633e-10
10 O 0 1.6602626218276129e-10
( O 0 6.289590376296061e-11
- O 0 3.1765181596199454e-09
4 O 0 3.65264929413911e-10
) O 0 2.8876031774038857e-11
; O 0 1.0974900849225477e-10
SIBPAL O 0 7.298812852241099e-05
Pempirical O 0 4.057939804624766e-06
value O 0 1.2167668650420183e-08
< O 0 4.508581064044392e-09
3 O 0 7.900899379187365e-11
x O 0 4.38880071174097e-10
10 O 0 5.547498571623066e-10
( O 0 5.624805482495887e-11
- O 0 2.512933638953996e-09
5 O 0 1.2628251222501774e-10
) O 0 5.357058113081292e-12
) O 0 4.044328674041031e-12
and O 0 3.814028953774695e-11
suggestive O 0 4.045376478245544e-09
evidence O 0 1.5069198111561377e-09
for O 0 1.388352766085177e-10
a O 0 7.077422536916345e-10
locus O 0 2.0046242443783058e-09
on O 0 4.799304953451156e-09
chromosome O 0 6.091706694633103e-08
4q O 0 1.651116292578081e-07
at O 0 3.4730295084273166e-08
D4S397 O 0 1.000701900011336e-06
( O 0 2.2606179428397155e-10
maximum O 0 3.629104483593437e-08
GENEHUNTER O 0 4.822775736101903e-05
- O 0 6.209615577290606e-08
PLUS O 0 6.595731605330002e-08
nonparametric O 0 4.557207375910366e-07
linkage O 0 8.627876724176531e-08
score O 0 1.843997621264748e-09
= O 0 4.2293393787140587e-10
3 O 0 2.648960772955178e-10
. O 0 4.697585723190123e-11
29 O 0 7.161681803147246e-10
, O 0 3.9149457981002556e-11
P O 0 9.7573984447763e-09
= O 0 1.17936563293064e-10
2 O 0 6.03058783466004e-11
. O 0 5.917136572386461e-12
57 O 0 9.840277204187231e-11
x O 0 2.5593155372760634e-10
10 O 0 2.743624494261354e-10
( O 0 3.244514726330472e-11
- O 0 1.229281343384514e-09
3 O 0 9.414836271703919e-11
) O 0 1.3595318447412463e-11
; O 0 2.5481065174526307e-11
SIBPAL O 0 2.4090086299111135e-05
Pempirical O 0 2.483375055817305e-06
value O 0 1.76974737087221e-08
< O 0 9.000671319370213e-09
1 O 0 1.192755755274888e-10
x O 0 6.749576453302097e-10
10 O 0 8.320446553966576e-10
( O 0 1.915672898089582e-10
- O 0 4.591379720864097e-09
3 O 0 7.354622466593241e-11
) O 0 5.6188192119888125e-12
) O 0 4.30555157499013e-12
that O 0 2.5989570738571555e-12
are O 0 2.4115556773729452e-11
linked O 0 2.259267262161302e-07
to O 0 5.402484148930853e-08
mental O 1 0.9999966621398926
health O 0 0.0007691115024499595
wellness O 0 0.00011648711370071396
. O 0 2.808594956604793e-07

These O 0 6.029030608090125e-09
findings O 0 1.582546205192159e-09
are O 0 1.1973046686042377e-11
consistent O 0 1.177518638151298e-09
with O 0 6.924909430605641e-12
the O 0 4.834939740239186e-11
hypothesis O 0 2.964088141599319e-10
that O 0 3.372329813403768e-13
certain O 0 1.3028313670948588e-11
alleles O 0 5.98817939678753e-11
could O 0 1.2013519345988044e-10
prevent O 0 1.2437034513368417e-08
or O 0 2.6075557268967486e-09
modify O 0 2.6388930152165813e-08
the O 0 1.0653731230547692e-09
clinical O 0 1.0134024108765516e-07
manifestations O 0 1.7247602102088422e-07
of O 0 5.732620138587663e-06
BPAD B-Disease 1 1.0
and O 0 1.522876047488353e-08
perhaps O 0 2.112094055206626e-09
other O 0 3.888172839250359e-10
related O 0 9.254536053049378e-06
affective B-Disease 0 0.22766217589378357
disorders I-Disease 1 0.9995494484901428
. O 0 1.5566622096230276e-05

Segregation O 0 0.0002810192236211151
distortion O 1 0.6854826211929321
in O 0 1.084765335690463e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.009374368004500866

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9066992402076721
DM B-Disease 1 1.0
) O 0 8.16135514725147e-09
is O 0 2.2225583873325405e-10
an O 0 2.2190173309954986e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 1.2039486074755246e-10
, O 0 2.2369234936592264e-11
in O 0 9.74252536284359e-12
the O 0 1.277747352368408e-10
typical O 0 7.221107978239161e-08
pedigree O 0 9.913286191931547e-09
, O 0 2.3669200280296288e-11
shows O 0 1.986664721620457e-10
a O 0 2.8796829504296184e-11
three O 0 1.334104354766552e-10
generation O 0 1.590227185488402e-07
anticipation O 0 2.5234155032194394e-07
cascade O 0 4.410691190059879e-07
. O 0 2.2495710538805724e-07

This O 0 1.0976518582950234e-09
results O 0 5.455591978176244e-09
in O 0 3.1255356081061336e-09
infertility B-Disease 1 0.9999858140945435
and O 0 6.314332858892158e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.416140887362417e-05
CDM B-Disease 1 0.8665217161178589
) O 0 1.9116458416235105e-11
with O 0 3.3557965434249937e-12
the O 0 2.1471384392679482e-10
disappearance O 0 3.3058884696401947e-07
of O 0 4.469191026146291e-07
DM B-Disease 1 1.0
in O 0 7.0517836014971635e-09
that O 0 7.582025007835114e-10
pedigree O 0 1.2140769456436828e-07
. O 0 9.228207176192882e-08

The O 0 3.1915674547633444e-09
concept O 0 5.224632282363473e-09
of O 0 4.477072046427111e-09
segregation O 0 9.258090472030744e-08
distortion O 0 3.0533067274518544e-07
, O 0 6.693519436634654e-12
where O 0 4.952446439054903e-12
there O 0 2.212641745172328e-12
is O 0 4.0661620121298925e-13
preferential O 0 8.303352450056423e-11
transmission O 0 8.585486988010871e-09
of O 0 1.8030575643646074e-10
the O 0 8.325268252562523e-11
larger O 0 2.997095072121425e-10
allele O 0 2.55318788333625e-09
at O 0 2.0230537245424784e-09
the O 0 1.7768805093965057e-08
DM B-Disease 1 1.0
locus O 0 1.87340525314994e-08
, O 0 9.765022124241796e-11
has O 0 3.8234376602275244e-12
been O 0 2.861974546242152e-11
put O 0 2.0087416452430062e-10
forward O 0 8.028356313083407e-10
to O 0 1.2609796540274942e-09
explain O 0 7.722142214561245e-08
partially O 0 4.7597886521089094e-08
the O 0 3.6698979966054424e-10
maintenance O 0 8.170894034265075e-06
of O 0 7.245292863444774e-07
DM B-Disease 1 1.0
in O 0 8.289909203540446e-09
the O 0 4.632583205932406e-09
population O 0 1.167334895413319e-09
. O 0 1.1865079585504645e-08

In O 0 2.919189334704697e-08
a O 0 3.2059048749033536e-09
survey O 0 1.0112471748868757e-08
of O 0 1.3585282232497775e-08
DM B-Disease 1 1.0
in O 0 1.2270400695513217e-08
Northern O 0 2.2216204342839774e-07
Ireland O 0 2.2831994783700793e-07
, O 0 1.2661806048086532e-09
59 O 0 1.1335798433265154e-07
pedigrees O 0 5.015950819142745e-07
were O 0 1.1112908282484568e-07
ascertained O 0 2.6250005248584785e-05
. O 0 5.691637738891586e-07

Sibships O 0 0.00033514879760332406
where O 0 1.7330586965513817e-09
the O 0 5.501574543154142e-11
status O 0 3.306011020498545e-10
of O 0 3.7885170001139556e-10
all O 0 2.0304119496827866e-11
the O 0 2.698203813156219e-11
members O 0 1.7018785686273574e-11
had O 0 2.5655358046328125e-11
been O 0 1.4380596539964596e-11
identified O 0 2.0558678370807826e-10
were O 0 1.1334452820754848e-10
examined O 0 1.0189505905700003e-09
to O 0 6.144135113878013e-12
determine O 0 8.717258026536001e-10
the O 0 2.0151925961275907e-10
transmission O 0 7.422299404424848e-06
of O 0 1.1446918080082469e-08
the O 0 2.7328526996939217e-08
DM B-Disease 1 1.0
expansion O 0 1.5660283736451674e-07
from O 0 6.846849753827655e-10
affected O 0 4.6047166080143143e-10
parents O 0 3.265530554297236e-11
to O 0 3.191284042580733e-11
their O 0 9.018573110530781e-10
offspring O 0 2.9687512892451196e-07
. O 0 2.2468437066436309e-07

Where O 0 9.157140823390364e-09
the O 0 1.5447135792712174e-09
transmitting O 0 1.255735696759075e-06
parent O 0 4.2444860959278685e-09
was O 0 3.673592274822113e-08
male O 0 3.1299876468438015e-08
, O 0 1.5579784129471363e-09
58 O 0 8.453535542685131e-07
. O 0 4.1495673031022307e-07

3 O 0 1.5732480562746787e-07
% O 0 2.2171622759969978e-08
of O 0 2.7087446174967056e-10
the O 0 2.147015482067971e-10
offspring O 0 8.135462969960372e-09
were O 0 2.0041310833107673e-09
affected O 0 1.1195167015642937e-09
, O 0 1.3768936511782126e-11
and O 0 1.4158996024249415e-11
in O 0 1.7246383141045207e-11
the O 0 3.9990812744639115e-11
case O 0 2.352773358083038e-11
of O 0 2.456411185569607e-10
a O 0 2.893504047474238e-10
female O 0 1.0898210334175928e-08
transmitting O 0 2.1599907995550893e-06
parent O 0 6.781505135222687e-09
, O 0 3.0895170866074295e-09
68 O 0 3.551734380380367e-06
. O 0 1.210464574796788e-06

7 O 0 1.9270814846095163e-06
% O 0 1.759271128776163e-07
were O 0 6.764917070967158e-09
affected O 0 4.1597573385843134e-08
. O 0 9.944518097881883e-08

Studies O 0 1.3630969419864414e-07
on O 0 4.809376008552135e-09
meiotic O 0 2.974489234475186e-06
drive O 0 4.097900045962888e-07
in O 0 1.154898132682547e-08
DM B-Disease 1 1.0
have O 0 1.138176705661742e-10
shown O 0 1.437325397590783e-10
increased O 0 9.008528645271241e-11
transmission O 0 8.833011544417957e-10
of O 0 2.126619887132808e-11
the O 0 1.9465965298004484e-11
larger O 0 5.350208817644919e-11
allele O 0 7.794733747346072e-10
at O 0 2.734306114859919e-09
the O 0 1.2411252470201362e-08
DM B-Disease 1 0.9999908208847046
locus O 0 3.086520550255045e-08
in O 0 5.482013953894693e-09
non O 0 1.2145755135861691e-05
- O 0 0.0014886826975271106
DM O 1 1.0
heterozygotes O 0 3.944772743125213e-06
for O 0 3.588918318087053e-08
CTGn O 0 0.0008778056944720447
. O 0 6.931330744919251e-07

This O 0 3.347037758061333e-09
study O 0 1.0385798887568853e-09
provides O 0 2.4418118568791947e-11
further O 0 1.173694388206803e-11
evidence O 0 1.4943939141698337e-10
that O 0 2.5507308938632622e-12
the O 0 3.393008540797382e-09
DM B-Disease 1 1.0
expansion O 0 1.1466341902632848e-06
tends O 0 2.8808411656200406e-08
to O 0 4.771673611791982e-10
be O 0 1.8310090110773558e-09
transmitted O 0 1.8192406514572212e-07
preferentially O 0 1.2980936503481644e-07
. O 0 1.3429985301627312e-07

Diagnosis O 1 0.9999982118606567
of O 1 0.9949631690979004
hemochromatosis B-Disease 1 1.0
. O 0 0.03663754090666771

If O 0 7.825358625268564e-05
untreated O 1 1.0
, O 0 4.024118425149936e-06
hemochromatosis B-Disease 1 1.0
can O 0 1.6238027455983683e-06
cause O 0 0.0002466894220560789
serious O 0 0.11489762365818024
illness O 1 0.9987819790840149
and O 0 2.5814950177505125e-10
early B-Disease 0 1.3278530275329103e-08
death I-Disease 0 3.101336742972194e-09
, O 0 1.221690370395434e-11
but O 0 5.683848357251886e-12
the O 0 1.217733830438661e-10
disease O 0 1.58064050737039e-08
is O 0 1.2304834234866391e-11
still O 0 7.680487495997923e-11
substantially O 0 7.519740385930618e-09
under O 0 1.5224060234686476e-07
- O 0 6.678320005448768e-06
diagnosed O 0 0.00038946743006817997
. O 0 1.0824068112924579e-06

The O 0 1.332105057372246e-07
cornerstone O 0 3.87549698643852e-06
of O 0 1.9858864774846552e-08
screening O 0 1.5560548405346708e-08
and O 0 7.925199385638848e-11
case O 0 3.960323388674247e-11
detection O 0 4.1457532518052176e-08
is O 0 1.1848552521065425e-11
the O 0 1.239288394128124e-10
measurement O 0 1.304723724615542e-07
of O 0 1.239067426439533e-08
serum O 0 2.3058225551153555e-08
transferrin O 0 5.8537469982411494e-08
saturation O 0 4.8597531332461585e-08
and O 0 4.5354633937400024e-10
the O 0 3.1201512484813065e-09
serum O 0 8.100148107814675e-08
ferritin O 0 9.988769988922286e-07
level O 0 1.022983951770584e-06
. O 0 1.9381567994969373e-07

Once O 0 1.8192336881384108e-07
the O 0 1.4434692330311805e-09
diagnosis O 0 2.7242247142567066e-06
is O 0 7.840895294153327e-11
suspected O 0 7.14830079573403e-08
, O 0 3.928449232581954e-10
physicians O 0 1.1346793726829674e-08
must O 0 4.256695440574276e-09
use O 0 1.8111972366341433e-08
serum O 0 1.9819187855318887e-06
ferritin O 0 0.00010680920968297869
levels O 0 1.1777497093135025e-05
and O 0 1.5733643721205226e-08
hepatic O 0 0.0001312574022449553
iron O 0 9.48693298141734e-07
stores O 0 2.9559032999060264e-09
on O 0 2.1595432109222656e-09
liver O 0 7.875168961390955e-08
biopsy O 0 2.8971416554668394e-07
specimens O 0 3.345850485558799e-09
to O 0 1.1371524555325863e-10
assess O 0 2.276235022691253e-08
patients O 0 1.5996042268540123e-09
for O 0 1.1703731039869325e-10
the O 0 2.655817343821809e-09
presence O 0 1.4827375771631068e-08
of O 0 1.007164541988459e-06
iron B-Disease 0 0.29662609100341797
overload I-Disease 0 0.17744357883930206
. O 0 2.704452754187514e-06

Liver O 1 0.999421238899231
biopsy O 1 0.9999001026153564
is O 0 3.3395639587041615e-09
also O 0 3.7387183626780285e-11
used O 0 1.485008782609043e-10
to O 0 1.832737572815546e-10
establish O 0 1.0841817221773908e-08
the O 0 6.822107878612371e-10
presence O 0 4.490051108696491e-10
or O 0 2.9421884373270757e-10
absence O 0 3.9098213164834306e-06
of O 0 7.722665031906217e-06
cirrhosis B-Disease 1 1.0
, O 0 7.261182211060202e-10
which O 0 1.2266357200807487e-11
can O 0 1.443928449029741e-10
affect O 0 4.363331385093261e-08
prognosis O 0 0.00032751468825154006
and O 0 1.5815784237815933e-08
management O 0 4.3869072214874905e-06
. O 0 8.160220659192419e-07

A O 0 1.4380870538843737e-07
DNA O 0 2.596322019599029e-07
- O 0 1.836037877289698e-09
based O 0 5.1452917447514235e-12
test O 0 1.9118354468994347e-11
for O 0 9.042229638656085e-12
the O 0 5.102238076482024e-10
HFE O 0 2.523932562326081e-05
gene O 0 2.620917649576171e-10
is O 0 2.3229367648175403e-12
commercially O 0 8.438973964075558e-10
available O 0 2.0924852128789695e-10
, O 0 5.4162781031041884e-12
but O 0 1.4633541774167202e-12
its O 0 2.119300964104412e-13
place O 0 2.1848635747834244e-11
in O 0 1.5262787561587388e-11
the O 0 1.81525225406709e-10
diagnosis O 0 2.0567484170896932e-05
of O 0 6.66015353090188e-07
hemochromatosis B-Disease 1 1.0
is O 0 3.6410419124166538e-09
still O 0 2.8877604751897934e-09
being O 0 3.678449544963769e-09
evaluated O 0 3.1386028354063455e-07
. O 0 1.9853833066463267e-07

Currently O 0 1.6201354924305633e-07
, O 0 4.505510131647128e-10
the O 0 1.8442251892292205e-10
most O 0 2.7542981784201004e-11
useful O 0 1.2261036630434319e-09
role O 0 2.6694774168944946e-10
for O 0 1.2429877439823489e-11
this O 0 7.819042288637057e-12
test O 0 6.892759973897711e-11
is O 0 3.017477327033058e-12
in O 0 5.01465839339299e-12
the O 0 3.087163510939739e-11
detection O 0 1.0468597793078516e-06
of O 0 3.984112311172794e-07
hemochromatosis B-Disease 1 1.0
in O 0 3.621289268451733e-09
the O 0 1.2088849921099154e-09
family O 0 2.1638135727641838e-10
members O 0 2.9157516678868234e-11
of O 0 3.447267471479165e-10
patients O 0 1.6049770401593833e-09
with O 0 4.570126568848032e-11
a O 0 1.0514198400812802e-09
proven O 0 3.173500090269954e-06
case O 0 8.437107679171163e-10
of O 0 5.227842159172269e-09
the O 0 1.6453217455136837e-08
disease O 0 8.14800205262145e-06
. O 0 2.443586879508075e-07

It O 0 3.2153602003148762e-09
is O 0 2.2322332871027584e-09
crucial O 0 1.5583142385366955e-06
to O 0 1.1094826959379134e-06
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 8.227036232710816e-06
because O 0 9.529005140507252e-09
phlebotomy O 1 0.9972947239875793
therapy O 0 0.1388241946697235
can O 0 5.897494936846215e-09
avert O 0 3.983333044743631e-06
serious O 1 0.999982476234436
chronic O 1 1.0
disease O 1 0.9999949932098389
and O 0 2.0356449859093573e-09
can O 0 1.7992167478109167e-10
even O 0 8.895546799170262e-11
lead O 0 3.002381676608934e-10
to O 0 7.95898069672063e-11
normal O 0 2.028998693504036e-07
life O 0 6.632730364941608e-09
expectancy O 0 4.243828470862354e-07
. O 0 9.147639867812529e-10
. O 0 1.3395648146286021e-08

Prevalence O 0 2.0181456420687027e-05
of O 0 5.3571096003679486e-08
the O 0 4.869114889061166e-08
I1307K O 0 9.732121543493122e-05
APC B-Disease 0 4.730744649350527e-07
gene O 0 4.533698971798117e-10
variant O 0 3.797857306420127e-10
in O 0 4.656017238424681e-11
Israeli O 0 6.301041821643594e-08
Jews O 0 2.0685380075491366e-09
of O 0 4.814237342110061e-10
differing O 0 1.6514603573547504e-10
ethnic O 0 7.165531362707256e-11
origin O 0 6.714343525615618e-10
and O 0 2.8463956192048556e-10
risk O 0 2.1129093852323422e-07
for O 0 3.270146862632828e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9557730555534363

BACKGROUND O 0 0.0005581420264206827
& O 0 1.7806416963139782e-06
AIMS O 0 9.357329133763415e-08
Israeli O 0 2.2253566100971511e-07
Jews O 0 1.3716481284120619e-08
of O 0 2.3400610338342176e-09
European O 0 7.108379662668085e-09
birth O 0 4.685280075023002e-08
, O 0 2.2927994225430126e-10
i O 0 1.595600318538004e-09
. O 0 4.385485030677927e-11
e O 0 7.238666610565048e-11
. O 0 3.713942001160042e-11
, O 0 7.981905414400359e-11
Ashkenazim O 0 1.0197617257290403e-06
, O 0 6.850399414393138e-11
have O 0 1.511679670329613e-11
the O 0 1.8622001718426873e-09
highest O 1 0.9751216769218445
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.0010100097861140966
of O 0 1.047738873438675e-08
any O 0 2.7357652254700326e-10
Israeli O 0 3.372859964656527e-07
ethnic O 0 3.551709681914872e-08
group O 0 4.702861655658808e-09
. O 0 1.0654817828026353e-07

The O 0 2.827719924880512e-07
I1307K O 0 1.6214835341088474e-05
APC B-Disease 0 2.1049289955499262e-07
gene O 0 9.446696758175221e-10
variant O 0 5.817902160032418e-09
was O 0 4.320828850268299e-08
found O 0 9.884507656821029e-10
in O 0 2.2621717832294053e-09
6 O 0 2.1916622472417657e-07
. O 0 2.1739597855230386e-07

1 O 0 1.7964586618290923e-07
% O 0 4.0052171357274347e-08
of O 0 1.2486420786217423e-09
American O 0 2.886888783582009e-10
Jews O 0 9.04298025350414e-10
, O 0 1.1795157732474859e-11
28 O 0 6.774856786684325e-10
% O 0 4.942166120791569e-10
of O 0 2.2055862691772177e-10
their O 0 1.570081842316995e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.0009564980864524841
, O 0 1.8197102158445944e-10
but O 0 9.234546287373302e-12
not O 0 5.1467051107034756e-12
in O 0 1.8588384997908491e-10
non O 0 4.5470747522813326e-07
- O 0 1.4937049286345427e-07
Jews O 0 1.4147495619454276e-07
. O 0 3.536493977662758e-07

We O 0 1.962267930366579e-07
assessed O 0 4.972461624674906e-07
the O 0 1.422940787421112e-08
I1307K O 0 1.736001286190003e-05
prevalence O 0 2.3027899587191314e-08
in O 0 1.0606257191958512e-11
Israeli O 0 6.636172500407156e-09
Jews O 0 1.6403637337347732e-09
of O 0 3.5044470103606784e-10
differing O 0 2.965626078044181e-10
ethnic O 0 1.511899633266367e-10
origin O 0 1.1752098183492876e-09
and O 0 4.579290835415861e-10
risk O 0 2.537784951073263e-07
for O 0 3.6402286696102237e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9863907098770142

METHODS O 0 4.190290837868815e-06
DNA O 0 2.1396719773747463e-07
samples O 0 2.6666240326989055e-09
from O 0 5.693497062697617e-11
500 O 0 9.69289301600007e-11
unrelated O 0 1.781787162258297e-09
Jews O 0 1.3671367371514975e-09
of O 0 7.2173738097092155e-09
European O 0 4.835058220464816e-08
or O 0 2.1713557618596724e-09
non O 0 7.660147502974723e-07
- O 0 9.770471542935866e-09
European O 0 1.0268972339133597e-09
origin O 0 6.682950859371317e-10
, O 0 3.349689232587383e-12
with O 0 6.769834259151564e-13
or O 0 3.909616120428838e-12
without O 0 8.67982422048108e-11
a O 0 9.132781336740337e-11
personal O 0 3.065539999624889e-08
and O 0 2.6299475930358085e-09
/ O 0 0.1185169517993927
or O 0 5.769280608802774e-09
family O 0 5.620111043214138e-10
history O 0 2.071921967328194e-09
of O 0 1.0437770647797606e-09
neoplasia B-Disease 0 2.0764377950399648e-07
, O 0 2.441784101303579e-11
were O 0 9.938417450117143e-11
examined O 0 7.279986058428278e-10
for O 0 1.6321976756272782e-11
the O 0 2.610983373951825e-10
I1307K O 0 4.0974459381004635e-08
variant O 0 2.035547008727434e-10
by O 0 1.907620936214549e-11
the O 0 6.47437034539955e-11
allele O 0 9.040238557744829e-10
- O 0 6.257978579782275e-10
specific O 0 4.291805799638837e-10
oligonucleotide O 0 6.889389965181181e-07
( O 0 9.656512922617821e-09
ASO O 1 0.9991030693054199
) O 0 2.305891921849934e-09
method O 0 7.386107654383522e-07
. O 0 2.406900421192404e-07

RESULTS O 0 1.3205054756326717e-06
In O 0 2.8789610695412193e-09
persons O 0 4.371325967866824e-09
at O 0 1.1081487949482494e-09
average O 0 1.2944481042609368e-09
risk O 0 1.8613158792035733e-09
for O 0 2.6231406380361477e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 8.503403137183341e-08
I1307K O 0 0.00015864391752984375
was O 0 1.47191734356511e-08
found O 0 1.6524466517342518e-10
in O 0 1.588324194390367e-10
5 O 0 1.3662535991443292e-08
. O 0 4.141185527828384e-08

0 O 0 3.322151798101913e-08
% O 0 1.3188998337909652e-08
of O 0 7.482351960241829e-10
120 O 0 9.353560592728627e-09
European O 0 3.0421013264003705e-08
and O 0 8.482064828285729e-09
1 O 0 4.898634529126866e-07
. O 0 2.9069721563246276e-07

6 O 0 1.8166296911203972e-07
% O 0 1.1192269333548666e-08
of O 0 8.885123192747812e-10
188 O 0 2.2443105152092357e-09
non O 0 1.6883946329926403e-07
- O 0 7.483943420538708e-08
European O 0 9.370884868076246e-08
Jews O 0 6.970307708797918e-07
( O 0 2.5801327740992974e-09
P O 0 1.5606968872816651e-06
= O 0 1.9607100387730725e-09
0 O 0 1.0391679877708171e-10
. O 0 8.992528249818221e-11
08 O 0 4.488392324475399e-09
) O 0 7.031418780556464e-10
. O 0 2.461746362314443e-08

It O 0 6.039077682373772e-09
occurred O 0 1.9071443091434048e-07
in O 0 3.47936635058943e-09
15 O 0 9.207724360749125e-08
. O 0 1.1813845190999928e-07

4 O 0 1.910002112026632e-07
% O 0 1.0571171493722886e-08
of O 0 6.702123855895081e-10
52 O 0 4.334132164274251e-09
Ashkenazi O 0 3.642947490334336e-07
Israelis O 0 2.1021096472395584e-06
with O 0 9.849412840878813e-09
familial O 1 0.6540887951850891
cancer B-Disease 1 0.9999921321868896
( O 0 9.812757895133473e-08
P O 0 0.028511127457022667
= O 0 4.471857550925051e-09
0 O 0 1.3380389851658236e-10
. O 0 2.359784243011198e-11
02 O 0 4.979075485245232e-10
) O 0 5.989874937196993e-13
and O 0 1.6537503788258134e-12
was O 0 1.1087528811737357e-10
not O 0 1.1028572152738114e-11
detected O 0 8.801932516178113e-10
in O 0 4.632207464827509e-11
51 O 0 1.4358144895254554e-08
non O 0 4.785350142810785e-07
- O 0 8.903385406711095e-08
European O 0 2.346954808274404e-08
Jews O 0 7.632394982692858e-08
at O 0 5.042588924197844e-08
increased O 0 9.628121233618003e-08
cancer B-Disease 0 4.2047551573887176e-07
risk O 0 1.5779814077632182e-07
. O 0 3.8168079186107207e-07

Colorectal B-Disease 1 0.9974411725997925
neoplasia I-Disease 1 0.9951274394989014
occurred O 0 0.20125539600849152
personally O 0 7.2996226663235575e-06
or O 0 1.6185031093129965e-09
in O 0 2.0333042194398132e-10
the O 0 2.8212943092853493e-10
families O 0 9.507318543544585e-11
of O 0 1.1249062792373365e-09
13 O 0 3.5438381118524376e-09
of O 0 3.3519889086619514e-09
20 O 0 1.402826743657215e-08
Ashkenazi O 0 1.5329496818594635e-06
I1307K O 0 1.1166722515554284e-06
carriers O 0 2.980733715407524e-10
, O 0 5.322351240288903e-11
8 O 0 7.519463940397486e-10
of O 0 8.818449859226973e-10
whom O 0 1.5465154490357236e-08
also O 0 1.5899459526735882e-10
had O 0 1.1328536997368133e-09
a O 0 7.026257353714982e-10
personal O 0 4.6371914663723146e-07
or O 0 1.0090237978488403e-08
family O 0 4.103278161693424e-09
history O 0 1.7396871498931432e-07
of O 0 7.46660475670069e-07
noncolonic O 0 0.0034499606117606163
neoplasia B-Disease 0 0.3813099265098572
. O 0 6.972303253860446e-06

CONCLUSIONS O 0 1.0342203495383728e-05
The O 0 1.7837304255863273e-07
I1307K O 0 3.073119296459481e-05
APC O 0 5.84363988309633e-07
variant O 0 4.22267767419271e-08
may O 0 7.765633691647622e-10
represent O 0 3.828390937599124e-09
a O 0 5.245980982948595e-09
susceptibility O 0 2.0566352532114252e-07
gene O 0 2.6054642887629598e-08
for O 0 7.31785974039667e-08
colorectal B-Disease 1 1.0
, I-Disease 0 2.203983740400872e-06
or I-Disease 0 6.411644193349275e-08
other I-Disease 0 3.275285109793913e-08
, I-Disease 0 8.218277613991631e-09
cancers I-Disease 1 0.9994508624076843
in O 0 3.199108391527261e-07
Ashkenazi O 1 0.9970190525054932
Jews O 0 1.4891138562234119e-06
, O 0 8.196857637088328e-10
and O 0 7.218127207053726e-10
partially O 0 1.8043947136447969e-07
explains O 0 3.0189730715335372e-09
the O 0 4.176463896943261e-10
higher O 0 3.6863109897922186e-08
incidence O 0 1.53830092131102e-06
of O 0 9.245414730685297e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.309494603508938e-08
European O 0 1.694099438509511e-07
Israelis O 0 3.3979565614572493e-06
. O 0 2.2022177859071235e-07

Systematic O 0 3.6879359299746284e-07
analysis O 0 2.8937936491502114e-08
of O 0 1.7363516846558014e-08
coproporphyrinogen O 0 4.998472377337748e-06
oxidase O 0 4.5695060180150904e-08
gene O 0 5.121177792943854e-08
defects O 0 4.928897851641523e-06
in O 0 7.338907259679672e-09
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999991655349731
and O 0 3.0056972377678903e-07
mutation O 0 5.273150236462243e-07
update O 0 1.9946839984186227e-06
. O 0 7.118775329217897e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999992847442627
( O 0 1.644723255367353e-07
HC B-Disease 1 1.0
) O 0 1.594013951944362e-07
is O 0 9.742651130295599e-09
an O 0 1.335714738814886e-08
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 9.754373604664579e-05
autosomal O 1 1.0
dominant O 1 0.9999983310699463
inheritance O 0 4.4476124458014965e-05
caused O 0 1.688244708475395e-07
by O 0 5.607112552041826e-10
deficient B-Disease 0 8.704208198651031e-08
activity I-Disease 0 3.5688272337353055e-09
of I-Disease 0 1.0150540852293943e-08
coproporphyrinogen I-Disease 0 1.40783856750204e-06
III I-Disease 0 0.0002085501328110695
oxidase I-Disease 0 2.1250054160759646e-08
( O 0 5.261192370653589e-09
CPO O 0 3.0758121738472255e-06
) O 0 3.778286128408581e-09
. O 0 1.6917583423037286e-07

Clinical O 0 0.0003136047744192183
manifestations O 0 0.0003577873285394162
of O 0 2.93186167255044e-06
the O 0 2.1759095147899643e-07
disease O 0 3.366022792761214e-05
are O 0 9.378896097256284e-12
characterized O 0 8.633461306972734e-11
by O 0 1.6187485379903777e-11
acute O 0 1.5055097719596233e-05
attacks O 0 1.443249786348133e-08
of O 0 0.3125689625740051
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 3.7767935623378435e-07
precipitated O 0 1.643920342075944e-07
by O 0 5.276925077457584e-11
drugs O 0 3.5535899223226863e-10
, O 0 1.6209760964058795e-11
fasting O 0 7.645826194391248e-09
, O 0 1.1684399003897283e-09
cyclical O 0 9.99113240141014e-07
hormonal O 0 1.5764125009809504e-06
changes O 0 1.242636482601256e-08
, O 0 5.579813944223133e-09
or O 0 1.468762889089703e-07
infectious B-Disease 0 0.04198254272341728
diseases I-Disease 1 0.7674545049667358
. O 0 7.648069185961504e-06

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 5.577741148954374e-07
also O 0 8.637434656399989e-10
be O 0 1.3207848148510948e-09
present O 0 5.5121702757787716e-08
. O 0 2.2458111459400243e-07

The O 0 1.4152786320664745e-07
seven O 0 1.0070937150885584e-07
exons O 0 7.597216153953923e-07
, O 0 3.439084295120409e-10
the O 0 2.108776930853651e-09
exon O 0 9.080373075676107e-08
/ O 0 3.448658603133481e-08
intron O 0 1.0754926194067593e-07
boundaries O 0 8.646912630361214e-10
and O 0 1.6683543435647152e-10
part O 0 1.1481043893368792e-09
of O 0 1.3117548824936875e-08
3 O 0 4.900351679992809e-09
noncoding O 0 4.106874129661264e-08
sequence O 0 2.3949495164821144e-10
of O 0 7.649001432241676e-10
the O 0 7.516194333589965e-10
CPO O 0 5.86977968453084e-08
gene O 0 7.716506600363715e-11
were O 0 1.9534450446112572e-10
systematically O 0 3.274550908205498e-10
analyzed O 0 2.7786778433736004e-10
by O 0 9.075334234109889e-12
an O 0 1.2395713795687602e-11
exon O 0 2.437059221094273e-09
- O 0 1.0761831426009394e-09
by O 0 1.2437645358076566e-09
- O 0 2.8758898906744434e-07
exon O 0 1.6160122129349475e-07
denaturing O 0 3.911905878339894e-06
gradient O 0 5.124514359522436e-07
gel O 0 9.481904044150724e-07
electrophoresis O 0 1.433691522834124e-06
( O 0 8.172040821818882e-09
DGGE O 0 0.04041239991784096
) O 0 6.542684449772906e-11
strategy O 0 6.162015342425775e-10
followed O 0 2.0668244893329302e-11
by O 0 1.2502510962283941e-12
direct O 0 2.1622734852622116e-11
sequencing O 0 2.414010991103055e-09
in O 0 8.027924158771071e-11
seven O 0 3.5885724947171127e-10
unrelated O 0 2.170971669102073e-08
heterozygous O 0 2.0789851618019384e-08
HC B-Disease 1 0.9999932050704956
patients O 0 0.007740073837339878
from O 0 7.205375140983961e-07
France O 0 1.6203747463805485e-06
, O 0 1.0578750098133582e-09
Holland O 0 1.4637731027278278e-08
, O 0 9.770387277008297e-11
and O 0 1.797103993395055e-10
Czech O 0 9.626047358324286e-06
Republic O 0 6.703059625579044e-05
. O 0 6.886743449285859e-06

Seven O 0 5.50771446228282e-08
novel O 0 5.383182233309469e-10
mutations O 0 5.36240940540722e-10
and O 0 7.783141492412327e-11
two O 0 3.975081028229077e-11
new O 0 3.9848884608728596e-11
polymorphisms O 0 3.536351655952785e-08
were O 0 2.7686077430644218e-08
detected O 0 7.805436439412006e-07
. O 0 1.7479959524280275e-07

Among O 0 6.176847477945557e-08
these O 0 5.387732482375895e-10
mutations O 0 4.220362670448452e-10
two O 0 4.032122552510842e-11
are O 0 1.1175768643845174e-10
missense O 0 2.8787766837012896e-07
( O 0 9.641049070197028e-10
G197W O 0 1.1739372894226108e-05
, O 0 1.008688577108785e-09
W427R O 0 1.614871962374309e-06
) O 0 3.945575810515578e-11
, O 0 1.2574934149522932e-11
two O 0 1.373046468189365e-11
are O 0 7.935545276449574e-11
nonsense O 0 3.097605656421365e-07
( O 0 6.751031400575869e-10
Q306X O 0 4.1663784031698015e-06
, O 0 4.292125266314173e-10
Q385X O 0 8.56818076044874e-07
) O 0 2.2812472397215622e-11
, O 0 9.894078611960566e-12
two O 0 1.0110122808382194e-11
are O 0 9.784444088278832e-12
small O 0 1.8036354354489248e-10
deletions O 0 1.3272294374644389e-09
( O 0 3.3212743666410915e-10
662de14bp O 0 2.0949528334313072e-06
; O 0 1.7404680474619738e-10
1168del3bp O 0 2.2620571371589904e-07
removing O 0 1.4951536897456208e-08
a O 0 2.1946557904328756e-09
glycine O 0 2.079187311210262e-08
at O 0 1.1903501295762453e-08
position O 0 1.1239483121983085e-08
390 O 0 3.5833283007491445e-09
) O 0 1.8189458619866095e-11
, O 0 2.8524853919881243e-12
and O 0 3.900067768736193e-12
one O 0 4.3505910679586535e-12
is O 0 2.847565716210254e-12
a O 0 1.151549272604413e-10
splicing O 0 2.0616264251316352e-08
mutation O 0 1.4427727901278331e-09
( O 0 1.4179921126178385e-10
IVS1 O 0 2.323907938261982e-05
- O 0 1.8380190169864363e-07
15c O 0 3.7307640923245344e-06
- O 0 1.6678204701747745e-06
- O 0 3.0601862022194837e-07
> O 0 3.081438038066153e-08
g O 0 1.7704148147501542e-09
) O 0 1.3325751960224785e-11
which O 0 1.4839879542219436e-12
creates O 0 2.171614450763304e-11
a O 0 2.2600477045386924e-11
new O 0 6.0770291576695e-11
acceptor O 0 8.8883858495592e-08
splice O 0 5.623179276881274e-06
site O 0 2.7866053642355837e-07
. O 0 6.210278797880164e-07

The O 0 4.907313382318534e-07
pathological O 0 6.74524562782608e-06
significance O 0 1.2606056998265558e-07
of O 0 2.3377333846497095e-08
the O 0 6.774459215819206e-09
point O 0 2.934093501494317e-08
mutations O 0 4.934331609973697e-09
G197W O 0 6.008169179949618e-07
, O 0 4.940206022041593e-10
W427R O 0 1.2594007330335444e-06
, O 0 8.52084305891232e-11
and O 0 3.049184169046093e-11
the O 0 2.056816938988959e-10
in O 0 1.1261880317192663e-09
- O 0 8.50649684025484e-09
frame O 0 4.857871971353234e-08
deletion O 0 3.8591903006590655e-09
390delGly O 0 1.1273835198721827e-08
were O 0 1.3515744079484193e-10
assessed O 0 2.42015990581379e-10
by O 0 1.913406932896322e-12
their O 0 1.3321380457065324e-11
respective O 0 4.707492617939124e-09
expression O 0 3.33952421271988e-10
in O 0 8.964660611066044e-12
a O 0 9.057177750848577e-12
prokaryotic O 0 2.998341575022323e-10
system O 0 1.079723643826469e-09
using O 0 5.484070975114719e-10
site O 0 1.5507918282864352e-09
- O 0 2.8561428777607034e-09
directed O 0 1.28041466318507e-09
mutagenesis O 0 1.8715446685746429e-06
. O 0 3.025298553893663e-07

These O 0 3.0084135183017224e-09
mutations O 0 1.7617308722961411e-09
resulted O 0 1.3741430215929995e-09
in O 0 4.34494593082313e-11
the O 0 1.2560558149132817e-10
absence O 0 3.6430304106715994e-08
or O 0 3.013558014242079e-10
a O 0 2.8421318076787827e-10
dramatic O 0 7.910996302484818e-09
decrease O 0 1.0529620197985423e-07
of O 0 6.364551552451303e-08
CPO O 0 3.938138434023131e-06
activity O 0 2.3809995752799296e-07
. O 0 1.2520247594238754e-07

The O 0 1.1656890563926936e-08
two O 0 5.403694713912444e-10
polymorphisms O 0 2.5483617438482042e-09
were O 0 2.6887420068177903e-10
localized O 0 2.825086609092864e-09
in O 0 1.3090341310917353e-10
noncoding O 0 1.068997264042082e-07
part O 0 1.0285124973918869e-09
of O 0 2.268416388062633e-08
the O 0 2.953277178363578e-09
gene O 0 1.1169418168144318e-10
1 O 0 4.38847430617173e-10
) O 0 1.04325055538812e-11
a O 0 2.687521594157971e-10
C O 0 5.1579387871925064e-08
/ O 0 1.311599717723766e-08
G O 0 2.2356472229034807e-08
polymorphism O 0 1.049456876955901e-08
in O 0 3.586601571292647e-10
the O 0 2.4592952119206757e-09
promotor O 0 5.7082816056208685e-05
region O 0 1.5967083299983642e-07
, O 0 5.589536611338985e-10
142 O 0 1.124503601346305e-08
bp O 0 2.096378182159242e-08
upstream O 0 7.2702630582455186e-09
from O 0 3.455575270372435e-10
the O 0 4.222552585364525e-10
transcriptional O 0 7.499172838265622e-09
initiation O 0 8.421388031365495e-09
site O 0 1.5258292407338558e-09
( O 0 4.044155288429607e-10
- O 0 1.0364990998823487e-07
142C O 0 6.0581260186154395e-06
/ O 0 5.5212304062024486e-08
G O 0 8.89001299242409e-08
) O 0 8.083051589169443e-11
, O 0 4.9860584411254294e-11
and O 0 2.7170536653908783e-11
2 O 0 1.2840777052769425e-10
) O 0 4.1158053527834415e-12
a O 0 4.860477992307821e-11
6 O 0 4.628412098028889e-10
bp O 0 3.478906607234933e-10
deletion O 0 2.4935378761803406e-10
polymorphism O 0 1.846873320943132e-09
in O 0 2.896949624631162e-10
the O 0 7.328370688064467e-10
3 O 0 6.19170759108556e-09
noncoding O 0 2.805960832574783e-07
part O 0 2.061165238487206e-09
of O 0 2.4352669214522393e-08
the O 0 3.2395046645206094e-08
CPO O 0 3.4189354209956946e-06
gene O 0 2.2161592561076304e-09
, O 0 3.5979205725844565e-10
574 O 0 1.2245990888004599e-08
bp O 0 1.9762511627163803e-08
downstream O 0 2.330178894283108e-08
of O 0 1.535425342424901e-09
the O 0 4.360647676282525e-10
last O 0 3.516016366944541e-10
base O 0 1.7566608168095854e-09
of O 0 5.15379294796503e-10
the O 0 2.3011410832385337e-10
normal O 0 1.8592906769754336e-08
termination O 0 9.189018435051821e-09
codon O 0 2.085419126274246e-08
( O 0 3.811332915937271e-10
+ O 0 2.2923689613207898e-08
574 O 0 2.0240202047716593e-07
delATTCTT O 0 2.5758004085219e-06
) O 0 4.59448079581648e-09
. O 0 1.480505744666516e-07

Five O 0 1.1363187013557763e-06
intragenic O 0 7.137938519008458e-05
dimorphisms O 0 1.4553245819115546e-05
are O 0 4.105045192659418e-10
now O 0 1.6430246052578923e-10
well O 0 1.1227772878097397e-10
characterized O 0 5.015763360205483e-10
and O 0 2.0954715393428636e-11
the O 0 1.117252887428144e-10
high O 0 4.737701897461477e-10
degree O 0 1.60928159687046e-08
of O 0 3.940247683686948e-09
allelic O 0 1.0590569843316189e-07
heterogeneity O 0 8.494794201396871e-08
in O 0 2.266162146824513e-09
HC B-Disease 1 0.9949618577957153
is O 0 1.7527049811505435e-09
demonstrated O 0 2.7951414516280693e-09
with O 0 1.1102018609987496e-11
seven O 0 2.11662076754493e-11
new O 0 1.2209065139087705e-13
different O 0 1.371192872787197e-12
mutations O 0 6.269896060673297e-12
making O 0 1.401572954917718e-11
a O 0 1.7827541526349577e-11
total O 0 3.4292854667050676e-10
of O 0 2.6600606162219265e-09
nineteen O 0 2.0653897081501782e-07
CPO O 0 2.9483592243195744e-06
gene B-Disease 0 5.019290583163638e-08
defects I-Disease 0 6.6185026526e-07
reported O 0 1.993821552304098e-09
so O 0 2.643399110713318e-10
far O 0 1.3346393989976946e-09
. O 0 1.450767062038949e-09
. O 0 6.62267112261361e-08

Coincidence O 0 3.732607638085028e-06
of O 0 3.892413857897736e-08
two O 0 6.926316742372762e-10
novel O 0 2.562671186367993e-10
arylsulfatase O 0 1.8604264084842725e-07
A O 0 4.4215209271669664e-09
alleles O 0 1.4384060609273774e-10
and O 0 3.0956498475731564e-10
mutation O 0 2.510657903798119e-09
459 O 0 1.4514015767019828e-08
+ O 0 1.206833246669703e-07
1G O 0 2.1447683593578404e-06
> O 0 3.4534636483840586e-08
A O 0 5.7870908065638105e-09
within O 0 1.0831952002021694e-09
a O 0 3.1928382160373303e-10
family O 0 1.1246381603768896e-09
with O 0 1.1197094806902896e-08
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.0992268206777567e-10
molecular O 0 1.2486872646988445e-09
basis O 0 4.76143879879487e-09
of O 0 3.874612186649529e-09
phenotypic O 0 2.238955119082675e-07
heterogeneity O 0 5.157160103408387e-06
. O 0 1.519428337815043e-06

In O 0 3.1830698077328634e-08
a O 0 2.6590714075069855e-09
family O 0 3.7573211209007695e-10
with O 0 2.6090157811964332e-11
three O 0 1.6394903490368762e-10
siblings O 0 9.010324930613933e-09
, O 0 3.957671430160348e-12
one O 0 1.3100046221403705e-12
developed O 0 1.2085316081211772e-10
classical O 0 1.3503330364983412e-07
late O 0 3.044527147721965e-05
infantile O 1 0.9999951124191284
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 8.467569045933487e-08
MLD B-Disease 1 1.0
) O 0 6.266673846511139e-10
, O 0 4.989026552992826e-11
fatal O 0 6.831525567463359e-09
at O 0 3.5177556423349188e-09
age O 0 4.577459300492137e-09
5 O 0 1.1683769229886565e-10
years O 0 4.009713047703478e-11
, O 0 1.080076349538328e-12
with O 0 5.852886317964101e-12
deficient O 0 2.3024217910005973e-07
arylsulfatase O 0 1.7542932255310006e-05
A O 0 2.881033651647158e-06
( O 0 6.339748725991967e-09
ARSA O 0 0.04254087060689926
) O 0 6.446239375623719e-11
activity O 0 1.2064593768457144e-09
and O 0 3.144967619661543e-11
increased O 0 5.1659503341738855e-09
galactosylsulfatide O 0 1.294537241847138e-06
( O 0 9.613199125624305e-09
GS O 1 0.7631115913391113
) O 0 1.5861008506590224e-08
excretion O 0 1.2401843605402973e-06
. O 0 2.2587525450035173e-07

The O 0 4.0152372093871236e-08
two O 0 5.985247297779495e-10
other O 0 9.780753984500734e-11
siblings O 0 7.492152676036312e-09
, O 0 2.7169292857176508e-11
apparently O 0 3.380033675171035e-08
healthy O 0 8.333793743986462e-07
at O 0 3.2723750820196074e-08
12 O 0 2.884766914235115e-08
( O 0 9.8644627188893e-11
1 O 0 6.782565620255809e-09
/ O 0 1.4924442126584836e-08
2 O 0 4.3137923788627575e-10
) O 0 5.075318203900947e-12
and O 0 9.245508872379737e-12
15 O 0 9.134628470297557e-11
years O 0 7.74619118848463e-11
, O 0 1.5243345865070812e-12
respectively O 0 1.4381261459472938e-10
, O 0 2.4213300635345103e-12
and O 0 1.1106588738984957e-12
their O 0 1.4292354626188608e-11
father O 0 9.867445527333985e-09
, O 0 1.449955711052553e-10
apparently O 0 1.7179729638883146e-08
healthy O 0 1.9788574334711484e-08
as O 0 5.20977982976234e-11
well O 0 1.6558666937616096e-10
, O 0 5.991274837358063e-11
presented O 0 5.285656357045809e-08
ARSA O 0 0.0015283463289961219
and O 0 9.521066601791972e-09
GS O 0 0.29975593090057373
values O 0 2.253283781783466e-09
within O 0 2.466970794312573e-10
the O 0 5.8103553218780135e-11
range O 0 2.3304356222553224e-09
of O 0 3.2347443834623846e-08
MLD B-Disease 1 1.0
patients O 0 4.5471279008779675e-06
. O 0 6.804388021919294e-07

Mutation O 0 2.377216468119059e-08
screening O 0 5.545311321242252e-09
and O 0 6.40725875133974e-11
sequence O 0 9.6881480615707e-10
analysis O 0 1.4834892203552386e-09
disclosed O 0 5.278379955342416e-09
the O 0 4.56039130070085e-11
involvement O 0 6.476612579575658e-09
of O 0 1.4483035881696082e-09
three O 0 1.8358618791847192e-10
different O 0 5.5782818364491504e-09
ARSA O 0 0.05207062140107155
mutations O 0 1.7108925387532281e-09
being O 0 3.0014429830416134e-10
the O 0 1.0198152738949418e-10
molecular O 0 2.2895798590383265e-09
basis O 0 1.6596247931488506e-08
of O 0 3.7046511636162904e-08
intrafamilial O 0 1.813812014006544e-05
phenotypic O 0 4.581065695674624e-06
heterogeneity O 0 1.970377707039006e-05
. O 0 4.230205377098173e-06

The O 0 8.178374599765448e-08
late O 0 2.815932248267927e-06
infantile O 0 0.0010673240758478642
patient O 0 4.858964985032799e-06
inherited O 0 0.0010784828336909413
from O 0 2.5751587529043718e-08
his O 0 6.731852408847772e-08
mother O 0 1.967792542245661e-07
the O 0 1.1132549104786449e-08
frequent O 0 3.9282190833489494e-09
0 O 0 5.999054586425245e-10
- O 0 4.17242107531024e-09
type O 0 4.3381187531110754e-09
mutation O 0 3.289827743557794e-09
459 O 0 5.2161088781588205e-09
+ O 0 7.233070142831366e-09
1G O 0 9.33087989096748e-08
> O 0 2.074650451433513e-09
A O 0 1.7375069161218448e-09
, O 0 5.122808427460157e-12
and O 0 3.386667248722608e-12
from O 0 2.6456625085158336e-11
his O 0 5.967510929849595e-10
father O 0 4.854500446072052e-08
a O 0 2.256749231932531e-10
novel O 0 2.5969166053685377e-11
, O 0 5.281755935393484e-12
single O 0 3.187465291709657e-10
basepair O 0 1.3177462676594587e-07
microdeletion O 0 2.593683916529699e-07
of O 0 1.4358171540607145e-08
guanine O 0 7.087601261446252e-08
at O 0 2.509677621276296e-08
nucleotide O 0 5.696895044593475e-08
7 O 0 1.3468998361076956e-08
in O 0 3.6813201376162397e-09
exon O 0 5.0226713455003846e-08
1 O 0 4.471030212727101e-09
( O 0 8.159420916697968e-10
7delG O 0 8.206326924664609e-07
) O 0 6.299417432131804e-09
. O 0 2.222069639401525e-07

The O 0 3.582270480251282e-08
two O 0 5.42447464724205e-09
clinically O 0 6.601946370210499e-05
unaffected O 0 3.858817478885612e-07
siblings O 0 4.409174803043925e-09
carried O 0 3.4834349293966227e-10
the O 0 2.265136828105696e-10
maternal O 0 5.265732383463728e-08
mutation O 0 3.6296010641478915e-09
459 O 0 9.710463544365666e-09
+ O 0 3.804030868082009e-08
1G O 0 3.918841002814588e-07
> O 0 1.7446740940840755e-08
A O 0 1.1492025997483779e-08
and O 0 9.928755040355952e-11
, O 0 7.582582131626658e-12
on O 0 3.4300166873446614e-11
their O 0 2.6917372844548204e-11
paternal O 0 7.280670288878355e-09
allele O 0 2.581816316293839e-09
, O 0 4.274590403863243e-11
a O 0 2.2446851669077894e-11
novel O 0 2.778485427845645e-11
cytosine O 0 3.2703395547173386e-09
to O 0 4.744538650847119e-10
thymidine O 0 2.709828379465762e-07
transition O 0 2.901653260778403e-06
at O 0 6.578544287094701e-08
nucleotide O 0 1.7772831029105873e-07
2435 O 0 4.386627097119344e-06
in O 0 5.327434937640874e-09
exon O 0 7.755885178539756e-08
8 O 0 2.4046731272875377e-09
, O 0 5.451124274191699e-11
resulting O 0 3.110582902365877e-10
in O 0 3.511048743409795e-11
substitution O 0 2.447521518789131e-09
of O 0 6.286358100737743e-09
alanine O 0 3.3758521311710865e-08
464 O 0 3.6723733387589164e-08
by O 0 5.703600258755159e-09
valine O 0 6.16492543485947e-05
( O 0 1.4439270223931544e-08
A464V O 0 4.1923849494196475e-05
) O 0 1.2264270488060447e-08
. O 0 2.0207684769957268e-07

The O 0 1.7543622732318909e-07
fathers O 0 2.1202892241944937e-07
genotype O 0 5.38130855431973e-08
thus O 0 2.3100970025780043e-08
was O 0 3.416454319449258e-07
7delG O 0 4.047651600558311e-05
/ O 0 9.644668898545206e-05
A464V O 0 0.00046962095075286925
. O 0 1.6271945924017928e-06

Mutation O 0 1.941006985362037e-06
A464V O 0 3.240628575440496e-05
was O 0 2.8563949427962143e-08
not O 0 1.93078594779017e-10
found O 0 1.7910199712201091e-10
in O 0 8.916355848098689e-11
18 O 0 1.3661598075032089e-08
unrelated O 0 3.369816795384395e-06
MLD B-Disease 1 1.0
patients O 0 3.0820910978945903e-07
and O 0 1.3246397312371982e-09
50 O 0 7.94194718878316e-08
controls O 0 5.162382308299129e-07
. O 0 3.593247583921766e-07

A464V O 0 0.0004600477695930749
, O 0 9.165423087154068e-09
although O 0 4.686546706267336e-09
clearly O 0 2.3191871534322672e-08
modifying O 0 5.017180342292704e-07
ARSA O 1 0.9853715300559998
and O 0 1.2988255093659973e-07
GS O 1 0.9999997615814209
levels O 0 2.5876951781356183e-07
, O 0 5.180686782346733e-11
apparently O 0 9.976787174181823e-10
bears O 0 1.1465134397425913e-09
little O 0 5.710553141469177e-10
significance O 0 1.5922013707481142e-09
for O 0 9.966093922342267e-11
clinical O 0 9.167769832174599e-08
manifestation O 0 1.768065658325213e-06
of O 0 5.5474679356848355e-06
MLD B-Disease 1 1.0
, O 0 3.323019726053644e-08
mimicking O 0 3.2561783314122295e-07
the O 0 2.6876678660414655e-08
frequent O 0 4.505854178660229e-07
ARSA O 0 0.0034510036930441856
pseudodeficiency O 0 6.127806409494951e-05
allele O 0 3.8034506815165514e-06
. O 0 1.2610520343514509e-06

Our O 0 4.037686096580728e-07
results O 0 6.876326175131453e-09
demonstrate O 0 3.5789158303600743e-09
that O 0 4.0146085240888585e-12
in O 0 4.76209436467423e-12
certain O 0 7.29162841217601e-11
genetic O 0 2.8982887201323138e-09
conditions O 0 6.821501870035718e-07
MLD B-Disease 1 1.0
- O 0 8.441454701824114e-05
like O 0 9.328065431191135e-09
ARSA O 1 0.8610560894012451
and O 0 7.154395298414329e-09
GS O 1 0.9786688089370728
values O 0 1.5376907525066486e-09
need O 0 1.3335242632361854e-10
not O 0 3.3286335927168453e-12
be O 0 1.646609584793346e-11
paralleled O 0 4.192044933404304e-09
by O 0 4.7067964109581695e-11
clinical O 0 9.529009048492298e-08
disease O 0 1.8652473343649945e-08
, O 0 1.733390687930214e-11
a O 0 4.6580513751726116e-11
finding O 0 3.105101065159488e-09
with O 0 9.570051001661639e-11
serious O 0 3.2227302426690585e-07
diagnostic O 0 2.8440272217267193e-06
and O 0 3.404666415462998e-08
prognostic O 0 8.308127689815592e-06
implications O 0 1.422349811264212e-07
. O 0 2.0537579814572382e-07

Moreover O 0 5.237463483354077e-06
, O 0 5.926848345438884e-09
further O 0 2.788768505013195e-08
ARSA O 0 9.537161531625316e-05
alleles O 0 3.6298917205357384e-09
functionally O 0 9.511213505675187e-08
similar O 0 3.025825701108431e-10
to O 0 2.3888921951709108e-09
A464V O 0 4.518864443525672e-06
might O 0 3.219144673050067e-10
exist O 0 1.469302457479671e-09
which O 0 6.861913381256413e-13
, O 0 1.5724911607215009e-12
together O 0 6.084324710720068e-11
with O 0 2.5914787676883932e-11
0 O 0 1.6188490548074697e-09
- O 0 1.518154491009227e-08
type O 0 1.352703407064837e-07
mutations O 0 2.5019880922627635e-07
, O 0 5.317382090197498e-10
may O 0 4.700350775266315e-09
cause O 0 1.0189723980147392e-06
pathological O 0 0.04665409028530121
ARSA O 1 0.9998769760131836
and O 0 1.2078257327630126e-07
GS O 1 0.9999995231628418
levels O 0 6.562277121702209e-08
, O 0 1.1206799377383447e-11
but O 0 1.407699369397608e-12
not O 0 3.017017191631055e-12
clinical O 0 1.640651725587361e-09
outbreak O 0 4.039329704053074e-10
of O 0 7.138388768979098e-10
the O 0 3.874996767905259e-09
disease O 0 6.259261340346711e-07
. O 0 1.2401739191147954e-08
. O 0 1.0918188309005927e-07

Human O 1 0.9469584822654724
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.989987313747406
to O 0 9.700513601273997e-07
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 4.024655481771333e-06
neurofibromatosis B-Disease 1 0.9999995231628418
type I-Disease 1 0.9646363854408264
1 I-Disease 0 0.015122855082154274
. O 0 1.1406431212890311e-06

Heterozygous O 0 9.839368431130424e-07
germ O 0 0.00011182186426594853
- O 0 1.1856752735184273e-06
line O 0 2.427508150049107e-08
mutations O 0 1.0907854619546242e-09
in O 0 6.658874146525662e-11
the O 0 3.630783174113361e-10
DNA O 0 6.56298016110668e-06
mismatch O 1 0.9989972710609436
repair O 0 0.020443156361579895
genes O 0 1.2553432959805377e-08
lead O 0 1.8015468228327336e-08
to O 0 8.827007036416035e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9781156182289124

The O 0 3.340165335430356e-07
disease O 0 5.20211006005411e-06
susceptibility O 0 6.2858575233804e-08
of O 0 2.515687391735355e-08
individuals O 0 1.0180088771960527e-08
who O 0 1.600807664203785e-08
constitutionally O 0 0.00015611106937285513
lack O 0 0.001048646168783307
both O 0 2.776236796009357e-09
wild O 0 2.126727682849605e-09
- O 0 1.4463574782297428e-09
type O 0 1.9085402147567265e-09
alleles O 0 4.5634043766007437e-10
is O 0 2.2694050805238675e-10
unknown O 0 3.0338188139467093e-07
. O 0 9.977576098663121e-08

We O 0 1.0155982721471446e-08
have O 0 1.026136554199697e-11
identified O 0 1.1866267690674448e-10
three O 0 9.585829525982081e-12
offspring O 0 1.040304301036521e-10
in O 0 1.9655719760147683e-11
a O 0 3.965634043368027e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9898080229759216
who O 0 2.9772479592793388e-08
developed O 0 5.624580808216706e-05
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.9999998807907104
at O 0 7.189883177716183e-08
a O 0 8.689100827741214e-11
very O 0 5.5341585480928046e-11
early O 0 1.0355160062758273e-09
age O 0 2.8750428704427122e-09
, O 0 3.491047511836043e-12
and O 0 3.273117454155594e-12
at O 0 5.877669184695122e-11
least O 0 3.729357968274005e-12
two O 0 1.5056592040860184e-12
of O 0 1.1282379544508281e-11
them O 0 5.2879250457549265e-12
displayed O 0 2.4539676957147094e-09
signs O 0 3.9911753901833436e-09
of O 0 3.076951315961196e-08
neurofibromatosis B-Disease 0 0.00023374905867967755
type I-Disease 0 1.084909740711737e-06
1 I-Disease 0 3.419844745167211e-07
( O 0 1.0972295960698375e-08
NF1 B-Disease 0 0.00014827073027845472
) O 0 1.3128862441647016e-08
. O 0 1.0560232510670176e-07

DNA O 0 1.370117814758487e-07
sequence O 0 1.6450917295074419e-09
analysis O 0 1.801744309304354e-10
and O 0 9.51565996137882e-12
allele O 0 1.6068353592135765e-10
- O 0 7.690147824090943e-11
specific O 0 2.4963255421117658e-11
amplification O 0 2.565974099866253e-09
in O 0 1.4839973000446705e-11
two O 0 6.171280153566272e-11
siblings O 0 9.354791608018331e-09
revealed O 0 5.03395725104383e-09
a O 0 3.4321057107433717e-10
homozygous O 0 2.0514983489761107e-08
MLH1 O 0 0.000313673255732283
mutation O 0 1.7665197304950198e-08
( O 0 1.2357389556072462e-09
C676T O 0 0.00039158054278232157
- O 0 0.0020168570335954428
- O 0 4.894274388789199e-05
> O 0 9.57764405029593e-06
Arg226Stop O 0 0.0006207278347574174
) O 0 3.2539320127256133e-09
. O 0 4.348625637362602e-08

Thus O 0 2.808835972700763e-07
, O 0 1.3033918389027122e-09
a O 0 1.371760038892944e-09
homozygous O 0 6.42159463382086e-08
germ O 0 0.0011867218418046832
- O 0 4.431090474099619e-06
line O 0 7.109649118319794e-07
MLH1 O 1 0.9999873638153076
mutation O 0 8.748548196990669e-08
and O 0 2.143391464315414e-09
consequent O 0 0.007456562481820583
mismatch O 1 1.0
repair O 1 1.0
deficiency O 0 0.0608835332095623
results O 0 3.6228179567388e-08
in O 0 3.7979078215677475e-10
a O 0 4.842316547737369e-10
mutator O 0 2.780496743071126e-06
phenotype O 0 6.395348695065195e-09
characterized O 0 7.376711463891183e-10
by O 0 2.378674479608378e-10
leukemia B-Disease 1 0.9999998807907104
and O 0 1.5554101082670968e-06
/ O 1 1.0
or O 0 0.400713175535202
lymphoma B-Disease 1 1.0
associated O 1 1.0
with O 0 4.67938334622886e-05
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9984013438224792
1 I-Disease 0 2.0993944417568855e-05
. O 0 1.1168832969588038e-08
. O 0 2.511262664484093e-08

Missense O 0 0.0003007112245541066
mutations O 0 5.927337198841087e-08
in O 0 9.012158797006009e-10
the O 0 5.894748023038687e-10
most O 0 2.8619311781552526e-11
ancient O 0 3.057106789938757e-09
residues O 0 1.4133007653072127e-08
of O 0 4.557248356462651e-09
the O 0 1.1352724982316431e-08
PAX6 O 0 0.0008581234142184258
paired O 0 2.4730559289309895e-07
domain O 0 8.51737809171027e-08
underlie O 0 5.990107183606597e-07
a O 0 5.736042751891546e-10
spectrum O 0 2.7164210791852383e-07
of O 0 3.4400827075842244e-07
human O 1 0.9999886751174927
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.999998927116394

Mutations O 0 2.5965348982026626e-07
of O 0 4.2047794579502806e-08
the O 0 7.396128598458063e-09
human O 0 7.028448578694224e-08
PAX6 O 1 0.9997004270553589
gene O 0 7.957843308759038e-07
underlie O 1 0.9999215602874756
aniridia B-Disease 1 1.0
( O 0 7.211527872641454e-07
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999364614486694
of I-Disease 0 0.005709931720048189
the I-Disease 0 8.6662723219888e-08
iris I-Disease 0 2.4106262230816355e-07
) O 0 2.3930638026747886e-10
, O 0 6.415231540435329e-11
a O 0 2.161309742287898e-10
rare O 0 1.1969976299042173e-07
dominant O 1 0.9999948740005493
malformation B-Disease 1 1.0
of I-Disease 1 0.9999076128005981
the I-Disease 1 0.9752615690231323
eye I-Disease 1 0.9999972581863403
. O 0 4.9041987949749455e-05

The O 0 5.328891106159972e-08
spectrum O 0 3.2222692425420973e-07
of O 0 4.0124653821749234e-08
PAX6 O 0 0.010111776180565357
mutations O 0 2.1243772962975527e-08
in O 0 2.837377666153884e-09
aniridia B-Disease 1 1.0
patients O 0 6.972635446800268e-08
is O 0 4.288718685740989e-11
highly O 0 2.8296813781025776e-09
biased O 0 6.5561569506655815e-09
, O 0 8.342749234502289e-12
with O 0 5.841833961017784e-12
92 O 0 1.0417408269347561e-08
% O 0 7.17338466404982e-10
of O 0 2.765194323517406e-11
all O 0 8.758080198567608e-12
reported O 0 6.392476131766855e-11
mutations O 0 3.383474611595716e-10
leading O 0 6.747722935962486e-10
to O 0 1.9151831509578443e-10
premature O 0 7.810441360334153e-08
truncation O 0 8.277450433524791e-06
of O 0 1.7440873989471584e-06
the O 0 2.1036646558059147e-07
protein O 0 3.5067174053438066e-08
( O 0 1.8987718342078352e-10
nonsense O 0 6.954850562124193e-08
, O 0 5.153023840964721e-11
splicing O 0 5.165969874099119e-09
, O 0 4.16618267662372e-11
insertions O 0 4.812642728779792e-09
and O 0 1.1400234228853279e-10
deletions O 0 1.2881651301199781e-09
) O 0 2.6113557496931783e-11
and O 0 3.8377470645833967e-10
just O 0 5.246741707765068e-09
2 O 0 5.512777345728637e-09
% O 0 1.2803754723123006e-09
leading O 0 3.552253283189977e-11
to O 0 1.7361957141068252e-12
substitution O 0 2.351872585570902e-10
of O 0 5.820318671467817e-10
one O 0 8.522923339304711e-11
amino O 0 5.321968421512224e-10
acid O 0 8.375534293891818e-11
by O 0 4.6723864360886935e-11
another O 0 4.919482043952428e-10
( O 0 1.2900092105638805e-09
missense O 0 3.030293328265543e-06
) O 0 5.482829301683978e-09
. O 0 2.8071650604033493e-07

The O 0 2.9427413394955693e-08
extraordinary O 0 3.1860462712529625e-08
conservation O 0 2.7146320746851416e-09
of O 0 1.2893819345549673e-09
the O 0 1.1740112215719023e-09
PAX6 O 0 3.141122579108924e-05
protein O 0 6.075273617511812e-09
at O 0 6.809991459633125e-10
the O 0 1.1078761241734014e-09
amino O 0 4.900195449408784e-08
acid O 0 6.246869332926508e-08
level O 0 2.14766646422504e-06
amongst O 0 3.9172678611976153e-07
vertebrates O 0 2.7021843607144547e-07
predicts O 0 8.399539730419292e-09
that O 0 1.7325189893835358e-10
pathological O 0 3.37482930490296e-07
missense O 0 2.564126816650969e-06
mutations O 0 5.8292988214248e-09
should O 0 5.712078032793499e-10
in O 0 2.880008731498407e-10
fact O 0 9.036135728557326e-10
be O 0 2.541312715820254e-10
common O 0 9.977015880124895e-10
even O 0 9.675252959917557e-11
though O 0 4.877900861011142e-11
they O 0 8.796636162544669e-12
are O 0 2.366139055520744e-11
hardly O 0 5.595598207008834e-09
ever O 0 6.765071614012186e-09
seen O 0 1.303579022504664e-08
in O 0 1.5564646460575204e-08
aniridia B-Disease 1 1.0
patients O 0 4.323782377468888e-06
. O 0 7.053917556731903e-07

This O 0 1.2891090417355144e-09
indicates O 0 2.6355919668930028e-09
that O 0 4.591337726678191e-12
there O 0 8.794623015950798e-12
is O 0 8.267470909262276e-13
a O 0 2.0240861070552896e-11
heavy O 0 2.201016258140953e-08
ascertainment O 0 0.00027493969537317753
bias O 0 5.301973615701172e-08
in O 0 2.4384666508225905e-10
the O 0 1.4073167631245553e-10
selection O 0 1.437731933506825e-09
of O 0 1.2712018104821254e-09
patients O 0 1.4444662133072939e-09
for O 0 3.103353130029518e-10
PAX6 O 0 2.1483023374457844e-05
mutation O 0 1.4898949851627208e-09
analysis O 0 3.3832942003542144e-10
and O 0 9.824912584888157e-12
that O 0 3.1604681979130467e-12
the O 0 4.2744949246831254e-10
missing O 0 2.582079332569265e-06
PAX6 O 1 0.9966625571250916
missense O 0 0.00034749635960906744
mutations O 0 1.8745996044344793e-07
frequently O 0 1.3480846661195756e-08
may O 0 3.495665268360426e-08
underlie O 0 1.1319230907247402e-05
phenotypes O 0 2.8222237347108603e-07
distinct O 0 8.381871197116197e-09
from O 0 2.4225544237310714e-08
textbook O 0 5.66151811653981e-06
aniridia B-Disease 1 0.9999992847442627
. O 0 4.496660039876588e-06

Here O 0 8.469215231343696e-07
we O 0 4.958484289829812e-09
present O 0 2.1307189346231326e-09
four O 0 3.3630276341511944e-10
novel O 0 5.636116573448646e-10
PAX6 O 0 8.453313967038412e-06
missense O 0 8.895345331438875e-07
mutations O 0 1.3457666092620002e-09
, O 0 1.30895363992245e-11
two O 0 1.2947234430404908e-11
in O 0 4.576005546708117e-11
association O 0 7.564268655890771e-11
with O 0 5.197591662620127e-11
atypical O 0 1.1219096762715708e-07
phenotypes O 0 1.8288444607605925e-06
ectopia B-Disease 0 0.0004459370975382626
pupillae I-Disease 0 4.3502848711796105e-05
( O 0 3.530619407943192e-10
displaced B-Disease 0 1.1155631973736035e-08
pupils I-Disease 0 4.369135808701685e-08
) O 0 1.8398834678023945e-09
and O 0 1.2479716815505526e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 0 0.0010212602792307734
( O 0 1.214469058652412e-08
searching B-Disease 0 5.217677608015947e-05
gaze I-Disease 0 8.309466466016602e-06
) O 0 2.2179889869189395e-10
, O 0 3.8905302590652724e-11
and O 0 1.0357441466990469e-11
two O 0 1.6617665576923457e-11
in O 0 3.140322030192877e-11
association O 0 8.123514361191297e-11
with O 0 2.223799790146419e-11
more O 0 2.3066033805196895e-10
recognizable O 0 6.691744829367963e-07
aniridia B-Disease 1 0.999984860420227
phenotypes O 0 6.91812329023378e-06
. O 0 1.2881237125839107e-06

Strikingly O 0 2.182065600209171e-06
, O 0 6.026797394476091e-10
all O 0 9.225432223702867e-11
four O 0 4.5531252379493736e-11
mutations O 0 3.5036033102509023e-11
are O 0 3.894849286839586e-12
located O 0 2.4310815513461925e-11
within O 0 2.34404440302427e-10
the O 0 1.1794449861213252e-09
PAX6 O 0 7.36060828785412e-05
paired O 0 1.576850081619341e-07
domain O 0 5.448180928624424e-08
and O 0 9.99732185924529e-10
affect O 0 5.355280663366102e-08
amino O 0 9.524698363350126e-09
acids O 0 1.3720209690593066e-10
which O 0 2.590138390226593e-12
are O 0 2.8066659239767144e-12
highly O 0 6.976833555327744e-10
conserved O 0 1.3856101821474454e-09
in O 0 6.519663281467913e-11
all O 0 2.2320660597596742e-10
known O 0 3.134885240285712e-09
paired O 0 2.7990381568088196e-07
domain O 0 5.899095754102746e-07
proteins O 0 3.992083819071013e-08
. O 0 1.6249602197149215e-07

Our O 0 3.204351344265888e-07
results O 0 6.947993291817056e-09
support O 0 1.4175871587696065e-09
the O 0 7.394851397890534e-11
hypothesis O 0 9.913313919751587e-11
that O 0 3.8468709419097954e-14
the O 0 5.531936670896687e-13
under O 0 1.0142402195878475e-10
- O 0 5.911231504285297e-10
representation O 0 9.200676331921898e-10
of O 0 4.688915922201886e-09
missense O 0 2.9566122066171374e-06
mutations O 0 2.567104750994531e-09
is O 0 1.6948652550863308e-11
caused O 0 2.75521383485966e-10
by O 0 1.327469245637758e-10
ascertainment O 0 0.00011624921171460301
bias O 0 3.81599960519452e-08
and O 0 2.256086567564708e-10
suggest O 0 1.990451137245941e-09
that O 0 3.0616420856888205e-12
a O 0 1.414010401823429e-11
substantial O 0 1.495965906705976e-09
burden O 0 8.912797966331709e-08
of O 0 2.1089797996864945e-07
PAX6 B-Disease 1 0.9999997615814209
- I-Disease 0 0.0006687545101158321
related I-Disease 0 0.0019855648279190063
disease I-Disease 1 0.6697918176651001
remains O 0 3.4613680099937483e-07
to O 0 2.7644153632877533e-10
be O 0 1.1621741347056513e-09
uncovered O 0 8.800805062492145e-07
. O 0 9.332870476441713e-09
. O 0 5.97012288494625e-08

The O 0 1.2982719965748402e-07
chromosomal O 0 5.131493594490166e-07
order O 0 2.1146899786828044e-09
of O 0 1.303112213690838e-07
genes O 0 7.18878609973217e-08
controlling O 0 2.0328414507275738e-07
the O 0 3.018830696532859e-08
major O 0 2.0209996876019432e-07
histocompatibility O 0 4.298743078834377e-05
complex O 0 7.247915618791012e-06
, O 0 2.2791752929407494e-09
properdin O 0 1.4691036085423548e-06
factor O 0 4.549102428086371e-09
B O 0 1.6812155934076145e-07
, O 0 2.7211935482718275e-10
and O 0 7.42459149716268e-10
deficiency B-Disease 0 4.567844734992832e-05
of I-Disease 0 8.728262059776171e-07
the I-Disease 0 3.69618149420603e-08
second I-Disease 0 5.6025747596777364e-08
component I-Disease 0 1.528979822751353e-07
of I-Disease 0 4.6564327504938774e-08
complement I-Disease 0 6.926203468538006e-07
. O 0 9.189229785988573e-07

The O 0 4.69530867519552e-08
relationship O 0 5.0983913979507633e-08
of O 0 1.4502891332313084e-08
the O 0 9.462043371044615e-10
genes O 0 4.2289199919665066e-10
coding O 0 2.147226751958442e-08
for O 0 5.47106075721171e-11
HLA O 0 1.7417541853248508e-09
to O 0 1.943005825677524e-11
those O 0 2.6665144051141176e-11
coding O 0 7.099494325757405e-08
for O 0 1.8119694633611516e-10
properdin O 0 1.3434724621674832e-07
Factor O 0 1.2823797579386564e-09
B O 0 1.020880802116153e-08
allotypes O 0 1.20322027896691e-07
and O 0 8.939293055787445e-11
for O 0 3.540586435146764e-10
deficiency B-Disease 0 3.248178245485178e-06
of I-Disease 0 3.603384470807214e-07
the I-Disease 0 8.273056018026637e-09
second I-Disease 0 2.176170355028262e-08
component I-Disease 0 3.103811963001135e-08
of I-Disease 0 5.493079413554369e-08
complement I-Disease 0 1.1915022213315751e-07
( O 0 2.5541964099318193e-09
C2 O 0 1.0931352107945713e-06
) O 0 5.7858707408486865e-11
was O 0 5.437554850828974e-10
studied O 0 2.1286634677153415e-09
in O 0 1.0202466475817129e-11
families O 0 2.4323942166004642e-11
of O 0 2.0036791670285936e-10
patients O 0 1.4639879530875533e-08
with O 0 3.4223170075620146e-08
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9999873638153076

Patients O 0 8.94430002063018e-07
were O 0 7.0108128191748165e-09
selected O 0 5.3432158697575e-10
because O 0 1.7221368428521622e-11
they O 0 5.013137908266296e-12
were O 0 7.309619576290061e-11
heterozygous O 0 2.6335805758392894e-10
or O 0 2.8710081534377707e-10
homozygous O 0 2.652341777320544e-07
for O 0 1.4761572856514249e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0026596463285386562

12 O 0 1.8466035101027956e-07
families O 0 2.8552931130576553e-09
with O 0 2.2934380783379282e-10
15 O 0 1.6294878335543217e-08
matings O 0 3.6520446883514524e-05
informative O 0 2.2263593564275652e-06
for O 0 4.768680241795664e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.947346613131231e-06
found O 0 5.8659967550056535e-08
. O 0 8.022654185424472e-08

Of O 0 1.1446607459220104e-05
57 O 0 1.7830083379521966e-05
informative O 0 9.693013680589502e-07
meioses O 0 2.5622034627303947e-06
, O 0 2.0673655842795569e-10
two O 0 4.277575862965399e-11
crossovers O 0 8.47691750127666e-10
were O 0 2.4279780963532005e-10
noted O 0 2.0764824582020225e-10
between O 0 6.157095722159056e-09
the O 0 3.191977384631173e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
gene O 0 7.774199617394117e-10
and O 0 1.3625672812267453e-10
the O 0 2.2390600484811785e-09
HLA O 0 1.0944417283553776e-07
- O 0 2.554748235183979e-08
B O 0 2.7144782421828495e-08
gene O 0 1.2906853363858772e-10
, O 0 5.0899471269738594e-12
with O 0 1.7389631401520944e-12
a O 0 2.291788460395683e-11
recombinant O 0 2.887758920877559e-10
fraction O 0 1.9812358420523424e-09
of O 0 2.629496176353996e-09
0 O 0 4.903942141254447e-09
. O 0 4.918079810067866e-08

035 O 0 0.007476018741726875
. O 0 2.7925489121116698e-05

A O 0 1.3408118775259936e-06
lod O 0 4.328234354034066e-06
score O 0 4.454221524952118e-08
of O 0 7.458034190221952e-09
13 O 0 1.139171978969955e-09
was O 0 3.568301210066238e-10
calculated O 0 4.052054247694059e-10
for O 0 2.119510261744395e-10
linkage O 0 3.741157115655369e-06
between O 0 5.141651490703225e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 5.0616495883559764e-08
HLA O 0 3.616104606862791e-07
- O 0 1.67822093999348e-08
B O 0 6.471821301090586e-09
at O 0 9.629742142580611e-11
a O 0 1.0007819226109937e-12
maximum O 0 5.7945150414018265e-12
likelihood O 0 5.136606764932772e-11
value O 0 2.977254554004105e-11
of O 0 1.6657524318230976e-11
the O 0 2.765194323517406e-11
recombinant O 0 3.253030345096164e-10
fraction O 0 1.840055441348909e-09
of O 0 4.487638705086283e-09
0 O 0 1.646250957776374e-08
. O 0 1.3475016658048844e-07

04 O 0 0.0010458356700837612
. O 0 3.7937341403448954e-05

18 O 0 2.1401535832410445e-07
families O 0 1.1426973811623498e-09
with O 0 9.863371230878215e-11
21 O 0 3.3780791497406426e-09
informative O 0 1.8384908040403047e-09
matings O 0 5.47022409591591e-08
for O 0 4.633331773806759e-10
both O 0 1.6164740657131915e-08
properdin O 0 2.219883754150942e-05
Factor O 0 1.2974179242064565e-07
B O 0 5.035049639445788e-07
allotype O 0 9.219259027304361e-07
and O 0 4.708327505653642e-09
HLA O 0 6.668759056083218e-07
- O 0 1.077003446425806e-07
B O 0 2.129542195916656e-07
were O 0 5.962826232774887e-09
found O 0 2.869137594174731e-09
. O 0 1.015410422411378e-08

Of O 0 9.485291229793802e-06
72 O 0 3.317001028335653e-05
informative O 0 8.004508913472819e-07
meioses O 0 1.4305161357697216e-06
, O 0 5.7947945053538064e-11
three O 0 5.616678996900326e-11
recombinants O 0 7.755974706924462e-08
were O 0 1.3659378073072048e-09
found O 0 1.2804994564685757e-10
, O 0 9.911833506737189e-12
giving O 0 5.2831988783808015e-11
a O 0 5.1723337418652093e-11
recombinant O 0 1.5776007167289663e-09
fraction O 0 7.714439753669922e-09
of O 0 2.8821437680903728e-08
0 O 0 2.8815170693974324e-08
. O 0 9.704412917699301e-08

042 O 0 0.005750797688961029
. O 0 3.682301758090034e-05

A O 0 6.5031808844651096e-06
lod O 0 1.5455148968612775e-05
score O 0 1.0257979710104337e-07
of O 0 3.2286667561720606e-08
16 O 0 6.899895765855035e-09
between O 0 1.2798097692723331e-08
HLA O 0 1.1449346004610561e-07
- O 0 2.0105911602286142e-08
B O 0 1.6753489262555377e-08
and O 0 2.2045894276789824e-10
Factor O 0 2.5193642727572296e-09
B O 0 7.854029426823672e-09
allotypes O 0 2.7998170892828966e-08
was O 0 6.082169212717758e-10
calculated O 0 4.573468548318971e-10
at O 0 4.382123483526179e-11
a O 0 2.7271871826800576e-12
maximum O 0 1.3343535998355804e-10
likelihood O 0 7.283347258635331e-10
value O 0 2.435450174864684e-10
of O 0 1.5727627533657085e-10
the O 0 8.99062491122038e-11
recombinant O 0 4.331749958730313e-10
fraction O 0 2.7235889099586075e-09
of O 0 7.56525775358341e-09
0 O 0 2.3140350080552707e-08
. O 0 1.568879071101037e-07

04 O 0 0.000850003445520997
. O 0 2.1676569303963333e-05

A O 0 5.815535928377358e-07
crossover O 0 8.011827645759695e-08
was O 0 1.1625539642068361e-08
shown O 0 1.2266323512477584e-09
to O 0 3.2425923057743944e-10
have O 0 4.065188463631131e-11
occurred O 0 1.661880055792153e-08
between O 0 8.262989736884663e-10
genes O 0 6.032739585659641e-11
for O 0 3.007653154307732e-11
Factor O 0 1.1104740460510243e-09
B O 0 5.4480113753641035e-09
and O 0 7.122802903047898e-10
HLA O 0 3.0049776000851125e-07
- O 0 4.4217935624146776e-07
D O 0 9.034161507770477e-08
, O 0 1.4860004893257894e-10
in O 0 4.956096644193053e-11
which O 0 1.3241861600288285e-11
HLA O 0 1.2601483412311154e-08
- O 0 1.2923051073698844e-08
D O 0 1.5805621700337724e-08
segregared O 0 1.2734876975173393e-07
with O 0 4.41605724210703e-10
HLA O 0 6.221637249836931e-07
- O 0 2.227670989896069e-07
A O 0 1.9472685153232305e-07
and O 0 8.0090281073808e-09
B O 0 7.3344567681488115e-06
. O 0 1.1422037715647093e-07

These O 0 1.0870267352913743e-08
studies O 0 3.1828921720489234e-09
suggest O 0 6.616882042287386e-10
that O 0 6.749115155635366e-13
the O 0 1.7198324361866746e-11
genes O 0 8.48259032459886e-11
for O 0 8.015775543324111e-11
Factor O 0 6.439194777385637e-08
B O 0 5.475987200043164e-05
and O 0 3.777870369958691e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.4365477696287599e-09
located O 0 7.058723605624095e-10
outside O 0 1.4873141607196771e-09
those O 0 3.5601077641445045e-11
for O 0 1.6527272606037258e-10
HLA O 0 4.396580521870419e-08
, O 0 4.006089557306858e-11
that O 0 1.1252758707475108e-12
the O 0 1.2926482800823536e-11
order O 0 7.08153743977924e-11
of O 0 3.3575686675391125e-09
genese O 0 3.629755553902214e-07
is O 0 3.3052982573167355e-10
HLA O 0 1.6553757475890052e-08
- O 0 1.2816247618729903e-08
A O 0 2.8893319736766898e-08
, O 0 1.991593140404646e-10
- O 0 3.548241034323496e-09
B O 0 1.4016257487980965e-08
, O 0 3.702217421519549e-10
- O 0 1.4677485893344056e-08
D O 0 1.6381758172201444e-08
, O 0 5.820849358073588e-11
Factor O 0 7.399613366487756e-09
B O 0 8.331632557201374e-07
allotype O 0 0.0006636520265601575
, O 0 5.565870537793671e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.3044630653435973e-10
that O 0 1.1138919647768475e-12
the O 0 7.096627452352067e-11
genes O 0 4.616802495860384e-09
coding O 0 0.04681913182139397
for O 0 3.7664020055672154e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.814704285787229e-08
Factor O 0 1.374434699386029e-08
B O 0 2.1393857352336454e-08
allotypes O 0 7.725368789124332e-08
are O 0 6.671952487019572e-12
approximately O 0 1.2730373179226095e-11
3 O 0 5.740384903529794e-11
- O 0 4.1381653659300355e-10
- O 0 5.671238478832663e-10
5 O 0 2.0615770202070394e-10
centimorgans O 0 3.2069891631181235e-08
from O 0 2.1423317286828336e-10
the O 0 4.5307252394266584e-10
HLA O 0 3.542981730220163e-08
- O 0 1.088973267115989e-08
A O 0 1.6242188038972927e-08
and O 0 3.3705618296409057e-09
HLA O 0 2.006026988965459e-06
- O 0 2.0580911552769976e-07
B O 0 3.5572554679674795e-08
loci O 0 1.3077297023045276e-09
, O 0 4.655944033093995e-12
and O 0 6.468031947710895e-13
that O 0 1.427719162512553e-13
the O 0 1.0991088247869207e-11
apparent O 0 6.6776539853208305e-09
lack O 0 1.1611714967330045e-07
of O 0 4.0279470425730324e-08
recombinants O 0 6.793509328417713e-06
between O 0 3.656282610009498e-09
the O 0 4.558054489400831e-10
Factor O 0 6.666620144812896e-09
B O 0 1.804491063239766e-07
gene O 0 7.595203754817703e-08
and O 0 1.6894380223675398e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.9633043635280956e-08
suggests O 0 3.309020002451035e-10
that O 0 4.4573462217208093e-13
these O 0 8.115081957110748e-13
two O 0 2.6831757302114845e-12
genes O 0 4.0974809656368905e-10
lie O 0 2.434162240660953e-07
in O 0 4.0408398849223204e-10
close O 0 5.402463187920148e-08
proximity O 0 5.1513218579657405e-08
to O 0 9.506054832186805e-10
one O 0 2.376326913022808e-09
another O 0 3.869975984116536e-08
. O 0 4.194374412236357e-07

Distribution O 0 7.451757824128435e-07
of O 0 2.8675094654317945e-07
emerin O 0 0.00020569394109770656
and O 0 1.1544642575245234e-08
lamins O 0 0.0003847625630442053
in O 0 1.0582321685603802e-09
the O 0 4.512538787082576e-09
heart O 0 1.1597387583606178e-06
and O 0 7.543295432732577e-10
implications O 0 3.969659712055318e-09
for O 0 1.3263083964432099e-09
Emery B-Disease 1 0.9890944361686707
- I-Disease 1 0.9999997615814209
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9669186472892761

Emerin O 0 0.0012746612774208188
is O 0 6.024030607676423e-09
a O 0 1.8425454495485383e-09
nuclear O 0 2.988684286719945e-07
membrane O 0 6.768598126427605e-08
protein O 0 4.799332486982166e-09
which O 0 3.743182847015802e-12
is O 0 1.5323489005458768e-11
missing O 0 1.3185275982152689e-08
or O 0 1.8288474901151375e-10
defective O 0 1.1751145478910985e-07
in O 0 3.3947304967085756e-09
Emery B-Disease 1 0.9830513000488281
- I-Disease 1 0.9999997615814209
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.36168211698532104
EDMD B-Disease 1 1.0
) O 0 8.435844023324535e-08
. O 0 1.1760877072219955e-07

It O 0 7.013216674067735e-10
is O 0 6.965780036116698e-11
one O 0 5.257776158895666e-11
member O 0 7.956434400213652e-10
of O 0 6.9890107035064375e-09
a O 0 3.96731358875968e-09
family O 0 3.479943666562235e-09
of O 0 4.309372627631092e-07
lamina O 1 0.9999997615814209
- O 0 0.00018147932132706046
associated O 0 5.243183522907202e-07
proteins O 0 2.2778268160550397e-10
which O 0 3.759668791569748e-12
includes O 0 5.068877956260209e-11
LAP1 O 0 7.008304237388074e-05
, O 0 6.127183205251185e-10
LAP2 O 0 0.14973919093608856
and O 0 2.9691213043747666e-08
lamin O 0 2.29721081268508e-05
B O 0 5.784373570349999e-06
receptor O 0 4.8123606433136956e-08
( O 0 2.1817227136011752e-08
LBR O 0 4.970092777512036e-05
) O 0 1.115846259835962e-08
. O 0 2.0072161532880273e-07

A O 0 1.2242498087289277e-05
panel O 0 1.4848438922854257e-07
of O 0 2.0920722931805358e-08
16 O 0 4.738264447468055e-09
monoclonal O 0 2.507971608167736e-10
antibodies O 0 9.190938288217154e-11
( O 0 8.823947822422795e-11
mAbs O 0 6.379877959261648e-08
) O 0 5.254507939866926e-11
has O 0 6.338106688791312e-12
been O 0 4.7001846859018315e-11
mapped O 0 9.325231697943082e-10
to O 0 3.06281770778849e-11
six O 0 9.36385066707679e-11
specific O 0 1.2141553040745379e-10
sites O 0 8.357023406624364e-11
throughout O 0 1.526288262443387e-10
the O 0 1.3767788298313377e-10
emerin O 0 2.4037799306597663e-08
molecule O 0 1.4018328164944194e-10
using O 0 7.384143296818024e-10
phage O 0 5.601556996026602e-09
- O 0 8.17805911879077e-09
displayed O 0 4.290964916719986e-09
peptide O 0 1.5165735334221608e-09
libraries O 0 2.5407698167612125e-10
and O 0 9.12034857358801e-12
has O 0 1.0462710342204473e-12
been O 0 8.172137445916494e-12
used O 0 1.0109356407550507e-10
to O 0 2.2774457875129883e-09
localize O 0 3.2963147532427683e-05
emerin O 0 0.0001692571968305856
in O 0 3.6242189249691137e-09
human O 0 4.160741085001973e-08
and O 0 5.913707212812369e-08
rabbit O 0 2.830298399203457e-06
heart O 0 0.00012554708519019186
. O 0 1.9050662558584008e-06

Several O 0 1.1920682396748816e-07
mAbs O 0 6.103209102548135e-07
against O 0 8.059717337971506e-10
different O 0 1.4472240073004627e-09
emerin O 0 9.465893526794389e-07
epitopes O 0 3.037648355075362e-08
did O 0 2.82274786878034e-10
not O 0 6.12407277666982e-11
recognize O 0 6.305280186857942e-10
intercalated O 0 4.052993318737208e-08
discs O 0 3.280171370079188e-07
in O 0 1.5879789150297086e-10
the O 0 4.6060433245287413e-10
heart O 0 1.8129189527371636e-07
, O 0 5.755558182829468e-11
though O 0 3.06827896423556e-11
they O 0 8.329965189846078e-12
recognized O 0 6.56958543121533e-10
cardiomyocyte O 0 1.5096945560344466e-07
nuclei O 0 2.0587579641073717e-08
strongly O 0 1.8406242086044244e-09
, O 0 1.2972874163796888e-10
both O 0 9.573907222559797e-10
at O 0 1.2456833786700372e-08
the O 0 1.4089889255330945e-08
rim O 0 8.57446096347303e-08
and O 0 4.1422873464647125e-10
in O 0 3.161642725402203e-09
intranuclear O 0 2.124371712852735e-05
spots O 0 7.979631391208386e-07
or O 0 3.059447450937114e-08
channels O 0 2.8379797640809556e-06
. O 0 2.6734397806649213e-07

A O 0 1.399188295181375e-05
polyclonal O 0 9.72502584772883e-06
rabbit O 0 1.296569735131925e-06
antiserum O 0 2.653365982041578e-06
against O 0 1.5452712887054076e-08
emerin O 0 6.356921949191019e-05
did O 0 5.1323127969737925e-09
recognize O 0 7.243700750336757e-09
both O 0 1.9926922334434494e-09
nuclear O 0 8.589634603595186e-08
membrane O 0 5.4147055728037685e-09
and O 0 6.114548450897317e-11
intercalated O 0 5.542170722350193e-09
discs O 0 1.7207211655545507e-08
but O 0 1.1148894307755342e-11
, O 0 4.2223126037188585e-13
after O 0 1.1979579654652905e-11
affinity O 0 7.082749317599557e-12
purification O 0 5.457972407363343e-10
against O 0 4.2498119606770857e-11
a O 0 2.1118673476649974e-10
pure O 0 2.5703602091198263e-07
- O 0 3.260674574789846e-08
emerin O 0 3.939371140404546e-07
band O 0 2.3507674029588088e-08
on O 0 1.1041360048480442e-09
a O 0 3.2563576835009655e-10
western O 0 7.419837633193538e-09
blot O 0 5.840876156071317e-07
, O 0 3.0678590223764957e-10
it O 0 3.951404828339555e-11
stained O 0 1.139933729632503e-07
only O 0 3.017917860059782e-10
the O 0 1.4104724055385987e-09
nuclear O 0 7.030378696981643e-07
membrane O 0 8.964402127276117e-07
. O 0 4.375415585400333e-07

These O 0 4.275956921873103e-09
results O 0 9.004977319371221e-10
would O 0 1.9499261580402383e-11
not O 0 3.807761397855991e-12
be O 0 1.7703961560644466e-11
expected O 0 3.274394921870538e-10
if O 0 2.6856769586025564e-10
immunostaining O 0 7.859785569053201e-07
at O 0 1.5829236810205316e-09
intercalated O 0 1.2169294016928234e-08
discs O 0 3.962679073765685e-08
were O 0 6.661164397847585e-10
due O 0 1.0825782048584642e-08
to O 0 7.769095783372038e-11
a O 0 1.0414478307518849e-10
product O 0 4.0157308034416417e-10
of O 0 7.262373480365625e-10
the O 0 1.7782052497139489e-09
emerin O 0 2.152768274754635e-06
gene O 0 6.800775498305711e-10
and O 0 1.434126983834716e-10
, O 0 1.2868377370633954e-11
therefore O 0 1.3844313195843228e-10
, O 0 1.1347166262165587e-11
cast O 0 2.1873247657566708e-10
some O 0 4.017795211114228e-12
doubt O 0 7.991796113770988e-10
upon O 0 2.2670602894958591e-10
the O 0 1.7527340689937887e-10
hypothesis O 0 5.248012691083659e-09
that O 0 7.76327474527605e-11
cardiac B-Disease 0 0.008337804116308689
defects I-Disease 0 0.00015410482592415065
in O 0 6.008071551377725e-08
EDMD B-Disease 1 1.0
are O 0 1.0443983455843409e-09
caused O 0 9.340896944820543e-10
by O 0 3.2164670232814885e-11
absence O 0 3.426693240271561e-08
of O 0 3.5939322629019443e-08
emerin O 0 1.6772768503869884e-05
from O 0 3.169402873481886e-08
intercalated O 0 1.4468073459283914e-06
discs O 0 7.179308795457473e-06
. O 0 5.450175422083703e-07

Although O 0 9.488778118793562e-07
emerin O 0 8.317926403833553e-05
was O 0 1.5347006865340518e-07
abundant O 0 5.709957395794163e-09
in O 0 6.028748333886114e-11
the O 0 6.237267924369405e-10
membranes O 0 3.057154884800184e-08
of O 0 2.2704464086586995e-08
cardiomyocyte O 0 1.9129711290588602e-06
nuclei O 0 5.411570214164385e-08
, O 0 1.5280331167044636e-10
it O 0 8.460513539754189e-12
was O 0 4.110837448223492e-09
absent O 0 1.405388871944524e-07
from O 0 7.113679090231528e-10
many O 0 2.5397911551650054e-10
non O 0 4.0341600993087923e-07
- O 0 2.3770903112563246e-07
myocyte O 0 4.871230339631438e-05
cells O 0 7.93371057739023e-08
in O 0 1.738475030599318e-09
the O 0 1.2227483026094887e-08
heart O 0 6.222495812835405e-06
. O 0 5.697470442100894e-07

This O 0 8.680954288742271e-10
distribution O 0 3.161793715733552e-09
of O 0 2.6671631569996634e-09
emerin O 0 2.7140126803715248e-06
was O 0 2.988135294756944e-09
similar O 0 2.840731989917078e-11
to O 0 2.4708308316023775e-11
that O 0 4.3497696763927785e-12
of O 0 2.4270210285948224e-09
lamin O 0 3.0367684189513966e-07
A O 0 2.3731889342570867e-08
, O 0 2.9275543794726744e-11
a O 0 4.72486702540742e-11
candidate O 0 2.0191295302396384e-09
gene O 0 1.8890404518412396e-10
for O 0 8.564870340732611e-11
an O 0 6.18164824883749e-11
autosomal O 0 2.2238300516619347e-06
form O 0 1.0381465926911915e-06
of O 1 0.9999953508377075
EDMD B-Disease 1 1.0
. O 0 0.0006976363947615027

In O 0 3.122766827345913e-07
contrast O 0 3.6176604112370114e-07
, O 0 3.1882649409453734e-08
lamin O 0 5.147710180608556e-05
B1 O 0 7.182915578596294e-05
was O 0 2.453267597957165e-07
absent O 0 1.2081603699698462e-06
from O 0 7.317158878805685e-09
cardiomyocyte O 0 5.820702426717617e-07
nuclei O 0 6.88271910576077e-08
, O 0 4.4868833648514794e-10
showing O 0 4.6781806872786547e-08
that O 0 1.699181684244877e-09
lamin O 0 1.0852847481146455e-05
B1 O 0 2.8204206046211766e-06
is O 0 4.9987423922370766e-11
not O 0 2.2074621644496695e-11
essential O 0 6.113365369486701e-09
for O 0 4.125374764019085e-10
localization O 0 6.245060649234802e-05
of O 0 2.4579114210609987e-07
emerin O 0 1.1079675459768623e-05
to O 0 3.480249199938612e-09
the O 0 1.1130808275083837e-08
nuclear O 0 3.894203018717235e-06
lamina O 1 0.7584934830665588
. O 0 3.8646617213089485e-06

Lamin O 1 0.9947764873504639
B1 O 0 0.0008051497279666364
is O 0 2.436129742378057e-09
also O 0 5.2981948689412306e-11
almost O 0 7.094911880223265e-10
completely O 0 7.661157042093691e-08
absent O 0 5.29360704604187e-07
from O 0 1.561406293149048e-08
skeletal O 0 0.037805791944265366
muscle O 0 1.9012800294149201e-06
nuclei O 0 2.7743815735448152e-05
. O 0 8.754172995395493e-06

In O 0 1.9952015009039314e-06
EDMD B-Disease 1 1.0
, O 0 1.353192446984508e-09
the O 0 1.2607120902785596e-10
additional O 0 3.4177866092832687e-10
absence O 0 1.0643967485179928e-08
of O 0 4.655198537761862e-08
lamin O 0 6.637049227720127e-05
B1 O 0 0.00013209815369918942
from O 0 3.106897850102541e-08
heart O 1 0.8242394328117371
and O 0 1.8000857835431816e-06
skeletal O 1 1.0
muscle O 0 0.37458696961402893
nuclei O 0 0.052080605179071426
which O 0 2.133887067046203e-09
already O 0 4.1617709278796156e-09
lack O 0 3.2533862395212054e-05
emerin O 0 2.964363739010878e-05
may O 0 3.99702410058822e-10
offer O 0 2.2708935426551946e-11
an O 0 8.717876680969239e-13
alternative O 0 5.758635790442668e-10
explanation O 0 9.827808566953422e-10
of O 0 1.5470398295747145e-09
why O 0 2.8037541177639014e-09
these O 0 6.068993640973019e-10
tissues O 0 5.6110657453700696e-08
are O 0 2.4232593709427874e-10
particularly O 0 3.080143917699729e-09
affected O 0 6.054336143535011e-09
. O 0 3.6699978611665074e-09
. O 0 7.376014110604956e-08

Genetic O 0 9.75127818492183e-07
mapping O 0 1.3204487459006486e-06
of O 0 6.170495225887862e-07
the O 0 1.6217986740230117e-06
copper B-Disease 0 0.0012511976528912783
toxicosis I-Disease 0 0.049010343849658966
locus O 0 3.6480713561104494e-08
in O 0 5.50592593739907e-09
Bedlington O 0 4.3875104893231764e-05
terriers O 0 3.1319996196543798e-06
to O 0 1.331588883601853e-08
dog O 0 5.722912419514614e-07
chromosome O 0 2.655338278145791e-07
10 O 0 9.583541071833679e-09
, O 0 6.385128537012008e-11
in O 0 6.409092007109152e-11
a O 0 4.324518243503661e-10
region O 0 3.10891380195244e-07
syntenic O 0 0.00016937278269324452
to O 0 1.7059036405697725e-09
human O 0 5.526263446853363e-09
chromosome O 0 9.593603067514778e-08
region O 0 9.725663403514773e-07
2p13 O 0 0.0009322761325165629
- O 0 8.546997378289234e-06
p16 O 0 5.133136255608406e-06
. O 0 2.891163148888154e-07

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9998112320899963
accumulation I-Disease 0 4.5426058932207525e-05
is O 0 3.5862596226010623e-10
recognized O 0 1.7119794470943361e-09
as O 0 1.7885108671844563e-10
an O 0 6.106976035979983e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 3.587022945339413e-07
man O 0 9.476262903262977e-07
, O 0 1.3913171725832285e-09
mouse O 0 2.709895738917112e-07
, O 0 1.2847795716197652e-08
rat O 0 2.1257945263641886e-05
and O 0 1.3300079615419236e-07
dog O 0 0.14895084500312805
. O 0 2.5029452444869094e-05

The O 0 1.2927739589940757e-07
major O 0 2.475156009040802e-07
cause O 0 1.7685511920717545e-05
of O 1 0.9998202919960022
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9996659755706787
in O 0 2.2903060781231943e-08
man O 0 9.503615672201704e-08
is O 0 1.5681618503737838e-10
a O 0 1.953319062053538e-09
dysfunctional O 0 3.875201400660444e-06
ATP7B O 1 0.9999969005584717
gene O 0 2.9298600878746583e-08
, O 0 5.486927578957079e-10
causing O 0 1.8586921157748293e-07
Wilson B-Disease 0 3.982485577580519e-05
disease I-Disease 0 5.143833186593838e-05
( O 0 5.240420541952062e-09
WD B-Disease 0 5.265121581032872e-05
) O 0 2.4722945912714067e-09
. O 0 5.626616328413547e-08

Mutations O 0 8.703831895218173e-07
in O 0 2.6951050280388245e-09
the O 0 9.567432179835578e-09
ATP7B O 1 0.9997608065605164
genes O 0 2.957871725328687e-09
have O 0 1.1297582661051742e-11
also O 0 1.5754091824485283e-12
been O 0 1.6361407020881735e-11
demonstrated O 0 7.948789404466083e-10
in O 0 5.216225784643314e-10
mouse O 0 3.757231681333906e-08
and O 0 2.4466363157671367e-08
rat O 0 2.0262759790057316e-05
. O 0 1.747060537127254e-06

The O 0 6.067807021281624e-07
ATP7B O 1 0.999542236328125
gene O 0 2.1318296461458885e-08
has O 0 6.419405285118529e-11
been O 0 2.1525675686362433e-10
excluded O 0 1.4880320309273998e-09
in O 0 4.4438196178386846e-11
the O 0 5.820585124993727e-10
much O 0 1.0985173659605607e-08
rarer O 0 6.505923010990955e-06
human O 0 1.5096301467565354e-05
copper B-Disease 1 0.9999634027481079
overload I-Disease 1 0.7627427577972412
disease O 0 3.931059472961351e-05
non B-Disease 0 3.588146000765846e-06
- I-Disease 0 1.1720501191803123e-07
Indian I-Disease 0 4.4291617484759627e-08
childhood I-Disease 0 1.789841553545557e-05
cirrhosis I-Disease 1 0.8750736117362976
, O 0 4.85388451654245e-10
indicating O 0 3.713883955924757e-08
genetic O 0 4.605643511013113e-08
heterogeneity O 0 5.693136131412757e-07
. O 0 2.734532529302669e-07

By O 0 9.103902520735119e-09
investigating O 0 8.634527404183245e-08
the O 0 6.939715468945451e-09
common O 0 7.507160262321122e-07
autosomal O 1 0.9999995231628418
recessive O 1 0.9999998807907104
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 4.600173753033232e-08
CT B-Disease 0 0.00019051320850849152
) O 0 1.3486317618216503e-09
in O 0 8.273339346942521e-09
Bedlington O 0 0.00034428638173267245
terriers O 0 3.774431206693407e-06
, O 0 1.9682815100008355e-10
we O 0 6.147642811482612e-11
have O 0 3.291737108584991e-12
identified O 0 1.087676892996825e-10
a O 0 6.520692406170037e-12
new O 0 3.7686000153858146e-12
locus O 0 2.377363861327808e-10
involved O 0 1.652315062550258e-09
in O 0 5.5629421069625096e-08
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0002043051936198026

We O 0 1.5090375171666892e-08
examined O 0 1.309280239780719e-08
whether O 0 1.713867103791955e-10
the O 0 3.11837056177211e-10
WD B-Disease 0 2.514659627195215e-06
gene O 0 1.2557983097849501e-08
ATP7B O 1 0.9964646100997925
was O 0 1.0914831705122197e-08
also O 0 2.3346642327726208e-11
causative O 0 7.783487188106619e-10
for O 0 7.83614076405037e-11
CT B-Disease 0 1.9597749201238912e-07
by O 0 2.4105725748846396e-10
investigating O 0 1.9705224119093145e-08
the O 0 5.9786562367492024e-09
chromosomal O 0 4.555479335976997e-06
co O 0 3.899101557180984e-07
- O 0 2.266470886524985e-07
localization O 0 0.07148823142051697
of O 0 8.332567631441634e-06
ATP7B O 1 0.9999985694885254
and O 0 4.821901766760561e-10
C04107 O 0 4.273056575243572e-08
, O 0 5.182796466302042e-13
using O 0 6.533253538859585e-12
fluorescence O 0 2.589490177840048e-09
in O 0 4.1843817299991315e-10
situ O 0 5.652107688547403e-07
hybridization O 0 3.254287506138098e-08
( O 0 5.817322179524353e-10
FISH O 0 1.4371629220022442e-07
) O 0 1.1165077751229546e-09
. O 0 4.309125856138962e-08

C04107 O 0 0.0005135142710059881
is O 0 4.44677494826351e-09
an O 0 2.5466695419140706e-10
anonymous O 0 1.6553473258795748e-08
microsatellite O 0 3.206910150765907e-07
marker O 0 1.0795454841172614e-07
closely O 0 1.0240621151069718e-07
linked O 0 3.2954740163404495e-06
to O 0 5.577145998358901e-07
CT B-Disease 1 0.9999538660049438
. O 0 2.4760112864896655e-05

However O 0 1.6824311614982435e-06
, O 0 3.900112943711065e-08
BAC O 0 3.987927266280167e-05
clones O 0 4.165783451526295e-08
containing O 0 3.391365188676332e-09
ATP7B O 0 7.422840280923992e-05
and O 0 1.728163390168902e-09
C04107 O 0 3.604560561143444e-06
mapped O 0 8.635598192086036e-08
to O 0 9.50047263081899e-10
the O 0 2.169078916480771e-09
canine O 0 1.322366358635918e-07
chromosome O 0 3.798093359819177e-07
regions O 0 3.9469375678891083e-07
CFA22q11 O 1 0.7770304679870605
and O 0 4.801468378445861e-08
CFA10q26 O 0 0.1628699004650116
, O 0 3.080518340414784e-10
respectively O 0 3.757710143048598e-09
, O 0 1.9480004415095564e-11
demonstrating O 0 4.124275143624345e-09
that O 0 7.296789561461736e-11
WD B-Disease 0 2.7424405857345846e-07
cannot O 0 1.896677259694002e-09
be O 0 8.307506349503058e-10
homologous O 0 3.067429332759275e-08
to O 0 6.371280392158951e-08
CT B-Disease 0 0.0007536346092820168
. O 0 2.436225031487993e-06

The O 0 1.4816387192695402e-06
copper O 0 3.1016279535833746e-06
transport O 0 3.329555227082892e-07
genes O 0 4.993870206249085e-08
CTR1 O 0 0.05334757640957832
and O 0 2.9067810380922765e-09
CTR2 O 1 0.9998461008071899
were O 0 1.548575845333744e-08
also O 0 2.1502027588993222e-11
excluded O 0 8.142164720226219e-10
as O 0 2.1216771395327072e-11
candidate O 0 1.0457718024881046e-09
genes O 0 3.0595903588448436e-10
for O 0 1.1403213789895617e-10
CT B-Disease 0 5.524091648112517e-06
since O 0 2.384958674994664e-09
they O 0 7.775782101537843e-11
both O 0 1.5953467713547553e-10
mapped O 0 2.0791041777101782e-08
to O 0 1.9426522612775443e-09
canine O 0 6.325257118078298e-07
chromosome O 0 3.2923201160883764e-06
region O 0 5.18664819537662e-05
CFA11q22 O 1 0.9993379712104797
. O 0 6.270604899327736e-06

2 O 0 8.38900996313896e-06
- O 0 1.2749688721669372e-05
22 O 0 5.101173314869811e-07
. O 0 3.724141492966737e-07

5 O 0 1.2668497220147401e-05
. O 0 3.108070814050734e-06

A O 0 4.7107462819440116e-07
transcribed O 0 1.4403049419797753e-07
sequence O 0 2.814829702657562e-09
identified O 0 3.6630813937676976e-09
from O 0 1.828024537298134e-10
the O 0 4.084871052523198e-10
C04107 O 0 1.8139287476515165e-06
- O 0 4.760666971748151e-09
containing O 0 5.439702022158599e-10
BAC O 0 4.6434674914053176e-06
was O 0 1.6066462604769072e-09
found O 0 5.0885521490906527e-11
to O 0 1.217844661921541e-11
be O 0 6.055438789287493e-11
homologous O 0 1.482013067821697e-09
to O 0 1.908888741519732e-10
a O 0 4.6104553508286017e-10
gene O 0 5.339904629586556e-10
expressed O 0 4.449572654774414e-10
from O 0 3.4591493558444597e-10
human O 0 5.397390867578622e-10
chromosome O 0 3.9089136372183475e-09
2p13 O 0 1.156425469162059e-06
- O 0 3.419270200311075e-08
p16 O 0 4.2339120653878126e-08
, O 0 2.4969065010038705e-11
a O 0 8.128536038709555e-11
region O 0 1.526551862696124e-08
devoid O 0 1.7027423382387497e-07
of O 0 2.0314716575597913e-09
any O 0 2.1074622047478897e-09
positional O 0 1.0751721220003674e-06
candidate O 0 7.418354925903259e-07
genes O 0 6.412084303519805e-07
. O 0 6.724268359903363e-07

Molecular O 0 6.507286087753528e-08
analysis O 0 7.052442629884581e-09
of O 0 2.732262638360794e-09
the O 0 2.863888903803513e-09
APC B-Disease 0 1.1476259942355682e-07
gene O 0 2.3574864282949193e-10
in O 0 7.702669752029934e-11
205 O 0 7.066860985283085e-10
families O 0 4.6334089343069707e-11
: O 0 6.026043813250892e-12
extended O 0 1.5575178924365218e-09
genotype O 0 6.113169348509473e-08
- O 0 4.326865976622685e-08
phenotype O 0 8.219876335147092e-09
correlations O 0 8.373881144052575e-09
in O 0 3.0226934844002074e-10
FAP B-Disease 0 1.861128673397161e-08
and O 0 4.5798913272943054e-11
evidence O 0 6.392321116877042e-10
for O 0 1.0238686634633787e-11
the O 0 3.713516993908428e-11
role O 0 1.0791575411062126e-09
of O 0 1.565673812820023e-08
APC B-Disease 0 7.498816785300733e-07
amino O 0 7.680410618604583e-08
acid O 0 2.38859279022563e-08
changes O 0 3.334995213322145e-08
in O 0 9.302044418291189e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.22991043329238892
. O 0 3.994241978944046e-06

BACKGROUND O 0 0.0533076673746109
/ O 0 2.5955323508242145e-06
AIMS O 0 2.724323451275268e-07
The O 0 1.2017535855335382e-09
development O 0 2.130269365352433e-07
of O 0 0.00015485251788049936
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.070678905065961e-09
a O 0 2.3314692190745667e-11
variable O 0 2.8162405740772556e-10
range O 0 4.2261866228798795e-10
of O 0 1.2361184298370631e-09
extracolonic O 0 5.459185103973141e-07
manifestations O 0 7.47077820051345e-07
in O 0 1.0770706921903184e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.347959420807456e-07
FAP B-Disease 0 7.813017646185472e-07
) O 0 3.0924145189015206e-11
is O 0 2.299449693154987e-12
the O 0 3.871651697157086e-12
result O 0 1.0202354933097624e-10
of O 0 4.8042392286618e-10
the O 0 5.245968659473021e-10
dominant O 0 1.6162218230419967e-07
inheritance O 0 1.0190442480961792e-06
of O 0 7.185868889791891e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 3.2590705245638674e-08
APC B-Disease 0 1.0192833315159078e-06
) O 0 3.0176894316724656e-09
gene O 0 2.4746643845219296e-08
mutations O 0 4.036884249103423e-08
. O 0 1.9613587198819005e-07

In O 0 3.597689257617276e-09
this O 0 1.476882227624543e-10
study O 0 7.097845228232202e-11
, O 0 1.3701967078311172e-12
direct O 0 1.1010139848444123e-11
mutation O 0 2.723289996287015e-11
analysis O 0 1.3548240307414972e-10
of O 0 1.5626769322985012e-10
the O 0 4.83604933876336e-10
APC B-Disease 0 1.9954470076299913e-08
gene O 0 1.7977418165227022e-10
was O 0 1.5585104318205367e-09
performed O 0 1.87365456483235e-09
to O 0 2.3292479056635784e-10
determine O 0 2.043055857825493e-08
genotype O 0 4.1887381030392135e-07
- O 0 4.677966458643823e-08
phenotype O 0 2.758175687844755e-09
correlations O 0 2.4060036185602485e-09
for O 0 4.689465829543771e-11
nine O 0 1.666145621470605e-08
extracolonic O 0 3.0845249057165347e-06
manifestations O 0 5.136399181537854e-07
and O 0 1.0845514486490515e-09
to O 0 5.300815342224041e-10
investigate O 0 1.765260115860201e-08
the O 0 4.045993762247235e-09
incidence O 0 6.581681191164535e-07
of O 0 9.484981688956395e-08
APC B-Disease 0 1.9635857029243198e-07
mutations O 0 3.6136165171285484e-09
in O 0 1.3049572089585126e-08
non O 1 0.9996322393417358
- O 1 0.9999997615814209
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.000552516314201057

METHODS O 0 1.7689981177682057e-05
The O 0 1.221347929458716e-07
APC B-Disease 0 4.052514839258947e-07
gene O 0 1.9532260253640743e-09
was O 0 4.914513684894928e-09
analysed O 0 2.6461611568606713e-08
in O 0 1.300599905551536e-10
190 O 0 1.2853820230418478e-09
unrelated O 0 1.108343816724755e-08
FAP B-Disease 0 1.953875283788875e-08
and O 0 1.7255900874868502e-10
15 O 0 1.3549208865981655e-08
non O 0 0.0005642995238304138
- O 1 0.9995691180229187
FAP O 1 0.9999974966049194
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.721279284718548e-08
using O 0 3.2177327469185e-10
denaturing O 0 1.9174738952187909e-07
gradient O 0 6.103939576007633e-09
gel O 0 2.2133047394845562e-08
electrophoresis O 0 1.6230606192380037e-08
, O 0 5.167580946485728e-11
the O 0 8.188821148946701e-11
protein O 0 1.9338966539272917e-10
truncation O 0 9.614225859877479e-09
test O 0 4.2187689452966026e-10
, O 0 1.589926974798761e-11
and O 0 1.5163318517474877e-11
direct O 0 1.762742618538482e-09
sequencing O 0 5.855437734680891e-07
. O 0 4.2817208623091574e-07

RESULTS O 0 2.6862387585424585e-06
Chain O 0 1.710054853276688e-08
terminating O 0 7.998952611387722e-09
signals O 0 7.3853301252313486e-09
were O 0 1.206030830758209e-10
only O 0 3.503501308510515e-12
identified O 0 1.3125719955375814e-10
in O 0 3.968071964760567e-12
patients O 0 1.5775576678311864e-10
belonging O 0 3.0698448227894914e-09
to O 0 2.4779112095529854e-10
the O 0 4.340684256476379e-09
FAP B-Disease 0 3.470537137673091e-07
group O 0 2.664624354498102e-10
( O 0 1.2394844872698485e-10
105 O 0 8.000206719316338e-08
patients O 0 3.4455879927008937e-08
) O 0 2.3094746115503995e-09
. O 0 8.730845024729206e-08

Amino O 0 2.1609344003081787e-06
acid O 0 9.046901006115604e-09
changes O 0 3.590345520887439e-10
were O 0 3.7552150278230556e-10
identified O 0 2.174247171193855e-10
in O 0 7.904814823544992e-12
four O 0 1.5114290027873345e-11
patients O 0 8.163464348953653e-11
, O 0 1.689609715159468e-12
three O 0 8.595566966529411e-12
of O 0 1.111597147662735e-09
whom O 0 2.1167652519693547e-08
belonged O 0 0.002992147346958518
to O 0 4.853923485370615e-09
the O 0 8.028226261558302e-08
non O 0 0.04781065136194229
- O 0 8.804173376120161e-06
FAP O 0 1.2172227798146196e-05
group O 0 9.997502559144777e-08
of O 1 0.9999939203262329
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999880790710449
. O 0 3.7176018850004766e-06

Genotype O 0 0.00021815595391672105
- O 0 1.4070685210754164e-05
phenotype O 0 2.2273482613854867e-07
correlations O 0 8.866508949267882e-08
identified O 0 1.0838012265423913e-08
significant O 0 4.271750508877403e-09
differences O 0 5.6684431370968014e-08
in O 0 1.217522471730348e-10
the O 0 2.2972075630622868e-10
nature O 0 1.3910756990753725e-09
of O 0 2.3646571367663682e-09
certain O 0 5.890952170517494e-09
extracolonic O 0 6.807920271967305e-06
manifestations O 0 1.9934655881570507e-07
in O 0 2.500025519935889e-09
FAP B-Disease 0 7.7885736970984e-08
patients O 0 6.098222482542326e-10
belonging O 0 4.181376134226866e-09
to O 0 1.6048781747990404e-10
three O 0 1.4035084205943349e-09
mutation O 0 1.9078422397456052e-08
subgroups O 0 1.5466341096725955e-07
. O 0 1.0716266274357622e-07

CONCLUSIONS O 0 4.785122200701153e-06
Extended O 0 3.0080971669121936e-07
genotype O 0 6.304937301138125e-07
- O 0 1.495416768193536e-07
phenotype O 0 8.885957747395423e-09
correlations O 0 1.0878937750646855e-08
made O 0 1.5659470942175346e-10
in O 0 4.423456392843583e-11
this O 0 1.9225534358957574e-11
study O 0 9.470217665619174e-11
may O 0 1.697997298322207e-11
have O 0 2.3912180829172014e-12
the O 0 1.1110852689288908e-11
potential O 0 6.388661127898487e-11
to O 0 2.5282722096453547e-11
determine O 0 8.840516763086725e-09
the O 0 1.4583353413755162e-09
most O 0 5.888272508469683e-11
appropriate O 0 2.951171307330469e-09
surveillance O 0 4.783342077985253e-08
and O 0 3.226533484834704e-10
prophylactic O 0 4.796891630576283e-07
treatment O 0 8.94558240815968e-08
regimens O 0 3.46340449652871e-08
for O 0 4.359256705610548e-11
those O 0 1.9343825152784433e-11
patients O 0 2.2952004880005816e-11
with O 0 1.4069020471199623e-12
mutations O 0 1.7777125604911959e-10
associated O 0 2.0663730726511176e-09
with O 0 1.0226630653420443e-10
life O 0 9.84364767475654e-09
threatening O 0 5.9556573006602775e-08
conditions O 0 0.00021425083104986697
. O 0 4.146108040004037e-06

This O 0 3.835378237226905e-09
study O 0 1.6563478366649065e-09
also O 0 9.23704775862566e-12
provided O 0 2.2538916913394935e-11
evidence O 0 5.100173061656221e-11
for O 0 5.106263502308028e-12
the O 0 1.7098182591990252e-10
pathological O 0 3.9827827436056396e-07
nature O 0 3.652637303730444e-09
of O 0 1.944669847375735e-08
amino O 0 1.3590129022134079e-08
acid O 0 1.4855534580249241e-09
changes O 0 7.000931084855111e-11
in O 0 1.339440780512291e-10
APC O 0 1.6929066148918537e-08
associated O 0 9.594002037260907e-09
with O 0 1.9858427402486e-10
both O 0 3.783550361902144e-09
FAP B-Disease 0 1.1927119203392067e-07
and O 0 4.078068993607076e-09
non O 1 0.9503511786460876
- O 1 0.9999994039535522
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.0001961755333468318
. O 0 1.5256466312507655e-08
. O 0 2.8615861680236776e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 3.798475881922059e-05
cancer B-Disease 1 0.8392393589019775
risk O 0 1.659731424297206e-06
of O 0 5.115993531035201e-07
the O 0 4.574341403440485e-07
APC O 0 1.7543301510158926e-05
I1307K O 0 8.972047362476587e-05
polymorphism O 0 2.9447792257997207e-06
. O 0 4.6363686578843044e-07

Germ O 1 0.7185811400413513
- O 0 4.0723458369029686e-05
line O 0 1.1545154166014981e-07
and O 0 2.3329884690781455e-09
somatic O 0 6.430572625504283e-07
truncating O 0 4.859002160628734e-07
mutations O 0 1.7638860372315435e-09
of O 0 2.485950778563506e-09
the O 0 8.314450239410576e-10
APC B-Disease 0 2.2557617995744295e-08
gene O 0 1.350159983815047e-10
are O 0 1.6424221357946855e-11
thought O 0 3.4644978552655914e-10
to O 0 4.520074037284161e-10
initiate O 0 3.5929226669395575e-06
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9995092153549194
formation O 1 0.5884048342704773
in O 0 9.646673424867913e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.021602356806397438
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 9.080580554154949e-08
respectively O 0 1.93522714653227e-06
. O 0 2.19994660710654e-07

Recently O 0 2.564662509030313e-07
, O 0 8.786869010179998e-10
an O 0 4.1785036541952536e-10
isoleucine O 0 0.00044550918391905725
- O 0 0.4657369554042816
- O 0 0.007202544715255499
> O 0 2.104801023961045e-05
lysine O 0 3.9488651282226783e-07
polymorphism O 0 2.932621967488558e-08
at O 0 3.601362097427341e-09
codon O 0 2.0353859042643307e-08
1307 O 0 1.2443896935110388e-07
( O 0 6.325963086695197e-10
I1307K O 0 9.678160495241173e-07
) O 0 8.867916817534294e-11
of O 0 1.4202774512028782e-09
the O 0 2.2924464548879087e-09
APC B-Disease 0 1.573114616348903e-07
gene O 0 9.998905037278405e-10
has O 0 9.844007553549972e-12
been O 0 5.7815356668822204e-11
identified O 0 3.306174778394677e-10
in O 0 3.385984201353942e-11
6 O 0 1.6434923422181669e-09
% O 0 1.5999949143363779e-09
- O 0 3.412777005440404e-10
7 O 0 7.798614531928649e-10
% O 0 3.2810090755397425e-10
of O 0 6.490356863064761e-11
the O 0 3.205958276630838e-10
Ashkenazi O 0 1.779200999862951e-07
Jewish O 0 1.608765920479982e-08
population O 0 2.2388850773324975e-09
. O 0 4.289338662033515e-08

To O 0 7.087195541544133e-08
assess O 0 6.243855636967055e-07
the O 0 6.179732281452743e-09
risk O 0 1.4062906394940455e-08
of O 0 1.5539659559138386e-09
this O 0 7.665501566833655e-11
common O 0 2.0247330478895265e-09
APC B-Disease 0 1.342686033467544e-07
allelic O 0 1.8636156084994582e-07
variant O 0 3.4384888181193674e-07
in O 0 2.544551023220265e-07
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 2.22735607735558e-08
we O 0 8.015044739018151e-10
have O 0 1.885806615031793e-11
analyzed O 0 7.825793346682985e-10
a O 0 1.6513429512698963e-11
large O 0 3.3015225969768025e-11
cohort O 0 4.04307787249536e-09
of O 0 6.7923271451775236e-09
unselected O 0 0.00011675444693537429
Ashkenazi O 0 3.0233393317757873e-06
Jewish O 0 1.2422624706687202e-07
subjects O 0 3.627302930908627e-06
with O 0 7.907104304649692e-09
adenomatous B-Disease 1 0.9429611563682556
polyps I-Disease 0 3.244747858843766e-06
and O 0 8.3090005986719e-09
. O 0 7.266688726303983e-07
or O 1 0.9999961853027344
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.3176879143372844e-08
for O 0 4.5572895457368645e-10
the O 0 2.3290370521067416e-08
APC O 0 1.2133389191149035e-06
I1307K O 0 1.099756445910316e-05
polymorphism O 0 1.0011276572186034e-06
. O 0 4.14448123819966e-07

The O 0 6.264791636567679e-07
APC O 0 1.4414774796023266e-06
I1307K O 0 2.666452928679064e-06
allele O 0 1.2173611452226396e-08
was O 0 8.662186523622495e-09
identified O 0 3.528002556762999e-09
in O 0 2.4198781867212915e-10
48 O 0 2.7527899959522983e-08
( O 0 5.057048529932828e-11
10 O 0 3.3212935179882663e-10
. O 0 2.3781244334886154e-11
1 O 0 2.7283345027662165e-10
% O 0 1.6701881544456398e-10
) O 0 1.980427974390686e-12
of O 0 2.622757844239487e-10
476 O 0 7.396413792548628e-08
patients O 0 1.3516664409962686e-07
. O 0 5.154575433152786e-07

Compared O 0 3.380143098752342e-08
with O 0 2.1358312687902448e-11
the O 0 2.2114825595775933e-11
frequency O 0 5.59210622252948e-10
in O 0 1.45660415153126e-12
two O 0 4.2460157026642797e-13
separate O 0 5.6223350627937485e-12
population O 0 4.4382756476078755e-13
control O 0 1.0895928256871024e-11
groups O 0 5.411907358886248e-13
, O 0 1.6935103493154191e-12
the O 0 9.807430562114305e-11
APC O 0 9.209235685148087e-08
I1307K O 0 2.9983937110955594e-07
allele O 0 3.4114056024492356e-09
is O 0 8.739691262360516e-12
associated O 0 3.336207421433812e-10
with O 0 7.294573799165871e-12
an O 0 7.329412250733913e-12
estimated O 0 2.395904585839048e-10
relative O 0 3.121938618733111e-08
risk O 0 9.148376278744763e-09
of O 0 2.8124645723437425e-08
1 O 0 8.226779186770727e-07
. O 0 5.720991680391307e-07

5 O 0 6.726604169671191e-06
- O 0 8.870500096236356e-06
1 O 0 3.516819049309561e-07
. O 0 3.107043369254825e-07

7 O 0 1.4862365560475155e-06
for O 0 3.224144222713221e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999923706054688
( O 0 2.0800680289312368e-08
both O 0 4.7962785743038694e-08
P O 0 2.6307467123842798e-05
= O 0 1.017205430997592e-08
. O 0 1.1117434750573807e-09
01 O 0 1.0850261844552733e-07
) O 0 4.713473500395082e-10
. O 0 1.4728581909650984e-08

Furthermore O 0 1.147721604866092e-06
, O 0 8.215107483167117e-10
compared O 0 2.5007789172803996e-09
with O 0 1.7243134697864093e-10
noncarriers O 0 3.0730739126738627e-06
, O 0 1.3979593038726534e-09
APC O 0 2.8897736115141015e-07
I1307K O 0 1.5457333120139083e-06
carriers O 0 7.275405833340187e-10
had O 0 3.14116233024464e-10
increased O 0 3.4733241283113614e-10
numbers O 0 1.3760804995488485e-10
of O 0 2.336591142793054e-09
adenomas B-Disease 0 7.709771307418123e-05
and O 0 5.928433779445186e-07
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 1 0.9999778270721436
patient O 1 0.9999891519546509
( O 0 5.024307192513788e-09
P O 0 8.260937647719402e-06
= O 0 1.9417518704045733e-09
. O 0 1.2441388197448333e-10
03 O 0 2.9160212022816268e-09
) O 0 3.2579574888585983e-12
, O 0 1.6574166084720732e-12
as O 0 1.0093296641186522e-12
well O 0 1.1730878421434277e-11
as O 0 7.990126789370056e-12
a O 0 5.1246385607273126e-11
younger O 0 1.5153135635159742e-08
age O 0 2.1817520234890253e-08
at O 0 2.2196630311555055e-08
diagnosis O 0 3.389324410818517e-05
. O 0 6.100974587752717e-07

We O 0 5.1931305478092327e-08
conclude O 0 2.3733073817311379e-07
that O 0 1.0586293647252276e-10
the O 0 1.2906391511080528e-09
APC O 0 2.849503744073445e-07
I1307K O 0 2.173475650124601e-06
variant O 0 4.343262460793085e-08
leads O 0 5.134359160052782e-09
to O 0 1.7770491744784067e-09
increased O 0 8.95708637926873e-07
adenoma B-Disease 1 1.0
formation O 1 0.9446108341217041
and O 0 5.795576996092677e-08
directly O 0 7.386024236666344e-08
contributes O 0 2.1332604571711045e-09
to O 0 2.6159832633432245e-10
3 O 0 2.796896048096187e-09
% O 0 3.809750737104878e-09
- O 0 3.4725158859494343e-10
4 O 0 2.5849192231142126e-10
% O 0 1.3874104642930263e-10
of O 0 7.019944348041207e-11
all O 0 3.276443838462484e-10
Ashkenazi O 0 3.279664815636352e-05
Jewish O 0 0.0008986149914562702
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.821010563522577e-05

The O 0 2.726324233037758e-08
estimated O 0 1.6528833413076427e-08
relative O 0 1.2545538652375399e-07
risk O 0 4.87849227681636e-09
for O 0 1.6886320119979814e-10
carriers O 0 5.766956356900721e-10
may O 0 3.6260150437783523e-10
justify O 0 4.768646366670737e-09
specific O 0 1.3689703537433928e-10
clinical O 0 9.47119715988265e-10
screening O 0 1.541198835219859e-10
for O 0 3.170516627015729e-11
the O 0 2.0523455157572812e-10
360 O 0 7.027454618224738e-09
, O 0 5.4270764965336227e-11
000 O 0 1.0665102578855112e-08
Americans O 0 2.7088636889160966e-10
expected O 0 5.186008289470578e-10
to O 0 2.6077284775993803e-10
harbor O 0 5.13249842626351e-09
this O 0 5.23280481445898e-11
allele O 0 3.318388452910881e-09
, O 0 7.999478163212004e-11
and O 0 3.414259847067669e-11
genetic O 0 5.727875951322403e-10
testing O 0 1.5389986507408082e-10
in O 0 5.5871860957235064e-12
the O 0 7.306827885800171e-12
setting O 0 2.200619408920801e-10
of O 0 2.7224916765433704e-10
long O 0 1.0458336419105763e-09
- O 0 3.1319686844000216e-09
term O 0 1.3285344380165043e-08
- O 0 4.6015142807220855e-09
outcome O 0 8.321339173278375e-09
studies O 0 1.9942285600649257e-09
may O 0 2.451013524085166e-11
impact O 0 4.3558515128161446e-10
significantly O 0 1.0959056773174325e-08
on O 0 3.29535623677657e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 0.001115403138101101
in O 0 1.642137953394851e-10
this O 0 5.622113191661171e-11
population O 0 2.7690488790810264e-10
. O 0 6.966544674469333e-09

Localization O 0 0.001523333601653576
of O 0 1.4508834738080623e-06
human O 0 3.6579942275238864e-07
BRCA1 O 0 1.0877276963583427e-06
and O 0 1.549482098184285e-09
its O 0 7.535109342038382e-11
loss O 0 1.5484037385604665e-09
in O 0 4.0268369194684794e-10
high O 0 1.50538657095467e-08
- O 0 3.6015888049689693e-09
grade O 0 1.6772961686228882e-08
, O 0 2.349433703141557e-10
non B-Disease 0 3.0679025257995818e-06
- I-Disease 0 0.0009209316340275109
inherited I-Disease 1 0.9999784231185913
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.31882670521736145

Although O 0 5.1698364700314414e-08
the O 0 3.79712750131489e-09
link O 0 3.2038467878692245e-08
between O 0 2.7348849851449586e-09
the O 0 6.002639274527155e-09
BRCA1 O 0 1.4938132153474726e-06
tumour B-Disease 1 1.0
- O 0 6.136826868896605e-07
suppressor O 0 6.369810279238663e-08
gene O 0 8.208090873651486e-10
and O 0 1.556157869231356e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 6.245011263672495e-08
established O 0 6.124254436912224e-09
, O 0 3.593966487261402e-12
the O 0 8.279120444765198e-12
role O 0 1.5078764625808816e-10
, O 0 4.599927643650359e-12
if O 0 4.7402004196839265e-12
any O 0 4.815392182222489e-11
, O 0 3.335365664214329e-11
of O 0 2.6521826956837913e-09
BRCA1 O 0 3.201330045499162e-08
in O 0 2.879850580228549e-09
non B-Disease 0 0.00041127315489575267
- I-Disease 0 0.028902539983391762
familial I-Disease 0 0.05096753314137459
cancers I-Disease 1 0.9999986886978149
is O 0 1.917166159159933e-08
unclear O 0 4.779320988745894e-06
. O 0 2.940049341759732e-07

BRCA1 O 0 0.0001468476839363575
mutations O 0 2.1472372679909313e-07
are O 0 8.493976633161537e-10
rare O 0 1.6129130253617063e-09
in O 0 6.152079956578405e-10
sporadic B-Disease 0 2.170952757296618e-05
cancers I-Disease 1 0.9998757839202881
, O 0 6.129404206411948e-10
but O 0 1.0067563449567274e-10
loss O 0 8.570336440527626e-09
of O 0 5.856722395947145e-07
BRCA1 O 0 2.416214783806936e-07
resulting O 0 2.8494079984398013e-08
from O 0 6.276159592033537e-10
reduced O 0 8.596264255977815e-10
expression O 0 2.52149273682889e-10
or O 0 3.001830728432964e-11
incorrect O 0 3.454166952465698e-09
subcellular O 0 2.1837509223132656e-07
localization O 0 7.798070100761834e-07
is O 0 2.15428425098807e-10
postulated O 0 3.8594034634797936e-09
to O 0 3.3693180190308425e-11
be O 0 7.95397220310079e-11
important O 0 4.2942216449404214e-10
in O 0 3.4606870147335655e-10
non B-Disease 0 4.527629062067717e-05
- I-Disease 0 0.16314595937728882
familial I-Disease 1 0.9999985694885254
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9999998807907104

Epigenetic O 0 0.0009681567316874862
loss O 0 5.1123142839060165e-06
, O 0 1.731918608527394e-09
however O 0 1.6915243650217349e-09
, O 0 2.029347176413232e-11
has O 0 4.2650008958561303e-13
not O 0 2.9084056669091696e-13
received O 0 1.363338044887974e-12
general O 0 3.1368619507476936e-11
acceptance O 0 9.168373282797404e-10
due O 0 7.914302102562942e-09
to O 0 2.047079450395728e-10
controversy O 0 9.479420581826048e-10
regarding O 0 4.736327996468503e-10
the O 0 4.948193521592259e-10
subcellular O 0 2.6260274808009854e-06
localization O 0 2.4636903617647476e-05
of O 0 7.082032880134648e-07
BRCA1 O 0 2.665720728600718e-07
proteins O 0 9.498534181417995e-10
, O 0 4.3343679340113184e-11
reports O 0 1.5097816052911384e-10
of O 0 1.2570743057604972e-10
which O 0 1.7633080325735184e-12
have O 0 4.105518876251768e-12
ranged O 0 2.0262820310534835e-09
from O 0 8.052107591804969e-11
exclusively O 0 1.5959168431223247e-09
nuclear O 0 2.461201731307483e-08
, O 0 5.975549222103638e-11
to O 0 1.270810817688428e-10
conditionally O 0 8.149750208019668e-09
nuclear O 0 6.748089020902626e-08
, O 0 1.2821148309694053e-10
to O 0 5.418370752074964e-10
the O 0 3.6439338657601184e-08
ER O 0 0.09363335371017456
/ O 0 5.0023204494209494e-06
golgi O 0 0.0013046544045209885
, O 0 1.7074922586957086e-09
to O 0 2.716538105573818e-09
cytoplasmic O 0 4.407218341384578e-07
invaginations O 0 9.37310414883541e-06
into O 0 2.951645505788747e-08
the O 0 3.539361159710097e-08
nucleus O 0 5.663855972670717e-06
. O 0 5.394070967668085e-07

In O 0 5.0375131621649416e-08
an O 0 9.43837674682868e-10
attempt O 0 9.401911427175946e-08
to O 0 9.390795696617715e-09
resolve O 0 7.051502961985534e-06
this O 0 6.945882757847244e-10
issue O 0 1.0925865767674736e-09
, O 0 1.458807033505316e-11
we O 0 2.3697613316109312e-11
have O 0 2.085288539066532e-11
comprehensively O 0 3.5130771181002274e-08
characterized O 0 3.4098248669067743e-09
19 O 0 9.966864666921538e-09
anti O 0 5.139956726907258e-08
- O 0 1.4636804053225205e-06
BRCA1 O 0 3.3271524557676457e-07
antibodies O 0 5.249764623016517e-09
. O 0 9.188110539071204e-08

These O 0 1.942949445776776e-08
reagents O 0 2.8039375266075695e-08
detect O 0 1.6965916671551895e-08
a O 0 2.1545321082783175e-09
220 O 0 1.370334672401441e-07
- O 0 9.72080442807055e-07
kD O 0 4.171626642346382e-06
protein O 0 3.4050557928821945e-08
localized O 0 2.282386901697464e-08
in O 0 2.0364557262730898e-10
discrete O 0 1.5655633234246125e-08
nuclear O 0 9.119060706552773e-08
foci O 0 2.562914005466155e-07
in O 0 4.73036942949534e-10
all O 0 3.951331761786747e-10
epithelial O 0 3.349524320128694e-07
cell O 0 1.0410000186311663e-06
lines O 0 4.837785727573873e-09
, O 0 4.8656235290822636e-12
including O 0 2.0420117419900352e-12
those O 0 1.1348593939586316e-11
derived O 0 4.16877776743263e-09
from O 0 2.1808865824368695e-08
breast B-Disease 0 1.7736148947733454e-05
malignancies I-Disease 0 0.0002239986788481474
. O 0 4.4662524487648625e-06

Immunohistochemical O 0 0.0010733359958976507
staining O 0 0.00010446365922689438
of O 0 2.749731265794253e-06
human O 0 6.883716650918359e-06
breast O 1 0.7850738167762756
specimens O 0 1.1642135859801783e-06
also O 0 8.370666937373983e-10
revealed O 0 4.699967703913899e-08
BRCA1 O 0 4.903112582610447e-08
nuclear O 0 1.457324572129437e-07
foci O 0 1.8871355678129476e-06
in O 0 4.514090434781792e-08
benign O 1 0.9997459053993225
breast O 1 0.9999960660934448
, O 0 4.615467332769185e-06
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.23067311942577362
low B-Disease 1 1.0
- I-Disease 1 0.9999938011169434
grade I-Disease 1 0.999998927116394
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.0010935105383396149

Conversely O 0 3.917285994248232e-06
, O 0 1.028744467390652e-08
BRCA1 O 0 1.0208403011802147e-07
expression O 0 1.3297640322207371e-08
was O 0 2.0372812770119708e-08
reduced O 0 5.266945102277987e-09
or O 0 2.2128635035478794e-10
undetectable O 0 8.431642051220933e-09
in O 0 1.806540507465204e-11
the O 0 6.915488320879959e-11
majority O 0 6.072707614546147e-11
of O 0 8.456811362300698e-10
high O 0 7.418567804506893e-08
- O 0 2.894330179969984e-07
grade O 0 4.787258149008267e-06
, O 0 4.555269228490033e-08
ductal B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 0 4.546456988663294e-09
suggesting O 0 7.418804681691427e-09
that O 0 1.5090524316252463e-11
absence O 0 5.9026522336580456e-08
of O 0 3.9143029084698355e-07
BRCA1 O 0 6.759095754205191e-07
may O 0 6.049150069742382e-10
contribute O 0 2.3526725012601446e-09
to O 0 5.320943130548983e-10
the O 0 2.9406694856959348e-09
pathogenesis O 0 2.9674922188860364e-05
of O 0 3.821476823873127e-08
a O 0 8.739633461374297e-10
significant O 0 2.3708353058538023e-09
percentage O 0 1.090842172146722e-08
of O 0 1.7747762148800916e-09
sporadic B-Disease 0 8.938879182096571e-05
breast I-Disease 1 0.7958564758300781
cancers I-Disease 1 0.9996083378791809
. O 0 8.7250322167165e-07
. O 0 1.583486664458178e-06

